Citrus Sinensis ID: 010680

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500----
Protein Sequence
MWRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH
Secondary Structure (PSIPRED)
ccccccccccccHHHHHHHHHHcccccccccccccEEEEEEEEccccccccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccccccccccEEEEEEEcccccHHHHHHHHHHccccccccccccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEcccccccccEEEccccccEEEEEEcccccEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccEEEEcccccccccccccccHHHHHcccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHcccHHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEHHHHHHHHHHHHHcccccccEEEccccEEEEEEEcccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccccccEEEEEEEccccHHHHHHHHHHHHHccccccEEEEEEEEccccccEEEEcccccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEcHHHEEEEEEEEcccccEEEEEEEcccEEEEEEEEcccccccccccHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHHccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mwrglrmyLCTRDYYIWLMIREIDPQLKSVlcrngnclfvqvhpvsdrnsavsslldsevpaqrqsihpppafgsspnlEALAIEAnnshnldgdnsvhanvqfsrpmheitfstddkpKLLSQLTALLADIGLNIqeahafstvdgysldvfvvdgwpyeETEQLRAALEKEVLKLErqgwpshrsssptsepedtgmkshpyhlkipndgtdvweidpkhlkfgskvasgsygdlyrgtycsqdvaikvlkperinsdMQKEFAQEVFIMRKVRHKNVVQFIgactkppslcivtefmsggsvYDYLHKLKGVFKLPSLLKVAIDVSkgmnylhqnnIIHRDLKAANLLMDENEVVKVADFGVARVKAqsgvmtaetgtyrwmapeviehkpydhkadvFSFGIVLWELLtgklpyeyltPLQAAVGVVqkglrptipknsqPKLAELLERCwqqdpalrpdFSEIIEILQQIAKEVGEENEerrkekssggflSVLRRGHH
Flexible Loop (DISEMBL)
MWRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLerqgwpshrsssptsepedtgmkSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLkperinsdMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVArvkaqsgvmtaetgtyrWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEvgeeneerrkekssggflsvlrrghh
Low Complexity Region (SEG)
MWRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKevgeeneerrkekssgGFLSVLRRGHH
Disordered region (IsUnstruct)
*WRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPV******************************************************************TF*****PKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALE**V*******************************LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI*******LAELLERCWQQDPALRPDFSEIIEILQQIA****************************
Disordered Region (DISOPRED)
**RG***YLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQV******************************FGSSPNLE**************************PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEE**************************************************TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG**TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL*************************VL*****
Disordered Region (DISEMBL)
MWRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE**********************SHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE***************GFLSVLRRGHH
Disordered Region (DISPRO)
*WRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVS******************************P**E*LAIEAN**************VQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE**********************SHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV*************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MWRGLRMYLCTRDYYIWLMIREIDPQLKSVLCRNGNCLFVQVHPVSDRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPxxxxxxxxxxxxxxxxxxxxxGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIxxxxxxxxxxxxxxxxxxxxxKSSGGFLSVLRRGHH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	504	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.527	0.682	0.450	4e-70
Q55GU0	916	Probable serine/threonine	yes	no	0.513	0.282	0.442	2e-64
Q54H46	642	Probable serine/threonine	no	no	0.545	0.428	0.423	4e-60
Q05609	821	Serine/threonine-protein	no	no	0.567	0.348	0.406	3e-59
Q54H45	690	Probable serine/threonine	no	no	0.517	0.378	0.426	8e-59
Q9FPR3	933	Serine/threonine-protein	no	no	0.533	0.288	0.419	4e-57
Q54TM7	1288	Probable serine/threonine	no	no	0.531	0.208	0.411	2e-55
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.525	0.163	0.407	5e-55
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.547	0.166	0.399	6e-55
P18161	1155	Dual specificity protein	no	no	0.509	0.222	0.395	9e-52

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  265 bits (678), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 122/271 (45%), Positives = 183/271 (67%), Gaps = 5/271 (1%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK----PERINSDMQKEFAQEVFI 271
           W  D   L  G+K ASG++  +YRG Y  + VA+K+++     E   + ++++F  EV +
Sbjct: 79  WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSK 330
           + ++ H N+VQFI AC KPP  CI+TE+MS G++  YL+K +     + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           GM YLH   +IHRDLK+ NLL+++   VKVADFG + ++ Q        GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           + KPY  K DV+SFGIVLWEL T  LP++ +TP+QAA  V +K  RP +P + QP LA L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318

Query: 451 LERCWQQDPALRPDFSEIIEILQQIAKEVGE 481
           ++RCW ++P+ RPDFS I+ +L++  + V E
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLEKYDECVKE 349

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  247 bits (630), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 115/260 (44%), Positives = 175/260 (67%), Gaps = 1/260 (0%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKV 275
           EI    LK  SK+  G++G +Y+G +    VAIK +K  E +N+ + +EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V  + ACT PP+LC +TE++ GGS+YD LH  K    +    K+AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           H + +IHRD+K+ NLL+DE+  VK+ DFG++++K++S  MT   G+  WM+PE++  + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835

Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
             K DV++FGI+LWEL TG+LPY  L  +Q A+ V  K LRP IP     +L+ L++ CW
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACW 895

Query: 456 QQDPALRPDFSEIIEILQQI 475
            QDP  RP F+EI+ +L +I
Sbjct: 896 HQDPLKRPSFTEILNLLNEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  232 bits (592), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 119/281 (42%), Positives = 175/281 (62%), Gaps = 6/281 (2%)

Query: 200 KSHPYHLKIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 256
           +S  Y+    ND T   D  +ID   +K G ++  G+YG++Y GT+    VA+K L    
Sbjct: 348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407

Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
           IN ++ KEF +E+ +M+ +RH NV+QF+G+C  PP +CI TE+M  GS+Y  LH      
Sbjct: 408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467

Query: 317 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
           +   L+K+ ID +KG+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   
Sbjct: 468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGAT 527

Query: 375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 434
           MTA  GT  W +PEV+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G
Sbjct: 528 MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREG 586

Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           +RP +P+N  PK  +LL  C  ++P+ RP   + +E L+ I
Sbjct: 587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  229 bits (585), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 122/300 (40%), Positives = 187/300 (62%), Gaps = 14/300 (4%)

Query: 191 TSEPEDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           +++ E   M + P    +PN        DG D+ +I    L    K+ +GS+G ++R  +
Sbjct: 512 SNQIEAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEW 570

Query: 243 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 302
              DVA+K+L  +  +++   EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S 
Sbjct: 571 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 630

Query: 303 GSVYDYLHKLKGVFKLPSL--LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 358
           GS+Y  LHK     +L     L +A DV+KGMNYLH  N  I+HRDLK+ NLL+D+   V
Sbjct: 631 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTV 690

Query: 359 KVADFGVARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
           KV DFG++R+KA + + + +  GT  WMAPEV+  +P + K+DV+SFG++LWEL T + P
Sbjct: 691 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 750

Query: 418 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           +  L P Q    V  K  R  IP+N  P++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 751 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  228 bits (581), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 114/267 (42%), Positives = 168/267 (62%), Gaps = 6/267 (2%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           DG D   ID + +K G ++  G++G++Y GT+    VA+K L    IN ++ KEF +E+ 
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +M+ +RH NV+QF+G+C   P +CI TE+M  GS+Y  LH  K       + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498

Query: 331 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           G+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   MTA  GT  W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           V+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G+RP  PK   PK  
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617

Query: 449 ELLERCWQQDPALRPDFSEIIEILQQI 475
           +LL+ C  ++P+ RP   + +EIL+ I
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  223 bits (567), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 115/274 (41%), Positives = 167/274 (60%), Gaps = 5/274 (1%)

Query: 211 DGTDV--WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 268
           D  DV   EI    L    ++  GSYG++Y   +   +VA+K    +  +     EF  E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V IMR++RH NVV F+GA T+PP+L IVTEF+  GS+Y  LH+ K        +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774

Query: 329 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-GTYRWM 385
           + GMN LH +   I+HRDLK  NLL+D N  VKV DFG++R+K  + + +  T GT  WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           APEV+ ++P + K DV+SFG++LWEL T +LP+  + P+Q    V  +  R  IPK   P
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 479
            +  ++  CWQ DP LRP F+++ E+L+ + + V
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLV 928

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  217 bits (552), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 112/272 (41%), Positives = 167/272 (61%), Gaps = 4/272 (1%)

Query: 216  WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
            WE+    +  G+++  G YG ++RG++   +VA+K+L  + +N  +  +  +EV ++ K+
Sbjct: 844  WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903

Query: 276  RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            RH N+V F+GACT+P S CIVTE++S GS+ + L            L++  D ++GM YL
Sbjct: 904  RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963

Query: 336  HQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
            H  N  IIHRDLK  NLL+D++  VKVADFG+A VK+ +   T   GT  W+APEV+  +
Sbjct: 964  HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022

Query: 394  PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
             Y  KADV+S+ IVLWELLT  +PY     +Q  V  + +G R  +P    PK A L+ R
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMPAWCPPKYAALMNR 1081

Query: 454  CWQQDPALRPDFSEIIEILQQIAKEVGEENEE 485
            CW+ DP  RP F EI+ I++ +  E  +E +E
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMISEFQKEKKE 1113

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  216 bits (549), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 113/277 (40%), Positives = 173/277 (62%), Gaps = 12/277 (4%)

Query: 210  NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
            N   + WEID   L+ G  + +G YG++Y+  +   +VA+K++  + ++ DM++ F +EV
Sbjct: 773  NTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEV 832

Query: 270  FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AID 327
             IM  +RH NVV F+ A TK P++CIV EFMS GS+YD L   + + ++P  LK+  A  
Sbjct: 833  KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGN-ELIPEIPYALKIKMAYQ 891

Query: 328  VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE---TGTYRW 384
             SKGM++LH + I+HRDLK+ NLL+D    VKV+DFG+ +VK++           GT  W
Sbjct: 892  ASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHW 951

Query: 385  MAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
            +APE++ +    D+  ADV+SFGI+LWELLT + PY+ +TP   AV V++ G+RP I   
Sbjct: 952  IAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPPISDE 1011

Query: 443  S----QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +      +  +L+++CW  D  +RP F EI+  L  I
Sbjct: 1012 AVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRLSNI 1048

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  215 bits (548), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 115/288 (39%), Positives = 178/288 (61%), Gaps = 12/288 (4%)

Query: 204  YHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INSDMQ 262
            + L+     +D WEID   L+ G ++ +G++G++++GT+   +VA+K++ P++ I  D++
Sbjct: 767  FSLRFRKGISDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIE 826

Query: 263  KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
            + F  EV +M  +RH NVV F+ A TKPP +CIV EFM+ GS++D L K + +  +P  L
Sbjct: 827  RNFKDEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFAL 885

Query: 323  KVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-- 378
            KV I    SKGM++LH + I HRDLK+ NLL+D    VKV+DFG+ + K+    +  E  
Sbjct: 886  KVKIAYQASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKF 945

Query: 379  TGTYRWMAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
             GT +W APE++ E +  D+  +DV+SFGI++WEL+T   PY  ++P   AV V++   R
Sbjct: 946  AGTIQWTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYR 1005

Query: 437  PTIPKNSQ----PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 480
            P I    +    P+  ELL  CW  DP +RP F EI+  L  +  + G
Sbjct: 1006 PVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMGDSG 1053

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2

 Score =  204 bits (520), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 106/268 (39%), Positives = 164/268 (61%), Gaps = 11/268 (4%)

Query: 218  IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
            ID   ++F  KV  G++ +++ G +    VAIK LK        ++ F +EV  ++K  H
Sbjct: 848  IDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKGNH 907

Query: 278  KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGM 332
            +N+V FIGAC KP   CI+TE+M+GGS+Y+ LH       K  +  P +LK+A D++ G+
Sbjct: 908  QNIVMFIGACYKPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGL 965

Query: 333  NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEV 389
             +LH   I+HRDL + N+L+DE   +K++DFG++R K++ G MT   G     RW  PE+
Sbjct: 966  LHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPEL 1025

Query: 390  IEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
             ++   Y  K DV+ F +V+WE+LTG++P+  L   QA+  V   GLRP IP+   P+L 
Sbjct: 1026 TKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIPEYCDPELK 1085

Query: 449  ELLERCWQQDPALRPDFSEIIEILQQIA 476
             LL +CW+ DP  RP F+ I+  L++I+
Sbjct: 1086 LLLTQCWEADPNDRPPFTYIVNKLKEIS 1113

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	504
297744550	580	unnamed protein product [Vitis vinifera]	0.922	0.801	0.825	0.0
359474826	1515	PREDICTED: uncharacterized mscS family p	0.920	0.306	0.811	0.0
449454245	573	PREDICTED: protein-tyrosine kinase 2-bet	0.920	0.809	0.801	0.0
283132359	578	ACT-domain-containing protein kinase [Lo	0.920	0.802	0.781	0.0
255560441	558	protein kinase, putative [Ricinus commun	0.880	0.795	0.800	0.0
356574129	581	PREDICTED: uncharacterized protein LOC10	0.912	0.791	0.765	0.0
224286063	594	unknown [Picea sitchensis]	0.865	0.734	0.794	0.0
378750734	547	serine threonine protein kinase [Piper c	0.918	0.846	0.723	0.0
18420244	575	ACT-like protein tyrosine kinase family	0.916	0.803	0.756	0.0
357444821	771	Protein kinase like protein [Medicago tr	0.873	0.570	0.757	0.0

>gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera]

 Score =  806 bits (2081), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/480 (82%), Positives = 429/480 (89%), Gaps = 15/480 (3%)

Query: 39  FVQVHPVSDR-NSAVSSLLDSEVP-----------AQRQSIHPPPAFGSSPNLEALAIEA 86
            VQVHP+SD  +  ++  + S  P           + +QSI PPPAFGSSPNLEALAIEA
Sbjct: 102 LVQVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEA 161

Query: 87  NNSH--NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST 144
           NNSH  + DGD+SVHA+ Q+SRPMHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFST
Sbjct: 162 NNSHVQDGDGDDSVHASSQYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFST 221

Query: 145 VDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPY 204
           VDGYSLDVFVVDGWPYEETEQLR ALEKEV K+E+Q WP+H S SPT E E+TG+K    
Sbjct: 222 VDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESD 281

Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
            + IPNDGTDVWEID + LKF +KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKE
Sbjct: 282 FVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKE 341

Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
           FAQEVFIMRKVRHKNVVQFIGACT+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV
Sbjct: 342 FAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKV 401

Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 384
           +IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW
Sbjct: 402 SIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 461

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT+PKN+ 
Sbjct: 462 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPKNTH 521

Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 504
           PKLAELLERCWQQDP LRPDFSEIIEILQQIAKEVG+E E+RRKEKSS GFLSVLRRGHH
Sbjct: 522 PKLAELLERCWQQDPTLRPDFSEIIEILQQIAKEVGDE-EDRRKEKSSSGFLSVLRRGHH 580

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera]

 Score =  790 bits (2039), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/482 (81%), Positives = 427/482 (88%), Gaps = 18/482 (3%)

Query: 36  NCLFVQVHPVSDR-NSAVSSLLDSEVP-----------AQRQSIHPPPAFGSSPNLEALA 83
           N + + VHP+SD  +  ++  + S  P           + +QSI PPPAFGSSPNLEALA
Sbjct: 128 NIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALA 187

Query: 84  IEANNSH--NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHA 141
           IEANNSH  + DGD+SVHA+   S+PMHEITFS+DDKPKLLSQLT LL+++ LNIQEAHA
Sbjct: 188 IEANNSHVQDGDGDDSVHAS---SQPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHA 244

Query: 142 FSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKS 201
           FSTVDGYSLDVFVVDGWPYEETEQLR ALEKEV K+E+Q WP+H S SPT E E+TG+K 
Sbjct: 245 FSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKC 304

Query: 202 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDM 261
               + IPNDGTDVWEID + LKF +KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDM
Sbjct: 305 ESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDM 364

Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 321
           QKEFAQEVFIMRKVRHKNVVQFIGACT+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+L
Sbjct: 365 QKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPAL 424

Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
           LKV+IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT
Sbjct: 425 LKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 484

Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT+PK
Sbjct: 485 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPK 544

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRR 501
           N+ PKLAELLERCWQQDP LRPDFSEIIEILQQIAKEVG+E E+RRKEKSS GFLSVLRR
Sbjct: 545 NTHPKLAELLERCWQQDPTLRPDFSEIIEILQQIAKEVGDE-EDRRKEKSSSGFLSVLRR 603

Query: 502 GH 503
           G+
Sbjct: 604 GY 605

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus]

 Score =  778 bits (2008), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/474 (80%), Positives = 416/474 (87%), Gaps = 10/474 (2%)

Query: 39  FVQVHPVSDRNSA--------VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSH 90
            VQV  VSD +SA          +  +S     RQS+HPPPAFGSSPNLEALA+EANN+ 
Sbjct: 102 LVQVQAVSDEHSADFADSCPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQ 161

Query: 91  NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSL 150
           +L+ D SVHA  QF RPMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSL
Sbjct: 162 DLEVDQSVHARTQFFRPMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSL 221

Query: 151 DVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPN 210
           DVFVVDGWPYEETE+L+ ALE EVL +ER+GWP+ +SSSP  E + T  K     ++IP 
Sbjct: 222 DVFVVDGWPYEETERLKTALESEVLLVERRGWPNQKSSSPVGELDITA-KCESDRVEIPT 280

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           DGTDVWEI+P+HLKF  KVASGSYGDLY+GTYCSQ+VAIKVLK ER+N+DMQ EFAQEV+
Sbjct: 281 DGTDVWEINPRHLKFEHKVASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVY 340

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK KG F+LPSLLKVAIDVSK
Sbjct: 341 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSK 400

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI
Sbjct: 401 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 460

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           EHKPYDHKADVFSFGIVLWELLTGKLPYE+LTPLQAAVGVVQKGLRPT+PK++ PKLA+L
Sbjct: 461 EHKPYDHKADVFSFGIVLWELLTGKLPYEFLTPLQAAVGVVQKGLRPTMPKHTNPKLADL 520

Query: 451 LERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 504
           LE+CWQQDP+ RPDF EII+IL QI KEV EE E+RRKEK SGGFLSVLRR HH
Sbjct: 521 LEKCWQQDPSCRPDFCEIIDILLQITKEVAEEGEDRRKEK-SGGFLSVLRRNHH 573

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus]

 Score =  760 bits (1963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/475 (78%), Positives = 413/475 (86%), Gaps = 11/475 (2%)

Query: 39  FVQVHPVSDRNSAVSSLLDS---------EVPAQRQSIHPPPAFGSSPNLEALAIEANNS 89
            VQVHP SD NSA S   DS            + RQSIHPPPAFGSSPNLEALA+E NNS
Sbjct: 106 LVQVHPTSDGNSADSFHSDSPGTESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNS 165

Query: 90  HNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 149
            ++D + SVHA+VQ+SRPMHEITFST+DKPKLLSQLTALLA+IGLNIQEAHAFST DGYS
Sbjct: 166 EDID-ERSVHASVQYSRPMHEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYS 224

Query: 150 LDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP 209
           LDVFVVDGWPYEETE+L+ ALEKE+LK+ERQ   + +S S   EP+   MK    HL IP
Sbjct: 225 LDVFVVDGWPYEETEKLKVALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIP 284

Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           NDGTDVWEID KHL +G+++ASGSYG+L++GTYCSQ+VAIKVLK E +N++MQ+EF QEV
Sbjct: 285 NDGTDVWEIDAKHLTYGNQIASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEV 344

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
           +IMRKVRHKNVVQFIGACTKPP LCI+TEFMSGGSVYDYLHK KG FK PSLLKVAIDVS
Sbjct: 345 YIMRKVRHKNVVQFIGACTKPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVS 404

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           KGMNYLHQ+NIIHRDLK ANLLMDEN VVKVADFGVARVKAQSGVMTAETGTYRWMAPEV
Sbjct: 405 KGMNYLHQHNIIHRDLKGANLLMDENGVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 464

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
           IEHKPYDHKADVFSFG+VLWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK  E
Sbjct: 465 IEHKPYDHKADVFSFGVVLWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKFVE 524

Query: 450 LLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 504
           LLER WQQD  LRPDFSEII+ILQ++AKEVG++ E+RR++K SGGFLS LRRGHH
Sbjct: 525 LLERSWQQDSTLRPDFSEIIDILQKLAKEVGDDGEDRRRDK-SGGFLSALRRGHH 578

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis]

 Score =  745 bits (1924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/471 (80%), Positives = 407/471 (86%), Gaps = 27/471 (5%)

Query: 39  FVQVHPVSDRNSAVSSLLDS----EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD- 93
            VQV PVSD NSA S L  S    +  + R+SIHPPPAFGSSPNLEALA+EA N      
Sbjct: 109 LVQVPPVSDGNSADSDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXL 168

Query: 94  GDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF 153
           G++ +  ++Q   PMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVF
Sbjct: 169 GNSDLLYHLQ---PMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVF 225

Query: 154 VVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 213
           VVDGWPYE                 +  WP+  S SP+SE + T +K  P H+ IPNDGT
Sbjct: 226 VVDGWPYE-----------------KHTWPT-LSLSPSSEHKQTKIKCDPDHVTIPNDGT 267

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           DVWEIDPK+LKF +KVASGSYGDLY+GTYCSQ+VAIK+LKPERINSD++KEFAQEVFIMR
Sbjct: 268 DVWEIDPKNLKFENKVASGSYGDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMR 327

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK KGVFKLPSLLKVAIDVSKGMN
Sbjct: 328 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMN 387

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHK
Sbjct: 388 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHK 447

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           PYDHKAD+FSF IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK++ PKLAELLE+
Sbjct: 448 PYDHKADIFSFAIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKHTHPKLAELLEK 507

Query: 454 CWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 504
           CWQQDPALRPDFSEIIE+LQQI KEVGEE  E RKEKSSGGFLSVLRRGHH
Sbjct: 508 CWQQDPALRPDFSEIIEMLQQIVKEVGEEG-EGRKEKSSGGFLSVLRRGHH 557

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574129|ref|XP_003555204.1| PREDICTED: uncharacterized protein LOC100804170 [Glycine max]

 Score =  733 bits (1892), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/478 (76%), Positives = 410/478 (85%), Gaps = 18/478 (3%)

Query: 39  FVQVHPVSDRNSAVSSLLDSEVPA-----------QRQSIHPPPAFGSSPNLEALAIEAN 87
            VQVHP S+ NSA     +S+ P             RQSIHPPPAFGSSPNLEALA+EAN
Sbjct: 110 LVQVHPTSNGNSA--DTFESDDPGIESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEAN 167

Query: 88  NSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDG 147
           NS +++ + S HANVQ+SR MHEIT STDDKPKLLSQLTALL++IGLNIQEAHAFST DG
Sbjct: 168 NSEDIEEEQSAHANVQYSRHMHEITISTDDKPKLLSQLTALLSEIGLNIQEAHAFSTTDG 227

Query: 148 YSLDVFVVDGWPYEETEQLRAALEKEVLK-LERQGWPSHRSSSPTSEPEDTGMKSHPYHL 206
           +SLDVFVV+GWP+EETE+L+AALE+ VLK +E +  P  +S S   +P+   MKS   +L
Sbjct: 228 FSLDVFVVEGWPHEETEKLKAALERGVLKKIEVKSSP--QSVSSVDKPDQAKMKSELDYL 285

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFA 266
            IP DGTDVWEIDPKHLK+G+++ASGSYG+L++G YCSQ+VAIKVLK + +NS++Q+EFA
Sbjct: 286 TIPTDGTDVWEIDPKHLKYGTQIASGSYGELFKGVYCSQEVAIKVLKADHVNSELQREFA 345

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QEV+IMRKVRHKNVVQFIGACTKPP LCIVTEFMSGGSVYDYLHK KG FK P+LLKVAI
Sbjct: 346 QEVYIMRKVRHKNVVQFIGACTKPPGLCIVTEFMSGGSVYDYLHKQKGFFKFPTLLKVAI 405

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 386
           DVSKGMNYLHQ+NIIHRDLKAANLLMDEN  VKVADFGVARVKAQSGVMTAETGTYRWMA
Sbjct: 406 DVSKGMNYLHQHNIIHRDLKAANLLMDENCTVKVADFGVARVKAQSGVMTAETGTYRWMA 465

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK
Sbjct: 466 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPK 525

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 504
             ELLER WQQDP LRPDFSEIIEILQQ+AKEVG + EER K+K  GG LSVLRRGHH
Sbjct: 526 YVELLERSWQQDPTLRPDFSEIIEILQQLAKEVG-DGEERHKDK-YGGLLSVLRRGHH 581

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224286063|gb|ACN40743.1| unknown [Picea sitchensis]

 Score =  713 bits (1841), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/437 (79%), Positives = 377/437 (86%), Gaps = 1/437 (0%)

Query: 66  SIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQL 125
           S HPPPAFGSSPNLEALA+EAN     D D   + +  F+RPMHEITFS+DDKPKLLSQL
Sbjct: 153 SAHPPPAFGSSPNLEALALEANKQSYGDDDTERNGDHIFARPMHEITFSSDDKPKLLSQL 212

Query: 126 TALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSH 185
           T+LLAD+GLNIQEAHAFST DGYSLDVFVVDGWP EE EQLR ALE E+   E+  W   
Sbjct: 213 TSLLADLGLNIQEAHAFSTTDGYSLDVFVVDGWPLEEMEQLRQALESEIANTEKTTWSKP 272

Query: 186 RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ 245
             SS   E    G  S+   ++IPNDGTD WEID K LKF  KVASGSYGDLYRGTYC Q
Sbjct: 273 SPSSSPIEQMAVGSGSNVECVRIPNDGTDDWEIDSKFLKFDYKVASGSYGDLYRGTYCGQ 332

Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           DVAIKVLK ER+++D+Q+EFAQEVFIMRKVRHKNVVQFIGACT+PP+LCIVTEFMSGGSV
Sbjct: 333 DVAIKVLKSERLDADLQREFAQEVFIMRKVRHKNVVQFIGACTRPPNLCIVTEFMSGGSV 392

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
           YDYLHK KGVFKLP+LLKVAIDVS+GM+YLHQNNIIHRDLKAANLLMDENEVVKVADFGV
Sbjct: 393 YDYLHKQKGVFKLPALLKVAIDVSRGMDYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 452

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 425
           ARV+AQSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIVLWELLTGKLPY+YLTPLQ
Sbjct: 453 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIVLWELLTGKLPYDYLTPLQ 512

Query: 426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE- 484
           AAVGVVQKGLRPTIPKN+ P+LA+LLERCWQQDP LRPDFSE+ EILQQ  KE G+E E 
Sbjct: 513 AAVGVVQKGLRPTIPKNTHPRLADLLERCWQQDPTLRPDFSEMTEILQQTLKEAGDEGEN 572

Query: 485 ERRKEKSSGGFLSVLRR 501
           ERRK+KSSGGF S  RR
Sbjct: 573 ERRKDKSSGGFFSAFRR 589

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|378750734|gb|AFC37605.1| serine threonine protein kinase [Piper colubrinum]

 Score =  701 bits (1809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/477 (72%), Positives = 388/477 (81%), Gaps = 14/477 (2%)

Query: 39  FVQVHPVSDRN-----------SAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEAN 87
            VQV PV D N           + V   L   V   +QS HPPP FGSS NLEAL++E +
Sbjct: 73  LVQVLPVIDENQNDFIQPSSDTTEVGKSLSGHV--SKQSAHPPPTFGSSANLEALSLETS 130

Query: 88  NSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDG 147
                D D++V     F+RPMHEIT ST DKPK+L+ LT +LA+IGLNI+EAH FST DG
Sbjct: 131 KQFAEDRDSAVDVGAIFARPMHEITLSTYDKPKILNLLTLMLAEIGLNIKEAHVFSTSDG 190

Query: 148 YSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLK 207
           +SLDVFVVDGWPYEETE L+ A+E E++K+E+Q W   RS    +    T + +   H++
Sbjct: 191 FSLDVFVVDGWPYEETELLKEAIEMEIIKIEKQMWLKPRSGLSIANIGKTCLSTASDHVE 250

Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 267
           IP+DGTDVWEID + LKF +KVASGSYGDLY GTYCSQDVAIKVLKPERIN DMQ+EFAQ
Sbjct: 251 IPSDGTDVWEIDVRKLKFENKVASGSYGDLYHGTYCSQDVAIKVLKPERINLDMQREFAQ 310

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           EV+IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS+YD LHK KGVFKLP+LLKVA+D
Sbjct: 311 EVYIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSLYDVLHKKKGVFKLPTLLKVALD 370

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 387
           VSKGMNYLHQNNI+HRDLK ANLLMDE+EVVKVADFGVARVKAQSGVMTAETGTYRWMAP
Sbjct: 371 VSKGMNYLHQNNIVHRDLKTANLLMDEHEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 430

Query: 388 E-VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E VI HK YDHKADVFSFGIVLWELLT K+PYEYLTP+QAAVGVVQKGLRPTIPK++ PK
Sbjct: 431 EMVIAHKAYDHKADVFSFGIVLWELLTAKIPYEYLTPVQAAVGVVQKGLRPTIPKHTHPK 490

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGH 503
           LAELLERCWQQDP  RPDF+EI EILQ IAKEV  + +ER KE+SSGGF SVLRR H
Sbjct: 491 LAELLERCWQQDPNGRPDFAEITEILQHIAKEVAADGDERHKERSSGGFFSVLRRNH 547

Source: Piper colubrinum

Species: Piper colubrinum

Genus: Piper

Family: Piperaceae

Order: Piperales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18420244|ref|NP_568041.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|332661531|gb|AEE86931.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana]

 Score =  696 bits (1797), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/477 (75%), Positives = 404/477 (84%), Gaps = 15/477 (3%)

Query: 40  VQVHPVSDRNSAVSSLLDS------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD 93
           ++VH V  + + +S+ LDS           R+SIHPPPAFGSSPNLEALA+ A+ S + D
Sbjct: 102 IEVHLVQVQPAGISADLDSTSNDAGHSSPTRKSIHPPPAFGSSPNLEALALAASLSQDED 161

Query: 94  GDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF 153
            DNSVH N  +SRP+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVF
Sbjct: 162 ADNSVHNNSLYSRPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVF 221

Query: 154 VVDGWPYEETEQLRAALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPND 211
           VVDGWPYEETE+LR +LEKE  K+E   Q WP  +S SP  E   TG ++H   + IPND
Sbjct: 222 VVDGWPYEETERLRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPND 278

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           GTDVWEI+ KHLKFG K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFI
Sbjct: 279 GTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFI 338

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           MRKVRHKNVVQFIGACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KG
Sbjct: 339 MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKG 398

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           M+YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIE
Sbjct: 399 MSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIE 458

Query: 392 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           HKPYDHKADVFS+GIVLWELLTGKLPYEY+TPLQAAVGVVQKGLRPTIPKN+ PKLAELL
Sbjct: 459 HKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELL 518

Query: 452 ERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKS--SGGFLSVLRRG--HH 504
           ER W+ D   RPDFSEIIE LQ+IAKEVGEE EE++K  +   GG  + LRR   HH
Sbjct: 519 ERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEGEEKKKSSTGLGGGIFAALRRSTTHH 575

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357444821|ref|XP_003592688.1| Protein kinase like protein [Medicago truncatula] gi|355481736|gb|AES62939.1| Protein kinase like protein [Medicago truncatula]

 Score =  696 bits (1795), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/449 (75%), Positives = 386/449 (85%), Gaps = 9/449 (2%)

Query: 39  FVQVHPVSDRNSA---------VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNS 89
            VQ+HP SD NSA         V S   S   + +Q I PPPAFGSSPNLEALA+E N+S
Sbjct: 108 LVQLHPSSDGNSADSFQSCAPGVDSGQSSSKYSSKQGILPPPAFGSSPNLEALALEENDS 167

Query: 90  HNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 149
            +L+ + SVHA+VQ+SRPMHEIT STDDKPKLLSQLTALLA++GLNIQEAHAFST DG+S
Sbjct: 168 EDLEEEQSVHASVQYSRPMHEITVSTDDKPKLLSQLTALLAEVGLNIQEAHAFSTTDGFS 227

Query: 150 LDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP 209
           LDVFVV+GWPYEETE+L+  LEKEVLK+ER    S +S S   E + + MK+      IP
Sbjct: 228 LDVFVVEGWPYEETEKLKETLEKEVLKIERGERSSQQSVSSVDECDQSRMKNELDRFTIP 287

Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           NDGTDVWEIDPKHLK+G+++AS SYG+LY+G YCSQ+VAIKVLK E ++S+MQKEFAQEV
Sbjct: 288 NDGTDVWEIDPKHLKYGTQIASASYGELYKGIYCSQEVAIKVLKAEHVSSEMQKEFAQEV 347

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
           +IMRKVRHKNVVQF+GACT+PP LCIVTEFMSGGSVYDYLHK KG FK P++LKVAIDVS
Sbjct: 348 YIMRKVRHKNVVQFMGACTQPPRLCIVTEFMSGGSVYDYLHKQKGFFKFPTVLKVAIDVS 407

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           KGMNYLHQ+NIIHRDLKAANLLMDEN VVKVADFGVARV+AQSGVMTAETGTYRWMAPEV
Sbjct: 408 KGMNYLHQHNIIHRDLKAANLLMDENGVVKVADFGVARVRAQSGVMTAETGTYRWMAPEV 467

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
           IEHKPYDHKADVFSFG+VLWELLTGKLPYE+LTPLQAA+GVVQKGLRPTIPK++ PK  +
Sbjct: 468 IEHKPYDHKADVFSFGVVLWELLTGKLPYEFLTPLQAAIGVVQKGLRPTIPKSTHPKFVQ 527

Query: 450 LLERCWQQDPALRPDFSEIIEILQQIAKE 478
           LLE+ WQQDP LRPDFSEIIE LQQ+AKE
Sbjct: 528 LLEKSWQQDPTLRPDFSEIIESLQQLAKE 556

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	504
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.916	0.803	0.737	1.2e-184
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.908	0.803	0.659	3.6e-160
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.861	0.794	0.672	4.7e-151
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.525	0.643	0.494	1.6e-70
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.529	0.649	0.476	1.8e-69
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.517	0.284	0.445	4.1e-64
TAIR|locus:2180992	333	AT5G01850 [Arabidopsis thalian	0.505	0.765	0.468	1e-59
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.587	0.386	0.398	4.2e-59
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.527	0.506	0.406	7.3e-59
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.545	0.428	0.419	8.4e-58

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 1791 (635.5 bits), Expect = 1.2e-184, P = 1.2e-184
 Identities = 352/477 (73%), Positives = 392/477 (82%)

Query:    40 VQVHPVSDRNSAVSSLLDS------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD 93
             ++VH V  + + +S+ LDS           R+SIHPPPAFGSSPNLEALA+ A+ S + D
Sbjct:   102 IEVHLVQVQPAGISADLDSTSNDAGHSSPTRKSIHPPPAFGSSPNLEALALAASLSQDED 161

Query:    94 GDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF 153
              DNSVH N  +SRP+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVF
Sbjct:   162 ADNSVHNNSLYSRPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVF 221

Query:   154 VVDGWPYEETEQLRAALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPND 211
             VVDGWPYEETE+LR +LEKE  K+E   Q WP  +S SP  E   TG ++H   + IPND
Sbjct:   222 VVDGWPYEETERLRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPND 278

Query:   212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
             GTDVWEI+ KHLKFG K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFI
Sbjct:   279 GTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFI 338

Query:   272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
             MRKVRHKNVVQFIGACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KG
Sbjct:   339 MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKG 398

Query:   332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
             M+YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIE
Sbjct:   399 MSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIE 458

Query:   392 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             HKPYDHKADVFS+GIVLWELLTGKLPYEY+TPLQAAVGVVQKGLRPTIPKN+ PKLAELL
Sbjct:   459 HKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELL 518

Query:   452 ERCWQQDPALRPDFSEIIEILQQIAKXXXXXXXXXXXXXXXXG--FLSVLRRG--HH 504
             ER W+ D   RPDFSEIIE LQ+IAK                G    + LRR   HH
Sbjct:   519 ERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEGEEKKKSSTGLGGGIFAALRRSTTHH 575

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
 Identities = 310/470 (65%), Positives = 363/470 (77%)

Query:    40 VQVHPVSDRNSAVSSLLDSEVPAQRQSIH-----PPPAFGSSPNLEALAIEANNSHNLDG 94
             VQV P  + NS      D  V    QS +      PP FGSSPN EAL  +A   H  D 
Sbjct:   106 VQVSPTLNGNSGDVDPSDPAVNEDAQSSYNSRSLAPPTFGSSPNFEALT-QAYKDHAQDD 164

Query:    95 DNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFV 154
             D++V+A +  SRPMHEITFST D+PKLLSQLT++L ++GLNIQEAHAFST DG+SLDVFV
Sbjct:   165 DSAVNAQLPNSRPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFV 224

Query:   155 VDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSH-PYHLKIPNDGT 213
             VDGW  EETE L+ AL+KE+ K + Q  P  +  S T    D       P  ++IP DGT
Sbjct:   225 VDGWSQEETEGLKDALKKEIRKFKDQ--PCSKQKSITFFEHDKSTNELLPACVEIPTDGT 282

Query:   214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
             D WEID K LK   KVA GSYG+L+RGTYCSQ+VAIK+LKPER+N++M +EF+QEV+IMR
Sbjct:   283 DEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMR 342

Query:   274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
             KVRHKNVVQFIGACT+ P+LCIVTEFM+ GS+YD+LHK KGVFK+ SLLKVA+DVSKGMN
Sbjct:   343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402

Query:   334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             YLHQNNIIHRDLK ANLLMDE+EVVKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHK
Sbjct:   403 YLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHK 462

Query:   394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
             PYDH+ADVFS+ IVLWELLTG+LPY YLTPLQAAVGVVQKGLRP IPK + PKL ELLE+
Sbjct:   463 PYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEK 522

Query:   454 CWQQDPALRPDFSEIIEILQQIAKXXXXXXXXXXXXXXXXGFLSVLRRGH 503
             CWQQDPALRP+F+EIIE+L Q+ +                G+ S L++GH
Sbjct:   523 CWQQDPALRPNFAEIIEMLNQLIREVGDDERHKDKHG---GYFSGLKKGH 569

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1474 (523.9 bits), Expect = 4.7e-151, P = 4.7e-151
 Identities = 296/440 (67%), Positives = 346/440 (78%)

Query:    40 VQVHP-VS-DRNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNS 97
             VQV P +S D + AV     S        +  PP FGSSPN EA  I   +    D D+ 
Sbjct:   105 VQVSPRISADSDPAVEEDAQSSHQPSGPGVLAPPTFGSSPNFEA--ITQGSKIVEDVDSV 162

Query:    98 VHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 157
             V+A +  +RPMHEITFST DKPKLLSQLT+LL ++GLNIQEAHAFSTVDG+SLDVFVVDG
Sbjct:   163 VNATLS-TRPMHEITFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDG 221

Query:   158 WPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWE 217
             W  EET+ LR AL KE+LKL+ Q     +S S   E + +  +  P  ++IP DGTD WE
Sbjct:   222 WSQEETDGLRDALSKEILKLKDQPGSKQKSIS-FFEHDKSSNELIPACIEIPTDGTDEWE 280

Query:   218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
             ID   LK   KVASGSYGDL+RGTYCSQ+VAIK LKP+R+N++M +EF+QEVFIMRKVRH
Sbjct:   281 IDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRH 340

Query:   278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             KNVVQF+GACT+ P+LCIVTEFM+ GS+YD+LHK K  FKL +LLKVA+DV+KGM+YLHQ
Sbjct:   341 KNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQ 400

Query:   338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
             NNIIHRDLK ANLLMDE+ +VKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPY+H
Sbjct:   401 NNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNH 460

Query:   398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 457
             KADVFS+ IVLWELLTG +PY +LTPLQAAVGVVQKGLRP IPK + PK+  LLERCW Q
Sbjct:   461 KADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQ 520

Query:   458 DPALRPDFSEIIEILQQIAK 477
             DP  RP F EIIE+LQQI K
Sbjct:   521 DPEQRPLFEEIIEMLQQIMK 540

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 1.6e-70, P = 1.6e-70
 Identities = 137/277 (49%), Positives = 194/277 (70%)

Query:   207 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-----PERIN 258
             K P +G    + W ID + L  G   A G++G LYRGTY  +DVAIK+L+     PE+  
Sbjct:   112 KYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQ 171

Query:   259 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
             + ++++F QEV ++  ++H N+V+FIGAC KP   CIVTE+  GGSV  +L K +    +
Sbjct:   172 A-LEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNR-AV 229

Query:   319 PSLLKV--AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 376
             P  L V  A+DV++GM Y+H+ N IHRDLK+ NLL+  +  +K+ADFGVAR++ Q+  MT
Sbjct:   230 PLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMT 289

Query:   377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
              ETGTYRWMAPE+I+H+PY  K DV+SFGIVLWEL+TG LP++ +T +QAA  VV +G+R
Sbjct:   290 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVR 349

Query:   437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
             PT+P +  P L E++ RCW  DP +RP F+EI+ +L+
Sbjct:   350 PTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLE 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 704 (252.9 bits), Expect = 1.8e-69, P = 1.8e-69
 Identities = 131/275 (47%), Positives = 192/275 (69%)

Query:   207 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSD-- 260
             + P +G    D W ID + L  G   A G++G LY+GTY  +DVAIK+L +PE       
Sbjct:   111 RYPTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQ 170

Query:   261 -MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKL 318
              M+++F QEV ++  ++H N+V+FIGAC KP   CIVTE+  GGSV  +L + +     L
Sbjct:   171 FMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 230

Query:   319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
                +K A+DV++GM Y+H  N IHRDLK+ NLL+  ++ +K+ADFGVAR++ Q+  MT E
Sbjct:   231 KLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 290

Query:   379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
             TGTYRWMAPE+I+H+ Y+ K DV+SFGIVLWEL+TG LP++ +T +QAA  VV +G+RPT
Sbjct:   291 TGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPT 350

Query:   439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
             +P +  P L++++ RCW  +P +RP F E++++L+
Sbjct:   351 VPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLE 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 628 (226.1 bits), Expect = 4.1e-64, Sum P(2) = 4.1e-64
 Identities = 118/265 (44%), Positives = 181/265 (68%)

Query:   213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI 271
             +D+ EI    LK  SK+  G++G +Y+G +    VAIK +K  E +N+ + +EF +E+ I
Sbjct:   653 SDI-EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711

Query:   272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
             + ++RH N+V  + ACT PP+LC +TE++ GGS+YD LH  K    +    K+AI +++G
Sbjct:   712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771

Query:   332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
             MNYLH + +IHRD+K+ NLL+DE+  VK+ DFG++++K++S  MT   G+  WM+PE++ 
Sbjct:   772 MNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLM 831

Query:   392 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP-KLAEL 450
              + Y  K DV++FGI+LWEL TG+LPY  L  +Q A+ V  K LRP IP N+ P +L+ L
Sbjct:   832 GEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP-NAWPYQLSHL 890

Query:   451 LERCWQQDPALRPDFSEIIEILQQI 475
             ++ CW QDP  RP F+EI+ +L +I
Sbjct:   891 IQACWHQDPLKRPSFTEILNLLNEI 915

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 1.0e-59, P = 1.0e-59
 Identities = 127/271 (46%), Positives = 183/271 (67%)

Query:   218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL----KPERINSDMQKEFAQEVFIMR 273
             +DPK L  GSK+  G++G +Y+G Y  Q VAIKV+    KP++  S ++  F +EV +M 
Sbjct:    13 VDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQ-QSSLESRFVREVNMMS 71

Query:   274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 332
             +V+H N+V+FIGAC K P + IVTE + G S+  YL  ++  +  LP  L  A+D+++ +
Sbjct:    72 RVQHHNLVKFIGAC-KDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARAL 130

Query:   333 NYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI- 390
             + LH N IIHRDLK  NLL+ EN + VK+ADFG+AR ++ + +MTAETGTYRWMAPE+  
Sbjct:   131 HCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYS 190

Query:   391 -------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
                    E K Y++K DV+SFGIVLWELLT ++P+E ++ LQAA     K  RP +P+  
Sbjct:   191 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGI 250

Query:   444 QPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
              P LA +++ CW +DP +RP FS+II +L +
Sbjct:   251 SPSLAFIVQSCWVEDPNMRPSFSQIIRLLNE 281

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 4.2e-59, Sum P(2) = 4.2e-59
 Identities = 121/304 (39%), Positives = 187/304 (61%)

Query:   178 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 237
             E  G  +  S+S  S    T   S    + + +D  D +EI  + L  G ++  GS G +
Sbjct:   444 ENMGSVNVNSASSASSCGSTS-SSVMNKVDMDSDCLD-YEILWEDLTIGEQIGQGSCGTV 501

Query:   238 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 297
             Y G +   DVA+KV   +  + ++   F QEV +M+++RH NV+ F+GA   P  LCIVT
Sbjct:   502 YHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVT 561

Query:   298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 355
             EF+  GS++  L + K    L   + +A D+++GMNYLH  +  IIHRDLK++NLL+D N
Sbjct:   562 EFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRN 621

Query:   356 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
               VKVADFG++R+K ++ + T   GT +WMAPEV+ ++  D K+DV+SFG+VLWEL+T K
Sbjct:   622 WTVKVADFGLSRIKHETYLTTNGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEK 681

Query:   416 LPYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
             +P+E L  +Q   AVG + + L   +PK+  P+   L+E CW  +P  RP F E+++ L+
Sbjct:   682 IPWENLNAMQVIGAVGFMNQRLE--VPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLR 739

Query:   474 QIAK 477
             ++ +
Sbjct:   740 ELQR 743

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
 Identities = 111/273 (40%), Positives = 178/273 (65%)

Query:   211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PER-----INSDMQKE 264
             + ++ + +D   L FG K A G Y  LY G Y  + VA+K++  P+      + + ++K+
Sbjct:   195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254

Query:   265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLK 323
             F +EV ++ ++ H NV++F+GA   PP  C++T+++  GS+  +LHK +     L  L++
Sbjct:   255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314

Query:   324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
              AID+++GM Y+H   IIHRDLK  N+L+DE   +K+ADFG+A  +    ++  + GTYR
Sbjct:   315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374

Query:   384 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
             WMAPE+I+ KP+  KADV+SFG+VLWE++ G +PYE + P+QAA  VV K +RP IP + 
Sbjct:   375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDC 434

Query:   444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIA 476
                +  L+E+CW   P  RP+F +I+++L+Q A
Sbjct:   435 PVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFA 467

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
 Identities = 118/281 (41%), Positives = 175/281 (62%)

Query:   200 KSHPYHLKIPNDGTDVWE---IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 256
             +S  Y+    ND T + +   ID   +K G ++  G+YG++Y GT+    VA+K L    
Sbjct:   348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407

Query:   257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
             IN ++ KEF +E+ +M+ +RH NV+QF+G+C  PP +CI TE+M  GS+Y  LH      
Sbjct:   408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467

Query:   317 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
             +   L+K+ ID +KG+ YLH +   I+HRDLK+ NLL+DEN  VKVADFG++ ++ Q   
Sbjct:   468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGAT 527

Query:   375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 434
             MTA  GT  W +PEV+  + Y  KADV+SFGI+LWE  T + PY  + P Q    V ++G
Sbjct:   528 MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREG 586

Query:   435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             +RP +P+N  PK  +LL  C  ++P+ RP   + +E L+ I
Sbjct:   587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	504
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-94
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-93
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-92
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-74
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-74
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-67
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-67
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-66
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-65
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-64
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-63
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-62
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-59
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-59
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-56
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-56
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-56
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-55
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-55
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-55
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-54
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-53
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-52
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-52
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-52
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-51
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-51
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-50
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-50
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-50
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-50
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-50
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-49
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-49
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-49
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-48
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-48
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-48
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-48
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-46
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-46
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-46
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-45
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-45
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-45
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-44
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-44
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-44
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-42
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-42
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-42
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-41
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-41
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-41
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-41
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-40
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-40
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-40
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-39
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-39
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-39
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-39
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-39
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-39
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-39
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-39
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-38
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-38
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-38
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-38
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-38
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-38
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-37
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-37
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-37
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-37
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-37
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-37
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-37
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-36
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-36
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-35
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-35
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-35
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-35
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-35
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-34
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-34
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-34
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-34
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-34
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-34
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-33
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-33
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-33
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-33
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-32
cd04928	68	cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC	2e-32
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-32
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-32
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-31
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-31
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-31
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-31
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-31
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-31
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-30
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-29
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-28
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-28
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-28
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-28
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-28
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-28
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-28
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-27
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-27
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-27
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-27
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-27
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-26
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-26
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-25
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-25
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-25
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-25
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-24
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-23
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-22
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-21
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-20
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-19
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-18
cd04900	73	cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU	3e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-18
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-17
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-15
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-12
cd04873	70	cd04873, ACT_UUR-ACR-like, ACT domains of the bact	5e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-08
PRK05092	931	PRK05092, PRK05092, PII uridylyl-transferase; Prov	6e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd02116	60	cd02116, ACT, ACT domains are commonly involved in	7e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
COG2844	867	COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
pfam01842	66	pfam01842, ACT, ACT domain	3e-06
cd04899	70	cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain	4e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
TIGR01693	850	TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
PRK05007	884	PRK05007, PRK05007, PII uridylyl-transferase; Prov	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
PRK00275	895	PRK00275, glnD, PII uridylyl-transferase; Provisio	6e-04
PRK03381	774	PRK03381, PRK03381, PII uridylyl-transferase; Prov	0.001
PRK03381	774	PRK03381, PRK03381, PII uridylyl-transferase; Prov	0.001
COG2844	867	COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran	0.002
PRK05092	931	PRK05092, PRK05092, PII uridylyl-transferase; Prov	0.003
TIGR01693	850	TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans	0.003
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  285 bits (732), Expect = 6e-94
 Identities = 101/259 (38%), Positives = 151/259 (58%), Gaps = 11/259 (4%)

Query: 223 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           L  G K+  G++G++Y+G           +VA+K LK +  +    +EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H NVV+ +G CT+   L IV E+M GG +  YL K +    L  LL  A+ +++GM YL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP 394
             N IHRDL A N L+ EN VVK++DFG++R            G    RWMAPE ++   
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           +  K+DV+SFG++LWE+ T G+ PY  ++  +  +  ++ G R   P N  P+L +L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 454 CWQQDPALRPDFSEIIEIL 472
           CW +DP  RP FSE++EIL
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  282 bits (724), Expect = 9e-93
 Identities = 99/260 (38%), Positives = 156/260 (60%), Gaps = 12/260 (4%)

Query: 223 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           L+ G K+  G++G++Y+GT           VA+K LK    + + ++EF +E  IM+K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H N+V+ +G CT+   L IVTE+M GG + D+L K      L  LL++A+ ++KGM YL 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHK 393
             N +HRDL A N L+ EN VVK++DFG++R   +        G     +WMAPE ++  
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            +  K+DV+SFG++LWE+ T G+ PY  ++  +  + +++ G R   P+N   +L EL+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238

Query: 453 RCWQQDPALRPDFSEIIEIL 472
           +CW  DP  RP FSE++E L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  281 bits (721), Expect = 3e-92
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 12/260 (4%)

Query: 223 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           L  G K+  G++G++Y+GT          +VA+K LK +  +    +EF +E  IMRK+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLD 59

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYL 335
           H N+V+ +G CT+   L IV E+M GG + DYL K +     L  LL  A+ +++GM YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHK 393
              N IHRDL A N L+ EN VVK++DFG++R          + G    RWMAPE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            +  K+DV+SFG++LWE+ T G+ PY  ++  +  +  ++KG R   P N  P+L +L+ 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238

Query: 453 RCWQQDPALRPDFSEIIEIL 472
           +CW +DP  RP FSE++EIL
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  258 bits (661), Expect = 3e-83
 Identities = 100/260 (38%), Positives = 152/260 (58%), Gaps = 19/260 (7%)

Query: 231 SGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            G++G++Y+G        + +VA+K LK E  + + +K+F +E  +M+K+ H NVV+ +G
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--------LLKVAIDVSKGMNYLHQ 337
            CT+   L +V E+M GG + DYL K + VF  P         LL  AI ++KGM YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKP 394
              +HRDL A N L+ E+ VVK++DFG++R          +TG     RWMAPE ++   
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           +  K+DV+SFG++LWE+ T G  PY  L+  +  +  ++KG R   P+    +L EL+  
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLS 242

Query: 454 CWQQDPALRPDFSEIIEILQ 473
           CWQ DP  RP FSE++E L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  235 bits (603), Expect = 1e-74
 Identities = 93/257 (36%), Positives = 146/257 (56%), Gaps = 10/257 (3%)

Query: 223 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
            +   K+ SGS+G +Y+  +    + VA+K+LK     S   +   +E+ I+R++ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V+ I A      L +V E+  GG ++DYL +  G        K+A+ + +G+ YLH N I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKPYDHK 398
           IHRDLK  N+L+DEN VVK+ADFG+A+   +S   +T   GT  +MAPEV+     Y  K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 399 ADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLER 453
            DV+S G++L+ELLTGK P+     L  LQ    ++   L    PK  +   +  +L+++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 454 CWQQDPALRPDFSEIIE 470
           C  +DP+ RP   EI++
Sbjct: 240 CLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  234 bits (599), Expect = 4e-74
 Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 6/251 (2%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +   K+  GS+G +Y        + VAIKV+K ++I  D ++   +E+ I++K++H N+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIV 60

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +          L +V E+  GG ++D L K +G             +   + YLH   I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
           HRDLK  N+L+DE+  VK+ADFG+AR       +T   GT  +MAPEV+  K Y    D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDP 459
           +S G++L+ELLTGK P+     L      + K   P  P      P+  +L+ +   +DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239

Query: 460 ALRPDFSEIIE 470
             R    E ++
Sbjct: 240 EKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  214 bits (548), Expect = 5e-67
 Identities = 77/247 (31%), Positives = 129/247 (52%), Gaps = 39/247 (15%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
            G +G +Y        + VAIK++K E  +S ++ E  +E+ I++K+ H N+V+  G   
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFE 61

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               L +V E+  GGS+ D L + +G      +L++ + + +G+ YLH N IIHRDLK  
Sbjct: 62  DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121

Query: 349 NLLMDENE-VVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFG 405
           N+L+D +   VK+ADFG+++ + +   ++    GT  +MAPEV+  K  Y  K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181

Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+EL                                 P+L +L+ +  Q+DP  RP  
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208

Query: 466 SEIIEIL 472
            EI+E L
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  216 bits (551), Expect = 5e-67
 Identities = 105/264 (39%), Positives = 159/264 (60%), Gaps = 12/264 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W I+ K LK G+ +  G +GD+  G Y  Q VA+K LK    +S   + F  E  +M  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 334
           RH N+VQ +G   +   L IVTE+M+ GS+ DYL  + + V  L   L  A+DV +GM Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 392
           L + N +HRDL A N+L+ E+ V KV+DFG+A+ +A  G    ++G    +W APE +  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173

Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG R   P+   P++ +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232

Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
           + CW+ DPA RP F ++ E L  I
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  213 bits (545), Expect = 4e-66
 Identities = 97/262 (37%), Positives = 151/262 (57%), Gaps = 14/262 (5%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G +  + DVAIK+++   ++ D   +F +E  +M K+ 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H N+VQ  G CTK   + IVTE+M+ G + +YL + KG      LL +  DV + M YL 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIE 391
            N  IHRDL A N L+ E+ VVKV+DFG+AR  +  Q    T+  GT    +W  PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           +  +  K+DV+SFG+++WE+ + GK+PYE  +  +  V  V  G R   PK +  ++  +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233

Query: 451 LERCWQQDPALRPDFSEIIEIL 472
           +  CW + P  RP F +++  L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  210 bits (537), Expect = 5e-65
 Identities = 88/246 (35%), Positives = 139/246 (56%), Gaps = 7/246 (2%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
             +   K+  G +G++Y+  +    ++VAIKV+K E  + + +++   E+ I++K +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +V++ G+  K   L IV EF SGGS+ D L           +  V  ++ KG+ YLH N 
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           IIHRD+KAAN+L+  +  VK+ DFG++   + +       GT  WMAPEVI  KPYD+KA
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 457
           D++S GI   EL  GK PY  L P++A   +   G  P +    +   +  + L++C Q+
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQK 237

Query: 458 DPALRP 463
           +P  RP
Sbjct: 238 NPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  208 bits (531), Expect = 5e-64
 Identities = 100/264 (37%), Positives = 150/264 (56%), Gaps = 15/264 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEID   ++   K+ +G +G+++ G +  +  VA+K LKP  ++    K+F  E  IM+K
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKK 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 333
           +RH  ++Q    CT    + IVTE M  GS+ +YL    G   KLP L+ +A  V+ GM 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 390
           YL   N IHRDL A N+L+ EN + KVADFG+ARV  +  +  A  G     +W APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176

Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
            +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  V +G R   P     +L +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235

Query: 450 LLERCWQQDPALRPDFSEIIEILQ 473
           ++  CW++DP  RP F    E LQ
Sbjct: 236 IMLDCWKEDPDDRPTF----ETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  205 bits (524), Expect = 6e-63
 Identities = 103/267 (38%), Positives = 156/267 (58%), Gaps = 13/267 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE-FAQEVFIMR 273
           WEI  + LK   K+ +G +G+++ GT+  +  VA+K LKP      M  E F QE  IM+
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFLQEAQIMK 56

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGM 332
           K+RH  +VQ    C++   + IVTE+MS GS+ D+L   +G   +LP L+ +A  +++GM
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 389
            YL   N IHRDL A N+L+ EN V K+ADFG+AR+       TA  G     +W APE 
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEA 175

Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
             +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  V++G R   P N   +L 
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELY 234

Query: 449 ELLERCWQQDPALRPDFSEIIEILQQI 475
           +L+ +CW +DP  RP F  +   L+  
Sbjct: 235 DLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  203 bits (519), Expect = 4e-62
 Identities = 79/246 (32%), Positives = 128/246 (52%), Gaps = 9/246 (3%)

Query: 226 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           G  +  GS+G +Y          +A+K ++    + +  +   +E+ I+  ++H N+V++
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 284 IGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
            G+       +L I  E++SGGS+   L K  G    P + K    + +G+ YLH N I+
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHK 398
           HRD+K AN+L+D + VVK+ADFG A+               GT  WMAPEVI  + Y   
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLRPTIPKNSQPKLAELLERCWQQ 457
           AD++S G  + E+ TGK P+  L    AA+  +   G  P IP++   +  + L +C ++
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243

Query: 458 DPALRP 463
           DP  RP
Sbjct: 244 DPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  196 bits (500), Expect = 2e-59
 Identities = 97/268 (36%), Positives = 156/268 (58%), Gaps = 14/268 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMR 273
           WE++   +    K+  G YG++Y G +      VA+K LK + +  +   EF +E  +M+
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 57

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKG 331
           +++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +     ++ +  LL +A  +S  
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 175

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++KG R   P+   PK+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKV 234

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQI 475
            EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 4e-59
 Identities = 91/249 (36%), Positives = 141/249 (56%), Gaps = 11/249 (4%)

Query: 222 HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
           + + G  +  G++G +Y+G        VAIK +  E+I  +  K   QE+ +++ ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---KGMNYLH 336
           +V++IG+     SL I+ E+   GS+   + K       P  L VA+ V    +G+ YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLH 116

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           +  +IHRD+KAAN+L  ++ VVK+ADFGVA ++   S    +  GT  WMAPEVIE    
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
              +D++S G  + ELLTG  PY  L P+ A   +VQ    P +P+   P+L + L +C+
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCF 235

Query: 456 QQDPALRPD 464
           Q+DP LRP 
Sbjct: 236 QKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  188 bits (478), Expect = 2e-56
 Identities = 89/252 (35%), Positives = 141/252 (55%), Gaps = 9/252 (3%)

Query: 228 KVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           K+  G++GD+Y+G      +VA+K  +        +K F QE  I+++  H N+V+ IG 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
           C +   + IV E + GGS+  +L K K    +  LL++++D + GM YL   N IHRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVF 402
           A N L+ EN V+K++DFG++R + + G+ T   G      +W APE + +  Y  ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 403 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           S+GI+LWE  + G  PY  ++  Q     ++ G R   P+    ++  L+ +CW  DP  
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238

Query: 462 RPDFSEIIEILQ 473
           RP FSEI   LQ
Sbjct: 239 RPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  187 bits (478), Expect = 4e-56
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 13/267 (4%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQK-EFAQEVFI 271
           IDP ++     +  G +G++ RG          DVAIK LK    +SD Q+ +F  E  I
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASI 58

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + I+TE+M  GS+  +L +  G F +  L+ +   ++ G
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG--TYRWMAPE 388
           M YL + N +HRDL A N+L++ N V KV+DFG++R    S    T + G    RW APE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I ++ +   +DV+SFGIV+WE+++ G+ PY  ++  Q  +  V+ G R   P +    L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSAL 237

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQ 474
            +L+  CWQ+D   RP FS+I+  L +
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  187 bits (475), Expect = 8e-56
 Identities = 95/260 (36%), Positives = 150/260 (57%), Gaps = 10/260 (3%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           I P  L    ++ SG +G ++ G +  +  VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G CT+   +C+V EFM  G + DYL   +G F   +LL + +DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
            +N+IHRDL A N L+ EN+VVKV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV+SFG+++WE+ + GK PYE  +  +  V  +  G R   P+ +   + EL++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQ 235

Query: 453 RCWQQDPALRPDFSEIIEIL 472
            CW++ P  RP FS ++  L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  185 bits (472), Expect = 2e-55
 Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 10/263 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 276 RHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           YL  NN +HRDL A N+L+ E+ V KV+DFG+   K  S          +W APE +  K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALREK 174

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + ++++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233

Query: 453 RCWQQDPALRPDFSEIIEILQQI 475
           +CW  D A RP F ++ E L+ I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  186 bits (473), Expect = 2e-55
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 7/264 (2%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WE   +      K+ SG +G+++ G +     VAIK+LK +  +   Q++F +EV  +++
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 333
           +RHK+++     C+    + I+TE M  GS+  +L   +G V  + SL+ +A  V++GM 
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-YRWMAPEVIEH 392
           YL + N IHRDL A N+L+ E+ V KVADFG+AR+  +   ++++    Y+W APE   H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             +  K+DV+SFGI+L+E+ T G++PY  +         +  G R   P     ++ +++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237

Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
             CW  +P  RP F  + E L  I
Sbjct: 238 LECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  186 bits (474), Expect = 4e-55
 Identities = 88/264 (33%), Positives = 143/264 (54%), Gaps = 22/264 (8%)

Query: 219 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           DP +  K   K+  G+ G++Y+ T  +  ++VAIK +   R+    ++    E+ IM+  
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDC 72

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           +H N+V +  +      L +V E+M GGS+ D + +       P +  V  +V +G+ YL
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPE 388
           H  N+IHRD+K+ N+L+ ++  VK+ADFG A   AQ   +T E        GT  WMAPE
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPE 186

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPK 446
           VI+ K Y  K D++S GI+  E+  G+ PY    PL+A   +  KG+ P +  P+   P+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPE 245

Query: 447 LAELLERCWQQDPALRPDFSEIIE 470
             + L +C  +DP  RP   E+++
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  181 bits (462), Expect = 6e-54
 Identities = 90/259 (34%), Positives = 145/259 (55%), Gaps = 8/259 (3%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           I+P  L F  ++ SG +G ++ G + +Q  VAIK +    ++ +   +F +E  +M K+ 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G CT+   L IVTEFM  G + +YL + +G      LL +  DV +GM YL 
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 394
           +N+ IHRDL A N L+    VVKV+DFG+ R        ++    +  +W  PEV     
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y  K+DV+SFG+++WE+ T GK+P+E  +  +  V ++ +G R   PK +   + E++  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236

Query: 454 CWQQDPALRPDFSEIIEIL 472
           CW + P  RP F+E++  +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  181 bits (460), Expect = 1e-53
 Identities = 94/261 (36%), Positives = 148/261 (56%), Gaps = 10/261 (3%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M K+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H+ +VQ  G CTK   + IVTE+MS G + +YL +    F+   LL++  DV +GM YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
               IHRDL A N L+D+   VKV+DFG++R        T+  G+    RW  PEV+ + 
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYS 176

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            +  K+DV++FG+++WE+ + GK+PYE     +    V Q GLR   P  +  K+  ++ 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235

Query: 453 RCWQQDPALRPDFSEIIEILQ 473
            CW +    RP F +++  ++
Sbjct: 236 SCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  179 bits (456), Expect = 5e-53
 Identities = 83/258 (32%), Positives = 143/258 (55%), Gaps = 18/258 (6%)

Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDM---QKEFA-QEVFIMRKVRHKNVVQ 282
           ++  GS+G +Y       D  + VLK   I+ S+M   ++E A  EV I++K+ H N+++
Sbjct: 7   QIGKGSFGKVYLVR-RKSDGKLYVLK--EIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---LLKVAIDVSKGMNYLHQNN 339
           +  +  +   LCIV E+  GG +   + K K   K      +L   + +   + YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDH 397
           I+HRD+K  N+ +  N +VK+ DFG+++V + +  + A+T  GT  +++PE+ ++KPY++
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNY 182

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 457
           K+D++S G VL+EL T K P+E    L+ A+ +++    P IP     +L  L+    Q+
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQK 241

Query: 458 DPALRPDFSEIIEILQQI 475
           DP  RP    I +ILQ  
Sbjct: 242 DPEERPS---IAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  178 bits (454), Expect = 1e-52
 Identities = 89/271 (32%), Positives = 139/271 (51%), Gaps = 11/271 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 270
           +EI  + +  G  +  G +GD+Y+G Y S +     VA+K  K     S  +K F QE +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           IMR+  H ++V+ IG  T+ P   IV E    G +  YL   K    L SL+  +  +S 
Sbjct: 60  IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 388
            + YL     +HRD+ A N+L+   + VK+ DFG++R         A  G    +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N  P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKE 478
             L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  179 bits (455), Expect = 1e-52
 Identities = 88/266 (33%), Positives = 143/266 (53%), Gaps = 13/266 (4%)

Query: 223 LKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           L+    + SG++G +Y+G +  +       VAIKVL+ E  +    KE   E ++M  V 
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H +VV+ +G C     + ++T+ M  G + DY+   K       LL   + ++KGM+YL 
Sbjct: 68  HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 393
           +  ++HRDL A N+L+   + VK+ DFG+A+ +        AE G    +WMA E I H+
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y HK+DV+S+G+ +WEL+T G  PYE + P      +++KG R   P      +  +L 
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLV 245

Query: 453 RCWQQDPALRPDFSEIIEILQQIAKE 478
           +CW  D   RP F E+I    ++A++
Sbjct: 246 KCWMIDAESRPTFKELINEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  177 bits (451), Expect = 2e-52
 Identities = 88/263 (33%), Positives = 151/263 (57%), Gaps = 14/263 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ + L  G  +  G +G + +G Y  Q VA+K +K +       + F +E  +M K+
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKL 56

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 334
            HKN+V+ +G       L IV E MS G++ ++L  + + +  +  LL+ ++DV++GM Y
Sbjct: 57  HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 392
           L    ++HRDL A N+L+ E+ V KV+DFG+ARV    G M  +      +W APE ++H
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKH 171

Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           K +  K+DV+S+G++LWE+ + G+ PY  ++ L+     V+KG R   P+     +  L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLM 230

Query: 452 ERCWQQDPALRPDFSEIIEILQQ 474
             CW+ +P  RP F ++ E L++
Sbjct: 231 TSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  175 bits (447), Expect = 2e-51
 Identities = 86/283 (30%), Positives = 139/283 (49%), Gaps = 32/283 (11%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQD-----VAIKVLKPERINSDMQKEFAQE 268
           WE+  + +    ++  GS+G +Y G      +      VAIK +  E  +   + EF  E
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNE 59

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLL 322
             +M++    +VV+ +G  +      +V E M+ G +  YL   +           P+L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 323 KV---AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--------KAQ 371
           K    A +++ GM YL     +HRDL A N ++ E+  VK+ DFG+ R         K  
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179

Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
            G++       RWMAPE ++   +  K+DV+SFG+VLWE+ T  + PY+ L+  +    V
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234

Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           +  G    +P+N   KL EL+  CWQ +P +RP F EI+  L+
Sbjct: 235 IDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  174 bits (443), Expect = 8e-51
 Identities = 86/260 (33%), Positives = 129/260 (49%), Gaps = 36/260 (13%)

Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            +  GS+G++Y+      +Q VAIKV+  E    +++ +  QE+  + + R   + ++ G
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYG 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L I+ E+  GGS  D L    G      +  +  +V  G+ YLH+   IHRD+
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPEVIEHKPYDHK 398
           KAAN+L+ E   VK+ADFGV      SG +T+         GT  WMAPEVI+   YD K
Sbjct: 125 KAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------E 449
           AD++S GI   EL  G+ P   L P++         L   IPKN+ P L          +
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRV--------LF-LIPKNNPPSLEGNKFSKPFKD 229

Query: 450 LLERCWQQDPALRPDFSEII 469
            +  C  +DP  RP   E++
Sbjct: 230 FVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  172 bits (439), Expect = 2e-50
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 19/266 (7%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
              +    +  G+   +Y    C   ++ VAIK +  E+  + +  E  +EV  M +  H
Sbjct: 1   DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL-HKLK-GVFKLPSLLKVAIDVSKGMNYL 335
            NVV++  +      L +V  ++SGGS+ D +      G      +  V  +V KG+ YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVI 390
           H N  IHRD+KA N+L+ E+  VK+ADFGV+   A  G  T +      GT  WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 391 E-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK--- 446
           E    YD KAD++SFGI   EL TG  PY    P++  +  +Q    P++   +  K   
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYS 237

Query: 447 --LAELLERCWQQDPALRPDFSEIIE 470
               +++  C Q+DP+ RP   E+++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  172 bits (437), Expect = 3e-50
 Identities = 98/264 (37%), Positives = 160/264 (60%), Gaps = 12/264 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + L+   K+ +G +G+++ GT+  +  VA+K LKP  ++ +    F +E  IM+K
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 333
           +RH  +VQ     ++ P + IVTE+MS GS+ D+L   +G   KLP+L+ +A  V+ GM 
Sbjct: 58  LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 390
           Y+ + N IHRDL++AN+L+ +  V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
            +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P++    L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHE 234

Query: 450 LLERCWQQDPALRPDFSEIIEILQ 473
           L+ +CW++DP  RP F  +   L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  171 bits (436), Expect = 4e-50
 Identities = 84/256 (32%), Positives = 137/256 (53%), Gaps = 13/256 (5%)

Query: 228 KVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           K+  GS+G + RG + +       VA+K LK +++ SD+  +F +E  IM  + H+N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
             G     P L +VTE    GS+ D L K   G F + +L   A+ ++ GM YL     I
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAPEVIEHKPYDH 397
           HRDL A N+L+  ++ VK+ DFG+ R   Q+    VM       + W APE +  + + H
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179

Query: 398 KADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
            +DV+ FG+ LWE+ T G+ P+  L+  Q    + ++G R   P+     +  ++ +CW 
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239

Query: 457 QDPALRPDFSEIIEIL 472
            +PA RP F+ + E L
Sbjct: 240 HNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  171 bits (435), Expect = 6e-50
 Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 7/251 (2%)

Query: 226 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHKNV 280
           G  + SGS+G +Y G         A+K +         Q   K+  QE+ ++ K++H N+
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           VQ++G   +  +L I  E + GGS+   L K  G F  P +      +  G+ YLH  N 
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKA 399
           +HRD+K AN+L+D N VVK+ADFG+A+   +     +  G+  WMAPEVI  +  Y   A
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G  + E+ TGK P+  L  + A   + +    P IP +   +  + + +C Q+DP
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 460 ALRPDFSEIIE 470
           +LRP  +E++E
Sbjct: 244 SLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  171 bits (436), Expect = 9e-50
 Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 39/288 (13%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +HLKF  ++  G +G +    Y          VA+K L           +F +E+ I+R 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62

Query: 275 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           + H+N+V++ G C KP   SL ++ E++  GS+ DYL + +    L  LL  +  + KGM
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMTAETGTYRWMAPE 388
           +YL     IHRDL A N+L++  ++VK++DFG+A+V  +      V         W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
            +    +   +DV+SFG+ L+EL T      Y  P Q+      + +     +    +L 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT------YGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 449 ELLE--------------------RCWQQDPALRPDFSEIIEILQQIA 476
           ELL+                     CW+ +P  RP F+++I I+ ++ 
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  170 bits (431), Expect = 2e-49
 Identities = 102/264 (38%), Positives = 157/264 (59%), Gaps = 12/264 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP    + M + F QE  IM+K
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 333
           +RH  +V      ++ P + IVTEFM  GS+ D+L +  G + KLP L+ +A  ++ GM 
Sbjct: 58  LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 390
           Y+ + N IHRDL+AAN+L+ +N V K+ADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
            +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P+     L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234

Query: 450 LLERCWQQDPALRPDFSEIIEILQ 473
           L++ CW++DP  RP F  I   L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  170 bits (431), Expect = 2e-49
 Identities = 87/263 (33%), Positives = 153/263 (58%), Gaps = 10/263 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WE+  + LK   K+ +G +G+++ G Y     VAIK LK   ++ +    F  E  +M++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 333
           ++H  +V+     T+ P + I+TE+M  GS+ D+L   +G+   +  L+ +A  +++GM 
Sbjct: 58  LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           ++ + N IHRDL+AAN+L+ E    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L EL
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYEL 235

Query: 451 LERCWQQDPALRPDFSEIIEILQ 473
           +  CW++ P  RP F  +  +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  169 bits (429), Expect = 3e-49
 Identities = 88/247 (35%), Positives = 142/247 (57%), Gaps = 12/247 (4%)

Query: 229 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           +  G++G++++GT   +  VA+K  K E +  +++ +F  E  I+++  H N+V+ IG C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
           T+   + IV E + GG    +L K K   K   L+K A+D + GM YL   N IHRDL A
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 348 ANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
            N L+ EN V+K++DFG++R     + + SG+        +W APE + +  Y  ++DV+
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVW 178

Query: 403 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           S+GI+LWE  + G  PY  +T  Q A   V+KG R + P+     + ++++RCW   P  
Sbjct: 179 SYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237

Query: 462 RPDFSEI 468
           RP FSE+
Sbjct: 238 RPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  168 bits (427), Expect = 1e-48
 Identities = 81/243 (33%), Positives = 126/243 (51%), Gaps = 14/243 (5%)

Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GSYG +Y+  +    Q VAIKV+  E    ++ KE    + I+++     +V++ G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L IV E+   GSV D +           +  +     KG+ YLH N  IHRD+
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 403
           KA N+L++E    K+ADFGV+  +    +    T  GT  WMAPEVI+   Y++KAD++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK---GLRPTIPKNSQPKLAELLERCWQQDPA 460
            GI   E+  GK PY  + P++A   +  K    L    P+   P+  + +++C  +DP 
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKWSPEFNDFVKKCLVKDPE 242

Query: 461 LRP 463
            RP
Sbjct: 243 ERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  168 bits (426), Expect = 1e-48
 Identities = 98/264 (37%), Positives = 157/264 (59%), Gaps = 12/264 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M+K
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 333
           +RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ GM 
Sbjct: 58  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 390
           Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175

Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
            +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 234

Query: 450 LLERCWQQDPALRPDFSEIIEILQ 473
           L+ +CW+++P  RP F  +   L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  167 bits (425), Expect = 2e-48
 Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 14/255 (5%)

Query: 231 SGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            G++G + +G Y  +      VA+K LK E I +  +KEF +E  +M ++ H  +V+ IG
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIG 63

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            C K   L +V E    G +  YL K +    +  L ++A  V+ GM YL   + +HRDL
Sbjct: 64  VC-KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121

Query: 346 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADV 401
            A N+L+      K++DFG++R + A S    A T      +W APE I +  +  K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181

Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           +S+G+ LWE  + G  PY  +      + +++ G R   P+    ++  ++  CW+  P 
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240

Query: 461 LRPDFSEIIEILQQI 475
            RP FSE+    ++ 
Sbjct: 241 DRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  166 bits (422), Expect = 5e-48
 Identities = 88/262 (33%), Positives = 153/262 (58%), Gaps = 9/262 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + +K   K+ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M+ 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 333
           ++H  +V+     TK   + I+TE+M+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              +  K+DV+SFGI+L+E++T GK+PY  ++        +Q+G R    +N   +L ++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236

Query: 451 LERCWQQDPALRPDFSEIIEIL 472
           ++ CW++    RP F  +  +L
Sbjct: 237 MKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  163 bits (415), Expect = 1e-46
 Identities = 88/300 (29%), Positives = 154/300 (51%), Gaps = 41/300 (13%)

Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 260
           +P D    WE+    L  G  +  G++G + +      D       VA+K+LK +    D
Sbjct: 1   LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58

Query: 261 MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 309
           +  +   E+ +M+ + +HKN++  +G CT+   L +V E+ + G++ D+L          
Sbjct: 59  L-SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 310 -----HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
                   +       L+  A  V++GM +L     IHRDL A N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 365 VAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GK 415
           +AR         K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G 
Sbjct: 178 LARDIHHIDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232

Query: 416 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            PY  + P++    ++++G R   P+N   +L  L+  CW + P+ RP F +++E L ++
Sbjct: 233 SPYPGI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  160 bits (407), Expect = 4e-46
 Identities = 84/253 (33%), Positives = 144/253 (56%), Gaps = 10/253 (3%)

Query: 228 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           ++  G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            CT+   + IV E + GG    +L       K+  L+++  + + GM YL   + IHRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADV 401
            A N L+ E  V+K++DFG++R + + GV  +  G      +W APE + +  Y  ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           +SFGI+LWE  + G +PY  L+  Q     +++G+R   P+     +  L+ERCW+ DP 
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238

Query: 461 LRPDFSEIIEILQ 473
            RP FS + + LQ
Sbjct: 239 QRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  161 bits (408), Expect = 5e-46
 Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 12/269 (4%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           EI P H+     + +G +G+++RG           VAIK LKP       Q +F  E  I
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASI 59

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK     I+TE+M  G++  YL    G F    L+ +   ++ G
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 387
           M YL   N +HRDL A N+L++ N   KV+DFG++RV      G  T   G    RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+SFGIV+WE+++ G+ PY  ++     +  +  G R   P +    
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + +L+ +CWQQD A RP F +I+ +L ++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  160 bits (405), Expect = 1e-45
 Identities = 95/268 (35%), Positives = 139/268 (51%), Gaps = 25/268 (9%)

Query: 229 VASGSYGDLYRGTYCSQD--------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           + SG++G++Y GT             VA+K L+    + + +KEF +E  +M    H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNY 334
           V+ +G C       I+ E M GG +  YL   +       +  L  LL + +DV+KG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 335 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGVMTAETG---TYRWMA 386
           L Q + IHRDL A N L+ E       VVK+ DFG+AR   +S     E       RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           PE +    +  ++DV+SFG+++WE+LT G+ PY  L   +  +  V  G R   P+N   
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPD 240

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQ 473
           K+ +L+  CW QDP+ RP F  I EILQ
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  159 bits (403), Expect = 2e-45
 Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 16/262 (6%)

Query: 220 PKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKE---FAQEVFI 271
           P + + G  +  G++G +Y    C      +++A+K +  +  + + +KE      E+ +
Sbjct: 1   PTNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           ++ ++H+ +VQ+ G      +L I  E+M GGSV D L K  G        K    + +G
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEG 116

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAP 387
           + YLH N I+HRD+K AN+L D    VK+ DFG ++    + +    M + TGT  WM+P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           EVI  + Y  KADV+S G  + E+LT K P+     + A   +  +   P +P +  P  
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 448 AELLERCWQQDPALRPDFSEII 469
              L R + ++   RP   E++
Sbjct: 237 RNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  159 bits (405), Expect = 4e-45
 Identities = 90/289 (31%), Positives = 154/289 (53%), Gaps = 26/289 (8%)

Query: 203 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPE 255
           PY LK        WE    +L FG  + +G++G +   T            VA+K+LKP 
Sbjct: 25  PYDLK--------WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP- 75

Query: 256 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 314
             +S  ++    E+ IM  +  H+N+V  +GACT    + ++TE+   G + ++L + + 
Sbjct: 76  TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135

Query: 315 VF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS 372
            F  L  LL  +  V+KGM +L   N IHRDL A N+L+   ++VK+ DFG+AR +   S
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195

Query: 373 GVMTAETGTYR----WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
             +    G  R    WMAPE I +  Y  ++DV+S+GI+LWE+ + G  PY  +      
Sbjct: 196 NYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253

Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 476
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++ +  
Sbjct: 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 6e-45
 Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 15/253 (5%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
            ++ SG+YGD+Y  R     + VAIKV+K E    D  +   QE+ ++++ RH N+V + 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           G+  +   L IV E+  GGS+ D     +G      +  V  +  KG+ YLH+   IHRD
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126

Query: 345 LKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVIEHK---PYDHKAD 400
           +K AN+L+ E+  VK+ADFGV A++ A      +  GT  WMAPEV   +    YD K D
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-----PKLAELLERCW 455
           +++ GI   EL   + P   L P++A   + +    P  PK        P   + +++C 
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PKLKDKEKWSPVFHDFIKKCL 244

Query: 456 QQDPALRPDFSEI 468
            +DP  RP  +++
Sbjct: 245 TKDPKKRPTATKL 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  156 bits (397), Expect = 3e-44
 Identities = 79/260 (30%), Positives = 134/260 (51%), Gaps = 17/260 (6%)

Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
            L+    +  GS G +Y+  +    +  A+K +     + + +K+  +E+  +R      
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPY 60

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN- 338
           VV+  GA  K   + IV E+M GGS+ D L K  G    P L  +A  + KG++YLH   
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDH 397
           +IIHRD+K +NLL++    VK+ADFG+++V   +        GT  +M+PE I+ + Y +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 398 KADVFSFGIVLWELLTGKLPYE------YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAEL 450
            AD++S G+ L E   GK P+       +   +QA    +  G  P++P     P+  + 
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPPPSLPAEEFSPEFRDF 235

Query: 451 LERCWQQDPALRPDFSEIIE 470
           +  C Q+DP  RP  +E+++
Sbjct: 236 ISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  156 bits (395), Expect = 3e-44
 Identities = 69/246 (28%), Positives = 132/246 (53%), Gaps = 15/246 (6%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G +++    +  +  A+K +   ++N   ++E   E  ++ K+    ++++  
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHR 343
           +      L IV E+   G ++  L   +G   LP   + +  I +  G+ +LH   I+HR
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 401
           D+K+ NL +D  + VK+ D GVA++ + +    A T  GT  +++PE+ E KPY+ K+DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQD 458
           ++ G+VL+E  TGK P++          ++ K +R   P + +    +LA+L+++C  +D
Sbjct: 185 WALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240

Query: 459 PALRPD 464
              RPD
Sbjct: 241 YRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  155 bits (394), Expect = 4e-44
 Identities = 91/263 (34%), Positives = 152/263 (57%), Gaps = 10/263 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M+ 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 333
           ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L  +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235

Query: 451 LERCWQQDPALRPDFSEIIEILQ 473
           + RCW+  P  RP F  I  +L 
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  152 bits (386), Expect = 1e-42
 Identities = 84/270 (31%), Positives = 141/270 (52%), Gaps = 14/270 (5%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ID   +K    + +G +G++ RG           VAIK LK        +++F  E  IM
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
            +  H N++   G  TK   + I+TEFM  G++  +L +  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWMA 386
            YL + N +HRDL A N+L++ N V KV+DFG++R           T +       RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           PE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P +   
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQI 475
            L +L+  CWQ+D   RP F +I+  L ++
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  151 bits (383), Expect = 7e-42
 Identities = 89/301 (29%), Positives = 149/301 (49%), Gaps = 41/301 (13%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G +G + R      D         VA+K+LK    + D+  +  
Sbjct: 7   WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLI 65

Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------ 313
            E+ +M+ + +HKN++  +G CT+   L ++ E+ + G++ ++L   +            
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 314 ---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 367
                     L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 368 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
                 K  +G +       +WMAPE +  + Y H++DV+SFGI++WE+ T G  PY  +
Sbjct: 186 DIDYYKKTSNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 481
            P++    ++++G R   P N   +L  L+  CW   P  RP F +++E L ++   V E
Sbjct: 241 -PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299

Query: 482 E 482
           E
Sbjct: 300 E 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  150 bits (379), Expect = 9e-42
 Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 12/268 (4%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 272
           ID   +K    + +G +G++  G           VAIK LK        +++F  E  IM
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
            +  H N++   G  TK   + IVTE+M  GS+  +L K  G F +  L+ +   ++ GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAPE 388
            YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P +    L
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAAL 238

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQI 475
            +L+  CWQ+D   RP F +I+ IL ++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  149 bits (379), Expect = 1e-41
 Identities = 91/284 (32%), Positives = 138/284 (48%), Gaps = 36/284 (12%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEFAQEV 269
           E+    +     +  G++G++Y G Y  +D       VA+K L PE  +   + +F  E 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------LLK 323
            IM K  H+N+V+ IG   +     I+ E M+GG +  +L + +   + PS      LL 
Sbjct: 61  LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETG 380
            A DV+KG  YL +N+ IHRD+ A N L+       V K+ADFG+AR   ++        
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY------ 174

Query: 381 TYR----------WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 429
            YR          WM PE      +  K DV+SFG++LWE+ + G +PY   T  Q  + 
Sbjct: 175 -YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVME 232

Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V  G R   PK     +  ++  CWQ  P  RP+F+ I+E +Q
Sbjct: 233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  149 bits (378), Expect = 1e-41
 Identities = 82/259 (31%), Positives = 135/259 (52%), Gaps = 16/259 (6%)

Query: 223 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           L++  ++ +G+ G     L+R T   + +A+K ++ E IN  +QK+  +E+ I+ K    
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPT--GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-Q 337
            +V F GA      + I  E+M GGS+   L +++G      L K+A+ V KG+ YLH +
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           + IIHRD+K +N+L++    +K+ DFGV+     S   T   GT  +MAPE I+   Y  
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSV 178

Query: 398 KADVFSFGIVLWELLTGKLPY-----EYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELL 451
           K+D++S G+ L EL TG+ PY           +    +V     P +P     P   + +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFV 237

Query: 452 ERCWQQDPALRPDFSEIIE 470
             C  +DP  RP + E++E
Sbjct: 238 NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  149 bits (378), Expect = 2e-41
 Identities = 83/278 (29%), Positives = 142/278 (51%), Gaps = 28/278 (10%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           EI    ++F  ++  G++G +Y+G          +  VAIK LK E     +Q+EF QE 
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 314
            +M  ++H N+V  +G CTK    C++ E+++ G ++++L                 +K 
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 373
                  L +AI ++ GM YL  ++ +HRDL A N L+ E   VK++DFG++R    +  
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179

Query: 374 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
             V +      RWM PE I +  +  ++D++SFG+VLWE+ + G  PY Y    Q  + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSNQEVIEM 238

Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           ++       P++   ++  L+  CW + PA RP F +I
Sbjct: 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 5e-41
 Identities = 84/262 (32%), Positives = 139/262 (53%), Gaps = 20/262 (7%)

Query: 229 VASGSYGDLYRGTY--CSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRH---KNV 280
           +  G+YG +YRG +    + VA+K++    P+   SD+Q+E A    ++ ++R     N+
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNI 64

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            ++ G+  K P L I+ E+  GGSV   +    G      +  +  +V   + Y+H+  +
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHK 398
           IHRD+KAAN+L+     VK+ DFGVA +  Q S   +   GT  WMAPEVI E K YD K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQ 457
           AD++S GI ++E+ TG  PY  +   + A+ ++ K   P +  N     L E +  C  +
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241

Query: 458 DPALRPDFSEIIEI--LQQIAK 477
           +P  R    E+++   ++  +K
Sbjct: 242 EPKERLSAEELLKSKWIKAHSK 263

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 1e-40
 Identities = 83/271 (30%), Positives = 141/271 (52%), Gaps = 22/271 (8%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE-FAQ 267
           +  D+WEI         ++  G++G +Y+  +    +  A K+++   I S+ + E F  
Sbjct: 2   NPNDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMV 51

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E+ I+ + +H N+V    A      L I+ EF  GG++   + +L+     P +  V   
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 386
           + + +N+LH + +IHRDLKA N+L+  +  VK+ADFGV A+ K+         GT  WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 387 PEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI-- 439
           PEV+     +  PYD+KAD++S GI L EL   + P+  L P++  +  + K   PT+  
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQ 230

Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           P        + L+ C  +DP  RP  +E+++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  146 bits (370), Expect = 2e-40
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 41/283 (14%)

Query: 223 LKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           LK G  +  G +G +  G     D     VA+K +K +       +EF  E   M+   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 278 KNVVQFIGAC------TKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SLLKVAI 326
            NV++ IG C       K P   ++  FM  G ++ +L   +      KLP  +LLK  +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----Y 382
           D++ GM YL   N IHRDL A N ++ E+  V VADFG+++ K  SG    +        
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPV 179

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP---------YEYLTPLQAAVGVVQ 432
           +W+A E +  + Y  K+DV++FG+ +WE+ T G+ P         Y+YL          +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL----------R 229

Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            G R   P++   +L +L+  CW+ DP  RP F+++ E+L+ I
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  146 bits (369), Expect = 2e-40
 Identities = 83/261 (31%), Positives = 146/261 (55%), Gaps = 20/261 (7%)

Query: 226 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSD-------MQKEFAQEVFIMRKVR 276
           G+ + SGS+G +Y G   S    +A+K ++   +++        M    A+E+ ++++++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H+N+VQ++G+      L I  E++ GGSV   L+   G F+   +      + KG+NYLH
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH 123

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--------WMAPE 388
              IIHRD+K AN+L+D    +K++DFG+++ K ++  ++ +T   R        WMAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           V++   Y  KAD++S G ++ E+LTGK P+   T LQA   + +    P IP N   +  
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAI 241

Query: 449 ELLERCWQQDPALRPDFSEII 469
           + LE+ ++ D   RP  +E++
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  145 bits (368), Expect = 3e-40
 Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 26/265 (9%)

Query: 229 VASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQK--EFAQEVFIMRKVRHKNVV 281
           +  G +G +Y GT    D      A+K L   RI +D+++  +F +E  IM+   H NV+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 282 QFIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
             +G C        +V  +M  G + +++        +  L+   + V+KGM YL     
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119

Query: 341 IHRDLKAANLLMDENEVVKVADFGVAR---------VKAQSGVMTAETGTYRWMAPEVIE 391
           +HRDL A N ++DE+  VKVADFG+AR         V   +G         +WMA E ++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQ 175

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
            + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEV 234

Query: 451 LERCWQQDPALRPDFSEIIEILQQI 475
           +  CW   P +RP FSE++  ++QI
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  144 bits (366), Expect = 4e-40
 Identities = 74/248 (29%), Positives = 132/248 (53%), Gaps = 7/248 (2%)

Query: 227 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
            K+  GSYG +Y+    S  Q  A+K +    ++   +++   E+ I+  V H N++ + 
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
            A      LCIV E+   G +   + K    + +     + ++ I + +G+  LH+  I+
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
           HRDLK+AN+L+  N++VK+ D G+++V  +  +   + GT  +MAPEV + +PY +K+D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           +S G +L+E+ T   P+E  + +Q     VQ+G  P IP      L   +    Q  P L
Sbjct: 185 WSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKL 243

Query: 462 RPDFSEII 469
           RP+  +I+
Sbjct: 244 RPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  144 bits (365), Expect = 1e-39
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 17/259 (6%)

Query: 226 GSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           G+K+  G++G +Y     + D    +A+K ++ +  +    KE A E+ ++  ++H N+V
Sbjct: 5   GNKIGGGTFGKVYTAV--NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           ++ G       + I  E+ SGG++ + L     +     +    + + +G+ YLH + I+
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYD 396
           HRD+K AN+ +D N V+K+ DFG A     +     E      GT  +MAPEVI      
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 397 HK---ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 451
                AD++S G V+ E+ TGK P+  L      +  V  G +P IP + Q  P+  + L
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL 241

Query: 452 ERCWQQDPALRPDFSEIIE 470
           +RC + DP  RP  SE+++
Sbjct: 242 DRCLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  145 bits (368), Expect = 1e-39
 Identities = 83/260 (31%), Positives = 142/260 (54%), Gaps = 13/260 (5%)

Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL +  ++H
Sbjct: 74  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132

Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A      AE G    +WMA E I H+ Y H++
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192

Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251

Query: 459 PALRPDFSEIIEILQQIAKE 478
              RP F E+I    ++A++
Sbjct: 252 ADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  145 bits (366), Expect = 1e-39
 Identities = 88/294 (29%), Positives = 148/294 (50%), Gaps = 41/294 (13%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLI 71

Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL                
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 367
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 368 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
                 K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  +
Sbjct: 192 HIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 247 -PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  144 bits (365), Expect = 2e-39
 Identities = 89/305 (29%), Positives = 144/305 (47%), Gaps = 56/305 (18%)

Query: 217 EIDPKHLKFGSKVASGSYGDLY-RGTYCSQD-----------------VAIKVLKPERIN 258
           E   + L F  K+  G +G+++       QD                 VA+KVL+P+  +
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-AS 59

Query: 259 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK------- 311
            + +++F +EV I+ ++   N+ + +G CT  P LC++ E+M  G +  +L K       
Sbjct: 60  DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119

Query: 312 -LKGVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 368
                  L   +LL +A  ++ GM YL   N +HRDL   N L+ +N  +K+ADFG++R 
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178

Query: 369 KAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GK 415
                     +  Y           RWMA E +    +  K+DV++FG+ LWE+LT   +
Sbjct: 179 -------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Query: 416 LPYEYLTP---LQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEII 469
            PYE+LT    ++ A    +   R      P N    + EL+  CW++D   RP F EI 
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291

Query: 470 EILQQ 474
             LQ+
Sbjct: 292 LFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  144 bits (365), Expect = 2e-39
 Identities = 90/303 (29%), Positives = 154/303 (50%), Gaps = 43/303 (14%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERI 257
           ++P D    WE     L  G  +  G +G +        D         VA+K+LK +  
Sbjct: 3   ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 258 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--- 313
             D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +   
Sbjct: 61  EKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 314 -----GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 361
                 + ++P        L+     V++GM YL     IHRDL A N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179

Query: 362 DFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
           DFG+AR         K  +G +       +WMAPE +  + Y H++DV+SFG+++WE+ T
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Query: 414 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
            G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L
Sbjct: 235 LGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Query: 473 QQI 475
            +I
Sbjct: 294 DRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  143 bits (363), Expect = 3e-39
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 27/253 (10%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K+LK E  ++DMQ +F +E  +M +  H N+V+ +G C     +C++ E+M+ G + 
Sbjct: 38  VAVKMLK-EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 307 DYLH-----------------KLKGVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDL 345
           ++L                  +  G+  LP      L +A  V+ GM YL +   +HRDL
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVF 402
              N L+ EN VVK+ADFG++R    +    A        RWM PE I +  Y  ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 403 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           ++G+VLWE+ + G  PY Y    +  +  V+ G   + P N   +L  L+  CW + P+ 
Sbjct: 217 AYGVVLWEIFSYGMQPY-YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275

Query: 462 RPDFSEIIEILQQ 474
           RP F+ I  ILQ+
Sbjct: 276 RPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  144 bits (365), Expect = 4e-39
 Identities = 90/294 (30%), Positives = 152/294 (51%), Gaps = 41/294 (13%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G +G +        D         VA+K+LK +  + D+  +  
Sbjct: 7   WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLV 65

Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +           K
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 367
           LP        L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Query: 368 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
                 K  +G +       +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  +
Sbjct: 186 NIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L ++
Sbjct: 241 -PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  141 bits (358), Expect = 8e-39
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 16/259 (6%)

Query: 226 GSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDM-QKEFA---QEVFIMRKVRHKNV 280
           G  +  G+YG +Y G T   Q +A+K ++ +  N    +KE+    +EV +++ ++H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           VQ++G C    ++ I  EF+ GGS+   L++  G    P   K    +  G+ YLH N +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKA-------QSGVMTAETGTYRWMAPEVIEHK 393
           +HRD+K  N+++  N ++K+ DFG AR  A        S ++ +  GT  WMAPEVI   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELL 451
            Y  K+D++S G  ++E+ TGK P   +  L A   +G   +GL P +P +      + +
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFV 242

Query: 452 ERCWQQDPALRPDFSEIIE 470
             C  +D   RP   +++ 
Sbjct: 243 TSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 1e-38
 Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 53/291 (18%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQE 268
           D T ++E+          +  G+YG +Y+  +    Q VAIK++    I  D ++E  +E
Sbjct: 3   DPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEE 52

Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 321
             I+RK   H N+  F GA  K           +V E   GGSV D +   KG+ K    
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109

Query: 322 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGV 374
           LK         +  +G+ YLH+N +IHRD+K  N+L+ +N  VK+ DFGV+  + +  G 
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 375 MTAETGTYRWMAPEVI--EHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                GT  WMAPEVI  + +P   YD ++DV+S GI   EL  GK P   + P++A   
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF- 228

Query: 430 VVQKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 470
                    IP+N  P L           + +  C  ++   RP   E++E
Sbjct: 229 --------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  142 bits (358), Expect = 1e-38
 Identities = 92/293 (31%), Positives = 149/293 (50%), Gaps = 34/293 (11%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           WE     +KF   +  G++G + R          + AIK+LK E  + +  ++FA E+ +
Sbjct: 1   WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55

Query: 272 MRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------- 320
           + K+  H N++  +GAC     L I  E+   G++ D+L K + +   P+          
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 321 -----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
                LL+ A DV+ GM YL +   IHRDL A N+L+ EN   K+ADFG++R +      
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 434
           T      RWMA E + +  Y  K+DV+SFG++LWE+++ G  PY  +T  +    + Q G
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234

Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERR 487
            R   P+N   ++ EL+ +CW+  P  RP F+       QI+ ++    E R+
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFA-------QISVQLSRMLEARK 280

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  141 bits (357), Expect = 3e-38
 Identities = 87/282 (30%), Positives = 149/282 (52%), Gaps = 23/282 (8%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           ++   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62

Query: 274 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 320
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 321 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
              P N   ++ +L+ +CW++ P  RP F++I+  L ++ +E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  140 bits (355), Expect = 4e-38
 Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 40/277 (14%)

Query: 229 VASGSYGDLYRGTYCS----QD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +  G++G ++ G         D   VA+K LK E  ++D +K+F +E  ++   +H+N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHK-------------LKGVFKLPSLLKVAIDV 328
           +F G CT+     +V E+M  G +  +L                 G   L  LL++A+ +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------ 382
           + GM YL   + +HRDL   N L+  + VVK+ DFG++R      V T  T  Y      
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184

Query: 383 ----RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 437
               RWM PE I ++ +  ++DV+SFG+VLWE+ T GK P+ Y    +  +  + +G   
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEVIECITQGRLL 243

Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             P+    ++ +++  CW++DP  R +  +I E LQ+
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  140 bits (354), Expect = 4e-38
 Identities = 82/246 (33%), Positives = 136/246 (55%), Gaps = 7/246 (2%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G++++G      + VAIK++  E    +++ +  QE+ ++ +     V ++ G
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 127

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 404
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           GI   EL  G+ P+  L P++  + ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 188 GITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246

Query: 465 FSEIIE 470
             E+++
Sbjct: 247 AKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  140 bits (353), Expect = 5e-38
 Identities = 84/254 (33%), Positives = 132/254 (51%), Gaps = 23/254 (9%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           ++  GS+G++Y+G      + VAIK++  E    +++ +  QE+ ++ +     + ++ G
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L I+ E++ GGS  D L    G  +   +  +  ++ KG++YLH    IHRD+
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           KAAN+L+ E   VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL--------AELLERCWQ 456
           GI   EL  G+ P   L P++             IPKNS P L         E +E C  
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSKPFKEFVEACLN 238

Query: 457 QDPALRPDFSEIIE 470
           +DP  RP   E+++
Sbjct: 239 KDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  138 bits (350), Expect = 1e-37
 Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 14/269 (5%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQEV 269
           E+D K +K    + +G +G+L RG  C +        VAI  L+    +   ++ F  E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRG--CLKLPSKRELPVAIHTLR-AGCSDKQRRGFLAEA 57

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
             + +  H N+V+  G  T+  ++ IVTE+MS G++  +L K +G      L+ +   ++
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAP 387
            GM YL +   +H+ L A  +L++ + V K++ F   +      + T  +G     W AP
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I++  +   +DV+SFGIV+WE+++ G+ PY  ++  Q  +  V+ G R   P+N    
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNL 236

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           L +L+  CWQ++   RP FS+I  IL ++
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  139 bits (351), Expect = 1e-37
 Identities = 81/260 (31%), Positives = 140/260 (53%), Gaps = 13/260 (5%)

Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +          VAIKVL+ E  +    KE   E ++M  V    V +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ +VT+ M  G + DY+ + K       LL   + ++KGM+YL +  ++H
Sbjct: 74  LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132

Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+     VK+ DFG+AR +        A+ G    +WMA E I H+ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192

Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 251

Query: 459 PALRPDFSEIIEILQQIAKE 478
              RP F E+++   ++A++
Sbjct: 252 SECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  138 bits (350), Expect = 2e-37
 Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 21/257 (8%)

Query: 239 RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIV 296
            G    + VA+K LKPE   + +  +  +E+ I+R + H+N+V++ G CT+     + ++
Sbjct: 28  EGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            EF+  GS+ +YL + K    L   LK A+ + KGM+YL     +HRDL A N+L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 357 VVKVADFGVAR-VKAQSGVMTAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
            VK+ DFG+ + ++      T +        W APE +    +   +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 413 T--------GKLPYEYLTPLQAA------VGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           T          L  + + P          V V+++G R   P N   ++ +L+ +CW+  
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266

Query: 459 PALRPDFSEIIEILQQI 475
           P+ R  F  +IE  + I
Sbjct: 267 PSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  138 bits (348), Expect = 2e-37
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 22/265 (8%)

Query: 226 GSKVASGSYGDLYRGTYCS--QDVAIK-VLKPERINS-------DMQKEFAQEVFIMRKV 275
           G  +  G+YG +Y     +  + +A+K V  P  I         DM K    E+  ++ +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H N+VQ++G  T    L I  E++ GGS+   L    G F+   +      V +G+ YL
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYL 124

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAPEVIE 391
           H   I+HRDLKA NLL+D + + K++DFG+++    +      M+ + G+  WMAPEVI 
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183

Query: 392 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL-- 447
              + Y  K D++S G V+ E+  G+ P+     + A   +  K   P IP +    L  
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243

Query: 448 --AELLERCWQQDPALRPDFSEIIE 470
              + L  C+  +P  RP   E+++
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  137 bits (347), Expect = 3e-37
 Identities = 83/252 (32%), Positives = 138/252 (54%), Gaps = 19/252 (7%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           ++  GS+G++++G      Q VAIK++  E    +++ +  QE+ ++ +     V ++ G
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           +  K   L I+ E++ GGS  D L       F++ ++LK   ++ KG++YLH    IHRD
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126

Query: 345 LKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           +KAAN+L+ E   VK+ADFGVA      ++K  + V     GT  WMAPEVI+   YD K
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIQQSAYDSK 181

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           AD++S GI   EL  G+ P   + P++    ++ K   PT+         E ++ C  +D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 459 PALRPDFSEIIE 470
           P+ RP   E+++
Sbjct: 241 PSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  137 bits (347), Expect = 6e-37
 Identities = 82/260 (31%), Positives = 141/260 (54%), Gaps = 13/260 (5%)

Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C  P ++ +VT+ M  G + DY+H+ K       LL   + ++KGM YL +  ++H
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132

Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192

Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 193 DVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251

Query: 459 PALRPDFSEIIEILQQIAKE 478
              RP F E+     ++A++
Sbjct: 252 ADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  136 bits (343), Expect = 9e-37
 Identities = 70/247 (28%), Positives = 133/247 (53%), Gaps = 7/247 (2%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++G+  LYR T     V  K +   R++   +++   E+ I+  ++H N++ +   
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 287 CTKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                +L I  E+ +GG++YD +  +   +F+   +L     +   ++Y+H+  I+HRD+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 403
           K  N+ + +  ++K+ DFG++++      M AET  GT  +M+PE+ +   Y+ K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 463
            G VL+ELLT K  ++   PL   V +VQ    P +   S  +L  L+    QQDP  RP
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHSLLQQDPEKRP 245

Query: 464 DFSEIIE 470
              E+++
Sbjct: 246 TADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  134 bits (340), Expect = 3e-36
 Identities = 78/251 (31%), Positives = 129/251 (51%), Gaps = 20/251 (7%)

Query: 238 YRGTYCSQDV------AIKVLKPERINSDMQKEFAQ----EVFIMRKVRHKNVVQFIGAC 287
           +   Y ++DV      A+K +   R  S  Q+E  +    E+ +M ++ H ++++ +GA 
Sbjct: 13  FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
            +     +  E+M+GGSV   L K  G FK   ++     + +G++YLH+N IIHRD+K 
Sbjct: 73  CEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131

Query: 348 ANLLMDEN-EVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKADV 401
           ANLL+D   + +++ADFG A   A  G    E      GT  +MAPEV+  + Y    DV
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191

Query: 402 FSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           +S G V+ E+ T K P+   ++   L     +      P+IP++  P L ++  RC +  
Sbjct: 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ 251

Query: 459 PALRPDFSEII 469
           P  RP   E++
Sbjct: 252 PEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  134 bits (339), Expect = 6e-36
 Identities = 86/282 (30%), Positives = 143/282 (50%), Gaps = 31/282 (10%)

Query: 221 KHLKFGSKVASGSYGD--LYRGTYCSQD----VAIKVLKPERINSDMQKE-FAQEVFIMR 273
           ++LK    +  G +G   LY     +      VA+K LK E          + +E+ I++
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61

Query: 274 KVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            + H+N+V++ G C++     L ++ E++  GS+ DYL K K    L  LL  A  + +G
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYR--WMAP 387
           M YLH  + IHRDL A N+L+D + +VK+ DFG+A+   +        E G     W A 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLTGKLPY--------EYLTPLQAAVGVV------QK 433
           E ++   + + +DV+SFG+ L+ELLT             E + P Q  + VV      ++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           G+R   PKN   ++  L++ CW+ +   RP F  +I IL+++
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  134 bits (338), Expect = 1e-35
 Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 29/282 (10%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS-QD-----VAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +HLKF  ++  G++G +    Y   QD     VA+K L+     ++  ++F +E+ I++ 
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61

Query: 275 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           ++H N+V++ G C      +L +V E++  GS+ DYL K +       LL  A  + KGM
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYR--WMAPE 388
            YL     +HRDL   N+L++    VK+ DFG+ +V  Q        E G     W APE
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYL------TPLQAAV----GVVQK 433
            +    +   +DV+SFG+VL+EL T        P E++         Q  V     +++ 
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             R   P     ++  +++ CW  DP+ RP FSE+   ++ I
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  133 bits (335), Expect = 2e-35
 Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 23/261 (8%)

Query: 229 VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 283
           +  G++G + +          D AIK +K E  + D  ++FA E+ ++ K+  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------------LLKVAIDV 328
           +GAC     L +  E+   G++ D+L K + +   P+               LL  A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           ++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T      RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R   P N   ++
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240

Query: 448 AELLERCWQQDPALRPDFSEI 468
            +L+ +CW++ P  RP F++I
Sbjct: 241 YDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  136 bits (341), Expect = 2e-35
 Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 27/273 (9%)

Query: 224 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRH-KNVV 281
           +   K+  GS+G++Y      + VA+KVL  +  + S   + F +E+ I+  + H  N+V
Sbjct: 3   RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +         SL +V E++ GGS+ D L K+  KG       L +   +   + YLH   
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 340 IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-------MTAETGTYRWMAPEVIE 391
           IIHRD+K  N+L+D +  VVK+ DFG+A++    G         +   GT  +MAPEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 392 HK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-----------GLRP 437
                     +D++S GI L+ELLTG  P+E      A    ++             L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           + P+      ++LL++   +DP  R   S  + 
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  133 bits (335), Expect = 2e-35
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 28/272 (10%)

Query: 223 LKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV 275
           ++F  ++   ++G +Y+G         +Q VAIK LK   IN+  Q  EF QE  +M ++
Sbjct: 7   VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAEL 64

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL----------------HKLKGVFKLP 319
            H N+V  +G  T+   +C++ E+++ G ++++L                  +K      
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 379
             L +AI ++ GM YL  +  +H+DL A N+L+ E   VK++D G++R    +     + 
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 380 GTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
            +    RWM PE I +  +   +D++SFG+VLWE+ +  L   Y    Q  + +V+K   
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
               ++  P++  L+  CWQ+ P+ RP F +I
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  132 bits (334), Expect = 2e-35
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 32/284 (11%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF  E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 59

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPSL- 321
             +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PSL 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 322 --LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQ 371
             +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K  
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
            G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ ++  Q    V
Sbjct: 180 KGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
           ++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 235 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  132 bits (333), Expect = 5e-35
 Identities = 79/287 (27%), Positives = 146/287 (50%), Gaps = 36/287 (12%)

Query: 223 LKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           L  G  +  G +G + + T            VA+K+LK E  +S   ++   E  ++++V
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------- 315
            H +V++  GAC++   L ++ E+   GS+  +L + + V                    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 316 ---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 371
                +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG++R V  +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 372 SGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  + P +   
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLF 239

Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +++ G R   P+N   ++  L+  CW+Q+P  RP F++I + L+++
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  131 bits (331), Expect = 1e-34
 Identities = 76/244 (31%), Positives = 120/244 (49%), Gaps = 27/244 (11%)

Query: 258 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGS---VYDYLHKL 312
           N D+QK+  +E+ I +  +   +V++ GA     S  + I  E+  GGS   +Y  + K 
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 372
            G      L K+A  V KG++YLH   IIHRD+K +N+L+     VK+ DFGV+     S
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 432
              T  TGT  +MAPE I+ KPY   +DV+S G+ L E+   + P+    P +    +  
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF----PPEGEPPLGP 213

Query: 433 KGLRPTIPKNSQPKLAE--------------LLERCWQQDPALRPDFSEIIE---ILQQI 475
             L   I     P+L +               +++C ++DP  RP   +++E   I  Q+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273

Query: 476 AKEV 479
            K+V
Sbjct: 274 KKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  130 bits (328), Expect = 1e-34
 Identities = 79/249 (31%), Positives = 135/249 (54%), Gaps = 13/249 (5%)

Query: 232 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 290
           G+YG +Y     S  V I + + PER +  +Q    +E+ +   ++H+N+VQ++G+ ++ 
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSDSEN 77

Query: 291 PSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               I  E + GGS+   L    G  K    +++     + +G+ YLH N I+HRD+K  
Sbjct: 78  GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137

Query: 349 NLLMDE-NEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP--YDHKADVFSF 404
           N+L++  + VVK++DFG ++  A     T   TGT ++MAPEVI+  P  Y   AD++S 
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197

Query: 405 GIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           G  + E+ TGK P+  L   QAA   VG+ +    P IP++   +    + RC++ DP  
Sbjct: 198 GCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDK 255

Query: 462 RPDFSEIIE 470
           R    ++++
Sbjct: 256 RASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  129 bits (325), Expect = 3e-34
 Identities = 76/250 (30%), Positives = 136/250 (54%), Gaps = 12/250 (4%)

Query: 228 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           ++ SG++G + +G Y  +    DVAIKVLK E   S  + E  +E  IM ++ +  +V+ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRM 60

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG C +  +L +V E  SGG +  +L   K    + +++++   VS GM YL   N +HR
Sbjct: 61  IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 344 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKA 399
           DL A N+L+      K++DFG+++ + A      A +      +W APE I  + +  ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+GI +WE  + G+ PY+ +   +  +  +++G R   P    P++  L++ CW   
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238

Query: 459 PALRPDFSEI 468
              RP+F+++
Sbjct: 239 WEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 3e-34
 Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 7/218 (3%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+KVLK ++I    + E    E  I+ ++ H  +V+   A      L +V E+  GG ++
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
            +L K +G F        A ++   + YLH   II+RDLK  N+L+D +  +K+ DFG+A
Sbjct: 82  SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140

Query: 367 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
           +  + S      T  GT  ++APEV+  K Y    D +S G++L+E+LTGK P+ Y    
Sbjct: 141 KELS-SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDR 198

Query: 425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           +     + K      P+   P+  +L+    Q+DP  R
Sbjct: 199 KEIYEKILKD-PLRFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  129 bits (326), Expect = 3e-34
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 29/264 (10%)

Query: 232 GSYGDLY----RGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           G +G+++    +G         V +K L+ +  + ++Q EF +E+ + RK+ HKNVV+ +
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKLSHKNVVRLL 74

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSL-----LKVAIDVSKGMNYLH 336
           G C +     ++ E+   G +  +L   K      K P L     + +   ++ GM++L 
Sbjct: 75  GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-------RWMAPEV 389
               +HRDL A N L+     VKV+   +++    S     E           RW+APE 
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLRNALIPLRWLAPEA 189

Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           ++   +  K+DV+SFG+++WE+ T G+LP+  L+  +    +    L   +P+    +L 
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 449 ELLERCWQQDPALRPDFSEIIEIL 472
           +L+ RCW  +P  RP FSE++  L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  128 bits (324), Expect = 7e-34
 Identities = 73/263 (27%), Positives = 132/263 (50%), Gaps = 26/263 (9%)

Query: 232 GSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFI 284
           G++G ++ G          ++V +K +K     S++Q     QE  ++  + H+N++  +
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPIL 74

Query: 285 GACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS-------LLKVAIDVSKGMNY 334
             C +   PP +     +M+ G++  +L + +              L+ +AI ++ GM+Y
Sbjct: 75  HVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR---WMAPEVIE 391
           LH+  +IH+D+ A N ++DE   VK+ D  ++R               R   WMA E + 
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           +K Y   +DV+SFG++LWEL+T G+ PY  + P + A   ++ G R   P N   +L  +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAV 251

Query: 451 LERCWQQDPALRPDFSEIIEILQ 473
           +  CW  DP  RP FS++++ L 
Sbjct: 252 MACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  128 bits (324), Expect = 8e-34
 Identities = 82/291 (28%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKP-----ERINSDM 261
           WE+  + +    ++  GS+G +Y G   ++D         VA+K +       ERI    
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGN--ARDIIKGEAETRVAVKTVNESASLRERI---- 54

Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---- 317
             EF  E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +    
Sbjct: 55  --EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 318 -----LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----- 367
                L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R     
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 368 ---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 423
               K   G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+ 
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            Q    V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+ 
Sbjct: 228 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  127 bits (321), Expect = 1e-33
 Identities = 72/250 (28%), Positives = 138/250 (55%), Gaps = 12/250 (4%)

Query: 228 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           ++ SG++G + +G Y      + VA+K+LK +  +  ++ E  +E  +M+++ +  +V+ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG C +  S  +V E    G +  +L K K V    ++ ++   VS GM YL + N +HR
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 344 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKA 399
           DL A N+L+      K++DFG+++ + A      A+T G +  +W APE + +  +  K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179

Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+SFG+++WE  + G+ PY+ +   +    +++ G R   P+   P++ +L++ CW   
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238

Query: 459 PALRPDFSEI 468
              RP F+ +
Sbjct: 239 VDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  128 bits (322), Expect = 1e-33
 Identities = 82/256 (32%), Positives = 129/256 (50%), Gaps = 36/256 (14%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG------ACTKPPSLCIVTE 298
           Q VA+K+LK +  +S   +EF +E   M++  H NV++ IG      A  + P   ++  
Sbjct: 28  QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87

Query: 299 FMSGGSVYDYLHKLK---GVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 353
           FM  G ++ +L   +     F LP  +L++  ID++ GM YL   N IHRDL A N +++
Sbjct: 88  FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147

Query: 354 ENEVVKVADFGVARVKAQSGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 409
           EN  V VADFG+++ K  SG       A     +W+A E +    Y   +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 410 ELLT-GKLP---------YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           E++T G+ P         Y YL           KG R   P +    + EL+ +CW  +P
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLI----------KGNRLKQPPDCLEDVYELMCQCWSPEP 256

Query: 460 ALRPDFSEIIEILQQI 475
             RP F  + + L+ I
Sbjct: 257 KCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  127 bits (320), Expect = 2e-33
 Identities = 68/245 (27%), Positives = 131/245 (53%), Gaps = 5/245 (2%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V  G++G ++  R     + V IK +  E++  D +     E  +++ + H N++++   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
             +  +L IV E+  GG++ +Y+ K    +    ++L   + +   ++++H   I+HRDL
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 346 KAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  N+L+D+++ VVK+ DFG++++ +         GT  +++PE+ E KPY+ K+D+++ 
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           G VL+EL + K  +E    L A V  +  G    I     P L +L+      DP+ RP 
Sbjct: 188 GCVLYELASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQ 246

Query: 465 FSEII 469
            S+I+
Sbjct: 247 LSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  126 bits (319), Expect = 3e-33
 Identities = 72/269 (26%), Positives = 138/269 (51%), Gaps = 13/269 (4%)

Query: 220 PKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMR 273
              L+    + SG +G +++G +  +       VAIK ++ +R      +E    +  M 
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMG 64

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
            + H  +V+ +G C    SL +VT+    GS+ D++ + +       LL   + ++KGM 
Sbjct: 65  SLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVI 390
           YL ++ ++HR+L A N+L+  + +V++ADFGVA +     +    +      +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
               Y H++DV+S+G+ +WE+++ G  PY  + P      +++KG R   P+     +  
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTIDVYM 242

Query: 450 LLERCWQQDPALRPDFSEIIEILQQIAKE 478
           ++ +CW  D  +RP F E+     ++A++
Sbjct: 243 VMVKCWMIDENVRPTFKELANEFTRMARD 271

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  126 bits (318), Expect = 3e-33
 Identities = 74/253 (29%), Positives = 137/253 (54%), Gaps = 11/253 (4%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKP---ERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           ++  GS+G +Y  +      +  +KVLK      +N +   +  QE  ++ K+ H  +V+
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN 339
           F  +  +  + CI+TE+  G  +   L +LK          + +  I +  G++Y+HQ  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEVIEHKPYDHK 398
           I+HRDLKA N+ +  N ++K+ DFGV+R+   S  + T  TGT  +M+PE ++H+ YD K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           +D++S G +L+E+      +E    L   + +V+ G  P++P+    +L  +++    +D
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQSMLNKD 244

Query: 459 PALRPDFSEIIEI 471
           P+LRP  +EI+  
Sbjct: 245 PSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  125 bits (316), Expect = 8e-33
 Identities = 73/245 (29%), Positives = 128/245 (52%), Gaps = 21/245 (8%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 38  VAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 307 DYL-------HKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
            +L         L        G   L  +L +A  ++ GM YL   + +HRDL   N L+
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155

Query: 353 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 409
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D++SFG+VLW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215

Query: 410 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           E+ T GK P+  L+  + A+  + +G     P+   P++  +++ CWQ++P  R    +I
Sbjct: 216 EIFTYGKQPWYQLSNTE-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Query: 469 IEILQ 473
              LQ
Sbjct: 275 HSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  124 bits (314), Expect = 1e-32
 Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 16/257 (6%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            +  GS+G + +    S  + +  K +    +    +++   EV I+R+++H N+V++  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 286 ACTKPPS--LCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---- 336
                 +  L IV E+  GG    +     K +   +   + ++   +   +   H    
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 337 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHK 393
             N ++HRDLK AN+ +D N  VK+ DFG+A++        A+T  GT  +M+PE + H 
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQLNHM 185

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            YD K+D++S G +++EL     P+     LQ A   +++G    IP     +L E+++ 
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELNEVIKS 244

Query: 454 CWQQDPALRPDFSEIIE 470
               DP  RP   E+++
Sbjct: 245 MLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

 Score =  118 bits (296), Expect = 2e-32
 Identities = 45/68 (66%), Positives = 53/68 (77%)

Query: 108 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 167
           MHEITF+  DKPKLLSQL++LL D+GLNI EAHAFST DG +LD+FVV GW   ET  L 
Sbjct: 1   MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60

Query: 168 AALEKEVL 175
            AL+KE+ 
Sbjct: 61  HALQKEID 68

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  125 bits (315), Expect = 2e-32
 Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 84/312 (26%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCSQD---------------------VAIKVLKPERINSD 260
           HL F  K+  G +G+++    C                        VA+K+L+P+  N +
Sbjct: 6   HLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61

Query: 261 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG---- 314
            + +F +EV I+ +++  N+++ +G C     LC++TE+M  G +  +L  H L      
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 315 ------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 362
                            SLL VA+ ++ GM YL   N +HRDL   N L+ EN  +K+AD
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 363 FGVARVKAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWEL 411
           FG++R            G Y           RWMA E I    +   +DV++FG+ LWE+
Sbjct: 182 FGMSR--------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233

Query: 412 LT--GKLPYEYLTPLQAAVGVVQKG-------------LRPTIPKNSQPKLAELLERCWQ 456
           L    + PY  LT  Q    V++                RP  P   Q  L EL+ +CW 
Sbjct: 234 LMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQVYLFRP--PPCPQG-LYELMLQCWS 286

Query: 457 QDPALRPDFSEI 468
           +D   RP FS+I
Sbjct: 287 RDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  123 bits (310), Expect = 4e-32
 Identities = 68/249 (27%), Positives = 139/249 (55%), Gaps = 7/249 (2%)

Query: 227 SKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
            K+  GS+G   L +     +   IK +   +++   ++E  +EV ++  ++H N+VQ+ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
            +  +  +L IV ++  GG +Y  ++  +GV F    +L   + +   + ++H   I+HR
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125

Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 401
           D+K+ N+ + ++  +K+ DFG+ARV   S V  A T  GT  +++PE+ E++PY++K+D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           ++ G VL+E+ T K  +E    ++  V  + +G  P +  +    L  L+ + ++++P  
Sbjct: 185 WALGCVLYEMCTLKHAFE-AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243

Query: 462 RPDFSEIIE 470
           RP  + I+E
Sbjct: 244 RPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  123 bits (311), Expect = 4e-32
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 22/273 (8%)

Query: 223 LKFGSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           L  G  +  G +G +  G     D    VA+K +K         ++F  E   M++  H 
Sbjct: 1   LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 279 NVVQFIGACTKP------PSLCIVTEFMSGGSVYDYL--HKLKGV-FKLPS--LLKVAID 327
           NV++ IG C +       PS  ++  FM  G ++ +L   +L      LP+  L+K   D
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE----TGTYR 383
           ++ GM YL   + IHRDL A N +++EN  V VADFG+++ K  +G    +        +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVK 179

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           W+A E +  + Y  K+DV+SFG+ +WE+ T G+ PY  +   +     +++G R   P +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPD 238

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               L  L+  CW  +P  RP F  +   L++ 
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  122 bits (308), Expect = 1e-31
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 37/267 (13%)

Query: 229 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 285
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E  QE+ +++K   H+N+  + G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 286 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 338
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+++LHQ+
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 394
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190

Query: 395 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---- 448
             YD K+D++S GI   E+  G  P   + P++A            IP+N  P+L     
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 241

Query: 449 -----ELLERCWQQDPALRPDFSEIIE 470
                  +E C  ++ + RP   ++++
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  123 bits (309), Expect = 1e-31
 Identities = 76/253 (30%), Positives = 132/253 (52%), Gaps = 28/253 (11%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K LK   + +  +K+F +E  ++  ++H+++V+F G C     L +V E+M  G + 
Sbjct: 38  VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 307 DYLH---------------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
            +L                + KG   L  +L +A  ++ GM YL   + +HRDL   N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVL 408
           +  N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG++L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Query: 409 WELLT-GKLPYEYLTPLQAAVGVVQKGL--RPTI-PKNSQPKLAELLERCWQQDPALRPD 464
           WE+ T GK P+  L+  +    + Q  +  RP + PK    ++ +++  CWQ++P  R +
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK----EVYDIMLGCWQREPQQRLN 271

Query: 465 FSEIIEILQQIAK 477
             EI +IL  + K
Sbjct: 272 IKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 1e-31
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 53/303 (17%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------------------VAIKVLKPERI 257
           E   + L+   K+  G +G+++    C  +                   VA+K+L+ + +
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56

Query: 258 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------K 311
               + +F +E+ IM ++++ N+++ +G C     LC++TE+M  G +  +L        
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 312 LKGVFKLPS-----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
                 +PS     LL +A+ ++ GM YL   N +HRDL   N L+  +  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 367 RVKAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWEL--LTGKLPYEY 420
           R    SG      G      RWMA E I    +   +DV++FG+ LWE+  L  + PY  
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Query: 421 LTPLQAAVGVVQ----KGLRPTIPKNSQPKLA-----ELLERCWQQDPALRPDFSEIIEI 471
           L+  Q      +    +G +  +   SQ  L      +L+ RCW +D   RP F++I   
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292

Query: 472 LQQ 474
           L++
Sbjct: 293 LRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  122 bits (307), Expect = 2e-31
 Identities = 76/247 (30%), Positives = 130/247 (52%), Gaps = 19/247 (7%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K LK    N+  +K+F +E  ++  ++H+++V+F G C +   L +V E+M  G + 
Sbjct: 38  VAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 307 DYL--HKLKGVF----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 354
            +L  H    V               +L +A  ++ GM YL   + +HRDL   N L+ E
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWEL 411
           N +VK+ DFG++R    +        T    RWM PE I ++ +  ++DV+S G+VLWE+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215

Query: 412 LT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            T GK P+  L+     +  + +G     P+    ++ +L+  CWQ++P +R +  EI  
Sbjct: 216 FTYGKQPWYQLSN-NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274

Query: 471 ILQQIAK 477
           +LQ +AK
Sbjct: 275 LLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  121 bits (306), Expect = 3e-31
 Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 14/251 (5%)

Query: 232 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTK 289
           G+YG + +  +      + V +    +NS  QK    ++ I MR V     V F GA  +
Sbjct: 12  GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71

Query: 290 PPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NIIHRDL 345
              + I  E M   S+   Y         +P   L K+A+ + K + YLH   ++IHRD+
Sbjct: 72  EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADV 401
           K +N+L++ N  VK+ DFG++     S   T + G   +MAPE I      K YD K+DV
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190

Query: 402 FSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDP 459
           +S GI + EL TG+ PY+ + TP Q    VV +   P +P     P+  + + +C +++ 
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNY 249

Query: 460 ALRPDFSEIIE 470
             RP++ E+++
Sbjct: 250 KERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (303), Expect = 3e-31
 Identities = 74/249 (29%), Positives = 136/249 (54%), Gaps = 8/249 (3%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G +Y  +    S+   IK +   ++    ++   +EV ++ K++H N+V F  
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           +  +   L IV E+  GG +   +++ +GV F    +L   + +S G+ ++H   I+HRD
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126

Query: 345 LKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 401
           +K+ N+ + +N  V K+ DFG+AR    S +  A T  GT  +++PE+ +++PY++K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           +S G VL+EL T K P+E     Q  + + Q    P  P  S+  L  L+ + ++  P  
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR-DLRSLISQLFKVSPRD 244

Query: 462 RPDFSEIIE 470
           RP  + I++
Sbjct: 245 RPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  120 bits (303), Expect = 7e-31
 Identities = 80/235 (34%), Positives = 124/235 (52%), Gaps = 28/235 (11%)

Query: 229 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 285
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E   E+ +++K   H+N+  + G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 286 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 338
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+ +LH +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 394
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 395 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
             YD+++D++S GI   E+  G  P   + P++A            IP+N  PKL
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  119 bits (301), Expect = 1e-30
 Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 17/255 (6%)

Query: 231 SGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
            G+YG ++  +        AIKV+ K + I  +   +   E  I+ + +   VV+   + 
Sbjct: 3   KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
               +L +V E++ GG +   L  + G            ++   + YLH N IIHRDLK 
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 348 ANLLMDENEVVKVADFGVARVKAQS-----GVMTAET----GTYRWMAPEVIEHKPYDHK 398
            N+L+D N  +K+ DFG+++V              E     GT  ++APEVI  + +   
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQ 456
            D +S G +L+E L G  P+   TP +     +  G    P   + S  +  +L+ +   
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEWPEDVEVS-DEAIDLISKLLV 239

Query: 457 QDPALRPDFSEIIEI 471
            DP  R     I EI
Sbjct: 240 PDPEKRLGAKSIEEI 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (302), Expect = 1e-30
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 42/272 (15%)

Query: 224 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----R 276
           KFG  +  GS+  +        +++ AIK+L   ++    +K   + V I ++V      
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV--KYVKIEKEVLTRLNG 60

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +++         +L  V E+   G +  Y+ K  G          A ++   + YLH
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARV-----------------KAQSGVMTAET 379
              IIHRDLK  N+L+D++  +K+ DFG A+V                  +Q        
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 380 ----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP----YEYLTPLQAAVGVV 431
               GT  +++PE++  KP    +D+++ G +++++LTGK P     EYLT  Q     +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK----I 234

Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRP 463
            K L  + P N  P   +L+E+    DP  R 
Sbjct: 235 LK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  119 bits (302), Expect = 1e-30
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 228 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y+       + VA+K ++ +     +     +E+ ++++++H N+V+ + 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 286 ACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                  L +V E+       D   YL K  G      +  +   + +G+ Y H + I+H
Sbjct: 66  VIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121

Query: 343 RDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--YRWMAPEVI-EHKP 394
           RDLK  N+L++ + V+K+ADFG+AR     ++      T E  T  YR  APE++   K 
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYR--APEILLGSKH 175

Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E++TGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  119 bits (300), Expect = 2e-30
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 14/210 (6%)

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           EV IMR  +H N+V+   +      L +V EF+ GG++ D +   +       +  V + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMA 386
           V K +++LH   +IHRD+K+ ++L+  +  VK++DFG  A+V  +     +  GT  WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 444
           PEVI   PY  + D++S GI++ E++ G+ PY    PLQA      K +R  +P   +  
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNL 238

Query: 445 ----PKLAELLERCWQQDPALRPDFSEIIE 470
               P+L   L+R   +DPA R   +E++ 
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  118 bits (297), Expect = 2e-30
 Identities = 72/246 (29%), Positives = 128/246 (52%), Gaps = 6/246 (2%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V  GSYG+  L R     +   IK L     +   +K   QE  ++ +++H N+V +  +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 287 CTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAIDVSKGMNYLHQNNIIHRD 344
                  L IV  F  GG +Y  L + KG     + +++  + ++  + YLH+ +I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+ +    ++KV D G+ARV + Q  + +   GT  +M+PE+  +KPY++K+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 463
            G  ++E+ T K  +     + + V  + +G  P +PK+  P+L EL+     + P  RP
Sbjct: 188 LGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRP 246

Query: 464 DFSEII 469
               I+
Sbjct: 247 SVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  116 bits (292), Expect = 2e-29
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 13/261 (4%)

Query: 220 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 274
           P + + G  +  G++G +Y        +++A+K ++ +  + +  KE      E+ +++ 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 275 VRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           + H+ +VQ+ G    P   +L I  E M GGS+ D L K  G        K    + +G+
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAPE 388
           +YLH N I+HRD+K AN+L D    VK+ DFG ++       SG  M + TGT  WM+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           VI  + Y  KAD++S G  + E+LT K P+     + A   +  +   P +P +      
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239

Query: 449 ELLERCWQQDPALRPDFSEII 469
           + L+R + +   LRP   E++
Sbjct: 240 DFLKRIFVE-AKLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  116 bits (292), Expect = 3e-29
 Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 20/276 (7%)

Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ 262
           H++   D  +VWEI         ++  G++G +Y+          A KV+  E  + +  
Sbjct: 3   HVRRDLDPNEVWEII-------GELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEEL 53

Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P + 
Sbjct: 54  EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113

Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 381
            +   + + + YLH   IIHRDLKA N+L+  +  +K+ADFGV+    ++     +  GT
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 382 YRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
             WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  K   
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEP 232

Query: 437 PTI--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           PT+  P     +  + L+    + P  RP  ++++E
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  115 bits (288), Expect = 7e-29
 Identities = 77/270 (28%), Positives = 142/270 (52%), Gaps = 26/270 (9%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 269
           + WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 5   EFWEII-------GELGDGAFGKVYK----AQNKETGVLAAAKVIDTKSEEELEDYMVEI 53

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+     P +  V     
Sbjct: 54  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 387
           + +NYLH+N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 172

Query: 388 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 440
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQP 231

Query: 441 KNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                +  + L++C +++   R   +++++
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  115 bits (288), Expect = 9e-29
 Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 15/260 (5%)

Query: 219 DP--KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DP  K+ +F  K+  G+ G +Y     +  Q+VAIK +    +    +KE    E+ +MR
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMR 71

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + +H N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 129

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248

Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC + D   R    E+++
Sbjct: 249 LNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  115 bits (288), Expect = 1e-28
 Identities = 84/298 (28%), Positives = 143/298 (47%), Gaps = 42/298 (14%)

Query: 217 EIDPKHLKFGSKVASGSYGDL----------YRGTYCSQD--------VAIKVLKPERIN 258
           E   K L F  K+  G +G++          +     S D        VA+K+L+ E  N
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59

Query: 259 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG-- 314
            + + +F +E+ IM +++  N+++ +  C     LC++TE+M  G +  +L  H+ +   
Sbjct: 60  KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 315 ------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 368
                      +L+ +A  ++ GM YL   N +HRDL   N L+ +N  +K+ADFG++R 
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178

Query: 369 KAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLT 422
              SG      G      RWM+ E I    +   +DV++FG+ LWE+LT   + PY  L+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238

Query: 423 PLQAAVGVVQ----KGLRPTIPKNSQ-PK-LAELLERCWQQDPALRPDFSEIIEILQQ 474
             Q      +    +G +  +PK +  P  L +L+  CW+++   RP F EI   L +
Sbjct: 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 72/236 (30%), Positives = 122/236 (51%), Gaps = 16/236 (6%)

Query: 220 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 274
           P + + G  +  G++G++Y        +++A+K +  +  + +  KE      E+ +++ 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60

Query: 275 VRHKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           +RH  +VQ+ G C + P    L I  E+M GGS+ D L K  G        +    + +G
Sbjct: 61  LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMA 386
           ++YLH N I+HRD+K AN+L D    VK+ DFG ++ + Q+  M+       TGT  WM+
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMS 177

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           PEVI  + Y  KADV+S    + E+LT K P+     + A   +  +  +P +P  
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  114 bits (285), Expect = 1e-28
 Identities = 79/262 (30%), Positives = 132/262 (50%), Gaps = 15/262 (5%)

Query: 220 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 274
           P + + G  +  G++G +Y        +++A K ++ +  + +  KE +    E+ +++ 
Sbjct: 1   PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60

Query: 275 VRHKNVVQFIGACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           ++H+ +VQ+ G C +     +L I  E+M GGSV D L K  G        K    + +G
Sbjct: 61  LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAP 387
           M+YLH N I+HRD+K AN+L D    VK+ DFG ++       SG  + + TGT  WM+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           EVI  + Y  KADV+S G  + E+LT K P+     + A   +  +   P +P +     
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238

Query: 448 AELLERCWQQDPALRPDFSEII 469
            + L  C   +   RP   E++
Sbjct: 239 RDFL-GCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  115 bits (289), Expect = 2e-28
 Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 14/167 (8%)

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 372
           L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR        V+  S
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235

Query: 373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 431
             +       +WMAPE I  K Y  ++DV+SFG++LWE+ + G  PY  +   +     +
Sbjct: 236 ARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           + G R   P+N+ P++  ++  CWQ DP  RP FS ++EIL  + +E
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  114 bits (285), Expect = 2e-28
 Identities = 71/249 (28%), Positives = 129/249 (51%), Gaps = 12/249 (4%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 284
           K+  G+ G ++     +  Q+VAIK +    +    +KE    E+ +M+++++ N+V F+
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L +V E+++GGS+ D +   +       +  V  +  + + +LH N +IHRD
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 345 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           +K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  K Y  K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPAL 461
            GI+  E++ G+ PY    PL+A   +   G  P +  P+   P   + L RC + D   
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEK 259

Query: 462 RPDFSEIIE 470
           R    E+++
Sbjct: 260 RGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  115 bits (290), Expect = 2e-28
 Identities = 53/158 (33%), Positives = 93/158 (58%), Gaps = 4/158 (2%)

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET 379
           LL  +  V+KGM++L   N IHRDL A N+L+    + K+ DFG+AR ++  S  +    
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 380 GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                +WMAPE I +  Y  ++DV+S+GI+LWE+ + G  PY  +        ++++G R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
              P+ +  ++ ++++ CW  DP  RP F +I+++++Q
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  112 bits (282), Expect = 3e-28
 Identities = 76/243 (31%), Positives = 126/243 (51%), Gaps = 17/243 (6%)

Query: 214 DVWEIDPKH-LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D+   +P+H  +   +V SG+YGD+Y  R  +  +  A+K++K E    D      QE+F
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIF 58

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++++ +H N+V + G+      L I  E+  GGS+ D  H + G      +  V  +  +
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV 389
           G+ YLH    +HRD+K AN+L+ +N  VK+ADFGV A++ A      +  GT  WMAPEV
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Query: 390 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
               ++  Y+   D+++ GI   EL   + P   L P++A   + +   +P       PK
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-------PK 230

Query: 447 LAE 449
           L +
Sbjct: 231 LKD 233

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  114 bits (287), Expect = 3e-28
 Identities = 61/165 (36%), Positives = 95/165 (57%), Gaps = 4/165 (2%)

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 375
           L  L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR   K    V 
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 376 TAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 433
             +     +WMAPE I  K Y  ++DV+SFG++LWE+ + G  PY  +   +     +++
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           G R   P+ + P++  ++  CW  +P  RP FSE++EIL  + +E
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  113 bits (284), Expect = 5e-28
 Identities = 90/298 (30%), Positives = 140/298 (46%), Gaps = 33/298 (11%)

Query: 219 DPKHLKFG-SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRK 274
           DP+ L     ++  GS+G +Y  R    ++ VAIK +      S+ + ++  +EV  +++
Sbjct: 12  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           +RH N +++ G   +  +  +V E+  G S  D L   K   +   +  +     +G+ Y
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVI-- 390
           LH +  IHRD+KA N+L+ E   VK+ADFG A +   A S V     GT  WMAPEVI  
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185

Query: 391 -EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLA 448
            +   YD K DV+S GI   EL   K P   +  + A   + Q    PT+  N       
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFR 244

Query: 449 ELLERCWQQDPALRPDFSE---------------IIEILQQIAKEVGE-ENEERRKEK 490
             ++ C Q+ P  RP   E               II+++Q+    V E +N + RK K
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQYRKMK 302

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  112 bits (282), Expect = 6e-28
 Identities = 79/257 (30%), Positives = 134/257 (52%), Gaps = 9/257 (3%)

Query: 219 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 17  DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V K ++ LH 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +     +  GT  WMAPE+I   PY 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ---PKLAELLER 453
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKL-KNLHKVSPSLKGFLDR 252

Query: 454 CWQQDPALRPDFSEIIE 470
              +DPA R   +E+++
Sbjct: 253 LLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  112 bits (280), Expect = 6e-28
 Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 18/255 (7%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA---QEVFIMRKVRHKNVVQ 282
           ++ SG+YGD+Y  R     +  AIKV+K E       ++FA   QE+ +M+  +H N+V 
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
           + G+  +   L I  EF  GGS+ D  H + G      +  V+ +  +G+ YLH    +H
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129

Query: 343 RDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV--IEHK-PYDHK 398
           RD+K AN+L+ +N  VK+ADFGV A++ A      +  GT  WMAPEV  +E K  Y+  
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP---KLAELLERCW 455
            D+++ GI   EL   + P   L P++A   + +   +P   K+           ++   
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249

Query: 456 QQDPALRPDFSEIIE 470
            ++P  RP   ++++
Sbjct: 250 TKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  112 bits (281), Expect = 8e-28
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 20/220 (9%)

Query: 259 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
           S ++K+  +E+ IM + R   +V F GA     ++C+  EFM  GS+ D ++K  G   +
Sbjct: 44  SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102

Query: 319 PSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
             L K+A+ V +G+ YL+  + I+HRD+K +N+L++    +K+ DFGV+     S    A
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159

Query: 378 ET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 435
           +T  GT  +M+PE I+   Y  K+DV+S GI + EL  GK P+ + + +         G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGI 218

Query: 436 -----------RPTIPKNSQPKLAELL-ERCWQQDPALRP 463
                       P +P +  P+      + C  +DP  RP
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score =  112 bits (282), Expect = 1e-27
 Identities = 61/164 (37%), Positives = 93/164 (56%), Gaps = 4/164 (2%)

Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 370
           K V  L  L+  +  V+KGM +L     IHRDL A N+L+ EN VVK+ DFG+AR   K 
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 371 QSGVMTAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  111 bits (279), Expect = 1e-27
 Identities = 77/253 (30%), Positives = 121/253 (47%), Gaps = 15/253 (5%)

Query: 232 GSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEV-FIMRKVRHKNVVQFIGACT 288
           G++G + +  +      + V K  R   D   QK    ++  +MR      +V+F GA  
Sbjct: 15  GAFGTVNKMLHKPSGTIMAV-KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 289 KPPSLCIVTEFM--SGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRD 344
           +     I  E M  S    Y Y++  LK V     L K+A+   K +NYL +   IIHRD
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADV 401
           +K +N+L+D N  +K+ DFG++     S   T + G   +MAPE I+      YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQPKLAELLERCWQQ 457
           +S GI L+E+ TGK PY     +   +  V KG    L  +  +   P     +  C  +
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253

Query: 458 DPALRPDFSEIIE 470
           D + RP + E++E
Sbjct: 254 DESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  111 bits (278), Expect = 2e-27
 Identities = 77/257 (29%), Positives = 129/257 (50%), Gaps = 22/257 (8%)

Query: 235 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 294
           G+ +RG   ++ V +K L+      D Q  F QEV   R++ H NV+Q +G C +     
Sbjct: 14  GEAHRGMSKAR-VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71

Query: 295 IVTEFMSGGSVYDYLHKLKGVFKLPS----LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 350
           +V EF   G + +YL   +G+    +    L ++A +V+ G+ +LHQ + IH DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 351 LMDENEVVKVADFGVARVK-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDH--KAD 400
            +  +  VK+ D+G+A  +  +   +T +      RW+APE++E       P D   K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191

Query: 401 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLERCW 455
           ++S G+ +WEL T    PY  L+  Q    VV+    K  +P +      +  E+++ CW
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW 251

Query: 456 QQDPALRPDFSEIIEIL 472
             DP  RP   E+ E+L
Sbjct: 252 -LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  111 bits (279), Expect = 2e-27
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 28/257 (10%)

Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 280
           K+  GS G   + R  +  + VA+K++       D++K+        EV IMR  +H+NV
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V+   +      L ++ EF+ GG++ D + + +       +  V   V + + YLH   +
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV 138

Query: 341 IHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           IHRD+K+ ++L+  +  VK++DFG  A++        +  GT  WMAPEVI   PY  + 
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQ---PKLAELLER 453
           D++S GI++ E++ G+ PY   +P+QA      K LR + P   KN+    P L + LER
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLER 253

Query: 454 CWQQDPALRPDFSEIIE 470
              ++P  R    E+++
Sbjct: 254 MLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  110 bits (277), Expect = 2e-27
 Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 4/203 (1%)

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAI 326
            I  ++RH N+V++     +   L IV + + G  + ++ + LK     F    +  + +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 327 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 385
            +   + YLH +  I+HRDL   N+++ E++ V + DFG+A+ K     +T+  GT  + 
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
            PE+++++PY  KADV++FG +L+++ T + P+     L  A  +V+    P        
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240

Query: 446 KLAELLERCWQQDPALRPDFSEI 468
            + +++  C   D   RPD  ++
Sbjct: 241 DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  110 bits (277), Expect = 2e-27
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 229 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           +  G +G +      S++   A+K +K   I    Q+E    E  I+ +  H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  + ++ E+  GG ++  L   +G+F +  +   +A  V     YLH   II+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  NLL+D N  VK+ DFG A+ K +SG  T    GT  ++APE+I +K YD   D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 404 FGIVLWELLTGKLPY 418
            GI+L+ELLTG+ P+
Sbjct: 178 LGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  110 bits (277), Expect = 2e-27
 Identities = 65/260 (25%), Positives = 135/260 (51%), Gaps = 13/260 (5%)

Query: 227 SKVASGSYGDLYRG--TYCSQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
            K+  G +  +Y+       + VA+K ++  E +++  +++  +E+ +++++ H NV+++
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67

Query: 284 IGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           + +  +   L IV E    G +     +  K K +    ++ K  + +   + ++H   I
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHK 398
           +HRD+K AN+ +    VVK+ D G+ R  + S    A +  GT  +M+PE I    Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 399 ADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCW 455
           +D++S G +L+E+   + P Y     L +    ++K   P +P +  S+  L +L+ RC 
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE-LRDLVSRCI 245

Query: 456 QQDPALRPDFSEIIEILQQI 475
             DP  RPD S ++++ +++
Sbjct: 246 NPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  113 bits (284), Expect = 2e-27
 Identities = 54/159 (33%), Positives = 96/159 (60%), Gaps = 4/159 (2%)

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
           L+  +  V+ GM +L   N +HRDL A N+L+ E ++VK+ DFG+AR   +     ++  
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300

Query: 381 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
           T+   +WMAPE I +  Y   +DV+SFGI+LWE+ T G  PY  L   +     +++G R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P ++  ++ E++++CW++   +RPDFS+++ ++  +
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  112 bits (282), Expect = 2e-27
 Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 34/260 (13%)

Query: 223 LKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           L+  +++ SG+ G +Y    R T   +  A+KV+        ++++  +E+ I+R V H 
Sbjct: 76  LERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH-EDTVRRQICREIEILRDVNHP 132

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLH 336
           NVV+          + ++ EFM GGS       L+G  +     L  VA  +  G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGS-------LEGTHIADEQFLADVARQILSGIAYLH 185

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVI--- 390
           + +I+HRD+K +NLL++  + VK+ADFGV+R+ AQ+  M    +  GT  +M+PE I   
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTD 243

Query: 391 -EHKPYDHKA-DVFSFGIVLWELLTGKLPYEY-----LTPLQAAVGVVQKGLRPTIPKNS 443
             H  YD  A D++S G+ + E   G+ P+          L  A+ + Q    P  P  +
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---PEAPATA 300

Query: 444 QPKLAELLERCWQQDPALRP 463
             +    +  C Q++PA R 
Sbjct: 301 SREFRHFISCCLQREPAKRW 320

Length = 353

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
            K+  G+YG +Y  R     + VAIK +K    +  + K   +E+ +++++ H N+++ +
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                   L +V EFM    +Y  +   +       +      + +G+ + H + I+HRD
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123

Query: 345 LKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWM-APEVI-EHKPYDHKADV 401
           LK  NLL++   V+K+ADFG+AR         T    T RW  APE++   K Y    D+
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDI 182

Query: 402 FSFGIVLWELLTGK 415
           +S G +  ELL+ +
Sbjct: 183 WSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (278), Expect = 2e-27
 Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 15/260 (5%)

Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAIK +    +    +KE    E+ +MR
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMR 71

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D +   +       +  V  +  + ++
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDF 248

Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC + D   R    E+++
Sbjct: 249 LNRCLEMDVDRRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-27
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 42/212 (19%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 280
           ++  G+YG +Y+       + VA+K     +I  + +KE       +E+ +++K+RH N+
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVY---DYL-HKLKGVFKLPSLLKVAIDVSK------ 330
           V+            IVT     GS+Y   +Y+ H L G+   P + K      K      
Sbjct: 61  VRLK---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL 109

Query: 331 --GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRW 384
             G+ YLH N I+HRD+K +N+L++ + V+K+ADFG+AR   K  S   T    T  YR 
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR- 168

Query: 385 MAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             PE++     Y  + D++S G +L EL  GK
Sbjct: 169 -PPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  110 bits (277), Expect = 4e-27
 Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 14/266 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK 274
           +  D   L+   ++ SG+ G +Y+  +      + V +  R  N +  K    ++ ++ K
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69

Query: 275 VRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGM 332
                 +V+  G       + I  E MS  +  D L K ++G      L K+ + + K +
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 333 NYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           +YL +   +IHRD+K +N+L+D +  VK+ DFG++     S   T   G   +MAPE I+
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 392 HKP----YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIP--KNSQ 444
                  YD +ADV+S GI L EL TG+ PY+   T  +    ++Q+   P++P  +   
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPPNEGFS 246

Query: 445 PKLAELLERCWQQDPALRPDFSEIIE 470
           P     ++ C  +D   RP + E+++
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  109 bits (274), Expect = 6e-27
 Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 16/225 (7%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           +A+KV+ P  I  ++QK+   E+ I+ K     ++ F GA      + I TEFM GGS+ 
Sbjct: 29  LAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
            Y            L ++A+ V KG+ YL    I+HRD+K +N+L++    VK+ DFGV+
Sbjct: 88  VY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142

Query: 367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE------- 419
                S +     GT  +MAPE I  + Y   +DV+S GI   EL  G+ PY        
Sbjct: 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201

Query: 420 YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPALRP 463
            L PLQ    +V +   P +P      K    + +C ++ P  RP
Sbjct: 202 SLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  109 bits (274), Expect = 9e-27
 Identities = 72/247 (29%), Positives = 122/247 (49%), Gaps = 16/247 (6%)

Query: 223 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 277
            +F   + +GS+G      ++G+   +  A+K+L   +I    Q E    E  I++ +RH
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             +V   G+     +L +V E++ GG ++ +L K  G F  P     A  V   + YLH 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS 119

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
            +I++RDLK  NLL+D +  +K+ DFG A+ + +    T   GT  ++APE+I  K Y  
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYTL-CGTPEYLAPEIILSKGYGK 177

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCW 455
             D ++ GI+++E+L G  P+    P+Q    + +K L  +   P    P   +L+    
Sbjct: 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSFFSPDAKDLIRNLL 233

Query: 456 QQDPALR 462
           Q D   R
Sbjct: 234 QVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (272), Expect = 1e-26
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)

Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D +   +       +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249

Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  108 bits (273), Expect = 1e-26
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 224 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHK 278
           + G K+  G+Y  +Y+       + VAIK +K                +E+ ++++++H 
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------KG 331
           N++  +       ++ +V EFM           L+ V K  S++    D+        +G
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMET--------DLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWM-APEV 389
           + YLH N I+HRDLK  NLL+  + V+K+ADFG+AR        MT +  T RW  APE+
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPEL 173

Query: 390 I---EHKPYDHKADVFSFGIVLWELLTGKLPY 418
           +    H  Y    D++S G +  ELL    P+
Sbjct: 174 LFGARH--YGVGVDMWSVGCIFAELLLRV-PF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  107 bits (268), Expect = 4e-26
 Identities = 86/290 (29%), Positives = 128/290 (44%), Gaps = 52/290 (17%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQE 268
           D +D WEI          +  G+YG +++          A+K+L P     D+ +E   E
Sbjct: 15  DPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAE 64

Query: 269 VFIMRKVR-HKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKL---- 318
             I++ +  H NVV+F G   K        L +V E  +GGSV D +   KG  K     
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121

Query: 319 --PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVM 375
             P +  +  +   G+ +LH N  IHRD+K  N+L+     VK+ DFGV A++ +     
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 376 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 430
               GT  WMAPEVI         YD + DV+S GI   EL  G  P   L P++A    
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239

Query: 431 VQKGLRPTIPKNSQPKLAE----------LLERCWQQDPALRPDFSEIIE 470
                   IP+N  P L +           + +C  +D   RP  S++++
Sbjct: 240 -------KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  106 bits (267), Expect = 4e-26
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 7/214 (3%)

Query: 250 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 309
           K ++   + + +      E  I++++ H  +V    +     ++ +V + + GG +  +L
Sbjct: 37  KCVEKGSVRNVLN-----ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL 91

Query: 310 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 369
            + K  F    +     ++   + YLH   IIHRD+K  N+L+DE   V + DF +A   
Sbjct: 92  SQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAV 428
               + T+ +GT  +MAPEV+  + Y    D +S G+  +E L GK PY      ++  +
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
              Q+      P     +  + + +  ++DP  R
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  107 bits (267), Expect = 6e-26
 Identities = 68/278 (24%), Positives = 135/278 (48%), Gaps = 28/278 (10%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 269
           EI+   ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 314
            +  +++H N+V  +G  TK   L ++  + S   ++++L                 +K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS- 372
             +    + +   ++ GM +L  ++++H+DL   N+L+ +   VK++D G+ R V A   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 373 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
             +M       RWM+PE I +  +   +D++S+G+VLWE+ + G  PY   +  Q  + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238

Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           ++       P +    +  L+  CW + P+ RP F +I
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  105 bits (264), Expect = 8e-26
 Identities = 67/245 (27%), Positives = 134/245 (54%), Gaps = 6/245 (2%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V  GS+G   L +     Q  A+K ++  + +S ++    +E  ++ K++H N+V F  +
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKES 66

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                 L IV E+  GG +   +   +G +F   ++L+  + +  G+ ++H+  ++HRD+
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 404
           K+ N+ + +N  VK+ DFG AR+    G       GT  ++ PE+ E+ PY++K+D++S 
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           G +L+EL T K P++  +     + V Q   +P +P +   +L  L+++ ++++P  RP 
Sbjct: 187 GCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS 245

Query: 465 FSEII 469
            + I+
Sbjct: 246 ATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  106 bits (266), Expect = 1e-25
 Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 4/171 (2%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K +   R+   +  +  +E+  ++  +H  VV+ +          +V E+M    + 
Sbjct: 28  VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
           + L   +       +      + KG+ Y+H N I+HRDLK ANLL+  + V+K+ADFG+A
Sbjct: 87  EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146

Query: 367 RV--KAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTG 414
           R+  + +  + + +  T  + APE++     YD   D+++ G +  ELL G
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 28/249 (11%)

Query: 229 VASGSYGDLY------RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK-NV 280
           ++ G++G +Y       G Y     AIKVLK   + +  Q      E  IM        V
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            +   +      L +V E+++GG     +  L G        +   +V  G+  LHQ  I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 399
           IHRD+K  NLL+D+   +K+ DFG++R     G+   +  GT  ++APE I     D  +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMS 174

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQ----PKLAELLER 453
           D +S G V++E L G  P+   TP      V    L   I  P+  +    P+  +L+ R
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINR 230

Query: 454 CWQQDPALR 462
               DPA R
Sbjct: 231 LLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  105 bits (265), Expect = 3e-25
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 232 GSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIG 285
           GS+G +     +GT   +  A+KVLK + I  D   E    E  ++    +H  + Q   
Sbjct: 6   GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  L  V E+++GG +  ++ +  G F  P     A ++  G+ +LH+  II+RDL
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  N+L+D    +K+ADFG+ +     GV T+   GT  ++APE++ ++PY    D ++ 
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182

Query: 405 GIVLWELLTGKLPYE 419
           G++L+E+L G+ P+E
Sbjct: 183 GVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  104 bits (262), Expect = 3e-25
 Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 38/278 (13%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 284
            V  GSYG +   +     Q VAIK    E  +  M K+ A +E+ +++++RH+N+V  I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
               +   L +V EF+   +V D L K         + K    + +G+ + H +NIIHRD
Sbjct: 67  EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVIEHKP-YDHKADVF 402
           +K  N+L+ ++ VVK+ DFG AR  A  G +  +    RW  APE++     Y    D++
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185

Query: 403 SFGIVLWELLTGK--LPYE------------------------YLTPLQAAVGVVQ---- 432
           + G ++ E+LTG+   P +                           PL A + + +    
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245

Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           + L    PK S   + +L ++C + DP  RP  S+++ 
Sbjct: 246 EPLEKRFPKLS-GLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  104 bits (261), Expect = 5e-25
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 15/273 (5%)

Query: 206 LKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRGT--YCSQDVAIKVLK--PERINSD 260
           +K P      ++ DP+ +  G  ++  GS+G +Y  T  + ++ VA+K +    ++ N  
Sbjct: 5   VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64

Query: 261 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 320
            Q +  +EV  +++++H N +++ G   K  +  +V E+  G S  D L   K   +   
Sbjct: 65  WQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
           +  +     +G+ YLH +N+IHRD+KA N+L+ E   VK+ADFG A   + +       G
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VG 179

Query: 381 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 437
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q    P
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP 238

Query: 438 TIPKNS-QPKLAELLERCWQQDPALRPDFSEII 469
           T+  N         ++ C Q+ P  RP  +E++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  103 bits (258), Expect = 9e-25
 Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 18/227 (7%)

Query: 228 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 284
           K+  GS G +   T  +  + VA+K +    +    ++E    EV IMR   H+NVV   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L +V EF+ GG++ D +   +       +  V + V + ++YLH   +IHRD
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 345 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           +K+ ++L+  +  +K++DFG  A+V  +     +  GT  WMAPEVI   PY  + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
            GI++ E++ G+ PY    PLQA      + +R  +P    P++ + 
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLP----PRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  103 bits (258), Expect = 9e-25
 Identities = 89/291 (30%), Positives = 130/291 (44%), Gaps = 54/291 (18%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQ 267
           D TD WEI          +  G+YG +Y+ T   +D    A+K+L P    SD+ +E   
Sbjct: 19  DPTDTWEII-------ETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEA 67

Query: 268 EVFIMRKV-RHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 321
           E  I++ +  H NVV+F G   K        L +V E  +GGSV + +   KG+      
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQR 124

Query: 322 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGV 374
           L  A+          G+ +LH N IIHRD+K  N+L+     VK+ DFGV A++ +    
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 375 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                GT  WMAPEVI  +      YD + DV+S GI   EL  G  P   + P++    
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF- 243

Query: 430 VVQKGLRPTIPKNSQPKL----------AELLERCWQQDPALRPDFSEIIE 470
                    IP+N  P L             + +C  +D   RP  + ++E
Sbjct: 244 --------KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score =  103 bits (258), Expect = 5e-24
 Identities = 53/159 (33%), Positives = 88/159 (55%), Gaps = 7/159 (4%)

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
           LL     V++GM +L   N +HRDL A N+L+ + ++VK+ DFG+AR         ++  
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298

Query: 381 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
           T+   +WMAPE I    Y   +DV+S+GI+LWE+ + G  PY  +         ++ G R
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDF---SEIIEIL 472
              P ++  ++ +++ +CW  +P  RP F   S+I+E L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 227 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
             V  G+YG + +   C      + VAIK  K    + D++K   +EV ++R++RH+N+V
Sbjct: 7   GVVGEGAYGVVLK---CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
               A  +   L +V E++   ++ + L    G     ++      + + + Y H +NII
Sbjct: 64  NLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWM-APEV-IEHKPYDH 397
           HRD+K  N+L+ E+ V+K+ DFG AR         +T    T RW  APE+ +    Y  
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-RWYRAPELLVGDTNYGK 181

Query: 398 KADVFSFGIVLWELLTG 414
             DV++ G ++ ELL G
Sbjct: 182 PVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  102 bits (256), Expect = 7e-24
 Identities = 56/169 (33%), Positives = 96/169 (56%), Gaps = 16/169 (9%)

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------V 368
           L  LL+ +  V++GM++L   N IHRD+ A N+L+ +  V K+ DFG+AR         V
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
           K  + +        +WMAPE I    Y  ++DV+S+GI+LWE+ + GK PY  +      
Sbjct: 271 KGNARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324

Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 476
             +V++G + + P  + P++  +++ CW  +P  RP FS+I +++Q+  
Sbjct: 325 YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  101 bits (252), Expect = 8e-24
 Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 19/263 (7%)

Query: 223 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN 279
           ++   ++  G+YG +Y+  +    V    +K  R+  D  K F Q   E+ I+ K     
Sbjct: 3   IEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYL- 335
           +V F GA     ++ +  E+M  GS+   Y      +G+ +   L ++   V KG+ +L 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLK 119

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----- 390
            ++NIIHRD+K  N+L++ N  VK+ DFGV+     S   T   G   +MAPE I     
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGP 178

Query: 391 -EHKPYDHKADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            ++  Y  ++DV+S G+ + E+  G+ PY  E    + A +  +  G  PT+P       
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238

Query: 448 AELLERCWQQDPALRPDFSEIIE 470
            + + +C  + P  RP +++++E
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  101 bits (252), Expect = 1e-23
 Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 15/274 (5%)

Query: 206 LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLK-PERINSD 260
           LK P      ++ DP+ L F    ++  GS+G +Y  R    ++ VAIK +    + +++
Sbjct: 9   LKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67

Query: 261 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 320
             ++  +EV  +++++H N +++ G   +  +  +V E+  G S  D L   K   +   
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 126

Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
           +  +     +G+ YLH +N+IHRD+KA N+L+ E   VK+ADFG A + + +       G
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VG 183

Query: 381 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 437
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q    P
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP 242

Query: 438 TIPKNS-QPKLAELLERCWQQDPALRPDFSEIIE 470
           T+  N         ++ C Q+ P  RP   E+++
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  100 bits (250), Expect = 1e-23
 Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 10/242 (4%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 287 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            T     P  LC + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADV 401
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 402 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 461 LR 462
            R
Sbjct: 240 KR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  100 bits (249), Expect = 1e-23
 Identities = 66/258 (25%), Positives = 134/258 (51%), Gaps = 11/258 (4%)

Query: 228 KVASGSYGDLYRGTYC---SQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           K+  G + ++YR T C    + VA+K ++  E +++  +++  +E+ +++++ H NV+++
Sbjct: 9   KIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 284 IGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           + +  +   L IV E    G +     Y  K K +    ++ K  + +   + ++H   +
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 341 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I    Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 400 DVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELLERCWQQ 457
           D++S G +L+E+   + P Y     L +    +++   P +P  +   KL EL+  C   
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247

Query: 458 DPALRPDFSEIIEILQQI 475
           DP  RPD   + +I +Q+
Sbjct: 248 DPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  100 bits (249), Expect = 2e-23
 Identities = 77/243 (31%), Positives = 119/243 (48%), Gaps = 12/243 (4%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 284
           ++  GS+G +Y  R    S+ VAIK +      S+ + ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           G   +  +  +V E+  G S  D L   K   +   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 401
           +KA N+L+ E  +VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPA 460
           +S GI   EL   K P   +  + A   + Q    P +            ++ C Q+ P 
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSEYFRNFVDSCLQKIPQ 256

Query: 461 LRP 463
            RP
Sbjct: 257 DRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  100 bits (250), Expect = 3e-23
 Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 9/186 (4%)

Query: 238 YRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVF-IMRKVRHKNVVQFIGACTKPPSL 293
           Y+ T   +  AIK LK   I +  + E     + +F      RH  +V           +
Sbjct: 20  YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77

Query: 294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 353
           C V E+ +GG +  ++H    VF  P  +  A  V  G+ YLH+N I++RDLK  NLL+D
Sbjct: 78  CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135

Query: 354 ENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
               VK+ADFG+ +     G  T+   GT  ++APEV+    Y    D +  G++++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 413 TGKLPY 418
            G+ P+
Sbjct: 196 VGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 16/225 (7%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L  +R+     ++ A  E  I+ KV  + +V    A      LC+V   M+GG + 
Sbjct: 22  ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81

Query: 307 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ + +  F     +  A  +  G+ +LHQ  I++RDLK  N+L+D++  V+++D G+
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141

Query: 366 A-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
           A  +K    +     GT  +MAPEV++ + YD   D F+ G  L+E++ G+ P+      
Sbjct: 142 AVELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR----- 195

Query: 425 QAAVGVVQKGLRP-------TIPKNSQPKLAELLERCWQQDPALR 462
           Q    V ++ L+          P    P+  +L E   Q+DP  R
Sbjct: 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  100 bits (249), Expect = 3e-23
 Identities = 73/228 (32%), Positives = 118/228 (51%), Gaps = 6/228 (2%)

Query: 248 AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A+KVL+ + + N   QK   A+   +++ V+H  +V    +      L  V +F++GG +
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
           + +L + +  F  P     A +++  + YLH  NI++RDLK  N+L+D    V + DFG+
Sbjct: 84  FFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142

Query: 366 ARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
            +   AQS   T   GT  ++APEVI  +PYD+  D +  G VL+E+L G  P+      
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202

Query: 425 QAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           +    ++ K L  RP     +   L ELLE+  Q+    + DF EI E
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 70/246 (28%), Positives = 123/246 (50%), Gaps = 18/246 (7%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 287 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 343 RDLKAANLLMDENEVVKVADFGVA----RVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH 397
           RDLK AN+L+DE+  V+++D G+A    + K  + V     GT+ +MAPEV++    YD 
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDS 175

Query: 398 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
            AD FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 457 QDPALR 462
           +D   R
Sbjct: 236 RDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 66/243 (27%), Positives = 126/243 (51%), Gaps = 21/243 (8%)

Query: 232 GSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQEVFIMRKVRHKNV 280
           GS+G ++      G    Q  A+KVLK       +R+ + M+++      I+ +V H  +
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAEVNHPFI 60

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V+   A      L ++ +F+ GG ++  L K + +F    +     +++  +++LH   I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 399
           I+RDLK  N+L+DE   +K+ DFG+++             GT  +MAPEV+  + +   A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D +SFG++++E+LTG LP++     +    +++  L   +P+   P+   LL   ++++P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNP 237

Query: 460 ALR 462
           A R
Sbjct: 238 ANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.1 bits (236), Expect = 6e-22
 Identities = 58/257 (22%), Positives = 129/257 (50%), Gaps = 9/257 (3%)

Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           K+  G + ++YR T     V + + K +    +++  + +  +E+ +++++ H NV+++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL---PSLLKVAIDVSKGMNYLHQNNII 341
            +  +   L IV E    G +   +   K   +L    ++ K  + +   + ++H   ++
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 342 HRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 400
           HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I    Y+ K+D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188

Query: 401 VFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQD 458
           ++S G +L+E+   + P Y     L +    +++   P +P +    +L +L+  C   D
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Query: 459 PALRPDFSEIIEILQQI 475
           P  RPD + + ++ +++
Sbjct: 249 PEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 59/247 (23%), Positives = 120/247 (48%), Gaps = 13/247 (5%)

Query: 237 LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ----FIGACTKPP 291
           +Y+G + +++V I+  K       +  +    E+  +R++   N+++     I      P
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAAN 349
            L ++ E+ + G + + L K K + FK  + L +AID  KG+  L++  N  +++L + +
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153

Query: 350 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 407
            L+ EN  +K+   G+ ++ +           Y   + +++      Y  K D++S G+V
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVV 211

Query: 408 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 467
           LWE+ TGK+P+E LT  +    ++ K     +P +   ++  ++E C   D   RP+  E
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271

Query: 468 IIEILQQ 474
           I+  L  
Sbjct: 272 ILYNLSL 278

Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 63/247 (25%), Positives = 127/247 (51%), Gaps = 8/247 (3%)

Query: 229 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +    + +++   A+KVL+ + I    +++   ++   +++ V+H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L  V ++++GG ++ +L + +  F  P     A +++  + YLH  NI++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRD 121

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+L+D    + + DFG+ +   + +G  +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 461
            G VL+E+L G  P+      +    ++ K   L+P I  +++  L  LL++   +    
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA 241

Query: 462 RPDFSEI 468
           + DF EI
Sbjct: 242 KDDFMEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 53/178 (29%), Positives = 99/178 (55%), Gaps = 10/178 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPPSLCIVTEFMSG 302
           AIK+LK + I   +Q +  +   + ++V     +   + Q          L  V E+++G
Sbjct: 29  AIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85

Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 362
           G +  ++ ++ G FK P  +  A +++ G+ +LH   II+RDLK  N+++D    +K+AD
Sbjct: 86  GDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIAD 144

Query: 363 FGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           FG+ +     G  T    GT  ++APE+I ++PY    D ++FG++L+E+L G+ P++
Sbjct: 145 FGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 54/232 (23%)

Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRK 274
             +   K+  G++G++Y+       + VA+K     +I    +K+       +E+ I++K
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63

Query: 275 VRHKNVVQFI--------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           ++H NVV  I         +  K  S+ +VT +M         H L G+ + PS   V +
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPS---VKL 112

Query: 327 DVSK----------GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 368
             S+          G+NYLH+N+I+HRD+KAAN+L+D   ++K+ADFG+AR         
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 369 KAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           K   G  T + T     RW   PE++   + Y    D++  G V  E+ T +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 71/249 (28%), Positives = 120/249 (48%), Gaps = 12/249 (4%)

Query: 229 VASGSYGDLYRGTYCSQDV--AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +    + +     A+KVL+ + I     QK   A+   +++ V+H  +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L  V ++++GG ++ +L + +  F  P     A +++  + YLH  NII+RD
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+L+D    V + DFG+ +   + S   +   GT  ++APEV+  +PYD   D + 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR- 462
            G VL+E+L G  P+      +    ++ K LR  +  N       LLE   Q+D   R 
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKRL 239

Query: 463 ---PDFSEI 468
               DF EI
Sbjct: 240 GAKDDFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 93.1 bits (231), Expect = 7e-21
 Identities = 57/200 (28%), Positives = 109/200 (54%), Gaps = 6/200 (3%)

Query: 225 FGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNV 280
           F   +  GS+G +        D   AIK+LK + +  + D++    ++  +  + +   +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            Q          L  V E+++GG +  ++ ++ G FK P  +  A ++S G+ +LH+  I
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGI 122

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 399
           I+RDLK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 400 DVFSFGIVLWELLTGKLPYE 419
           D +++G++L+E+L G+ P++
Sbjct: 183 DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 24/235 (10%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           V +KVL  +  +S     F +   +M ++ HK++V+  G C +  ++ +V E++  G + 
Sbjct: 33  VVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENE----VVK 359
            +LH+ K    L   L VA  ++  ++YL    ++H ++   N+L+     NE     +K
Sbjct: 89  VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148

Query: 360 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE--HKPYDHKADVFSFGIVLWELLT-G 414
           ++D G+        V++ E    R  W+APE I          AD +SFG  L E+ + G
Sbjct: 149 LSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203

Query: 415 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
           + P   L+  +       +     +P     +LA L+ +CW  DP  RP F  I+
Sbjct: 204 EEPLSTLSSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 46/128 (35%), Positives = 80/128 (62%), Gaps = 2/128 (1%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           L  V E+++GG +   + ++ G FK P  +  A +++ G+ +LH   II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 353 DENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 411
           D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++FG++L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 412 LTGKLPYE 419
           L G+ P+E
Sbjct: 195 LAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRKV 275
             +    + SG+YG +         + VAIK  K   +  D     A+    E+ ++R +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDD--LIDAKRILREIKLLRHL 56

Query: 276 RHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--- 326
           RH+N++  +    +PPS      + IVTE M      D LHK   V K P  L       
Sbjct: 57  RHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHK---VIKSPQPLTDDHIQY 107

Query: 327 ---DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 379
               + +G+ YLH  N+IHRDLK +N+L++ N  +K+ DFG+AR     + + G +T   
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 380 GT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
            T  YR  APE++     Y    D++S G +  ELLT K
Sbjct: 168 VTRWYR--APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 69/264 (26%), Positives = 127/264 (48%), Gaps = 25/264 (9%)

Query: 228 KVASGSYGDLYRGT----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           ++ +G +G +  G     Y    V +K L+      + Q +F +E    R ++H N++Q 
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQC 60

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP----SLLKVAIDVSKGMNYLHQNN 339
           +G CT+     +V EF   G +  YL   +    +     +L ++A +++ G+ +LH+NN
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEH---- 392
            IH DL   N L+  +  VK+ D+G++  K +          +   RW+APE+++     
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180

Query: 393 ---KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV-QKGLRPTIPKNSQP-- 445
                   +++V+S G+ +WEL   G  PY +L+  Q     V ++ L+   P+   P  
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240

Query: 446 -KLAELLERCWQQDPALRPDFSEI 468
            +  E+++ CW Q P  RP   E+
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 1/145 (0%)

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E  +++ V H +V++           C+V    S   +Y YL K      +   L +   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 387
           + +G+ YLH   IIHRD+K  N+ +++ + V + D G A+    +       GT    AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 388 EVIEHKPYDHKADVFSFGIVLWELL 412
           EV+    Y+ KAD++S GIVL+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 92.1 bits (228), Expect = 1e-20
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 5/194 (2%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+LK E I   D       E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +      LC V E+++GG ++ +L + + VF          ++   ++YLH   I++RDL
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 346 KAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     +  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 405 GIVLWELLTGKLPY 418
           G+V++E++ G+LP+
Sbjct: 182 GVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 28/217 (12%)

Query: 223 LKFGSKVASGSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 277
            + G  + +GS+G +    ++GT   +  AIK LK   I    Q +  AQE  I+ ++ H
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK------- 330
             +V  + +      +  + EF+ GG ++ +L K     + P+      DV+K       
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPN------DVAKFYHAELV 128

Query: 331 -GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPE 388
               YLH  +II+RDLK  NLL+D    VKV DFG A +V  ++  +    GT  ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPE 185

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 425
           VI+ K +    D ++ G++L+E + G  P+   TP +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 51/175 (29%), Positives = 93/175 (53%), Gaps = 7/175 (4%)

Query: 248 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           A+K+LK E I +  + E A    E  +++  RH  +     +      LC V E+ +GG 
Sbjct: 24  AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           ++ +L + + VF          ++   + YLH  ++++RDLK  NL++D++  +K+ DFG
Sbjct: 82  LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140

Query: 365 VARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           + +     G  M    GT  ++APEV+E   Y    D +  G+V++E++ G+LP+
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 5e-20
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 57/291 (19%)

Query: 224 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA--------QEVFIMR 273
           K   ++  G++G +Y        + VAIK +K         K+F         +EV  +R
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLR 52

Query: 274 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKG 331
           K+  H N+V+      +   L  V E+M G ++Y  +   KG     S+++  I  + +G
Sbjct: 53  KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI 390
           + ++H++   HRDLK  NLL+   EVVK+ADFG+AR        T    T RW  APE++
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RWYRAPEIL 170

Query: 391 EHKP-YDHKADVFSFGIVLWELLTGKLP--------------YEYL-TP----------L 424
                Y    D+++ G ++ EL T + P                 L TP          L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 425 QAAVG-----VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            + +G          L   IP N+ P+  +L++   + DP  RP  S+ ++
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 90.4 bits (224), Expect = 6e-20
 Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 20/253 (7%)

Query: 229 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +      S     A+KVL+ + I    ++    A+   +++ ++H  +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L  V ++++GG ++ +L + +  F  P     A +V+  + YLH  NII+RD
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRD 121

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVIEHKPYDHKA 399
           LK  N+L+D    V + DFG+ +     GV   ET     GT  ++APEV+  +PYD   
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D +  G VL+E+L G  P+      Q    ++ K L+  +P        +LL     +D 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKDQ 235

Query: 460 ALR----PDFSEI 468
             R     DF EI
Sbjct: 236 RRRLGAKADFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 41/215 (19%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 279
           +K+  G++G+++  R     Q VA+K     ++  + +KE F     +E+ I++ ++H+N
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 280 VVQFIGACTKPP--------SLCIVTEFMSGGSVYDYLHKLKGV-------FKLPSLLKV 324
           VV  I  C            S  +V EF          H L G+       F L  + KV
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124

Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAET 379
              +  G+ Y+H+N I+HRD+KAAN+L+ ++ ++K+ADFG+AR       ++    T   
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 380 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLT 413
            T  +  PE+ +  + Y    D++  G ++ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF-- 283
           ++  G+YG +YR   T   + VA+K ++ +     +     +E+ ++  +RH N+V+   
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 284 IGACTKPPSLCIVTEFMSG--GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +       S+ +V E+      S+ D    +   F    +  + + + +G+ YLH+N II
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHKA 399
           HRDLK +NLL+ +   +K+ADFG+AR     +  MT +  T  + APE++     Y    
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190

Query: 400 DVFSFGIVLWELLTGK 415
           D+++ G +L ELL  K
Sbjct: 191 DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 51/174 (29%), Positives = 94/174 (54%), Gaps = 2/174 (1%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV- 305
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
           +   H  +  F+    +  A ++  G+  LHQ  I++RDLK  N+L+D++  ++++D G+
Sbjct: 89  FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           A    +   +    GT  +MAPEV++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 6/218 (2%)

Query: 248 AIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+K+LK E I   D       E  +++  RH  +     +      LC V E+ +GG ++
Sbjct: 24  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +L + + VF          ++   ++YLH + N+++RDLK  NL++D++  +K+ DFG+
Sbjct: 84  FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142

Query: 366 ARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
            +   + G  M    GT  ++APEV+E   Y    D +  G+V++E++ G+LP+      
Sbjct: 143 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202

Query: 425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 203 KLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 65/260 (25%), Positives = 123/260 (47%), Gaps = 29/260 (11%)

Query: 235 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 294
            ++Y  T  ++ V +K LK    +S  Q EF Q+    R ++H N++Q +G C +     
Sbjct: 14  SEIYTDTGVAR-VVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71

Query: 295 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           +V E+   G +  YL +    +   +L  L ++A +++ G+ ++H++N +H DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDH 397
           +  +  VKV D+G+   + +   +  E       RW+APE++           + KP   
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188

Query: 398 KADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLE 452
            ++V++ G+ LWEL      PY +L+  +    V++    K  +P +      +  E+L+
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ 247

Query: 453 RCWQQDPALRPDFSEIIEIL 472
            CW   P  R    E+  +L
Sbjct: 248 FCWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y+G      Q VA+K ++ E     +     +E+ ++++++H N+V    
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHR 343
              +   L ++ EF+S   +  YL  L KG +    L+K  +  + +G+ + H   ++HR
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125

Query: 344 DLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKP-YDH 397
           DLK  NLL+D   V+K+ADFG+AR     V+    V T E  T  + APEV+   P Y  
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 398 KADVFSFGIVLWELLTGK 415
             D++S G +  E+ T K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 119

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 402 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 237

Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 238 SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 5/176 (2%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L  +R+      E A  E  I+ KV  + +V    A      LC+V   M+GG + 
Sbjct: 22  ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81

Query: 307 DYLHKLKGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
            +++ +      F  P        +  G+ +LHQ  II+RDLK  N+L+D +  V+++D 
Sbjct: 82  YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDL 141

Query: 364 GVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           G+A  +K          GT  +MAPE+++ + YD   D F+ G+ L+E++  + P+
Sbjct: 142 GLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 49/173 (28%), Positives = 91/173 (52%), Gaps = 2/173 (1%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88

Query: 307 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ +    F+    L  A ++  G+  LH+ N ++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 148

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           A    +   +    GT  +MAPEV+ ++ Y    D +  G +++E++ G+ P+
Sbjct: 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 88.8 bits (220), Expect = 8e-19
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 18/193 (9%)

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVMTAETGTY 382
           I V   ++++H  ++IHRD+K+AN+L+  N +VK+ DFG +++ A +    V     GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
            ++APE+   KPY  KAD+FS G++L+ELLT K P++    ++  +     G    +P +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPS 268

Query: 443 SQPKLAELLERCWQQDPALRPD-------------FSEIIEILQ-QIAKEVGEENEERRK 488
             P++ E++      DP  RP               S ++EI+Q Q        +   R+
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQ 328

Query: 489 EKSSGGFLSVLRR 501
            + +   L V RR
Sbjct: 329 IQQTKQLLQVERR 341

Length = 496

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 38/208 (18%)

Query: 232 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           GS+G +     +GT  ++  AIK LK + +  D   E      + R+V        +   
Sbjct: 6   GSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECT---MVERRV--------LALA 52

Query: 288 TKPPSLC-------------IVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGM 332
            + P L               V E+++GG   D +  +   G F        A ++  G+
Sbjct: 53  WEHPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGL 109

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI 390
            +LH+  II+RDLK  N+L+D++  +K+ADFG+ +    +G   A T  GT  ++APE++
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEIL 168

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPY 418
           + + Y+   D +SFG++L+E+L G+ P+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 44/235 (18%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-------- 266
            I  ++++ G+ +  G+YG + +   T   + VAIK +K   I++D+ K+          
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 267 ----QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
               +E+ IM +++H+N++  +    +   + +V + M+          LK V      L
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DLKKVVDRKIRL 116

Query: 323 KVA------IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 374
             +      + +  G+N LH+   +HRDL  AN+ ++   + K+ADFG+AR         
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 375 -------------MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
                        MT++  T  + APE++   + Y    D++S G +  ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 11/196 (5%)

Query: 232 GSYGDLYR-----GTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQF 283
           G YG +++     G    +  A+KVLK   I  + QK+ A    E  I+  V+H  +V  
Sbjct: 7   GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDL 65

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           I A      L ++ E++SGG ++ +L + +G+F   +      ++S  + +LHQ  II+R
Sbjct: 66  IYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYR 124

Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVF 402
           DLK  N+L+D    VK+ DFG+ +     G +T    GT  +MAPE++    +    D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184

Query: 403 SFGIVLWELLTGKLPY 418
           S G +++++LTG  P+
Sbjct: 185 SLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)

Query: 227 SKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 279
           +++  G+YG +YR         VA+K LK E+     +KE F     +E+ I+ K++H N
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPN 65

Query: 280 VVQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK------LPSLLK-VAIDVSK 330
           +V    +   +    + +V E++         H LK + +      L S +K + + +  
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMA 386
           G+ +LH N I+HRDLK +NLL++   ++K+ DFG+AR +  S     T    T  YR  A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYR--A 174

Query: 387 PEVIEHKP-YDHKADVFSFGIVLWELLTGK 415
           PE++     Y    D++S G +  ELLT K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 78.7 bits (195), Expect = 3e-18
 Identities = 29/72 (40%), Positives = 40/72 (55%), Gaps = 6/72 (8%)

Query: 108 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---E 161
             E+   T D+P L +++   L  +GLNI +A  F+T DGY+LD FVV   DG P    E
Sbjct: 1   GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60

Query: 162 ETEQLRAALEKE 173
              ++R ALE  
Sbjct: 61  RLARIREALEDA 72

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 62/239 (25%), Positives = 120/239 (50%), Gaps = 12/239 (5%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           V +G++G ++  R        A+KV+    +    Q++    E  ++++V H  +++   
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  L ++ E++ GG ++ YL +  G F   + L  A ++   + YLH   I++RDL
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 405
           K  N+L+D+   +K+ DFG A+ K +    T   GT  ++APEVI+ K ++   D ++ G
Sbjct: 128 KPENILLDKEGHIKLTDFGFAK-KLRDRTWTL-CGTPEYLAPEVIQSKGHNKAVDWWALG 185

Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALR 462
           I+++E+L G  P+    P     G+ +K L   +  P++      +L+++    D   R
Sbjct: 186 ILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 232 GSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           GS+G   L R     +  A+KVLK + I  + D++    ++  +     H  + Q     
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
             P  L  V EF++GG +  ++ K +  F        A +++  + +LH   II+RDLK 
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKL 124

Query: 348 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 406
            N+L+D     K+ADFG+ +    +G  T+   GT  ++APE+++   Y    D ++ G+
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184

Query: 407 VLWELLTGKLPYE 419
           +L+E+L G  P+E
Sbjct: 185 LLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 2/174 (1%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88

Query: 307 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ +    F     +  A +++ G+  LH+  I++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           A    +   +    GT  +MAPEV++++ Y    D +  G +++E++ GK P+ 
Sbjct: 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 49/292 (16%)

Query: 224 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
             G          L +    +  VA+K +  +  + +  K   QE+   R+++H N++ +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAI--DVSKGMNYLHQNN 339
           + +      L +V+  M+ GS  D    LK  F   LP L    I  DV   ++Y+H   
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIE 391
            IHR +KA+++L+  +  V ++    +        R +       +      W++PEV++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 392 H--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL-RPTIP---- 440
              + Y+ K+D++S GI   EL  G +P++ +      L+   G V   L + T P    
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241

Query: 441 --KNSQPKLA---------------------ELLERCWQQDPALRPDFSEII 469
               S+                         + +E C Q+DP  RP  S+++
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 83.9 bits (207), Expect = 9e-18
 Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 229 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 282
           +  GS+G ++    +GT  +Q  AIK LK + +  + D++    ++  +     H  +  
Sbjct: 3   LGKGSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
                    +L  V E+++GG +  ++   HK    F LP     A ++  G+ +LH   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKG 116

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKPY 395
           I++RDLK  N+L+D +  +K+ADFG+ +   ++ +  A+T    GT  ++APE++  + Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 396 DHKADVFSFGIVLWELLTGKLPY 418
           +   D +SFG++L+E+L G+ P+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 21/234 (8%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           V +KVL P   + D+   F +   +MR+V HK++V   G C +     +V EF+  G + 
Sbjct: 35  VILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 359
            ++H+   V   P   KVA  ++  ++YL   +++H ++   N+L+       +    +K
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152

Query: 360 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE-HKPYDHKADVFSFGIVLWEL-LTGK 415
           ++D G+        V++ +    R  W+APE +E  K     AD +SFG  LWE+   G+
Sbjct: 153 LSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207

Query: 416 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
           +P +  T L       +       P  S  +LA+L+  C   DP  RP F  I+
Sbjct: 208 IPLKDKT-LAEKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)

Query: 232 GSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           GS+G +        D   AIKVLK + I  + D+     ++  +    +H  +       
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
                L  V E+++GG +   + + +  F  P     A +V+  + +LH++ +I+RDLK 
Sbjct: 66  QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124

Query: 348 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 406
            N+L+D     K+ADFG+ +    +GV T    GT  ++APE+++   Y    D ++ G+
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184

Query: 407 VLWELLTGKLPYE 419
           +++E++ G+ P+E
Sbjct: 185 LMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 69/221 (31%), Positives = 109/221 (49%), Gaps = 37/221 (16%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 267
           VWE+ P   +  S V SG+YG       CS       + VAIK L     ++   K   +
Sbjct: 10  VWEV-PDRYQNLSPVGSGAYG-----QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYL--HKLKG---VF 316
           E+ +++ + H+NV+  +   T   SL       +VT  M G  + + +   KL      F
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF 122

Query: 317 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 376
            +  +L+       G+ Y+H   IIHRDLK +N+ ++E+  +K+ DFG+AR       MT
Sbjct: 123 LVYQILR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MT 173

Query: 377 AETGTYRW-MAPEVIEHK-PYDHKADVFSFGIVLWELLTGK 415
               T RW  APE++ +   Y+   D++S G ++ ELLTGK
Sbjct: 174 GYVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 64/251 (25%), Positives = 127/251 (50%), Gaps = 25/251 (9%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     Q  A+KV+K E ++ D   ++ Q E  +  +      +  + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 342
           +C +  S L +V E+++GG +  ++ + +   KLP       A ++   +N+LH+  II+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D +  +K+ D+G+ +     G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 402 FSFGIVLWELLTGKLPYEYLTP----------LQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           ++ G++++E++ G+ P++ +T            Q    +++K +R  IP+    K + +L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---ILEKPIR--IPRFLSVKASHVL 234

Query: 452 ERCWQQDPALR 462
           +    +DP  R
Sbjct: 235 KGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 224 KFGSKVASGSYGDLYR------GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR- 276
           K   K+  G++ ++ +      G Y     AIK +K +   S  Q    +E+  +R++  
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56

Query: 277 HKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           H N+++ I      K   L +V E M   ++Y+ +   K       +      + K +++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APE-VIEH 392
           +H+N I HRD+K  N+L+  ++++K+ADFG  R        T    T RW  APE ++  
Sbjct: 116 MHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTD 173

Query: 393 KPYDHKADVFSFGIVLWELLT 413
             Y  K D+++ G V +E+L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 45/174 (25%), Positives = 93/174 (53%), Gaps = 2/174 (1%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L  +R+     ++ A  E  I+ KV    +V    A      LC+V   M+GG + 
Sbjct: 22  ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81

Query: 307 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ +     ++  ++  +  ++ G+ +LH  +I++RD+K  N+L+D+    +++D G+
Sbjct: 82  YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL 141

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           A        +T   GT  +MAPE+++ +PY +  D F+ G  ++E++ G+ P++
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 23/200 (11%)

Query: 228 KVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF---IMRKVRHKNV 280
           K+  G +G +     + T   +    K++K +  N+        E     +M+   + N 
Sbjct: 23  KLIDGKFGKVSVLKHKPT--QKLFVQKIIKAKNFNAI-------EPMVHQLMKD--NPNF 71

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           ++   + T      ++ +++  G ++D L K +G      + K+   + + +N LH++NI
Sbjct: 72  IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130

Query: 341 IHRDLKAANLLMDENEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           IH D+K  N+L D  +  + + D+G+ ++           GT  + +PE I+   YD   
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSF 187

Query: 400 DVFSFGIVLWELLTGKLPYE 419
           D ++ G++ +ELLTGK P++
Sbjct: 188 DWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 40/213 (18%)

Query: 227 SKVASGSYGDLYRGTYC--SQDVAIKVLKP-ERINSDMQKEFAQ----EVFIMRKVRHKN 279
           S +  G+YG +   T+      VAIK + P E       + F Q    E+ I+R+ +H+N
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHEN 64

Query: 280 VVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-----DV 328
           ++  I    +PPS        IV E M        L+K   + K   L    I      +
Sbjct: 65  IIG-ILDIIRPPSFESFNDVYIVQELMETD-----LYK---LIKTQHLSNDHIQYFLYQI 115

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMTAETGTYRW 384
            +G+ Y+H  N++HRDLK +NLL++ N  +K+ DFG+AR+       +G +T    T RW
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RW 174

Query: 385 M-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
             APE+ +  K Y    D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 13/177 (7%)

Query: 244 SQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMS 301
            Q+VAIK ++KP       ++ + +E+ +++ +RH+N++        P   +  VTE + 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93

Query: 302 GGSVYDYLHKLKGVFKL-PSLLK-VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 359
                  LH+L     L    ++     + +G+ Y+H   ++HRDLK +N+L++EN  +K
Sbjct: 94  TD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148

Query: 360 VADFGVARVKAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
           + DFG+AR+  Q   MT    T  + APE+ +  + YD + D++S G +  E+L GK
Sbjct: 149 ICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)

Query: 221 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 275
           K  +  ++V  G YG ++    + T   + VA+K +K   +   +  +    E  I+   
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           + + +V+ + A      L +  E++ GG     L+ L GV           ++ + ++ L
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL 117

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEH 392
           H+   IHRDLK  N L+D +  +K+ DFG+++     A S V     G+  +MAPEV+  
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRG 172

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
           K YD   D +S G +L+E L G  P+   TP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 52/172 (30%), Positives = 92/172 (53%), Gaps = 6/172 (3%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           L  V EF++GG +  ++   KG F L      A ++  G+ +LH   II+RDLK  N+++
Sbjct: 71  LFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129

Query: 353 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
           D +  +K+ADFG+ +     G   A T  GT  ++APE+++   Y    D +SFG++L+E
Sbjct: 130 DRDGHIKIADFGMCKENV-FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188

Query: 411 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           +L G+ P+      +    +      P  P+    +  ++LE+ +++DP  R
Sbjct: 189 MLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 81.2 bits (200), Expect = 8e-17
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)

Query: 223 LKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-QEVFIMRKVRHK 278
             F   + +GS+G +   TY ++D   VAIK  +  +I    Q +    E  I+  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMNYLH 336
             V   G+      L +V EF+ GG  + +L + K   + P+ +    A  +     YL 
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ 148

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
             NI++RDLK  NLL+D++  +K+ DFG A+V   +   T   GT  ++APE++ +  + 
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHG 206

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPL 424
             AD ++ GI ++E+L G  P+    PL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 46/176 (26%), Positives = 92/176 (52%), Gaps = 7/176 (3%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           L ++ ++++GG ++ +L++ +  F    +     ++   +++LHQ  II+RD+K  N+L+
Sbjct: 80  LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 353 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP--YDHKADVFSFGIVL 408
           D    V + DFG+++         A +  GT  +MAPEVI      +D   D +S G++ 
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 462
           +ELLTG  P+       +   + ++ L+  P  PK    +  + +++  ++DP  R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 66/250 (26%), Positives = 126/250 (50%), Gaps = 21/250 (8%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L       +  A+KV+K E +N D   ++ Q E  +     +   +  + 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V EF+SGG   D +  ++   KLP       + ++S  +N+LH+  II+
Sbjct: 63  SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 402 FSFGIVLWELLTGKLPYEYLT----PLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K + +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLK 237

Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 238 GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 10/177 (5%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 298
           Q+VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       +V E
Sbjct: 42  QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101

Query: 299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 358
            M   ++   +       ++  LL     +  G+ +LH   IIHRDLK +N+++  +  +
Sbjct: 102 LMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157

Query: 359 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
           K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G 
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 38/99 (38%), Positives = 61/99 (61%), Gaps = 3/99 (3%)

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--QSGVMTAETGTYRWMAP 387
           +G+ YLH   I+HRD+K  NLL++ N V+K+ DFG+ARV+   +S  MT E  T  + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 388 EVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 425
           E++     Y    D++S G +  ELL  ++ ++  +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           SK+  GSYG ++  R     Q VAIK       +  ++K   +E+ ++++++H N+V  I
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLL--KVAIDVSKGMNYLHQNNII 341
               +   L +V E+      +  L++L K    +P  L  K+     + +N+ H++N I
Sbjct: 67  EVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKA 399
           HRD+K  N+L+ +   +K+ DFG AR+    G    +    RW  APE++     Y    
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182

Query: 400 DVFSFGIVLWELLTG 414
           DV++ G V  ELLTG
Sbjct: 183 DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 81.2 bits (200), Expect = 2e-16
 Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 23/252 (9%)

Query: 239 RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVT 297
           RG+   + V  K +    +N + Q  +A+ E+  +    H  +V+          L ++ 
Sbjct: 88  RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144

Query: 298 EFMSGGSVYDYLHKLKGVFK--LP------SLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
           E+ SGG   D   ++K   K  LP       LL   I ++  ++ +H   ++HRDLK+AN
Sbjct: 145 EYGSGG---DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSAN 199

Query: 350 LLMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 406
           + +    ++K+ DFG ++  + S    V ++  GT  ++APE+ E K Y  KAD++S G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 407 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 466
           +L+ELLT   P++  +  +    V+     P  P      +  LL+    ++PALRP   
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 467 EII--EILQQIA 476
           +++  E L+ +A
Sbjct: 319 QLLHTEFLKYVA 330

Length = 478

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 267
           VWE+ P+      +V SG+YG +     CS       + VAIK L     +    K   +
Sbjct: 10  VWEL-PERYTSLKQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY----LHKLKGV-FKLPSLL 322
           E+ +++ ++H+NV+  +   T   S     EF     V  Y    L K+ G       + 
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSG---DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120

Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 382
            +   +  G+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T 
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTR 178

Query: 383 RWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
            + APEVI +   Y+   D++S G ++ E+LTGK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 51/168 (30%), Positives = 90/168 (53%), Gaps = 15/168 (8%)

Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+ D +  LK   
Sbjct: 38  IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQV--LKKAG 94

Query: 317 KLPS--LLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA----RVK 369
           ++P   L K++I V +G+ YL +   I+HRD+K +N+L++    +K+ DFGV+       
Sbjct: 95  RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154

Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
           A S V     GT  +M+PE ++   Y  ++D++S G+ L E+  G+ P
Sbjct: 155 ANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 37/261 (14%)

Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           G +   G YG+L++      +V +KVL  ++ + +  + F +   +M ++ HK++V   G
Sbjct: 14  GIRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            C       +V E++  GS+  YL K K +  +   L+VA  ++  +++L    + H ++
Sbjct: 67  VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126

Query: 346 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEH-KP 394
            A N+L+   E         +K++D G++       V+  E    R  W+ PE IE+ + 
Sbjct: 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQN 181

Query: 395 YDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGL-----RPTIPKNSQPKLA 448
               AD +SFG  LWE+ +G   P   L          QK L     R  +P     +LA
Sbjct: 182 LSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWTELA 233

Query: 449 ELLERCWQQDPALRPDFSEII 469
            L+ +C   +P  RP F  II
Sbjct: 234 NLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 58/193 (30%), Positives = 105/193 (54%), Gaps = 9/193 (4%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V  G+YG +   R     + VAIK  K    N ++++   +E+ ++R ++ +N+V+   A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 344
             +   L +V E++   ++ + L ++  GV   P  ++  I  + K +++ H+N+I+HRD
Sbjct: 69  FRRRGKLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRD 125

Query: 345 LKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWM-APEVIEHKPYDHKADVF 402
           +K  NLL+  N+V+K+ DFG AR +   S     E    RW  +PE++   PY    D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185

Query: 403 SFGIVLWELLTGK 415
           S G +L EL  G+
Sbjct: 186 SVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 45/266 (16%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKV----RHKNV 280
           +++G+YG +Y  R     Q  A+K     +IN    + +   Q+VF+ R +     +  V
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMK-----KINKQNLILRNQIQQVFVERDILTFAENPFV 63

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP---SLLKVAIDVSKGMNYLHQ 337
           V    +      LC+V E++ GG   D    LK +  LP   + +  A  V   + YLH 
Sbjct: 64  VSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------------------ 379
             I+HRDLK  NLL+     +K+ DFG++++    G+M+  T                  
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 380 --GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR- 436
             GT  ++APEVI  + Y    D ++ GI+L+E L G +P+   TP +    V+   +  
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 437 PTIPKNSQPKLAELLERCWQQDPALR 462
           P   +       +L+ R  +Q+P  R
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 12  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 71  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRW 182

Query: 384 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
           + APE+ +    Y+   D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 2/173 (1%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 29  ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK 88

Query: 307 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ +    F     +  A ++  G+  L +  I++RDLK  N+L+D+   ++++D G+
Sbjct: 89  FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL 148

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           A    +   +    GT  +MAPEVI ++ Y    D +  G +++E++ G+ P+
Sbjct: 149 AVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161

Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Query: 415 KL 416
            +
Sbjct: 222 GV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 16/220 (7%)

Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           A E  I+R + H +++Q  G  T     C++        +Y YL   + +  +  +L + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI-AICDILAIE 188

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA--RVKAQSGVMTAETGTYR 383
             V + + YLH+N IIHRD+KA N+ ++    V + DFG A   V   +       GT  
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK--------LPYEYLTPLQAAVGVVQKGL 435
             APE++   PY    D++S GIVL+E+ T          L  +  +  Q  + + + G 
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308

Query: 436 RPT-IPKNSQPKLAELLERCWQQD---PALRPDFSEIIEI 471
            P   P ++Q  L E+     ++    P  RP ++ + E+
Sbjct: 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348

Length = 391

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFA-QEVFIMRKVRHKNVVQFI 284
           K+  G+YG +++     +   I  LK  R++ D +     A +E+ ++++++HKN+V+  
Sbjct: 7   KIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                   L +V E+     +  Y     G      +      + KG+ + H +N++HRD
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124

Query: 345 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 398
           LK  NLL+++N  +K+ADFG+AR     V+  S    AE  T  +  P+V+   K Y   
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTS 180

Query: 399 ADVFSFGIVLWELLTGKLP 417
            D++S G +  EL     P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 78/325 (24%)

Query: 237 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 296
           L R T     V +++   E    +  K    EV +    RH N++      T    L ++
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77

Query: 297 TEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
           + FM+ GS       LK  F        + ++L  A+   +G+NYLHQN  IHR++KA++
Sbjct: 78  SPFMAYGSAN---SLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASH 131

Query: 350 LLMDENEVVKVADFGV--------ARVKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKA 399
           +L+  + +V ++             + K         T    W++PE++      Y+ K+
Sbjct: 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191

Query: 400 DVFSFGIVLWELLTGKLPYEYL---------------TPLQAAV---------------- 428
           D++S GI   EL TG++P++ +               +PL                    
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251

Query: 429 -----GVVQKGLRPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
                 VV  G+  T+          K   P    L+E C QQDP  RP  S ++     
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HA 309

Query: 475 IAKEVGEENEERRKEKSSGGFLSVL 499
             K+V        KE++ G  LS+L
Sbjct: 310 FFKQV--------KEQTQGSILSLL 326

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 21/237 (8%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           V +KVL P   + D+   F +   +M +V H ++    G C +     +V EF+  G + 
Sbjct: 47  VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 359
             L K KG   +   + VA  ++  ++YL   N++H ++ A N+L+         +  +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 360 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKA-DVFSFGIVLWEL-LTGK 415
           ++D GV+        ++ E    R  W+APE +        A D +SFG  L E+   G+
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 416 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
           +P +  TP +      +K  R  +P+ S  +LA L+ +C   +P  RP F  I+  L
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 50/162 (30%), Positives = 88/162 (54%), Gaps = 3/162 (1%)

Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+ D + K  G  
Sbjct: 42  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 100

Query: 317 KLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
               L KV+I V KG+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S + 
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
            +  GT  +M+PE ++   Y  ++D++S G+ L E+  G+ P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 47/223 (21%)

Query: 224 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK 278
           +    +  G+YG +Y+         ++ AIK  K ++     + +   +E+ ++R+++H+
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDY----------LHKLKGVFKLP-----SLLK 323
           NVV  +    +     +   ++    ++DY           H+      +P     SLL 
Sbjct: 63  NVVSLVEVFLEHADKSV---YL----LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAE- 378
             ++   G++YLH N ++HRDLK AN+L+     E  VVK+ D G+AR+        A+ 
Sbjct: 116 QILN---GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 379 -----TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLT 413
                T  YR  APE++    H  Y    D+++ G +  ELLT
Sbjct: 173 DPVVVTIWYR--APELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 7/164 (4%)

Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+   L + K   
Sbjct: 42  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 98

Query: 317 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 373
           ++P   L KV+I V +G+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S 
Sbjct: 99  RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157

Query: 374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
           +  +  GT  +M+PE ++   Y  ++D++S G+ L EL  G+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ E  +  +     +E+ +++++ H N+V+ + 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 344
                  L +V EF+    +  Y+         P L+K  +  + +G+ Y H + ++HRD
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124

Query: 345 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDHK 398
           LK  NLL+D    +K+ADFG+AR     V+      T E  T  + APE+ +  + Y   
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTP 180

Query: 399 ADVFSFGIVLWELLTGK 415
            D++S G +  E++  +
Sbjct: 181 VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 33/201 (16%)

Query: 239 RGTY---CS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           RG Y   CS       + VAIK +     N    K   +E+ ++R + H+NV+  I    
Sbjct: 15  RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIM 73

Query: 289 KPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLH 336
            PP       + IV E M        LH+   + +    L           + +G+ Y+H
Sbjct: 74  PPPHREAFNDVYIVYELMDTD-----LHQ---IIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKP 394
             N++HRDLK +NLL++ N  +K+ DFG+AR  ++ G  MT    T  + APE++     
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    DV+S G +  ELL  K
Sbjct: 186 YTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 28/234 (11%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           VWE+ P+  +  + V SG+YG +     T   Q VA+K L     +    +   +E+ ++
Sbjct: 10  VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           + ++H+NV+  +   T   S+       +VT  M           L  + K   L    +
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHV 120

Query: 327 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
                 + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR       MT    T
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT 178

Query: 382 YRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
             + APE+ +    Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 227 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 280
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 281 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-VAIDVSKGMNY 334
           V+    CT     +   L +V E +    +  YL K+         +K +   + +G+++
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+    
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185

Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E+   K
Sbjct: 186 YATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQD--- 96

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

Query: 415 KLPY 418
           K+ +
Sbjct: 215 KILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 12/196 (6%)

Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+    +  ++         LP +      + +G+ + H + ++HRD
Sbjct: 67  VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKPYDHKA 399
           LK  NLL++    +K+ADFG+AR     GV     T E  T  + APE+ +  K Y    
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182

Query: 400 DVFSFGIVLWELLTGK 415
           D++S G +  E++T +
Sbjct: 183 DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 51/195 (26%), Positives = 102/195 (52%), Gaps = 10/195 (5%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQF 283
           K+  G+Y  +Y+G      + VA+K +    ++++        +E+ +M++++H+N+V+ 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 284 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                    L +V E+M      Y   H ++G     ++      + KG+ + H+N ++H
Sbjct: 64  HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKAD 400
           RDLK  NLL+++   +K+ADFG+AR         + E  T  + AP+V+   + Y    D
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183

Query: 401 VFSFGIVLWELLTGK 415
           ++S G ++ E++TG+
Sbjct: 184 IWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)

Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEF 299
           +VA+K L     N    K   +E+ +++ V HKN++  +   T   SL       +V E 
Sbjct: 48  NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 359
           M   ++   +H      ++  LL     +  G+ +LH   IIHRDLK +N+++  +  +K
Sbjct: 108 MDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163

Query: 360 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           + DFG+AR    + +MT    T  + APEVI    Y    D++S G ++ EL+ G + ++
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 16/197 (8%)

Query: 228 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 280
           K+  G+Y  +Y+G     D  VA+K ++ E       +E A     +EV +++ ++H N+
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLKDLKHANI 66

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V          SL +V E++    +  YL        + ++      + +G+NY H+  +
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHK 398
           +HRDLK  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P++ +    Y  +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185

Query: 399 ADVFSFGIVLWELLTGK 415
            D++  G + +E+ TG+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 3/131 (2%)

Query: 290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
              L +VT++MSGG ++ +L K +G F          ++   + +LH+ +I++RDLK  N
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126

Query: 350 LLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEV-IEHKPYDHKADVFSFGIV 407
           +L+D    + + DFG+++        T    GT  ++APEV ++ K Y    D +S G++
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 408 LWELLTGKLPY 418
           ++E+  G  P+
Sbjct: 187 VFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)

Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           K   +E+ I++ + H+ ++  I A     ++C+V          D    +     LP  L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK----CDLFTYVDRSGPLP--L 184

Query: 323 KVAIDVSKGM----NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
           + AI + + +     YLH   IIHRD+K  N+ +DE E   + DFG A    +       
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241

Query: 379 TGTYRWM------APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
              Y W       +PE++   PY  K D++S G+VL+E+    + 
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           +WE+ P   +   +V SG+YG     T CS         VAIK L     +    K   +
Sbjct: 10  IWEV-PDRYRDLKQVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ +++ ++H+NV+  +   T   SL       +V  FM        L KL    KL   
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLSED 118

Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 379
            +  +   + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR +  S  MT   
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTGYV 176

Query: 380 GTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
            T  + APEVI     Y    D++S G ++ E+LTGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 39/200 (19%)

Query: 243 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 286
           C + VA+K +    + +D Q  K   +E+ I+R++ H N+V+               +G+
Sbjct: 29  CDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 341
            T+  S+ IV E+M           L  V +   L +         + +G+ Y+H  N++
Sbjct: 85  LTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136

Query: 342 HRDLKAANLLMD-ENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPEVIEH-KPY 395
           HRDLK AN+ ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P ++     Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196

Query: 396 DHKADVFSFGIVLWELLTGK 415
               D+++ G +  E+LTGK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 49/175 (28%), Positives = 94/175 (53%), Gaps = 6/175 (3%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           L ++ +++SGG ++ +L++ +  F    +   + ++   + +LH+  I++RD+K  N+L+
Sbjct: 80  LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138

Query: 353 DENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA-DVFSFGIVLW 409
           D    V + DFG+++  +  +     +  GT  +MAPE+I  K    KA D +S GI+++
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198

Query: 410 ELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 462
           ELLTG  P+           V ++ L+  P  P    P+  +LL +  ++DP  R
Sbjct: 199 ELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 51/278 (18%)

Query: 229 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQF 283
           +  G+YG +Y+       + VA+K ++       +     +E+ +++++    H N+V+ 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 284 IGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSK----GMN 333
           +  C  P       L +V E +    +  YL K       P L    I D+ +    G++
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVD 121

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVIE 391
           +LH + I+HRDLK  N+L+  +  VK+ADFG+AR+ +    +T+   T  YR  APEV+ 
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--APEVLL 179

Query: 392 HKPYDHKADVFSFGIVLWEL---------------------LTGKLPYEYLTPLQAAVGV 430
              Y    D++S G +  EL                     + G LP E   P   ++  
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPRNVSLPR 238

Query: 431 VQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRP 463
                       S       +  +LL++    +P  R 
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      L +V E+M GG + + +       K         +V   ++ +H   +IHRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 168

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 399
           K  N+L+D++  +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 400 DVFSFGIVLWELLTGKLPY 418
           D +S G+ L+E+L G  P+
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 30/216 (13%)

Query: 222 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRK 274
                 ++  G+YG +Y  R     + VA+K     ++  D +KE       +E+ I+R+
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62

Query: 275 VRHKNVVQFIGACT-KPPSLCIVTEFMSGGSVYDYL-HKLKGVFK----------LPSLL 322
           + H+N+V      T K  +L    +  +   V++Y+ H L G+ +          + S +
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETG 380
           K  ++   G+NY H+ N +HRD+K +N+L++    +K+ADFG+AR+    +S   T +  
Sbjct: 123 KQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 381 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 415
           T  +  PE ++  + Y    DV+S G +L EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 280
           K+  G+Y  +++G        VA+K ++ E       +E A     +EV +++ ++H N+
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLE------HEEGAPCTAIREVSLLKNLKHANI 65

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI---DVSKGMNYLHQ 337
           V           L +V E++      D    L     L S+  V I    + +G++Y H+
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPY 395
             I+HRDLK  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P+V +    Y
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 396 DHKADVFSFGIVLWELLTGK 415
               D++  G +L+E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 31/248 (12%)

Query: 244 SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI-VTEFMS 301
             +VAIK+L+ +    + Q   F +E  +  ++ H N+V  + +   PP L   V E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---V 358
           G ++ + L    G        ++ + V   +   H   I+HRDLK  N+++ +  V    
Sbjct: 63  GRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 359 KVADFGVARV-----KAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
           KV DFG+  +      A    +T  T   GT  + APE +  +P    +D++++G++  E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 411 LLTGK----------LPYEYLTPLQAAVGVVQKG------LRPTIPKNSQPKLAELLERC 454
            LTG+          + Y+ L+P+  ++     G      LR  + K+ + + A      
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR-AASAPAL 240

Query: 455 WQQDPALR 462
            ++  AL 
Sbjct: 241 AERFRALE 248

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      L +V E+M GG + + +       K         +V   ++ +H    IHRD+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDV 168

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 399
           K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 400 DVFSFGIVLWELLTGKLPY 418
           D +S G+ L+E+L G  P+
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/248 (23%), Positives = 122/248 (49%), Gaps = 15/248 (6%)

Query: 229 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN-V 280
           + +G+YG ++      G    +  A+KVLK   I   +   +    E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V    A      L ++ ++++GG ++ +L + +  FK   +   + ++   + +LH+  I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE--HKPYD 396
           I+RD+K  N+L+D N  V + DFG+++   +  V  A +  GT  +MAP+++      +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 454
              D +S G++++ELLTG  P+       +   + ++ L+  P  P+       ++++R 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 455 WQQDPALR 462
             +DP  R
Sbjct: 247 LMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 15/198 (7%)

Query: 228 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y+      ++ +A+K ++ E+ +  +     +E+ ++++++H N+V+   
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 344
                  L +V E++    +  ++       K P L+K  +  + +G+ Y H + ++HRD
Sbjct: 69  VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127

Query: 345 LKAANLLMDE-NEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDH 397
           LK  NLL+D     +K+ADFG+AR     V+      T E  T  + APE+ +  + Y  
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRT----FTHEVVTLWYRAPEILLGSRHYST 183

Query: 398 KADVFSFGIVLWELLTGK 415
             D++S G +  E++  K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 9/94 (9%)

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------VMTAETGTYR 383
           K + Y+H  N+IHRDLK +N+L++ +  VK+ADFG+AR  ++        V+T    T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176

Query: 384 WM-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
           W  APE+ +    Y    D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 281
           +++  G+YG +Y  R  +    VA+K ++ +     +     +EV +++++    H N+V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 282 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKG----VFKLPSLLKVAIDVSKGM 332
           + +  C      +   + +V E +    +  YL K+         +  L++  +   +G+
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 392
           ++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  + APEV+  
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 393 KPYDHKADVFSFGIVLWELLTGK 415
             Y    D++S G +  E+   K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     Q  A+K+L K E I       F +E  IM     + +VQ   
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110

Query: 286 ACTKPPSLCIVTEFMSGG------SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           A      L +V E+M GG      S YD   K    +    +L  A+D       +H   
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDA------IHSMG 162

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE----HK 393
            IHRD+K  N+L+D++  +K+ADFG       +G++  +T  GT  +++PEV++      
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
            Y  + D +S G+ L+E+L G  P+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 47/192 (24%), Positives = 97/192 (50%), Gaps = 6/192 (3%)

Query: 228 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+Y  +++G     +  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                 SL +V E++    +  Y+     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 72  IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130

Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 403
           K  NLL++E   +K+ADFG+AR K+  +   + E  T  +  P+V +    Y  + D++ 
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190

Query: 404 FGIVLWELLTGK 415
            G + +E+ +G+
Sbjct: 191 VGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWM 385
           G+ Y+H  N++HRDLK  NLL++ +  +K+ DFG+AR         +G MT    T RW 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175

Query: 386 -APEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
            APE+ +  + Y    DV+S G +L ELL  K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)

Query: 228 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 283
           K+  GSY  +Y+G      + VA+KV+   R+  +    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                   +L +V E++    +  Y+ K  G     ++      + +G++Y+HQ  I+HR
Sbjct: 69  HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 344 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 401
           DLK  NLL+ +   +K+ADFG+AR K+  S   + E  T  +  P+V +    Y    D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187

Query: 402 FSFGIVLWELLTGKLPYEYLTPLQ 425
           +  G +  E++ G   +  +  +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 58/239 (24%), Positives = 111/239 (46%), Gaps = 9/239 (3%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +   R     +  A+K ++   I   S++    A+   ++ +V    +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLK 59

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +   P  L +V  F++GG ++ +L + +G F L        ++   +  LH+ N+I+RD
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 345 LKAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+L+D    + + DFG+ ++            GT  ++APE++    Y    D ++
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
            G++L+E+LTG  P+      +    ++Q+ LR   P        +LL     +DP  R
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 8/90 (8%)

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GVMTAETGTYRW 384
           +G+ Y+H  N+IHRDLK +NLL++E+  +++ DFG+AR  + S       MT    T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176

Query: 385 M-APEVIEHKP-YDHKADVFSFGIVLWELL 412
             APE++   P Y    D++S G +  E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.9 bits (173), Expect = 8e-13
 Identities = 67/292 (22%), Positives = 135/292 (46%), Gaps = 48/292 (16%)

Query: 228 KVASGSYGDLY-------RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           K+ +G +G+++       +  +C + ++ + LK ER  S    +   EV +MR+++HKN+
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKS----QLVIEVNVMRELKHKNI 74

Query: 281 VQFIGACTKPPS--LCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 335
           V++I       +  L I+ EF   G +   +   +K+ G  +  +++ +   +   + Y 
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 336 HQ-------NNIIHRDLKAANLLM-----------------DENEVVKVADFGVARVKAQ 371
           H          ++HRDLK  N+ +                 +   + K+ DFG+++    
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 372 SGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
             +  +  GT  + +PE++ H  K YD K+D+++ G +++EL +GK P+         + 
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254

Query: 430 VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 480
            +++G  P +P K    +L  L++         RP  S +  +  QI K VG
Sbjct: 255 ELKRG--PDLPIKGKSKELNILIKNLLNLSAKERP--SALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 47/276 (17%)

Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           ++ G  G  Y+G      +   V +   +NS    E A     M K++H N+V+ IG C 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDL 345
                 ++ E++ G ++ + L  L    +     K+AI ++K + +LH      ++    
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIGIAKALRFLHCRCSPAVV---- 805

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKADVFS 403
                L  E  ++   D    R+     + T         ++APE  E K    K+D++ 
Sbjct: 806 --VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGV----------------VQKGLRPTIPKNSQPKL 447
           FG++L ELLTGK      +P  A  GV                +   + P+I  +     
Sbjct: 864 FGLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917

Query: 448 AELLE------RCWQQDPALRPDFSEIIEILQQIAK 477
            E++E       C   DP  RP  +++++ L+  ++
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 80/293 (27%), Positives = 119/293 (40%), Gaps = 68/293 (23%)

Query: 229 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNV 280
           +  GSYG +     T+  + VAIK     +IN      SD  +   +E+ ++R +RH ++
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATR-ILREIKLLRLLRHPDI 61

Query: 281 VQFIGACTKPPS------LCIVTEFMSGG-----SVYDYLHKLKGVFKLPSLLKVAIDVS 329
           V+ I     PPS      + +V E M           D L      F L  LL+      
Sbjct: 62  VE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWM- 385
             + Y+H  N+ HRDLK  N+L + +  +K+ DFG+ARV      + +   +    RW  
Sbjct: 115 -ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 386 APEVIE--HKPYDHKADVFSFGIVLWELLTGK-------------LPYEYL-TPLQAAVG 429
           APE+       Y    D++S G +  E+LTGK             L  + L TP    + 
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 430 VVQ--------KGLRPTIP-------KNSQPKLAELLERCWQQDPALRPDFSE 467
            V+          +R   P        N+ P    LLER    DP  RP   E
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 10/194 (5%)

Query: 228 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 283
           K+  GSY  +Y+G      Q VA+KV+    + ++    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                   +L  V E+M    +  Y+ +  G     ++      + +G+ Y+H  +I+HR
Sbjct: 69  HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 344 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 401
           DLK  NLL+     +K+ADFG+AR K+  S   ++E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 402 FSFGIVLWELLTGK 415
           +  G +  E+L G+
Sbjct: 188 WGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 20/195 (10%)

Query: 235 GDLYRGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 293
           GD+Y         A+KV+K   + +      F +E  I+       + Q   A     +L
Sbjct: 26  GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76

Query: 294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLLM 352
            +V E+  GG +   L++ +  F    + +  + ++   ++ +HQ   +HRD+K  N+L+
Sbjct: 77  YLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 353 DENEVVKVADFG-VARVKAQSGVM-TAETGTYRWMAPEVIE------HKPYDHKADVFSF 404
           D    +K+ADFG  AR+ A   V      GT  ++APEV+          Y  + D +S 
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 405 GIVLWELLTGKLPYE 419
           G++ +E++ G+ P+ 
Sbjct: 196 GVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD

 Score = 60.6 bits (148), Expect = 5e-12
 Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 2/69 (2%)

Query: 110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-DGWPYEETEQLRA 168
            +     D+P LL+ +T +LAD+GLNI +A   ST    +LDVF V D        +  A
Sbjct: 2   VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60

Query: 169 ALEKEVLKL 177
            LE+ +   
Sbjct: 61  RLEEALEDA 69

This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 10/193 (5%)

Query: 228 KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 283
           K+  GSY  +Y+G      Q VA+K +   R+  +    F   +E  +++ ++H N+V  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                   +L +V E++    +  Y+    G   + ++      + +G+ Y HQ  ++HR
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 344 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 401
           DLK  NLL+ E   +K+ADFG+AR K+  S   + E  T  +  P+V+     Y    D+
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187

Query: 402 FSFGIVLWELLTG 414
           +  G + +E+ TG
Sbjct: 188 WGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 45/163 (27%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-------VAIDVSKGMNYLHQNNIIHRDL 345
           L +V E+M GG + + L + K VF      +       +A+D       +H+   IHRD+
Sbjct: 76  LYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127

Query: 346 KAANLLMDENEVVKVADFGVA-----------------------------RVKAQSGVMT 376
           K  N+L+D +  +K+ADFG+                              R   Q  V  
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 377 -AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
            +  GT  ++APEV+   PY  + D +S G++L+E+L G  P+
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 42/144 (29%), Positives = 77/144 (53%), Gaps = 4/144 (2%)

Query: 229 VASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           ++ G++G +Y  R    S+  A+KV+ K + IN +M  +   E   +   +   +V    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     ++ +V E++ GG V   LH + G F     +K   +V+  ++YLH++ IIHRDL
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130

Query: 346 KAANLLMDENEVVKVADFGVARVK 369
           K  N+L+     +K+ DFG+++V 
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           V ++ +  E   ++M      E+ + +   H N+V +         L +VT FM+ GS  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87

Query: 307 DYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+  +  V ++   
Sbjct: 88  DLICTHFMDGMSEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146

Query: 365 V--------ARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTG 414
                     R++              W++PEV++   + YD K+D++S GI   EL  G
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206

Query: 415 KLPYEYLTPLQAAVGVVQKGLRPTIP 440
            +P++ +   Q    ++ + L  T+P
Sbjct: 207 HVPFKDMPATQ----MLLEKLNGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 38/226 (16%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
            +  G  G++Y      CS+ VA+K ++ +   N  ++K F +E  I   + H  +V   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-------------LPSLLKVAIDVSKG 331
             C+    +     ++ G   Y     LK V++             + + L +   +   
Sbjct: 69  SICSDGDPVYYTMPYIEG---YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK------------AQSGVMTAE- 378
           + Y+H   ++HRDLK  N+L+     V + D+G A  K             +  +  +  
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 379 ------TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                  GT  +MAPE +   P     D+++ G++L+++LT   PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 60.9 bits (148), Expect = 7e-11
 Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 20/170 (11%)

Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 362
            S+ D L           +  V +     +  LH+        K+ N+L+  + ++K+  
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52

Query: 363 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 422
            G     A      +    Y +MAPEVI+ + Y  KAD++S GI L+E L  +LPY    
Sbjct: 53  DGSV---AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108

Query: 423 PLQAAVGVVQKGLRPTIPKNSQPK--------LAELLERCWQQDPALRPD 464
            L A + ++  G+    P++              + +  C  + P  R  
Sbjct: 109 ELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 228 KVASGSYGDLYRGTYCSQDVA---IKVLKPERINSD-------------MQKEFAQEVFI 271
           K+  G+YG +Y+    ++D     +  LK  R+  D             + +  ++ ++I
Sbjct: 8   KIGEGTYGKVYK----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLP--SLLKVAIDV 328
           +R +  ++V +  G     PSL +V E++      +   +       LP  ++      +
Sbjct: 64  VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV-KAQSGVMTAETGTYRWMA 386
            KG+ + H++ ++HRDLK  NLL+D +  ++K+AD G+ R         T E  T  + A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 387 PEV-IEHKPYDHKADVFSFGIVLWELLTG 414
           PEV +    Y    D++S G +  E+   
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 28/236 (11%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           K  K G+ + +GS+G +Y    C   S+ VAIK     ++  D Q +  +E+ IM+ + H
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIK-----KVLQDPQYK-NRELLIMKNLNH 118

Query: 278 KNVV----QFIGACTKPPS----LCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLK--VAI 326
            N++     +   C K       L +V EF+   +V+ Y+ H  +    LP  L    + 
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR--VKAQSGVMTAETGTYR 383
            + + + Y+H   I HRDLK  NLL+D N   +K+ DFG A+  +  Q  V    +  YR
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237

Query: 384 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
             APE+ +    Y    D++S G ++ E++ G   +   + +   V ++Q    PT
Sbjct: 238 --APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Length = 440

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)

Query: 248 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+KVL K E I  +  K    E  I+  + H  +     +      LC+V ++  GG ++
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 307 DYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF-- 363
             L +  G           A +V   + YLH   I++RDLK  N+L+ E+  + ++DF  
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149

Query: 364 -------GVARVKAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 395
                       KA                  + E         GT  ++APEVI    +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209

Query: 396 DHKADVFSFGIVLWELLTGKLPY 418
               D ++ GI+L+E+L G  P+
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)

Query: 203 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPE 255
           P  L  P D    WE+   +L  G  + SG++G +   T         +  VA+K+LK  
Sbjct: 23  PMQL--PYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST 78

Query: 256 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 314
             +S+ Q     E+ IM  +  H N+V  +GACTK   + I+TE+   G + DYLH+ K 
Sbjct: 79  ARSSEKQA-LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Query: 315 VF 316
            F
Sbjct: 138 TF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 3/109 (2%)

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           +Y YL        L  +  VA  +   ++Y+H   IIHRD+K  N+L++  E + + DFG
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305

Query: 365 VA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
            A   R    +       GT    APEV+   PY    D++S G+V++E
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 36/136 (26%), Positives = 73/136 (53%), Gaps = 11/136 (8%)

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAAN 349
           +L +V ++  GG +   L K +   +LP  +      ++   ++ +HQ + +HRD+K  N
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132

Query: 350 LLMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHKP-----YDHKADVF 402
           +LMD N  +++ADFG      + G +  +   GT  +++PE+++        Y  + D +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192

Query: 403 SFGIVLWELLTGKLPY 418
           S G+ ++E+L G+ P+
Sbjct: 193 SLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 57/183 (31%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLL 351
           L  V +++ GG +   L +L G+F+   L +  I +++  +  +H+   IHRD+K  N+L
Sbjct: 76  LYFVMDYIPGGDMMSLLIRL-GIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133

Query: 352 MDENEVVKVADFGVA--------------------------------------------- 366
           +D +  +K+ DFG+                                              
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193

Query: 367 ----RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 422
               R  A S V     GT  ++APEV+    Y    D +S G++L+E+L G+ P+   T
Sbjct: 194 RQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248

Query: 423 PLQ 425
           P +
Sbjct: 249 PAE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 37/135 (27%), Positives = 74/135 (54%), Gaps = 11/135 (8%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 350
           L +V ++  GG +   L K +   +LP  + +  I ++   ++ +HQ + +HRD+K  N+
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133

Query: 351 LMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHK-----PYDHKADVFS 403
           L+D N  +++ADFG      Q G +  +   GT  +++PE+++        Y  + D +S
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193

Query: 404 FGIVLWELLTGKLPY 418
            G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 41/122 (33%), Positives = 62/122 (50%), Gaps = 11/122 (9%)

Query: 206 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQ---DVAIKVLKPERIN 258
           +++P D    WE     L  G  + SG++G +  GT      SQ    VA+K+LKP   +
Sbjct: 24  MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81

Query: 259 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 317
           S+ Q     E+ IM  +  H N+V  +GACTK   + I+TE+   G + +YLHK +  F 
Sbjct: 82  SEKQA-LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140

Query: 318 LP 319
             
Sbjct: 141 SR 142

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 56/227 (24%)

Query: 226 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           G KV  G+YG +Y+         +D A+K ++   I+    +E A    ++R+++H NV+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVI 61

Query: 282 QFIGACTKPPSLCIVTEFMSGGS-----VYDY----------LHKLKGVFKLP------- 319
                        +   F+S        ++DY           H+     K P       
Sbjct: 62  S------------LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109

Query: 320 --SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSG 373
             SLL   +D   G++YLH N ++HRDLK AN+L+     E   VK+AD G AR+     
Sbjct: 110 VKSLLYQILD---GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 374 VMTAETG----TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 415
              A+      T+ + APE ++  + Y    D+++ G +  ELLT +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           +L ++ EF+ GG +   L K   + +  +   +A +    ++ +HQ   IHRD+K  NLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLL 133

Query: 352 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 375
           +D    VK++DFG+                              ++ KA++       + 
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
            +  GT  ++APEV     Y+   D +S G++++E+L G  P+   TP
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           +L ++ EF+ GG +   L K   + +  +   +A  V   ++ +HQ   IHRD+K  NLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDNLL 133

Query: 352 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 375
           +D    VK++DFG+                              ++ KA++       + 
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
            +  GT  ++APEV     Y+   D +S G++++E+L G  P+   TP
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 34/216 (15%)

Query: 226 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           G KV  G+YG +Y+         ++ A+K ++   I+    +E A    ++R+++H NV+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVI 61

Query: 282 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLP-SLLKVAI-DV 328
             Q +        + ++ ++      +D  H +K            +LP S++K  +  +
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 329 SKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETG---- 380
             G++YLH N ++HRDLK AN+L+     E   VK+AD G AR+        A+      
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 381 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 415
           T+ + APE ++  + Y    D+++ G +  ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional

 Score = 55.3 bits (134), Expect = 6e-08
 Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 7/73 (9%)

Query: 110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 166
           E+T    D P L S++    A  G NI +A  F+T DG +LD F +    G   +E  +L
Sbjct: 734 EVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRL 793

Query: 167 ---RAALEKEVLK 176
                A+E   L 
Sbjct: 794 ARLAKAIED-ALS 805

Length = 931

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 54/235 (22%)

Query: 248 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+K L K + +N +       E  I+ +  ++ VV+   +     +L  V +++ GG + 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 307 DYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
             L ++  VF  P +L      +++  +  +H+   IHRD+K  N+L+D +  +K+ DFG
Sbjct: 90  SLLIRM-EVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 365 V------------------------------------------------ARVKAQSGVMT 376
           +                                                A  + Q  +  
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 431
           +  GT  ++APEV+  K Y    D +S G++L+E+L G+ P+   TP +  + V+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 37/135 (27%), Positives = 75/135 (55%), Gaps = 11/135 (8%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 350
           L +V ++  GG +   L K +   +LP  + +  + ++   ++ +HQ   +HRD+K  N+
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133

Query: 351 LMDENEVVKVADFGVA-RVKAQSGVMTA-ETGTYRWMAPEVIE-----HKPYDHKADVFS 403
           L+D+N  +++ADFG   R+ A   V +    GT  +++PE+++        Y  + D +S
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193

Query: 404 FGIVLWELLTGKLPY 418
            G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 49/128 (38%)

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVA---------------------------- 366
           +H+   IHRD+K  NLL+D    +K++DFG+                             
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 367 ----------------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
                           R  A S V     GT  ++APEV     Y+ + D +S G++++E
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 411 LLTGKLPY 418
           +L G  P+
Sbjct: 232 MLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 9/106 (8%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGT---YCSQD----VAIKVLKPERINSDMQKEFA 266
           + WE    +L+FG  + +G++G +   T      +D    VA+K+LK    ++D ++   
Sbjct: 31  EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKA-SAHTDEREALM 89

Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 311
            E+ I+  + +HKN+V  +GACT    + ++TE+   G + ++L K
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 53/211 (25%)

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 350
           +L  V +++ GG +   L ++ G+F    L +  I +++  +  +H+   IHRD+K  N+
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 351 LMDENEVVKVADFGV--------------------------------------------- 365
           L+D +  +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 366 ---ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 422
              A  + Q  +  +  GT  ++APEV+    Y    D +S G++L+E+L G+ P+   T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252

Query: 423 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 451
           PL+  + V+       IP  ++  P+ ++L+
Sbjct: 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme

 Score = 46.1 bits (110), Expect = 7e-07
 Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAA 169
           +T S  D+P LL+++ ++LA+ G+NI      ++ DG   D+F VVDG    + E+L  A
Sbjct: 1   LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD--GDLEKLLEA 58

Query: 170 LE 171
           LE
Sbjct: 59  LE 60

Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 8/109 (7%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     LK G  +  G++G +          T   + VA+K+LK    +S+ +   ++ 
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 61

Query: 269 VFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 316
             ++    H NVV  +GACTKP   L ++ EF   G++ +YL   +G F
Sbjct: 62  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones]

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)

Query: 98  VHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-- 155
           V  +V+      E+     D+P+L + + A L+  GL+I +A  F+T DGY+LD F+V  
Sbjct: 674 VLISVRPHSGGTEVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLE 733

Query: 156 -DGWPYEETEQLR------AALEKEVLKLERQGWPSHRSSSPTSEPE 195
            DG+P EE  +         AL     +  R+     +       P 
Sbjct: 734 PDGFPVEEDRRAALRGELIEALLSGKAQPPRRRRIPRKLRHFPIPPR 780

Length = 867

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 14/112 (12%)

Query: 216 WEIDPKHLKFGSKVASGSYG--------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 267
           WE     LK G  +  G++G         + +   C + VA+K+LK E   +   K    
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLK-EGATASEYKALMT 59

Query: 268 EVFIMRKV-RHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVF 316
           E+ I+  +  H NVV  +GACTKP  P + IV E+   G++ +YL   +  F
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|190133 pfam01842, ACT, ACT domain

 Score = 44.3 bits (105), Expect = 3e-06
 Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRA 168
             +     D+P LL+++   LAD G+NI+     ++ D   +   VV     E+ E    
Sbjct: 1   TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59

Query: 169 ALEK 172
           AL+K
Sbjct: 60  ALKK 63

This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66

>gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

 Score = 44.4 bits (106), Expect = 4e-06
 Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)

Query: 117 DKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY--EETEQLRAALE 171
           D+P LL+ +T +LA++GLNI  A   +T+   + DVF V   DG P   E  E LRAAL 
Sbjct: 9   DRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEALRAALG 67

Query: 172 KEV 174
           + +
Sbjct: 68  EAL 70

This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 9/171 (5%)

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           S+ +V +   GG ++ ++ K   +     + + A ++   ++ LH+  I+ RDL   N+L
Sbjct: 59  SVFLVLQHAEGGKLWSHISKFLNI-PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 411
           +D+   +++  F        S    A    Y   APEV          D +S G +L+EL
Sbjct: 118 LDDRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFEL 175

Query: 412 LTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           LTGK      T ++     +       IP+    +   LL++  Q +P  R
Sbjct: 176 LTGK------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)

Query: 216 WEIDPKHLKFGSKVASGSYGDL--------YRGTYCSQDVAIKVLKPERINSDMQKEFAQ 267
           WE     L+ G  +  G++G +         + + C   VA+K+LK E   +   K    
Sbjct: 2   WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLK-EGATASEHKALMS 59

Query: 268 EVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 316
           E+ I+  +  H NVV  +GACTKP   L ++ EF   G++ ++L   +  F
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 21/144 (14%)

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLL 351
           +CIV     G  + D++ K  G F    L ++       ++Y H   +++H DLK  N+L
Sbjct: 207 MCIVMP-KYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264

Query: 352 MDENEV----------------VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           M+ ++                 V++ D G    +  S      T  YR  +PEV+    +
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGW 322

Query: 396 DHKADVFSFGIVLWELLTGKLPYE 419
            +  D++S G +++EL TGKL Y+
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYD 346

Length = 467

>gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 4/85 (4%)

Query: 110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 166
           E+     D+P L +++   LA + L++ +A   +T DG +LD FVV    G P       
Sbjct: 670 EVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVF 729

Query: 167 RAALEKEVLKLE-RQGWPSHRSSSP 190
           +  L+  V  L      P   S+  
Sbjct: 730 QELLQGLVDVLAGLAKDPDTISARR 754

This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 8/129 (6%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 30  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             +     H N+V  +GACT      ++TE+   G + ++L + +  F  P     A   
Sbjct: 90  KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAA 149

Query: 329 SKGMNYLHQ 337
               N LHQ
Sbjct: 150 LY-KNLLHQ 157

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 5/75 (6%)

Query: 103 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP 159
           Q +R   EI   + D+P L + + A L    L++ +A  F++ DG ++D F+V   DG P
Sbjct: 696 QATRGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSP 755

Query: 160 YEET--EQLRAALEK 172
             +   + +R ALE+
Sbjct: 756 LSQDRHQVIRKALEQ 770

Length = 884

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 43/207 (20%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 243 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 302
           C + +A +V    R    ++     E+  + ++ H+N+++         +  ++T+    
Sbjct: 192 CERLIAKRVKAGSRAAIQLE----NEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247

Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDENEVV 358
             +Y +++     +K   LLK    + K     + Y+H   +IHRD+K  N+ ++ +  +
Sbjct: 248 -DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306

Query: 359 KVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
            + DFG A      R     G +    GT    +PE++    Y    D++S G++L ++L
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Query: 413 TGKLPYEYLTPLQAAVGVVQKGLRPTI 439
           +         P+    G   K L   I
Sbjct: 363 SHD-----FCPIGDGGGKPGKQLLKII 384

Length = 501

>gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional

 Score = 42.4 bits (100), Expect = 6e-04
 Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 7/72 (9%)

Query: 115 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY----EETEQLR 167
             D+    +   A +  + LNI +A   ++   ++LD ++V   DG P        EQ+R
Sbjct: 711 APDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIR 770

Query: 168 AALEKEVLKLER 179
             L + +   + 
Sbjct: 771 EGLTEALRNPDD 782

Length = 895

>gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional

 Score = 41.5 bits (98), Expect = 0.001
 Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 26/135 (19%)

Query: 52  VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP-MHE 110
             ++L  E         P P     P   ALA           D  VH  +  + P M E
Sbjct: 560 CRAVLAGEPLP-----EPEPL---DPAQLALA----------ADGGVHVEIAPADPHMVE 601

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD---GWPYEET---E 164
           +T    D+  LLS+   +LA   L ++ A    + DG ++  FVV    G P +     +
Sbjct: 602 VTVVAPDRRGLLSKAAGVLALHRLRVRSASV-RSHDGVAVLEFVVSPRFGSPPDAALLRQ 660

Query: 165 QLRAALEKEVLKLER 179
            LR AL+ ++  L R
Sbjct: 661 DLRRALDGDLDVLAR 675

Length = 774

>gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional

 Score = 41.5 bits (98), Expect = 0.001
 Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 115 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAALEKE 173
             D+P LL++L   L   G++++ A   +T+    +DVF V         +  RAA+E+ 
Sbjct: 714 AADRPGLLARLARALERAGVDVRWARV-ATLGADVVDVFYVTGAAGGPLADA-RAAVEQA 771

Query: 174 VL 175
           VL
Sbjct: 772 VL 773

Length = 774

>gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones]

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 14/114 (12%)

Query: 63  QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLL 122
                 PP        L    I             V      S     +     D+P LL
Sbjct: 756 LSGKAQPPRRRRIPRKLRHFPIPP----------RVTILPTASNDKTVLEVRALDRPGLL 805

Query: 123 SQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 176
           + L  + AD+GL++  A   +T      DVF+V      + + L A L + +L+
Sbjct: 806 AALAGVFADLGLSLHSAKI-TTFGERVEDVFIVTD---ADGQALNAELRQSLLQ 855

Length = 867

>gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional

 Score = 40.2 bits (95), Expect = 0.003
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 9/85 (10%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY---SLDVF-VVDGWPYEETEQL 166
           I  +  D+P LL  LT  L+D+ LNI  AH    +  Y   ++DVF V D +  + T + 
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYVTDLFGLKITNEA 901

Query: 167 R-AALEKEVLKLERQGWPSHRSSSP 190
           R AA+ + +L    +G    R++ P
Sbjct: 902 RQAAIRRALLAALAEGEAEARAARP 926

Length = 931

>gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 1/51 (1%)

Query: 105 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 155
           SR    +     D+P LL+++   L ++GL+IQ A   +T    + DVF V
Sbjct: 776 SRKATIMEVRALDRPGLLARVGRTLEELGLSIQSAK-ITTFGEKAEDVFYV 825

This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.7 bits (91), Expect = 0.003
 Identities = 18/73 (24%), Positives = 38/73 (52%), Gaps = 6/73 (8%)

Query: 295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 354
           IV E++ G  + D ++           L+++ ++ + +  LH   IIH DL  +N+++  
Sbjct: 76  IVMEYIEGEPLKDLINSNG-----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130

Query: 355 NEVVKVADFGVAR 367
            ++  + DFG+A 
Sbjct: 131 GKIY-LIDFGLAE 142

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	504
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
smart00090	237	RIO RIO-like kinase.	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.4
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
cd04928	68	ACT_TyrKc Uncharacterized, N-terminal ACT domain o	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.88
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.65
PRK09902	216	hypothetical protein; Provisional	98.61
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
cd04900	73	ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1,	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.26
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.17
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.15
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.14
cd04927	76	ACT_ACR-like_2 Second ACT domain, of a novel type	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.97
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
cd04925	74	ACT_ACR_2 ACT domain-containing protein which is c	97.89
PRK10593	297	hypothetical protein; Provisional	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.52
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.5
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.47
PRK05231	319	homoserine kinase; Provisional	97.44
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.4
cd04897	75	ACT_ACR_3 ACT domain-containing protein which is c	97.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.16
cd04896	75	ACT_ACR-like_3 ACT domain-containing protein which	97.08
cd04926	72	ACT_ACR_4 C-terminal ACT domain, of a novel type o	97.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.99
cd04895	72	ACT_ACR_1 ACT domain-containing protein which is c	96.98
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.88
PF01842	66	ACT: ACT domain; InterPro: IPR002912 The ACT domai	96.86
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.85
PLN02756	418	S-methyl-5-thioribose kinase	96.81
PRK05092	931	PII uridylyl-transferase; Provisional	96.79
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.7
PRK04374	869	PII uridylyl-transferase; Provisional	96.69
PRK00275	895	glnD PII uridylyl-transferase; Provisional	96.64
TIGR01693	850	UTase_glnD [Protein-PII] uridylyltransferase. This	96.63
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.63
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.62
KOG2270	520	consensus Serine/threonine protein kinase involved	96.62

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6e-56  Score=457.21  Aligned_cols=272  Identities=49%  Similarity=0.897  Sum_probs=255.0

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECCcc-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~-VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .....|.++..++.+.+.||+|+||+||+|.|.|+. ||||++.....+......|.+|+.+|++++|||||+|+|+|..
T Consensus        31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            334678999999999999999999999999999999 9999999876665557899999999999999999999999999


Q ss_pred             CC-CceeEEEecCCCchHHHHHh-hcccCChHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECCCC-cEEEEeecc
Q 010680          290 PP-SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENE-VVKVADFGV  365 (504)
Q Consensus       290 ~~-~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~-IiHrDLkp~NILl~~~~-~vkL~DFGl  365 (504)
                      ++ .++||||||++|+|.++++. .+..+++..++.++.||++||+|||+++ ||||||||+|||++.+. ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            88 79999999999999999988 4788999999999999999999999999 99999999999999997 999999999


Q ss_pred             ceeccCC-CccccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010680          366 ARVKAQS-GVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN  442 (504)
Q Consensus       366 a~~~~~~-~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~  442 (504)
                      ++..... ..++...||+.|||||++.  ...|+.|+||||||++||||+||+.||....+.+.+..++..+.||.+|..
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            9988766 4666689999999999999  679999999999999999999999999999999999999999999999999


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +++.+..||.+||+.||..||+|.+++..|+.+.......
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence            9999999999999999999999999999999999877754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-53  Score=439.19  Aligned_cols=262  Identities=37%  Similarity=0.739  Sum_probs=239.5

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECCc-cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~-~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|+++.+.+++.++||+|.||.||.|.|.+. +||+|.++......   ..|.+|+++|++|+|+|||+++++|+.+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            678999999999999999999999999999987 89999999875443   57889999999999999999999999988


Q ss_pred             CceeEEEecCCCchHHHHHh-hcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+|||||||+.|+|.+||+. .++.+....++.++.|||+||+||+++++|||||.++||||+++..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999987 45679999999999999999999999999999999999999999999999999999555


Q ss_pred             CCCccccC--CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSGVMTAE--TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~~~~~~--~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ++......  --...|+|||.+....|+.||||||||++||||+| |+.||.+++..+.+.. +.++.|.+.|..||+++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~v  433 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEV  433 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHH
Confidence            44332222  23578999999999999999999999999999999 9999999999887755 77899999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .++|..||..+|++||||..+...|+++...
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999999999999999999999999988764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-50  Score=396.91  Aligned_cols=250  Identities=32%  Similarity=0.551  Sum_probs=225.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC-c
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-L  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~  293 (504)
                      .+..++++.++.||+|+.|+||++.+.  ++.+|+|++. ...+....+++.+|++++++.+|||||.+||+|..+.. .
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            466678899999999999999999875  7789999994 34566778999999999999999999999999999985 9


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||.||||.+++.. .+.+++..+.+++.++++||.|||. .+||||||||+|||++..|.|||||||.++....+
T Consensus       154 sI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999999999986 4889999999999999999999995 89999999999999999999999999999877766


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-CcHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIPKN-SQPK  446 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~p~~p~~-~~~~  446 (504)
                       .-.+.+||..|||||.+.+..|+.++||||||++++||.+|+.||...     ...+....++. +..|..|.. ++++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSPE  310 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCHH
Confidence             446789999999999999999999999999999999999999999763     55666555554 456777876 9999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++..||++||.+||++.|+++
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-49  Score=414.31  Aligned_cols=249  Identities=27%  Similarity=0.469  Sum_probs=229.3

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ....|+.++.||+|+|+.+|+++.  +|+.||+|++.+... .....+.+.+||+|.+.|.|||||+|+++|++.++.||
T Consensus        16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            346799999999999999999987  689999999987654 34556778999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~  374 (504)
                      |.|+|+.++|..+++ .+.+++++.++.++.||+.||.|||+++|||||||..|++++++.+|||+|||+|.....+ ..
T Consensus        96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            999999999999998 4789999999999999999999999999999999999999999999999999999877654 56


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..+.+|||-|.|||++....++..+||||+|||||-||+|++||+..+-.+.+..+.....  .+|..++.+.++||.++
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999988888888776654  36779999999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.+++.
T Consensus       253 L~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLD  268 (592)
T ss_pred             hcCCcccCCCHHHHhc
Confidence            9999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=397.75  Aligned_cols=247  Identities=30%  Similarity=0.572  Sum_probs=224.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|.+.++||+|+||+||+|+++  +..||||.+.....+...++-+..|+.+|+.++|||||++++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            46888889999999999999874  6789999999888888888889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC------CcEEEEeeccceeccCC
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------EVVKVADFGVARVKAQS  372 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~------~~vkL~DFGla~~~~~~  372 (504)
                      ||.||+|.+|++. ++.+++..+..++.||+.||++||+++||||||||.|||++..      -.+||+|||+|+.....
T Consensus        90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            9999999999987 6789999999999999999999999999999999999999865      46999999999998877


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~-~~~p~~p~~~~~~l~~Ll  451 (504)
                      ....+.+|++.|||||++..+.|+.|+|+||+|++||+|++|+.||+..++.+....+.+. ...|.++..++..+.+|+
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll  248 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL  248 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence            7777889999999999999999999999999999999999999999999998877654433 345666677888888999


Q ss_pred             HHhhhcCCCCCCCHHHH
Q 010680          452 ERCWQQDPALRPDFSEI  468 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~el  468 (504)
                      ...++.+|..|-++.+-
T Consensus       249 ~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  249 ISLLQRNPKDRISFEDF  265 (429)
T ss_pred             hHHHhcCccccCchHHh
Confidence            99999999999887764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=413.00  Aligned_cols=267  Identities=38%  Similarity=0.745  Sum_probs=238.7

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      +...+|+|..+++.++..||+|+||+||+|.|.| +||||+++.+..+.+..+.|++|+.++++-+|.||+-|.|+|..+
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            3447899999999999999999999999999987 599999999988888899999999999999999999999999998


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +. .||+.+|+|-+||.+++..+.+|.....+.|+.||++||.|||.++|||||||..||++.+++.|||+|||++....
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            86 89999999999999999988899999999999999999999999999999999999999999999999999997654


Q ss_pred             CC---CccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCC
Q 010680          371 QS---GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPK  441 (504)
Q Consensus       371 ~~---~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~---~p~  441 (504)
                      .-   .......|...|||||++.   ..+|+..+||||||+|+|||++|.+||......+.+..+-+..++|.   +..
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence            43   2344557889999999994   45899999999999999999999999997777666665544434443   346


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +++.++++|+..||.+++++||.|.+|+..|+.++..+
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            78889999999999999999999999999998887743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=392.79  Aligned_cols=245  Identities=28%  Similarity=0.477  Sum_probs=222.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+.+++|++.++||+|+||+||.++.  +++-+|+|++++.... ....+....|..||.+++||.||+++..|+++..+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45678899999999999999999975  5678999999877543 34577889999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+|+||+.||.|..+|++ .+.|++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+
T Consensus       101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999987 7889999999999999999999999999999999999999999999999999999655554


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       ...+.+||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+..+....+.+.. .+..|..++.+.++++.
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence             4455699999999999999999999999999999999999999999999988888877654 34566779999999999


Q ss_pred             HhhhcCCCCCC
Q 010680          453 RCWQQDPALRP  463 (504)
Q Consensus       453 ~cl~~dP~~RP  463 (504)
                      ++|..||++|.
T Consensus       259 ~LL~rdp~~RL  269 (357)
T KOG0598|consen  259 KLLKRDPRQRL  269 (357)
T ss_pred             HHhccCHHHhc
Confidence            99999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-49  Score=395.11  Aligned_cols=250  Identities=25%  Similarity=0.419  Sum_probs=215.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+.|.+.+.||+|+||.|-+|..  +++.||||+++......     .......+|+++|++|+|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            46788889999999999999965  57899999998654322     123346799999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEEeeccceec
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVK  369 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~---~~vkL~DFGla~~~  369 (504)
                      .|||||||+||.|.+++-. .+.+.+..-..+++|++.|+.|||++||+||||||+|||+..+   -.+||+|||+|+..
T Consensus       251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            9999999999999999976 5678888889999999999999999999999999999999866   67999999999999


Q ss_pred             cCCCccccCCCCCCccCcccccCCCC--C-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CCCCCCCCC
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKPY--D-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---LRPTIPKNS  443 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~~--s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~---~~p~~p~~~  443 (504)
                      .....|.+.+|||.|.|||++..+.+  . .++|+||+||+||-+|+|.+||........+.+.+.++   +-|.....+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            88888999999999999999976643  3 47899999999999999999998765544333333333   335566789


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++..+||.+||..||++|||+.|+++
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            999999999999999999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-49  Score=375.69  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=221.7

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEE-eeeCCCC-ce
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG-ACTKPPS-LC  294 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~~-~~  294 (504)
                      ...+|++.++||+|+||+||++..  +|..||.|.++-+..+....+....|+.+|++|+|||||++++ .+...+. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            346799999999999999999964  6889999999988888888999999999999999999999998 4544444 89


Q ss_pred             eEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          295 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~--~~--IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      ||||||.+|+|...++..   +..+++..+|+++.|++.||..+|+  ..  |+||||||.||+++.+|.|||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            999999999999998643   4569999999999999999999999  45  9999999999999999999999999999


Q ss_pred             eccCCCc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCcH
Q 010680          368 VKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-KNSQP  445 (504)
Q Consensus       368 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p-~~~~~  445 (504)
                      ....... ....+|||.||+||++...+|+.|+||||+||++|||+.-++||.+.+-.+...++.+ +.-|++| ...+.
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p~~~YS~  255 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLPDEHYST  255 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCcHHHhhh
Confidence            8776543 3467999999999999999999999999999999999999999999988887777655 4455566 78899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++..|+..|+..||+.||+...++.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             HHHHHHHHHccCCcccCCCcchHHH
Confidence            9999999999999999998544433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=403.01  Aligned_cols=263  Identities=33%  Similarity=0.646  Sum_probs=240.7

Q ss_pred             cCCCCCCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       208 ~~~~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      +.....+.|+|.-+.+.-++.||+|+.|.||+|+..++.||||.++.-         -..+|+-|++|+||||+.|.|+|
T Consensus       111 ~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  111 HKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeee
Confidence            344556789998888888889999999999999999999999987632         12478899999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      +..+.+|||||||..|-|+..|+. ..+++...+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            999999999999999999999987 7789999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...+-..+..+.||..|||||+|...+.++|+|||||||||||||||..||.+.+...++.++-...+..++|..||+.+
T Consensus       261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence            77776677788999999999999999999999999999999999999999999988888888888888889999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +-||++||+..|.+||+|++|+..|.=+-.++-
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            999999999999999999999998876554444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-46  Score=385.12  Aligned_cols=262  Identities=34%  Similarity=0.661  Sum_probs=222.5

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  287 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~  287 (504)
                      |++..++|++.++||+|+||.||+|.+.       ++.||||+++... .......+.+|+.+++++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            7888899999999999999999999752       3569999998543 333456789999999999 899999999988


Q ss_pred             eCCC-CceeEEEecCCCchHHHHHhhc-----------------------------------------------------
Q 010680          288 TKPP-SLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  313 (504)
Q Consensus       288 ~~~~-~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  313 (504)
                      ...+ .+++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7644 5789999999999999997532                                                     


Q ss_pred             --------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCC
Q 010680          314 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTY  382 (504)
Q Consensus       314 --------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~  382 (504)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....+++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2377788899999999999999999999999999999999999999999999975433211   12234567


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      .|+|||++.+..++.++|||||||+||||++ |..||......+.....+..+..+..+..+++++.+++.+||+.||.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999999999999999999999997 999998866555555555566666677889999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHHH
Q 010680          462 RPDFSEIIEILQQIAKE  478 (504)
Q Consensus       462 RPs~~ell~~L~~l~~~  478 (504)
                      |||+.++++.|++++.+
T Consensus       321 RPs~~el~~~l~~~~~~  337 (338)
T cd05102         321 RPTFSALVEILGDLLQE  337 (338)
T ss_pred             CcCHHHHHHHHHHHHhc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=390.19  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=225.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      .-.+.+|++++.||.|+|++|++|+.  .++.||||++.+..... ...+.+..|-.+|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34567999999999999999999986  46789999998765533 2345577899999999 79999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+|+||+++|.|.++|++ .|.|.+..++.++.+|+.||+|||++|||||||||+|||+|.++++||+|||.|+.....
T Consensus       149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999999999998 588999999999999999999999999999999999999999999999999999865443


Q ss_pred             Cc--------------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010680          373 GV--------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT  438 (504)
Q Consensus       373 ~~--------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~  438 (504)
                      ..              ....+||..|.+||++.....+..+|+|+|||+||.|+.|.+||.+.+.......++.-.  -.
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--y~  305 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--YE  305 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--cc
Confidence            21              134789999999999999999999999999999999999999999999988888877654  35


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       439 ~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      +|...++...+|++++|..||.+|++..||.+.
T Consensus       306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            888999999999999999999999999988754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-47  Score=397.00  Aligned_cols=328  Identities=28%  Similarity=0.494  Sum_probs=276.2

Q ss_pred             cccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCC
Q 010680          133 GLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDG  212 (504)
Q Consensus       133 ~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~~~~~~~~s~~sss~~~~~~~~~~~~~~~~~~~~~~~  212 (504)
                      .||++.+.+|+.+..-.|+-+   |+...++.+|++++.+.....+..+|.++--....+......     .....| ..
T Consensus        31 ~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~h~~~t-----~~~~~p-~~  101 (1039)
T KOG0199|consen   31 LLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPSHPAQT-----NSVANP-SI  101 (1039)
T ss_pred             HhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCCccccccc-----cCCCCc-CC
Confidence            589999999999999888866   999999999999999877666666665432211111000000     001111 22


Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      ....-|..+++++.++||+|+||.|++|.|+.     -.||||+++.+.... ....|++|+.+|.+|+|+|+++|||+.
T Consensus       102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvV  180 (1039)
T KOG0199|consen  102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVV  180 (1039)
T ss_pred             CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeee
Confidence            34457788899999999999999999999963     349999999876655 568899999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHh-hcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      .+ ..+.||||+++.|+|.+.|++ .+..|....+..|+.||+.||.||.++++|||||..+|||+-....|||+|||++
T Consensus       181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence            88 568899999999999999988 5677999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCC----CCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          367 RVKAQSGVMTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       367 ~~~~~~~~~~~~~----gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      +-......+....    -.+.|+|||.+.+..|+.++|||+|||+||||++ |..||.+....+++..+- ++.+.+.|+
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk  338 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPK  338 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCC
Confidence            9877665443322    3578999999999999999999999999999999 999999999999988765 788888999


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      .|++++++++.+||..+|.+||+|..|.+.+
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            9999999999999999999999999997543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-47  Score=379.10  Aligned_cols=252  Identities=30%  Similarity=0.524  Sum_probs=219.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC--Ccee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCI  295 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~l  295 (504)
                      ..++..++.||+|+||.||++.+.  |+..|||.+....  ....+.+.+|+.+|++++|||||+++|......  .++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            455777899999999999999886  5889999987662  222567899999999999999999999754444  5899


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccC---
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ---  371 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~---  371 (504)
                      .|||+++|+|.+++.+..+.++++.+..++.||++||.|||++|||||||||+|||++. ++.+||+|||+++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999987668999999999999999999999999999999999999999 79999999999986653   


Q ss_pred             -CCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          372 -SGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       372 -~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                       ........||+.|||||++... ..+.++|||||||++.||+||+.||.. ....+....+......|.+|..++++.+
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence             2234456899999999999863 233599999999999999999999998 6777777777777777899999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ++|.+|+..||++||||.++++.--
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChh
Confidence            9999999999999999999986543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=362.01  Aligned_cols=239  Identities=27%  Similarity=0.480  Sum_probs=220.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|++.+.||.|+||.|.+++.  .+..+|+|+++.... .-...++..+|..+|+.+.||+++++++.+.+...+||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            346788899999999999999976  467799999987654 33456778899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||++||.|..+|++ .++|+++.++.++.||+.|++|||+++|++|||||+|||+|.+|.+||+|||+|+.....  .
T Consensus       122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            9999999999999987 688999999999999999999999999999999999999999999999999999876654  5


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      -+.+|||.|+|||++..++|+.++|+||||+++|||+.|.+||...++.+.+.+++...++  +|...++++++|+.++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999999999999999887655  88999999999999999


Q ss_pred             hcCCCCC
Q 010680          456 QQDPALR  462 (504)
Q Consensus       456 ~~dP~~R  462 (504)
                      +.|-.+|
T Consensus       277 ~vD~t~R  283 (355)
T KOG0616|consen  277 QVDLTKR  283 (355)
T ss_pred             hhhhHhh
Confidence            9999888

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=393.30  Aligned_cols=269  Identities=33%  Similarity=0.655  Sum_probs=244.8

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-----cc-EEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCCceEEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QD-VAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIG  285 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~-VAvK~lk~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~  285 (504)
                      ...|++..++..+.++||+|+||.||+|++.-     .. ||||..+.. ......+.+|.+|+++|++++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            45799999999999999999999999998632     13 899999963 366788899999999999999999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      ++.....+++|||+|.||+|.++|++..+.++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999999999777899999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccc-cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          366 ARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       366 a~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      ++......... ..--..+|+|||.+....|+.++|||||||++||+++ |..||.+....+....++..+.+...|...
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            98665322222 1224679999999999999999999999999999999 899999999999999998999999999999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      |.++..++.+||..||++||++.++.+.|+.+......
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999999887653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=383.67  Aligned_cols=249  Identities=29%  Similarity=0.570  Sum_probs=223.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~  291 (504)
                      .....|.+++.||+|+||.|+.|..  ++..||||++......   ......+.+|+.+++.++ ||||++++.++..+.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4456899999999999999999976  5789999988775222   134556778999999999 999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeeccceec-
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVK-  369 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~~-  369 (504)
                      .+|+||||+.||.|++++.. .+.+++..+.+++.||+.|++|||++||+||||||+|||++.+ +++||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999998 8999999999999999999999999999999999999999999 99999999999988 


Q ss_pred             cCCCccccCCCCCCccCcccccCCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-cHH
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKP-YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPK  446 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~-~~~  446 (504)
                      .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..+.......+...  ...+|..+ +++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLSPE  250 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCCHH
Confidence            4666788899999999999999988 87 7899999999999999999999998777776664433  34577888 999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      ++.|+.+||..||.+|+++.+|+
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHh
Confidence            99999999999999999999998

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-45  Score=367.45  Aligned_cols=259  Identities=22%  Similarity=0.390  Sum_probs=226.0

Q ss_pred             eeeCCCceeee--eeeeeeCceEEEEEEECCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeC---
Q 010680          216 WEIDPKHLKFG--SKVASGSYGDLYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTK---  289 (504)
Q Consensus       216 ~~i~~~~~~i~--~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---  289 (504)
                      +.++.++++..  ..||+|++|.||+|.+.|+.||||+++...... ...+.|.+|+.+|++++||||+++++++.+   
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            34555555555  679999999999999999999999998654332 335778899999999999999999998866   


Q ss_pred             -CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          290 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       290 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                       ...+++||||++||+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence             4568999999999999999976 46789999999999999999999985 99999999999999999999999999997


Q ss_pred             eccCCCccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      .....  .....|+..|+|||++.+  ..|+.++|||||||++|||++|..||...+..+....+.....++..+..+++
T Consensus       172 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (283)
T PHA02988        172 ILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL  249 (283)
T ss_pred             hhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence            65432  234578999999999976  68999999999999999999999999999888877777777777778878999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      ++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999999998754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=362.29  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=217.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|+...++|+|+||.||+++.  +|+-||||.+.....+....+-..+|+++|+++.|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4577788999999999999976  57889999998776667777778899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc-CCCcccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~-~~~~~~~  377 (504)
                      ||. -++.+-|......++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... .....+.
T Consensus        82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            995 46667777778889999999999999999999999999999999999999999999999999999887 4456778


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------CCCC
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLRP  437 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~-------------------~~~p  437 (504)
                      .+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+.+..+....+...                   +.+.
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            899999999999977 68999999999999999999999999998887776655421                   1111


Q ss_pred             CCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 TIP----------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ~~p----------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +-|          +.++.-+.+++.+||..||++|++.+|++.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111          345667899999999999999999999973

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.8e-46  Score=401.35  Aligned_cols=265  Identities=31%  Similarity=0.601  Sum_probs=234.9

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEE
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF  283 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l  283 (504)
                      ......++...+.++.++||+|+||+||+|...+       +.||||.+|.. .+.+.+++|.+|+.+|..++|||||+|
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            3456678999999999999999999999998653       45999999965 344578999999999999999999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc-------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  350 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NI  350 (504)
                      +|+|..++.+|+|+|||..|+|.+||....             .+++..+.+.|+.||+.||.||-++.+|||||..+|+
T Consensus       555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC  634 (774)
T KOG1026|consen  555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC  634 (774)
T ss_pred             EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence            999999999999999999999999996432             2377889999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeeccceeccCCCccc---cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 010680          351 LMDENEVVKVADFGVARVKAQSGVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA  426 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~~~~~---~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~  426 (504)
                      ||+++..|||+|||+++..-......   ...-..+|||||.|..+.|+.++|||||||+|||+++ |..||.+.+..+.
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence            99999999999999998544332222   2234679999999999999999999999999999999 9999999999998


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +..+-+..+ .+.|..||.++++||..||+.+|.+||+|+||-..|++.-+
T Consensus       715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            877665555 78899999999999999999999999999999999998755

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-46  Score=384.29  Aligned_cols=270  Identities=31%  Similarity=0.638  Sum_probs=243.3

Q ss_pred             CCCceeeCCCceeeeeeeeeeCceEEEEEEECCc------cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEE
Q 010680          212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG  285 (504)
Q Consensus       212 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~------~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~  285 (504)
                      +...++++.+...+.++||.|.||.||+|.|..-      .||||..|.+... +..+.|.+|..+|++++||||++++|
T Consensus       380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIG  458 (974)
T KOG4257|consen  380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIG  458 (974)
T ss_pred             CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheee
Confidence            3446788888899999999999999999998642      3999999976543 34788999999999999999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      +|...+ .+||||.++-|.|..||+.++..++...+..++.||+.||.|||++++|||||..+|||+.....|||+|||+
T Consensus       459 v~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  459 VCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             eeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence            998764 7899999999999999999889999999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010680          366 ARVKAQSGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  442 (504)
Q Consensus       366 a~~~~~~~~~~~~~g--t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~  442 (504)
                      +|...+.....+..|  ...|||||.++-..|+.++|||.||+.|||++. |..||.+..+.+.+ ..+.++.|++.|++
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPN  616 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCC
Confidence            998888776665555  568999999999999999999999999999997 99999998887665 44678999999999


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccchH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE  484 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~  484 (504)
                      ||+.|+.|+.+||..+|.+||.|.+|...|.+++++-..+..
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~  658 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSS  658 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhH
Confidence            999999999999999999999999999999999996665433

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.5e-45  Score=374.20  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=217.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|++++.||+|+||.||+++.  +|+.+|+|++++... ..+..+.++.|-.+|...++|+||+++.+|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            557899999999999999999965  678899999987654 44567889999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC----
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----  371 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~----  371 (504)
                      ||||++||++..+|.+ .+.|++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||+|||++.-...    
T Consensus       219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999999999999987 78999999999999999999999999999999999999999999999999999842110    


Q ss_pred             ------------------CCcc-----c---------------------cCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 010680          372 ------------------SGVM-----T---------------------AETGTYRWMAPEVIEHKPYDHKADVFSFGIV  407 (504)
Q Consensus       372 ------------------~~~~-----~---------------------~~~gt~~y~APE~l~~~~~s~ksDVwSlGvv  407 (504)
                                        ....     .                     ..+|||-|||||++.+++|+..+|+||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                              0000     0                     1259999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 010680          408 LWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPKNSQPKLAELLERCWQQDPALRPD---FSEII  469 (504)
Q Consensus       408 L~eLltG~~Pf~~~~~~~~~~~v~~~~--~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs---~~ell  469 (504)
                      |||||.|.+||...++.++...++...  +.-+-...++++..+||.+|+. ||++|..   +.||.
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            999999999999999999998887654  3333335678999999999999 9999964   55554

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-44  Score=355.73  Aligned_cols=256  Identities=29%  Similarity=0.575  Sum_probs=222.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ++.++|++.+.||+|+||.||+|.+.     +..||+|.++... .......|.+|+.++++++||||+++++++...+.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            56788999999999999999999753     4579999998653 33445779999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .++||||+++++|.+++....+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999987654322


Q ss_pred             Ccc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 GVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 ~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      ...  ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+ ..+.+++.+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHH
Confidence            211  12345678999999999999999999999999999875 99999988877655543 455566678889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ++.+||+.+|.+||++.+|++.|.++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=364.49  Aligned_cols=257  Identities=32%  Similarity=0.529  Sum_probs=225.6

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      ...|.++.++|++.++||.|..++||+|..  .++.||||++..+..+.+ ...+.+|+..|+.++||||++.+..|..+
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            356788899999999999999999999986  578899999998877666 78899999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ..+|+||.||.+||+.+++... ...+.+..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+-..
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999654 456999999999999999999999999999999999999999999999999988655


Q ss_pred             cCCCc----c-ccCCCCCCccCcccc--cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Q 010680          370 AQSGV----M-TAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------  436 (504)
Q Consensus       370 ~~~~~----~-~~~~gt~~y~APE~l--~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------  436 (504)
                      ..++.    . ...+||++|||||++  ....|+.|+||||||++..||.+|..||..+.|.+....-++....      
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            44431    1 456899999999996  3457999999999999999999999999999999988776654321      


Q ss_pred             --CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 --PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 --p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                        -+..+..+..+++++..||.+||.+|||++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              1112445678999999999999999999999984

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-45  Score=404.55  Aligned_cols=264  Identities=35%  Similarity=0.658  Sum_probs=236.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC---c----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS---Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      ++..+.+++.+.||+|.||.||.|.+.+   .    .||||.++.. .+.....+|.+|..+|++++|||||+++|+|.+
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3667889999999999999999998853   2    3888888864 345667899999999999999999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhh------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      ....+|++|||+||+|..||++.      ...++...++.++.||++||.||+++++|||||.++|+|++....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999987      567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCcc--ccC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010680          364 GVARVKAQSGVM--TAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI  439 (504)
Q Consensus       364 Gla~~~~~~~~~--~~~-~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~  439 (504)
                      |+|+..-.....  ... .-..+|||||.+....|+.|+|||||||+|||++| |..||...++.+....++..+ |.+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~  925 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP  925 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence            999943333221  122 33579999999999999999999999999999999 999999999999988877777 9999


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          440 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       440 p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      |..||..+.++|.+||+.+|++||+|..|++.+.++.+...+.
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence            9999999999999999999999999999999999999877654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=375.90  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=221.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC-Ccee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP-SLCI  295 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~-~~~l  295 (504)
                      .++|.+.++||.|+||.||+|+.  .++.||||.+|......+. -.-++|+..|++++ ||||+++.+++.+.+ .+|+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            46899999999999999999975  5788999999987555432 23467999999999 999999999998887 8999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||| ..+|+++++..+..|++..+..|+.||++||+|+|.+|+.|||+||+|||+.....|||+|||+||........
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            99999 67999999988889999999999999999999999999999999999999999999999999999998888889


Q ss_pred             ccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Q 010680          376 TAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----------------  438 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~----------------  438 (504)
                      +..+.|.+|+|||++. ..-|+.+.|+|++|||++|+.+-++-|.+.+..+.+.++++--..|.                
T Consensus       167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf  246 (538)
T KOG0661|consen  167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF  246 (538)
T ss_pred             chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence            9999999999999984 56689999999999999999999999999999888877663211111                


Q ss_pred             ------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          439 ------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       439 ------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                  +-..+++++.+||.+|+..||++||||.|.++.
T Consensus       247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                        114478999999999999999999999998753

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-45  Score=382.56  Aligned_cols=247  Identities=31%  Similarity=0.538  Sum_probs=227.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      -|++++-||.|+.|.|.+|++  +|+.+|||++... .........+.+|+-||+.+.||||+++|++++...++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            367778999999999999987  5899999999776 4455566788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      |++||.|++++-. +|++++..+.+++.||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|.....+....+.
T Consensus        93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence            9999999999987 789999999999999999999999999999999999999999999999999999998888888999


Q ss_pred             CCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          379 TGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ||+|.|.|||++.|.+|+ .++||||.|||||.||+|++||++.+-...+.++.+..+  .+|.++++++.+||.+|+..
T Consensus       172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~V  249 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLDV  249 (786)
T ss_pred             CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhcc
Confidence            999999999999999996 789999999999999999999998888877777654443  57899999999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 010680          458 DPALRPDFSEIIEI  471 (504)
Q Consensus       458 dP~~RPs~~ell~~  471 (504)
                      ||.+|.|..||++.
T Consensus       250 Dp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  250 DPSTRITTEEILKH  263 (786)
T ss_pred             CccccccHHHHhhC
Confidence            99999999999763

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=378.96  Aligned_cols=245  Identities=30%  Similarity=0.575  Sum_probs=224.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|.+.+.||+|+||.||+|+.  +.+.||||.+.+........+.+.+|++|++.++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4688889999999999999965  56789999998877777778899999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-ccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~  377 (504)
                      |+.| +|..+|.. .+.++++.+..++.|++.||.|||+++|+|||+||.|||++..+.+|+||||+|+.+..... .+.
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9976 99999987 78999999999999999999999999999999999999999999999999999998877653 445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      .-|||.|||||++.+++|+..+|+||+||++|||++|++||...+-.+....++....+  .|...+..+..+++.+|.+
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHHHHHHhhc
Confidence            57999999999999999999999999999999999999999988887777777766544  4568999999999999999


Q ss_pred             CCCCCCCHHHHH
Q 010680          458 DPALRPDFSEII  469 (504)
Q Consensus       458 dP~~RPs~~ell  469 (504)
                      ||.+|.+..+++
T Consensus       238 dP~~RltW~~Ll  249 (808)
T KOG0597|consen  238 DPAQRLTWTDLL  249 (808)
T ss_pred             ChhhcccHHHHh
Confidence            999999999887

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=380.42  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=221.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~  292 (504)
                      .+...+|.+.++||+|+||+|+++..+  ++.+|||++|++.. ..+..+....|.+|+...+ ||.+++++..|+++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            567789999999999999999999886  46799999998754 5566778888999988886 9999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc-C
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~-~  371 (504)
                      +|+||||+.||++..+.+  .+.|++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++... .
T Consensus       444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999554443  4889999999999999999999999999999999999999999999999999999766 4


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      .....+.+|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+....++..  .+..|..++.+..++|
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence            44566789999999999999999999999999999999999999999999999888887755  4568899999999999


Q ss_pred             HHhhhcCCCCCCCH
Q 010680          452 ERCWQQDPALRPDF  465 (504)
Q Consensus       452 ~~cl~~dP~~RPs~  465 (504)
                      +++|.++|++|...
T Consensus       600 ~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhccCcccccCC
Confidence            99999999999754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.7e-44  Score=373.11  Aligned_cols=263  Identities=32%  Similarity=0.629  Sum_probs=225.9

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      .+.|.+..++|++++.||+|+||.||++.+.       +..||||+++.... .+....+.+|+.+++.+ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            4568888899999999999999999998753       24699999986532 33456788999999999 899999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc---------------------------------------------------
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  313 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  313 (504)
                      +++...+..|+||||+++|+|.+++....                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            99999999999999999999999986432                                                   


Q ss_pred             ------------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          314 ------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       314 ------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                                        ..+++..+++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                              23677889999999999999999999999999999999999999999999999765433221


Q ss_pred             ---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          376 ---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       376 ---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                         ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...............+..+..+...++++.+++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence               12234678999999998999999999999999999997 99999887666666666666667777778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+||+.||.+||++.++++.|++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.2e-44  Score=373.49  Aligned_cols=262  Identities=30%  Similarity=0.612  Sum_probs=225.2

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      ...|.+..++|+++++||+|+||.||+|++.       +..||||+++.... ......+.+|+.+|+.+ +||||++++
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            3467888889999999999999999999752       34699999985432 33456788999999999 899999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc---------------------------------------------------
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  313 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  313 (504)
                      +++...+..++||||++||+|.+++....                                                   
T Consensus       106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            99999999999999999999999996532                                                   


Q ss_pred             -----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          314 -----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       314 -----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                                             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                   136778889999999999999999999999999999999999999999999998654


Q ss_pred             CCCcc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          371 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       371 ~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++ |..||............+..+.++..+...+.+
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE  345 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence            43221   12234678999999999999999999999999999998 999998877666666777777777777788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.+|+.+||+.||++||++.++++.|++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-45  Score=377.29  Aligned_cols=246  Identities=30%  Similarity=0.552  Sum_probs=220.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ..|.-..+||.|+.|.||.+...  ++.||||.+.......  .+-+.+|+.+|+..+|+|||++++.+...+.+++|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            45677789999999999999874  5779999987654333  3557899999999999999999999988899999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ||+||+|.|.+..  ..+++.++..++.++++||+|||.+||+|||||.+|||++.+|.+||+|||++....... ...+
T Consensus       351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999999999965  458999999999999999999999999999999999999999999999999998766655 5567


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+|||.|||||++..+.|++|.||||||++.+||+.|++||-..+|.++.+.+...+. +...+..+++.|++|+.+||.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            7999999999999999999999999999999999999999999999999888766543 234567899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .|+++|+++.|||+
T Consensus       509 ~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  509 VDVEQRASAKELLE  522 (550)
T ss_pred             cchhcCCCHHHHhc
Confidence            99999999999985

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-44  Score=358.47  Aligned_cols=245  Identities=23%  Similarity=0.401  Sum_probs=215.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||++...  ++.||||+++.... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999875  78899999875432 2234567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            99999999999976 567899999999999999999999999999999999999999999999999999765432  234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++.+.+|+.+||+.
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCC
Confidence            57999999999999999999999999999999999999999998887766665543  3456778899999999999999


Q ss_pred             CCCCCCC-----HHHHHH
Q 010680          458 DPALRPD-----FSEIIE  470 (504)
Q Consensus       458 dP~~RPs-----~~ell~  470 (504)
                      ||.+||+     +.++++
T Consensus       236 dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         236 DRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CHHHccCCccCCHHHHhc
Confidence            9999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-43  Score=350.36  Aligned_cols=247  Identities=37%  Similarity=0.724  Sum_probs=211.7

Q ss_pred             eeeeeeeeeCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          224 KFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++.+.||.|+||.||+|++.      +..|+||+++.. ........|.+|+.++++++||||++++|++...+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            56789999999999999998      567999999753 34445788999999999999999999999999888899999


Q ss_pred             EecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--
Q 010680          298 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--  374 (504)
                      ||+++|+|.++|... ...+++..+..++.||+.||.|||+++|+|+||+++||+++.++.+||+|||++........  
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999886 56799999999999999999999999999999999999999999999999999987632221  


Q ss_pred             -cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          375 -MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       375 -~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       .........|+|||.+....++.++||||||+++|||++ |+.||...+..+....+ .++.++..+..++..+.+++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence             223356789999999988889999999999999999999 78999999887766665 666777788899999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~~L  472 (504)
                      +||+.||++||++.++++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=373.40  Aligned_cols=262  Identities=37%  Similarity=0.720  Sum_probs=237.7

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+.|+++..++....+||-|.||.||.|.|+.  -.||||.+|.+.   -..++|+.|+.+|+.+.|||+|+++|+|+.+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            37899999999999999999999999999975  459999999653   3368999999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ..+|||+|||..|+|.+||+.++. .++.-.++.++.||..||+||..+++|||||.++|+|+.++..|||+|||+++.+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999999988754 4677778899999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccCCC---CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          370 AQSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       370 ~~~~~~~~~~g---t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ..+ ..++..|   ...|.|||.+....|+.|+|||+||++|||+.| |-.||.+.+..+. ++.+.+++|...|..|++
T Consensus       416 tgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  416 TGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             cCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCH
Confidence            654 3344444   568999999999999999999999999999999 9999999987665 577999999999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+++||+.||+.+|.+||+|.|+-+.|+.+++..
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            9999999999999999999999999999887643

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.9e-43  Score=353.46  Aligned_cols=254  Identities=32%  Similarity=0.593  Sum_probs=211.4

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC------------------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV  280 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~------------------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI  280 (504)
                      ...+|++.++||+|+||.||++.+.                  +..||+|+++... .......|.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            3467889999999999999999752                  2359999998653 34456789999999999999999


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHHHHHhhc------------------ccCChHHHHHHHHHHHHHHHHHHHCCcee
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIH  342 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiH  342 (504)
                      +++++++...+..|+||||+++++|.+++....                  ..+++..+..++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999986531                  23677889999999999999999999999


Q ss_pred             ccCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCC
Q 010680          343 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLP  417 (504)
Q Consensus       343 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~P  417 (504)
                      |||||+|||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999975433221   122345789999999988899999999999999999986  6788


Q ss_pred             CCCCCHHHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          418 YEYLTPLQAAVGVVQ---K---GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       418 f~~~~~~~~~~~v~~---~---~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      |...+..+....+..   .   ...+..+..+++.+.+++.+||+.||.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            988776655443321   1   1123345678899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.4e-43  Score=369.08  Aligned_cols=264  Identities=32%  Similarity=0.622  Sum_probs=227.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~  284 (504)
                      .+.|+++..+|.++++||+|+||.||+|++.+       ..||||+++... .....+.+.+|+.+|+++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            36789999999999999999999999998642       359999997643 3344567999999999996 99999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc---------------------------------------------------
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------  313 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  313 (504)
                      +++...+..||||||+++|+|.+++.+..                                                   
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            99999999999999999999999986532                                                   


Q ss_pred             --------------------------------------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          314 --------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       314 --------------------------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                                                                  ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        236777889999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~  425 (504)
                      ||++.++.+||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999986543321   122346788999999999999999999999999999997 999998876655


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .....+..+.++..+..+++++.+++.+||+.||++||++.++.+.|++++.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            5555566666777788899999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-43  Score=352.10  Aligned_cols=248  Identities=21%  Similarity=0.344  Sum_probs=209.3

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      |++.+.||+|+||.||++..  +++.||+|++...... ......+.+|+.++++++|+||+++++++...+.+++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999976  5788999998765432 23345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      +++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR  161 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence            99999998886533 46899999999999999999999999999999999999999999999999999876544444556


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .||..|+|||++.+..|+.++|||||||++|+|++|+.||...+.......+.  ........+..+++++.+|+.+||+
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  241 (285)
T cd05631         162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT  241 (285)
T ss_pred             CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhh
Confidence            79999999999999999999999999999999999999998765432221111  1222345667789999999999999


Q ss_pred             cCCCCCCC-----HHHHHH
Q 010680          457 QDPALRPD-----FSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs-----~~ell~  470 (504)
                      .||.+||+     +.++++
T Consensus       242 ~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         242 KNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCHHHhcCCCCCCHHHHhc
Confidence            99999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-44  Score=367.07  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=218.8

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCce
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  294 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~  294 (504)
                      ..+.|+.+++||+|.||.||+|++  +|+.||+|.++.+...........+||.||++|+||||++|.+..+..  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            345788889999999999999987  567799999998877777778889999999999999999999998776  6899


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+||| .-+|.-++....-.|+++++.-+++||+.||+|+|++||+|||||.+|||||.+|.+||+|||+|++..... 
T Consensus       195 lVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            999999 458888887756689999999999999999999999999999999999999999999999999999766554 


Q ss_pred             -ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010680          374 -VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  435 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------  435 (504)
                       .++..+-|.+|+|||++.+. .|+.++|+||.||||.||+.|++.|.+.+..+....+...-.                
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             57888899999999999765 699999999999999999999999999988877766553211                


Q ss_pred             --CCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 --RPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 --~p~~---------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                        +|..         ...+++...+|+..+|..||.+|.|+.+.+.
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              1111         1456788999999999999999999998863

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-43  Score=362.41  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=216.3

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|++.+.||+|+||.||+|++.  ++.||||+++.... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            3467999999999999999999884  67899999975432 22345678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            9999999999999976 567899999999999999999999999999999999999999999999999999865433  2


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...++.+....+...  +..+|..+++.+.+|+.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHHh
Confidence            3457999999999999999999999999999999999999999988887766665543  34567788999999999999


Q ss_pred             hcCCCCCCC-----HHHHH
Q 010680          456 QQDPALRPD-----FSEII  469 (504)
Q Consensus       456 ~~dP~~RPs-----~~ell  469 (504)
                      +.||.+||+     +.+++
T Consensus       251 ~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHh
Confidence            999999996     57766

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-43  Score=361.70  Aligned_cols=241  Identities=26%  Similarity=0.462  Sum_probs=210.2

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.||+|+||.||+++.  .++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  467899999986432 2344567888999999999999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTY  382 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~  382 (504)
                      +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999976 567899999999999999999999999999999999999999999999999999754322 2334567999


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      .|+|||++.+..|+.++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|.+||..||++|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            999999999999999999999999999999999999887776655554433  345678899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 010680          463 P-----DFSEIIE  470 (504)
Q Consensus       463 P-----s~~ell~  470 (504)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~ll~  250 (323)
T cd05571         238 LGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            9     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.6e-43  Score=342.20  Aligned_cols=251  Identities=35%  Similarity=0.675  Sum_probs=217.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ++.++|++.++||+|+||.||++.+.. ..+|+|.++.....   ...+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            356789999999999999999998864 47999998754332   35688899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc-
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-  375 (504)
                      |||+++++|.++++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999999876667899999999999999999999999999999999999999999999999998754332211 


Q ss_pred             -ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 -~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.. +.++..+...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence             22345678999999998899999999999999999999 9999998887776666543 44555677788999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L  472 (504)
                      ||+.+|++||++.++++.|
T Consensus       237 c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         237 CWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HccCCcccCcCHHHHHHhh
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-42  Score=342.66  Aligned_cols=256  Identities=37%  Similarity=0.714  Sum_probs=222.8

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      |+++..+|.+.++||+|+||.||+|.+.  ++.||+|+++...   .....+.+|+.+++.++||||+++++++...+.+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            6788889999999999999999999874  6789999987542   2346788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999999997543 45889999999999999999999999999999999999999999999999999765433


Q ss_pred             Cccc--cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 ~~~~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      ....  ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+.. ........+..+..+++++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCCCCCCCCCCHHHHH
Confidence            2111  1234568999999999999999999999999999998 99999887765544 334556677788899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ++.+||+.||++||++.++++.|+++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=360.09  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=214.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||+++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999884  678999999865322 234567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ....
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999976 56789999999999999999999999999999999999999999999999999975543  2345


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCCC---CCCcHHHHHHH
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---RPTIP---KNSQPKLAELL  451 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---~p~~p---~~~~~~l~~Ll  451 (504)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.....   .+...   ..+++++.+++
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            6799999999999999999999999999999999999999998887766555443221   11111   25689999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~  471 (504)
                      .+||..+|.+||++.++++.
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999854

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.8e-43  Score=347.15  Aligned_cols=254  Identities=31%  Similarity=0.619  Sum_probs=219.5

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +..+|++.+.||+|+||.||+|...+       ..||+|.++... .......|.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            44678999999999999999998643       459999987543 3445677999999999999999999999999988


Q ss_pred             CceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      ..|++|||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||+||++++++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            9999999999999999997532               4578889999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 010680          357 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~  432 (504)
                      .+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+.... +.
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i~  240 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-IR  240 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Confidence            99999999997543322   2233456889999999988899999999999999999998 9999998887765544 44


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      ....+..+..+++++.+|+.+||+.||.+||++.+|++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            455566788999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-42  Score=341.88  Aligned_cols=256  Identities=34%  Similarity=0.675  Sum_probs=221.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |.|+.++|++.++||+|+||.||+|.+. +..||+|.++....   ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            6788899999999999999999999874 46799999875432   2467899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++... ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999764 3568889999999999999999999999999999999999999999999999998655432


Q ss_pred             c--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ....+.+.+..++.++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  122345678999999998889999999999999999998 99999887776655443 3445555566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.+||+.+|++||++.++++.|+++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-43  Score=336.47  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=217.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|...++||+|.||.||+|++  +|+.||||.++.............+||+.|+.++|+||+.++++|.....+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999987  57889999999886666666778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      || ..+|+..++.....++...+..++.++++|++|||++.|+||||||.|+||+.+|.+||+|||+|+.+.... ..+.
T Consensus        82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            99 569999999888889999999999999999999999999999999999999999999999999999877654 3344


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------  438 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~------------------  438 (504)
                      .+-|.+|+|||++.| +.|+..+|+||.||++.||+-|.+-|.+.+..+....+.+.-..|.                  
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~  240 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ  240 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence            588999999998855 5799999999999999999999999998888776665553221111                  


Q ss_pred             --------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          439 --------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       439 --------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                              +...+++++.+|+.+||.+||.+|+++.|.++.
T Consensus       241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                    123457788999999999999999999998753

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=380.52  Aligned_cols=261  Identities=33%  Similarity=0.641  Sum_probs=238.2

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--C---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g---~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+|+.+..+|.++||.|.||+||+|..+  +   ..||||.+|... ....+.+|+.|+.||-+.+||||++|.|+.++.
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            4899999999999999999999999874  3   459999999754 556688999999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ....||+|||++|+|+.||+++.+.|+.-++..+++.|+.||.||-+.|+|||||.++|||++.+...||+|||++|...
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999775


Q ss_pred             CCC--ccccCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSG--VMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~--~~~~~~g--t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ++.  ..+..-|  ..+|.|||.|....++.++||||||++|||.++ |..||=++++.+.+.. +.++.|.+.|..||.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCPA  861 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCcH
Confidence            543  1122222  479999999999999999999999999999998 9999999999887766 667899999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .|.+||..||++|-.+||.|.||+..|.+++..
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            999999999999999999999999999999764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-43  Score=361.60  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=218.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC---ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.++||+|+||.||+|.+.+   ..||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            5667789999999999999999998643   4699999865432 23345678899999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999999976 567899999999999999999999999999999999999999999999999999865432


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                        .....||+.|+|||++.+..++.++|||||||++|||++|..||...++......+....  ..+|..+++.+.+++.
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence              334579999999999999999999999999999999999999999888877666655443  3467788999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHHH
Q 010680          453 RCWQQDPALRP-----DFSEIIEI  471 (504)
Q Consensus       453 ~cl~~dP~~RP-----s~~ell~~  471 (504)
                      +||+.||.+|+     ++.++++.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcC
Confidence            99999999995     78887653

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-42  Score=351.24  Aligned_cols=258  Identities=30%  Similarity=0.610  Sum_probs=221.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +...+|++.+.||+|+||.||+|++.  ++    .||||+++... ......++.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            45678999999999999999999863  33    38999987542 334457789999999999999999999998765 


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++++||+++|+|.+++......++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999999999999987667789999999999999999999999999999999999999999999999999986544


Q ss_pred             CCcc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~~---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. ..+...+.++..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHH
Confidence            3221   12234678999999999999999999999999999998 9999988776554 34556666666778889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+++.+||..||.+||++.+++..|..+...
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            9999999999999999999999999888664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=363.01  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=216.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||++...  ++.||||+++..... ......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999986  788999999865332 244567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      ||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999874 789999999999999999999999999999999999999999999999999997654332    


Q ss_pred             --------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 010680          374 --------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA  427 (504)
Q Consensus       374 --------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~  427 (504)
                                                ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                      223456899999999999999999999999999999999999999998887777


Q ss_pred             HHHHh--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 010680          428 VGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALRPD-FSEIIEI  471 (504)
Q Consensus       428 ~~v~~--~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs-~~ell~~  471 (504)
                      ..+..  .....+....+++++.++|.+||. ||.+||+ +.++++.
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            66665  333322233469999999999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-44  Score=355.36  Aligned_cols=247  Identities=23%  Similarity=0.489  Sum_probs=225.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      -+|++.+.||+|.||.|-++..  .|+.||||.++++.. +......+.+||+||..|+||||+++|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4788999999999999999975  588999999988765 4455678999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||..+|.|+||+.. ++.+++..+..|+.||+.|+.|+|.++++|||||.+|||+|.++++||+|||++..+.+....++
T Consensus       133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence            99999999999987 78899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ++|++.|.+||++++.+|. +.+|-||||++||-|+.|.+||++.+.......+.....+.   +..|.....||+.||.
T Consensus       212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRWMLM  288 (668)
T ss_pred             hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHHHHh
Confidence            9999999999999999995 78999999999999999999999999877777666555443   2345678899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 010680          457 QDPALRPDFSEIIEI  471 (504)
Q Consensus       457 ~dP~~RPs~~ell~~  471 (504)
                      .||++|.|+.+|...
T Consensus       289 VNP~RRATieDiAsH  303 (668)
T KOG0611|consen  289 VNPERRATIEDIASH  303 (668)
T ss_pred             cCcccchhHHHHhhh
Confidence            999999999998654

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.7e-43  Score=358.81  Aligned_cols=261  Identities=33%  Similarity=0.644  Sum_probs=222.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  287 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~  287 (504)
                      |.+..++|++.+.||.|+||.||+|...       ++.||+|+++... .......+.+|+.+++++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            7888889999999999999999999653       2579999988543 233456788899999999 799999999987


Q ss_pred             eC-CCCceeEEEecCCCchHHHHHhhc-----------------------------------------------------
Q 010680          288 TK-PPSLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  313 (504)
Q Consensus       288 ~~-~~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  313 (504)
                      .. ...++++|||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 456789999999999999986432                                                     


Q ss_pred             -------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCC
Q 010680          314 -------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYR  383 (504)
Q Consensus       314 -------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~  383 (504)
                             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578889999999999999999999999999999999999999999999999976433221   122345678


Q ss_pred             ccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       384 y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      |+|||++.+..++.++|||||||++|||++ |..||......+........+.++..+...++++.+++.+||+.+|++|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999998 9999987665555555566666777778889999999999999999999


Q ss_pred             CCHHHHHHHHHHHHH
Q 010680          463 PDFSEIIEILQQIAK  477 (504)
Q Consensus       463 Ps~~ell~~L~~l~~  477 (504)
                      |++.++++.|+++++
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=365.71  Aligned_cols=247  Identities=33%  Similarity=0.561  Sum_probs=218.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ..|...++||+|+||.||+|.+  +++.||||++..+.. .+...++.+|+.+|.+++++||.+.|+.+..+..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            3466668999999999999987  467899999998754 3446889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ||.||++.+.|.. .+.+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.+||+|||++....... ....
T Consensus        92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            9999999999975 4555888999999999999999999999999999999999999999999999997665543 3367


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      .+|||.|||||++.+..|+.|+||||||++.+||++|.+||....|......+ .+...|.....+++.+++++..||.+
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHHHHHhhc
Confidence            89999999999999999999999999999999999999999999996554432 34445666678999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      ||+.||+|.++++
T Consensus       250 ~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  250 NPEFRPSAKELLK  262 (467)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999985

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=340.35  Aligned_cols=256  Identities=35%  Similarity=0.642  Sum_probs=221.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      +++++|++.+.||+|+||.||+|.+.     ...||||+++... .......|.+|+.+++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            35678999999999999999999874     2469999987653 34446778999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .+++|||+++++|.+++....+.+++..+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||+++.....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999876778999999999999999999999999999999999999999999999999999876421


Q ss_pred             -Cccc--cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          373 -GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       373 -~~~~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                       ....  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ......+.+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  238 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALY  238 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHH
Confidence             1111  2244678999999999999999999999999999998 99999888776655444 34455566778899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +++.+||+.+|++||++.++++.|+++
T Consensus       239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         239 QLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-42  Score=363.60  Aligned_cols=263  Identities=33%  Similarity=0.641  Sum_probs=228.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~  284 (504)
                      ...|++..++|.++++||+|+||.||+|++.+       ..||||+++.... ......+.+|+.+|.++. ||||++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            34599999999999999999999999998743       4699999986532 333457889999999998 99999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhcc--------------------------------------------------
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG--------------------------------------------------  314 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  314 (504)
                      +++...+..++||||+++|+|.++++..+.                                                  
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            999999999999999999999999975321                                                  


Q ss_pred             -----------------------------------------------cCChHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010680          315 -----------------------------------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  347 (504)
Q Consensus       315 -----------------------------------------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp  347 (504)
                                                                     .+++..++.++.||+.||.|||+++|+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           256667889999999999999999999999999


Q ss_pred             CcEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 010680          348 ANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  423 (504)
Q Consensus       348 ~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~  423 (504)
                      +|||+++++.+||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999999999999998643322   1223356789999999998889999999999999999998 8999988777


Q ss_pred             HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       424 ~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+.....+..+.++..|..++.++.+++.+||..+|.+||++.+|++.|++++
T Consensus       348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            77666767777777888889999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-42  Score=338.88  Aligned_cols=245  Identities=28%  Similarity=0.579  Sum_probs=212.9

Q ss_pred             eeeeeCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~----~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +||+|+||.||+|.+    .+..||+|+++..........++.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999975    35679999998765556667889999999999999999999998864 5678999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc----cccCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET  379 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~  379 (504)
                      +|.+++.. ...+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||+++.......    .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999975 46789999999999999999999999999999999999999999999999999976544321    12223


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      +++.|+|||.+....++.++|+||||+++|||++ |..||...+..+... .+.++..+..|..+++++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4678999999988889999999999999999998 999999877765544 45566677788899999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 010680          459 PALRPDFSEIIEILQQI  475 (504)
Q Consensus       459 P~~RPs~~ell~~L~~l  475 (504)
                      |++||++.+|.+.|++.
T Consensus       239 p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         239 VDERPGFAVVELRLRNY  255 (257)
T ss_pred             chhCcCHHHHHHHHhcc
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=358.53  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=213.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCCceEE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQF  283 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~------------~~~~~~~Ei~iL~~l~HpnIv~l  283 (504)
                      ...++|++.+.||+|+||.|-+|..  .++.||||++.+......            ..+...+||.+|+++.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999987  467899999975432211            13578999999999999999999


Q ss_pred             EEeeeCC--CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEE
Q 010680          284 IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA  361 (504)
Q Consensus       284 ~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~  361 (504)
                      +.+..++  +.+|||+|||..|.+...=.. +..+++.++++++.+++.||+|||.+|||||||||+|+|++++|+|||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            9998765  468999999998887543221 2238999999999999999999999999999999999999999999999


Q ss_pred             eeccceeccCC------CccccCCCCCCccCcccccCC---CC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 010680          362 DFGVARVKAQS------GVMTAETGTYRWMAPEVIEHK---PY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV  431 (504)
Q Consensus       362 DFGla~~~~~~------~~~~~~~gt~~y~APE~l~~~---~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~  431 (504)
                      |||.+......      ......+|||.|+|||...+.   .| +.+.||||+||+||.|+.|++||.+....+...+++
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99999866332      123346899999999998662   23 468899999999999999999999999999999998


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       432 ~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      ...+.-+..+.+.+.+++||.+||.+||++|.+..+|...
T Consensus       333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            8877655555689999999999999999999999887643

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.9e-42  Score=339.31  Aligned_cols=252  Identities=36%  Similarity=0.685  Sum_probs=217.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECCc-cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g~-~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ++.++|++.+.||+|+||.||+|.+.+. .||||.++.....   ...+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            3567899999999999999999988664 5999998865332   35688999999999999999999999988899999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc-
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-  375 (504)
                      |||+++++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.++........ 
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999999875567899999999999999999999999999999999999999999999999998765443221 


Q ss_pred             -ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 -~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                       ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+ ..+.++..+...++.+.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHH
Confidence             12235678999999998889999999999999999998 99999888776655554 3455666677789999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L~  473 (504)
                      ||+.||.+||++.++++.|+
T Consensus       237 cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         237 CWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HcCCCcccCCCHHHHHHhhC
Confidence            99999999999999988763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.2e-43  Score=356.10  Aligned_cols=241  Identities=25%  Similarity=0.464  Sum_probs=209.4

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.||+|+||.||++..  .++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999986  467899999986532 2344567788999999999999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY  382 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~  382 (504)
                      +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99998876 56789999999999999999999999999999999999999999999999999875322 22334567999


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+.......+....  ..+|..+++++.++|.+||..||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            9999999999999999999999999999999999998887776665554433  34677899999999999999999999


Q ss_pred             C-----CHHHHHH
Q 010680          463 P-----DFSEIIE  470 (504)
Q Consensus       463 P-----s~~ell~  470 (504)
                      |     ++.++++
T Consensus       238 ~~~~~~~~~~~l~  250 (323)
T cd05595         238 LGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHc
Confidence            8     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-42  Score=347.33  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||++++.  ++.||||+++...........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999885  5779999998765545556778899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--ccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~  376 (504)
                      |++++.+..+. ...+.+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99887665544 445679999999999999999999999999999999999999999999999999998654322  223


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------------C-C
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------L-R  436 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-------------------~-~  436 (504)
                      ...||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+....                   . .
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4578999999999999999999999999999999999999998876554433221100                   0 0


Q ss_pred             C----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 P----------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p----------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +          .....+++++.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0          011236788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-42  Score=336.85  Aligned_cols=254  Identities=39%  Similarity=0.738  Sum_probs=223.0

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      |.++.++|++.+.||.|+||.||++...++.||||.++....   ....+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            556778899999999999999999999999999999986533   45778999999999999999999999998899999


Q ss_pred             EEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999997643 268999999999999999999999999999999999999999999999999997663322 


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                       .....+..|+|||.+....++.++||||||+++|+|++ |..||...+..+... .+....++..+..+++.+.+++.+
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHHHHHHHH
Confidence             23345678999999988889999999999999999997 999998877655443 344555666778889999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ||..+|++||++.++++.|+++
T Consensus       235 ~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         235 CWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HhccChhhCcCHHHHHHHHhcC
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=355.94  Aligned_cols=238  Identities=24%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||+|+||.||++++.  ++.||+|+++.... .......+.+|+.++++++||||+++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999874  67799999875432 334456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCCCCc
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW  384 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y  384 (504)
                      .+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999976 567999999999999999999999999999999999999999999999999999754332 233445799999


Q ss_pred             cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 010680          385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       385 ~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                      +|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++..+++++.+++.+||+.||.+||+
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            9999999999999999999999999999999999988877766665543  34567789999999999999999999986


Q ss_pred             H---HHHH
Q 010680          465 F---SEII  469 (504)
Q Consensus       465 ~---~ell  469 (504)
                      +   .+++
T Consensus       238 ~~~~~e~l  245 (312)
T cd05585         238 YNGAQEIK  245 (312)
T ss_pred             CCCHHHHH
Confidence            4   5554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-42  Score=337.71  Aligned_cols=253  Identities=36%  Similarity=0.702  Sum_probs=219.4

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee-CCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~  294 (504)
                      |.++..+|++.+.||+|+||.||++...+..||+|.++...    ....+.+|+.+++.++|+|++++++++. ..+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            56778899999999999999999999999999999987542    2457889999999999999999999754 556789


Q ss_pred             eEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999976443 48899999999999999999999999999999999999999999999999987543321


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+.... +.+...+..+..+++.+.+++.
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHH
Confidence              23345668999999999999999999999999999997 9999988776555444 3455566777889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +||+.+|++|||+.++++.|+++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         234 QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-42  Score=345.75  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEEeee-----C
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K  289 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~-----~  289 (504)
                      .+|++.+.||+|+||.||+|.+.   ++.||||+++...........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999873   46799999886544443345566777777766   6999999999875     3


Q ss_pred             CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ...+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456899999995 69999987643 4589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  437 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----------  437 (504)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+           
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            655544455678999999999998899999999999999999999999999887766655544321100           


Q ss_pred             --------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                    .+...+++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                          011346788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-42  Score=337.28  Aligned_cols=256  Identities=37%  Similarity=0.677  Sum_probs=221.4

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |+++.++|++.++||+|+||.||+|.+. ++.||||.++.....   ...+.+|+.++++++||||+++++++...+..|
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            6778889999999999999999999874 467999998865432   456889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +||||+++++|.+++.... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997643 468999999999999999999999999999999999999999999999999998765332


Q ss_pred             ccc--cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 VMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~~~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ...  ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......+ ........+..++..+.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            111  1123457999999999999999999999999999999 99999988876665554 3444555677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.+||+.+|.+||++.++++.|+++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-42  Score=345.40  Aligned_cols=249  Identities=22%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|.+.++||.|+||.||+|...  ++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            457999999999999999999874  67899999975432 222356778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||++ ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            9996 59999997766678999999999999999999999999999999999999999999999999997644322 234


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------------  436 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------------------  436 (504)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......                   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4578999999999865 56899999999999999999999999887766554443321100                   


Q ss_pred             -CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 -PT--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 -p~--------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                       +.        ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             00        11346788999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=359.83  Aligned_cols=248  Identities=22%  Similarity=0.361  Sum_probs=212.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||+++.  .++.||||+++.... .......+.+|+.+|+.++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            3688999999999999999987  467899999975432 2344566888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999976 5679999999999999999999999999999999999999999999999999987532211    


Q ss_pred             -----------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 010680          374 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY  418 (504)
Q Consensus       374 -----------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf  418 (504)
                                                         .....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011236999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 010680          419 EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEIIE  470 (504)
Q Consensus       419 ~~~~~~~~~~~v~~~~~~p~~p~--~~~~~l~~Ll~~cl~~dP~~RPs---~~ell~  470 (504)
                      ...++.+....+.........|.  .+++++.++|.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99888777766654333333333  568999999999996 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.7e-42  Score=343.84  Aligned_cols=257  Identities=33%  Similarity=0.598  Sum_probs=217.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCcee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g--~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ++|++.+.||+|+||.||+|....  .  .+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+.+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            578899999999999999998743  2  3788888743 2334456789999999999 69999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEE
Q 010680          296 VTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV  360 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL  360 (504)
                      +|||+++++|.+++....               +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999999999999997532               34788999999999999999999999999999999999999999999


Q ss_pred             EeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010680          361 ADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI  439 (504)
Q Consensus       361 ~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~  439 (504)
                      +|||++..............+..|+|||++....++.++|||||||++|||++ |..||...+..+....+ ..+..+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~~~~~~~  239 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRMEK  239 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCC
Confidence            99999864332211222233567999999999999999999999999999997 99999988877655544 44556667


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          440 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       440 p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +..+++++.+++.+||+.+|.+||++.++++.|.+++...
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            7889999999999999999999999999999999888644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.7e-42  Score=350.35  Aligned_cols=251  Identities=25%  Similarity=0.421  Sum_probs=211.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +..++|++.++||+|+||.||++.+.  +..||+|+++... .......+.+|+.+|++++||||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999885  6779999988642 34456779999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            9999999999999976 45689999999999999999999986 6999999999999999999999999998755432 2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV------------------------  430 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v------------------------  430 (504)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+                        
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34457999999999999999999999999999999999999999765543322111                        


Q ss_pred             ---------------------HhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          431 ---------------------VQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       431 ---------------------~~~~~~p~~p-~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                           +....++..+ ..+++++.+||.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 0111112222 2467899999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-42  Score=355.68  Aligned_cols=242  Identities=25%  Similarity=0.448  Sum_probs=210.1

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.||+|+||.||++..  .++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999986  467899999986532 3344567889999999999999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY  382 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~  382 (504)
                      +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99998876 56789999999999999999999999999999999999999999999999999875332 22334557999


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+|..+++++.+++.+||..||.+|
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            999999999999999999999999999999999999888776655544332  345778899999999999999999999


Q ss_pred             C-----CHHHHHHH
Q 010680          463 P-----DFSEIIEI  471 (504)
Q Consensus       463 P-----s~~ell~~  471 (504)
                      |     ++.++++.
T Consensus       238 ~~~~~~~~~~il~h  251 (328)
T cd05593         238 LGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCCHHHHhcC
Confidence            7     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-42  Score=341.05  Aligned_cols=256  Identities=31%  Similarity=0.579  Sum_probs=217.0

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      |++..++|++.++||+|+||.||+|.+.+       ..||||+++... ......++.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            67778899999999999999999997643       459999986542 2334567899999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcc---------cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKG---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~---------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      .....++||||+++++|.+++.....         .+++..+..++.|++.||.|||++|++||||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999999975322         356778899999999999999999999999999999999999999


Q ss_pred             EEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 010680          360 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       360 L~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      |+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433221   112345788999999999999999999999999999999 799999887766554443 344


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .+..+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            45667888999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-41  Score=344.63  Aligned_cols=265  Identities=32%  Similarity=0.633  Sum_probs=225.8

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|++..++|.+++.||+|+||.||++.+.+         ..+|+|+++... .......+.+|+.+++.+ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            4678888999999999999999999997632         359999998653 233456788899999999 79999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++...+..|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997632               24788899999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      ||+++.++.+||+|||.++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9999999999999999987543321   1122234578999999998899999999999999999998 89999876654


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +. ...+....++..+..++.++.+++.+||..+|.+||++.++++.|++++....
T Consensus       250 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 EL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            44 34455566667788899999999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-42  Score=353.77  Aligned_cols=241  Identities=27%  Similarity=0.471  Sum_probs=209.1

Q ss_pred             eeeeeeCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          227 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ++||+|+||.||+++.     .++.||||+++....  .......+.+|+.+|+.++||||+++++++..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975     467799999986432  223345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      ++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999976 5678889999999999999999999999999999999999999999999999997543332 23345


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|.+||+.|
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence            7999999999999999999999999999999999999999988877766665543  34577889999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 010680          459 PALRP-----DFSEIIE  470 (504)
Q Consensus       459 P~~RP-----s~~ell~  470 (504)
                      |++||     ++.++++
T Consensus       239 p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         239 PSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HhHcCCCCCCCHHHHhc
Confidence            99999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=336.47  Aligned_cols=250  Identities=36%  Similarity=0.684  Sum_probs=216.5

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      +..+|++.+.||+|+||.||++.+.+ ..+|+|+++.....   ...+.+|+.+++.++||||+++++++......|+||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            45678899999999999999998754 57999998754332   246788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc--
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~--  375 (504)
                      ||++|++|.+++....+.+++..+..++.||+.|+.|||++||+||||||+||+++.++.+||+|||+++........  
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999999876667899999999999999999999999999999999999999999999999999765432211  


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... +....++..+..+++++.+++.+|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHH
Confidence            11223467999999998999999999999999999999 8999988877665544 445666677788999999999999


Q ss_pred             hhcCCCCCCCHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L  472 (504)
                      |..+|++||++.++++.|
T Consensus       238 l~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-42  Score=357.26  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=209.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||+||++...  ++.||||+++.... .......+.+|+.++++++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36889999999999999999874  67899999975432 2334467888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      ||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999976 5679999999999999999999999999999999999999999999999999987432110    


Q ss_pred             --------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 010680          374 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL  421 (504)
Q Consensus       374 --------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~  421 (504)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012347999999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 010680          422 TPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQ--QDPALRPDFSEIIEI  471 (504)
Q Consensus       422 ~~~~~~~~v~~~~~~p~~p~--~~~~~l~~Ll~~cl~--~dP~~RPs~~ell~~  471 (504)
                      ++.+....+........+|.  .+++++.+++.+|+.  .++..||++.||++.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            88877776664332333333  468899999998664  223356899999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-42  Score=339.73  Aligned_cols=256  Identities=32%  Similarity=0.600  Sum_probs=221.6

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      |+++.++|.+.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            67888999999999999999999998743       569999987543 3344567889999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhc---------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      .....++||||+++++|.+++....         ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999996532         2467888999999999999999999999999999999999999999


Q ss_pred             EEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 010680          360 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       360 L~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      |+|||+++......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||...++.+....+. .+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence            99999987544332   1223456789999999988889999999999999999998 999999888777665544 555


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .+..|..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            66778888999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-42  Score=360.72  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=209.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .|+++++||+|+||+||+|...  ++.||||+++.... .......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999874  57799999976433 33456778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-----
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----  373 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----  373 (504)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......     
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999976 4678999999999999999999999999999999999999999999999999975321000     


Q ss_pred             -------------------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHH
Q 010680          374 -------------------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  410 (504)
Q Consensus       374 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~e  410 (504)
                                                                 .....+||+.|+|||++.+..|+.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                       0123469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhh--hcCCCCCCCHHHHHH
Q 010680          411 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCW--QQDPALRPDFSEIIE  470 (504)
Q Consensus       411 LltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~cl--~~dP~~RPs~~ell~  470 (504)
                      |++|..||...++.+....+........+|  ..+++++.+||.+|+  ..++..||++.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999888776666555433223333  367899999999954  555666999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.6e-42  Score=345.83  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|+.  .++.||||+++..... .....+.+|+.+++.++||||+++++++..+...|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            35789999999999999999987  4678999998754322 22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  376 (504)
                      ||+ +++|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            999 56888888776678999999999999999999999999999999999999999999999999999754332 2334


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCC----------------CCC
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGL----------------RPT  438 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~~----------------~p~  438 (504)
                      ...+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+.....                .+.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            5678999999999865 45899999999999999999999999876543222 21111000                000


Q ss_pred             -----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 -----IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 -----~p---------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                           .+         ...++.+.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 00         123467899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-41  Score=339.60  Aligned_cols=255  Identities=30%  Similarity=0.582  Sum_probs=216.4

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ++.++|++.++||+|+||.||+|.+      .+..||+|.++... .......+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            3456789999999999999999985      34679999988543 3344577899999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc----------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  355 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~  355 (504)
                      ..|+||||+++++|.+++....                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999999985321                247788899999999999999999999999999999999999


Q ss_pred             CcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 010680          356 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV  431 (504)
Q Consensus       356 ~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~  431 (504)
                      +.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||...++...... +
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-V  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence            999999999997653322   1223345778999999998889999999999999999998 9999988776554443 4


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       432 ~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      .....+..+..+++.+.+++.+||+.||.+||++.++++.|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            4444556778899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=335.76  Aligned_cols=252  Identities=31%  Similarity=0.582  Sum_probs=216.4

Q ss_pred             eeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC-----
Q 010680          223 LKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-----  292 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-----  292 (504)
                      |++++.||+|+||.||+|+...     ..||||.++...........+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642     569999998766555666789999999999999999999998866554     


Q ss_pred             -ceeEEEecCCCchHHHHHhh-----cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          293 -LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       293 -~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                       .+++|||+++++|..++...     ...+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             78999999999999998543     235889999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010680          367 RVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  442 (504)
Q Consensus       367 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~  442 (504)
                      +.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||...++.+.... +..+..+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~  239 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-LRHGNRLKQPED  239 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcC
Confidence            86544321   112235678999999998899999999999999999999 9999988877666544 344556677889


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +++++.+++.+||+.||.+||++.++++.|+++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-42  Score=349.93  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----CCce
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~  294 (504)
                      +|++.++||+|+||.||+|..  .++.||||+++...........+.+|+.++++++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478899999999999999987  467899999875433334456788999999999999999999987543     2479


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      +||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            999999 5789998875 4679999999999999999999999999999999999999999999999999997543221 


Q ss_pred             ---ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Q 010680          374 ---VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ----------------  432 (504)
Q Consensus       374 ---~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~----------------  432 (504)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234579999999999865  6789999999999999999999999987654332211100                


Q ss_pred             ------cCCCCC-------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 ------KGLRPT-------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ------~~~~p~-------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            ......       ....+++.+.+++.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  000000       11346788999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-43  Score=356.67  Aligned_cols=238  Identities=26%  Similarity=0.438  Sum_probs=208.4

Q ss_pred             eeeeeeCceEEEEEEE-----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          227 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      +.||+|+||.||++..     .++.||+|+++...........+.+|+.++++++||||+++++++..++.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864     46789999998654433445567889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCC
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG  380 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~g  380 (504)
                      +++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......|
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            9999999976 567899999999999999999999999999999999999999999999999999765443 23334578


Q ss_pred             CCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 010680          381 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  460 (504)
Q Consensus       381 t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~  460 (504)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  ...+|..+++.+.++|.+||+.||.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            99999999999999999999999999999999999999988887766665543  2456778899999999999999999


Q ss_pred             CCCCHHH
Q 010680          461 LRPDFSE  467 (504)
Q Consensus       461 ~RPs~~e  467 (504)
                      +||++.+
T Consensus       239 ~R~~a~~  245 (318)
T cd05582         239 NRLGAGP  245 (318)
T ss_pred             HcCCCCC
Confidence            9999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=343.87  Aligned_cols=260  Identities=32%  Similarity=0.652  Sum_probs=224.4

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEe
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA  286 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~  286 (504)
                      .|.+..++|.+.+.||+|+||.||+++..       +..||+|+++... .......+.+|+.+++++ +||||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            46788889999999999999999999752       2469999987643 234456789999999999 79999999999


Q ss_pred             eeCCCCceeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          287 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      +...+..++||||+++++|.++++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999999999976433 389999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          366 ARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       366 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...............+..+..+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            975443221   122345788999999999999999999999999999998 9999988776666666666666666677


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ..++++.+++.+||+.+|++||++.++++.|+++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            8899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=359.16  Aligned_cols=256  Identities=33%  Similarity=0.595  Sum_probs=210.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-CceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-SLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~  297 (504)
                      .+.|.-.+.||+|+||.||+|...+ ..||||.+.......  ..+|.+|+.++.+++|||+|+|+|+|.+.+ ..+||+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            3566667899999999999999876 889999887654332  456999999999999999999999999988 499999


Q ss_pred             EecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECCCCcEEEEeeccceeccC-C
Q 010680          298 EFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~---IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~  372 (504)
                      |||++|+|.++|+.... .++|..+.+|+.++++||+|||...   ||||||||+|||+|++...||+|||+|+.... .
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            99999999999988666 8999999999999999999999954   99999999999999999999999999976654 3


Q ss_pred             CccccC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhc-----CCCCCCC
Q 010680          373 GVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT------PLQAAVGVVQK-----GLRPTIP  440 (504)
Q Consensus       373 ~~~~~~-~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~------~~~~~~~v~~~-----~~~p~~p  440 (504)
                      ...... .||..|+|||.+..+..+.|+||||||++|.||+||+.|.+...      ..+.+...+..     ...|.+.
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            332233 89999999999998889999999999999999999998887532      12222222222     2233333


Q ss_pred             -CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          441 -KNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       441 -~~~~-----~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                       ...+     ..+..+..+|++.+|.+||++.|+++.|+.+..
T Consensus       312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence             2222     236778889999999999999999888855543

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-41  Score=335.21  Aligned_cols=245  Identities=31%  Similarity=0.624  Sum_probs=211.4

Q ss_pred             eeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      .||+|+||.||+|.+.    +..||+|+++... .......+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999764    3359999987653 34445779999999999999999999998864 5689999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc----cccCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET  379 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~  379 (504)
                      +|.+++......+++..+++++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.......    .....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99999987667899999999999999999999999999999999999999999999999999975433221    12223


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      +++.|+|||.+....++.++||||||+++|+|++ |..||......+.. ..+.++.++..+..+++++.+++.+||..|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            4678999999998889999999999999999996 99999988776654 445566677788899999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 010680          459 PALRPDFSEIIEILQQI  475 (504)
Q Consensus       459 P~~RPs~~ell~~L~~l  475 (504)
                      |++||++.++.+.|+.+
T Consensus       239 ~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         239 WEDRPNFAKVEERMRTY  255 (257)
T ss_pred             hhhCcCHHHHHHHHhhh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-41  Score=335.62  Aligned_cols=251  Identities=29%  Similarity=0.542  Sum_probs=211.8

Q ss_pred             eeeeeeeeeCceEEEEEEECCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------CCc
Q 010680          224 KFGSKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PSL  293 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~  293 (504)
                      .++++||+|+||.||+|.+...    .||+|.++...........+.+|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4678999999999999987532    589999887655566678899999999999999999999987432      346


Q ss_pred             eeEEEecCCCchHHHHHhh-----cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          294 CIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +++|||+++++|.+++...     ...+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            8999999999999987432     23478999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          369 KAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       369 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      ......   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.... +..+..+..+..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  240 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDCL  240 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence            543321   122245778999999999999999999999999999999 8999988777655444 44455555677889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ..+.+++.+||+.||++|||+.++++.|+++
T Consensus       241 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         241 DGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2e-41  Score=337.06  Aligned_cols=257  Identities=31%  Similarity=0.616  Sum_probs=219.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +...+|++.++||+|+||.||+|++.  ++    .||+|+++... .......+.+|+.+++.+.||||+++++++... 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            45678999999999999999999863  33    48999987543 344467789999999999999999999998754 


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++++||+++|+|.+++....+.+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999999999987667799999999999999999999999999999999999999999999999999986643


Q ss_pred             CCcc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~~---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ....   ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......... ..+..+..+..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHH
Confidence            3221   12234678999999999999999999999999999998 99999877665544 3455555666677899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .+++.+||..||++||++.++++.|..+..
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999998877644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.8e-41  Score=338.18  Aligned_cols=258  Identities=28%  Similarity=0.576  Sum_probs=218.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +...+|++.+.||.|+||.||+|.+  .++    .|++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            3456788899999999999999988  344    3777776533 223344678889999999999999999998764 4


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++++||+++|+|.+++....+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999987677899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ..   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+... ...+..+..+..+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHH
Confidence            22   1223356778999999998899999999999999999998 9999988776543 44556666777777889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+++.+||..||.+||++.++++.|..+.+.
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999887753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-42  Score=354.95  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=214.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|.+.++||+|+||.||++..  .++.||||+++.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3688999999999999999987  467899999986533 2344567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--c
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~  375 (504)
                      ||++|++|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999999988667899999999999999999999999999999999999999999999999999986554332  2


Q ss_pred             ccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHH
Q 010680          376 TAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKL  447 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l  447 (504)
                      ....||+.|+|||++.      ...++.++|||||||++|+|++|..||...+.......+.........|  ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3347899999999986      5568899999999999999999999999888777666655433222223  3578999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+|+.+||. +|.+||++.+++.
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhC
Confidence            999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-42  Score=337.53  Aligned_cols=256  Identities=34%  Similarity=0.649  Sum_probs=221.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +....+|++.++||.|+||.||+|.+. +..+|+|+++...  ......+.+|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            344567899999999999999999875 5779999987653  2234678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          296 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... 
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999999997643 458999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...++..+..+++.+.+++.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence            1223345778999999998899999999999999999998 899998887766655544 55667778899999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +||+.||.+|||+.++++.|+++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhcC
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.8e-42  Score=341.60  Aligned_cols=261  Identities=31%  Similarity=0.642  Sum_probs=224.8

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~  285 (504)
                      ..|+++.++|++.+.||+|+||.||++.+.+       ..+|+|.++.... ......+.+|+.+++++ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4678899999999999999999999998643       4699999886533 33456788999999999 7999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhh---------------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  350 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NI  350 (504)
                      ++...+.++++|||+++++|.++++..               .+.+++..+..++.||+.||.|||+++|+||||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999999642               34688999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 010680          351 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA  426 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~  426 (504)
                      +++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999986543321   122235678999999998899999999999999999998 9999988776655


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      ... ...+..+..+..++.++.+|+.+||..||++|||+.++++.|+++.
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            544 4455566777888999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.5e-42  Score=344.63  Aligned_cols=261  Identities=32%  Similarity=0.606  Sum_probs=218.7

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      +..++|++.+.||+|+||.||+|.+.  +.  .+|+|.++.. ........+.+|+.++.++ +||||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            45678999999999999999999864  33  3577776643 2344567888999999999 89999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  357 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~  357 (504)
                      .|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999997532               25788999999999999999999999999999999999999999


Q ss_pred             EEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 010680          358 VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR  436 (504)
Q Consensus       358 vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~  436 (504)
                      +||+|||+++............++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+.... .....+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~  241 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR  241 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence            99999999864322212222334678999999988889999999999999999998 9999988776655443 344455


Q ss_pred             CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       437 p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +..+..+++++.+++.+||+.+|++||++.+++..|.+++....
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            56667788999999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-41  Score=335.20  Aligned_cols=256  Identities=36%  Similarity=0.668  Sum_probs=218.2

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |.+...+|++.++||+|+||.||+|++.+ ..||+|+++.....   ...+.+|+.+++.++||||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            56777889999999999999999998754 46999999864432   3568899999999999999999998754 5689


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999999997643 458899999999999999999999999999999999999999999999999997654433


Q ss_pred             cc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ..  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ........+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCCCCCCccccCHHHHHH
Confidence            22  12345678999999998899999999999999999999 89999888776655443 3344445567789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      +.+||+.||++||++.++++.|++.+
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=359.83  Aligned_cols=249  Identities=20%  Similarity=0.301  Sum_probs=209.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||++..  .++.||||++..... .......+.+|+.++++++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688899999999999999977  567899999865432 3344567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      ||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999976 5678999999999999999999999999999999999999999999999999986321100    


Q ss_pred             --------------------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHH
Q 010680          374 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW  409 (504)
Q Consensus       374 --------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~  409 (504)
                                                                  .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 010680          410 ELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALR---PDFSEIIEI  471 (504)
Q Consensus       410 eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~--~~~~~l~~Ll~~cl~~dP~~R---Ps~~ell~~  471 (504)
                      ||++|..||...+..+....+........+|.  .+++++.+||.+|+. +|.+|   +++.+++..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999998887766655554332333333  578999999999997 77765   599988764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=341.23  Aligned_cols=301  Identities=24%  Similarity=0.404  Sum_probs=244.4

Q ss_pred             ChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCC------CCCCCCCCCCccccCCCCCCceeeCCCceeeeeeeeee
Q 010680          159 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEP------EDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG  232 (504)
Q Consensus       159 ~~~~~~~l~~~l~~~~~~~~~~~~~s~~sss~~~~~------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~i~~~LG~G  232 (504)
                      +.++.++|.+|++....++.++....... +|....      .+....+...++.-+......-.+..++|.++++||+|
T Consensus       101 s~~eRq~W~~AIq~vsn~l~q~e~~~tn~-~p~~~~d~~~~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGkG  179 (516)
T KOG0690|consen  101 SAEERQEWIEAIQAVSNRLKQEELMDTNG-NPEGEMDVNMGSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGKG  179 (516)
T ss_pred             CHHHHHHHHHHHHHHhhhhhhhhhcccCC-CccccccccCCCCCccccceeeeecccccccccceeccchhhHHHHhcCC
Confidence            47788999999998777666554211110 110000      00011111111211222223346677899999999999


Q ss_pred             CceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHH
Q 010680          233 SYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL  309 (504)
Q Consensus       233 ~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l  309 (504)
                      .||.|-+++.  +++.+|||+++++.. ..+....-..|-++|+..+||.+..+...++..+++|+||||..||.|+-+|
T Consensus       180 TFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL  259 (516)
T KOG0690|consen  180 TFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL  259 (516)
T ss_pred             ccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh
Confidence            9999998865  578899999998764 4556677788999999999999999999999999999999999999999999


Q ss_pred             HhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCCCCCCccCcc
Q 010680          310 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPE  388 (504)
Q Consensus       310 ~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~APE  388 (504)
                      .. ...+++..+..+...|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++.....+ .+.+.+|||.|.|||
T Consensus       260 sr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPE  338 (516)
T KOG0690|consen  260 SR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPE  338 (516)
T ss_pred             hh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCch
Confidence            76 6789999999999999999999999999999999999999999999999999998655544 567889999999999


Q ss_pred             cccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 010680          389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  463 (504)
Q Consensus       389 ~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RP  463 (504)
                      ++....|+.++|+|.+|++||||+||++||...+......-++...+  .+|..++++.+.|+..+|.+||.+|.
T Consensus       339 VleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  339 VLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence            99999999999999999999999999999998887766666655544  48899999999999999999999994

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-41  Score=334.63  Aligned_cols=255  Identities=24%  Similarity=0.454  Sum_probs=214.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||+|+.  .++.||||.++... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688899999999999999986  57889999887533 34455667899999999999999999999999889999999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+++++|.+++...   ...++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            999999999988542   3457889999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....  ..+....+......+..+..++..+.+++
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            2234568899999999998889999999999999999999999996543  23333333222333333356788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+||..+|++||++.++++.|+++
T Consensus       242 ~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         242 SMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHCCCCcccCcCHHHHHHHHHHh
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.1e-41  Score=343.60  Aligned_cols=266  Identities=31%  Similarity=0.626  Sum_probs=225.6

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ  282 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~  282 (504)
                      ...|.+...+|.+.++||+|+||.||+++..         ...||+|+++... .......+.+|+.+++.+ +||||++
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence            3567888899999999999999999999752         2459999988543 334466788999999999 5999999


Q ss_pred             EEEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010680          283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  347 (504)
Q Consensus       283 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp  347 (504)
                      +++++......|++|||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  162 (314)
T cd05099          83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA  162 (314)
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            9999999889999999999999999997532               3478889999999999999999999999999999


Q ss_pred             CcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 010680          348 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  423 (504)
Q Consensus       348 ~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~  423 (504)
                      +|||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999975543211   122234568999999998899999999999999999999 9999988776


Q ss_pred             HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       424 ~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .+.... ......+..+..++.++.+++.+||+.||++||++.++++.|.++...+.
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         243 EELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             HHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            555444 44455566778889999999999999999999999999999999877553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.7e-42  Score=351.79  Aligned_cols=262  Identities=34%  Similarity=0.646  Sum_probs=221.0

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC  287 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~  287 (504)
                      |++..++|++.++||+|+||.||+|.+       .++.||||+++.... ......+.+|+.++.++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            778888999999999999999999974       346799999986533 33456788999999999 689999999987


Q ss_pred             eCC-CCceeEEEecCCCchHHHHHhhc-----------------------------------------------------
Q 010680          288 TKP-PSLCIVTEFMSGGSVYDYLHKLK-----------------------------------------------------  313 (504)
Q Consensus       288 ~~~-~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  313 (504)
                      ... ...+++|||+++|+|.++++...                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 46789999999999999986532                                                     


Q ss_pred             -------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---ccc
Q 010680          314 -------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTA  377 (504)
Q Consensus       314 -------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~  377 (504)
                                   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                         2367778899999999999999999999999999999999999999999999976433221   112


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||............+..+.++..|...++++.+++.+||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            235678999999998999999999999999999997 9999987665555555566666777777888999999999999


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHH
Q 010680          457 QDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       457 ~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .||.+||++.++++.|+.+++.
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-41  Score=335.98  Aligned_cols=256  Identities=33%  Similarity=0.629  Sum_probs=219.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--C---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g---~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      |+..+|++.+.||+|+||.||+|...  +   ..+|+|.++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            34568899999999999999999763  2   3699999876433 3446788999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .|+||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||+++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999876677899999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc--c--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          373 GV--M--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       373 ~~--~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ..  .  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+ ....+++.+..+++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAAL  238 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCCCHHH
Confidence            21  1  12233568999999998899999999999999999886 99999888776655443 4445556667789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+++.+||+.+|.+||++.++++.|+++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=332.41  Aligned_cols=249  Identities=29%  Similarity=0.513  Sum_probs=218.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +.|++.+.||+|+||.||++..  .++.||+|.++......   .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4578889999999999999976  47889999987553322   234578899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |+||++|++|.+++.. .+.++...+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999999976 466899999999999999999999999999999999999999999999999998754332111


Q ss_pred             ----ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          376 ----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       376 ----~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                          ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+..............+.++..+++.+.+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence                3346788999999999999999999999999999999999999888777777676666667778889999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||..+|.+||++.++++
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         241 RRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHhhcCcccCCCHHHHhh
Confidence            9999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.8e-42  Score=349.11  Aligned_cols=241  Identities=25%  Similarity=0.415  Sum_probs=208.9

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCC-CceEEEEeeeCCCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~  297 (504)
                      +|++.+.||+|+||.||+|...  ++.||||+++.... .......+..|+.+++.+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999875  46799999986432 233456788899999999865 5888999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~  376 (504)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999976 56789999999999999999999999999999999999999999999999999875322 22334


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  .+..|..+++++.+++.+||.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            557999999999999999999999999999999999999999988877766665543  355778899999999999999


Q ss_pred             cCCCCCCCH
Q 010680          457 QDPALRPDF  465 (504)
Q Consensus       457 ~dP~~RPs~  465 (504)
                      .||.+|++.
T Consensus       238 ~~P~~R~~~  246 (324)
T cd05587         238 KHPAKRLGC  246 (324)
T ss_pred             cCHHHcCCC
Confidence            999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.2e-42  Score=349.96  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=207.8

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHH---HhcCCCCceEEEEeeeCCCCceeE
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      |++.+.||+|+||.||++.+.  ++.||||+++.... .......+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            577899999999999999874  67899999986432 223345666776655   566799999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~  375 (504)
                      |||++|++|..+++.  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988854  57999999999999999999999999999999999999999999999999998753322 233


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....  +..|..+++.+.++|.+||
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHh
Confidence            45679999999999999999999999999999999999999999888877666655433  3467789999999999999


Q ss_pred             hcCCCCCC-----CHHHHHH
Q 010680          456 QQDPALRP-----DFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RP-----s~~ell~  470 (504)
                      +.||.+||     ++.++++
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhh
Confidence            99999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-42  Score=353.44  Aligned_cols=242  Identities=26%  Similarity=0.462  Sum_probs=209.3

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.||+|+||.||++..  .++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  567899999986533 2334567788999999999999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      +|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            99998876 4678999999999999999999998 7999999999999999999999999999875432 2233455799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            9999999999999999999999999999999999999888776665554433  34567789999999999999999999


Q ss_pred             CC-----CHHHHHHH
Q 010680          462 RP-----DFSEIIEI  471 (504)
Q Consensus       462 RP-----s~~ell~~  471 (504)
                      |+     ++.++++.
T Consensus       238 R~~~~~~~~~~il~h  252 (325)
T cd05594         238 RLGGGPDDAKEIMQH  252 (325)
T ss_pred             hCCCCCCCHHHHhcC
Confidence            96     88888743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-41  Score=338.67  Aligned_cols=259  Identities=29%  Similarity=0.568  Sum_probs=218.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      |+++.++|++.++||+|+||.||+|...       +..||+|.++.... ......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            7888999999999999999999999753       23699999875432 233456889999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhc---------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      .....|+||||+++|+|.+++....         ..++...+..++.||+.||.|||+++|+||||||+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532         2345667889999999999999999999999999999999999999


Q ss_pred             EEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 010680          360 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       360 L~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+....+. .+.
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~  238 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGG  238 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence            999999875433221   112345678999999998899999999999999999998 899998887766554443 344


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+..+..+++.+.+++.+||+.||++||++.++++.|++.+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            45567788899999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-41  Score=337.96  Aligned_cols=253  Identities=31%  Similarity=0.599  Sum_probs=216.9

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ...+|.+.+.||+|+||.||+|+..       +..||||+++.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4567888999999999999999763       35799999876432 334578999999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc-------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~v  358 (504)
                      ..++||||+++++|.+++....             ..+++..+..++.||+.|+.|||++||+||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997532             347888999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 010680          359 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  434 (504)
Q Consensus       359 kL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~  434 (504)
                      ||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. .+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cC
Confidence            999999997543222   1223345788999999999999999999999999999998 999998877766555443 44


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ..+..+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            445566789999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.2e-42  Score=340.15  Aligned_cols=255  Identities=25%  Similarity=0.525  Sum_probs=217.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      ++..+|++.++||+|+||.||+|...       ++.||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            45567889999999999999999864       3569999998543 334456788999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhh---------------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  355 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~  355 (504)
                      ...++++||+.+++|.+++...               +..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998531               2347888899999999999999999999999999999999999


Q ss_pred             CcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 010680          356 EVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV  431 (504)
Q Consensus       356 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~  431 (504)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875433221   223356789999999988889999999999999999998 899998888776655544


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       432 ~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      . ...+..+..+++.+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            3 44455678899999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-41  Score=330.26  Aligned_cols=248  Identities=25%  Similarity=0.486  Sum_probs=218.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|.+.+.||+|+||.||+++.  .++.|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477889999999999999987  467899999887655666678899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          300 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ++|++|.+++... ...++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...... ....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9999999999875 4578999999999999999999999999999999999999999999999999988655432 2334


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+. .+..+.++..+++.+.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHccC
Confidence            578899999999999999999999999999999999999998887665555544 3445667778899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      +|++||++.++++
T Consensus       240 ~p~~Rp~~~~ll~  252 (256)
T cd08529         240 DYRQRPDTFQLLR  252 (256)
T ss_pred             CcccCcCHHHHhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=341.19  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=210.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .|++.++||+|+||.||++..  +++.||||++....... .....+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377889999999999999987  46789999987643322 234557789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          299 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      |+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999988653 34689999999999999999999999999999999999999999999999999987654444445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ..|+..|+|||++.+..++.++||||||+++|+|++|..||...+.......+.  .....+..+..+++.+.+|+.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            678999999999999999999999999999999999999998765533222211  112334566778999999999999


Q ss_pred             hcCCCCCC-----CHHHHHH
Q 010680          456 QQDPALRP-----DFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RP-----s~~ell~  470 (504)
                      ..||.+||     ++.+++.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhc
Confidence            99999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-41  Score=332.58  Aligned_cols=254  Identities=37%  Similarity=0.687  Sum_probs=218.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |++..++|++.++||+|+||.||++... +..||+|.++.....   ...+.+|+.++++++|+||+++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            6778889999999999999999999864 467999998865443   3568899999999999999999998754 5688


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999999999997643 458999999999999999999999999999999999999999999999999997654432


Q ss_pred             cc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+....+ .....++.+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence            11  12345678999999988889999999999999999999 99999888776655543 4455666778889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +.+||..+|.+|||+.++.+.|++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-43  Score=329.16  Aligned_cols=252  Identities=23%  Similarity=0.450  Sum_probs=225.4

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .|.+  ++|++++.||+|-||.||+|+.+.  --||+|++-+... ......++.+|++|-..|+||||+++|+++-+..
T Consensus        18 ~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   18 TWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            3444  579999999999999999998764  4599999876543 3345678999999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..|+++||.++|+|+..|...+ ..+++.....++.|++.|+.|+|.+++|||||||+|+|++.++.+||+|||-+....
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999999998543 459999999999999999999999999999999999999999999999999997666


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                       .+...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||+..+..+.+..+..-  +-.+|..++.+.+++
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~~a~dl  252 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISGGAADL  252 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccChhHHHH
Confidence             55667889999999999999999999999999999999999999999999987877777654  345779999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~  471 (504)
                      |.+|+.++|.+|.+..|+++.
T Consensus       253 I~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHhccCccccccHHHHhhh
Confidence            999999999999999988753

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-41  Score=330.64  Aligned_cols=245  Identities=33%  Similarity=0.672  Sum_probs=210.2

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCc
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS  304 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  304 (504)
                      ++||+|+||.||+|+.  .++.||+|.++.. ...+....+.+|+.+++.++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3689999999999987  5788999988754 234456779999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccc---cCCCC
Q 010680          305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT---AETGT  381 (504)
Q Consensus       305 L~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~gt  381 (504)
                      |.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........   ....+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999997655678999999999999999999999999999999999999999999999999987543321111   11234


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  460 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~  460 (504)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||...+....... .....+...+..++..+.+++.+||+.+|+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            57999999998889999999999999999998 9999988777554433 444556667788899999999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 010680          461 LRPDFSEIIEILQ  473 (504)
Q Consensus       461 ~RPs~~ell~~L~  473 (504)
                      +||++.++++.|+
T Consensus       239 ~Rps~~~~~~~l~  251 (252)
T cd05084         239 QRPSFSTVHQELQ  251 (252)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.2e-41  Score=337.60  Aligned_cols=258  Identities=29%  Similarity=0.578  Sum_probs=220.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      |...+|.+.+.||+|+||.||++...       +..+|+|.++..  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            45567899999999999999999742       244889988753  334456789999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhc------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~v  358 (504)
                      +..++||||+++++|.+++....            ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997532            248999999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 010680          359 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  434 (504)
Q Consensus       359 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~  434 (504)
                      ||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+. .+
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QG  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence            9999999975433221   122345778999999999999999999999999999998 999998887766655544 34


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ..+..+..+++++.+++.+||+.||.+||++.++.+.|+++.+.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            44456677899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.9e-41  Score=333.77  Aligned_cols=255  Identities=32%  Similarity=0.608  Sum_probs=218.8

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      +..+|++.+.||+|+||.||+|....     ..||||+++... ......+|..|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            44678899999999999999998742     259999987643 344567899999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++....+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999999998766779999999999999999999999999999999999999999999999999987544322


Q ss_pred             cc---ccC---CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          374 VM---TAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       374 ~~---~~~---~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ..   ...   ..+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+ ....+.+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHH
Confidence            11   111   12457999999999999999999999999999986 99999888776665554 344555566788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.+++.+||..+|.+||++.+++..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-42  Score=357.84  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=209.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .|++.++||+|+||.||+|..  .++.||||++..... .......+.+|+.++++++||||+++++.+..++.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999987  467799999875432 23445678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC------
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------  372 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~------  372 (504)
                      |++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999976 467899999999999999999999999999999999999999999999999997522100      


Q ss_pred             ------------------------------------------CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHH
Q 010680          373 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  410 (504)
Q Consensus       373 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~e  410 (504)
                                                                ......+||+.|+|||++.+..|+.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00112468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 010680          411 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPD---FSEIIE  470 (504)
Q Consensus       411 LltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~cl~~dP~~RPs---~~ell~  470 (504)
                      |++|+.||...++.+....+.........|  ..+++++.++|.+|+ .+|.+|++   +.+++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999988877776665433333333  467899999999976 59999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.6e-42  Score=356.36  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=215.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.++||+|+||.||++...  ++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456678999999999999999999874  67899999975432 223345678899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999999865  468899999999999999999999999999999999999999999999999998654432


Q ss_pred             c--cccCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcH
Q 010680          374 V--MTAETGTYRWMAPEVIEHK----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP  445 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~--~~~~  445 (504)
                      .  .....||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.......+........+|.  .++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence            2  2345799999999998653    478999999999999999999999998888777666665433333443  5789


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 010680          446 KLAELLERCWQQDPAL--RPDFSEIIEI  471 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~--RPs~~ell~~  471 (504)
                      ++.+||.+||+.+|.+  ||++.++++.
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            9999999999999987  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=358.47  Aligned_cols=251  Identities=25%  Similarity=0.459  Sum_probs=231.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC-ceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~lV  296 (504)
                      .++|..++++|+|+||.++..+.+  +..+++|.+..........+...+|+.+++++.|||||.+.+.|..++. +|||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357888999999999998877654  5679999999888888778889999999999999999999999998888 9999


Q ss_pred             EEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-c
Q 010680          297 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~  374 (504)
                      |+|++||+|.+.+.+.+ ..+++..+++++.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+...... .
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999999999998776 569999999999999999999999999999999999999999999999999999887776 5


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ....+||+.||+||++.+.+|+.|+|||||||++|||++-+++|...+....+..+.+.. -.++|...+.+++.++..|
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence            556789999999999999999999999999999999999999999999988888877665 4568899999999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEI  471 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~  471 (504)
                      +..+|..||++.+++..
T Consensus       242 l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  242 LRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhcCCccCCCHHHHhhC
Confidence            99999999999999876

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=365.20  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=217.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC----
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----  291 (504)
                      ....+|.+.+.||+|+||+||++..  .++.||||+++...........+.+|+.++..++|+||++++..+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3446899999999999999999976  5788999999877666666778899999999999999999988764332    


Q ss_pred             ----CceeEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          292 ----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       292 ----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                          .+++||||+++|+|.+++...   ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                267999999999999998653   3468899999999999999999999999999999999999999999999999


Q ss_pred             cceeccCC---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          365 VARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       365 la~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      +++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+.. +..+..+.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~  267 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLPP  267 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence            99765432   123345799999999999999999999999999999999999999998887666555443 33445778


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++++.+++.+||+.||.+||++.++++
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            89999999999999999999999999875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-41  Score=339.89  Aligned_cols=264  Identities=31%  Similarity=0.620  Sum_probs=225.3

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      .|++...+|.+.+.||+|+||.||++++.         +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            46788899999999999999999999752         2359999987543 234457789999999999 799999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      +++......++||||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997632               347788899999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~  425 (504)
                      |+++.++.+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999997654322   1222345678999999998889999999999999999998 889998887766


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .... +....+...+..++..+.+++.+||+.+|.+||++.++++.|++++.-..
T Consensus       248 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         248 LFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            5544 44555666778899999999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.5e-42  Score=358.28  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=209.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||++...  ++.||||++..... .......+.+|+.+|+.++||||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999864  67899999875432 2233466889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-----  372 (504)
                      ||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999999976 567899999999999999999999999999999999999999999999999997422100     


Q ss_pred             ---------------------------------------CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh
Q 010680          373 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT  413 (504)
Q Consensus       373 ---------------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt  413 (504)
                                                             ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00113469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 010680          414 GKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALRP---DFSEIIEI  471 (504)
Q Consensus       414 G~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~~cl~~dP~~RP---s~~ell~~  471 (504)
                      |+.||...++.+....+........+  ...+++++.++|.+|+ .+|.+|+   ++.++++.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999988877665554432222222  3467899999999977 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-41  Score=347.60  Aligned_cols=241  Identities=24%  Similarity=0.410  Sum_probs=208.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      +|++.+.||+|+||.||+|...  ++.||||+++.... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999875  46799999986532 2233456777888888774 799999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  376 (504)
                      ||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999876 467899999999999999999999999999999999999999999999999999754322 2334


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....  ..+|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHHcc
Confidence            5679999999999999999999999999999999999999999988877766665443  45677899999999999999


Q ss_pred             cCCCCCCCH
Q 010680          457 QDPALRPDF  465 (504)
Q Consensus       457 ~dP~~RPs~  465 (504)
                      .||.+|+++
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05616         238 KHPGKRLGC  246 (323)
T ss_pred             cCHHhcCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-41  Score=362.62  Aligned_cols=247  Identities=22%  Similarity=0.353  Sum_probs=213.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..|.+.+.||+|+||.||+|...   ++.||+|.+...  .......+.+|+.+|+.++||||+++++++..++.+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34899999999999999999764   456888876543  2344466788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||++||+|.+++...   ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999999988642   34688999999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          375 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       375 ---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                         ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .+..+..+++++.++|
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALL  303 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCccCCHHHHHHH
Confidence               334569999999999999999999999999999999999999999888777666655433 3456678899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||..||++||++.+++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            9999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.9e-42  Score=347.10  Aligned_cols=240  Identities=25%  Similarity=0.442  Sum_probs=204.7

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHh-cCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ++||+|+||.||+|++.  ++.||||+++.... .......+..|..++.. .+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875  56799999986532 22334455667777765 4799999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            999999876 567999999999999999999999999999999999999999999999999999764332 233455799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+..  ..+.+|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999998887766655433  356678889999999999999999999


Q ss_pred             CCCHH-HHH
Q 010680          462 RPDFS-EII  469 (504)
Q Consensus       462 RPs~~-ell  469 (504)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05592         238 RLGVDGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.1e-41  Score=333.92  Aligned_cols=260  Identities=27%  Similarity=0.548  Sum_probs=221.8

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-  289 (504)
                      .++.++|++.+.||+|+||.||+|.+..      ..|++|.++.. ........+.+|+.++++++||||+++++++.. 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3567889999999999999999998754      67999998743 344456778999999999999999999998765 


Q ss_pred             CCCceeEEEecCCCchHHHHHhhc-------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEe
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD  362 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~D  362 (504)
                      +...++++||+++++|.+++....       ..+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            467889999999999999997642       4588999999999999999999999999999999999999999999999


Q ss_pred             eccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 010680          363 FGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT  438 (504)
Q Consensus       363 FGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~  438 (504)
                      ||+++.......   .....++..|+|||++.+..++.++||||||+++||+++ |.+||...++.+.... ...+.++.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-LKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH-HHcCCCCC
Confidence            999975433221   122346778999999998899999999999999999999 9999998877665443 44455656


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       439 ~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+..+++++.+++.+||..||++||++.++++.|+++.+.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            6677899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.7e-42  Score=348.29  Aligned_cols=241  Identities=23%  Similarity=0.367  Sum_probs=208.0

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ++||+|+||.||+|+..  ++.||||+++.... .......+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875  56899999986532 233456677899998876 799999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            999999876 567899999999999999999999999999999999999999999999999999754332 233455799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....  ...|..+++++.+++.+||+.||++
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHH
Confidence            99999999999999999999999999999999999999988877776665433  3456678999999999999999999


Q ss_pred             CC-------CHHHHHH
Q 010680          462 RP-------DFSEIIE  470 (504)
Q Consensus       462 RP-------s~~ell~  470 (504)
                      ||       ++.++++
T Consensus       238 R~~~~~~~~~~~~~~~  253 (321)
T cd05591         238 RLGCVASQGGEDAIKQ  253 (321)
T ss_pred             cCCCCCCCCCHHHHhc
Confidence            99       6777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.2e-41  Score=337.22  Aligned_cols=257  Identities=29%  Similarity=0.580  Sum_probs=219.4

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ...+|.+.+.||+|+||.||++...       +..+++|.++...  ......+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            3457888899999999999999753       2348888876542  333467889999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      ..++||||+++++|.+++....               +.+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999997532               3478899999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 010680          357 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~  432 (504)
                      .++|+|||+++......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...++.+.... ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-IT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hh
Confidence            99999999997543322   1223456788999999999999999999999999999998 9999988877665444 44


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+..+..+..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            5555566778899999999999999999999999999999999663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.7e-42  Score=349.45  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~  293 (504)
                      +|++.++||+|+||.||+++.     .++.||+|+++....  .......+.+|+.+++.++ ||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999875     467899999875422  2233456888999999995 89999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999999999999976 5678999999999999999999999999999999999999999999999999997543322


Q ss_pred             --ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          374 --VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                        ......||+.|+|||++.+. .++.++|||||||++|||++|..||....    .......+.  ...+.++..+++.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  237 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGPE  237 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHH
Confidence              22345799999999999765 47899999999999999999999996432    122222222  3446677889999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 010680          447 LAELLERCWQQDPALRP-----DFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RP-----s~~ell~  470 (504)
                      +.+++.+||+.||++||     ++.++++
T Consensus       238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            99999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.6e-41  Score=331.35  Aligned_cols=259  Identities=32%  Similarity=0.632  Sum_probs=221.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ++...+|.+.++||.|+||.||+|.+.+     ..||||...... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            5667789999999999999999998743     358999887543 24456789999999999999999999998876 4


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            57899999999999999987556789999999999999999999999999999999999999999999999999976544


Q ss_pred             CCcc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          372 SGVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       372 ~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ....  +...++..|+|||.+....++.++||||||+++|+|++ |..||...+..+.... ...+.++..+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY  238 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence            3221  12234568999999988899999999999999999996 9999988877665544 445556667788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +++.+||..+|.+|||+.++++.|+++..+
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=329.93  Aligned_cols=255  Identities=38%  Similarity=0.708  Sum_probs=221.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |+++.++|.+.++||+|+||.||++... +..||||.++.....   ...+.+|+.++++++|+||+++++++......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            6788899999999999999999999875 367999998865433   356889999999999999999999999888999


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +||||+++++|.+++.... ..+++..+..++.||+.|+.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997644 468999999999999999999999999999999999999999999999999997654321


Q ss_pred             c--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.......+ ....+...+...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence            1  112234678999999999899999999999999999998 99999888776655554 3455556677789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +.+||+.+|.+||++.++.+.|++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.5e-42  Score=348.18  Aligned_cols=236  Identities=25%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++...  ++.||||+++.... .......+..|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  67899999976432 233456677888888876 699999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      ++|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            999999876 467999999999999999999999999999999999999999999999999998754322 234456799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  ....|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999999999999999999999999999999988887766665443  34566778999999999999999999


Q ss_pred             CCCH
Q 010680          462 RPDF  465 (504)
Q Consensus       462 RPs~  465 (504)
                      ||++
T Consensus       238 R~~~  241 (320)
T cd05590         238 RLGS  241 (320)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.5e-41  Score=336.61  Aligned_cols=254  Identities=30%  Similarity=0.608  Sum_probs=217.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +|++.+.||+|+||.||+|....       ..+++|.++.... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            46788999999999999998642       4589998875533 334567899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhc-----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010680          295 IVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  351 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NIL  351 (504)
                      ++|||+.+++|.+++....                       ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999986421                       34778899999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 010680          352 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA  427 (504)
Q Consensus       352 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~  427 (504)
                      +++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999975433221   122345678999999988889999999999999999998 99999887766544


Q ss_pred             HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       428 ~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                       .......++..+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 -NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             3455556667788899999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-41  Score=346.13  Aligned_cols=250  Identities=25%  Similarity=0.445  Sum_probs=208.4

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +..++|++.++||.|+||.||++.+.  +..+|+|+++... .......+.+|++++++++||||+++++++...+.+|+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            45678999999999999999999885  6679999987653 33445678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||||+++++|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999976 46689999999999999999999985 7999999999999999999999999998754322 2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------------------
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-------------------------  429 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~-------------------------  429 (504)
                      .....||..|+|||++.+..++.++|||||||++|+|++|+.||......+....                         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            2345789999999999999999999999999999999999999976544322110                         


Q ss_pred             ------------------HHhcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          430 ------------------VVQKGLRPTIPK-NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       430 ------------------v~~~~~~p~~p~-~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                        .+.....+..+. ..++++.+|+.+||+.||++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                              011111122222 35788999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.9e-41  Score=349.32  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=204.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------  291 (504)
                      .++|++.+.||+|+||.||++..  .++.||||+++...........+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999976  4688999999866545555677889999999999999999999886543      


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+|+||||+. ++|.+.+.   ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            4699999995 46766664   3588899999999999999999999999999999999999999999999999986655


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  435 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------  435 (504)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....                
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            5455566889999999999999999999999999999999999999987665433222111100                


Q ss_pred             ----CC--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 ----RP--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ----~p--------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                          ++                    ......++.+.+||.+||..||++|||+.|++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                00                    011234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.3e-41  Score=329.57  Aligned_cols=254  Identities=38%  Similarity=0.700  Sum_probs=216.6

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |++...+|.+.++||+|+||.||++.+.+ ..+|+|.+.....   ....+.+|+.+++.++|||++++++++.. ...+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence            56677789999999999999999998754 4699998875432   23568889999999999999999998754 5688


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999997643 347889999999999999999999999999999999999999999999999997654332


Q ss_pred             cc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+.+.... ......+..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCHHHHHH
Confidence            11  12345678999999998899999999999999999999 9999998877665544 34455566677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +.+||..||.+||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.1e-41  Score=331.03  Aligned_cols=254  Identities=33%  Similarity=0.651  Sum_probs=219.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |+|..++|++.++||+|+||.||+|.. .++.||+|.+......   ...+.+|+.+++.++|+||+++++++. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            678888999999999999999999987 4578999998865433   357889999999999999999999875 45689


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999999999986543 468889999999999999999999999999999999999999999999999997655332


Q ss_pred             cc--ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ..  ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+.... +....++..+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence            21  22345678999999998899999999999999999999 9999988877655544 34555666778889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +.+||..+|++||++.+++..|++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-41  Score=328.55  Aligned_cols=245  Identities=40%  Similarity=0.730  Sum_probs=216.8

Q ss_pred             eeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          227 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      +.||+|+||.||++...     +..|++|+++...... ....+.+|+.+++.++|+||+++++++......++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46899999999999886     6679999998764433 46788999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhh--------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          302 GGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       302 ggsL~~~l~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +++|.+++...        ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999875        4779999999999999999999999999999999999999999999999999998665432


Q ss_pred             ---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          374 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       374 ---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                         ......++..|+|||.+....++.++||||||+++|+|++ |..||...+..+....+. .+.+...+..+++++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYE  238 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHHHH
Confidence               2234467889999999988889999999999999999999 699999987776665544 35666778889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ++.+||..+|.+||++.++++.|+
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHhhC
Confidence            999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=340.81  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=214.1

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC---
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---  289 (504)
                      .|++. ..|...+.||.|+||.|+.+.+  +|+.||||.+.....+.-..++..+|+++|+.++|+||+.+.+++..   
T Consensus        17 ~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            44544 4455578999999999999987  47889999988655566667889999999999999999999998865   


Q ss_pred             --CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          290 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       290 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                        -+.+|+|+|+| +.+|...++. +..++...+..+++||++||.|+|+.||+||||||.|+|++.+..+||+|||+|+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence              24579999999 7799999976 4559999999999999999999999999999999999999999999999999999


Q ss_pred             eccC---CCccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 010680          368 VKAQ---SGVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------  432 (504)
Q Consensus       368 ~~~~---~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~-----------  432 (504)
                      ....   ...++..+.|.+|.|||++ ....|+.+.||||+||++.||++|++-|.+.+....+..++.           
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8864   5677888999999999997 567899999999999999999999999987765544333321           


Q ss_pred             -------------cCCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 -------------KGLRPTIP-----KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 -------------~~~~p~~p-----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                   ....|..|     ++.++...+|+++||..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                         11222222     578899999999999999999999999874

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.4e-41  Score=348.17  Aligned_cols=246  Identities=27%  Similarity=0.461  Sum_probs=204.0

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ...+|++.++||+|+||.||++++.  ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++|
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            3467888899999999999999874  6889999987543 334457789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      |||+.+++|.+.     ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus       151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            999999998653     234677888999999999999999999999999999999999999999999998654332 23


Q ss_pred             ccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          376 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ....||..|+|||++..     ...+.++|||||||++|||++|+.||......  ............+..+..+++++.
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            45579999999999843     23456899999999999999999999743221  122222233445566778899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +||.+||+.||++||++.|+++
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999976

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-41  Score=361.10  Aligned_cols=251  Identities=23%  Similarity=0.378  Sum_probs=203.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------  290 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------  290 (504)
                      ...+|+++++||+|+||.||+|..  .++.||||.+....      ....+|+.+|+.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            446799999999999999999987  46789999886432      2235799999999999999998876322      


Q ss_pred             --CCceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeec
Q 010680          291 --PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFG  364 (504)
Q Consensus       291 --~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFG  364 (504)
                        ..+++||||++ ++|.+++..   ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              23678999996 578777653   246789999999999999999999999999999999999999665 79999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------  435 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------  435 (504)
                      +++............||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.+...        
T Consensus       217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            9986655444455678999999999865 4699999999999999999999999998877665554433111        


Q ss_pred             -------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHHH
Q 010680          436 -------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQIA  476 (504)
Q Consensus       436 -------------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell--~~L~~l~  476 (504)
                                         +..+|...++++.+||.+||..||.+|||+.|++  ..++.+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                               1123445788999999999999999999999998  4455543

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.3e-41  Score=329.61  Aligned_cols=256  Identities=34%  Similarity=0.641  Sum_probs=218.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~---~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      |..++|+..+.||+|+||.||+|...  ++   .+|+|.++... .......+.+|+.++++++||||+++++++...+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45567888999999999999999864  33   59999987543 23345678999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .++||||+++++|.+++....+.+++..+..++.|++.|+.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999999765432


Q ss_pred             Ccc----ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          373 GVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       373 ~~~----~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...    .....++.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. .....+.+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHH
Confidence            211    11223457999999998889999999999999999997 999998877766555443 444555666789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+++.+||+.+|++||++.++++.|+++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=345.66  Aligned_cols=241  Identities=25%  Similarity=0.433  Sum_probs=207.6

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++.+.  ++.||||+++.... .......+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  56899999986432 223456677899999888 699999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++...... ......||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            999998876 4679999999999999999999999999999999999999999999999999997533222 23345689


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...  .+..|..+++++.++|.+||..||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999999999999999999999999999999988877666555443  34567788999999999999999999


Q ss_pred             CCCH-----HHHHH
Q 010680          462 RPDF-----SEIIE  470 (504)
Q Consensus       462 RPs~-----~ell~  470 (504)
                      ||++     .++++
T Consensus       238 R~s~~~~~~~~ll~  251 (318)
T cd05570         238 RLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCCCCCCHHHHhc
Confidence            9999     66653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=341.30  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=223.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      -.+..+.|++.+.||.|.-|+||++...+  ..+|+|++.++... .+...+...|-.||+.++||.++.+|..++.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            36777889999999999999999999876  67999999887654 3445677789999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .|+|||||+||+|..+++++. +.|++..++.++.+++.||+|||-.|||+|||||+||||-++|+|.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999999998765 4599999999999999999999999999999999999999999999999998731100


Q ss_pred             ---------------------------------C-C-----------------------ccccCCCCCCccCcccccCCC
Q 010680          372 ---------------------------------S-G-----------------------VMTAETGTYRWMAPEVIEHKP  394 (504)
Q Consensus       372 ---------------------------------~-~-----------------------~~~~~~gt~~y~APE~l~~~~  394 (504)
                                                       . .                       .....+||-.|.|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                       001236899999999999999


Q ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHH
Q 010680          395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEII  469 (504)
Q Consensus       395 ~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs----~~ell  469 (504)
                      .+.++|+|+|||+|||||.|..||.+.+..++...++.+.++-+-...++..+++||+++|.+||.+|..    +.||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999887765555578899999999999999999987    77765

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=347.57  Aligned_cols=241  Identities=23%  Similarity=0.416  Sum_probs=202.4

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||+++..  ++.||||+++..... ......+..|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999874  678999999865432 23456688899999998 699999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            999998875 56799999999999999999999999999999999999999999999999999874322 2233456799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--------~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||....        ........... ....+|..+++++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~  238 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASSVLKG  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999996321        11222222222 2345778899999999999


Q ss_pred             hhhcCCCCCCC------HHHHH
Q 010680          454 CWQQDPALRPD------FSEII  469 (504)
Q Consensus       454 cl~~dP~~RPs------~~ell  469 (504)
                      ||+.||.+||+      +.+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHh
Confidence            99999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.7e-41  Score=350.93  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=213.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.++||+|+||.||++.+.  ++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344567999999999999999999875  57899999875322 223345688899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999965  468999999999999999999999999999999999999999999999999998764433


Q ss_pred             c--cccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP  445 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~--~~~~  445 (504)
                      .  .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+........+|.  .+++
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  23557999999999997643    78899999999999999999999998888777777665444444444  5689


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 010680          446 KLAELLERCWQQDPAL--RPDFSEIIEI  471 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~--RPs~~ell~~  471 (504)
                      .+.+++.+||..++.+  |+++.++++.
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            9999999999855543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=331.44  Aligned_cols=258  Identities=33%  Similarity=0.624  Sum_probs=221.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +...+|++.+.||+|+||.||+|.+.  +.    .||+|.++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45578899999999999999999863  22    489998876533 3445778999999999999999999999887 7


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++......+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            88999999999999999988777799999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~~---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ....   ....++..|+|||.+....++.++|+||||+++|||++ |..||......+....+ ..+.....+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHH
Confidence            2211   11223568999999988899999999999999999998 99999988776655443 3455556677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+++.+||..||..||++.++++.|.++.+.
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-40  Score=341.58  Aligned_cols=264  Identities=31%  Similarity=0.626  Sum_probs=225.2

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|++...+|++++.||+|+||.||++.+.+         ..||+|+++.. ........+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            5689999999999999999999999997532         25899988754 2334457889999999999 79999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++...+..+++|||+++++|.+++....               ..+++..+..++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999997532               24778889999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|||++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543221   222334578999999999999999999999999999998 89999888766


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +.... +.....+..+..++.++.+++.+||+.+|.+||++.++++.|+++....
T Consensus       244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            65544 4445566677888999999999999999999999999999999997644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.9e-42  Score=347.75  Aligned_cols=237  Identities=27%  Similarity=0.431  Sum_probs=202.5

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||+||+|..  .++.||||++..... .......+..|.. +++.++||||+++++.+...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999988  468899999975432 2223344555554 56889999999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            999999976 56789999999999999999999999999999999999999999999999999875332 2234455799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..++..+++.+.++|.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            99999999999999999999999999999999999999888777666655443  3456678999999999999999999


Q ss_pred             CCCHH
Q 010680          462 RPDFS  466 (504)
Q Consensus       462 RPs~~  466 (504)
                      ||++.
T Consensus       238 R~~~~  242 (323)
T cd05575         238 RLGAK  242 (323)
T ss_pred             CCCCC
Confidence            99874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-41  Score=344.84  Aligned_cols=240  Identities=25%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ++||+|+||.||++++.  ++.||+|+++.... .......+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999874  67899999986432 122345567788887754 899999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            999999876 56789999999999999999999999999999999999999999999999999875322 2234456799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..  ..+..|..+++++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999999999999999999999999999999988877665544432  345677789999999999999999999


Q ss_pred             CCCHH-HHH
Q 010680          462 RPDFS-EII  469 (504)
Q Consensus       462 RPs~~-ell  469 (504)
                      ||++. +++
T Consensus       238 R~~~~~~~~  246 (316)
T cd05620         238 RLGVVGNIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-41  Score=343.64  Aligned_cols=240  Identities=24%  Similarity=0.416  Sum_probs=204.2

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHh-cCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||+|.+.  ++.||||+++.... .......+..|..+++. ++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875  56799999986532 12234556678888876 4899999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            999999976 467899999999999999999999999999999999999999999999999998753322 223345789


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  .+..|..++.++.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCHhh
Confidence            9999999999999999999999999999999999999988876665554332  34567778999999999999999999


Q ss_pred             CCCHH-HHH
Q 010680          462 RPDFS-EII  469 (504)
Q Consensus       462 RPs~~-ell  469 (504)
                      ||++. +++
T Consensus       238 R~~~~~~l~  246 (316)
T cd05619         238 RLGVKGDIR  246 (316)
T ss_pred             cCCChHHHH
Confidence            99997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-41  Score=351.30  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=212.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.+.||+|+||.||++...  ++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            556688999999999999999999874  67899999875322 233345678899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++||+|.+++..  ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            999999999999999865  458899999999999999999999999999999999999999999999999998665433


Q ss_pred             c--cccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQP  445 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~  445 (504)
                      .  .....||+.|+|||++.+..    ++.++|||||||++|||++|..||...+.......+........+|  ..+++
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence            2  23457999999999996543    7899999999999999999999999888877776666543333333  46899


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 010680          446 KLAELLERCWQQDPAL--RPDFSEIIEI  471 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~--RPs~~ell~~  471 (504)
                      .+.++|.+||..++.+  |+++.++++.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            9999999999843332  6788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-41  Score=330.80  Aligned_cols=248  Identities=33%  Similarity=0.617  Sum_probs=208.3

Q ss_pred             eeeeeeCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecC
Q 010680          227 SKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g--~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      +.||+|+||.||+|...+  .  .+++|.++.. ........+.+|+.+++++ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999998743  2  4688888743 2334456788999999999 79999999999999999999999999


Q ss_pred             CCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          302 GGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       302 ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      +++|.+++....               ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999997532               24788999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ..............+..|+|||++....++.++||||||+++|||++ |..||...+..+....+ ....+...+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDD  238 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-hCCCCCCCCCcCCH
Confidence            63322111122234667999999998999999999999999999997 99999887766554443 34455566777889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      ++.+++.+||..||.+||++.+++..|.+++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=332.42  Aligned_cols=251  Identities=31%  Similarity=0.573  Sum_probs=207.5

Q ss_pred             eeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCce
Q 010680          223 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  294 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~  294 (504)
                      |++.+.||+|+||+||++.+      .+..||+|+++... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48889999999999988764      35679999998653 223456788999999999999999999987653  3578


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ++|||+++++|.+++..  ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||+++.......
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999999965  4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHhcCCC
Q 010680          375 ----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGVVQKGLR  436 (504)
Q Consensus       375 ----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--------------~~~~~v~~~~~~  436 (504)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||......              ............
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                12234567799999998888999999999999999999999998643211              111122233444


Q ss_pred             CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       437 p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      +..+..++.++.+++.+||+.+|++||++.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            5567788999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9e-41  Score=333.02  Aligned_cols=253  Identities=29%  Similarity=0.576  Sum_probs=215.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~-------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      ++..++.+.++||+|+||.||++..       .+..+|+|.++..  .......+.+|+.+++.++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4567788999999999999999964       2346889987743  344567899999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhc--------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      ...+++|||+++++|.+++....              ..+++..+..++.||+.|+.|||++||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997643              2478899999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 010680          357 VVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~  432 (504)
                      .+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+ .
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence            999999999975543221   112235678999999999999999999999999999998 99999887776655444 3


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .+..+..+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            44455667789999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-40  Score=325.77  Aligned_cols=250  Identities=36%  Similarity=0.715  Sum_probs=216.1

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      +..+|++.+.||.|+||.||++.+. +..+|+|.++.....   ...+.+|++++++++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            5678899999999999999999875 678999998765433   246888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--c
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~  375 (504)
                      ||+++++|.+++....+.+++..+..++.|++.|+.|||+++++||||||+||+++.++.+||+|||+++.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999999987667789999999999999999999999999999999999999999999999999875543221  1


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||........... ...+.++..+...++.+.+++.+|
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHH
Confidence            22335678999999998889999999999999999998 9999987776555444 344455556677899999999999


Q ss_pred             hhcCCCCCCCHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L  472 (504)
                      |+.+|++||++.++++.|
T Consensus       238 l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         238 WKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cccChhhCCCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7e-41  Score=328.16  Aligned_cols=245  Identities=33%  Similarity=0.647  Sum_probs=213.8

Q ss_pred             eeeeeeCceEEEEEEECC---c--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          227 SKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g---~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      ++||+|+||.||+|.+..   +  .||||.++..... ...+.+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998742   2  5899999876544 566789999999999999999999999888 88999999999


Q ss_pred             CCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----ccc
Q 010680          302 GGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMT  376 (504)
Q Consensus       302 ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~  376 (504)
                      +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999997754 578999999999999999999999999999999999999999999999999997654422    112


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........+..++..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3456789999999999999999999999999999998 999999888877666665555555667788999999999999


Q ss_pred             hcCCCCCCCHHHHHHHHH
Q 010680          456 QQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       456 ~~dP~~RPs~~ell~~L~  473 (504)
                      +.+|.+||++.++++.|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-41  Score=347.07  Aligned_cols=239  Identities=26%  Similarity=0.438  Sum_probs=202.1

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHH-HHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++.+.  ++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999874  567999998754321 22233444444 457889999999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            999999976 56788999999999999999999999999999999999999999999999999975332 2234456799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+..+++.+.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHH
Confidence            99999999999999999999999999999999999999888877666655443  2355678999999999999999999


Q ss_pred             CCCHHHH
Q 010680          462 RPDFSEI  468 (504)
Q Consensus       462 RPs~~el  468 (504)
                      ||++.+.
T Consensus       238 R~~~~~~  244 (325)
T cd05602         238 RLGAKDD  244 (325)
T ss_pred             CCCCCCC
Confidence            9987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-40  Score=331.04  Aligned_cols=254  Identities=30%  Similarity=0.562  Sum_probs=209.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~  291 (504)
                      ..+|++.+.||+|+||.||++.+      .+..||||.++..  .......+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            45788999999999999999975      3567999998754  34445788999999999999999999998643  34


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            67899999999999999987667799999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcc----ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh
Q 010680          372 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAVGVVQ  432 (504)
Q Consensus       372 ~~~~----~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------------~~~~~v~~  432 (504)
                      ....    ....++..|+|||++.+..++.++||||||+++|||++|..|+......               ......+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3211    1122345699999999889999999999999999999987776432211               11122333


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ...+...+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            4445556678899999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.6e-41  Score=335.09  Aligned_cols=242  Identities=22%  Similarity=0.370  Sum_probs=200.0

Q ss_pred             eeeeCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||+|+||.||++..  .++.||+|.+....... .....+..|+.++++++||||+++++.+..+..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999976  47889999987543322 2234556799999999999999999999999999999999999999


Q ss_pred             HHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCc
Q 010680          306 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW  384 (504)
Q Consensus       306 ~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y  384 (504)
                      .+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            98886533 35888999999999999999999999999999999999999999999999999876554444456789999


Q ss_pred             cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       385 ~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +|||++.+..++.++|||||||++|+|++|..||...........+......   +.....+++++.+|+.+||+.||.+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            9999999888999999999999999999999999765332221222222111   1222467899999999999999999


Q ss_pred             CCCHHHHHH
Q 010680          462 RPDFSEIIE  470 (504)
Q Consensus       462 RPs~~ell~  470 (504)
                      ||++.|+++
T Consensus       241 R~~~~~~~~  249 (277)
T cd05607         241 RLGSREKND  249 (277)
T ss_pred             CCCCccchh
Confidence            999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-40  Score=331.08  Aligned_cols=253  Identities=32%  Similarity=0.590  Sum_probs=213.7

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ..++|++.+.||+|+||.||+|.+.+       ..||+|.++... .......|.+|+.+++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            44678899999999999999998854       568888876442 3334567899999999999999999999999888


Q ss_pred             CceeEEEecCCCchHHHHHhhc------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEe
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVAD  362 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~D  362 (504)
                      ..++||||++|++|.+++....      ..+++..+..++.||+.||.|||+++++||||||+||+++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999997643      2588899999999999999999999999999999999998654   699999


Q ss_pred             eccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 010680          363 FGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT  438 (504)
Q Consensus       363 FGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~  438 (504)
                      ||+++.......   ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+...... .+....++.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~  241 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTGGGRLD  241 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCcCC
Confidence            999976532211   112233568999999998889999999999999999997 999999877765543 344455666


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       439 ~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            77889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.2e-41  Score=345.60  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=206.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~  291 (504)
                      .++|++.+.||+|+||.||++..  .++.||||+++...........+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999976  467899999987655555567788999999999999999999987543      3


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..|+||||+. ++|.+.+.   ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        96 ~~~lv~e~~~-~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhc-ccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            4699999995 47777664   3588899999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  435 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------  435 (504)
                      ........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++....                
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            5555567899999999999999999999999999999999999999987765444332221100                


Q ss_pred             ------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          436 ------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       436 ------------------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                              ....+...+.++.+||.+||..||.+|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                    001112345678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=326.22  Aligned_cols=246  Identities=31%  Similarity=0.594  Sum_probs=210.2

Q ss_pred             eeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          227 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      ++||+|+||.||+|.+..     ..||+|.++..... .....+.+|+.+++.+.||||+++++++.. +..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            479999999999998743     56999998866443 455778999999999999999999998764 46799999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc----cc
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----TA  377 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~----~~  377 (504)
                      +++|.+++... ..+++..+..++.|++.||.|||.++++|+||||+||+++.++.+||+|||+++........    ..
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999863 47899999999999999999999999999999999999999999999999999765433211    11


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... .........+..+++.+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            223568999999999999999999999999999998 9999988877655444 34455566778899999999999999


Q ss_pred             cCCCCCCCHHHHHHHHHHHH
Q 010680          457 QDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       457 ~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+|++||++.++++.|+++.
T Consensus       237 ~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         237 YRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CChhhCcCHHHHHHHHHhcc
Confidence            99999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-40  Score=326.18  Aligned_cols=248  Identities=26%  Similarity=0.475  Sum_probs=215.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||.|+||.||++..  .++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+...+.+|++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            478889999999999999987  467899999875432 33456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-ccc
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~  377 (504)
                      +++++|.+++.... ..++...+..++.||+.||.|||++||+|+||||+||++++++.++|+|||.++....... ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            99999999986543 4588999999999999999999999999999999999999999999999999976654332 234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .+..+..+..++..+.+++.+||+.
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence            578999999999999899999999999999999999999999887766655544 4445557778899999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 010680          458 DPALRPDFSEIIEI  471 (504)
Q Consensus       458 dP~~RPs~~ell~~  471 (504)
                      ||++||++.+++..
T Consensus       239 ~P~~Rp~~~~il~~  252 (255)
T cd08219         239 NPRSRPSATTILSR  252 (255)
T ss_pred             CcccCCCHHHHhhc
Confidence            99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-40  Score=332.84  Aligned_cols=255  Identities=31%  Similarity=0.593  Sum_probs=216.0

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      ++.++|++.+.||.|+||.||++...       +..||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            45577899999999999999999863       4679999987543 344557799999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhc---------------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLK---------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      ...++||||+++++|.+++....                     ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997432                     246788899999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~  425 (504)
                      |+++.++.++|+|||+++......   .......+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987543221   1122345678999999998899999999999999999998 889998887766


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      ....+. .+..+..+..++.++.+++.+||+.||.+||++.|+++.|++
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            555433 344445567889999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-41  Score=343.30  Aligned_cols=251  Identities=18%  Similarity=0.309  Sum_probs=209.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||+++..  ++.||||+++... ........+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999874  6789999987532 22334566888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--c
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~  375 (504)
                      ||++|++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999987667899999999999999999999999999999999999999999999999999876544332  2


Q ss_pred             ccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHH
Q 010680          376 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKL  447 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~---p~~~~~~l  447 (504)
                      ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+....+........+   ...+++.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            23469999999999863     45788999999999999999999999988877766665543322222   23578999


Q ss_pred             HHHHHHhhhcCCC--CCCCHHHHHHH
Q 010680          448 AELLERCWQQDPA--LRPDFSEIIEI  471 (504)
Q Consensus       448 ~~Ll~~cl~~dP~--~RPs~~ell~~  471 (504)
                      .+++.+|+..+++  .||++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999998865443  37888888754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.9e-41  Score=350.96  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=208.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||++..  .++.||||+++.... .......+.+|+.++..++||||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688899999999999999987  467899999975422 3344567888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      ||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......    
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999976 5678999999999999999999999999999999999999999999999999986432110    


Q ss_pred             --------------------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 010680          374 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL  421 (504)
Q Consensus       374 --------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~  421 (504)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            011346999999999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 010680          422 TPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEIIE  470 (504)
Q Consensus       422 ~~~~~~~~v~~~~~~p~~p~--~~~~~l~~Ll~~cl~~dP~~RPs---~~ell~  470 (504)
                      ++......+........+|.  .+++++.++|.+|+ .||.+|++   +.++++
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            88777666654332233333  46889999999987 49999985   556553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-42  Score=334.48  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=214.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee--CCCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV  296 (504)
                      ++|+.+++|++|+||.||+|+++  ++.||+|.++.+.........-.+||.+|.+++|||||.+-.+..  +-+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            57889999999999999999874  677999999977544444455789999999999999999988764  44568999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~  375 (504)
                      ||||+ -+|..++...+.+|....+.-++.|+++|++|||.+.|+|||||++|+|++..|.+||+|||+||..... ..+
T Consensus       156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            99995 5999999998889999999999999999999999999999999999999999999999999999987665 467


Q ss_pred             ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 010680          376 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------------  437 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----------------  437 (504)
                      +..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++-|.+.+..+.+..+.+.-..|                 
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            78889999999999866 569999999999999999999999999988887777665421111                 


Q ss_pred             ------------CCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------------TIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------------~~p~~-~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                  .++.. +++.-.+|+..+|..||.+|.|+.|.++
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                        11111 5578899999999999999999999874

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.1e-41  Score=346.21  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=206.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~  291 (504)
                      .++|++.+.||+|+||.||++..  .++.||||+++...........+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999986  467899999986654555567788999999999999999999987543      3


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..|+||||++ ++|.+++..   .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            4699999995 577777743   578889999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------  436 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------  436 (504)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++.....               
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            55555678999999999999999999999999999999999999999887766554444321110               


Q ss_pred             -----C--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 -----P--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 -----p--------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                           +                    ......+..+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 0                    011123467899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-40  Score=326.79  Aligned_cols=251  Identities=34%  Similarity=0.701  Sum_probs=216.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      |-+...+|++.+.||+|+||.||++...++.||+|.++...    ....+.+|+.+++.++||||+++++++... ..++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            34455789999999999999999999999999999987542    235788999999999999999999998765 4799


Q ss_pred             EEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      +|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997643 35889999999999999999999999999999999999999999999999999754332  


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... ..++.++..+..+++.+.+++.+
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHH
Confidence            223344678999999998899999999999999999998 9999998877655443 44556666677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L~~  474 (504)
                      ||+.+|++||++.++++.|++
T Consensus       233 ~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         233 CWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HcCCChhhCcCHHHHHHHHcc
Confidence            999999999999999988763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-40  Score=325.80  Aligned_cols=256  Identities=23%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||.|+||.||+|...  ++.||+|.++.... .......+.+|+.++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46889999999999999999884  78899999875433 3344678999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+++++|.+++...   ...++...+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++...... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999998642   3458899999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC-CCcHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPK-NSQPKLAELL  451 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~p~~p~-~~~~~l~~Ll  451 (504)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..........+..+..+. .++..+.+++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            22345688999999999999999999999999999999999999965431 112222233344444554 7888999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+||..+|++||++.+|++.|+++.
T Consensus       242 ~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHcCCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=334.88  Aligned_cols=255  Identities=27%  Similarity=0.552  Sum_probs=211.7

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECC----------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCS----------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  281 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g----------------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv  281 (504)
                      +...+|++.++||+|+||.||++...+                ..||+|.++... .......|.+|++++++++|+||+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            345689999999999999999987532                248999988653 344566799999999999999999


Q ss_pred             EEEEeeeCCCCceeEEEecCCCchHHHHHhhc-----------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010680          282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  350 (504)
Q Consensus       282 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NI  350 (504)
                      ++++++...+..++||||+++++|.+++....           ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532           1367888999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 010680          351 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ  425 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~  425 (504)
                      +++.++.+||+|||+++.......   .....++..|+|||++.+..++.++||||||+++|+|++  |..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999975433221   122345778999999998889999999999999999998  778998877666


Q ss_pred             HHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          426 AAVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       426 ~~~~v~~------~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .......      .......+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            5444322      11223345668899999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-40  Score=333.70  Aligned_cols=254  Identities=33%  Similarity=0.599  Sum_probs=213.2

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV  280 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g------------------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI  280 (504)
                      ...+|++.++||+|+||.||+++..+                  ..||+|.+.... .......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            34678899999999999999987643                  348999988653 33456789999999999999999


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHHHHHhhc----------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  350 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NI  350 (504)
                      +++++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997643          2689999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 010680          351 LMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ  425 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~  425 (504)
                      +++.++.++|+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999997543332   1223456788999999988889999999999999999998  788998777665


Q ss_pred             HHHHHHhc------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          426 AAVGVVQK------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       426 ~~~~v~~~------~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ........      ......+..++.++.+++.+||+.||.+||++.+|++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            54443321      1112334567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.8e-41  Score=331.49  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=208.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..+|++.++||+|+||.||+|+.  .++.||+|+++....  .....+.+|+.++++++||||+++++.+...+..++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            35789999999999999999987  467899999875422  22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999875 5678999999999999999999999999999999999999999999999999997654322 233


Q ss_pred             cCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHH
Q 010680          377 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAEL  450 (504)
Q Consensus       377 ~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~---p~~~~~~l~~L  450 (504)
                      ...+++.|+|||.+.   ...++.++|+||||+++|||++|..||....+.............+..   +..++..+.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            457889999999984   445788999999999999999999999776665544333333322222   23467899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~  471 (504)
                      +.+||+.+|++||++.++++.
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcC
Confidence            999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.5e-41  Score=347.61  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=205.8

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-----Cce
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~  294 (504)
                      +|++.++||+|+||.||++..  .++.||||.+............+.+|+.+++.++||||+++++++..+.     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467889999999999999986  5788999998765444445577889999999999999999999988776     789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC--
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--  372 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--  372 (504)
                      +||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999995 688888765 567999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 010680          373 GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------------------  432 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~-------------------  432 (504)
                      .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++.+....+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            233455789999999999774 589999999999999999999999988776554433321                   


Q ss_pred             ----cCCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 ----KGLRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ----~~~~p-------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                          ....+       ......++++.+||.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                11111       123456789999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-40  Score=332.57  Aligned_cols=248  Identities=22%  Similarity=0.352  Sum_probs=209.0

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      |+..+.||+|+||+||++.+.  ++.||+|++....... .....+.+|+.+|+.++|+||+.+++++..++..|++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999874  6789999987654332 2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      +++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            99999999886543 46999999999999999999999999999999999999999999999999999765443334455


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhh
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+...  ......+..+++++.+|+.+||+
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT  241 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence            7899999999999899999999999999999999999999877654433332221  12234567788999999999999


Q ss_pred             cCCCCCCC-----HHHHHH
Q 010680          457 QDPALRPD-----FSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs-----~~ell~  470 (504)
                      .||.+||+     +.+++.
T Consensus       242 ~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         242 KDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHhHcCCCcccChHHHHc
Confidence            99999999     555543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.3e-41  Score=333.06  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=201.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEEeeeC-----CC
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----PP  291 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~-----~~  291 (504)
                      +|++.+.||+|+||.||+|...  ++.||+|.++...........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999874  67899999886543333334456677776655   69999999998754     24


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..+++|||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            5789999996 58988887643 458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------  435 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------  435 (504)
                      .........||..|+|||++.+..++.++|||||||++|+|++|.+||......+....+.....               
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            54444556789999999999988999999999999999999999999987766554444332100               


Q ss_pred             ---CC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 ---RP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ---~p-------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                         .+       .....++..+.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00       011356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.9e-40  Score=325.27  Aligned_cols=254  Identities=35%  Similarity=0.670  Sum_probs=217.9

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |++..++|++.++||+|+||.||++.+. +..+|+|.++..   ......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            6788899999999999999999999864 466999988754   2234678899999999999999999999887 6789


Q ss_pred             eEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++|||+++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764 3457888999999999999999999999999999999999999999999999997654332


Q ss_pred             c--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .  .....++..|+|||++....++.++|+||||+++|+|++ |..||...+....... ...+.....+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCcccCCHHHHHH
Confidence            1  122345678999999998889999999999999999998 9999998776655544 33455555667889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +.+||+.+|++||++.++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.6e-41  Score=344.24  Aligned_cols=237  Identities=22%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++...  ++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  57799999986533 233456678899988776 799999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      ++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            999998875 567999999999999999999999999999999999999999999999999999753322 233445799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--------~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||....        .......... .....+|..++.++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~  238 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKS  238 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999995311        1122222222 23345788899999999999


Q ss_pred             hhhcCCCCCCCH
Q 010680          454 CWQQDPALRPDF  465 (504)
Q Consensus       454 cl~~dP~~RPs~  465 (504)
                      ||+.||.+||++
T Consensus       239 ~L~~dP~~R~~~  250 (329)
T cd05618         239 FLNKDPKERLGC  250 (329)
T ss_pred             HhcCCHHHcCCC
Confidence            999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7e-41  Score=334.31  Aligned_cols=242  Identities=24%  Similarity=0.383  Sum_probs=200.2

Q ss_pred             eeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||+|+||+||++..  +++.||+|.+...... ......+..|+.+++.++|+||+++++++......|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999986  4678999998764332 22345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCCCC
Q 010680          306 YDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT  381 (504)
Q Consensus       306 ~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt  381 (504)
                      .+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            9887532   3568999999999999999999999999999999999999999999999999997654432 23345789


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDP  459 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~p~~p~~~~~~l~~Ll~~cl~~dP  459 (504)
                      +.|+|||++.+..++.++||||||+++|+|++|+.||...............  ......+..+++.+.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            9999999999999999999999999999999999999765432211111111  11234566789999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 010680          460 ALRP-----DFSEIIE  470 (504)
Q Consensus       460 ~~RP-----s~~ell~  470 (504)
                      ++||     ++.++++
T Consensus       241 ~~R~~~~~~~~~~~l~  256 (280)
T cd05608         241 EKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHhcCCCCCCHHHHhc
Confidence            9999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-40  Score=326.38  Aligned_cols=246  Identities=33%  Similarity=0.612  Sum_probs=212.9

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      |.+++.||.|+||.||+|..  .++.||+|.+.......       ...+.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56778999999999999986  46789999887653321       2345688999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++.. .+.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999987654221


Q ss_pred             -------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          374 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       374 -------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                             ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+. ....+..+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCHH
Confidence                   1123457889999999998889999999999999999999999999877766554433 35567788889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.++|.+||+.||.+||++.++++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhh
Confidence            999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.9e-41  Score=341.11  Aligned_cols=241  Identities=24%  Similarity=0.425  Sum_probs=208.0

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      +|++.+.||+|+||.||++...  ++.||||+++.... .......+..|+.+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3678899999999999999874  67899999986432 2234466788999998886 477888999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999876 5679999999999999999999999999999999999999999999999999987543322 233


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...|..+++++.+++.+||+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcc
Confidence            4568999999999999999999999999999999999999999988877776665543  35677889999999999999


Q ss_pred             cCCCCCCCH
Q 010680          457 QDPALRPDF  465 (504)
Q Consensus       457 ~dP~~RPs~  465 (504)
                      .+|.+|++.
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05615         238 KHPSKRLGC  246 (323)
T ss_pred             cCHhhCCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-41  Score=328.91  Aligned_cols=247  Identities=34%  Similarity=0.615  Sum_probs=208.3

Q ss_pred             eeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |++++.||+|+||+||++...+  +.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6889999999999999999865  46999999977554444445567999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec-cCCCccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQSGVMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~-~~~~~~~~~~  379 (504)
                      ++++|.+++.. .+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999983 678899999999999999999999999999999999999999999999999999763 3334455678


Q ss_pred             CCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCC--CCCCCCcHHHHHHHHH
Q 010680          380 GTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRP--TIPKNSQPKLAELLER  453 (504)
Q Consensus       380 gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~p--~~p~~~~~~l~~Ll~~  453 (504)
                      ++..|+|||++. +..++.++||||||+++|+|++|..||......   .............  ......++.+.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 888999999999999999999999999987332   2222222211111  1112334899999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||++||++.++++
T Consensus       240 ~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSGGGSTTHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-41  Score=345.59  Aligned_cols=238  Identities=27%  Similarity=0.433  Sum_probs=202.8

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++..  .++.||||+++.... .......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987  467899999975432 2233445556655 57789999999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            999998875 56799999999999999999999999999999999999999999999999999875322 2233455799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ...+...+..+.+++.+||..||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHh
Confidence            99999999999999999999999999999999999999888777666655433  3345578899999999999999999


Q ss_pred             CCCHHH
Q 010680          462 RPDFSE  467 (504)
Q Consensus       462 RPs~~e  467 (504)
                      ||++.+
T Consensus       238 R~~~~~  243 (325)
T cd05604         238 RLGAKE  243 (325)
T ss_pred             cCCCCC
Confidence            998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-40  Score=324.74  Aligned_cols=249  Identities=32%  Similarity=0.591  Sum_probs=208.3

Q ss_pred             eeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee-CCCCceeEEEec
Q 010680          227 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCIVTEFM  300 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~~  300 (504)
                      +.||+|+||.||+|.+.     +..||||.+... ........+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999863     245999987643 23344577889999999999999999999775 455689999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-----cc
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VM  375 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~  375 (504)
                      .+++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......     ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            9999999998766667888889999999999999999999999999999999999999999999997543321     11


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+.... +..+..+..+..+++.+.+++.+|
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHH
Confidence            23345778999999988899999999999999999999 6778887776665444 344455556777899999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      |..+|++||++.++++.|++++.
T Consensus       239 l~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         239 WHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCChhhCCCHHHHHHHHHHHhc
Confidence            99999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-40  Score=333.29  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      |++.+.||+|+||.||++.+.  ++.||||.+...... ......+.+|+.+++.++|+||+.+++.+...+..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999874  678999998764332 23345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      ++|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR  161 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence            99999999986533 35899999999999999999999999999999999999999999999999999765544433445


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      .|+..|+|||++.+..++.++||||||+++|+|++|..||......   ....... .......+..+++++.+|+.+||
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHHh
Confidence            7899999999999999999999999999999999999999865432   2222222 22233456778999999999999


Q ss_pred             hcCCCCCCC-----HHHHHH
Q 010680          456 QQDPALRPD-----FSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs-----~~ell~  470 (504)
                      +.||.+|||     +.++++
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCHHHccCCCCCchHHHHc
Confidence            999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.7e-40  Score=321.72  Aligned_cols=245  Identities=35%  Similarity=0.666  Sum_probs=211.4

Q ss_pred             eeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ++||+|+||.||+|... +..||+|+++... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999864 5679999987653 334456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc--ccCCCCCC
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--TAETGTYR  383 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~gt~~  383 (504)
                      .+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            9999776667899999999999999999999999999999999999999999999999999754332211  12234677


Q ss_pred             ccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       384 y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      |+|||++....++.++||||||+++|+|++ |..||........... .....+...+..++..+.+++.+||+.+|++|
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            999999998889999999999999999998 9999998877665544 34556666778899999999999999999999


Q ss_pred             CCHHHHHHHHH
Q 010680          463 PDFSEIIEILQ  473 (504)
Q Consensus       463 Ps~~ell~~L~  473 (504)
                      |++.++++.|.
T Consensus       239 p~~~~l~~~l~  249 (250)
T cd05085         239 PKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHhc
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6e-41  Score=343.54  Aligned_cols=251  Identities=18%  Similarity=0.323  Sum_probs=211.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||+++..  ++.||+|+++... ........+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999874  5679999987532 22333456888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc--
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM--  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~--  375 (504)
                      ||++||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999999999999876678999999999999999999999999999999999999999999999999999765543322  


Q ss_pred             ccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHH
Q 010680          376 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKL  447 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p---~~~~~~l  447 (504)
                      ....||+.|+|||++.+     ..++.++||||||+++|+|++|+.||...+..+....+.....+..+|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23569999999999875     568899999999999999999999999888877776666544433333   3468999


Q ss_pred             HHHHHHhhhcCCCC--CCCHHHHHHH
Q 010680          448 AELLERCWQQDPAL--RPDFSEIIEI  471 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~--RPs~~ell~~  471 (504)
                      .+++.+|+..++.+  |+++.++++.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcC
Confidence            99999999866544  4578777643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-40  Score=328.29  Aligned_cols=256  Identities=22%  Similarity=0.442  Sum_probs=214.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||++..  .+..||||.+..... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999986  578899998865432 3345578899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+++++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            999999999998642   3468999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .+....+......+..+..+++.+.+++
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence            22345789999999999999999999999999999999999999975433  2222222222222333456888999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+||..||++|||+.+|++.++++.
T Consensus       242 ~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         242 NMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHhcCCCcccCCCHHHHHHHHhhhc
Confidence            9999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=326.02  Aligned_cols=248  Identities=30%  Similarity=0.579  Sum_probs=212.8

Q ss_pred             ceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +|++++.||.|+||.||+|.. .++.+|+|.++.....    ......+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467789999999999999976 5677999998754322    23345688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC----
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----  372 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~----  372 (504)
                      |||++|++|.+++.+ .+.++...+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++......    
T Consensus        81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999976 467899999999999999999999999999999999999999999999999998754221    


Q ss_pred             ---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHH
Q 010680          373 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPKNSQPKLA  448 (504)
Q Consensus       373 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~-~~~p~~p~~~~~~l~  448 (504)
                         .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+........... ...+..+..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence               1223346899999999999999999999999999999999999999887766554443332 445667888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++.+||+.+|.+||++.+++.
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=348.18  Aligned_cols=260  Identities=28%  Similarity=0.561  Sum_probs=223.4

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .-++..+.+.++++||+|.||.|.++...+ ..||||+++.+. ......+|..|+++|.+|+||||++++|+|..++.+
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            346777889999999999999999998876 889999999764 445578999999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhccc-CChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      |+|||||+.|+|.+|+..+.-+ +......+|+.||+.||+||.+.++|||||.++|+|++.++++||+|||++|..-..
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999999999875333 355667789999999999999999999999999999999999999999999854333


Q ss_pred             Cccc---cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHH---hcC---CCCCCCC
Q 010680          373 GVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQAAVGVV---QKG---LRPTIPK  441 (504)
Q Consensus       373 ~~~~---~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~~~~v~---~~~---~~p~~p~  441 (504)
                      ....   ..+-..+|||||.+.-++++.++|+|+||++|||+++  ...||..++..+.....-   ..+   .-+..|.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            2222   2245689999999999999999999999999999875  789999988877655432   211   2345778


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .|+.++.++|.+||..+-.+||+|+++-..|++.
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999888764

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.6e-41  Score=342.73  Aligned_cols=251  Identities=18%  Similarity=0.327  Sum_probs=211.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||.||++...  ++.||+|++..... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999875  56799999865322 2233456888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--c
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~  375 (504)
                      ||+++|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999987667899999999999999999999999999999999999999999999999999975433322  2


Q ss_pred             ccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHH
Q 010680          376 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKL  447 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p---~~~~~~l  447 (504)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....+..+|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2357999999999985     3468899999999999999999999999988888777766544333333   4679999


Q ss_pred             HHHHHHhhhcCCCC--CCCHHHHHHH
Q 010680          448 AELLERCWQQDPAL--RPDFSEIIEI  471 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~--RPs~~ell~~  471 (504)
                      .+|+.+|+..++.+  |+++.++++.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCC
Confidence            99999999665444  6889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-40  Score=335.42  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=206.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|.+.++||+|+||.||+|+..  ++.||+|.++..... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            467999999999999999999874  677999998765322 22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||++ ++|.+++......++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus        84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            9996 58988887766678999999999999999999999999999999999999999999999999997644332 233


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------------  435 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------------------  435 (504)
                      ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...-.                    
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            4568999999999865 5689999999999999999999999987766544333221100                    


Q ss_pred             -CC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 -RP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 -~p-------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                       ..       .....+++++.+||.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             00       011346889999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.9e-40  Score=322.64  Aligned_cols=249  Identities=24%  Similarity=0.453  Sum_probs=218.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||.|+||.||.++.  .++.+++|.+.....+......+.+|+.++++++|+||+++++++...+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999998887765  567899999887665566677889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          300 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      +++++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            9999999999764 3568999999999999999999999999999999999999999999999999998664443 2344


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.... .+..+..++.++.+++.+||+.
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHccc
Confidence            578999999999988889999999999999999999999999887777666655433 3345577899999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 010680          458 DPALRPDFSEIIEI  471 (504)
Q Consensus       458 dP~~RPs~~ell~~  471 (504)
                      +|.+||++.++++.
T Consensus       240 ~p~~R~s~~~ll~~  253 (256)
T cd08221         240 DPEKRPTADEVLDQ  253 (256)
T ss_pred             CcccCCCHHHHhhC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-41  Score=343.30  Aligned_cols=237  Identities=26%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ++||+|+||.||++++.  ++.||+|++..... .......+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  67899999875432 2223344555554 68889999999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            999988875 56789999999999999999999999999999999999999999999999999875322 2233445789


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      +.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  ...++...+..+.+++.+||+.||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999999999999999999999999999999988876666555543  34566788899999999999999999


Q ss_pred             CCCHH
Q 010680          462 RPDFS  466 (504)
Q Consensus       462 RPs~~  466 (504)
                      ||++.
T Consensus       238 R~~~~  242 (321)
T cd05603         238 RLGAK  242 (321)
T ss_pred             cCCCC
Confidence            99764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-40  Score=331.88  Aligned_cols=254  Identities=29%  Similarity=0.557  Sum_probs=209.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECC------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  281 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g------------------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv  281 (504)
                      .++|++.++||+|+||.||++.+.+                  ..||+|+++... .......+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4578999999999999999985432                  358999987542 344457899999999999999999


Q ss_pred             EEEEeeeCCCCceeEEEecCCCchHHHHHhhc----------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010680          282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  351 (504)
Q Consensus       282 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NIL  351 (504)
                      ++++++...+..++||||+++++|.+++....          ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999997632          23677889999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 010680          352 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQA  426 (504)
Q Consensus       352 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~  426 (504)
                      ++.++.++|+|||+++.......   .....++..|+|||...+..++.++|+|||||++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999975433221   112234678999999888889999999999999999998  7899987776655


Q ss_pred             HHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          427 AVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       427 ~~~v~~------~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      ......      .....+.+..+++.+.+++.+||+.||.+||++.+|++.|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            433211      111223456788999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-40  Score=331.18  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=211.8

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~  291 (504)
                      ...|++.++||+|+||.||++++      .+..||+|.++... .......+.+|+.+++.++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            34578899999999999999975      35679999987653 234456799999999999999999999988765  5


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            67899999999999999977556789999999999999999999999999999999999999999999999999976543


Q ss_pred             CCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------------CHHHHHHHHHhc
Q 010680          372 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--------------TPLQAAVGVVQK  433 (504)
Q Consensus       372 ~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~--------------~~~~~~~~v~~~  433 (504)
                      ...    .....++..|+|||.+.+..++.++||||||+++|+|++++.|+...              ............
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321    12345677899999998888999999999999999999987664221              111222233344


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.+.+.+..+++.+.+|+.+||+.||++||++.++++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            455556778899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=324.38  Aligned_cols=248  Identities=32%  Similarity=0.540  Sum_probs=214.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||.|+||.||++...  ++.+++|+++....  .....+.+|+.++++++||||+++++++.....+|++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            57889999999999999999874  57799999986532  245788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|.+++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            999999999998766789999999999999999999999999999999999999999999999999987554332 2344


Q ss_pred             CCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCcHHHHHHH
Q 010680          378 ETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKNSQPKLAELL  451 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~---~p~~~~~~l~~Ll  451 (504)
                      ..++..|+|||.+.+.   .++.++|+||||+++|+|++|..||...++.+...........+.   .+...+.++.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI  240 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence            5788999999999776   899999999999999999999999998887766655544433322   2334578899999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||..+|.+||++.+++.
T Consensus       241 ~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         241 KKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHcCCChhhCCCHHHHhc
Confidence            9999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-40  Score=341.15  Aligned_cols=237  Identities=22%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||++...  ++.||+|+++..... ......+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  577999999865432 33456688899999888 599999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            999998875 46799999999999999999999999999999999999999999999999999975332 2233456799


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL------TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~------~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...      ...+........ ....+|..+++.+.+++.+||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999532      222333333322 233577889999999999999


Q ss_pred             hcCCCCCCCH
Q 010680          456 QQDPALRPDF  465 (504)
Q Consensus       456 ~~dP~~RPs~  465 (504)
                      +.||.+|+++
T Consensus       239 ~~dP~~R~~~  248 (327)
T cd05617         239 NKDPKERLGC  248 (327)
T ss_pred             ccCHHHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.1e-40  Score=321.12  Aligned_cols=248  Identities=27%  Similarity=0.492  Sum_probs=213.9

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-CCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E  298 (504)
                      .|++.+.||+|+||.||++..  .++.||+|.+............+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            378899999999999999987  45789999998765555566778999999999999999999988764 445789999


Q ss_pred             ecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          299 FMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      |+++++|.+++.... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            999999999997643 458999999999999999999999999999999999999999999999999997654322 233


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. .+..+..+...++.+.+++.+||+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence            4568999999999999999999999999999999999999998877665554433 344556677889999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++||++.++++
T Consensus       240 ~~p~~Rp~~~~~l~  253 (257)
T cd08223         240 KRPEKRPSVKSILR  253 (257)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=327.32  Aligned_cols=250  Identities=21%  Similarity=0.398  Sum_probs=222.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|.+.++||+|.|+.||++..  +|+.+|+|++..........+++.+|+.|.+.|+|||||++++.+......|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            36788889999999999999855  6889999999877666666788999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~~~  374 (504)
                      |+|.|+.|..-+-. +..+++..+-.++.||+.+|.|+|.+||||||+||+|+|+-.   ..-+||+|||+|........
T Consensus        90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            99999999877655 366888899999999999999999999999999999999953   34699999999988875445


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLE  452 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~~Ll~  452 (504)
                      .....|||.|||||++...+|+..+|||+-|++||-||.|++||-+.+....+..+++....  ++...+++++.++|++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            56778999999999999999999999999999999999999999998888888888776554  3345789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||..||.+|.|+.|.++
T Consensus       249 rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  249 RMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccChhhhccHHHHhC
Confidence            999999999999999873

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-40  Score=321.75  Aligned_cols=248  Identities=33%  Similarity=0.589  Sum_probs=216.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +|+..+.||+|+||.||+|..  .++.|++|.+.....   ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            366778999999999999987  478899999865432   234567789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      +||+++++|.+++.+ .+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            999999999999976 4568999999999999999999999999999999999999999999999999998665544445


Q ss_pred             cCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          377 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...++..|+|||.+.... ++.++|+||||+++|+|++|..||......+...........+.++..+++.+.+++.+||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567899999999997776 8999999999999999999999998877666665555545566778889999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.+|.+||++.+++.
T Consensus       240 ~~~p~~Rp~~~~~l~  254 (258)
T cd06632         240 QRDPSLRPTAAELLE  254 (258)
T ss_pred             hcCcccCcCHHHHhc
Confidence            999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=344.50  Aligned_cols=249  Identities=24%  Similarity=0.474  Sum_probs=224.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCcee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l  295 (504)
                      ...|++++.||.|.||.||++...  |+.+|+|++++.... ......+.+|+.+|+++. |||||+++++++....+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457899999999999999999874  688999999876543 234567899999999999 9999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEEEEeeccceeccC
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ  371 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~----~~vkL~DFGla~~~~~  371 (504)
                      |||++.||.|.+.+...  .+++..+..++.||+.++.|||+.||+||||||+|+|+...    +.+|++|||++.....
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999775  39999999999999999999999999999999999999643    4799999999998887


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAE  449 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~p~~p~~~~~~l~~  449 (504)
                      .......+||+.|+|||++...+|+..+||||+|+++|.|++|.+||...+.......+....+  ..+....++..+.+
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd  271 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD  271 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence            6677888999999999999999999999999999999999999999999998888877776544  33445678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+|+..||..|+++.++++
T Consensus       272 ~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHhcccCcccCCCHHHHhc
Confidence            999999999999999999987

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-40  Score=327.92  Aligned_cols=248  Identities=26%  Similarity=0.386  Sum_probs=205.8

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||+|+||.||+|+.  +++.||||.++...........+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            478889999999999999987  467899999876544444456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          300 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       300 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ++ ++|.+++....  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            96 68988886543  568999999999999999999999999999999999999999999999999997554322 233


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------------  435 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------------------  435 (504)
                      ...+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+.............                    
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            4567899999998865 4578999999999999999999999987765544433221100                    


Q ss_pred             -------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 -------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 -------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                             .......+++++.++|.+||..||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   00112357889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-40  Score=320.99  Aligned_cols=248  Identities=26%  Similarity=0.464  Sum_probs=217.0

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|.+.+.||.|+||.||++..  .++.+|||.+............+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999876  567899999987665666678899999999999999999999999988999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeeccceeccCCCcccc
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      +++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.+ +.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            99999999997653 358999999999999999999999999999999999999865 4689999999987655444445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... .....++..+++++.+++.+||+.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccC
Confidence            6789999999999988899999999999999999999999988877666555444 334456778899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      +|.+||++.+++.
T Consensus       240 ~p~~Rpt~~~ll~  252 (256)
T cd08220         240 DPSKRPQLSQIMA  252 (256)
T ss_pred             ChhhCCCHHHHhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.2e-40  Score=321.00  Aligned_cols=248  Identities=25%  Similarity=0.468  Sum_probs=215.9

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~  297 (504)
                      +|++.+.||+|+||.||++..  .++.||+|+++...........+.+|+.++++++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999976  46789999998766666667789999999999999999999997753  44578999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH-----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH-----~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ||+++++|.+++...   ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999764   467899999999999999999999     899999999999999999999999999999876


Q ss_pred             cCCCc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          370 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       370 ~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..... ..+..+..+.++...+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-HHHhcCCCCCCccccCHHHH
Confidence            55433 34457899999999999888999999999999999999999999987754444 34455555667888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhh
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-41  Score=332.18  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=214.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCC-----
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP-----  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~-----  291 (504)
                      ...|...++||+|+||+||+|..  +|+.||+|.++.+...+.......+|+.+|+.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45678888999999999999976  5788999999876544444556789999999999999 999999998776     


Q ss_pred             -CceeEEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          292 -SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       292 -~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                       .+++|+||+ ..+|.+++....   ..++...+..++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             789999999 679999998765   357888999999999999999999999999999999999999999999999999


Q ss_pred             eccCC-CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 010680          368 VKAQS-GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------  438 (504)
Q Consensus       368 ~~~~~-~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-------  438 (504)
                      ....+ ...+.+++|..|+|||++.+. .|+...||||+||+++||+++++-|.+.+..+....+.+.-..|.       
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            77644 347788999999999999776 799999999999999999999999999988877776654321110       


Q ss_pred             ---------C-----C-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          439 ---------I-----P-------KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       439 ---------~-----p-------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                               +     +       +...+...+++.+||+.+|.+|.|+...+..
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                     1     1       2223578899999999999999999998764

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-40  Score=346.88  Aligned_cols=243  Identities=25%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +....|++.++||+|+||.||++.+  +++.||||....        ..+.+|+.+|++++||||+++++++......|+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4456799999999999999999987  467899997542        346789999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC--C
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~  373 (504)
                      |+|++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            99999 5789988876 467899999999999999999999999999999999999999999999999999753322  2


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH---------------
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVV---------------  431 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-------~~~~~~v~---------------  431 (504)
                      ......||+.|+|||++.+..|+.++|||||||++|||++|..||.....       ......+.               
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            23345799999999999999999999999999999999999987743210       01111110               


Q ss_pred             -----------hcCC-CCC-CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          432 -----------QKGL-RPT-IP-----KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       432 -----------~~~~-~p~-~p-----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                 .... .+. .+     ..++.++.+||.+||+.||.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                       0000 000 00     134678999999999999999999999984

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=343.72  Aligned_cols=247  Identities=23%  Similarity=0.436  Sum_probs=227.2

Q ss_pred             CceeeeeeeeeeCceEEEEEE--ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~--~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .-|.+.+-||+|-|+.|-+++  ++|..||||++.+...+.-....+.+|++.|+.++|||||++|.+......+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            357777899999999999886  489999999999888877777889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEeeccceeccCCCcccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      +-.+|+|+||+-+....+.+..+.+++.||+.|+.|+|+..+|||||||+||.+. .-|-|||.|||++..+......++
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            9999999999998888999999999999999999999999999999999999875 568999999999998888888889


Q ss_pred             CCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+|+..|-|||++.+..|+ +++||||||++||.|+||++||+..+..+..-.++.=.  -.+|..++.++++||..||.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--YtvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--ccCchhhhHHHHHHHHHHHh
Confidence            9999999999999999998 57899999999999999999999888877776666543  34788999999999999999


Q ss_pred             cCCCCCCCHHHHH
Q 010680          457 QDPALRPDFSEII  469 (504)
Q Consensus       457 ~dP~~RPs~~ell  469 (504)
                      .||.+|.+.++|.
T Consensus       256 RdPkkRAslEeI~  268 (864)
T KOG4717|consen  256 RDPKKRASLEEIV  268 (864)
T ss_pred             cCchhhccHHHHh
Confidence            9999999999986

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.1e-40  Score=323.39  Aligned_cols=245  Identities=30%  Similarity=0.547  Sum_probs=200.1

Q ss_pred             eeeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ++||+|+||.||+|+..    ...+|+|.++... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            36899999999999753    2457888776432 344456788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhhcc----cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---c
Q 010680          303 GSVYDYLHKLKG----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M  375 (504)
Q Consensus       303 gsL~~~l~~~~~----~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~  375 (504)
                      |+|.+++.....    ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999999976432    245778889999999999999999999999999999999999999999999865433221   1


Q ss_pred             ccCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC----CCCCCCCC
Q 010680          376 TAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL----RPTIPKNS  443 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~----~p~~p~~~  443 (504)
                      ....++..|+|||++.       ...++.++|||||||++|||++ |..||....+.+..........    .+..+..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            2234567899999974       3457889999999999999999 8999998887766555544332    23445578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ++.+.+++..|| .||++||++.++++.|.
T Consensus       240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         240 SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            899999999999 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-40  Score=330.66  Aligned_cols=259  Identities=31%  Similarity=0.625  Sum_probs=218.1

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +...+|+..+.||+|+||.||+|.+.  +.    .||+|.++... ......++.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            34567888999999999999999863  43    47889887543 233345788999999999999999999998754 


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++++||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            46799999999999999987666789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..+..+..+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHH
Confidence            221   122345678999999999999999999999999999997 999998776544 344555666666677788999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+++.+||..+|++||++.++++.|.++....
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            99999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-40  Score=319.60  Aligned_cols=245  Identities=35%  Similarity=0.683  Sum_probs=211.4

Q ss_pred             eeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ++||.|+||.||++.+. ++.||+|.++..... .....+.+|+.++++++|+||+++++++......++||||++|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            46899999999999875 788999998865433 4567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc---ccCCCCC
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTY  382 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~  382 (504)
                      .+++......++...+..++.+++.|+.|||+++++||||||+||+++.++.+||+|||+++........   .....+.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9999776667899999999999999999999999999999999999999999999999999755422111   1123356


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      .|+|||.+.+..++.++|+||||+++|+|++ |..||........... .........+..++..+.+++.+||..+|.+
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            7999999998899999999999999999999 8999988876554444 3344455667788999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 010680          462 RPDFSEIIEILQ  473 (504)
Q Consensus       462 RPs~~ell~~L~  473 (504)
                      ||++.++++.|+
T Consensus       239 Rp~~~ell~~l~  250 (251)
T cd05041         239 RPSFSEIYNELQ  250 (251)
T ss_pred             CcCHHHHHHHhh
Confidence            999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.1e-40  Score=327.83  Aligned_cols=248  Identities=28%  Similarity=0.501  Sum_probs=211.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+.|++.++||.|+||.||+|+..  ++.|++|++...  .......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            356899999999999999999874  578999998754  3445677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  376 (504)
                      ||+++++|..++.+....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            999999999988766677999999999999999999999999999999999999999999999999998654332 2233


Q ss_pred             cCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHH
Q 010680          377 AETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAE  449 (504)
Q Consensus       377 ~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~~  449 (504)
                      ...+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...++......... ...+  ..+..++.++.+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSMEFRD  247 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCccCCCCcccCHHHHH
Confidence            456889999999984     44578899999999999999999999988777665544432 2222  235577889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+||+.||++||++.++++
T Consensus       248 li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         248 FLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHhcCCcccCcCHHHHhc
Confidence            999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.9e-40  Score=324.82  Aligned_cols=247  Identities=32%  Similarity=0.540  Sum_probs=207.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCC------C
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP------P  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~------~  291 (504)
                      ..|++.+.||.|+||.||+|..  .++.||+|+++...   .....+.+|+.+++.+ +|+||+++++++...      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4577788999999999999987  46789999987542   2235678899999998 699999999988653      3


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+|++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            5789999999999999997643 468999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-CccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          371 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       371 ~~-~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .. .......|++.|+|||++.     +..|+.++|||||||++|+|++|..||....+............+...+..++
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence            32 2334557899999999985     34688999999999999999999999988777666655544444444556788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .++.+|+.+||..||.+||++.++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            99999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-39  Score=321.53  Aligned_cols=248  Identities=29%  Similarity=0.525  Sum_probs=211.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  293 (504)
                      .+|++.+.||+|+||.||+|..  ++..||||.+.....   .......+.+|+.++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788899999999999999986  467899999864322   223456788999999999999999999988653  457


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  372 (504)
                      +++|||++|++|.+++.. .+.+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            899999999999999876 456888999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                         .......++..|+|||++.+..++.++||||||+++|+|++|+.||..................+..|...+..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               12334568899999999988889999999999999999999999998877766665555555566677788889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+||. +|.+||++.+++.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhc
Confidence            9999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-40  Score=326.10  Aligned_cols=255  Identities=31%  Similarity=0.618  Sum_probs=215.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~  291 (504)
                      ..+|++.+.||+|+||.||++.+.      +..||||+++..... .....|.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            356788899999999999999864      467999999866443 356789999999999999999999999877  55


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..+++|||+++++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            78999999999999999987666799999999999999999999999999999999999999999999999999986653


Q ss_pred             CCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhc
Q 010680          372 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQK  433 (504)
Q Consensus       372 ~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--------------~~~~~~v~~~  433 (504)
                      ...    .....++..|+|||.+....++.++||||||+++|||++|..|+.....              .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221    1123456679999999888999999999999999999999999865322              1222333444


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ..+...+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            455555677889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-40  Score=325.20  Aligned_cols=248  Identities=29%  Similarity=0.499  Sum_probs=208.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|..  .++.||+|+++...  ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            35788899999999999999987  46789999987653  223456788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999876 5679999999999999999999999999999999999999999999999999987554322 233


Q ss_pred             cCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHHHHH
Q 010680          377 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKLAEL  450 (504)
Q Consensus       377 ~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p---~~~~~~l~~L  450 (504)
                      ...|++.|+|||++.   ...++.++|+|||||++|+|++|..||....+.............+...   ..++..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            457899999999984   4568899999999999999999999997766555444433333322211   2467889999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      +.+||..+|++||++.++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            99999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-39  Score=322.93  Aligned_cols=245  Identities=27%  Similarity=0.502  Sum_probs=198.8

Q ss_pred             eeeeeeCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||+|+||.||+|.+.+    ..+|+|.++.... ......+.+|+.+++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            368999999999998643    4589998876543 23345788999999999999999999999998999999999999


Q ss_pred             CchHHHHHhhc----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---c
Q 010680          303 GSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M  375 (504)
Q Consensus       303 gsL~~~l~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~  375 (504)
                      ++|.+++....    ...++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999997532    2356677889999999999999999999999999999999999999999999975433221   1


Q ss_pred             ccCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC----CCCCCCCCC
Q 010680          376 TAETGTYRWMAPEVIEHK-------PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG----LRPTIPKNS  443 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~----~~p~~p~~~  443 (504)
                      ....++..|+|||++.+.       .++.++|+||||+++|||++ |..||....+.+.........    ..+.+....
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            234567889999998642       36789999999999999996 999998877766543332221    123333456


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ++.+.+++.+|| .+|++|||+.+|+..|+
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            788999999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=327.50  Aligned_cols=247  Identities=30%  Similarity=0.524  Sum_probs=212.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||.|+||.||++.+.  +..||+|+++..  .......+.+|+.++++++||||+++++.+..+...|+|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            46888999999999999999874  678999998754  34445778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~  377 (504)
                      |+++++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... .....
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            99999999999876678999999999999999999999999999999999999999999999999988654332 22334


Q ss_pred             CCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHH
Q 010680          378 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAEL  450 (504)
Q Consensus       378 ~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~~L  450 (504)
                      ..+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...++.+....+. ....+  ..+..++.++.++
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-cCCCCCcCCcccCCHHHHHH
Confidence            56899999999974     4557889999999999999999999999888766655543 33222  2355788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      +.+||+.+|.+||++.++++
T Consensus       242 i~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHhccChhhCcCHHHHhc
Confidence            99999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=363.17  Aligned_cols=263  Identities=32%  Similarity=0.682  Sum_probs=235.3

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI  284 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~  284 (504)
                      .|+++.+.+++.+.||+|.||.|++|...         ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            89999999999999999999999999753         245999999977655 66788999999999996 99999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      |+|+..+.+++|+||+..|+|.++|+..+               ..++...++.++.||+.||+||+++++|||||.++|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999999999999999999999998866               348899999999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCCccc--cCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSGVMT--AETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~~~~--~~~g--t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      ||++++..+||+|||+|+.........  ...|  ...|||||.+....|+.++||||||++|||+++ |..||.+....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            999999999999999999655443332  2222  456999999999999999999999999999999 99999997744


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ......++.+.+...|..|+++++++|..||+.+|++||+|.++.+.|...+.+
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            445668899999999999999999999999999999999999999999997654

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-39  Score=318.40  Aligned_cols=248  Identities=41%  Similarity=0.761  Sum_probs=214.4

Q ss_pred             eeeeeeeeeeCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          223 LKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.+.+.||.|+||.||++.+..      ..||+|+++.... ......+.+|+.+++.++|+||+++++.+...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567899999999999998864      7799999976533 22567899999999999999999999999998999999


Q ss_pred             EEecCCCchHHHHHhhccc-CChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          297 TEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |||+++++|.+++...... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999999765444 999999999999999999999999999999999999999999999999999766544222


Q ss_pred             c--cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          376 T--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       376 ~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                      .  ...+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+. ....+..+..++.++.+++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence            2  2336789999999988889999999999999999998 899998877766655543 44556667779999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~~L  472 (504)
                      +||..||++|||+.++++.|
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      239 QCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHCcCChhhCcCHHHHHhhC
Confidence            99999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.9e-40  Score=323.51  Aligned_cols=254  Identities=27%  Similarity=0.544  Sum_probs=215.2

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ..++|++.+.||+|+||.||+|+..       .+.|++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3467889999999999999999863       3569999886542 2234677999999999999999999999999989


Q ss_pred             CceeEEEecCCCchHHHHHhhc--------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      ..|+||||+++++|.+++....        ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997643        15899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 010680          364 GVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIP  440 (504)
Q Consensus       364 Gla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p  440 (504)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....................+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9986443221  2223356778999999988889999999999999999998 899998877766655554444444456


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      ..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-39  Score=318.93  Aligned_cols=248  Identities=24%  Similarity=0.481  Sum_probs=217.0

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||+|+||.||+++.  .++.||+|.++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999976  467899999886555555567899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-ccc
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~  377 (504)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999999997643 3578999999999999999999999999999999999999999999999999976544322 223


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. .+..+..+..++.++.+++.+||+.
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence            468889999999999899999999999999999999999998877766665554 3445567788899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      +|.+||++.++++
T Consensus       240 ~p~~Rp~~~~vl~  252 (256)
T cd08218         240 NPRDRPSVNSILE  252 (256)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.2e-40  Score=320.55  Aligned_cols=247  Identities=32%  Similarity=0.545  Sum_probs=213.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|...  ++.|++|.++...    ....+.+|+.++++++||||+++++.+.....+|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            357888999999999999999875  5789999987542    1578999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||+++++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            9999999999998767789999999999999999999999999999999999999999999999999987654432 233


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||....+.+....+.... .....+..++.++.+++.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            4468899999999999999999999999999999999999998877765544332211 111234467789999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.||++||++.++++
T Consensus       238 ~~~P~~Rps~~~il~  252 (256)
T cd06612         238 VKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.3e-40  Score=334.82  Aligned_cols=251  Identities=22%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             eeeeeeee--CceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          225 FGSKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       225 i~~~LG~G--~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      +.++||+|  +||+||++..  +++.||||.++...........+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7889999976  4688999999876555555667888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC------
Q 010680          301 SGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------  373 (504)
Q Consensus       301 ~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~------  373 (504)
                      ++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+......+      
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            999999999754 3458999999999999999999999999999999999999999999999998654322111      


Q ss_pred             --ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 010680          374 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------  436 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------------  436 (504)
                        ......++..|+|||++.+  ..|+.++|||||||++|||++|..||......+...........             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              1122356788999999976  46899999999999999999999999876654433332211100             


Q ss_pred             -------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 010680          437 -------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       437 -------------------------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l  475 (504)
                                                     ......+++.+.+|+.+||+.||++|||+.++++  .++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                           0011235678999999999999999999999986  35443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-39  Score=322.03  Aligned_cols=248  Identities=29%  Similarity=0.505  Sum_probs=211.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~  293 (504)
                      .+|+..+.||+|+||.||++..  .+..||+|+++.....   ......+.+|+.+++.++||||+++++.+..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4678889999999999999986  4678999998754322   2345678899999999999999999998765  3567


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  372 (504)
                      ++++||+++++|.+++.. .+.++....+.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++..... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            899999999999999976 456899999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                         .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+...........+.++..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence               11223468899999999999999999999999999999999999998887776666655555667778888999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++ +||..+|++||++.+++.
T Consensus       241 li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhc
Confidence            99 688899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.9e-41  Score=332.34  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=206.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--C---Cce
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P---SLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~---~~~  294 (504)
                      .|.-.+++|+|+||.||+|...  ++.||||..-.+..      .-.+|+.+|+.+.|||||+++.++...  .   .+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            3666789999999999999874  57899998765532      224699999999999999999887432  2   356


Q ss_pred             eEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~~~  370 (504)
                      +|||||+ .+|+++++..   +..++.-.+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            8999995 5999999743   5678888999999999999999999999999999999999965 999999999999988


Q ss_pred             CCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 010680          371 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------  437 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------------  437 (504)
                      .........-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+.+..+++--..|            
T Consensus       178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            8777778888999999999865 579999999999999999999999999988877766655311111            


Q ss_pred             ---------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 010680          438 ---------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIA  476 (504)
Q Consensus       438 ---------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l~  476 (504)
                                     -.....+++..+|+.++|..+|.+|.++.|++.  .++.+.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                           133567899999999999999999999999873  344443

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.3e-40  Score=323.09  Aligned_cols=238  Identities=27%  Similarity=0.503  Sum_probs=196.5

Q ss_pred             eeeeeeCceEEEEEEECC--------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          227 SKVASGSYGDLYRGTYCS--------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g--------------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      +.||+|+||.||+|+...              ..|++|++...  .......|.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999998532              24888887654  23445678899999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-------EEEEeecc
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-------VKVADFGV  365 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~-------vkL~DFGl  365 (504)
                      .++||||+++++|..++....+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.       ++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999998776677999999999999999999999999999999999999987664       89999999


Q ss_pred             ceeccCCCccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          366 ARVKAQSGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       366 a~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      +.....   .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+... ......  ......
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--~~~~~~  232 (262)
T cd05077         159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--MLVTPS  232 (262)
T ss_pred             CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--cCCCCC
Confidence            864432   23446788999999986 567899999999999999998 5999998765544322 222211  223345


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      ++++.+|+.+||+.||.+||++.+|++.|
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            67899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-39  Score=323.93  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=206.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|...  ++.||+|++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888999999999999999874  6789999987554333344668899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            9999888877654 4578999999999999999999999999999999999999999999999999998665433 2334


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------------C-C
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------L-R  436 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-------------------~-~  436 (504)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+....                   . .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            567889999999865 568899999999999999999999998877655443322100                   0 0


Q ss_pred             CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p~---------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.         .....+..+.+|+.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00         01245788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.1e-40  Score=367.76  Aligned_cols=253  Identities=22%  Similarity=0.428  Sum_probs=212.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~  292 (504)
                      +....+|++.++||+|+||+||++++.  +..||+|+++...........|.+|+.+|++++|||||++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445568999999999999999999874  5679999998766666667889999999999999999999998754  356


Q ss_pred             ceeEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEECC--------
Q 010680          293 LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-------NIIHRDLKAANLLMDE--------  354 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~-------~IiHrDLkp~NILl~~--------  354 (504)
                      +||||||+++++|.++|...   .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999753   35799999999999999999999994       4999999999999964        


Q ss_pred             ---------CCcEEEEeeccceeccCCCccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 010680          355 ---------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP  423 (504)
Q Consensus       355 ---------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~  423 (504)
                               .+.+||+|||++.............||+.|+|||++.+  ..++.++||||||||||+|++|..||.....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                     23599999999987655444455679999999999854  4589999999999999999999999987766


Q ss_pred             HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       424 ~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .......+....... ....++++.+||.+||..+|.+||++.|++.
T Consensus       249 ~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        249 FSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            555555444432221 2456899999999999999999999999984

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-39  Score=324.13  Aligned_cols=242  Identities=29%  Similarity=0.507  Sum_probs=202.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||+|+||.||+|.+  .++.||+|++.... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            578889999999999999986  56789999987543 344456799999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  379 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  379 (504)
                      +++++|..+     ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ......
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence            999998654     34688889999999999999999999999999999999999999999999999765432 334567


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCC-CCCCcHHHHHHH
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVVQKGLRPTI-PKNSQPKLAELL  451 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-------~~~~~~v~~~~~~p~~-p~~~~~~l~~Ll  451 (504)
                      ||..|+|||++.+..++.++|+||||+++|+|++|..||.....       ......+.. ...+.. ....++++.+++
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCCCCCCCCcCCHHHHHHH
Confidence            89999999999999999999999999999999999999965322       122222121 122222 345788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~  471 (504)
                      .+||+.+|.+||++.++++.
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcC
Confidence            99999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-39  Score=324.49  Aligned_cols=246  Identities=28%  Similarity=0.504  Sum_probs=209.2

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |++.++||.|+||.||+|.+.  +..+++|.+...  .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            577889999999999999885  466888888643  3344577889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~  379 (504)
                      ++++|..++......+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .......
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI  164 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence            999999988765678999999999999999999999999999999999999999999999999998654332 1233456


Q ss_pred             CCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHH
Q 010680          380 GTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       380 gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ++..|+|||++.     +..++.++|+|||||++|+|++|.+||...++.+......... .....+..++.++.++|.+
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK  244 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence            899999999983     4567889999999999999999999999888776655544322 1223456788999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+||++.++++
T Consensus       245 ~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         245 CLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.6e-40  Score=326.05  Aligned_cols=237  Identities=27%  Similarity=0.482  Sum_probs=196.7

Q ss_pred             eeeeeCceEEEEEEECC--------------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 010680          228 KVASGSYGDLYRGTYCS--------------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV  281 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g--------------------------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv  281 (504)
                      .||+|+||.||+|....                          ..||+|++...  .......|.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            68999999999997421                          23888988654  233456788999999999999999


Q ss_pred             EEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-----
Q 010680          282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----  356 (504)
Q Consensus       282 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-----  356 (504)
                      ++++++...+..++||||+++++|..++....+.+++..+..++.||++||+|||+++|+||||||+|||++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999977677899999999999999999999999999999999999997643     


Q ss_pred             --cEEEEeeccceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Q 010680          357 --VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 --~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~~~~~v~~  432 (504)
                        .+|++|||++.....   .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+... ...
T Consensus       160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE  235 (274)
T ss_pred             cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence              489999998854322   223457888999998865 56899999999999999995 6999998876655432 222


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      ..  ...+...++.+.++|.+||+.+|++||++.++++.|
T Consensus       236 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         236 KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22  234455667899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-39  Score=326.06  Aligned_cols=244  Identities=27%  Similarity=0.461  Sum_probs=213.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|.+.+.||+|+||.||++.+  .++.||+|+++.... .......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3688999999999999999987  468899999875433 2334567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+++++|.+++.. .+.++...+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            99999999999977 467999999999999999999999999999999999999999999999999999765543  334


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.  ...+.++...++.+.+++.+||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccC
Confidence            578999999999988889999999999999999999999998877655555444  234567778899999999999999


Q ss_pred             CCCCCC-----CHHHHH
Q 010680          458 DPALRP-----DFSEII  469 (504)
Q Consensus       458 dP~~RP-----s~~ell  469 (504)
                      ||.+||     ++.+++
T Consensus       236 ~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         236 DLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CHHHccCcccCCHHHHH
Confidence            999998     667765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-39  Score=318.69  Aligned_cols=248  Identities=30%  Similarity=0.544  Sum_probs=211.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||+|+||.||+|..  .++.|++|+++...........+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            478889999999999999986  467899999987655555678899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc----
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----  375 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~----  375 (504)
                      +++++|.+++.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.........    
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999976 456889999999999999999999999999999999999999999999999999765443221    


Q ss_pred             -ccCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHH
Q 010680          376 -TAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAE  449 (504)
Q Consensus       376 -~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~--~~~l~~  449 (504)
                       ....++..|+|||++.+..   ++.++||||||+++|+|++|..||..................+.+|...  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1346789999999998766   8899999999999999999999997664333222223334455555544  899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+||+.+|.+||++.+++.
T Consensus       240 li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhc
Confidence            999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=322.78  Aligned_cols=246  Identities=33%  Similarity=0.554  Sum_probs=213.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||.|+||.||+|..  .++.||+|++.... .......+.+|+.+++.++|+||+++++++..+..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3578889999999999999987  46789999987653 23345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~  377 (504)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++..... .....
T Consensus        80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            9999999999976  37899999999999999999999999999999999999999999999999999876544 23345


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN-SQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~-~~~~l~~Ll~~cl~  456 (504)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|..||...++...... ......+..+.. +++++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            5788999999999988899999999999999999999999988776655443 333445555555 88999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|++||++.++++
T Consensus       237 ~~p~~Rpt~~~il~  250 (274)
T cd06609         237 KDPKERPSAKELLK  250 (274)
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-40  Score=337.74  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=204.6

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--  290 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--  290 (504)
                      .|++ .++|++.+.||+|+||.||+|..  .++.||||+++...........+.+|+.+|++++||||+++++++...  
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            4444 36799999999999999999976  457799999986544434456678999999999999999999887543  


Q ss_pred             ----CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          291 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       291 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                          ...|+++|++ +++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                3468999998 8899888753  56999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------  435 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------  435 (504)
                      +....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....          
T Consensus       166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            86543  2345678999999999876 5789999999999999999999999987665544433321100          


Q ss_pred             -----------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 -----------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 -----------~p~~--------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                 .+..        ....++.+.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       0011        1235677899999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-40  Score=326.88  Aligned_cols=248  Identities=22%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||+|+||.||+|++  +|+.||+|.++...........+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478889999999999999988  478899999976544444446678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~  378 (504)
                      ++ ++|.+++....+.+++..+..++.||++||.|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            95 5888888766678999999999999999999999999999999999999999999999999999754432 223345


Q ss_pred             CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhc------------------CCCC-
Q 010680          379 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQK------------------GLRP-  437 (504)
Q Consensus       379 ~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf-~~~~~~~~~~~v~~~------------------~~~p-  437 (504)
                      .++..|+|||++.+. .++.++|||||||++|+|++|..|| ...+.......+...                  ...+ 
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM  239 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence            678999999998664 4799999999999999999988885 433333222221110                  0000 


Q ss_pred             --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              .....+++++.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                    112356789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-39  Score=319.52  Aligned_cols=236  Identities=26%  Similarity=0.499  Sum_probs=196.7

Q ss_pred             eeeeeeCceEEEEEEECCcc------------EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          227 SKVASGSYGDLYRGTYCSQD------------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~------------VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +.||+|+||.||+|.+.+..            |++|+++.....   ...+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999886433            778877654321   5778999999999999999999999888 7789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-------cEEEEeeccce
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-------VVKVADFGVAR  367 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-------~vkL~DFGla~  367 (504)
                      +||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999999987555789999999999999999999999999999999999999887       79999999997


Q ss_pred             eccCCCccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      ....   .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...+......... ..  ...+....
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~--~~~~~~~~  230 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ--HRLPMPDC  230 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC--CCCCCCCc
Confidence            6543   2234567789999999776  78999999999999999999 688998776443332222 22  12223334


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      ..+.+++.+||..+|.+||++.++++.|
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            8899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-39  Score=320.44  Aligned_cols=251  Identities=24%  Similarity=0.477  Sum_probs=214.2

Q ss_pred             eeeeeeeeeeCceEEEEEEECC---ccEEEEEecCCC--------CChHHHHHHHHHHHHHHh-cCCCCceEEEEeeeCC
Q 010680          223 LKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPER--------INSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKP  290 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g---~~VAvK~lk~~~--------~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~  290 (504)
                      |++.+.||+|+||.||+|...+   +.+|+|.++...        .......++.+|+.++.+ ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            6778899999999999998754   679999886432        123345667889988875 7999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      +..+++|||++|++|.+++..   ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            999999999999999998854   24568999999999999999999996 68999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      .............|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+......+.....++++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED  241 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHH
Confidence            87665544456678999999999999889999999999999999999999998877766666655544444344477899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      +.+++.+||+.||++||++.|+.+.+.
T Consensus       242 l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         242 VTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            999999999999999999999988775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-39  Score=326.91  Aligned_cols=246  Identities=27%  Similarity=0.503  Sum_probs=210.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|++.++||+|+||.||+|..  .++.||+|.+......  ....+.+|+.+++.++||||+++++.+......|+|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            5788899999999999999986  4678999998765433  24668899999999999999999999998899999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++|++|.+++..  ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            9999999999864  468899999999999999999999999999999999999999999999999987543322 2234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..+++.|+|||.+.+..++.++|||||||++|+|++|+.||...++............ ....+..+++.+.+++.+||.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence            5789999999999998899999999999999999999999988777554443332221 122355678899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++||++.++++
T Consensus       256 ~~p~~Rpt~~eil~  269 (296)
T cd06654         256 MDVEKRGSAKELLQ  269 (296)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2e-39  Score=326.72  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=206.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|.+.++||.|+||.||+|.+.  ++.||+|.++..... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            457999999999999999999874  678999998754322 22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||++ ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            9996 69999998766778999999999999999999999999999999999999999999999999997544322 233


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------------  435 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------------------  435 (504)
                      ...+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+..+....+...-.                    
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            4567899999999865 4588999999999999999999999988776544332221100                    


Q ss_pred             CC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 RP--------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ~p--------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+        .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00        011356888999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-39  Score=319.45  Aligned_cols=252  Identities=30%  Similarity=0.565  Sum_probs=210.5

Q ss_pred             eeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------
Q 010680          223 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  291 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------  291 (504)
                      |++.+.||+|+||.||+|.+.     ++.||||+++.........+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            466789999999999999753     467999999877666666778999999999999999999999875432      


Q ss_pred             CceeEEEecCCCchHHHHHhhc-----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      ..++++||+.+++|.+++....     ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            2368899999999998875321     24788899999999999999999999999999999999999999999999999


Q ss_pred             eeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010680          367 RVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN  442 (504)
Q Consensus       367 ~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~  442 (504)
                      +......   ......+++.|++||.+....++.++||||||+++|+|++ |.+||...+..+....+. .......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  239 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD  239 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence            7654322   1123345678999999999999999999999999999999 999998877655444333 3334445567


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +++.+.+++.+||+.+|++||++.++++.|+++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-39  Score=345.86  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=196.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC------CCceEEEEeee
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACT  288 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~~  288 (504)
                      ++...+|++.++||+|+||.||+|.+  .++.||||+++...   .....+..|+.+++.++|      .+++++++++.
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            44567899999999999999999987  46779999997431   223455668888877765      45888888886


Q ss_pred             CC-CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC----------
Q 010680          289 KP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE----------  356 (504)
Q Consensus       289 ~~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~----------  356 (504)
                      .+ ..+|+|||++ |++|.+++.+ .+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++          
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            54 5689999998 8899998876 4679999999999999999999998 5999999999999998765          


Q ss_pred             ------cEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 010680          357 ------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV  430 (504)
Q Consensus       357 ------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v  430 (504)
                            .+||+|||.+....  ...+..+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+....+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                  49999999885432  2344568999999999999999999999999999999999999999887765433322


Q ss_pred             HhcC-------------------------CCCCCC---------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          431 VQKG-------------------------LRPTIP---------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       431 ~~~~-------------------------~~p~~p---------------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ....                         +++...               ....+.+.+||.+||+.||.+|||+.|+++
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            1110                         000000               012356789999999999999999999986

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-39  Score=322.54  Aligned_cols=247  Identities=31%  Similarity=0.536  Sum_probs=203.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||||.++....... ...+..|+.+ ++.++||||+++++++..++..|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            36888999999999999999874  78899999986543333 3445556654 67778999999999999999999999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ||++ ++|.+++...   ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9995 6888887642   34689999999999999999999997 99999999999999999999999999998655443


Q ss_pred             ccccCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCC-CCCcHHH
Q 010680          374 VMTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIP-KNSQPKL  447 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-~~~~~~~~v~~~~~~p~~p-~~~~~~l  447 (504)
                      ..+...++..|+|||.+.+    ..++.++|+||||+++|+|++|..||... ...+....... ...+.++ ..++.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  237 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEF  237 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHH
Confidence            4444578999999998854    55789999999999999999999999753 33344434333 3334443 4578999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++.+||..+|.+||++.++++
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-39  Score=321.61  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=210.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||.|+||.||+|++  .++.||+|++............+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478899999999999999987  468899999987655455567899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--cccc
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~  377 (504)
                      + +++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 999999998766789999999999999999999999999999999999999999999999999998665433  2334


Q ss_pred             CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 010680          378 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------------  437 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-------------------  437 (504)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+.......+......+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            5789999999998654 46899999999999999999999998776654443333211110                   


Q ss_pred             ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ---------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                               ......+..+.+++.+||+.||++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     011345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4e-39  Score=318.31  Aligned_cols=252  Identities=29%  Similarity=0.492  Sum_probs=207.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +++.+.+.....||+|+||.||+|++.  +..||+|.++..  .....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            344445555568999999999999864  467999988754  2334567899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccC--ChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ  371 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l--~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~  371 (504)
                      +|+||+++++|.+++......+  +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999999998654555  78888999999999999999999999999999999986 67999999999875433


Q ss_pred             CC-ccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SG-VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~-~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      .. ......+++.|+|||.+...  .++.++|+||||+++|+|++|..||........ ..........+.++..+++++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA  241 (268)
T ss_pred             CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence            22 23345689999999998654  388999999999999999999999976543222 222222234466788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++.+||+.+|.+||++.+++.
T Consensus       242 ~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         242 KNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHh
Confidence            99999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-39  Score=321.24  Aligned_cols=246  Identities=38%  Similarity=0.681  Sum_probs=207.6

Q ss_pred             eeeeeeCceEEEEEEECC--------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          227 SKVASGSYGDLYRGTYCS--------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g--------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.||+|+||.||+|+...        +.+|||.+..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998643        5699998865422 2345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhh------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-----cEEEEeeccce
Q 010680          299 FMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKVADFGVAR  367 (504)
Q Consensus       299 ~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-----~vkL~DFGla~  367 (504)
                      |+++++|.+++...      ...+++..+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999753      23478899999999999999999999999999999999999877     89999999987


Q ss_pred             eccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          368 VKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       368 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+ ..+.++..+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENC  238 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccc
Confidence            5433211   122345788999999998899999999999999999998 99999887776654443 344455667788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      +..+.+++.+||..+|.+||++.++++.|++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            9999999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-39  Score=327.49  Aligned_cols=248  Identities=24%  Similarity=0.424  Sum_probs=206.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||++.+.  +..+|+|.++... .......+.+|+.++++++||||+++++.+..++.+|+|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            36889999999999999999874  5679999987542 34455678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      |++|++|.+++.+ .+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...... ....
T Consensus        80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            9999999999976 4678999999999999999999998 59999999999999999999999999998754332 2334


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------------
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--------------------------  431 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--------------------------  431 (504)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..||...+.........                          
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            578999999999988889999999999999999999999997554322221110                          


Q ss_pred             ---------hcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          432 ---------QKGLRPTIPK-NSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       432 ---------~~~~~p~~p~-~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                               .....+..|. .+++++++++.+||..||++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0111122222 367889999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=338.79  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=198.1

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc---CCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ||+|+||+||+|...  ++.||||++..... .......+..|..++...   +||||+++++.+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874  68899999865322 222334556677777665   699999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            999999876 577999999999999999999999999999999999999999999999999998753322 233456799


Q ss_pred             CCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 010680          382 YRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA  460 (504)
Q Consensus       382 ~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~  460 (504)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....+. ....+++++.+++.+||+.||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHH
Confidence            999999998654 58999999999999999999999998887766655544333221 2235789999999999999999


Q ss_pred             CCCC----HHHHHH
Q 010680          461 LRPD----FSEIIE  470 (504)
Q Consensus       461 ~RPs----~~ell~  470 (504)
                      +||+    +.++++
T Consensus       239 ~R~~~~~~~~~ll~  252 (330)
T cd05586         239 HRLGAHRDAVELKE  252 (330)
T ss_pred             HCCCCCCCHHHHhc
Confidence            9984    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.7e-40  Score=321.49  Aligned_cols=246  Identities=30%  Similarity=0.521  Sum_probs=210.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||+|+||.||++...  ++.||+|.+..... ......+.+|+.+++.++||||+++++.+.....+++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            5778899999999999999885  67899999876533 34567789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      +++++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~  159 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF  159 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence            99999999998765789999999999999999999999 99999999999999999999999999998655432222 26


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHH
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIPKN-SQPKLAELLE  452 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~p~~p~~-~~~~l~~Ll~  452 (504)
                      .++..|+|||.+.+..++.++||||||+++|+|++|..||...     ...+..... .....+..+.. +++++.++|.
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHHHHHHH
Confidence            7889999999999999999999999999999999999999754     222332222 23334445554 8899999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||..||++||++.+++.
T Consensus       239 ~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         239 LCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHcCCCchhCcCHHHHhh
Confidence            999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-39  Score=324.11  Aligned_cols=248  Identities=26%  Similarity=0.465  Sum_probs=209.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||++.+.  +..||+|.++... .......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            36888999999999999999885  7889999987542 33445778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhh--cccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |++|++|..++...  ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999999988753  2378999999999999999999997 59999999999999999999999999998755332 23


Q ss_pred             ccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcCCCCCCCCCCcHHH
Q 010680          376 TAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG--VVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~--v~~~~~~p~~p~~~~~~l  447 (504)
                      ....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||...........  ....+..+.++..+++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            345688899999998543      358899999999999999999999976554332221  122344556777899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .++|.+||+.+|++||++.+++.
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhc
Confidence            99999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-39  Score=317.36  Aligned_cols=248  Identities=34%  Similarity=0.569  Sum_probs=212.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||.|+||+||+|..  .+..+|+|++....... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            3688999999999999999986  46789999987654444 56789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhh--cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--
Q 010680          299 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  374 (504)
Q Consensus       299 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--  374 (504)
                      ++++++|.+++...  ...+++..+..++.||+.||.|||++||+||||+|+||++++++.++|+|||++........  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764  24689999999999999999999999999999999999999999999999999875544322  


Q ss_pred             ---cccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----CCCcH
Q 010680          375 ---MTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-----KNSQP  445 (504)
Q Consensus       375 ---~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p-----~~~~~  445 (504)
                         .....|+..|+|||++... .++.++|+||||+++|+|++|..||...++.+.......... +..+     ..+++
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKKYSK  238 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCccccccccH
Confidence               1334689999999998776 789999999999999999999999998877666655544321 1122     25678


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+.+++.+||..||++||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhh
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=351.19  Aligned_cols=241  Identities=30%  Similarity=0.553  Sum_probs=211.7

Q ss_pred             eeeeeCceEEEEEEECCcc--EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          228 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g~~--VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      +||+|.||+||-|++....  .|||-+...  ++...+-+..||.+.++|+|.|||+++|.+..++.+-|.||.++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            6999999999999987654  677776543  344456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccC--ChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEeeccceeccCC-CccccCCCC
Q 010680          306 YDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQS-GVMTAETGT  381 (504)
Q Consensus       306 ~~~l~~~~~~l--~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~-~~~~~~~gt  381 (504)
                      .++|+..-|++  .+.++..+.+||++||.|||.+.|||||||-+||||+ ..|.+||+|||.++....- ....+.+||
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            99999888888  7888999999999999999999999999999999996 5799999999999765544 345678999


Q ss_pred             CCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          382 YRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       382 ~~y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      ..|||||++..+  .|+.++|||||||++.||.||++||..+...+++ ..+-.-...|++|..++.+.+.+|.+|+.+|
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd  819 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD  819 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence            999999999654  6999999999999999999999999877655554 4444455678999999999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 010680          459 PALRPDFSEIIE  470 (504)
Q Consensus       459 P~~RPs~~ell~  470 (504)
                      |.+||++.+++.
T Consensus       820 ~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  820 PCDRPSAKDLLQ  831 (1226)
T ss_pred             cccCccHHHhcc
Confidence            999999999863

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-40  Score=322.79  Aligned_cols=238  Identities=26%  Similarity=0.488  Sum_probs=199.2

Q ss_pred             eeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          227 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      +.||+|+||.||+|....         ..||+|.+...  .......+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            368999999999997632         34888887643  2334567889999999999999999999999989999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------EEEEeeccceec
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VKVADFGVARVK  369 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~--------vkL~DFGla~~~  369 (504)
                      ||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999999876667899999999999999999999999999999999999987664        699999988644


Q ss_pred             cCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ..   .....++..|+|||++.+ ..++.++||||||+++|+|++| .+||...++..... ...  .++.+|...+.++
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~  232 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAPKWTEL  232 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCCCcHHH
Confidence            32   233567889999999976 4589999999999999999998 57777666654332 222  2345666778899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      .+++.+||+.||++|||+.++++.|
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhc
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=326.61  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=212.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||++...  ++.||||.+....... .....+.+|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999874  5889999998764432 35567899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--
Q 010680          298 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--  374 (504)
                      ||+.|++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9999999999997643 5689999999999999999999999999999999999999999999999999864322110  


Q ss_pred             ----------------------------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 010680          375 ----------------------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA  426 (504)
Q Consensus       375 ----------------------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~  426 (504)
                                                  .....||..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                        1123678899999999998999999999999999999999999998887777


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEIIE  470 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs----~~ell~  470 (504)
                      ...+.............++.+.+++.+||..||++||+    +.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            66666544433333347899999999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.8e-39  Score=318.06  Aligned_cols=241  Identities=27%  Similarity=0.439  Sum_probs=210.6

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||.|+||.||+++..  ++.||+|++..... .......+.+|+.+++.++||||+++++.+..+...|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999986  78899999976543 234557799999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCcc
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM  385 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~  385 (504)
                      .+++.+ ...++...+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++............++..|+
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            999976 4568999999999999999999999999999999999999999999999999998665543334457899999


Q ss_pred             CcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 010680          386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  463 (504)
Q Consensus       386 APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RP  463 (504)
                      |||.+....++.++|+||||+++|+|++|..||....  +.+....+......+..|..+++++.++|.+||+.||++||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            9999988889999999999999999999999998776  55555555544456667777899999999999999999999


Q ss_pred             C-----HHHHHH
Q 010680          464 D-----FSEIIE  470 (504)
Q Consensus       464 s-----~~ell~  470 (504)
                      +     +.|+++
T Consensus       240 ~~~~~~~~~l~~  251 (262)
T cd05572         240 GNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHhc
Confidence            9     777654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.7e-39  Score=325.60  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=212.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +|++.+.||+|+||.||++...  ++.||+|.++.... .......+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999874  57799999876532 22345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-----
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----  373 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----  373 (504)
                      |++|++|.+++.. .+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++......     
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9999999999976 4678999999999999999999999999999999999999999999999999986421110     


Q ss_pred             -----------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCC
Q 010680          374 -----------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPK  441 (504)
Q Consensus       374 -----------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~  441 (504)
                                 ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+.......... .+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                       11123578899999999888999999999999999999999999998887766655544332 233334


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                      .+++++.++|.+||+.||++||++.++.+.|+.
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            678999999999999999999998777766666

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.6e-40  Score=321.77  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=213.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +|++.++||.|+||.||++...  ++.||+|++...... ....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999875  788999999765432 2456789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      |+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++............
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999763 67899999999999999999999999999999999999999999999999999766554444556


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .|+..|+|||.+....++.++|+||||+++|+|++|..||...+.  ......... ...+..+...++.+.++|.+||+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHcc
Confidence            789999999999888899999999999999999999999987764  222222222 24566778899999999999999


Q ss_pred             cCCCCCCCH--HHHH
Q 010680          457 QDPALRPDF--SEII  469 (504)
Q Consensus       457 ~dP~~RPs~--~ell  469 (504)
                      .||.+||++  .+++
T Consensus       239 ~~p~~R~~~~~~~l~  253 (258)
T cd05578         239 RDPQKRLGDNLKDLK  253 (258)
T ss_pred             CChhHcCCccHHHHh
Confidence            999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.8e-40  Score=346.07  Aligned_cols=243  Identities=28%  Similarity=0.427  Sum_probs=204.8

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-C-----CCceEEEEeeeCCCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-H-----KNVVQFIGACTKPPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~~~~  293 (504)
                      +|.+.+.||+|+||.|.+|.+.  ++.||||++|..   .....+...|+.+|..|+ |     -|||++++++...+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            7899999999999999999874  688999999975   344556677999999998 4     4899999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CcEEEEeeccceecc
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKA  370 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~--~~vkL~DFGla~~~~  370 (504)
                      |||+|.+ +.+|+++++.++ ..+++..++.++.||+.||.+||+.||||+||||+|||+..-  ..|||+|||.++...
T Consensus       264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            9999999 789999998754 459999999999999999999999999999999999999643  379999999998766


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------  434 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------  434 (504)
                      +.-.  ..+.+..|+|||+|.+.+|+.++||||||||++||++|.+-|.+.+..+....+++--                
T Consensus       343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            5433  6788999999999999999999999999999999999999998877766554433110                


Q ss_pred             ----------------------------------CCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          435 ----------------------------------LRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       435 ----------------------------------~~p~~p-----------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                                                        ..-..|           ......+.++|.+||..||.+|+|+.|.+
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence                                              000011           12235689999999999999999999987


Q ss_pred             H
Q 010680          470 E  470 (504)
Q Consensus       470 ~  470 (504)
                      +
T Consensus       501 ~  501 (586)
T KOG0667|consen  501 N  501 (586)
T ss_pred             c
Confidence            4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.3e-39  Score=320.94  Aligned_cols=246  Identities=33%  Similarity=0.582  Sum_probs=213.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      .|+..++||.|+||.||+|.+  .++.||||+++.... ......+.+|+.++++++||||+++++.+...+..|+||||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            466778999999999999987  467899999875432 34457889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      ++|++|.+++..  +.++...+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            999999999864  568999999999999999999999999999999999999999999999999997654432 22334


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...++...... ......+.++..++..+.+++.+||+.+
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence            678899999999988899999999999999999999999988877655543 3344456667778899999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 010680          459 PALRPDFSEIIEI  471 (504)
Q Consensus       459 P~~RPs~~ell~~  471 (504)
                      |++||++.+++..
T Consensus       241 p~~Rp~~~~il~~  253 (277)
T cd06640         241 PSFRPTAKELLKH  253 (277)
T ss_pred             cccCcCHHHHHhC
Confidence            9999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=324.29  Aligned_cols=250  Identities=29%  Similarity=0.500  Sum_probs=210.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +..++|++.++||+|+||.||++.+.  ++.||+|++.... .......+.+|+.+++.++||||+++++.+...+.+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            34568899999999999999999875  7889999987543 23446788999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++...... .
T Consensus        81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence            9999999999999876 5678999999999999999999997 59999999999999999999999999998654322 2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCC-C
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-----------QAAVGVVQKGLRPTIPK-N  442 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-----------~~~~~v~~~~~~p~~p~-~  442 (504)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......           .....+.. ...+.++. .
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD  237 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence            23457899999999998889999999999999999999999999865442           11222221 22233333 3


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      ++.++.+|+.+||+.||++||++.++++.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            78899999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-39  Score=361.02  Aligned_cols=258  Identities=21%  Similarity=0.356  Sum_probs=211.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+|++.++||+|+||.||+|.+.  ++.||||+++.... ......++.+|+.++++++||||+++++++...+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47899999999999999999874  68899999986533 2344577999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhh----------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          298 EFMSGGSVYDYLHKL----------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       298 E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      ||++|++|.+++...          ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999998642          1235567788999999999999999999999999999999999999999999997


Q ss_pred             eccCCC-------------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 010680          368 VKAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV  428 (504)
Q Consensus       368 ~~~~~~-------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~  428 (504)
                      ......                   .....+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            652110                   0112469999999999999999999999999999999999999998755443322


Q ss_pred             HHHh-cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 010680          429 GVVQ-KGLRPTIPKNSQPKLAELLERCWQQDPALRP-DFSEIIEILQQIAKE  478 (504)
Q Consensus       429 ~v~~-~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RP-s~~ell~~L~~l~~~  478 (504)
                      .... ..........+++.+.+++.+||+.||++|| ++.++++.|+..++.
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            2111 1111111246789999999999999999996 577788888887664

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=352.92  Aligned_cols=259  Identities=24%  Similarity=0.410  Sum_probs=217.1

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEe-ee
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGA-CT  288 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~~  288 (504)
                      +..++|..-++++.+.|.+|+|+.||++...+  ..||+|.+-..  +....+.+.+||.+|++|. |+|||.+++. ..
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            35678999999999999999999999998853  68999987654  6677888999999999997 9999999993 21


Q ss_pred             C------CCCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEE
Q 010680          289 K------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       289 ~------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~vk  359 (504)
                      .      .-.++|.||||.||+|-|+++++ ...|++.++++|+.|+++|+.+||...  |||||||-+||||+.++.+|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            1      12457999999999999999754 345999999999999999999999997  99999999999999999999


Q ss_pred             EEeeccceeccCCCccc----------cCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 010680          360 VADFGVARVKAQSGVMT----------AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA  426 (504)
Q Consensus       360 L~DFGla~~~~~~~~~~----------~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~  426 (504)
                      |||||.|..........          ....|+.|+|||++   .+.+.++|+|||+|||+||-|+....||+......+
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI  266 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI  266 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence            99999997544432111          12469999999998   578899999999999999999999999987644333


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                          +...+.-+.....+..|.+||..||+.||++||++.|++..+-.+..
T Consensus       267 ----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 ----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                33333333335788999999999999999999999999998888754

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-39  Score=321.08  Aligned_cols=247  Identities=30%  Similarity=0.522  Sum_probs=205.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeC------CC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK------PP  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~------~~  291 (504)
                      ..|++.++||.|+||.||+|.+  .++.||+|++...   ......+..|+.+++++ +|+||+++++++..      ..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            5678889999999999999987  4678999998653   23345688899999998 69999999998853      45


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+|++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            6799999999999999997643 458888899999999999999999999999999999999999999999999987543


Q ss_pred             CC-CccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          371 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       371 ~~-~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .. .......|+..|+|||.+.     ...++.++|+||||+++|+|++|..||....+................+..++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence            32 1233456899999999985     45688899999999999999999999987776655554443333333445688


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .++.++|.+||+.||.+||++.++++
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            99999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-39  Score=322.32  Aligned_cols=246  Identities=28%  Similarity=0.519  Sum_probs=211.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|++.++||.|+||.||+|..  .++.||+|.+.....  .....+.+|+.+++.++||||+++++.+...+..|+|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            5689999999999999999975  578899999875432  234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            9999999998864  468999999999999999999999999999999999999999999999999987544332 2234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..++..|+|||.+.+..++.++|+|||||++|+|++|..||...++......+..... ....+..+++.+.++|.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            5688999999999998899999999999999999999999998887665544433221 223456788999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+||++.+++.
T Consensus       255 ~dp~~Rpt~~~il~  268 (296)
T cd06655         255 MDVEKRGSAKELLQ  268 (296)
T ss_pred             cChhhCCCHHHHhh
Confidence            99999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.4e-39  Score=311.72  Aligned_cols=248  Identities=29%  Similarity=0.551  Sum_probs=220.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||+|+||.||++.+.  ++.||+|++............+.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999886  78899999987766656677899999999999999999999999988999999999


Q ss_pred             cCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          300 MSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       300 ~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      +++++|.+++....   ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            99999999998753   779999999999999999999999999999999999999999999999999997665443 23


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....... ...+.++..++..+.+++.+||
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHc
Confidence            345688999999999998999999999999999999999999988887666665544 3355677788999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      ..+|++||++.++++
T Consensus       240 ~~~p~~Rp~~~~ll~  254 (258)
T cd08215         240 QKDPEERPSIAQILQ  254 (258)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-39  Score=336.40  Aligned_cols=244  Identities=23%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      -..+|.+.++||+|+||.||++...+    ..||+|.+...       ..+.+|+.+|++++||||+++++++......|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            34679999999999999999997643    56999987643       23467999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      +|||++ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       163 lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        163 MVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            999999 5689998844 57899999999999999999999999999999999999999999999999999975543321


Q ss_pred             ---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----------------
Q 010680          375 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQ----------------  432 (504)
Q Consensus       375 ---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~----------------  432 (504)
                         .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   ......+..                
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence               2245799999999999999999999999999999999999999965432   111111110                


Q ss_pred             ---------cCCCCCC--C-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          433 ---------KGLRPTI--P-----KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       433 ---------~~~~p~~--p-----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                               ...++..  +     ...+.++.++|.+||..||++||++.+++..
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     0111111  1     2346788999999999999999999998754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.2e-39  Score=323.34  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=207.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV  296 (504)
                      ++|++.+.||.|+||.||+|++.  ++.+|+|.++...........+.+|+.++++++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999985  67899999986544444445677899999999999999999998776  889999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~  375 (504)
                      |||++ ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++..... ...
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99996 5999999876667999999999999999999999999999999999999999999999999999866554 233


Q ss_pred             ccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------------
Q 010680          376 TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------  434 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------------  434 (504)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...-                    
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            445678999999998654 46899999999999999999999998877655544332210                    


Q ss_pred             ---------CCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 ---------LRPTIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ---------~~p~~p~~-~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                               ....++.. +++.+.++|.+||+.||++||++.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                     11122233 5888999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-39  Score=321.14  Aligned_cols=245  Identities=33%  Similarity=0.586  Sum_probs=211.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      .|+..+.||+|+||.||+|.+  .+..||+|+++.... ......+.+|+.++++++||||+++++.+...+..|+||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            466778899999999999976  467899999875432 33456789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      +++++|.+++..  +.+++..+..++.||+.|+.|||++|++|+||+|+||++++++.++|+|||++....... .....
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999999864  578999999999999999999999999999999999999999999999999997654332 22234


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .++..|+|||.+.+..++.++|+||||+++|||++|..||....+...... ......+..+..++.++.+++.+||+.+
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNKD  240 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            688999999999999999999999999999999999999987766554433 3334455566778899999999999999


Q ss_pred             CCCCCCHHHHHH
Q 010680          459 PALRPDFSEIIE  470 (504)
Q Consensus       459 P~~RPs~~ell~  470 (504)
                      |++||++.++++
T Consensus       241 p~~Rp~~~~il~  252 (277)
T cd06642         241 PRFRPTAKELLK  252 (277)
T ss_pred             cccCcCHHHHHH
Confidence            999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.3e-39  Score=319.10  Aligned_cols=250  Identities=29%  Similarity=0.498  Sum_probs=204.8

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeee-----CC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT-----KP  290 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~-----~~  290 (504)
                      ..++|++.+.||+|+||.||++..  .++.+|+|+++...   .....+.+|+.+++.+ +||||+++++++.     ..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            457889999999999999999977  46789999986532   2235678899999999 6999999999873     34


Q ss_pred             CCceeEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      +..++||||++|++|.+++...   ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            5689999999999999987532   3568889999999999999999999999999999999999999999999999997


Q ss_pred             eccCCC-ccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 010680          368 VKAQSG-VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIP  440 (504)
Q Consensus       368 ~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p  440 (504)
                      ...... ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||....+........... .....+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP  252 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence            654332 223446899999999985     3458899999999999999999999998877655443322211 112234


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      ..++..+.+++.+||+.||++||++.++++.
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            5567899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-38  Score=312.71  Aligned_cols=247  Identities=31%  Similarity=0.534  Sum_probs=214.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||+|++|.||+++..  ++.|+||++...... .....+.+|+.++++++|+||+++++++...+.+++||||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            5788899999999999999875  788999998866432 4567899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc-cc
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~  377 (504)
                      +++++|.+++.. ...+++..+..++.||+.||.|||+ ++++||||+|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          81 MDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            999999999976 3779999999999999999999999 99999999999999999999999999999866543322 24


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKN-SQPKLAELLERC  454 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~p~~p~~-~~~~l~~Ll~~c  454 (504)
                      ..++..|+|||.+....++.++|+||||+++|+|++|..||....  ..............+..+.. ++..+.+++.+|
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  239 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC  239 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence            567899999999999899999999999999999999999998774  22223333334444556666 899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |..+|++||++.++++
T Consensus       240 l~~~p~~R~~~~~ll~  255 (264)
T cd06623         240 LQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ccCChhhCCCHHHHHh
Confidence            9999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=343.83  Aligned_cols=245  Identities=30%  Similarity=0.471  Sum_probs=218.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .|.-.+.||.|+||.||-+++  +.+.||||.+....- +.....++..|+..|++++|||++.+-|++..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466678999999999999987  467799999987643 34567889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      || -||-.|++.-.+.++.+-.+..|..+.+.||.|||+.+.||||||+.|||+++.|.|||+|||.|......   ..+
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsF  182 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSF  182 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcc
Confidence            99 67999999888889999999999999999999999999999999999999999999999999999766543   467


Q ss_pred             CCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          379 TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       379 ~gt~~y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      +|||.|||||+|   ..+.|+-++||||||++..||...++|+..++...+.+.+.+.....-.....+..++.++..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            899999999998   45679999999999999999999999999999999999887654332234568899999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      ++-|.+|||..++++
T Consensus       263 qKipqeRptse~ll~  277 (948)
T KOG0577|consen  263 QKIPQERPTSEELLK  277 (948)
T ss_pred             hhCcccCCcHHHHhh
Confidence            999999999998863

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=316.09  Aligned_cols=244  Identities=25%  Similarity=0.493  Sum_probs=198.2

Q ss_pred             eeeeeCceEEEEEEEC-Cc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSYGDLYRGTYC-SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~-g~---~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +||+|+||.||+|... +.   .+++|.++... .......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            6899999999999753 32   35566665432 2334678999999999999999999999999999999999999999


Q ss_pred             chHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---cccc
Q 010680          304 SVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTA  377 (504)
Q Consensus       304 sL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~  377 (504)
                      +|.+++++..   ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......   ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            9999997642   345667788999999999999999999999999999999999999999999986432211   1234


Q ss_pred             CCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC----CCCCCCCCCcH
Q 010680          378 ETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQP  445 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~----~~p~~p~~~~~  445 (504)
                      ..++..|+|||++..       ..++.++||||||+++|||++ |..||...+..+....+....    .++.++...++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE  240 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence            467899999999843       346789999999999999997 688998877766655544332    34555667889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      .+.+++..|| .+|++||++.++++.|.
T Consensus       241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         241 RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            9999999999 67999999999988774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.2e-39  Score=324.38  Aligned_cols=246  Identities=28%  Similarity=0.504  Sum_probs=210.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|++.++||+|+||.||++..  .++.||+|.+......  ....+.+|+.+++.++|+||+++++.+......|+|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            6788899999999999999986  5788999998754332  24668899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|.+++.+  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            9999999999864  567889999999999999999999999999999999999999999999999987654332 2234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++..........+. ....+..+++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            5788999999999999999999999999999999999999987666444333222221 123456778899999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++||++.++++
T Consensus       255 ~~p~~Rps~~~il~  268 (297)
T cd06656         255 MDVDRRGSAKELLQ  268 (297)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=319.71  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||+|+||.||+|.+.  ++.||+|+++...........+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6889999999999999999874  67899999886655555567889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--cccc
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~  377 (504)
                      ++++.+..+..+ ...++...+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.......  ....
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            988666655543 5668999999999999999999999999999999999999999999999999987655443  3344


Q ss_pred             CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------------C
Q 010680          378 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------------L  435 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~---------------------~  435 (504)
                      ..++..|+|||++.+. .++.++|+||||+++|+|++|.+||...+..+.........                     .
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            5788999999999887 88999999999999999999999998766554433321100                     0


Q ss_pred             ---------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 ---------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ---------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                               ....+..+++++.+++.+||..+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                     00123345889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-39  Score=316.57  Aligned_cols=248  Identities=31%  Similarity=0.542  Sum_probs=207.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +|.+.+.||.|+||.||+|..  .++.||+|.++.....        ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975  5788999988643211        122456888999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++... +.++...+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999774 6789999999999999999999999999999999999999999999999999975433


Q ss_pred             CC---ccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC----CC
Q 010680          372 SG---VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP----KN  442 (504)
Q Consensus       372 ~~---~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p----~~  442 (504)
                      ..   ......++..|+|||.+....  ++.++|+||||+++|+|++|..||......+...........+.++    ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21   123346889999999987654  8999999999999999999999998776665555444333333333    35


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.++.+++.+||..+|++||++.++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            6889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-39  Score=316.80  Aligned_cols=248  Identities=30%  Similarity=0.543  Sum_probs=209.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      +|+..+.||+|+||.||++..  +++.||+|+++.....    ......+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367788999999999999986  5788999998754322    2245678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCCC-
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG-  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~-  373 (504)
                      |+||++|++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+....... 
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999976 46789999999999999999999999999999999999998776 59999999987654321 


Q ss_pred             ----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHH
Q 010680          374 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                          ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   .............+..+...+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                11234678999999999888999999999999999999999999975432   23333333344556677788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.+++.+||..+|.+||++.++++
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhc
Confidence            999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-38  Score=308.83  Aligned_cols=248  Identities=32%  Similarity=0.581  Sum_probs=218.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~  297 (504)
                      +|++.+.||+|++|.||+|...  ++.|++|+++...........+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677899999999999999886  78899999987655455678899999999999999999999999887  7899999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---  374 (504)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999874 4899999999999999999999999999999999999999999999999999987766543   


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      .....++..|+|||.+....++.++||||||+++|+|++|..||.... .......+......+.++...++.+.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            445678999999999988889999999999999999999999998766 3334444433345567788889999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||..||++||++.+++.
T Consensus       240 ~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         240 CLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hCcCChhhCCCHHHHhh
Confidence            99999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-39  Score=335.18  Aligned_cols=242  Identities=25%  Similarity=0.414  Sum_probs=196.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ...|++.+.||+|+||.||+|+..  ++.||+|+....        ....|+.++++++||||+++++++...+..|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            356999999999999999999985  457999985433        2346899999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+ .++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus       137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  215 (357)
T PHA03209        137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG  215 (357)
T ss_pred             Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence            999 5689999877677899999999999999999999999999999999999999999999999999976544444445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCHH---------HHHHHHHhc-CCCC-CCC-----
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEYLTPL---------QAAVGVVQK-GLRP-TIP-----  440 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~---------~~~~~v~~~-~~~p-~~p-----  440 (504)
                      ..||+.|+|||++.+..|+.++|||||||++|||+++. .+|......         .....++.. +..+ .++     
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  295 (357)
T PHA03209        216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS  295 (357)
T ss_pred             ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence            67999999999999999999999999999999999854 444332110         011111110 0000 000     


Q ss_pred             -------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          441 -------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       441 -------------------------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                               ..++.++.+||.+||+.||.+|||+.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                     244667788999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=313.47  Aligned_cols=248  Identities=28%  Similarity=0.504  Sum_probs=213.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  293 (504)
                      .+|++.+.||+|+||.||+|..  +++.||+|++....   ........+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5688999999999999999986  46789999875432   1234456788999999999999999999988654  457


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  372 (504)
                      +++|||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            899999999999999876 456889999999999999999999999999999999999999999999999999754321 


Q ss_pred             ---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                         ...+...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.................++.+|..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence               12234568999999999998889999999999999999999999999887777776666666677888999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+||. +|..||++.+++.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhc
Confidence            9999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-40  Score=343.68  Aligned_cols=248  Identities=28%  Similarity=0.491  Sum_probs=226.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ...|.+.+.||+|.|+.|.+++.  ++..||||++.+...+....+.+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            34688889999999999999986  5788999999998888777777999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+.+|.+++|+.+ .+...+..+..++.|++.|++|||+++|+|||||++|||++.+-++||+|||++..+.......+
T Consensus       135 eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  135 EYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             EeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence            99999999999987 56677799999999999999999999999999999999999999999999999999987778889


Q ss_pred             CCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+|++.|.|||++.+..|+ +.+|+||+|++||-|++|.+||++.+-.+.-..++...++  +|..++.++.++|+++|-
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~lv  291 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKFLV  291 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHHhhc
Confidence            9999999999999999885 7899999999999999999999988776666666655554  777888999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|.+|++.+++.+
T Consensus       292 l~Pskr~~~dqim~  305 (596)
T KOG0586|consen  292 LNPSKRGPCDQIMK  305 (596)
T ss_pred             cCccccCCHHHhhh
Confidence            99999999999864

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-39  Score=320.53  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=206.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++..........+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999984  6789999987654444455678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|..+... ...+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            9999888887654 4568999999999999999999999999999999999999999999999999987654332 2334


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------------CC
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------LR  436 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------------~~  436 (504)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++|++||...+..+....+....                    ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            568899999999865 457889999999999999999999998666544332222100                    00


Q ss_pred             C---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p---------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +         .....++..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0         012356888999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-38  Score=307.23  Aligned_cols=246  Identities=35%  Similarity=0.633  Sum_probs=213.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|.+.+.||+|++|.||++...  ++.+++|++.....  .....+.+|+.++++++|+||+++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4677899999999999999985  67899999986543  3457889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  379 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  379 (504)
                      +++++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99999999998755689999999999999999999999999999999999999999999999999997665443234567


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhhc
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCWQQ  457 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~--~~~~l~~Ll~~cl~~  457 (504)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+..  ++..+.+++.+||+.
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence            88999999999888899999999999999999999999998866665554443 333333333  388999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      ||.+|||+.++++
T Consensus       238 ~p~~R~t~~~~l~  250 (253)
T cd05122         238 NPEKRPTAEQLLK  250 (253)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-38  Score=315.33  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=201.1

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCC--CCceeEE
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP--PSLCIVT  297 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~lV~  297 (504)
                      |++.++||+|+||.||+|+.  .++.||+|+++....... .....+|+.+++++. |+||+++++++...  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            56788999999999999987  467899999876533332 234457888898886 99999999999877  8899999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||+++..........
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence            9996 5888888765667999999999999999999999999999999999999999 9999999999986655444445


Q ss_pred             CCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------CCCC-
Q 010680          378 ETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------RPTI-  439 (504)
Q Consensus       378 ~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------~p~~-  439 (504)
                      ..++..|+|||.+. +..++.++|||||||++|||++|..||...++.+..........                .... 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            67899999999764 45578999999999999999999999988776554333221100                0001 


Q ss_pred             ----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          440 ----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       440 ----------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                ...++.++.+++.+||+++|++||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                      1356789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-38  Score=321.43  Aligned_cols=246  Identities=29%  Similarity=0.455  Sum_probs=208.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..|++.++||+|+||.||+|+.  .++.||+|++.... ........+.+|+.+++.++||||+++++++...+..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588889999999999999987  47889999987543 23344567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+. |+|.+++....+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            9995 6888887765677999999999999999999999999999999999999999999999999998754332   34


Q ss_pred             CCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          378 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       378 ~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..+++.|+|||++.   ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.+++.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            56888999999874   456889999999999999999999999888776665554433222222345788999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||++||++.+++.
T Consensus       251 l~~~p~~Rp~~~~il~  266 (307)
T cd06607         251 LQKIPQDRPSSEELLK  266 (307)
T ss_pred             hcCChhhCcCHHHHhc
Confidence            9999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.2e-39  Score=312.44  Aligned_cols=248  Identities=29%  Similarity=0.530  Sum_probs=212.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|.+.+.||+|+||.||++...  +..||+|.+............+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999874  67899999876544444556788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCCCc-cc
Q 010680          300 MSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-MT  376 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~-~~  376 (504)
                      +++++|.+++....+ .+++..+..++.|++.||.|||+++|+|+||||+||++++++ .+||+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            999999999976433 578999999999999999999999999999999999999886 469999999876544322 22


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+...+..+.+++.+||.
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHHhc
Confidence            34689999999999888899999999999999999999999988777666555443 33445566788999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|++||++.++++
T Consensus       240 ~~p~~Rpt~~~ll~  253 (257)
T cd08225         240 VSPRDRPSITSILK  253 (257)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.8e-39  Score=320.42  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=201.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|...++||+|+||.||++.+.  ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            46677789999999999999874  678999998765333 44567889999999996 999999999999988999999


Q ss_pred             EecCCCchHHHHH---h-hcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          298 EFMSGGSVYDYLH---K-LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       298 E~~~ggsL~~~l~---~-~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      ||+. ++|.++..   . ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            9985 56655432   2 236789999999999999999999985 9999999999999999999999999999765544


Q ss_pred             CccccCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCC----CCCCCc
Q 010680          373 GVMTAETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPT----IPKNSQ  444 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~~v~~~~~~p~----~p~~~~  444 (504)
                      .......|+..|+|||++.+.   .++.++||||||+++|+|++|+.||...... +....+. .+..+.    .+..++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (288)
T cd06616         162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEEREFS  240 (288)
T ss_pred             CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCCccC
Confidence            444455789999999999765   6899999999999999999999999766532 2222222 122222    223578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++.+|+.+||+.||++||++.++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-38  Score=319.75  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +|++.+.||.|+||.||+|.+.  ++.||||.++.....   ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999874  678999999866443   33445678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      |||+ +++|.+++......+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||+++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 899999997644479999999999999999999999999999999999999999999999999998665432 23


Q ss_pred             ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 010680          376 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------------  436 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------------  436 (504)
                      ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+......                  
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            34467889999999854 56789999999999999999999888876655443333221100                  


Q ss_pred             ---CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ---PT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ---p~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                         +.     .....+.++.+++.+||+.||++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               00     11345788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.2e-38  Score=313.86  Aligned_cols=246  Identities=34%  Similarity=0.588  Sum_probs=212.8

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      -|++.++||+|+||.||+|..  .+..||||++..... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            467788999999999999976  467899999875432 33456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      +++++|.+++..  +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999999864  568999999999999999999999999999999999999999999999999987554322 22334


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... +.....+..+..++.++.+++.+||+.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            688899999999888899999999999999999999999988776555444 3344456677788999999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 010680          459 PALRPDFSEIIEI  471 (504)
Q Consensus       459 P~~RPs~~ell~~  471 (504)
                      |.+||++.++++.
T Consensus       241 p~~Rp~~~~~l~~  253 (277)
T cd06641         241 PSFRPTAKELLKH  253 (277)
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-38  Score=321.96  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=207.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCce
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  294 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~  294 (504)
                      ..++|++.+.||.|+||.||+|.+  .++.||+|+++...........+.+|+.++++++|+||+++++++...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            346799999999999999999987  478899999876544333344567899999999999999999998654  4689


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-C
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~  373 (504)
                      +||||+. ++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus        85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            9999995 5899998876678999999999999999999999999999999999999999999999999999865543 2


Q ss_pred             ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 010680          374 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------  437 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p---------------  437 (504)
                      ..+...++..|+|||++.+ ..++.++||||||+++|+|++|.+||...++.+....+......+               
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            3334456888999999865 568999999999999999999999999888777665544321100               


Q ss_pred             --CC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --TI-----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --~~-----------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                        ..           ....++++.++|.+||+.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00           0125788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=325.13  Aligned_cols=244  Identities=25%  Similarity=0.428  Sum_probs=216.8

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~  292 (504)
                      .|...+|.++.+||+|+||.|.++..+|  +.+|||+++++..- .+..+--..|-++|.... -|.+++++..++.-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            6777899999999999999999998866  55999999987542 222333345667776664 5889999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||+.||+|.-.+++ -+++.++.+..++.+|+.||-|||++|||+||||.+|||++.+|++||+|||+++...-.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999998887 688999999999999999999999999999999999999999999999999999865554


Q ss_pred             C-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          373 G-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 ~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      + ...+.+|||.|+|||++..++|+.++|+||||++||||+.|++||++.+..+....++....  ..|+.++.+..++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHH
Confidence            4 44577999999999999999999999999999999999999999999999998888887764  58899999999999


Q ss_pred             HHhhhcCCCCCC
Q 010680          452 ERCWQQDPALRP  463 (504)
Q Consensus       452 ~~cl~~dP~~RP  463 (504)
                      ...|.+.|.+|.
T Consensus       582 kg~ltK~P~kRL  593 (683)
T KOG0696|consen  582 KGLLTKHPGKRL  593 (683)
T ss_pred             HHHhhcCCcccc
Confidence            999999999994

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=343.93  Aligned_cols=246  Identities=29%  Similarity=0.513  Sum_probs=214.8

Q ss_pred             eeeeeeeeeeCceEEEEEEECCc--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      +.|+-.||.|+||.||++.....  ..|-|++...  +......+.-||.||..+.||+||+++++|..++.++|+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45567899999999999987643  3567777643  4556788999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee-ccCCCccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~-~~~~~~~~~~~  379 (504)
                      .||-....+-.....++++++..+++|++.||.|||+++|||||||+.|||++-+|.|+|+|||++-. .........++
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI  191 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI  191 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence            99999999888889999999999999999999999999999999999999999999999999998743 22223456789


Q ss_pred             CCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHH
Q 010680          380 GTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       380 gt~~y~APE~l-----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~  453 (504)
                      |||.|||||++     ...+|+.++||||||++|.||..+.+|....++...+..+.... .....|...+..+.+++.+
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~  271 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKR  271 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHH
Confidence            99999999987     46789999999999999999999999999999999988865542 2233567888999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||.+||..||++++|++
T Consensus       272 cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  272 CLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHhcCCccCCCHHHHhh
Confidence            99999999999999873

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-38  Score=322.10  Aligned_cols=240  Identities=23%  Similarity=0.400  Sum_probs=186.3

Q ss_pred             eeeeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCCceeEEEe
Q 010680          226 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF  299 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~  299 (504)
                      +++||+|+||.||+|...    ++.||+|.++.....    ..+.+|+.+|++++||||+++++++..  ....|++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999863    467999998765332    346789999999999999999998854  4457899999


Q ss_pred             cCCCchHHHHHhh--------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEEeeccce
Q 010680          300 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  367 (504)
Q Consensus       300 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl----~~~~~vkL~DFGla~  367 (504)
                      + +++|.+++...        ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            9 56888887532        1258889999999999999999999999999999999999    456789999999998


Q ss_pred             eccCCC----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhc
Q 010680          368 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------LQAAVGVVQK  433 (504)
Q Consensus       368 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---------~~~~~~v~~~  433 (504)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.....         ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    2334578999999999976 4589999999999999999999999964321         0111111000


Q ss_pred             -C----------------------CCC-------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          434 -G----------------------LRP-------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       434 -~----------------------~~p-------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                       +                      ...             ......++++.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0                      000             001123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-38  Score=327.72  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=204.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~  291 (504)
                      ..+|++.+.||+|+||.||++..  .++.||||+++...........+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            36799999999999999999986  578899999876544445556788899999999999999999987643      3


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..|+||||+. ++|.+.+..   .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            4699999994 588888754   288999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------  436 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------  436 (504)
                      ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...-..               
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            54445567899999999999999999999999999999999999999876654433222211000               


Q ss_pred             -----C---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 -----P---------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 -----p---------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                           +                     ..+...++.+.++|.+||+.||.+||++.|++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0                     001234667899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=306.41  Aligned_cols=247  Identities=35%  Similarity=0.637  Sum_probs=217.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||+|++|.||+++.  .++.|++|.+............+.+|+.++++++|||++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            477889999999999999987  467899999987765555677899999999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-cccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~  378 (504)
                      +++++|.+++.. .+.+++..+..++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999976 47799999999999999999999999999999999999999999999999999986654332 2345


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .++..|+|||...+..++.++|||+||+++|+|++|..||...++........ ....+.++..+++.+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            68899999999988889999999999999999999999998877665555544 34456677889999999999999999


Q ss_pred             CCCCCCHHHHHH
Q 010680          459 PALRPDFSEIIE  470 (504)
Q Consensus       459 P~~RPs~~ell~  470 (504)
                      |++||++.+++.
T Consensus       239 p~~R~~~~~~l~  250 (254)
T cd06627         239 PNLRPTAKQLLK  250 (254)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=313.07  Aligned_cols=247  Identities=33%  Similarity=0.541  Sum_probs=205.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC-----
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP-----  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~-----  291 (504)
                      .++|++.+.||.|+||.||+|...  ++.+++|+++....   ....+.+|+.+++++ +|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            367889999999999999999884  57799999875432   346788999999999 6999999999986644     


Q ss_pred             -CceeEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          292 -SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       292 -~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                       .+++||||+++++|.+++...   +..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence             479999999999999998754   3678999999999999999999999999999999999999999999999999987


Q ss_pred             eccCCC-ccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--
Q 010680          368 VKAQSG-VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--  439 (504)
Q Consensus       368 ~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--  439 (504)
                      ...... ......|+..|+|||++..     ..++.++||||||++||+|++|..||....+......+.... .+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  240 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKS  240 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCc
Confidence            644322 2334568999999998753     357889999999999999999999998776655555543322 2222  


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          440 PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       440 p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +...++++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2346789999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-38  Score=316.31  Aligned_cols=248  Identities=21%  Similarity=0.387  Sum_probs=205.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.+.||.|+||.||+|+.  .++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            377889999999999999987  467899999876554444456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          300 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       300 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      +. ++|.+++... .+.+++..+..++.||+.||+|||+++++|+||+|+||+++.++.+||+|||+++...... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            95 6899888654 3568999999999999999999999999999999999999999999999999987544322 2234


Q ss_pred             CCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 010680          378 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------------  437 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-------------------  437 (504)
                      ..++..|+|||++.+.. ++.++||||||+++|+|+||+.||...+..............+                   
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            45788999999886644 6889999999999999999999998776655444333211110                   


Q ss_pred             --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              .+...+++++.++|.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    012356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=311.52  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=221.9

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK  289 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~  289 (504)
                      ...+..+.++++++..||+|+.|.|++.++..  ...|||.+.... +++..++++..+.++.+-+ +|+||+.+|+|..
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            34456677888999999999999999998865  789999998654 4555677888888766665 8999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +...+|.||.| +..+..++....+++++..+-++...+++||.||..+ +|||||+||+|||+|+.|++|+||||.+..
T Consensus       163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            99999999999 6789999988889999999999999999999999875 899999999999999999999999999998


Q ss_pred             ccCCCccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCC--C
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPK--N  442 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-~~~~~~~~v~~~~~~p~~p~--~  442 (504)
                      ..++...+...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+- +.++..-.++. ...|.++.  .
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~g  320 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMG  320 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccC
Confidence            888888888899999999999953   46999999999999999999999999874 45666666665 33355553  3


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .++.+.+++..||++|+.+||.+.++++
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            7999999999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-38  Score=318.65  Aligned_cols=255  Identities=26%  Similarity=0.493  Sum_probs=209.4

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP  290 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~  290 (504)
                      ..|.++.++|++.++||+|+||.||+|.+.  ++.||||.++..... .....+..|+.++.+.. ||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            456777889999999999999999999986  788999999765332 23456667777666665 99999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ...|++|||+ +++|.+++....+.+++..+..++.||+.||.|||+ .||+||||+|+||++++++.+||+|||++...
T Consensus        87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            9999999998 558888877666789999999999999999999997 59999999999999999999999999998765


Q ss_pred             cCCCccccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCC--CC
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIP--KN  442 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~p~~p--~~  442 (504)
                      ..........++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+... ..+..+  ..
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCC
Confidence            5444444556888999999986553    88999999999999999999999976433 3333333332 222233  24


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      +++++.+++.+||+.||.+||++.+++..
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            78999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-39  Score=311.31  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=218.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~------~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~  291 (504)
                      ..|.-.+.||.|..+.|.++..  +++..|+|++.....      .....+.-.+|+.||+++. ||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3456667899999999988754  578899998864321      1234556778999999985 999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+++|+|.|+.|.|.|+|.. .-.+++....+|+.|++.|++|||.++|+||||||+|||++++.++||+|||+++....
T Consensus        97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999987 56799999999999999999999999999999999999999999999999999998888


Q ss_pred             CCccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCC
Q 010680          372 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPKNS  443 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--~~p~~p~~~  443 (504)
                      .......+|||+|.|||.+.      +..|+..+|+|+.|++||.||.|.+||-.....-....+++..  ++.+-..++
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            88888899999999999983      5578999999999999999999999997655555554444433  344556788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK  477 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l~~  477 (504)
                      +...++||.+||+.||.+|.|++|.++  .+..+..
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            999999999999999999999999984  4555444

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-38  Score=308.79  Aligned_cols=247  Identities=30%  Similarity=0.525  Sum_probs=216.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||.|+||.||+++.  .++.+|+|.++...........+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999976  467899999987655555567788999999999999999999999988999999999


Q ss_pred             cCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccc
Q 010680          300 MSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       300 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      +++++|.+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            9999999998653   356888999999999999999999999999999999999999999999999999766544 333


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+ .....+..+..++.++.+++.+||+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCchhhCHHHHHHHHHHcC
Confidence            456889999999999999999999999999999999999999988876555444 3444556667889999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|++||++.++++
T Consensus       239 ~~p~~Rp~~~~~l~  252 (256)
T cd08530         239 VKPKLRPNCDKILA  252 (256)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.5e-38  Score=314.15  Aligned_cols=248  Identities=29%  Similarity=0.475  Sum_probs=205.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCC-----C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-----P  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-----~  291 (504)
                      .++|.+.+.||+|+||.||++..  .++.+|+|++....   .....+.+|+.+++++ +||||+++++++...     .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            46799999999999999999987  46789999987542   2235677899999999 799999999988643     3


Q ss_pred             CceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          292 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ..++||||++|++|.++++.   ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            57999999999999998864   245689999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCC-ccccCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCC
Q 010680          369 KAQSG-VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPK  441 (504)
Q Consensus       369 ~~~~~-~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~  441 (504)
                      ..... ......|+..|+|||++...     .++.++|||||||++|+|++|+.||....+.+....+..... ....+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            44322 22345688999999998543     368899999999999999999999998877666555433221 112244


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..+..+.+++.+||+.+|++||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            56788999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=338.79  Aligned_cols=243  Identities=23%  Similarity=0.352  Sum_probs=196.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ...|.+.+.||+|+||.||++.+.  ++.||||....        ..+.+|+.+|++++|+|||++++++...+..|+||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            346899999999999999999885  56799996432        23568999999999999999999999989999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---  374 (504)
                      |++ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus       240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            999 5799999877566799999999999999999999999999999999999999999999999999986543321   


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------H-HHHHHHHHhcC-C-----------
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT------P-LQAAVGVVQKG-L-----------  435 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~------~-~~~~~~v~~~~-~-----------  435 (504)
                      .....||..|+|||++.+..++.++|||||||+||||++|..|+....      + ...+..+++.. .           
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            223469999999999999999999999999999999999876553211      0 11122222211 0           


Q ss_pred             --------------CCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          436 --------------RPTIP-------KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       436 --------------~p~~p-------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                    ++...       ...++++.+||.+||+.||.+|||+.|+++.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                          00000       1345689999999999999999999999863

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=313.44  Aligned_cols=245  Identities=31%  Similarity=0.560  Sum_probs=207.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .|++.+.||+|+||.||+|.+  .++.||+|+++... .......+.+|+.+++.++   |||++++++++...+..|+|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            467788999999999999987  46789999987543 2334567889999999997   99999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      |||++|++|.+++..  +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999999999999865  478999999999999999999999999999999999999999999999999997654432 23


Q ss_pred             ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~-~~~~~l~~Ll~~  453 (504)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+........ .....+.++. ..+.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-PKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-ccCCCCCCCcccCCHHHHHHHHH
Confidence            34578999999999864 55789999999999999999999999887765544332 2222333444 378899999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||++||++.+++.
T Consensus       238 ~l~~~p~~R~~~~~il~  254 (277)
T cd06917         238 CLDEEPKERLSAEELLK  254 (277)
T ss_pred             HcCCCcccCcCHHHHhh
Confidence            99999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-38  Score=315.30  Aligned_cols=247  Identities=33%  Similarity=0.591  Sum_probs=212.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.+.||.|+||.||++.+.  ++.|++|+++....   ....+.+|+.+++.++|+||+++++.+......|+++|
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            45777889999999999999885  78899999986533   45678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++|++|.+++......++...+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            999999999998754489999999999999999999999999999999999999999999999999886543322 2234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...++......+......+. .+..++..+.+++.+||+
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV  255 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhc
Confidence            4578899999999988999999999999999999999999998877665555443333221 223478999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|.+||++.+++.
T Consensus       256 ~~p~~Rpt~~~il~  269 (286)
T cd06614         256 KDPEKRPSAEELLQ  269 (286)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=315.19  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|..  .++.||||.++..... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5788999999999999999987  4678999998764322 223456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+. ++|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            996 59999998766778999999999999999999999999999999999999999999999999987543221 2223


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh---cC------------------
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQ---KG------------------  434 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~---~~------------------  434 (504)
                      ..++..|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+..   ..                  
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            457889999999865 568999999999999999999999997655 2222111110   00                  


Q ss_pred             CC---C----CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 LR---P----TIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ~~---p----~~p~~~~--~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..   +    .....++  .++.+++.+||+.+|++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00   0    0001233  78899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-38  Score=315.23  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=203.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCC-----
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS-----  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~-----  292 (504)
                      ++|++.+.||+|+||.||+|.+  .++.||||+++...........+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3688899999999999999987  4678999998765443334567888999999996 6999999998876665     


Q ss_pred             ceeEEEecCCCchHHHHHhhc----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccce
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVAR  367 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~  367 (504)
                      .|+||||+++ +|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7999999975 8988886532    35799999999999999999999999999999999999998 8899999999997


Q ss_pred             eccCC-CccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 010680          368 VKAQS-GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------  438 (504)
Q Consensus       368 ~~~~~-~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-------  438 (504)
                      ..... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+.       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            55332 22334467889999998854 5679999999999999999999999988777665554433211000       


Q ss_pred             -------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 -------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 -------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                         ..+.+++++.++|.+||..||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                               11357889999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=314.21  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |++.++||.|++|.||+|.+  .+..||+|++............+.+|+.+++.++|||++++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            46678999999999999986  5788999999866544444567888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          301 SGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       301 ~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                       +++|.+++.... ..+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||+++...... .....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence             569999987644 368999999999999999999999999999999999999999999999999997543322 22344


Q ss_pred             CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 010680          379 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------  436 (504)
Q Consensus       379 ~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------------  436 (504)
                      .+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+.......+.+....                     
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            678899999988654 5799999999999999999999999887765544443321110                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            ......+++.+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  0123456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.2e-38  Score=318.77  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=212.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..|+..+.||+|+||.||+++.  .+..||+|++..... ..+....+.+|+.++++++|||++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3477788999999999999987  467899999875432 3345567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+. |+|.+++......+++..+..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++.....   ...
T Consensus       105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            9996 588888876677799999999999999999999999999999999999999999999999999865432   234


Q ss_pred             CCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          378 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       378 ~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..+++.|+|||.+.   ...++.++||||||+++|+|++|..||...........+......+..+..+++.+.+++.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            56889999999973   456899999999999999999999999888776666665555444444557788999999999


Q ss_pred             hhcCCCCCCCHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L  472 (504)
                      |+.+|.+||++.++++.+
T Consensus       261 l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         261 LQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccCCcccCcCHHHHHhCh
Confidence            999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4e-38  Score=317.01  Aligned_cols=254  Identities=17%  Similarity=0.248  Sum_probs=192.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCCceE
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNVVQ  282 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~---------~~~~~~Ei~iL~~l~HpnIv~  282 (504)
                      ++...+|++.++||+|+||.||+|...+.     .+|+|+..........         ......+...+..+.|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            45667899999999999999999987543     5677764432211100         011223444566778999999


Q ss_pred             EEEeeeCCC----CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 010680          283 FIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       283 l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~v  358 (504)
                      +++.+....    ..++++|++ ..++.+.+.. ....++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            998765443    236778877 4577776654 3446788899999999999999999999999999999999999999


Q ss_pred             EEEeeccceeccCCC--------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Q 010680          359 KVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--  428 (504)
Q Consensus       359 kL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~--  428 (504)
                      +|+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|..||..........  
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998654321        1223469999999999999999999999999999999999999998774322111  


Q ss_pred             ---HHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          429 ---GVVQKGLRP-TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       429 ---~v~~~~~~p-~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                         ....+-..+ .....+++.+.+++..||+.+|++||++.++++.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence               111111111 12346789999999999999999999999999876

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.5e-38  Score=313.16  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=199.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.+.||+|+||.||+|..  +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            5788999999999999999976  478899999875532 2223466789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++...... ....
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            995 68877776555678888999999999999999999999999999999999999999999999987543322 2234


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----------------CCCCC-
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQK----------------GLRPT-  438 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~----------------~~~p~-  438 (504)
                      ..+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..... ......                ...+. 
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            467899999999875 45889999999999999999999999866543221 111100                00000 


Q ss_pred             ----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ----IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ----~p---------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                          .+         ...++.+.+++.+|+..||.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                00         112578999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-38  Score=319.21  Aligned_cols=243  Identities=29%  Similarity=0.499  Sum_probs=205.5

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |.....||.|+||.||++..  .+..||||.+...  .......+.+|+.+++.++|+||+++++.+...+..|+||||+
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34456799999999999986  4678999998653  2334567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      ++++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++....... ......
T Consensus       102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence            99999998854  568999999999999999999999999999999999999999999999999986543222 223456


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhc
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~~cl~~  457 (504)
                      |+..|+|||.+.+..++.++|+||||+++|||++|..||...++.+....+. ....+..  ....++.+.+++.+||..
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHHHHccC
Confidence            8999999999998899999999999999999999999998877766544432 2222222  235788999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      ||.+|||+.++++
T Consensus       259 ~P~~Rpt~~~il~  271 (292)
T cd06658         259 EPSQRATAQELLQ  271 (292)
T ss_pred             ChhHCcCHHHHhh
Confidence            9999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.9e-38  Score=319.68  Aligned_cols=240  Identities=23%  Similarity=0.396  Sum_probs=185.6

Q ss_pred             eeeeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee--CCCCceeEEEe
Q 010680          226 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIVTEF  299 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~  299 (504)
                      +++||+|+||.||+|+..    +..||+|.++....    ...+.+|+.++++++||||+++++++.  .....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            468999999999999864    35799999875432    235778999999999999999999884  35567999999


Q ss_pred             cCCCchHHHHHhh--------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEEeeccce
Q 010680          300 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  367 (504)
Q Consensus       300 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl----~~~~~vkL~DFGla~  367 (504)
                      ++ ++|.+++...        ...+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            95 5888877532        1347888999999999999999999999999999999999    466789999999998


Q ss_pred             eccCCC----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh-
Q 010680          368 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAVGVVQ-  432 (504)
Q Consensus       368 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------~~~~~v~~-  432 (504)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|||+||.+||......         .....+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            654332    2234578999999999876 45899999999999999999999999643211         00000000 


Q ss_pred             ----------------------cCC-C------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 ----------------------KGL-R------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ----------------------~~~-~------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                            ... .            .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                                  000 0            0011123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=308.83  Aligned_cols=242  Identities=27%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.||.|+||.||+|..  .++.||||+++..... ......+..|..+ ....+|+|++++++++...+.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999987  4688999998754332 2223344555544 4455899999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY  382 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  382 (504)
                      ++|.+++.. .+.+++..+..++.||+.||.|||+++|+||||+|+||++++++.+||+|||+++....   .....++.
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            999999976 46789999999999999999999999999999999999999999999999999875443   23446889


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHhhhcCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPA  460 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~p~~p~~~~~~l~~Ll~~cl~~dP~  460 (504)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....  .+.....+++.+.+++.+||+.+|+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  237 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA  237 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence            99999999888899999999999999999999999988877665555443322  2234456889999999999999999


Q ss_pred             CCCCHHHHHHHH
Q 010680          461 LRPDFSEIIEIL  472 (504)
Q Consensus       461 ~RPs~~ell~~L  472 (504)
                      +||++.++.+.|
T Consensus       238 ~R~~~~~~~~~l  249 (260)
T cd05611         238 KRLGANGYQEIK  249 (260)
T ss_pred             HccCCCcHHHHH
Confidence            999776554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-37  Score=310.96  Aligned_cols=246  Identities=29%  Similarity=0.483  Sum_probs=202.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~  297 (504)
                      +|++.++||.|++|.||++..  .++.+|+|.+..... ......+.+|+++++.++||||+++++++..  .+.+|+||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            578889999999999999987  467899999885432 3446778999999999999999999998754  34689999


Q ss_pred             EecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||++|++|.+++...   ...++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence            999999999987542   3568889999999999999999999999999999999999999999999999986544322 


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCC------CCC
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIP------KNS  443 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~p~~p------~~~  443 (504)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||...     .+.+....+. ....+.++      ...
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (287)
T cd06621         160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGNGIKW  238 (287)
T ss_pred             cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCCCCch
Confidence            22446788999999999999999999999999999999999999765     2233332222 21122222      234


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+.+++.+||..+|.+|||+.|+++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-38  Score=313.22  Aligned_cols=241  Identities=25%  Similarity=0.405  Sum_probs=200.2

Q ss_pred             eeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||+|+||+||++..  +++.||+|++...... ......+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999976  4788999998754332 22345667899999999999999999999999999999999999999


Q ss_pred             HHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCc
Q 010680          306 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW  384 (504)
Q Consensus       306 ~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y  384 (504)
                      .+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997643 36899999999999999999999999999999999999999999999999998765544344455788999


Q ss_pred             cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       385 ~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      +|||.+.+..++.++|+||||+++|+|++|+.||...........+.  ........+..+++.+.++|.+||+.||.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            99999988889999999999999999999999997654311111111  1122345667789999999999999999999


Q ss_pred             C-----CHHHHH
Q 010680          463 P-----DFSEII  469 (504)
Q Consensus       463 P-----s~~ell  469 (504)
                      |     ++.+++
T Consensus       241 ~~~~~~~~~~ll  252 (277)
T cd05577         241 LGCRGGSADEVR  252 (277)
T ss_pred             cCCCcccHHHHH
Confidence            9     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.6e-38  Score=312.83  Aligned_cols=249  Identities=22%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||.|++|.||+|...  ++.||+|.++...........+.+|+.+++.++||||+++++++......|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999874  6789999987654444445678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccCC-Ccc
Q 010680          299 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS-GVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~-~~~  375 (504)
                      |++ ++|.+++..... .+++..+..++.||+.||+|||+++|+||||+|+||+++. ++.+||+|||++...... ...
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            995 588888765332 3678888999999999999999999999999999999985 557999999999754332 222


Q ss_pred             ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 010680          376 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------------  437 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----------------  437 (504)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+......+                 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            34567899999999865 468999999999999999999999998877665554433210000                 


Q ss_pred             --C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --~--------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                        .        .....++++.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0        12356788999999999999999999999885

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=323.18  Aligned_cols=245  Identities=31%  Similarity=0.520  Sum_probs=215.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +-|.++.+||+|+||.||++.+  .|+.||||.+..+    ...+++..|+.||+++..|+||++||.+.....++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3477889999999999999965  5888999997754    236788999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ||..|++.|.++..+.++++..+..++.+-++||+|||...-||||||+.|||++.+|..||+|||+|....+.- ...+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999999999888999999999999999999999999999999999999999999999999999997554432 2345


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERCW  455 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~~Ll~~cl  455 (504)
                      ..|||.|||||++..-.|+.++||||||++..||..|++||.+..|..++.-+-.+ ..|  ..|...+.++.+++++||
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHHHHHHh
Confidence            68999999999999999999999999999999999999999999887766543221 111  234567889999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      -++|++|.++.++++
T Consensus       268 iK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  268 IKKPEERKTALRLCE  282 (502)
T ss_pred             cCCHHHHHHHHHHhh
Confidence            999999999999874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.8e-38  Score=314.59  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=200.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC-----
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-----  292 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-----  292 (504)
                      .++|++.++||.|+||.||++..  +++.||||.+............+.+|+.++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            45799999999999999999987  46889999987554333334456789999999999999999998866543     


Q ss_pred             ---ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          293 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       293 ---~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                         .++||||+. ++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence               499999995 5898888765567999999999999999999999999999999999999999999999999999755


Q ss_pred             cCCC-----ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCC---
Q 010680          370 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPT---  438 (504)
Q Consensus       370 ~~~~-----~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~p~---  438 (504)
                      ....     ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...++......+..-  ...+.   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            4322     12234678899999988654 4789999999999999999999999877654332221110  00000   


Q ss_pred             ------------C-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ------------I-------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ------------~-------------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                  .             +...++.+.++|.+||..||.+||++.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                        0             1123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-37  Score=312.17  Aligned_cols=243  Identities=30%  Similarity=0.521  Sum_probs=206.2

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |.-.++||.|++|.||++..  .++.|++|.++..  .......+.+|+.+++.++||||+++++++...+..++++||+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            44457999999999999976  4677999988643  2233456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      +|++|.+++..  +.++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+....... ......
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            99999999976  578999999999999999999999999999999999999999999999999886543322 223356


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhc
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~~cl~~  457 (504)
                      |++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+... ..+..  +..+++.+.+++.+||+.
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHccc
Confidence            899999999999888999999999999999999999999887776665544332 22222  234788999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      +|++||++.++++
T Consensus       256 ~p~~Rpt~~~il~  268 (285)
T cd06648         256 DPAQRATAAELLN  268 (285)
T ss_pred             ChhhCcCHHHHcc
Confidence            9999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.5e-38  Score=315.19  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-----
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----  291 (504)
                      ..++|++.+.||+|+||.||+|...  ++.||||+++...........+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3467888999999999999999984  678999999865433334456788999999999999999999887654     


Q ss_pred             -----CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          292 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       292 -----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                           .+++|+||+++ +|.+++......+++..+..++.||+.||.|||++||+|+||||+||++++++.+||+|||++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence                 78999999965 788888765567999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCC--ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 010680          367 RVKAQSG--VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  437 (504)
Q Consensus       367 ~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------  437 (504)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+....+......+      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            7654432  1223356888999998865 457899999999999999999999998776655544433211110      


Q ss_pred             ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ----------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                            .....+++.+.+++.+||+.||.+||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                  011246889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-38  Score=308.89  Aligned_cols=241  Identities=27%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||.|+||.||++.+.  ++.|++|+++.... .......+.+|+.+++.++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985  78899999976543 234457788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---------ccc
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---------VMT  376 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---------~~~  376 (504)
                      .+++.+. +.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......         ...
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999763 478999999999999999999999999999999999999999999999999987543331         122


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~--~~~l~~Ll~~c  454 (504)
                      ...++..|+|||.+....++.++|+||||+++|+|++|..||....+.+....+.....  ..+..+  ++.+.+++.+|
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~  237 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLISKL  237 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHHHH
Confidence            34678899999999888899999999999999999999999998887776655544332  233444  89999999999


Q ss_pred             hhcCCCCCCCHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L  472 (504)
                      |+.+|.+||++..+.+.|
T Consensus       238 l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         238 LVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             hcCCHhhcCCCccHHHHh
Confidence            999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-38  Score=309.75  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCceeEEE
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTE  298 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~E  298 (504)
                      |++.++||+|+||.||+|+..  ++.+|+|+++...........+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999875  57899999987653444456788999999999999999999999887  78999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--ccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~  376 (504)
                      |++ ++|.+++......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++.......  ..+
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            996 58999887655689999999999999999999999999999999999999999999999999998665543  233


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------------  437 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------------------  437 (504)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......+                  
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            4467889999998764 468999999999999999999999998877655444332211000                  


Q ss_pred             -----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -----------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -----------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                 .....+++.+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       011123788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-38  Score=310.42  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=209.0

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |++.+.||.|++|.||++..  .++.+++|.++...........+.+|+.+++.++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45678999999999999987  4778999999876555455678889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      ++ +|.+++......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            64 8998887766789999999999999999999999999999999999999999999999999997665543 233456


Q ss_pred             CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------------
Q 010680          380 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------  437 (504)
Q Consensus       380 gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p---------------------  437 (504)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+                     
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            88899999999776 78999999999999999999999998877665544433221110                     


Q ss_pred             -------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                             .....++.++.++|.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   112346788999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.1e-38  Score=317.42  Aligned_cols=244  Identities=28%  Similarity=0.478  Sum_probs=206.1

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |....+||.|+||.||++..  .++.||||+++....  .....+.+|+.+++.++||||+++++.+..++..|+||||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            33455799999999999976  478899999865432  23456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      ++++|..++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......
T Consensus       101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            99999998754  568999999999999999999999999999999999999999999999999986443322 223457


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      |+..|+|||++.+..++.++||||||+++|||++|..||...++.+....+.... .....+...++.+.+++.+||+.+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  258 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE  258 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence            8999999999998899999999999999999999999998877766554433221 112233467889999999999999


Q ss_pred             CCCCCCHHHHHH
Q 010680          459 PALRPDFSEIIE  470 (504)
Q Consensus       459 P~~RPs~~ell~  470 (504)
                      |.+||++.++++
T Consensus       259 P~~Rps~~~ll~  270 (297)
T cd06659         259 PQERATAQELLD  270 (297)
T ss_pred             cccCcCHHHHhh
Confidence            999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=309.03  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=205.2

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEEeeeCCCC-----
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPS-----  292 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~-----  292 (504)
                      |++.+.||+|+||.||+|++.  ++.||+|+++...........+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567899999999999999985  68899999986544444445677788877766   59999999999987776     


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            899999996 58999887643 3589999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  437 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------------  437 (504)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+..+....+......+              
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            444445568899999999999999999999999999999999999999887766655544321100              


Q ss_pred             ---C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ---T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ---~--------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                         .        .....++.+.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               0        01234577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-37  Score=309.53  Aligned_cols=247  Identities=25%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|++.++||.|++|.||+|+.  .++.||||+++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            478899999999999999997  4678999998865332 2235677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          300 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       300 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      +++ +|.+++....  ..+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||+++...... ...
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            975 8998886543  468999999999999999999999999999999999999999999999999997544322 223


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------CCC-
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------RPT-  438 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------~p~-  438 (504)
                      ...++..|++||++.+ ..++.++||||||+++|+|++|..||...+..+....+.....                ... 
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            4567889999999865 4578999999999999999999999987776554443332110                001 


Q ss_pred             ----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ----------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                +...+++.+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      11345788999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6e-38  Score=315.40  Aligned_cols=246  Identities=28%  Similarity=0.506  Sum_probs=207.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|++.+.||+|+||.||++..  .++.||+|.+.....  .....+.+|+.++++++||||+++++.+...+..|+|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            5788899999999999999975  567899999864422  234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|.+++.+  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9999999999865  457889999999999999999999999999999999999999999999999886544332 2234


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCW  455 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~cl  455 (504)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.. ...+.  .+..++..+.+++.+||
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccccCHHHHHHHHHHc
Confidence            4688999999999888899999999999999999999999987766544332221 11222  23456788999999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 010680          456 QQDPALRPDFSEIIEI  471 (504)
Q Consensus       456 ~~dP~~RPs~~ell~~  471 (504)
                      ..+|++||++.+++..
T Consensus       254 ~~~p~~Rp~~~~il~h  269 (293)
T cd06647         254 EMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-37  Score=311.62  Aligned_cols=241  Identities=28%  Similarity=0.452  Sum_probs=194.6

Q ss_pred             eeeeeCceEEEEEEE--CCccEEEEEecCCCCChH-HHHHHHHHHHHHH---hcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMR---KVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~-~~~~~~~Ei~iL~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      .||+|+||.||++..  +++.||+|.+........ ....+.+|..+++   ..+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  467899999876543322 2233444544443   3479999999999999899999999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCC
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  381 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt  381 (504)
                      |++|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++...... ......||
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence            9999999876 567999999999999999999999999999999999999999999999999998754432 22345789


Q ss_pred             CCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 010680          382 YRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP  459 (504)
Q Consensus       382 ~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP  459 (504)
                      ..|+|||.+. +..++.++|+|||||++|+|++|..||....... .............++..+++++.++|.+||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986 4668999999999999999999999997543211 1111122234456777899999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 010680          460 ALRP-----DFSEIIE  470 (504)
Q Consensus       460 ~~RP-----s~~ell~  470 (504)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~~~~  254 (279)
T cd05633         239 SKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHhcCCCCCCHHHHHh
Confidence            9999     5887765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=303.37  Aligned_cols=261  Identities=21%  Similarity=0.333  Sum_probs=212.0

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-  290 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-  290 (504)
                      +..-|+.++|+|.++||+|+|+-||+++.  ++..+|+|.+....  .+..+...+|+...++++||||++++++...+ 
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            34578999999999999999999999875  56779999998763  45567889999999999999999999876433 


Q ss_pred             ----CCceeEEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEE
Q 010680          291 ----PSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA  361 (504)
Q Consensus       291 ----~~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~vkL~  361 (504)
                          ...||+++|...|+|.+.++...   ..+++..+++|+.+|++||.+||+..  ++||||||.|||+++.+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                34899999999999999987552   36999999999999999999999998  9999999999999999999999


Q ss_pred             eeccceeccCCC----------ccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHH
Q 010680          362 DFGVARVKAQSG----------VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQA  426 (504)
Q Consensus       362 DFGla~~~~~~~----------~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~  426 (504)
                      |||.++.....-          ....+.-|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-.  ...
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            999987433211          122345789999999995   55678999999999999999999999963211  111


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      +..+......-+.....++.+.+++..|++.||.+||++.+++..++++.
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11111111111122348899999999999999999999999999998764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9e-38  Score=319.07  Aligned_cols=253  Identities=25%  Similarity=0.444  Sum_probs=203.2

Q ss_pred             eeeeee--CceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G--~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      .+||.|  +||+||++.+  .++.||||+++.........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  9999999987  678999999987655555567889999999999999999999999999999999999999


Q ss_pred             CchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-------
Q 010680          303 GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-------  374 (504)
Q Consensus       303 gsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-------  374 (504)
                      ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            99999987643 3588999999999999999999999999999999999999999999999986543222111       


Q ss_pred             -cccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------
Q 010680          375 -MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-----------------  434 (504)
Q Consensus       375 -~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-----------------  434 (504)
                       .....++..|+|||++.+  ..++.++|||||||++|+|++|..||......+.........                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             111235667999999976  357899999999999999999999998776554443322111                 


Q ss_pred             ----------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHHHHHh
Q 010680          435 ----------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQIAKEV  479 (504)
Q Consensus       435 ----------------------------~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell--~~L~~l~~~~  479 (504)
                                                  .+...+..+++.+.+|+.+||+.||++|||+.+++  ..+..+.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                        01112234667899999999999999999999997  4566665543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.8e-38  Score=316.86  Aligned_cols=248  Identities=22%  Similarity=0.396  Sum_probs=203.6

Q ss_pred             eeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          223 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.+++.+|.|+++.||+++.+++.||||+++...........+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            44566777778888888888899999999987655555677899999999999999999999999999999999999999


Q ss_pred             CchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--------
Q 010680          303 GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--------  373 (504)
Q Consensus       303 gsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--------  373 (504)
                      ++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999764 3468999999999999999999999999999999999999999999999999886443221        


Q ss_pred             ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010680          374 VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------  435 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------  435 (504)
                      ......++..|+|||++.+  ..++.++|+|||||++|+|++|..||.................                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233457788999999865  4688999999999999999999999987765544333221110                


Q ss_pred             ----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 ----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ----------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                      ....+...++++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                            00111233567899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=314.48  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=196.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEE----CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCce
Q 010680          222 HLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~----~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~  294 (504)
                      .|++.++||+|+||.||+|..    .++.||+|.++.... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            477889999999999999987    457899999987431 222345678899999999999999999999887  7899


Q ss_pred             eEEEecCCCchHHHHHhhc----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----CCcEEEEeeccc
Q 010680          295 IVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA  366 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~----~~~vkL~DFGla  366 (504)
                      +||||++ ++|.+++....    ..+++..++.++.||+.||.|||+++|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999995 57777765322    36889999999999999999999999999999999999999    899999999999


Q ss_pred             eeccCCCc----cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh
Q 010680          367 RVKAQSGV----MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ---------AAVGVVQ  432 (504)
Q Consensus       367 ~~~~~~~~----~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~---------~~~~v~~  432 (504)
                      +.......    .....++..|+|||++.+ ..++.++||||||+++|+|++|++||.......         ....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76543322    223467889999998865 468999999999999999999999997544321         0000000


Q ss_pred             ------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 ------------------------KGLRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ------------------------~~~~p~~p-----------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                              .......+           ...+.++.+++.+||+.||++|||+.+++.
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                    00011111           156678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.2e-38  Score=320.75  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=205.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----CCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~  293 (504)
                      .+|++.+.||+|+||.||++..  +++.||||.++...........+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999986  468899999886543444456678899999999999999999987644     347


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  372 (504)
                      |+|+||+ +++|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            9999999 5789988875 567999999999999999999999999999999999999999999999999999765443 


Q ss_pred             CccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 010680          373 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------------------  432 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~-------------------  432 (504)
                      .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.+.+.......+..                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23345578899999998864 4689999999999999999999999987654322211110                   


Q ss_pred             ----cC---CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 010680          433 ----KG---LR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  475 (504)
Q Consensus       433 ----~~---~~---p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~--L~~l  475 (504)
                          ..   .+   ......+++++.+++.+||+.+|.+||++.++++.  |..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                00   00   01224678999999999999999999999999865  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-37  Score=308.50  Aligned_cols=247  Identities=25%  Similarity=0.483  Sum_probs=212.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ++|.+.+.||+|+||.||+++.  .++.||+|++..... .......+.+|+.++++++ ||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3688999999999999999987  578899999876433 2334567889999999999 99999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--  374 (504)
                      |||+++++|.+++.+ .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999999987 45799999999999999999999999999999999999999999999999999875443221  


Q ss_pred             -------------------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 010680          375 -------------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       375 -------------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                                         .....++..|+|||++....++.++|+||||+++|+|++|..||...+.......+..  .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~  237 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--L  237 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--c
Confidence                               1123578899999999888899999999999999999999999998876655555442  3


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDF----SEIIE  470 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~----~ell~  470 (504)
                      ...++..+++.+.+++.+||+.+|.+||++    .++++
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            345677889999999999999999999999    77653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-38  Score=325.06  Aligned_cols=255  Identities=21%  Similarity=0.360  Sum_probs=212.7

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~  291 (504)
                      ..+.+....|++.++||+|+.+.||++...+ +.+|+|.+.....+.....-|.+|+..|.+|+ |.+||++|++-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            4567888999999999999999999998754 66888888777777888899999999999996 899999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+||||||= ..+|..+|++....++...+..+..||+.++.++|+.||||.||||.|+|+-. |.+||+|||.|.....
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            999999985 77999999987666666689999999999999999999999999999999974 7899999999986554


Q ss_pred             CC---ccccCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCC
Q 010680          372 SG---VMTAETGTYRWMAPEVIEHKP-----------YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLR  436 (504)
Q Consensus       372 ~~---~~~~~~gt~~y~APE~l~~~~-----------~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-~v~~~~~~  436 (504)
                      +.   .....+||+-||+||.+....           .++++|||||||+||+|+.|+.||........-. .+...+..
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            32   344668999999999984332           5578999999999999999999998765433332 33332233


Q ss_pred             CCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 PTIPKNSQPK-LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p~~p~~~~~~-l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      -++|..-+.. +.++|..||..||.+||++.++|+
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            3444433333 999999999999999999999874

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-37  Score=311.69  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=207.3

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      |...++||+|+||.||+|+.  .++.|++|++..... .......+.+|+.+++.++|||++++++++......|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            45567899999999999986  577899999875433 334456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  379 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  379 (504)
                      +. ++|.+++......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....   ......
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~  178 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV  178 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence            95 68888887666779999999999999999999999999999999999999999999999999986432   233457


Q ss_pred             CCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          380 GTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       380 gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      |+..|+|||++.   ...++.++||||||+++|+|++|..||...+....................++..+.+++.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            889999999984   45688999999999999999999999988877766666554433333344677889999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .+|.+||++.+++.
T Consensus       259 ~~P~~Rp~~~~~l~  272 (313)
T cd06633         259 KIPQERPASAELLR  272 (313)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-37  Score=312.79  Aligned_cols=247  Identities=30%  Similarity=0.451  Sum_probs=208.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..|...+.||+|+||.||+|..  .++.||+|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3477778999999999999987  467899999875422 3344567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+. ++|.+++......++...+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....   ...
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~  170 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANX  170 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccc
Confidence            9995 688888866566789999999999999999999999999999999999999999999999999876543   234


Q ss_pred             CCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          378 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       378 ~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..+++.|+|||.+.   ...++.++|||||||++|+|++|..||...+..+..............+..++..+.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56889999999974   456888999999999999999999999887766655554443332233456888999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEI  471 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~  471 (504)
                      |..+|.+||++.+++..
T Consensus       251 l~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         251 LQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             hhCCcccCCCHHHHhhC
Confidence            99999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-37  Score=309.71  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  293 (504)
                      .|++.+.||.|+||.||++..     +++.||+|+++....  .....+.+.+|+.+++.+ +|+||+.+++.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367889999999999999976     567899999876432  123346788899999999 589999999999998889


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999997654332


Q ss_pred             --ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHH
Q 010680          374 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                        ......|+..|+|||.+.+  ..++.++||||||+++|+|++|..||......   ......... ..+..+..+++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHH
Confidence              2224568999999999865  34788999999999999999999999643221   112221211 234567788999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 010680          447 LAELLERCWQQDPALRP-----DFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RP-----s~~ell~  470 (504)
                      +.+++.+||+.||++||     ++.+++.
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            99999999999999997     5666643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=338.38  Aligned_cols=258  Identities=32%  Similarity=0.602  Sum_probs=228.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      ..+++..++||+|+||+||+|.|.      +-+||||++..... ...-.++..|+.+|.+++|||+++++++|.... +
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            345677789999999999999873      35699999875533 334578999999999999999999999998765 8


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      .||++||++|+|.||++..++.+-....+.|..||++||.|||.++++||||.++|||+.+-.++||.|||+++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999998765543


Q ss_pred             -ccccCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          374 -VMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       374 -~~~~~~g--t~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                       ...+..|  .+.|||-|.+....|++++|||||||++||++| |..||++....+ +.+.++++.|...|+.|+.++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYM  931 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHH
Confidence             2333333  568999999999999999999999999999999 999999987654 56778899999999999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +|.+||..|+..||+|+++...+..+.++..
T Consensus       932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            9999999999999999999999998876543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-37  Score=307.77  Aligned_cols=241  Identities=28%  Similarity=0.433  Sum_probs=195.5

Q ss_pred             eeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHH---HHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVF---IMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      .||+|+||.||++..  .++.||||++....... .....+..|..   +++...||+|+.+++++...+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999876  46789999987654332 21223344443   4445579999999999999999999999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCC
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  381 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt  381 (504)
                      |++|.+++.. .+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++...... ......|+
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence            9999998875 567999999999999999999999999999999999999999999999999998754332 22345789


Q ss_pred             CCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 010680          382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP  459 (504)
Q Consensus       382 ~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP  459 (504)
                      ..|+|||++.+ ..++.++||||+|+++|+|++|+.||....... ...........+..+..+++++.+++.+||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            99999999974 468999999999999999999999997653211 1111122334456777889999999999999999


Q ss_pred             CCCC-----CHHHHHH
Q 010680          460 ALRP-----DFSEIIE  470 (504)
Q Consensus       460 ~~RP-----s~~ell~  470 (504)
                      .+||     ++.++++
T Consensus       239 ~~R~~~~~~~~~~ll~  254 (278)
T cd05606         239 NRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HhccCCCCCCHHHHHh
Confidence            9999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=322.62  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=215.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEE--ECCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~--~~g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..+.|..-++||+|+||.||-+.  .+|+-+|+|.+.+.+... ....-..+|-.||.+++.+.||.+-.++.+++.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            4666788888999999999999764  578899999987665543 2334567899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      |+|+..|.||+|.-+|.+.. ..|++..+..++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|......
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999998887654 46999999999999999999999999999999999999999999999999999998888


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~L  450 (504)
                      ......+||.+|||||++....|+...|+|||||+||||+.|..||........-..+-  ........+...+++++++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            88888899999999999999999999999999999999999999997543322211111  1222345778999999999


Q ss_pred             HHHhhhcCCCCCCCHH
Q 010680          451 LERCWQQDPALRPDFS  466 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~  466 (504)
                      .+.+|++||.+|....
T Consensus       421 c~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHccCHHHhccCC
Confidence            9999999999997654

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-37  Score=315.31  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=211.0

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-----Cce
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC  294 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~  294 (504)
                      +|++.+.||.|+||.||+|+..  ++.||||.+..........+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999874  688999998865443455678999999999999999999999987765     789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ++|||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9999996 589998876 4589999999999999999999999999999999999999999999999999998765543 


Q ss_pred             ---ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 010680          374 ---VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------  437 (504)
Q Consensus       374 ---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------------  437 (504)
                         ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+......+            
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23455788999999999877 89999999999999999999999998877655444433211100            


Q ss_pred             -----------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 010680          438 -----------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  475 (504)
Q Consensus       438 -----------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~--L~~l  475 (504)
                                       .....+++.+.+++.+||+.+|.+||++.+++..  |+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                             0123467889999999999999999999999863  5544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-37  Score=335.27  Aligned_cols=250  Identities=17%  Similarity=0.288  Sum_probs=189.8

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECC---ccEEEEEe---------------cCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVL---------------KPERINSDMQKEFAQEVFIMRKVRHKNVV  281 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g---~~VAvK~l---------------k~~~~~~~~~~~~~~Ei~iL~~l~HpnIv  281 (504)
                      ..+|++.++||+|+||+||++....   ..+++|.+               +...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3679999999999999999986532   12222211               11111223456688999999999999999


Q ss_pred             EEEEeeeCCCCceeEEEecCCCchHHHHHhhc----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010680          282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  357 (504)
Q Consensus       282 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~  357 (504)
                      ++++++...+..|+|+|++ +++|.+++....    .......+..++.||+.||.|||++|||||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999999 568888775421    22345677889999999999999999999999999999999999


Q ss_pred             EEEEeeccceeccCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC-CCCCC--CHHHHHHHHHh
Q 010680          358 VKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYL--TPLQAAVGVVQ  432 (504)
Q Consensus       358 vkL~DFGla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~-Pf~~~--~~~~~~~~v~~  432 (504)
                      +||+|||+++......  ......||..|+|||++.+..|+.++|||||||++|||++|.. ||...  .+......++.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~  385 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID  385 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence            9999999998665432  2234579999999999999999999999999999999999775 45322  22222222221


Q ss_pred             cCC---------------------CCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 KGL---------------------RPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ~~~---------------------~p~~---------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ...                     ....         ...++.++.++|.+||+.||.+|||+.|++.
T Consensus       386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000                     0000         0134567888899999999999999999975

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=315.62  Aligned_cols=251  Identities=26%  Similarity=0.449  Sum_probs=200.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----CCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~  293 (504)
                      ++|++.++||+|+||.||+|.+  +++.||||+++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            5799999999999999999976  47889999987532 223456688899999999999999999876543     347


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+|+||++ ++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            99999995 588887753  578999999999999999999999999999999999999999999999999997654322


Q ss_pred             ----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 010680          374 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK---------------  433 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~---------------  433 (504)
                          ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+...               
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence                1223468999999998754 56899999999999999999999999765543322211100               


Q ss_pred             ---------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 010680          434 ---------GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI  475 (504)
Q Consensus       434 ---------~~~p~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~--L~~l  475 (504)
                               ...+.     .....++++.+++.+||+.||++||++.++++.  |...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                     00000     113457889999999999999999999999865  5444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-37  Score=310.46  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=200.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------  291 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||||++............+.+|+.+++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999874  678999998765433333346778999999999999999998775433      


Q ss_pred             --CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          292 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       292 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                        .+++||||+. ++|...+......+++..+..++.||++||.|||++||+|+||||+||++++++.+||+|||+++..
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              4699999995 5788877765668999999999999999999999999999999999999999999999999999754


Q ss_pred             cCCCc------------cccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 010680          370 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR  436 (504)
Q Consensus       370 ~~~~~------------~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~  436 (504)
                      .....            .+...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+.......+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            43221            122356888999998865 45899999999999999999999999887765544433221100


Q ss_pred             C---------------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 P---------------------TI-------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p---------------------~~-------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +                     ..       .....+.+.+++.+||+.||.+|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0                     00       0234478899999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=305.67  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=202.8

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      |++.+.||+|+||.||+|+..  ++.|+||.+........ .....+|+..+++++ ||||+++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            567889999999999999984  57799999876543222 334567999999999 99999999999999999999999


Q ss_pred             cCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          300 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      + +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence            9 889999987644 47899999999999999999999999999999999999999999999999999876554444556


Q ss_pred             CCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Q 010680          379 TGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------------  437 (504)
Q Consensus       379 ~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------------------  437 (504)
                      .++..|+|||++. ...++.++|+||||+++|+|++|.+||...+.......+..-...+                    
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            7899999999884 4568899999999999999999999998776655443322110000                    


Q ss_pred             --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              ......++.+.+++.+||+.||++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                    011223678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-37  Score=317.81  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=201.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC----CCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~  294 (504)
                      .+|++.+.||.|+||.||+|..  +++.||+|++............+.+|+.+|+.++||||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5788889999999999999986  47889999998654444445678889999999999999999987753    34679


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      +||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999995 689998865 4569999999999999999999999999999999999999999999999999997544322 


Q ss_pred             ----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 010680          374 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK---------------  433 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~---------------  433 (504)
                          ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                1234578999999999865 56899999999999999999999999876544332211110               


Q ss_pred             ---------CCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          434 ---------GLRPTI-----PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       434 ---------~~~p~~-----p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                               ......     ....++++.++|.+||+.+|.+||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                     001111     1446889999999999999999999998875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.6e-37  Score=308.80  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=207.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  293 (504)
                      +|++.+.||+|+||.||+++.     .++.||||+++.....  ......+.+|+.+++.+ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377889999999999999875     3467999998754322  22346688999999999 599999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999999999999876 4678999999999999999999999999999999999999999999999999987654332


Q ss_pred             c--cccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      .  .....|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||....    ..+....+.  ...+..+..+++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccCH
Confidence            2  22346889999999987654  7889999999999999999999996432    222222222  223456777899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+.+++.+||+.||++|||+.++.+.|...
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            999999999999999999998887777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=352.33  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=219.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|.++++||+|+||.|.+++.+  ++-||+|++++-.. ......-|..|-.+|..-+.+.|++++.+|.++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            455678999999999999999999874  67799999986432 233346788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+|||||+||+|..++.+.. ++++..+..++..|+.||+.||+.|+|||||||+|||||..|++||+|||.+-....++
T Consensus       151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            99999999999999999865 89999999999999999999999999999999999999999999999999987666555


Q ss_pred             c--cccCCCCCCccCccccc----C-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCc
Q 010680          374 V--MTAETGTYRWMAPEVIE----H-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQ  444 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~----~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~  444 (504)
                      .  ....+|||-|++||++.    + +.|+..+|+||+||++|||+.|..||...+..+++-.++.-.....+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            3  33568999999999983    3 579999999999999999999999999999999998888765555566  5689


Q ss_pred             HHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPD---FSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs---~~ell~  470 (504)
                      ++.++||++.+. +|+.|..   +.++..
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            999999999886 5678876   777653

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4e-37  Score=302.31  Aligned_cols=247  Identities=29%  Similarity=0.529  Sum_probs=208.5

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +|.+.++||+|+||.||++.+.  +..+++|+++...   ........+.+|+.++++++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999875  3457777766432   2223345677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||++|++|+||||+||+++. +.++|+|||+++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            9999999999988642   356899999999999999999999999999999999999975 579999999997654332


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......... .+..+..+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence             2334568899999999988889999999999999999999999998776665555443 35556677788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||..||++||++.++++
T Consensus       239 ~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         239 SMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHhcCChhhCcCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=298.28  Aligned_cols=236  Identities=28%  Similarity=0.424  Sum_probs=206.1

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      ||.|+||.||++...  ++.+|+|+++..... ......+..|+.++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875  688999998765432 23566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCCCCc
Q 010680          306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW  384 (504)
Q Consensus       306 ~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y  384 (504)
                      .+++.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++...... .......++..|
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            999976 356899999999999999999999999999999999999999999999999999765443 233455788999


Q ss_pred             cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 010680          385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       385 ~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                      +|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..  ....++...+..+.+++.+||..||++||+
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999888899999999999999999999999988776555444443  345677888999999999999999999999


Q ss_pred             HHH
Q 010680          465 FSE  467 (504)
Q Consensus       465 ~~e  467 (504)
                      +.+
T Consensus       238 ~~~  240 (250)
T cd05123         238 SGG  240 (250)
T ss_pred             ccc
Confidence            944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-36  Score=312.56  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=207.9

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-  291 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-  291 (504)
                      .|.+ .++|++.+.||+|+||.||++..  .+..||||+++...........+.+|+.+|+.++||||+++++++.... 
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4555 36799999999999999999976  4678999998765444445567889999999999999999999887654 


Q ss_pred             -----CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          292 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       292 -----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                           .+++||||+ |++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                 348999999 7899888864  57899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------  436 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------  436 (504)
                      ......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......         
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            754332  234567899999999865 45889999999999999999999999877654443333221110         


Q ss_pred             --------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHH
Q 010680          437 --------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQI  475 (504)
Q Consensus       437 --------------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell--~~L~~l  475 (504)
                                          ......+++.+.++|.+|++.||.+||++.+++  ..++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                                012246788899999999999999999999988  444444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=331.32  Aligned_cols=244  Identities=27%  Similarity=0.526  Sum_probs=204.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC--cee
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCI  295 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~l  295 (504)
                      -+++..+||+|+|-+||+|.+.  |-.||--.++...  .+....++|..|+.+|+.|+||||+++|.+|.+..+  +.+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            3566789999999999999875  4445533333222  234556889999999999999999999999987665  778


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEC-CCCcEEEEeeccceeccCC
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--~IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~  372 (504)
                      |+|.|..|+|..|+.+ -+.+....+..|++||++||.|||++  -|||||||.+||+|+ ..|.|||+|+|+|.....+
T Consensus       121 iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999999987 46688899999999999999999998  499999999999997 5689999999999887766


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCC-CCCCCcHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPT-IPKNSQPKLAEL  450 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~p~-~p~~~~~~l~~L  450 (504)
                      .... -+|||.|||||+.. ..|++.+||||||++|+||+|+..||.. .++.+++.++. .|..|. +.+--.|+++++
T Consensus       200 ~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  200 HAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             ccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhhccCCHHHHHH
Confidence            4443 68999999999998 6699999999999999999999999965 56667666655 455543 444557899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      |.+|+.. ..+|||+.|+|+
T Consensus       277 IekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHhcC-chhccCHHHHhh
Confidence            9999999 899999999974

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.4e-37  Score=307.28  Aligned_cols=241  Identities=30%  Similarity=0.491  Sum_probs=204.1

Q ss_pred             eeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCC
Q 010680          225 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      ...+||+|+||.||++..  +++.||||.+...  .......+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            346899999999999987  4678999987643  223456788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~gt  381 (504)
                      ++|.+++..  +.+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++....... ......++
T Consensus       102 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         102 GALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            999998753  568999999999999999999999999999999999999999999999999986543321 22345688


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQQDP  459 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~cl~~dP  459 (504)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+ .....+.  ....+++.+.+++.+||..||
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence            9999999998888999999999999999999999999887766554333 2222222  234578899999999999999


Q ss_pred             CCCCCHHHHHH
Q 010680          460 ALRPDFSEIIE  470 (504)
Q Consensus       460 ~~RPs~~ell~  470 (504)
                      .+||++.+++.
T Consensus       259 ~~R~~~~~ll~  269 (292)
T cd06657         259 AQRATAAELLK  269 (292)
T ss_pred             ccCcCHHHHhc
Confidence            99999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.3e-37  Score=314.36  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCC--CCcee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP--PSLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~~~~l  295 (504)
                      ++|++.+.||+|+||.||+|.+  .++.||||.+............+.+|+.+++++ +||||+++++++...  ..+|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            5688889999999999999987  467899998865433344456677899999999 999999999987643  35799


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--  373 (504)
                      ||||++ ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        87 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          87 VFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             Eecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999996 599998865  378888999999999999999999999999999999999999999999999997554322  


Q ss_pred             ----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------
Q 010680          374 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------  436 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------  436 (504)
                          ......||..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+......            
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                2233468999999998754 56789999999999999999999999876655433322211100            


Q ss_pred             -----------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          437 -----------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       437 -----------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                       ....+.++.++.+++.+||+.||++||++.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                             01123468899999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-37  Score=314.50  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=206.0

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ..|++. .+|.+.+.||+|+||.||+|..  +++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            456664 5799999999999999999986  4788999998765444444566889999999999999999999886543


Q ss_pred             ------CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          292 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       292 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                            .+|+|+||+. .+|..++   ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          88 SGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             cCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence                  3589999995 4776655   34689999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------
Q 010680          366 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------  435 (504)
Q Consensus       366 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------  435 (504)
                      ++....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....         
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432  2334567889999999866 4689999999999999999999999988775554433222100         


Q ss_pred             ------------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 010680          436 ------------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIA  476 (504)
Q Consensus       436 ------------~p~~--------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l~  476 (504)
                                  .+..        ....++++.++|.+||+.||.+||++.+++.  .++.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                        0001        1246788999999999999999999999984  466553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=311.27  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             eeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~------------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..+.+.||.|+||.||+|.+  .++.||||+++.......            ....+.+|+.+++.++|+||+++++++.
T Consensus        11 ~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   90 (335)
T PTZ00024         11 IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV   90 (335)
T ss_pred             hhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence            34567899999999999986  467899999875432220            1124778999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ..+..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+++.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         91 EGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             cCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence            9999999999995 689998865 56789999999999999999999999999999999999999999999999999976


Q ss_pred             ccCC---------------CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 010680          369 KAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       369 ~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~  432 (504)
                      ....               .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            5411               112234568899999998764 478999999999999999999999988877655444332


Q ss_pred             cCCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          433 KGLRP--------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       433 ~~~~p--------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ....+                          .....+++++.+++.+||+.+|++||++.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11100                          011345788999999999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-37  Score=303.21  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=205.9

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |++.+.||+|.||.||+|+..  ++.||+|+++...........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999875  688999999876534444567888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccCC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      + ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++...... ......
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            6 59999998755679999999999999999999999999999999999999999999999999997654432 333456


Q ss_pred             CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------------CC--
Q 010680          380 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-------------------RP--  437 (504)
Q Consensus       380 gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-------------------~p--  437 (504)
                      ++..|+|||.+.+. .++.++||||||+++|||++|..||...+.......+.....                   .+  
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            67889999998766 789999999999999999999999987765554433322100                   00  


Q ss_pred             ------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            ...+..+..+.+++.+||..||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                  011234778999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-36  Score=301.74  Aligned_cols=238  Identities=21%  Similarity=0.403  Sum_probs=192.6

Q ss_pred             ceeeeeee--eeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeE
Q 010680          222 HLKFGSKV--ASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       222 ~~~i~~~L--G~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .|++.+.+  |+|+||.||++..  ++..+|+|+++.......       |+.....+ +||||+++++.+...+..|+|
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            44555554  9999999999986  467899999876533221       22222222 699999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCCCcc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~  375 (504)
                      |||+++++|.+++... ..+++..+..++.||++||.|||+.|++||||||+||+++.++ .++|+|||+++.....   
T Consensus        88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            9999999999999763 4899999999999999999999999999999999999999988 9999999998765432   


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ....++..|+|||++.+..++.++||||||+++|+|++|..||.............  ........+..+++.+.++|.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS  243 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence            23468999999999999999999999999999999999999997554322111111  1122334556789999999999


Q ss_pred             hhhcCCCCCCC-HHHHHH
Q 010680          454 CWQQDPALRPD-FSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs-~~ell~  470 (504)
                      ||+.+|.+||+ +.++++
T Consensus       244 ~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        244 MLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HhccChhhCCchHHHHhc
Confidence            99999999996 688864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-36  Score=309.32  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=197.9

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeC----CCC
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS  292 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~  292 (504)
                      +|++.+.||+|+||.||++.+.    +..||||.++...........+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999986    45799999876543444456788899999999 59999999986532    245


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .++++||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            68899998 4689998865 567899999999999999999999999999999999999999999999999999754432


Q ss_pred             C-----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 010680          373 G-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------  433 (504)
Q Consensus       373 ~-----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~-------------  433 (504)
                      .     ......||..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......++..             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            2     1233478999999998765 57899999999999999999999999876544332221110             


Q ss_pred             -------------CCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          434 -------------GLR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       434 -------------~~~---p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                   ...   +.....++..+.+++.+||+.||.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                         000   0112345788999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=326.13  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=229.0

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECCcc--EEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~--VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +..++++++.-||-|+||.|-+....++.  +|+|++++... +....+++..|-.||.+.+.|.||++|..+.+....|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            44567788889999999999999988776  89999987654 5566788999999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      +.||-|-||.|...|++ ++.|...++..++..++.|++|||++|||+|||||+|++++.+|.+||.|||+|+....+..
T Consensus       497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999999988 78999999999999999999999999999999999999999999999999999998888888


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      .-+.+|||.|.|||++..+..+.++|.||||+++||||+|.+||.+.++...+..++.......+|..++....+||.++
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL  655 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence            88899999999999999999999999999999999999999999999999999888877667789999999999999999


Q ss_pred             hhcCCCCCCC
Q 010680          455 WQQDPALRPD  464 (504)
Q Consensus       455 l~~dP~~RPs  464 (504)
                      +..+|.+|..
T Consensus       656 Cr~~P~ERLG  665 (732)
T KOG0614|consen  656 CRDNPTERLG  665 (732)
T ss_pred             HhcCcHhhhc
Confidence            9999999975

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-37  Score=314.06  Aligned_cols=250  Identities=27%  Similarity=0.437  Sum_probs=206.1

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .|++. ++|.+.+.||+|+||.||+|...  ++.||||+++...........+.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            34453 57999999999999999999884  6789999987654444445677889999999999999999987765544


Q ss_pred             ------ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          293 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       293 ------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                            .++|+||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence                  89999999 7799998864  57899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------  437 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------  437 (504)
                      ......  .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+......+        
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765432  345578899999999855 468899999999999999999999998777655444332211000        


Q ss_pred             ---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ---------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ---------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                           ......++++.+++.+||+.||.+|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                 011245889999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-36  Score=311.27  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC---
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP---  290 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---  290 (504)
                      |.+. ++|.+.+.||+|+||.||++..  +++.||+|+++...........+.+|+.++++++||||+++++++...   
T Consensus        13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            4443 6799999999999999999975  478899999986543444456788899999999999999999987543   


Q ss_pred             ---CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          291 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       291 ---~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                         ...|++++++ |++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence               3467888887 8899988854  468999999999999999999999999999999999999999999999999987


Q ss_pred             eccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-----------  435 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-----------  435 (504)
                      ....  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....           
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            5433  2344578899999999865 5789999999999999999999999987665444333221100           


Q ss_pred             -------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          436 -------------RPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       436 -------------~p~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                                   .+.     .....++++.++|.+||+.||.+||++.+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                         000     112457889999999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=305.47  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=214.9

Q ss_pred             CCCceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCCceEEEEeee
Q 010680          212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACT  288 (504)
Q Consensus       212 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~  288 (504)
                      ....|++..++++-...||.|+||+|++-.+  .|+..|||.++.... ...+++++.|... ++.-++||||++||++.
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            3456788888899899999999999998866  478899999997654 3446778888875 55557999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHh----hcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      .++..+|.||.| ..||..+...    .+..+++..+-.|+...+.||+||-.. +|||||+||+|||++..|.||||||
T Consensus       134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            999999999999 6787765432    246799999999999999999999875 8999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--  439 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--  439 (504)
                      |.+.....+-..+...|...|||||.+.  ...|+.++||||||++|||+.||..||.+++..-.....+..+..|.+  
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence            9998777777778889999999999994  456999999999999999999999999987764333333333333322  


Q ss_pred             C---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          440 P---KNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       440 p---~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      +   .+.+..+..++.-|+.+|-..||.+.++++.
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2   2468899999999999999999999998753

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=354.45  Aligned_cols=248  Identities=30%  Similarity=0.481  Sum_probs=214.7

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ++..+.+||.|.||.||-|..  +|+..|+|-++...........+.+|..++..++|||+|+.+|+--+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            345567899999999999975  578899998886654445556788999999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-----c
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----V  374 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~  374 (504)
                      |+||+|.+.+.. .+..++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|.....+.     .
T Consensus      1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999999975 5557777788899999999999999999999999999999999999999999997654442     2


Q ss_pred             cccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      .....||+.|||||++.+   ++...++||||||||+.||+||+.||..++..=++.-.+..+-.|.+|..++++-+++|
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            334589999999999964   45678999999999999999999999887766555555677889999999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      ++||..||..|-++.||++
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHH
Confidence            9999999999988876654

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.2e-36  Score=307.43  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=200.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-CCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~  297 (504)
                      ++|.+.+.||.|+||.||++..  +++.||||.+..........+.+.+|+.+++.++||||+++++++.. ....|++|
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            5699999999999999999976  46789999987654444445678899999999999999999998865 55789999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+ +++|.+++..  ..++...+..++.||+.||.|||+++|+||||+|+||++++++.++|+|||.+.....  ....
T Consensus        90 e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~  164 (328)
T cd07856          90 ELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG  164 (328)
T ss_pred             ehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence            999 6789888864  5678888999999999999999999999999999999999999999999999875432  2234


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------------c
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------------------K  433 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~-----------------------~  433 (504)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|..||....+......+..                       .
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            567889999999865 6789999999999999999999999987665332211110                       0


Q ss_pred             -CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          434 -GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       434 -~~~p~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                       .....     ....+++++.++|.+||+.+|++||++.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00001     113567899999999999999999999998643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=321.22  Aligned_cols=243  Identities=25%  Similarity=0.421  Sum_probs=213.3

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCc
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS  304 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  304 (504)
                      +.||+|.||+||-|++  +|+.||||++.+.++.......+++|+.||+++.||.||.+.-.|+.++..++|||.+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            6899999999999976  58999999999988877667889999999999999999999999999999999999997766


Q ss_pred             hHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEEeeccceeccCCCccccCCCC
Q 010680          305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVMTAETGT  381 (504)
Q Consensus       305 L~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~gt  381 (504)
                      |.-.|...++.+++.....++.||+.||.|||-+||+|+||||+|||+...   ..+||||||+||+..........+||
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT  729 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT  729 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence            666677778999999999999999999999999999999999999999654   47999999999999988888888999


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL  461 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~  461 (504)
                      |.|.|||++..+.|...-|+||.|+++|--|+|..||..............--..|.....++++..+||..+|+..-.+
T Consensus       730 PAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~k  809 (888)
T KOG4236|consen  730 PAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRK  809 (888)
T ss_pred             ccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999996544322222212222345556789999999999999999999


Q ss_pred             CCCHHHHH
Q 010680          462 RPDFSEII  469 (504)
Q Consensus       462 RPs~~ell  469 (504)
                      |-|..+.+
T Consensus       810 Rysvdk~l  817 (888)
T KOG4236|consen  810 RYSVDKSL  817 (888)
T ss_pred             hcchHhhc
Confidence            99887654

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.4e-36  Score=310.73  Aligned_cols=245  Identities=23%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--------  290 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------  290 (504)
                      .+|.+.+.||.|+||.||+|...  ++.||+|.+.....  ...+.+.+|+.++++++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            67999999999999999999874  67899999876533  3346788999999999999999999766543        


Q ss_pred             ------CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEee
Q 010680          291 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADF  363 (504)
Q Consensus       291 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DF  363 (504)
                            ...|+||||++ ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+||
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                  35789999996 589888853  56899999999999999999999999999999999999974 567899999


Q ss_pred             ccceeccCCC----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----
Q 010680          364 GVARVKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----  434 (504)
Q Consensus       364 Gla~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~----  434 (504)
                      |+++......    ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...++...........    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997643221    1223467889999998744 568899999999999999999999998877655544433211    


Q ss_pred             -------------------CCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 -------------------LRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 -------------------~~p~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                         ..+.     ....++.++.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                               0000     12356788999999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-36  Score=333.93  Aligned_cols=147  Identities=27%  Similarity=0.478  Sum_probs=133.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .++|.+.++||+|+||.||+|.+.  ++.||||+++.... .......+..|+.+++.++||||+++++++.....+|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357899999999999999999986  78899999976433 445567788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      |||+.|++|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999976 4678999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.1e-37  Score=338.61  Aligned_cols=246  Identities=26%  Similarity=0.452  Sum_probs=194.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--------  290 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------  290 (504)
                      .+|+..+.||+|+||.||+++.  +|+.||||.+.... +......+.+|+.+|.+|+|||||+++.+|...        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            4677888999999999999976  68999999998765 556667889999999999999999998543100        


Q ss_pred             --------------------------------------------------------------------------------
Q 010680          291 --------------------------------------------------------------------------------  290 (504)
Q Consensus       291 --------------------------------------------------------------------------------  290 (504)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC
Q 010680          291 -------------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN  339 (504)
Q Consensus       291 -------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~  339 (504)
                                                     -.+||-||||+..+|.++++.+.-.-....+++++.+|+.||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                           0258999999998888888763222247789999999999999999999


Q ss_pred             ceeccCCCCcEEECCCCcEEEEeeccceecc-------------------CCCccccCCCCCCccCcccccCC---CCCc
Q 010680          340 IIHRDLKAANLLMDENEVVKVADFGVARVKA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDH  397 (504)
Q Consensus       340 IiHrDLkp~NILl~~~~~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~---~~s~  397 (504)
                      ||||||||.||++++++.|||+|||+|+...                   ..+..+..+||..|+|||++.+.   .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999997511                   01234566899999999999654   4999


Q ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       398 ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~---p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      |+|+||||+|++||+.   ||...-..-.+..-++++--|..   ...-.+.-+.+|+.|++.||.+||||.|+|.
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999986   66543222222333344433332   3334466789999999999999999999873

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=299.05  Aligned_cols=242  Identities=24%  Similarity=0.397  Sum_probs=199.2

Q ss_pred             ceeee-eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeC----CCCc
Q 010680          222 HLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPSL  293 (504)
Q Consensus       222 ~~~i~-~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~~  293 (504)
                      +|.+. ++||-|-.|.|..+..  +++.+|+|++...       ...++|+++.-.. .|||||.+++++.+    ...+
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            34433 4799999999998865  5788999998743       3456788875444 59999999998754    3456


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceec
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK  369 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~  369 (504)
                      .+|||+|+||.|...++... ..|++..+..|+.||+.|+.|||+.+|.||||||+|+|...   +..+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            79999999999999998753 35999999999999999999999999999999999999964   457999999999988


Q ss_pred             cCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hc--CCCCCCCCCC
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV----QK--GLRPTIPKNS  443 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~----~~--~~~p~~p~~~  443 (504)
                      ..+..+.+.+-||.|.|||++....|+..+|+||+|++||-||+|.+||..........++.    ..  .+..+-...+
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence            88888889999999999999999999999999999999999999999997554322222211    11  1222223567


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++..+++|+++|..+|.+|.|+.++++
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            899999999999999999999999864

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=321.19  Aligned_cols=252  Identities=26%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------CceeEEE
Q 010680          227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------SLCIVTE  298 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------~~~lV~E  298 (504)
                      +.||+|+||.||+|+.  +|+.||||.++... .....+..-+|+++|++++|||||+++++-....      ...+|||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            6899999999999985  58999999998765 3344677889999999999999999998765443      4579999


Q ss_pred             ecCCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCC--cEEEEeeccceeccCC
Q 010680          299 FMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKAQS  372 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~--~~~--~vkL~DFGla~~~~~~  372 (504)
                      ||.||+|+..|++..  ..+++..++.++.+++.||.|||++||+||||||.||++-  ++|  ..||+|||.|+...++
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~  177 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN  177 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence            999999999997643  4599999999999999999999999999999999999983  333  5899999999999998


Q ss_pred             CccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcC-------------
Q 010680          373 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKG-------------  434 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~----~~~~~~~v~~~~-------------  434 (504)
                      ...+..+||..|.+||++. .+.|+..+|.|||||++|++.||..||...-    ..+....+..+.             
T Consensus       178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eN  257 (732)
T KOG4250|consen  178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEEN  257 (732)
T ss_pred             CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccC
Confidence            8899999999999999998 4889999999999999999999999995321    122333322111             


Q ss_pred             ------CCCCCCCCCcHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHh
Q 010680          435 ------LRPTIPKNSQPK----LAELLERCWQQDPALRP--DFSEIIEILQQIAKEV  479 (504)
Q Consensus       435 ------~~p~~p~~~~~~----l~~Ll~~cl~~dP~~RP--s~~ell~~L~~l~~~~  479 (504)
                            ...++|...++.    +...+..+|..+|.+|-  .+.+....+.+++...
T Consensus       258 gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  258 GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                  111234444444    45667788899999998  7778877777777643

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=272.06  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=214.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      +|+-.++||+|.||+||+|+.  +++.||+|.++.+..+........+|+-+|+.+.|.|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455668999999999999976  457799999998776666667789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      | ...|..|....++.+....+..++.|+++||.|+|+.+++|||+||.|+||+.+|.+|++|||+++.+..+. ....+
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            9 679999999999999999999999999999999999999999999999999999999999999999877654 56778


Q ss_pred             CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC------C------------
Q 010680          379 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP------T------------  438 (504)
Q Consensus       379 ~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p------~------------  438 (504)
                      +-|..|.+|.++.+. -|+...|+||.||++.|+.. |++-|.+.+-.+....+...-..|      .            
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            899999999998664 58999999999999999997 899999988877777765432111      1            


Q ss_pred             CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ~p---------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .|         +.++..-++|+++++.-+|.+|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11         223445679999999999999999988754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-35  Score=309.29  Aligned_cols=244  Identities=22%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .++.+.|..++-||-|+||+|.++..  +...+|+|.+++.. ...........|-.||...+.+.||+||..|.+++.+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            46677888899999999999999965  44569999997654 3455567788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec---c
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK---A  370 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~---~  370 (504)
                      |+||+|++||++..+|-+ .+-|.+..+..++.++..|+++.|..|+|||||||+|||||.+|+|||+|||++.-+   .
T Consensus       705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999999999976 688999999999999999999999999999999999999999999999999998411   1


Q ss_pred             CCC-----------ccc-----------------------------cCCCCCCccCcccccCCCCCchhHHHHHHHHHHH
Q 010680          371 QSG-----------VMT-----------------------------AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE  410 (504)
Q Consensus       371 ~~~-----------~~~-----------------------------~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~e  410 (504)
                      ++.           .|.                             ..+||+.|+|||++....|+..+|+||.|+||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence            100           000                             1259999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          411 LLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       411 LltG~~Pf~~~~~~~~~~~v~~--~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      |+.|++||-..++.+...+++.  ..+.-....+++.++.+||.+++. +++.|
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~R  916 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSR  916 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhh
Confidence            9999999998888777666543  233333446789999999987653 34455

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.8e-35  Score=286.81  Aligned_cols=218  Identities=22%  Similarity=0.266  Sum_probs=183.1

Q ss_pred             eCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHH
Q 010680          232 GSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL  309 (504)
Q Consensus       232 G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l  309 (504)
                      |.||.||++.+  +++.||+|.++...       .+.+|...+....||||+++++++......++||||++|++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            88999999987  56789999987642       2334555556667999999999999999999999999999999999


Q ss_pred             HhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCccc
Q 010680          310 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV  389 (504)
Q Consensus       310 ~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~  389 (504)
                      .+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+......  .....++..|+|||.
T Consensus        77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            76 456899999999999999999999999999999999999999999999999987654432  233456778999999


Q ss_pred             ccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 010680          390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF  465 (504)
Q Consensus       390 l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~  465 (504)
                      +.+..++.++|+||+|+++|+|++|..|+......      ........+|..+++.+++++.+||+.||.+||++
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            98888999999999999999999999887643211      11122334667789999999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=300.10  Aligned_cols=250  Identities=32%  Similarity=0.654  Sum_probs=204.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEEeeeCCC----Cce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~~~  294 (504)
                      .++.+.+.||+|.||+||+|.|.|+.||||++...     ....+.+|.+|.+.  |+|+||+.|+++-....    .++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            57888999999999999999999999999998743     23567777777765  59999999999865543    479


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      ||++|.+.|||+|||..  ..++....++++..++.||++||..        .|.|||||..|||+.+++..-|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999975  7899999999999999999999963        4999999999999999999999999999


Q ss_pred             eeccCCC-----ccccCCCCCCccCcccccCC----CCC--chhHHHHHHHHHHHHHh-----C-----CCCCCCCCH--
Q 010680          367 RVKAQSG-----VMTAETGTYRWMAPEVIEHK----PYD--HKADVFSFGIVLWELLT-----G-----KLPYEYLTP--  423 (504)
Q Consensus       367 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~----~~s--~ksDVwSlGvvL~eLlt-----G-----~~Pf~~~~~--  423 (504)
                      -......     .....+||.+|||||++...    .|+  ..+||||||.|+||+..     |     ++||.+..+  
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            7654431     23456899999999998543    121  35899999999999875     2     378865433  


Q ss_pred             ---HHHHHHHHhcCCCCCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          424 ---LQAAVGVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       424 ---~~~~~~v~~~~~~p~~p~~~~-----~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                         .+...-+..+.+||.+|....     ..+..+|+.||..||.-|.|+--+.+.|.++.+
T Consensus       444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence               233333446678888886443     347788999999999999999999999998865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-34  Score=277.69  Aligned_cols=236  Identities=35%  Similarity=0.563  Sum_probs=203.3

Q ss_pred             CceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHHH
Q 010680          233 SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH  310 (504)
Q Consensus       233 ~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~  310 (504)
                      +||.||+|.+.  ++.+|+|++........ ...+.+|+..+++++|+||+++++.+......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999985  48899999886543322 5789999999999999999999999998889999999999999999997


Q ss_pred             hhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccc
Q 010680          311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI  390 (504)
Q Consensus       311 ~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l  390 (504)
                      ... .++...+..++.+++.++.|||+.+|+|+||+|.||+++.++.++|+|||.+.............+++.|++||.+
T Consensus        80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            633 3899999999999999999999999999999999999999999999999999877665455566789999999999


Q ss_pred             cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHH
Q 010680          391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCWQQDPALRPDFSEI  468 (504)
Q Consensus       391 ~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~--~~~~l~~Ll~~cl~~dP~~RPs~~el  468 (504)
                      .+..++.++|+|+||+++|+|++|..||.....................+..  ++.++.+++.+||..+|++||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            9888999999999999999999999999884444444454544433332222  88999999999999999999999999


Q ss_pred             HH
Q 010680          469 IE  470 (504)
Q Consensus       469 l~  470 (504)
                      ++
T Consensus       239 ~~  240 (244)
T smart00220      239 LQ  240 (244)
T ss_pred             hh
Confidence            75

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=290.44  Aligned_cols=240  Identities=23%  Similarity=0.419  Sum_probs=199.6

Q ss_pred             eeeeeeCceEEEEEE--ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~--~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.||+|+|+.|-.+.  +++..+|||++.+...  ..+.++.+|++++.+.+ |+||++++++|+++..+|+|||.|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            579999999997764  5789999999987633  34678899999999886 999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeeccceeccCC--------
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQS--------  372 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~--------  372 (504)
                      +|..++++ +..|++..+.++.++|+.||.|||.+||.||||||+|||....+   -||||||.+..-....        
T Consensus       162 plLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            99999987 67799999999999999999999999999999999999997554   4999999987532211        


Q ss_pred             CccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhc
Q 010680          373 GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------------PLQAAVGVVQK  433 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--------------~~~~~~~v~~~  433 (504)
                      ....+.+|+..|||||+..     ..-|+.++|+||||+|||-||+|.+||.+.-              -.+....-++.
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            1233567899999999873     3458999999999999999999999996531              12334444454


Q ss_pred             CCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          434 GLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       434 ~~~p~~p----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.- ++|    ..++.+.++++..+|..|+.+|.++.+++.
T Consensus       321 GkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  321 GKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            432 233    468999999999999999999999998876

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=290.34  Aligned_cols=248  Identities=21%  Similarity=0.395  Sum_probs=211.7

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHH-HHHHHHHHHHHHhc-CCCCceEEEEeeeC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDM-QKEFAQEVFIMRKV-RHKNVVQFIGACTK  289 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~-~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~  289 (504)
                      ..|.+...+|.+.++||+|+|+.|.++...  .+.+|+|++|++..+.+. ..-...|-.+..+. +||.+|.++..++.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            567888899999999999999999998764  567999999988776543 23344465555544 69999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +..+++|.||++||+|.-++++ ..+++++.+..+...|+.||.|||++|||.||||.+|||+|.+|++||+|+|+++..
T Consensus       323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999999999988876 678999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHH-HHhcCCCCCCC
Q 010680          370 AQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-------LTPLQAAVG-VVQKGLRPTIP  440 (504)
Q Consensus       370 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~-------~~~~~~~~~-v~~~~~~p~~p  440 (504)
                      ..++ ...+.+|||.|.|||++.+..|...+|+|+||++|+||+.|+.||+-       .+..+.... ++.+..  .+|
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence            6655 45578999999999999999999999999999999999999999952       222333333 344444  378


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCC
Q 010680          441 KNSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                      ..++-....++...|++||.+|..
T Consensus       480 rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcC
Confidence            888989999999999999999953

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=309.17  Aligned_cols=238  Identities=23%  Similarity=0.372  Sum_probs=200.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHh-cCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ...|.+...+|.|+|+.|-.+..  +++..++|++.....      ...+|+.++.. -+||||+++++.+.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            45788888899999999998866  567899999986622      22346655444 4699999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-CCCCcEEEEeeccceeccCCCcc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl-~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||.+.|+-|.+.+... ..+. ..+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++.....  .
T Consensus       395 ~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~  470 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C  470 (612)
T ss_pred             ehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence            9999999888887652 2233 7788899999999999999999999999999999 68999999999999876655  4


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...+-|..|.|||++...+|++++||||||++||+||+|+.||..-.....+   ...-..+.+...+++..++|+.+||
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~~~~s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQMPKFSECVSDEAKDLLQQLL  547 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcCCccccccCHHHHHHHHHhc
Confidence            4556788999999999999999999999999999999999999876655333   3333345566899999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.||.+||++.++..
T Consensus       548 ~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  548 QVDPALRLGADEIGA  562 (612)
T ss_pred             cCChhhCcChhhhcc
Confidence            999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=339.64  Aligned_cols=244  Identities=23%  Similarity=0.403  Sum_probs=193.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      .++..+.||+|+||.||+|..  .+..||||.++.....      ...|+.++++++|||||++++++...+..|+||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            355667899999999999986  5778999998753221      13468899999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccc
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH---~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      +++|+|.++++.    +++..+.+++.||++||+|||   +.+|+||||||+||+++.++..++. ||.......   ..
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            999999999963    789999999999999999999   6799999999999999998888775 666543322   22


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH-----hcCCCCCC------C
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-----LQAAVGVV-----QKGLRPTI------P  440 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-----~~~~~~v~-----~~~~~p~~------p  440 (504)
                      ...+|+.|+|||++.+..|+.++|||||||++|||++|+.||.....     .+......     ....++.+      +
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            34688999999999999999999999999999999999999853211     11111100     00111111      1


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .....++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            122345778999999999999999999999999886633

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=295.78  Aligned_cols=252  Identities=31%  Similarity=0.517  Sum_probs=207.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEEeeeCCC----Cc
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL  293 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~~  293 (504)
                      ...+++.+.||+|.||.||+|++.++.||||++...     ..+.|.+|-.|.+.  +.|+||++|+++-....    .+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            455777889999999999999999999999998743     35678888887765  46999999999876555    78


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCcEEEEeec
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                      +||+||.+.|+|.+||..  ..++|....+++..+++||+|||+.         .|+|||||..||||..|+..-|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999975  7899999999999999999999963         59999999999999999999999999


Q ss_pred             cceeccCCC---ccccCCCCCCccCcccccCCC-CC-----chhHHHHHHHHHHHHHhCCC------------CCC----
Q 010680          365 VARVKAQSG---VMTAETGTYRWMAPEVIEHKP-YD-----HKADVFSFGIVLWELLTGKL------------PYE----  419 (504)
Q Consensus       365 la~~~~~~~---~~~~~~gt~~y~APE~l~~~~-~s-----~ksDVwSlGvvL~eLltG~~------------Pf~----  419 (504)
                      +|.......   .....+||.+|||||++.+.- +.     .+.||||+|.|||||++...            ||+    
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            998765432   334578999999999997652 22     36899999999999998432            332    


Q ss_pred             -CCCHHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          420 -YLTPLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       420 -~~~~~~~~~~v~~~~~~p~~p~~~-----~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                       ..+-.+...-++++..||.+|...     ...+.+.++.||..|++-|.|+.=+-+.+.++..-
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence             123344455577888899888533     45689999999999999999999888888887553

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=288.51  Aligned_cols=262  Identities=25%  Similarity=0.497  Sum_probs=224.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .+...+++....+-+|.||.||+|.|..       +.|-+|.++... +.-....+.+|..++..+.|||+..+.+++..
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            4445667777889999999999996543       347788877543 33445778999999999999999999998754


Q ss_pred             -CCCceeEEEecCCCchHHHHHhhc-------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEE
Q 010680          290 -PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA  361 (504)
Q Consensus       290 -~~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~  361 (504)
                       ....+.++.++.-|+|..||..++       +.++..++..++.|++.||+|||+.||||.||.++|.+|++.-.|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             455678889999999999998443       346777889999999999999999999999999999999999999999


Q ss_pred             eeccceeccCC---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 010680          362 DFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP  437 (504)
Q Consensus       362 DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p  437 (504)
                      |=.++|..-..   ..-..+.....||+||.+.+..|+.++|+||||++||||+| |+.||...+|.+... .+.++.|.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhcccee
Confidence            99999854332   23344567889999999999999999999999999999999 999999999998764 46789999


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ..|.+||+++..+|.-||...|++||+|+|+...|.++..+++
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999887764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=269.71  Aligned_cols=217  Identities=32%  Similarity=0.490  Sum_probs=189.8

Q ss_pred             ceeeCCCceeeeeeeeeeCceEE--EEEEECCccEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCCceEEEEeeeCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~V--y~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+++..+++.-+..||+|+||.|  |+-.+.|+-.|+|.++.. .+.+.+++..+|+.+ ++...+|.+|.|||+.....
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            37888889999999999999986  555668999999999865 456667888889886 45567999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          292 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      ..+|.||.| ..||..+..+   ..+.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|.||+||||.+.
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999999 7788887643   367899999999999999999999987 89999999999999999999999999998


Q ss_pred             eccCCCccccCCCCCCccCccccc----CCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQK  433 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~  433 (504)
                      ...++-..+...|...|||||.+.    ...|+.++||||||+++.||.+++.||+. .++++....++..
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            888777777788999999999984    44799999999999999999999999975 5788888777754

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.4e-35  Score=283.76  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=194.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-CCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPS  292 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~  292 (504)
                      ...|+...+||+|.||.||+|...      ...+|||.++.+......-....+|+.+++.++||||+.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356888899999999999999543      2369999998763333333456789999999999999999998876 778


Q ss_pred             ceeEEEecCCCchHHHHHhhc----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEEEEeec
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFG  364 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~----~~vkL~DFG  364 (504)
                      +++++||.+ -+|.+.++-.+    ..++...+..|+.||+.|+.|||++=|+||||||.|||+..+    |.|||+|||
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            899999995 48888886442    458899999999999999999999999999999999999877    899999999


Q ss_pred             cceeccCCC----ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC-------HHH-----HH
Q 010680          365 VARVKAQSG----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT-------PLQ-----AA  427 (504)
Q Consensus       365 la~~~~~~~----~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-------~~~-----~~  427 (504)
                      ++|.+...-    .....+-|..|+|||++.+. .|+.+.|||+.||++.||++-.+-|.+..       |.+     .+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            999876642    12233569999999998764 69999999999999999999988885421       211     11


Q ss_pred             HHHHhcC---CCCC---C--------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          428 VGVVQKG---LRPT---I--------------------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       428 ~~v~~~~---~~p~---~--------------------------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..++--.   .+|.   .                          .+.-++...+|+.++|+.||.+|.|+.+.++
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            1111000   0000   0                          0223455889999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=288.85  Aligned_cols=245  Identities=25%  Similarity=0.410  Sum_probs=198.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--C----CceEEEEeeeCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--K----NVVQFIGACTKPP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~~~~~~~~  291 (504)
                      ..+|.+.+.+|+|.||.|.++.+.  +..||||+++..   ....+...-|+++|+++.+  |    -+|++.+++.-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            578999999999999999998764  567999999854   3344556679999999953  2    3788888999999


Q ss_pred             CceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----------------
Q 010680          292 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----------------  354 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~----------------  354 (504)
                      +.|||+|.+ |.|++++|..+ ..+++...+..++.|++++|.|||+++++|.||||+|||+.+                
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999999999 88999999764 356999999999999999999999999999999999999942                


Q ss_pred             ----CCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Q 010680          355 ----NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA---  427 (504)
Q Consensus       355 ----~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~---  427 (504)
                          +-.|+|+|||.|+...+.  ....+.|..|.|||++.+-+++.++||||+||||+|+.+|..-|...+..+..   
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM  321 (415)
T ss_pred             ccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence                226999999999866554  35668899999999999999999999999999999999999999776543321   


Q ss_pred             HHHHh-----------------cC----------------CCCCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 010680          428 VGVVQ-----------------KG----------------LRPTIP--------KNSQPKLAELLERCWQQDPALRPDFS  466 (504)
Q Consensus       428 ~~v~~-----------------~~----------------~~p~~p--------~~~~~~l~~Ll~~cl~~dP~~RPs~~  466 (504)
                      ..++.                 .+                .++..|        .....+|.+||++||.+||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            11111                 00                000111        11234589999999999999999999


Q ss_pred             HHHH
Q 010680          467 EIIE  470 (504)
Q Consensus       467 ell~  470 (504)
                      |++.
T Consensus       402 EAL~  405 (415)
T KOG0671|consen  402 EALS  405 (415)
T ss_pred             HHhc
Confidence            9874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=305.29  Aligned_cols=247  Identities=32%  Similarity=0.531  Sum_probs=208.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeee-----CCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT-----KPPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~-----~~~~  292 (504)
                      ..++|.+.||.|.+|.||+++.  .++.+|+|++.....   ..+++..|.++|+.+. |||++.++|++.     .++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3466678999999999998865  678899999886543   3456777889988875 899999999884     3467


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ++||||||.|||..|+++... ..+.+..+..|+..++.|+.+||.+.+||||||-.|||++.++.||++|||++...+.
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            899999999999999997654 5689999999999999999999999999999999999999999999999999875544


Q ss_pred             C-CccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCc
Q 010680          372 S-GVMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQ  444 (504)
Q Consensus       372 ~-~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~  444 (504)
                      . +...+.+||+.|||||++..     ..|+..+|+||||++-.||--|.+|+.++.|..+...+-+... +...|...+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs  255 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS  255 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence            3 34567789999999999943     3578899999999999999999999999999888776543321 122356778


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .++.++|..||.+|.++||+..++++
T Consensus       256 ~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  256 KKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             HHHHHHHHHHHhhccccCcchhhhcc
Confidence            99999999999999999999998874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-35  Score=276.20  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----  290 (504)
                      .+.+.|.-..+||+|.||.||+|+.  .++.||+|++--+...........+|+.+|..+.|+|++.++..|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3456777788999999999999865  467799987654333333345668899999999999999999987432     


Q ss_pred             ---CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          291 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       291 ---~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                         ..+|+|+.+|+ .+|.-+|......+++..+.+++.++..||.|+|++.|+|||+||+||||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence               34799999995 58888888767789999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC-----ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------CC
Q 010680          368 VKAQSG-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK------GL  435 (504)
Q Consensus       368 ~~~~~~-----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~------~~  435 (504)
                      .+..+.     ..+..+-|..|.+||.+.+ ..|+++.|||..||+|.||+|+.+-+.+.+..+.+..+..-      ..
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            765543     2344567999999999865 57999999999999999999999999988877665443311      11


Q ss_pred             CCC--------------CC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 RPT--------------IP-------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ~p~--------------~p-------------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +|.              .+             -.-.++..+|+++++..||.+|+++++++.
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            111              11             111357889999999999999999999873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-32  Score=292.14  Aligned_cols=254  Identities=19%  Similarity=0.275  Sum_probs=185.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------------------CCccEEEEEecCCCCCh------------HHHHHHH
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------------------CSQDVAIKVLKPERINS------------DMQKEFA  266 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------------------~g~~VAvK~lk~~~~~~------------~~~~~~~  266 (504)
                      ....++|++.++||+|+||.||+|.+                  .++.||||.++......            ...+.+.
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34577899999999999999999964                  23569999987542110            0112234


Q ss_pred             HHHHHHHhcCCCCc-----eEEEEeeeC--------CCCceeEEEecCCCchHHHHHhhcc-------------------
Q 010680          267 QEVFIMRKVRHKNV-----VQFIGACTK--------PPSLCIVTEFMSGGSVYDYLHKLKG-------------------  314 (504)
Q Consensus       267 ~Ei~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~-------------------  314 (504)
                      .|+.++.+++|.++     ++++++|..        .+..++|+||+++++|.++++...+                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            57777778876554     667777643        3467999999999999999874321                   


Q ss_pred             ----cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccc--cCCCCCCccCcc
Q 010680          315 ----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT--AETGTYRWMAPE  388 (504)
Q Consensus       315 ----~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~gt~~y~APE  388 (504)
                          .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.........  ...+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                23566788999999999999999999999999999999999999999999997554332222  234588999999


Q ss_pred             cccCCC--------------------CC--chhHHHHHHHHHHHHHhCCC-CCCCCCHHHHHHH-----------HHhcC
Q 010680          389 VIEHKP--------------------YD--HKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVG-----------VVQKG  434 (504)
Q Consensus       389 ~l~~~~--------------------~s--~ksDVwSlGvvL~eLltG~~-Pf~~~~~~~~~~~-----------v~~~~  434 (504)
                      ++....                    |+  .+.|+||+||++|+|++|.+ ||...........           +....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            985332                    11  24799999999999999886 7764322221111           11112


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDP---ALRPDFSEIIE  470 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP---~~RPs~~ell~  470 (504)
                      ........+++...+|+.+||..+|   .+|+|+.|+++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            2223345678999999999999876   68999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.8e-32  Score=295.25  Aligned_cols=246  Identities=16%  Similarity=0.211  Sum_probs=168.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEe----
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA----  286 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~----  286 (504)
                      ....++|.+.++||+|+||.||+|++.      +..||||.++.....    +.+..|  .++...+.++..++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            345678999999999999999999874      467999987643211    111111  1122222222222211    


Q ss_pred             --eeCCCCceeEEEecCCCchHHHHHhhccc-------------------CChHHHHHHHHHHHHHHHHHHHCCceeccC
Q 010680          287 --CTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL  345 (504)
Q Consensus       287 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------------------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL  345 (504)
                        ......+++|+||+++++|.+++......                   .....+..++.||+.||.|||+++|+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              24566789999999999999998753211                   112345679999999999999999999999


Q ss_pred             CCCcEEECC-CCcEEEEeeccceeccCC--CccccCCCCCCccCcccccCC----------------------CCCchhH
Q 010680          346 KAANLLMDE-NEVVKVADFGVARVKAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDHKAD  400 (504)
Q Consensus       346 kp~NILl~~-~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksD  400 (504)
                      ||+|||++. ++.+||+|||+++.....  .......+|+.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 579999999999754332  233456789999999976322                      2445679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------CCCCCC----------CCCCcHHHHHHHHHhhhcCCC
Q 010680          401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK----------GLRPTI----------PKNSQPKLAELLERCWQQDPA  460 (504)
Q Consensus       401 VwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~----------~~~p~~----------p~~~~~~l~~Ll~~cl~~dP~  460 (504)
                      ||||||+||||+++..|+...  .......+..          ...+..          .........+||.+||+.||.
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999987765421  1111111111          000100          111223456899999999999


Q ss_pred             CCCCHHHHHH
Q 010680          461 LRPDFSEIIE  470 (504)
Q Consensus       461 ~RPs~~ell~  470 (504)
                      +|||+.++++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.1e-33  Score=279.30  Aligned_cols=248  Identities=20%  Similarity=0.391  Sum_probs=199.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-----hHHHHHHHHHHHHHHhcCCCCceEEEEeee-CCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-----SDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~  292 (504)
                      ++|-++..||+|+|+.||++.+.  .+.||||+-......     ....+...+|..|.+.|+||.||++|+++. +...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            56777888999999999999764  567999996543222     233456778999999999999999999985 5567


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEC---CCCcEEEEeeccce
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD---ENEVVKVADFGVAR  367 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--~IiHrDLkp~NILl~---~~~~vkL~DFGla~  367 (504)
                      +|-|+|||+|.+|.-||.. ...+++..+..|+.||+.||.||...  .|||-||||.|||+-   ..|.+||+|||+++
T Consensus       543 FCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             ceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            8999999999999999976 56789999999999999999999986  599999999999994   45789999999999


Q ss_pred             eccCCCc--------cccCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh
Q 010680          368 VKAQSGV--------MTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG---VVQ  432 (504)
Q Consensus       368 ~~~~~~~--------~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~---v~~  432 (504)
                      ++.+...        .....||++|.+||.+.-    ...+.|+||||+||++|.++.|+.||...-..+.+..   ++.
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            8776432        234579999999999832    2468899999999999999999999976544443322   111


Q ss_pred             c-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          433 K-GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       433 ~-~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      . ...-+..+.++++..++|++||++.-++|.+..++.
T Consensus       702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            1 111122356789999999999999999998877764

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4.3e-32  Score=254.46  Aligned_cols=243  Identities=20%  Similarity=0.382  Sum_probs=197.0

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC--Cc
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SL  293 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~--~~  293 (504)
                      ..++|++.+++|+|-|++||.|..  .++.++||++|+..     .+.+.+|+.||+.|. ||||+.+++...++.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            357899999999999999999974  67889999999752     467889999999998 999999999987653  46


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~  372 (504)
                      .+|+||+.+.+...+.    .+++...+..++.++++||.|+|+.||+|||+||.|++||. ...++|+|+|+|......
T Consensus       111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            7999999876655444    45888899999999999999999999999999999999985 457999999999887776


Q ss_pred             CccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH-------------------
Q 010680          373 GVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVV-------------------  431 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~-~~~~~~~~~~v~-------------------  431 (504)
                      ......+.+..|-.||.+ .-+.|+.+-|+|||||+|..|+..+.||. +.++.+....+.                   
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            666666778889999998 45678999999999999999999888884 333333222221                   


Q ss_pred             --------hcCCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          432 --------QKGLR--------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       432 --------~~~~~--------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              ....+        +....-.+++..+|+.++|..|-.+|+|+.|.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                    11111        1111234689999999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.2e-30  Score=243.46  Aligned_cols=209  Identities=37%  Similarity=0.686  Sum_probs=186.6

Q ss_pred             eeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchH
Q 010680          229 VASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY  306 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~  306 (504)
                      ||+|++|.||++...  ++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++||++|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999987  7889999998764332 3467899999999999999999999999988999999999999999


Q ss_pred             HHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccCCC-ccccCCCCCCc
Q 010680          307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG-VMTAETGTYRW  384 (504)
Q Consensus       307 ~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y  384 (504)
                      +++......++...+..++.++++++.+||++|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            999764457899999999999999999999999999999999999999 8999999999998665443 23345678899


Q ss_pred             cCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 010680          385 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP  463 (504)
Q Consensus       385 ~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RP  463 (504)
                      ++||.+... .++.+.|+|++|+++++|                                 ..+.+++.+|++.||.+||
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence            999999877 888999999999999999                                 6899999999999999999


Q ss_pred             CHHHHHHH
Q 010680          464 DFSEIIEI  471 (504)
Q Consensus       464 s~~ell~~  471 (504)
                      ++.++++.
T Consensus       207 ~~~~l~~~  214 (215)
T cd00180         207 SAKEILEH  214 (215)
T ss_pred             CHHHHhhC
Confidence            99998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=294.22  Aligned_cols=248  Identities=25%  Similarity=0.425  Sum_probs=194.1

Q ss_pred             eeeeeeeCceE-EEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          226 GSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       226 ~~~LG~G~fG~-Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      .+.+|.|+.|+ ||+|.+.++.||||.+-.+.     .....+||..|+.-+ |||||++++.-.+....||..|.| ..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            35689999987 89999999999999976542     344568999999885 999999999999999999999999 67


Q ss_pred             chHHHHHhh--ccc-CChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---C--CcEEEEeeccceeccCCC--
Q 010680          304 SVYDYLHKL--KGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVVKVADFGVARVKAQSG--  373 (504)
Q Consensus       304 sL~~~l~~~--~~~-l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~--~~vkL~DFGla~~~~~~~--  373 (504)
                      +|.+++...  ... ...-..+.+..|++.||++||+.+||||||||.||||+.   +  ..++|+|||+++......  
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            999999763  111 111345788999999999999999999999999999975   2  479999999998665443  


Q ss_pred             --ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHH
Q 010680          374 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAE  449 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p-~~p~~~~~~l~~  449 (504)
                        ......||.+|+|||++....-..++|||||||++|+.++ |..||......+...  +...... .+......+..+
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~~~~~L~~L~~~~d~eA~d  745 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LTGNYTLVHLEPLPDCEAKD  745 (903)
T ss_pred             hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--hcCccceeeeccCchHHHHH
Confidence              2345579999999999988888889999999999999999 599998765544322  2111110 011111128899


Q ss_pred             HHHHhhhcCCCCCCCHHHHH------------HHHHHHHHHhcc
Q 010680          450 LLERCWQQDPALRPDFSEII------------EILQQIAKEVGE  481 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell------------~~L~~l~~~~~~  481 (504)
                      ||.+|++++|..||++.+++            ..|+++-.++..
T Consensus       746 LI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~  789 (903)
T KOG1027|consen  746 LISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEK  789 (903)
T ss_pred             HHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhh
Confidence            99999999999999999986            456666555543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-33  Score=265.76  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=198.8

Q ss_pred             eeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-----CceeEE
Q 010680          225 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLCIVT  297 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~lV~  297 (504)
                      -.+.||-|+||.||..++  .|+.||+|.+.....+-..-+.+.+|+++|...+|.|++..++......     .+|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            346899999999999987  5788999988765444445678899999999999999999888765543     357899


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC--Ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVM  375 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~  375 (504)
                      |.|. -+|...+-. ...++...+.-+.+||++||.|||+.||+||||||.|+|++.+..+||||||+++.....  ..|
T Consensus       137 ELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            9994 477777654 677899999999999999999999999999999999999999999999999999976544  468


Q ss_pred             ccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------
Q 010680          376 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ----------------------  432 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~----------------------  432 (504)
                      +.++-|..|.|||++.+ ..|+.+.||||.||++.||+..+.-|...+|.+...-+..                      
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence            88899999999999866 4699999999999999999999999988777665443321                      


Q ss_pred             -cCCCCC-C--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          433 -KGLRPT-I--------PKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       433 -~~~~p~-~--------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                       .+.+++ .        +..-..+...++.+++.+||++|.+..+.+..
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence             222211 1        11223467788999999999999988776543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=268.35  Aligned_cols=132  Identities=24%  Similarity=0.432  Sum_probs=112.5

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----C---CCceEEEEee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----H---KNVVQFIGAC  287 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~l~~~~  287 (504)
                      +...+|.+.++||+|-|++||++.++  ++.||+|+.|..   ....+....||++|++++     |   .+||+|++.|
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            34578999999999999999999775  567999999853   344566778999999985     2   4799999988


Q ss_pred             eC----CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEC
Q 010680          288 TK----PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD  353 (504)
Q Consensus       288 ~~----~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~  353 (504)
                      ..    +.++|||+|++ |.+|..++.... ..++...+..|++||+.||.|||.+ ||||.||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            54    45789999999 889999987653 5699999999999999999999985 999999999999994

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=260.46  Aligned_cols=247  Identities=24%  Similarity=0.327  Sum_probs=203.1

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-----
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----  291 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----  291 (504)
                      .+.+|.-.+.+|.|.- .|.-+-+  .+++||+|.+.....+....++..+|..++..++|+||+.++.+++...     
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3456666778888888 5665543  5889999988776555555677889999999999999999999987654     


Q ss_pred             -CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 -SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                       ..|+|||+| ..+|...+.   -.+...++..+..|++.|+.|||+.||+||||||+||++..+..+||.|||+|+...
T Consensus        94 ~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   94 QEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence             469999999 679988886   356778899999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------  438 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~------------  438 (504)
                      ..-.++..+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+..+....+.+.-..|.            
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            77678888999999999999888899999999999999999999999987655444333332111110            


Q ss_pred             ----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ----------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ----------------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                                  .++.-...+++++.+||-.||++|.|+.++|.
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                        11223456899999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.7e-30  Score=242.40  Aligned_cols=212  Identities=33%  Similarity=0.580  Sum_probs=182.9

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |.+.+.||.|++|.||++...  ++.+|+|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            456789999999999999885  588999999865433 24678889999999999999999999999889999999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--ccccC
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAE  378 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~  378 (504)
                      ++++|.+++......+++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999998744338999999999999999999999999999999999999999999999999998766543  33455


Q ss_pred             CCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCC
Q 010680          379 TGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGL  435 (504)
Q Consensus       379 ~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~~~  435 (504)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.....+.+..+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            678899999999 777888899999999999999999999977 566555555555543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=9.5e-32  Score=275.78  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC------CCceEEEEeeeCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~~~~~  291 (504)
                      ..+|.+..-.|.|-|++|.+|.+.  ++.||||+|+..   .-+.+.=+.|+.||++|+.      -++++++..|...+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            356777778899999999999874  678999999864   3445666789999999973      47899999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeecccee
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV  368 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~  368 (504)
                      ++|||+|-+ ..+|.+.|.+...  .|....+..++.|++.||..|-..||+|.||||+||||++. ..+||||||.|..
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence            999999998 6799999988654  47788999999999999999999999999999999999875 4699999999976


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------  434 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------  434 (504)
                      ...+. .+.+.-+..|.|||++.+.+|+...|+||+||+||||.||+.-|.+.++.+++.-.+.-.              
T Consensus       587 ~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  587 ASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             ccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence            66543 344556778999999999999999999999999999999999999988777655433110              


Q ss_pred             -----------------------------CCCC------------CCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 -----------------------------LRPT------------IPK---NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 -----------------------------~~p~------------~p~---~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                                   ..|.            .|.   ..-..|.+||.+||..||++|.|..|.|+
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                                         0010            111   11245889999999999999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=285.29  Aligned_cols=247  Identities=29%  Similarity=0.493  Sum_probs=217.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|.+..++|+|+||.||++++  .++..|+|++|.+..+  ...-+.+|+-+++..+|||||.++|.+.....++|+||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            5688889999999999999987  5788999999976432  34567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~  377 (504)
                      ||.||+|.+.-+- .+.+++.++..+.+..++|++|||+.|=+|||||-.|||+++.|.+|++|||.+-..... .....
T Consensus        93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            9999999997765 788999999999999999999999999999999999999999999999999998544332 23446


Q ss_pred             CCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHHHHHH
Q 010680          378 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKLAELL  451 (504)
Q Consensus       378 ~~gt~~y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p---~~~~~~l~~Ll  451 (504)
                      ..||+.|||||+.   ....|...+|||++|++..|+-.-++|.....+.++..-.-..++.|...   ...++.+.+|+
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fv  251 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFV  251 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHH
Confidence            7899999999987   45679999999999999999999999999999999988877777666533   45688999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      +.|+.++|.+||++..++.
T Consensus       252 K~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  252 KGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHhcCCCccCCChhhhee
Confidence            9999999999999988763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=267.80  Aligned_cols=198  Identities=27%  Similarity=0.450  Sum_probs=173.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHH------HHHHHHHHHHHhcC---CCCceEEEEeeeC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ------KEFAQEVFIMRKVR---HKNVVQFIGACTK  289 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~------~~~~~Ei~iL~~l~---HpnIv~l~~~~~~  289 (504)
                      ++|...+.+|+|+||.|+++.++.  ..|+||.+.+++.-.+..      -.+-.||.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468899999999999999998864  569999998876533322      23557999999998   9999999999999


Q ss_pred             CCCceeEEEec-CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 PPSLCIVTEFM-SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 ~~~~~lV~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .+.+||+||-. +|.+|.+++.. +..+++..+..|++|++.|+++||+.||||||||-+||.++.+|.+||+|||.+-.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99999999965 45689999976 67799999999999999999999999999999999999999999999999999853


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEY  420 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~  420 (504)
                       ..++.....+||..|.|||++.+.+|- ..-|||++|++||.++....||..
T Consensus       720 -~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 -TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             345667788999999999999999884 568999999999999999988853

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-28  Score=239.52  Aligned_cols=260  Identities=20%  Similarity=0.324  Sum_probs=219.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~  293 (504)
                      .+-.-.|+++++||+|+||.++.|+.  .+++||||.-......    -++..|.+..+.|. .++|+++|.+...+.+.
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            34456799999999999999999974  7899999986543222    34666888888886 69999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCcEEEEeecccee
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARV  368 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-----~~~vkL~DFGla~~  368 (504)
                      .||+|++ |.||+|++.-+...|+..+++.+|.|++.-|+|+|++.+|.|||||+|+||+.     ...|.|+|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 99999999999999999999999999999999999999999999999999974     34699999999987


Q ss_pred             ccCCCc--------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC-
Q 010680          369 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLR-  436 (504)
Q Consensus       369 ~~~~~~--------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~-  436 (504)
                      ..+...        .....||.+||+-....+.+-+.+.|+-|||-+++++|-|.+||.++..   .+.+.++-..... 
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            666532        3345899999999999999999999999999999999999999988643   3444443322211 


Q ss_pred             --CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          437 --PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       437 --p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                        ..+...+|.++...|.-.-..+..+-|+++-+..++.+++..++.
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence              123356788999999999999999999999999999999998874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=231.09  Aligned_cols=259  Identities=23%  Similarity=0.325  Sum_probs=218.8

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~  293 (504)
                      .|-...|+++++||+|+||.+|.|..  .|+.||||+-+...-.+    .+.-|.++.+.|++ ..|+.+..+..+...-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45567899999999999999999976  57899999976553333    46678999999985 8899999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceecc
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKA  370 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~~  370 (504)
                      .+||+.+ |.||.++++-+...++..+++.++-|++.-++|+|.+++|||||||+|+|++-   ...+.++|||+|+..-
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999999 99999999998999999999999999999999999999999999999999974   4579999999998654


Q ss_pred             CCC--------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCC-
Q 010680          371 QSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPT-  438 (504)
Q Consensus       371 ~~~--------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~p~-  438 (504)
                      +..        .....+||.+|.+-....+..-+.+.|+-|+|.+|.++.-|.+||++..+   .+.+..+.++....+ 
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            432        22345899999998888888889999999999999999999999998754   445555555443322 


Q ss_pred             --CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          439 --IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       439 --~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                        ..+..|.++...+..|-..-.++-|+..-+.+.+.-++..+.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence              346778999999999999999999999999988888877665

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-27  Score=244.20  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=207.0

Q ss_pred             ceeeeeeeeeeCceEEEEEEECCc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCC----CCceEEEEee-eCCCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCSQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRH----KNVVQFIGAC-TKPPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g~---~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~~~~-~~~~~~  293 (504)
                      +|++.++||+|+||.||.+.....   .+|+|+.........  ..+..|+.++..+..    +++..+++.+ ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            799999999999999999998654   599998775432221  156778898888873    6999999999 577788


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CcEEEEeeccce
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVAR  367 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-----~~vkL~DFGla~  367 (504)
                      ||||+.+ |.+|.++..... +.++..++..++.|++.+|++||+.|++||||||.|++++..     ..++|.|||+++
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999998 999999886655 789999999999999999999999999999999999999865     469999999998


Q ss_pred             --eccC-CC-------c-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---
Q 010680          368 --VKAQ-SG-------V-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK---  433 (504)
Q Consensus       368 --~~~~-~~-------~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~---  433 (504)
                        .... .+       . .....||.+|+++.+..+.+.+.+.|+||++.++.+|+.|.+||...........+.+.   
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3211 11       1 22345999999999999999999999999999999999999999876643322222221   


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ..........+.++..++..+-..+...+|.+..+...|+++....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence            11111334567788999998888999999999999999998887653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-29  Score=237.01  Aligned_cols=254  Identities=31%  Similarity=0.641  Sum_probs=221.4

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .|+.+++.+..+|.....|+.|+|+|.|.+++.|+++........-+.|..|.-.|+-..||||+.++++|..++++.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            46677888889999999999999999999999999998777777778899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEE--eeccceeccC
Q 010680          297 TEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA--DFGVARVKAQ  371 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~vkL~--DFGla~~~~~  371 (504)
                      ..||+-|+|+..|+...+ .....++.+++.+|++||+|||+..  |----|....|+||++-+.+|+  |--++   -+
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---fq  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---FQ  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---ee
Confidence            999999999999987544 3677899999999999999999974  4444688999999998776653  32222   11


Q ss_pred             CCccccCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s---~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                         .....-.|.||+||.+..++-+   .++|+|||++++|||.|...||...++.+--.++.-.++|+.+|+.++..+.
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence               1122347899999999887755   4789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .|+.-|++.||.+||.|..++..|+++.
T Consensus       420 klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            9999999999999999999999998763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4.3e-28  Score=224.84  Aligned_cols=164  Identities=24%  Similarity=0.374  Sum_probs=134.7

Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY  382 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  382 (504)
                      |+|.+++......+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6899999876677999999999999999999999998      999999999999999  9999876543    236899


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------CCCCCcH--HHHHHHHHh
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------IPKNSQP--KLAELLERC  454 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~------~p~~~~~--~l~~Ll~~c  454 (504)
                      .|||||++.+..|+.++|||||||++|||++|+.||............+.....+.      .+...+.  ++.+++.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976654333322222222221      1122333  699999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      |..||.+||++.++++.+..+..+
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhcccccccCHHHHHHHHHHHHHH
Confidence            999999999999999988777554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.3e-29  Score=283.48  Aligned_cols=192  Identities=17%  Similarity=0.238  Sum_probs=143.6

Q ss_pred             cCC-CCceEEEEee-------eCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010680          275 VRH-KNVVQFIGAC-------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK  346 (504)
Q Consensus       275 l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLk  346 (504)
                      ++| +||+++++++       .....+++++||+ +++|.++|......+++..++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777777766       2334577889988 779999998656679999999999999999999999999999999


Q ss_pred             CCcEEECCC-------------------CcEEEEeeccceeccCCC-----------------ccccCCCCCCccCcccc
Q 010680          347 AANLLMDEN-------------------EVVKVADFGVARVKAQSG-----------------VMTAETGTYRWMAPEVI  390 (504)
Q Consensus       347 p~NILl~~~-------------------~~vkL~DFGla~~~~~~~-----------------~~~~~~gt~~y~APE~l  390 (504)
                      |+||||+..                   +.+|++|||+++......                 ......||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   445666666665321100                 01123578899999999


Q ss_pred             cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       391 ~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+..|+.++|||||||+||||++|.+|+.....  ..... .....+.......+....++.+||+.+|.+||++.|+++
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSL-RHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHH-HHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            999999999999999999999999988764321  11111 111222222223456789999999999999999999974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=228.64  Aligned_cols=242  Identities=20%  Similarity=0.310  Sum_probs=185.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE-eeeCCCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG-ACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~-~~~~~~~~~lV  296 (504)
                      +.|.+.+.||+|.||.+-++.+.+  +.+++|.+.....   .+++|.+|..---.| .|.||+.-|+ +|+..+.++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            568888999999999999998864  5699998876533   357788887654444 3899998886 46777788899


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEEeeccceeccCCCc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~  374 (504)
                      +||++-|+|..-+..  ..+-+....+++.|+++|+.|+|++++||||||.+||||-.  .-+|||||||+.+..+..-.
T Consensus       101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999887754  55788888999999999999999999999999999999943  34899999999875443211


Q ss_pred             cccCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCC---CC
Q 010680          375 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIPK---NS  443 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~---~~~~~~~~v~~~~~~p~~p~---~~  443 (504)
                        ..--+..|.+||+....     ..++.+|+|.||+++|.+|||++||+..   ++.-.......++..+..|+   ..
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence              11235568899987432     3467899999999999999999999742   22222333344555555554   56


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      ++.+..+.++-|..+|++|=-..+..
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHH
Confidence            78899999999999999994444433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=4.6e-25  Score=216.69  Aligned_cols=248  Identities=30%  Similarity=0.497  Sum_probs=205.4

Q ss_pred             eeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChH-HHHHHHHHHHHHHhcCCC-CceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~-~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      |.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+++.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            667889999999999999988 8899999987765543 578899999999999988 7999999997777789999999


Q ss_pred             CCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCCC----
Q 010680          301 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG----  373 (504)
Q Consensus       301 ~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~----  373 (504)
                      .++++.+++....  ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......    
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997776533  2789999999999999999999999999999999999999988 79999999998555443    


Q ss_pred             ---ccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC----CCC
Q 010680          374 ---VMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRP----TIP  440 (504)
Q Consensus       374 ---~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~p----~~p  440 (504)
                         ......||..|+|||.+.+   ..++...|+|++|++++++++|..||.....   .......+.....+    ...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS  240 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence               2356689999999999987   5789999999999999999999999877763   33333333333322    122


Q ss_pred             CCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          441 KNS----QPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       441 ~~~----~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                      ...    ...+.+++.+|+..+|..|.+..+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            222    2578999999999999999998877654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=5.7e-27  Score=236.80  Aligned_cols=242  Identities=22%  Similarity=0.366  Sum_probs=187.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~  294 (504)
                      ..|+..++||.|+|++||+++..     ...||+|.+.....    ...+..|+++|..+. +.||+++.+++...+..+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            45788899999999999999753     35699999876532    345788999999986 899999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceeccCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~-  372 (504)
                      +|+||++.....++...    ++...+..++..+++||.++|.+|||||||||.|+|.+. .+.-.|+|||+|...... 
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999888887755    678999999999999999999999999999999999984 678899999998611000 


Q ss_pred             -----Cc---------c------------------------------ccCCCCCCccCcccccCC-CCCchhHHHHHHHH
Q 010680          373 -----GV---------M------------------------------TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIV  407 (504)
Q Consensus       373 -----~~---------~------------------------------~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvv  407 (504)
                           ..         +                              ....||++|.|||++... .-++++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                 00         0                              011499999999998654 46789999999999


Q ss_pred             HHHHHhCCCCCCCCCH-HHHHHHH---------------------Hh--------------cCC-------------CCC
Q 010680          408 LWELLTGKLPYEYLTP-LQAAVGV---------------------VQ--------------KGL-------------RPT  438 (504)
Q Consensus       408 L~eLltG~~Pf~~~~~-~~~~~~v---------------------~~--------------~~~-------------~p~  438 (504)
                      +..++++..||-.... ..+...+                     .+              ..+             ...
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            9999999999942111 0000000                     00              000             000


Q ss_pred             -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 -IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 -~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                       .....+..+.+|+.+|+..||.+|.|+++.|+
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             11233558999999999999999999999874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.8e-24  Score=223.47  Aligned_cols=164  Identities=19%  Similarity=0.201  Sum_probs=129.1

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE---CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceE-EEEeeeCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTKP  290 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~---~g~~VAvK~lk~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~  290 (504)
                      .-...|.+.+.||+|+||+||+|.+   .++.||||++.....   .......|.+|+.+|++++|+|++. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            3456799999999999999999976   356689998764311   2334567999999999999999985 5442    


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL-kp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +..|+||||++|++|.. +..    ..   ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            45799999999999963 211    11   1467899999999999999999999 999999999999999999999866


Q ss_pred             cCCCc---------cccCCCCCCccCcccccCC
Q 010680          370 AQSGV---------MTAETGTYRWMAPEVIEHK  393 (504)
Q Consensus       370 ~~~~~---------~~~~~gt~~y~APE~l~~~  393 (504)
                      .....         .+...+++.|+|||.+...
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            54431         1234678899999998543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2e-24  Score=228.22  Aligned_cols=234  Identities=26%  Similarity=0.421  Sum_probs=196.9

Q ss_pred             eeeeCceEEEEE-----EECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecCC
Q 010680          229 VASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       229 LG~G~fG~Vy~~-----~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +|.|+||.|++.     .+.+.-+|+|++++.............|..++..++ ||.+++++.+++.+..++++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            689999999865     345677999999876554433346667888999888 99999999999999999999999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY  382 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  382 (504)
                      |.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++........   +||.
T Consensus        82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~  157 (612)
T KOG0603|consen   82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY  157 (612)
T ss_pred             chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence            999988865 566788888899999999999999999999999999999999999999999999876654332   8999


Q ss_pred             CccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       383 ~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      .|||||+++  .+..++|.||||++++||++|..||..    +....+..  ..+..|...+....+++.+++..+|.+|
T Consensus       158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nr  229 (612)
T KOG0603|consen  158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENR  229 (612)
T ss_pred             hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence            999999998  678899999999999999999999987    34444433  2356888999999999999999999999


Q ss_pred             CCH--HHHHHHHHH
Q 010680          463 PDF--SEIIEILQQ  474 (504)
Q Consensus       463 Ps~--~ell~~L~~  474 (504)
                      ...  ..+.+..+.
T Consensus       230 Lg~~~~~~~eik~h  243 (612)
T KOG0603|consen  230 LGAGPDGVDEIKQH  243 (612)
T ss_pred             hccCcchhHHHhcc
Confidence            755  344444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.9e-23  Score=228.99  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=187.3

Q ss_pred             eeeeeeeeeCceEEEEEEEC--CccEEEEEec----CCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          224 KFGSKVASGSYGDLYRGTYC--SQDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk----~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .....+|.|++|.|+.....  ....+.|..+    ...........+..|..+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776543  2223333322    22112222233667888888999999988877776665555569


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      |||++ +|+.++.. .+.++...+..+++|++.|+.|+|+.||.|||+|++|++++.+|.+||+|||.+..+....    
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99998 99999865 3578999999999999999999999999999999999999999999999999997665443    


Q ss_pred             -ccccCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCC------CCCCCCCCc
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGL------RPTIPKNSQ  444 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~k-sDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~~------~p~~p~~~~  444 (504)
                       .....+|+..|+|||++.+..|++. .||||.|++++.|.+|+.||......+.. ........      ...+...++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             2345689999999999999999874 79999999999999999999755443322 11110000      011234567


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ...+.+|.+||+.||.+|.++.+|++
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhh
Confidence            78899999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.7e-22  Score=191.61  Aligned_cols=141  Identities=17%  Similarity=0.183  Sum_probs=109.3

Q ss_pred             eeeeeeeCceEEEEEEE-CCccEEEEEecCCCCChHH------------------------HHHHHHHHHHHHhcCCCCc
Q 010680          226 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM------------------------QKEFAQEVFIMRKVRHKNV  280 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~------------------------~~~~~~Ei~iL~~l~HpnI  280 (504)
                      ...||+|+||.||+|.. .|+.||||+++........                        .....+|+.+++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999987 5889999999865322111                        1123459999999988776


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEECCCCcEE
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      .........  ..+|||||++|+++...+.. .+.++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            433322222  23899999988777655333 46789999999999999999999 799999999999999998 47899


Q ss_pred             EEeeccceecc
Q 010680          360 VADFGVARVKA  370 (504)
Q Consensus       360 L~DFGla~~~~  370 (504)
                      |+|||+|....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.8e-22  Score=194.14  Aligned_cols=172  Identities=15%  Similarity=0.207  Sum_probs=136.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChH-HHHH------HHHHHHHHHhcCCCCceEEEEeeeCC--
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRHKNVVQFIGACTKP--  290 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~-~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~~~--  290 (504)
                      ..+|+..+.||.|+||.||+....+..+|||++++...... ....      +.+|+..+.++.|++|..+..++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            57899999999999999999888888999999987654332 2222      57899999999999999988875432  


Q ss_pred             ------CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          291 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       291 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                            ...+|+|||++|.+|.++..     ++.    ....+++.+|..+|+.|++|||+||+||+++.++ ++|+|||
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                  35789999999999988742     222    3456999999999999999999999999999988 9999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL  412 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLl  412 (504)
                      ..+.........           ..+....|+.++|+|+||+++.-+.
T Consensus       180 ~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            886543322111           1344556788999999999997654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-21  Score=196.75  Aligned_cols=195  Identities=23%  Similarity=0.357  Sum_probs=151.1

Q ss_pred             CCCCceEEEEeeeCC---------------------------CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHH
Q 010680          276 RHKNVVQFIGACTKP---------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV  328 (504)
Q Consensus       276 ~HpnIv~l~~~~~~~---------------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI  328 (504)
                      .|||||++.++|.+.                           ..+|+||..+ .-+|..|+..  ...+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence            599999999877432                           2578999887 5699999964  556788888999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEC--CC--CcEEEEeeccceeccCCC-------ccccCCCCCCccCcccccCCC---
Q 010680          329 SKGMNYLHQNNIIHRDLKAANLLMD--EN--EVVKVADFGVARVKAQSG-------VMTAETGTYRWMAPEVIEHKP---  394 (504)
Q Consensus       329 ~~gL~yLH~~~IiHrDLkp~NILl~--~~--~~vkL~DFGla~~~~~~~-------~~~~~~gt~~y~APE~l~~~~---  394 (504)
                      ++|+.|||++||.|||+|.+|||+.  ++  ..+.|+|||.+---...+       ..-..-|...-||||+.+..+   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999994  33  368999999874222211       111224678899999986543   


Q ss_pred             ---CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          395 ---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       395 ---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                         --.|+|.|+.|.+.||+++...||...-.........++..-|.+|..+++.+++++..+|+.||.+|++..-....
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence               12589999999999999999999976443333333356666788999999999999999999999999987654444


Q ss_pred             HH
Q 010680          472 LQ  473 (504)
Q Consensus       472 L~  473 (504)
                      |+
T Consensus       511 l~  512 (598)
T KOG4158|consen  511 LN  512 (598)
T ss_pred             HH
Confidence            43

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.6e-21  Score=183.17  Aligned_cols=142  Identities=16%  Similarity=0.160  Sum_probs=111.2

Q ss_pred             eeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChH------------------------HHHHHHHHHHHHHhcCCCCc
Q 010680          226 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSD------------------------MQKEFAQEVFIMRKVRHKNV  280 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~------------------------~~~~~~~Ei~iL~~l~HpnI  280 (504)
                      ...||+|+||.||+|... |+.||||+++.......                        ....+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999874 89999999987532100                        01234679999999999987


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEE
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      .....+....  .||||||++|+++...... ...++...+..++.|++.++.++|+ +||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            5444333322  4899999988865443222 3567888999999999999999999 9999999999999999 78999


Q ss_pred             EEeeccceeccC
Q 010680          360 VADFGVARVKAQ  371 (504)
Q Consensus       360 L~DFGla~~~~~  371 (504)
                      |+|||+++....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=8.3e-23  Score=225.27  Aligned_cols=239  Identities=19%  Similarity=0.251  Sum_probs=181.9

Q ss_pred             ceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ++...+.||++.|=+|.++++....|+||++-+...  +-....+-..|++ ...+++||++.+..+.......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            678889999999999999999877799999754432  2122233344555 5667899999999888888888999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC----CCcc
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVM  375 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~----~~~~  375 (504)
                      . .-+|+|.+.. +.-+..-+...|+.||+.||.-+|..||+|+|||.+||||+.-+.+.|+||..-+..--    +...
T Consensus       103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            9 5699999975 45577778889999999999999999999999999999999999999999987653211    1112


Q ss_pred             ccC----CCCCCccCcccccCC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCCCCHH-------HHHHHHHh
Q 010680          376 TAE----TGTYRWMAPEVIEHK----------P-YDHKADVFSFGIVLWELLT-GKLPYEYLTPL-------QAAVGVVQ  432 (504)
Q Consensus       376 ~~~----~gt~~y~APE~l~~~----------~-~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~-------~~~~~v~~  432 (504)
                      +..    ..-.+|.|||.+...          + .+++.||||+||+++||++ |++||......       .....+++
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le  260 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE  260 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence            211    234579999998431          2 5678999999999999998 89999521110       00011111


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~  471 (504)
                              ...+..+++|+..|++.||.+|.++++.++.
T Consensus       261 --------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  261 --------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             --------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                    1223479999999999999999999999876

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=1.2e-21  Score=195.29  Aligned_cols=232  Identities=17%  Similarity=0.284  Sum_probs=152.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC----------CCceEEEEee-
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH----------KNVVQFIGAC-  287 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~H----------pnIv~l~~~~-  287 (504)
                      .+..++.||.|+++.||.+++.  ++.+|+|+...... .....+.+.+|.-....+.+          -.++--++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            5778889999999999999985  58999998754432 23346677777755554322          1122211111 


Q ss_pred             -----------eCCC-----CceeEEEecCCCchHHHHHhh---ccc---CChHHHHHHHHHHHHHHHHHHHCCceeccC
Q 010680          288 -----------TKPP-----SLCIVTEFMSGGSVYDYLHKL---KGV---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL  345 (504)
Q Consensus       288 -----------~~~~-----~~~lV~E~~~ggsL~~~l~~~---~~~---l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL  345 (504)
                                 .+..     +.+++|+-+ -++|.+++...   ...   +.......+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                       1111     346788888 56888886432   111   233344566689999999999999999999


Q ss_pred             CCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHhCCCC
Q 010680          346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLP  417 (504)
Q Consensus       346 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvvL~eLltG~~P  417 (504)
                      +|+|++++.+|.++|+||+...........  ...+..|.+||....        ..++.+.|.|+||+++|.|.||..|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999988765543221  445678999998743        3578899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 010680          418 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR  462 (504)
Q Consensus       418 f~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R  462 (504)
                      |....+......    .+. ... ++|+.++.||..+|+.||.+|
T Consensus       250 f~~~~~~~~~~~----~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW----DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG----GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc----cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            986644222111    122 223 889999999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.5e-21  Score=182.61  Aligned_cols=183  Identities=15%  Similarity=0.141  Sum_probs=141.1

Q ss_pred             eeeeeeeeCceEEEEEEECCccEEEEEecCCCCChH--HHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecC
Q 010680          225 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      ....|++|+||+||.+...+.+++.+.++.......  ....+.+|+++|++|. |++|++++++    ...+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            346899999999999888888888888775543211  2235789999999996 4889999986    34689999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCcEEEEeeccceeccCCCcc----c
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVKAQSGVM----T  376 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDL-kp~NILl~~~~~vkL~DFGla~~~~~~~~~----~  376 (504)
                      |.+|.+.+..  +      ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........    .
T Consensus        82 G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         82 GAAMYQRPPR--G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             CccHHhhhhh--h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            9998764421  1      1357789999999999999999999 799999999999999999999855443310    0


Q ss_pred             ----------cCCCCCCccCcccccCC-CCC-chhHHHHHHHHHHHHHhCCCCCC
Q 010680          377 ----------AETGTYRWMAPEVIEHK-PYD-HKADVFSFGIVLWELLTGKLPYE  419 (504)
Q Consensus       377 ----------~~~gt~~y~APE~l~~~-~~s-~ksDVwSlGvvL~eLltG~~Pf~  419 (504)
                                -...++.|++|+...-- ..+ ...++++.|+-+|.++|+..|+-
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                      11357778888764322 334 57899999999999999887763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.1e-19  Score=173.84  Aligned_cols=136  Identities=23%  Similarity=0.399  Sum_probs=115.7

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      +.||+|++|.||+|.+.+..|++|+.........      ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5799999999999999999999998775443221      1245788999999999999877666666677889999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +|++|.+++....    . ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.++.
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986521    2 7889999999999999999999999999999999 78899999999854

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=7.6e-20  Score=205.31  Aligned_cols=250  Identities=20%  Similarity=0.283  Sum_probs=189.5

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEEeee
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACT  288 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~  288 (504)
                      ...+++....|.|.+.||.|+||.||+|+. .++.||+|+-++.....-++     =.+++.+|+   -+.|..+..+..
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHc
Confidence            346788899999999999999999999976 47789999988765433111     112233333   245555666666


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCcEEEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVA  361 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-------~~~vkL~  361 (504)
                      -.+..++|+||.+-|+|.++++. .+.+++..+..++.|++..++.||..+|||+||||+|+||..       ...++|+
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             cCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            66778899999999999999984 677999999999999999999999999999999999999942       3469999


Q ss_pred             eecccee---ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 010680          362 DFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT  438 (504)
Q Consensus       362 DFGla~~---~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~  438 (504)
                      |||.+..   +.+........+|-.+-.+|+..+++++..+|.|.|+.+++-||.|+.           .. +..+..-.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y-----------~q-~~~g~~~~  911 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY-----------ME-VKNGSSWM  911 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-----------HH-hcCCccee
Confidence            9999853   333334556678999999999999999999999999999999999963           11 22221111


Q ss_pred             ----CCCCCcH-HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          439 ----IPKNSQP-KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       439 ----~p~~~~~-~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                          ++..... -..+++..+|+.|-..=|...+|...|+.++.+--
T Consensus       912 ~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  912 VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence                2222222 34678888888555455788888888888777554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=1e-20  Score=208.84  Aligned_cols=204  Identities=28%  Similarity=0.412  Sum_probs=155.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|..++.|..|+||.||..+++  .+.+|+|+-+...        +.+-  ++.....|.+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee----------------
Confidence            356888899999999999999765  6789986633221        1110  22222333333                


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                           |+-...+.. -+.++...        +.+++|||+.||+|||+||+|++|+.-|++|++|||+++......    
T Consensus       136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 344444432 34555433        889999999999999999999999999999999999986432211    


Q ss_pred             ------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCCCCC
Q 010680          374 ------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-KGLRPTIP  440 (504)
Q Consensus       374 ------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~-~~~~p~~p  440 (504)
                                  .-...+||+.|+|||++..+.|...+|+|++|+++||.+-|+.||.+.++.+....++. ....|+-.
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d  281 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED  281 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence                        11123799999999999999999999999999999999999999999999887766554 33455666


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCC
Q 010680          441 KNSQPKLAELLERCWQQDPALRP  463 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RP  463 (504)
                      ...+++.++++.++|+.+|..|-
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhc
Confidence            77889999999999999999994

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=7e-20  Score=193.42  Aligned_cols=207  Identities=31%  Similarity=0.569  Sum_probs=168.1

Q ss_pred             HHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q 010680          272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-IHRDLKAANL  350 (504)
Q Consensus       272 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I-iHrDLkp~NI  350 (504)
                      |+.+.|.|+.+|+|.+.+++..++|.+||+.|+|.|.+......+++.....+.++|++||.|||...| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999998866778888888999999999999999876 9999999999


Q ss_pred             EECCCCcEEEEeeccceeccCC---CccccCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHhCCCCCCC
Q 010680          351 LMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKP-------YDHKADVFSFGIVLWELLTGKLPYEY  420 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~-------~s~ksDVwSlGvvL~eLltG~~Pf~~  420 (504)
                      +++..-.+||+|||+.......   .......-..-|.|||.+....       .+.+.|+||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766431   1111222456799999996542       35679999999999999999999965


Q ss_pred             ----CCHHHHHHHHHh---cCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          421 ----LTPLQAAVGVVQ---KGLRPTIPK--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       421 ----~~~~~~~~~v~~---~~~~p~~p~--~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                          ..+.+.+..+..   ..++|.+..  ..++++..++.+||..+|..||++.++...+..+...
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence                333344444333   224555442  4566799999999999999999999998888877664

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.9e-19  Score=173.10  Aligned_cols=134  Identities=16%  Similarity=0.220  Sum_probs=104.2

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-----CCCCceEEEEeeeCCC---Cce-eE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPP---SLC-IV  296 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~~~-lV  296 (504)
                      .+.||+|+||.||....... .+||++.....  ...+.+.+|+.+++.+     .||||++++|++.++.   ..+ +|
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46899999999997333333 46888876432  2346789999999999     5799999999998763   333 78


Q ss_pred             EEe--cCCCchHHHHHhhcccCChHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEECCC----CcEEEEeeccc
Q 010680          297 TEF--MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM-NYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVA  366 (504)
Q Consensus       297 ~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL-~yLH~~~IiHrDLkp~NILl~~~----~~vkL~DFGla  366 (504)
                      |||  +.+++|.+++.+  +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    ..++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557999999965  346655  35678888777 99999999999999999999743    37999995444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4e-19  Score=168.50  Aligned_cols=132  Identities=20%  Similarity=0.362  Sum_probs=108.3

Q ss_pred             eeeeeCceEEEEEEECCccEEEEEecCCCCCh------HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINS------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      .||+|+||.||+|.+.+..|++|+........      ....++.+|+.+++.+.|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            37999999999999999999999976533211      123567889999999998865544444455666799999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      |++|.+++.....        .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||+++.
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998754211        7899999999999999999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=8.2e-19  Score=172.01  Aligned_cols=143  Identities=16%  Similarity=0.187  Sum_probs=112.1

Q ss_pred             ceeeeeeeeeeCceEEEEEE---ECCccEEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 010680          222 HLKFGSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR  276 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~---~~g~~VAvK~lk~~~~~~----------------------~~~~~~~~Ei~iL~~l~  276 (504)
                      -|.+.+.||+|+||.||+|.   ..|+.||||+++......                      .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46777899999999999998   367899999988643210                      01234678999999998


Q ss_pred             CC--CceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEC
Q 010680          277 HK--NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMD  353 (504)
Q Consensus       277 Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~-IiHrDLkp~NILl~  353 (504)
                      +.  .++++++.    ...++||||++|.+|...... ...+....+..++.||+.++.+||+.| |+||||||+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            63  34555543    235899999999888765532 344566677899999999999999999 99999999999999


Q ss_pred             CCCcEEEEeeccceecc
Q 010680          354 ENEVVKVADFGVARVKA  370 (504)
Q Consensus       354 ~~~~vkL~DFGla~~~~  370 (504)
                       ++.++|+|||.+....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999986443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.4e-18  Score=187.95  Aligned_cols=135  Identities=21%  Similarity=0.343  Sum_probs=113.8

Q ss_pred             eeeeeeeeeCceEEEEEEECCccEEEEEecCCCCC-h-----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          224 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-S-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~-~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ...++||+|+||+||+|.+.+..+++|+....... .     .....+.+|+.+++.++|++++..+.++......++||
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            45789999999999999998888777764322111 1     12356889999999999999988877777777789999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ||++|++|.+++.         ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999885         346789999999999999999999999999999 578899999999965

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.1e-19  Score=189.09  Aligned_cols=170  Identities=25%  Similarity=0.450  Sum_probs=137.6

Q ss_pred             CCceeEEEecCCCchHHHHHhh--cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .++||.|++|...+|.++|...  ....++.....++.|++.|++|   ++.+|||+||.||....+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3579999999999999999643  3456778899999999999999   9999999999999999999999999999976


Q ss_pred             ccCCC-------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          369 KAQSG-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       369 ~~~~~-------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      .....       .++..+||..||+||.+.+..|+.++||||||++|+||+.   +|........+...++.+..|+...
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~  482 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFL  482 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHh
Confidence            65544       5677899999999999999999999999999999999998   2332222333344455555443333


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFS  466 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~  466 (504)
                      .-.+.-..|+.+++.+.|.+||++.
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchHH
Confidence            3345667999999999999999443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.3e-18  Score=161.92  Aligned_cols=137  Identities=19%  Similarity=0.237  Sum_probs=108.4

Q ss_pred             eeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCCh--------------------HHHHHHHHHHHHHHhcCCC--C
Q 010680          223 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--N  279 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~--------------------~~~~~~~~Ei~iL~~l~Hp--n  279 (504)
                      |.+.+.||+|+||.||++.. .++.||||+++......                    .....+.+|+.++.++.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            56678999999999999987 58899999977543110                    0112367799999999887  4


Q ss_pred             ceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEE
Q 010680          280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       280 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      ++..++.    ...++||||++|++|.+....       .....++.+|+.++.++|+.||+||||||+||++++++.++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            5555542    345899999999998765421       34567889999999999999999999999999999999999


Q ss_pred             EEeeccceecc
Q 010680          360 VADFGVARVKA  370 (504)
Q Consensus       360 L~DFGla~~~~  370 (504)
                      |+|||.+....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999996444

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=4.7e-17  Score=152.59  Aligned_cols=138  Identities=21%  Similarity=0.288  Sum_probs=100.9

Q ss_pred             eeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHH----------------------HHHHHHHHHhcCCCC--c
Q 010680          226 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE----------------------FAQEVFIMRKVRHKN--V  280 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~----------------------~~~Ei~iL~~l~Hpn--I  280 (504)
                      .+.||+|+||.||+|... ++.||||+++...........                      ...|...+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            468999999999999876 888999998865332211111                      135666677765543  4


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHH-HHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcE
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~v  358 (504)
                      .+.++.    ...++||||++|+.+.. .+.....   ...+..++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            555543    23589999999854321 1221111   16678999999999999999 9999999999999999 8999


Q ss_pred             EEEeeccceeccC
Q 010680          359 KVADFGVARVKAQ  371 (504)
Q Consensus       359 kL~DFGla~~~~~  371 (504)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.9e-16  Score=140.84  Aligned_cols=132  Identities=17%  Similarity=0.219  Sum_probs=114.2

Q ss_pred             eeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCCCCceeEEEecCC
Q 010680          225 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.+.||.|.++.||+++..+..+++|..+....    ...+.+|+.+++.++|  .++++++.+....+..+++|||++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            357899999999999999888999999876532    4578899999999987  5999999988888889999999988


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +.+..+        +......++.+++.++.+||..   +++|+|++|+||++++.+.++++|||.++.
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            877654        4456677899999999999985   799999999999999989999999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.9e-16  Score=154.24  Aligned_cols=136  Identities=14%  Similarity=0.162  Sum_probs=107.3

Q ss_pred             eeee-eeCceEEEEEEECCccEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhcCCCCc--eEEEEeeeCCCC
Q 010680          227 SKVA-SGSYGDLYRGTYCSQDVAIKVLKPERI-----------NSDMQKEFAQEVFIMRKVRHKNV--VQFIGACTKPPS  292 (504)
Q Consensus       227 ~~LG-~G~fG~Vy~~~~~g~~VAvK~lk~~~~-----------~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~~~  292 (504)
                      ..|| .|+.|+||.....+..++||..+....           .......+.+|+.++.+++|++|  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4687 899999999988899999998864321           11223567889999999998875  677776433222


Q ss_pred             ----ceeEEEecCC-CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          293 ----LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       293 ----~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                          .++|||+++| .+|.+++..  ..++..    .+.+|+.+|.+||++||+||||||+|||++.++.++|+|||.++
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence                2599999997 689988854  345543    35789999999999999999999999999998999999999986


Q ss_pred             e
Q 010680          368 V  368 (504)
Q Consensus       368 ~  368 (504)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            4

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=3.7e-18  Score=187.36  Aligned_cols=249  Identities=25%  Similarity=0.426  Sum_probs=197.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g---~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..|.+.+-||+|+|+.|-.....+   ..+|+|.+...............|..+-+.+. |+|++.+++........+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456666779999999988776532   34666666554433344455666888888887 99999999999999999999


Q ss_pred             EEecCCCchHHHH-HhhcccCChHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCC-cEEEEeeccceeccC-C
Q 010680          297 TEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQ-S  372 (504)
Q Consensus       297 ~E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~-~  372 (504)
                      ++|..|+++.+.+ .......+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..... .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999999999988 442226777889999999999999999 99999999999999999999 999999999986655 3


Q ss_pred             C---ccccCCC-CCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcC--CCCCCCCCCc
Q 010680          373 G---VMTAETG-TYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKG--LRPTIPKNSQ  444 (504)
Q Consensus       373 ~---~~~~~~g-t~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~--~~p~~p~~~~  444 (504)
                      +   .....+| ++.|+|||...+..| ....|+||.|+++.-+++|..||......... .......  ........++
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS  259 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence            2   3334578 999999999988544 56789999999999999999999765443322 1112111  1234556788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      ....+++.+++..+|..|.+.+++.
T Consensus       260 ~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  260 DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             hhhhhcccccccCCchhcccccccc
Confidence            8999999999999999999988764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.6e-13  Score=146.13  Aligned_cols=139  Identities=17%  Similarity=0.262  Sum_probs=99.2

Q ss_pred             eeeeeeCceEEEEEEE-CCccEEEEEecCCCCCh---H-------------------------H----------HHHHHH
Q 010680          227 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D-------------------------M----------QKEFAQ  267 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~---~-------------------------~----------~~~~~~  267 (504)
                      +.||+|++|.||+|+. .|+.||||+.++.....   +                         .          .-.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4699999999999987 58999999987652110   0                         0          012555


Q ss_pred             HHHHHHhcC-----CCCc--eEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHH-HHHHHHHCC
Q 010680          268 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-GMNYLHQNN  339 (504)
Q Consensus       268 Ei~iL~~l~-----HpnI--v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~-gL~yLH~~~  339 (504)
                      |+..+.+++     +++|  ++++..+  ....+|||||++|++|.++........   ....++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            666666653     2332  3333222  234689999999999998875422222   23456666666 478899999


Q ss_pred             ceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          340 IIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       340 IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ++|+|++|.||+++.++.++++|||++....
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.7e-14  Score=153.02  Aligned_cols=246  Identities=23%  Similarity=0.288  Sum_probs=185.8

Q ss_pred             Cceeeeeeeee--eCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCc
Q 010680          221 KHLKFGSKVAS--GSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~--G~fG~Vy~~~~----~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~  293 (504)
                      ..+.+.+.+|+  |.+|.||.+.-    .+..+|+|.-+...........=.+|+.-.++++ |+|.++.+..+...+.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34556678899  99999998865    4567898874433222222223345666666665 89999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEECCC-CcEEEEeecccee
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV  368 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~----gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~  368 (504)
                      ++-+|++ |.+|..+.+.....++...++....+...    |+.++|+.+|+|-|+||+||++..+ ...+++|||+...
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence            9999999 78999998876666899999999999999    9999999999999999999999999 8899999999987


Q ss_pred             ccCCCc-cc-----cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 010680          369 KAQSGV-MT-----AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK  441 (504)
Q Consensus       369 ~~~~~~-~~-----~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~  441 (504)
                      ...... ..     ...|...|++||+.++. ++.+.|+|++|.++.+..+|..+.........  ...++. ...++..
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSW--SQLRQGYIPLEFCE  349 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCc--cccccccCchhhhc
Confidence            665541 11     22678899999998776 78999999999999999887655532210000  001111 1122334


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..+.++...+.+|+..+|-.|+++..+++
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            45667888999999999999998887653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.9e-13  Score=123.60  Aligned_cols=127  Identities=17%  Similarity=0.196  Sum_probs=98.1

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEEEecCCCc
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGS  304 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggs  304 (504)
                      .+.|+.|.++.||+++..+..|++|+......   ....+..|+.+++.+.+.++ ++++....  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            35789999999999999999999999765421   12345789999998876554 45655443  34579999999988


Q ss_pred             hHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEECCCCcEEEEeeccce
Q 010680          305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-----IHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       305 L~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I-----iHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      +.+.      ..   ....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7643      01   113456899999999999985     9999999999999 6789999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=3.6e-12  Score=138.02  Aligned_cols=138  Identities=19%  Similarity=0.275  Sum_probs=91.0

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC----------------------------h----HHHH-----
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN----------------------------S----DMQK-----  263 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~----------------------------~----~~~~-----  263 (504)
                      |+. +.||+|++|.||+|+..  |+.||||++++....                            .    +..+     
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            444 67999999999999874  799999999865210                            0    1111     


Q ss_pred             -HHHHHHHHHHhcC----CCC---ceEEEEeeeCCCCceeEEEecCCCchHHHHHhh-cc----cCChHHHHHHHHHHHH
Q 010680          264 -EFAQEVFIMRKVR----HKN---VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KG----VFKLPSLLKVAIDVSK  330 (504)
Q Consensus       264 -~~~~Ei~iL~~l~----Hpn---Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~----~l~~~~~~~i~~qI~~  330 (504)
                       ++.+|+..+.+++    +.+   |++++.-+  ....+|||||+.|+.|.++-.-. .+    .+....+..++.|+  
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence             2344554444443    332   23333222  23467999999999998753211 12    23333344444444  


Q ss_pred             HHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          331 GMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       331 gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                           ...|++|+|+||.||+++.++    .++++|||++....
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 458999999999999999888    99999999987553

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=9.6e-12  Score=133.57  Aligned_cols=163  Identities=15%  Similarity=0.245  Sum_probs=126.9

Q ss_pred             ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHH
Q 010680          242 YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL  321 (504)
Q Consensus       242 ~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~  321 (504)
                      ..+.+|.|++.+....  .......+-++.|+.++||||++++..+...+.+|||+|-+.  .|..++..    +....+
T Consensus        35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence            3567888888876532  333456677889999999999999999999999999999883  67777766    336677


Q ss_pred             HHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc-ccCCCCCCccCcccccCCCCCchh
Q 010680          322 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKA  399 (504)
Q Consensus       322 ~~i~~qI~~gL~yLH-~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ks  399 (504)
                      ..-+.||+.||.||| ..+++|++|.-..|+++..|.+||++|.++........+ ....--..|..|+.+....  -..
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence            788899999999998 568999999999999999999999999998755543321 1111223456666654332  457


Q ss_pred             HHHHHHHHHHHHHhC
Q 010680          400 DVFSFGIVLWELLTG  414 (504)
Q Consensus       400 DVwSlGvvL~eLltG  414 (504)
                      |.|.|||++||++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=2.4e-13  Score=151.17  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=189.6

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      +....+.+.+.+-+-+|+++.++.++-.  +...++|+.+.... .....+....+-.++-..++|-++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4556667778888999999999987653  33455555443211 11112333344444444456777776666556677


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec-cC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQ  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~-~~  371 (504)
                      .+++++|+.|++|...|+. .+..+...+..+...+.++.+|||+..++|||++|.|+|+..+++.+++|||..... ..
T Consensus       879 ~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            8999999999999999987 445666777888899999999999999999999999999999999999999843210 00


Q ss_pred             --------------------C-----------CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 010680          372 --------------------S-----------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY  420 (504)
Q Consensus       372 --------------------~-----------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~  420 (504)
                                          .           .......||+.|.+||...+......+|+|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                0           001123689999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 010680          421 LTPLQAAVGVVQK-GLRPTIPKNSQPKLAELLERCWQQDPALRPDFS  466 (504)
Q Consensus       421 ~~~~~~~~~v~~~-~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~  466 (504)
                      .++.+....+... ...|..+...+++..+++...+..+|.+|-.+.
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998887665543 234566678899999999999999999997655

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=5.3e-12  Score=119.95  Aligned_cols=138  Identities=17%  Similarity=0.204  Sum_probs=99.9

Q ss_pred             eeeeeeCceEEEEEEEC--------CccEEEEEecCCCCC--------------------hHHHHHH----HHHHHHHHh
Q 010680          227 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERIN--------------------SDMQKEF----AQEVFIMRK  274 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--------g~~VAvK~lk~~~~~--------------------~~~~~~~----~~Ei~iL~~  274 (504)
                      ..||.|--+.||.|...        +..+|||+.+.....                    ..-.+.+    .+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754        368999987632110                    1112223    379999999


Q ss_pred             cCC--CCceEEEEeeeCCCCceeEEEecCCCchHH-HHHhhcccCChHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcE
Q 010680          275 VRH--KNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANL  350 (504)
Q Consensus       275 l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~IiHrDLkp~NI  350 (504)
                      +..  -++++.+++    ...+|||||+.+..+.. .+..  ..++...+..+..+++.+|..| |+.||+|+||++.||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            864  466777764    45689999997653322 2222  2345556778889999999999 899999999999999


Q ss_pred             EECCCCcEEEEeeccceeccC
Q 010680          351 LMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~  371 (504)
                      |++ ++.++|+|||.+.....
T Consensus       157 L~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEE-CCcEEEEECCCceeCCC
Confidence            997 46799999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.7e-11  Score=113.66  Aligned_cols=133  Identities=22%  Similarity=0.348  Sum_probs=102.8

Q ss_pred             eeeeeCceEEEEEEECCccEEEEEecCCCC-ChHH-----HHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          228 KVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDM-----QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~-~~~~-----~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      .+++|+-+.+|.+.+.|.++.+|.=.+... .+..     ...-.+|+.++.++.--.|..-+=+..+++...|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            578899999999999888888886433322 2221     2346679999999986665544444566677889999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      |..|.+++...        ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++...
T Consensus        83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          83 GELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             ChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99999999763        144666677777789999999999999999998765 999999999643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.1e-12  Score=139.29  Aligned_cols=243  Identities=21%  Similarity=0.218  Sum_probs=180.8

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCcee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..+|..+..||.|.|+.|+.....   +..+++|.++...........-..|+.+...+. |.+++..+..|......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            346788899999999999987653   456888887766554433344455777766665 8999998888888888889


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeeccceeccCCCc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~~  374 (504)
                      --||++++++...+ .....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||......-. .
T Consensus       344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-~  421 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-S  421 (524)
T ss_pred             chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-c
Confidence            99999999888776 335668888999999999999999999999999999999999886 78999999998642211 1


Q ss_pred             cccCCCCCCc-cCcccccCCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          375 MTAETGTYRW-MAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       375 ~~~~~gt~~y-~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~-Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                      ....-.+..| .+|......++..+.|+|+||..+.+.++|.. ++....     ...++.+..+..+..- ..+..+..
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~~i~~~~~p~~~~~~-~~~q~~~k  495 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SLTIRSGDTPNLPGLK-LQLQVLLK  495 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ceeeecccccCCCchH-Hhhhhhhh
Confidence            1112223334 35566677788899999999999999999764 222111     1123334444444433 78889999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      .+...++..||.+.++..
T Consensus       496 v~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  496 VMINPDRKRRPSAVELSL  513 (524)
T ss_pred             hhcCCccccchhhhhhcc
Confidence            999999999999887653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=9.2e-12  Score=123.56  Aligned_cols=190  Identities=21%  Similarity=0.356  Sum_probs=137.5

Q ss_pred             HHhcCCCCceEEEEeeeCCC-----CceeEEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHC--Cce
Q 010680          272 MRKVRHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN--NII  341 (504)
Q Consensus       272 L~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~--~Ii  341 (504)
                      |-++.|.|||+++.++.+..     ...+++|||+.|+|..+|++.+   ..+......+|+.||+.||.|||+.  -|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            44557999999999986543     4688999999999999997543   4577888899999999999999998  599


Q ss_pred             eccCCCCcEEECCCCcEEEEeeccceec-----cCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 010680          342 HRDLKAANLLMDENEVVKVADFGVARVK-----AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL  416 (504)
Q Consensus       342 HrDLkp~NILl~~~~~vkL~DFGla~~~-----~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~  416 (504)
                      |+++..+.|++..++-+|++----....     .........++-++|.+||.=.....+.++|||+||....||..|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            9999999999999998887532211100     00012223467789999998766667788999999999999987664


Q ss_pred             C-CCCCC---HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          417 P-YEYLT---PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       417 P-f~~~~---~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      - -...+   ..+....+.. ++       -.+.=++++.+|++..|..||++.+++
T Consensus       281 q~tnseS~~~~ee~ia~~i~-~l-------en~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  281 QSTNSESKVEVEENIANVII-GL-------ENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             ccCCCcceeehhhhhhhhee-ec-------cCccccCcCcccccCCCCCCcchhhhh
Confidence            3 22211   1122111111 11       112235789999999999999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=5.5e-11  Score=113.70  Aligned_cols=139  Identities=19%  Similarity=0.288  Sum_probs=105.9

Q ss_pred             eeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCC---CCceeEEEec
Q 010680          227 SKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTEFM  300 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~  300 (504)
                      +.|+.|.++.||+++..+ +.+++|+....... .....+.+|+.+++.+.+  ..+++++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998876 88999997654321 124567889999999986  3467788777654   2668999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  337 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-------------------------------------------  337 (504)
                      +|.++.+.+..  ..++......++.+++++|.+||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99988775531  345666666777777777777763                                           


Q ss_pred             -------------CCceeccCCCCcEEECC--CCcEEEEeecccee
Q 010680          338 -------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARV  368 (504)
Q Consensus       338 -------------~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~  368 (504)
                                   ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         24699999999999998  67789999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=5.6e-10  Score=114.34  Aligned_cols=251  Identities=18%  Similarity=0.313  Sum_probs=172.8

Q ss_pred             eeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceE--------EEEeeeCCCCce
Q 010680          224 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ--------FIGACTKPPSLC  294 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~~~~~~~~~~~  294 (504)
                      ..++.||+|+-+.+|-.-.-+..|| |+.........     .+.+..|.+. .||-+-.        ++|. ......-
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecchhhchhh-eeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence            3457899999999997655555565 55443322111     1122223332 3554332        1211 1122256


Q ss_pred             eEEEecCCCc-hHHHHH-----hhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          295 IVTEFMSGGS-VYDYLH-----KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       295 lV~E~~~ggs-L~~~l~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ++|..++|.. +..+++     +......|+.+++.+..++.+.+.||..|.+-+|++++|+|+++++.|.|.|-..-.+
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            7888887653 222221     1123477899999999999999999999999999999999999999999999776666


Q ss_pred             ccCCCccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCC-------CHHHHHHHH-----
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTG-KLPYEYL-------TPLQAAVGV-----  430 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~-------~~~~~~~~v-----  430 (504)
                      ..........+|...|.+||.-+     +..-+...|.|.||++++++|.| +.||.+.       .+.+.....     
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            66556677789999999999864     44556789999999999999985 9999753       233322110     


Q ss_pred             ---HhcCCCCC---C-CCCCcHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHhcc
Q 010680          431 ---VQKGLRPT---I-PKNSQPKLAELLERCWQQD--PALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       431 ---~~~~~~p~---~-p~~~~~~l~~Ll~~cl~~d--P~~RPs~~ell~~L~~l~~~~~~  481 (504)
                         -+.+.+|.   + ...+++.+..|..+|+..-  +.-||+++.++..|..+.+++..
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence               11222221   1 1456899999999999654  56899999999999999888864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=2.2e-10  Score=105.99  Aligned_cols=144  Identities=23%  Similarity=0.289  Sum_probs=107.1

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCC-Ch-----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~-~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ...|-+|+-+.|+++.+.|+...||.=..... .+     -..++..+|+++|.++.--.|.--.=++.+...-+|+|||
T Consensus        12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45688899999999999999988886332222 11     1245678899999998755553333334455566899999


Q ss_pred             cCC-CchHHHHHhhcccCChH-HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeeccceec
Q 010680          300 MSG-GSVYDYLHKLKGVFKLP-SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK  369 (504)
Q Consensus       300 ~~g-gsL~~~l~~~~~~l~~~-~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~~  369 (504)
                      ++| .++.+++......-..+ ....++.+|-..+.-||.++|||+||..+||++..++   .+.++|||++...
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            976 37888887654333333 3378999999999999999999999999999997654   3589999998644

>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains

Probab=99.16  E-value=7.4e-11  Score=92.24  Aligned_cols=67  Identities=67%  Similarity=1.026  Sum_probs=64.5

Q ss_pred             ceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHH
Q 010680          108 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV  174 (504)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~  174 (504)
                      |+||.+.+.|+|.|+++++.+|+..|+||..|.+|+|.||+.+|+|+|.+|..++.+.|++++++.+
T Consensus         1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~   67 (68)
T cd04928           1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI   67 (68)
T ss_pred             CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence            5899999999999999999999999999999999999999999999999999999999999998764

This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=9.8e-10  Score=109.66  Aligned_cols=139  Identities=14%  Similarity=0.059  Sum_probs=99.6

Q ss_pred             eeeeCceEEEEEEECCccEEEEEecCCCCCh---------HHHHHHHHHHHHHHhcCCCCc--eEEEEeeeC-----CCC
Q 010680          229 VASGSYGDLYRGTYCSQDVAIKVLKPERINS---------DMQKEFAQEVFIMRKVRHKNV--VQFIGACTK-----PPS  292 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~---------~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~-----~~~  292 (504)
                      +-......|++..+.|+.|.||.........         .-...+.+|...+.++...+|  +..+++...     ...
T Consensus        30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~  109 (268)
T PRK15123         30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT  109 (268)
T ss_pred             EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence            3333444577888888999999765432111         001147788888888854333  334444432     234


Q ss_pred             ceeEEEecCCC-chHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCcEEEEee
Q 010680          293 LCIVTEFMSGG-SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVADF  363 (504)
Q Consensus       293 ~~lV~E~~~gg-sL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-------~~~vkL~DF  363 (504)
                      .+||||++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||++.       +..+.++||
T Consensus       110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            68999999876 899998542 234556677889999999999999999999999999999975       468999999


Q ss_pred             ccce
Q 010680          364 GVAR  367 (504)
Q Consensus       364 Gla~  367 (504)
                      +.++
T Consensus       190 ~r~~  193 (268)
T PRK15123        190 HRAQ  193 (268)
T ss_pred             Cccc
Confidence            9885

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=4.6e-09  Score=99.35  Aligned_cols=127  Identities=20%  Similarity=0.274  Sum_probs=85.1

Q ss_pred             EEEEEEE-CCccEEEEEecCCCCC------------------------hHHHHHHHHHHHHHHhcCCC--CceEEEEeee
Q 010680          236 DLYRGTY-CSQDVAIKVLKPERIN------------------------SDMQKEFAQEVFIMRKVRHK--NVVQFIGACT  288 (504)
Q Consensus       236 ~Vy~~~~-~g~~VAvK~lk~~~~~------------------------~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~  288 (504)
                      .||.|.. .+..+|||+.+....+                        .-......+|.+.|.++..-  ++++++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4888876 5778999997642111                        01234467899999999865  567777553 


Q ss_pred             CCCCceeEEEecC--CCchHHHHHhhcccCChHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          289 KPPSLCIVTEFMS--GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY-LHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       289 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~y-LH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                         ..+|||||++  |..+..+...   .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               3579999998  6566554332   22245667788888886666 579999999999999999987 899999999


Q ss_pred             ceecc
Q 010680          366 ARVKA  370 (504)
Q Consensus       366 a~~~~  370 (504)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            86544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1.5e-08  Score=97.21  Aligned_cols=106  Identities=17%  Similarity=0.278  Sum_probs=82.9

Q ss_pred             HHHHHHHHHHHhcCCCC--ceEEEEeeeCC----CCceeEEEecCCC-chHHHHHhhcccCChHHHHHHHHHHHHHHHHH
Q 010680          263 KEFAQEVFIMRKVRHKN--VVQFIGACTKP----PSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL  335 (504)
Q Consensus       263 ~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yL  335 (504)
                      ....+|...+..+..-+  ++..+++....    ...++|||+++|. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            35677888777775433  34455554432    2348999999885 79999876322 66777889999999999999


Q ss_pred             HHCCceeccCCCCcEEECCCC---cEEEEeeccceec
Q 010680          336 HQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK  369 (504)
Q Consensus       336 H~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~~  369 (504)
                      |.+||+|+|+++.|||++.++   .+.++||+.++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=1.1e-07  Score=100.16  Aligned_cols=211  Identities=17%  Similarity=0.214  Sum_probs=152.8

Q ss_pred             ceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee----CCCCceeEEEecCC-CchH
Q 010680          234 YGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT----KPPSLCIVTEFMSG-GSVY  306 (504)
Q Consensus       234 fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~g-gsL~  306 (504)
                      -.+.|++..  +|..|.+|.+...+....  .....-+++++++.|+|||+|..++.    .+..+++|++|.++ ++|+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            356888865  578899999854332211  11234577899999999999999876    34568999999986 4788


Q ss_pred             HHHHhh--------------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          307 DYLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       307 ~~l~~~--------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      ++.-..              +.+.++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+..|...+...+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            765321              234678899999999999999999999999999999999999889999888877654433


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      .      +       |-++.   -.+-|.=.||.+++.|.||..- +......+...+        .+....+.++++++
T Consensus       447 ~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v  502 (655)
T KOG3741|consen  447 P------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVV  502 (655)
T ss_pred             C------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHH
Confidence            2      0       11211   2357999999999999998642 232222222122        23456778999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~  471 (504)
                      .-....++++ -+..+++..
T Consensus       503 ~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  503 EYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHhcCccc-ccHHHHHHH
Confidence            9999999886 677777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=3.4e-08  Score=96.99  Aligned_cols=135  Identities=19%  Similarity=0.258  Sum_probs=101.9

Q ss_pred             eeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCCh--------------------HHHHHHHHHHHHHHhcCCC--Cc
Q 010680          224 KFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--NV  280 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~--------------------~~~~~~~~Ei~iL~~l~Hp--nI  280 (504)
                      .++.+||-|--+.||.|... |.++|||.-+..+.+-                    -......+|..+|.+|...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45678999999999999874 8999999865432211                    1233466799999998755  67


Q ss_pred             eEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEE
Q 010680          281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV  360 (504)
Q Consensus       281 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL  360 (504)
                      ++.++    .+..++||||++|..|+..-      ++....-.++..|+.-+.-+-..||||+|+.+-||+++++|.+.+
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            77664    34568999999987776432      234445566667777777667999999999999999999999999


Q ss_pred             Eeecccee
Q 010680          361 ADFGVARV  368 (504)
Q Consensus       361 ~DFGla~~  368 (504)
                      +||--+..
T Consensus       244 IDwPQ~v~  251 (304)
T COG0478         244 IDWPQAVP  251 (304)
T ss_pred             EeCccccc
Confidence            99987643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=5.4e-07  Score=97.44  Aligned_cols=140  Identities=18%  Similarity=0.271  Sum_probs=92.8

Q ss_pred             eeeeeeCceEEEEEEEC-CccEEEEEecCCCCCh---H-------------------------HH----------HHHHH
Q 010680          227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS---D-------------------------MQ----------KEFAQ  267 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~---~-------------------------~~----------~~~~~  267 (504)
                      +-|+++|-|.||+|+.. |+.||||+.++.....   +                         ..          -.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            46899999999999987 8999999987542110   0                         00          12445


Q ss_pred             HHHHHHhcC-----CCC--ceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCc
Q 010680          268 EVFIMRKVR-----HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI  340 (504)
Q Consensus       268 Ei~iL~~l~-----Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I  340 (504)
                      |+..+.+++     .++  |++++.  .-...-.|+|||+.|..+.+........++...+.....++.  +..+=..|+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            555555553     233  333432  223345799999999999998543334455333333222222  233334899


Q ss_pred             eeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          341 IHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       341 iHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +|.|..|.||+++.+|.+.+.|||......
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCC
Confidence            999999999999999999999999986443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.65  E-value=8.6e-09  Score=111.55  Aligned_cols=144  Identities=19%  Similarity=0.305  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCCCc-----cc-----cCCCCCCccCcccccCCC
Q 010680          326 IDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-----MT-----AETGTYRWMAPEVIEHKP  394 (504)
Q Consensus       326 ~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~-----~~~gt~~y~APE~l~~~~  394 (504)
                      .+++.||.|+|.. ++||++|.|++|.++.++.+||+.|+++........     .+     .......|.|||.+.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3444999999975 899999999999999999999999998854333111     11     113456899999999988


Q ss_pred             CCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       395 ~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~--~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      .+.++|+||+|+++|.+.. |+.-+.............  .....-.....+|+++++-|.+++..++..||++.++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            8899999999999999994 555554332211111111  11112234578899999999999999999999766654

>PRK09902 hypothetical protein; Provisional

Probab=98.61  E-value=6.4e-07  Score=85.85  Aligned_cols=139  Identities=12%  Similarity=0.087  Sum_probs=102.2

Q ss_pred             eeeCceEEEEEEECCccEEEEEecCCCC---C-hHHHHHHHHHHHHHHhcCCCC--ceEEEEeeeC--C--CCceeEEEe
Q 010680          230 ASGSYGDLYRGTYCSQDVAIKVLKPERI---N-SDMQKEFAQEVFIMRKVRHKN--VVQFIGACTK--P--PSLCIVTEF  299 (504)
Q Consensus       230 G~G~fG~Vy~~~~~g~~VAvK~lk~~~~---~-~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~--~--~~~~lV~E~  299 (504)
                      |+|+.+-|++-.+.|+.+-+|.-.....   . +-....|.+|+..|+++..-+  +++.+.....  +  -..+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            6688888999888888888887542110   0 223567899999999886422  4555522211  1  125799998


Q ss_pred             cCC-CchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEEeecccee
Q 010680          300 MSG-GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV  368 (504)
Q Consensus       300 ~~g-gsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~--vkL~DFGla~~  368 (504)
                      ++| -+|.+++... -.+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            854 4888888542 134566667899999999999999999999999999999987677  99999987753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=1.2e-06  Score=85.39  Aligned_cols=135  Identities=17%  Similarity=0.251  Sum_probs=85.7

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEeeeCCCCceeEEEecCCCc
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGS  304 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggs  304 (504)
                      ..||.|..+.||+.  .+..+++|+..... .   .....+|.++++.+..-+  +++.++++...+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            47899999999984  36678888876532 1   234678999999887543  4778888877777889999998863


Q ss_pred             -hHHHH---------------------Hhhc-ccCChHHH-HHHHH----------HHHH-HHHHHHH----CCceeccC
Q 010680          305 -VYDYL---------------------HKLK-GVFKLPSL-LKVAI----------DVSK-GMNYLHQ----NNIIHRDL  345 (504)
Q Consensus       305 -L~~~l---------------------~~~~-~~l~~~~~-~~i~~----------qI~~-gL~yLH~----~~IiHrDL  345 (504)
                       +...+                     +... ...+.... ..+..          ++.. ...+|..    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     1100 01111111 11100          1111 1222221    24789999


Q ss_pred             CCCcEEECCCCcEEEEeecccee
Q 010680          346 KAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       346 kp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998853

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=1.2e-06  Score=84.39  Aligned_cols=139  Identities=17%  Similarity=0.207  Sum_probs=94.4

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChH-HHH------HHHHHHHHHHhcC---CCCceEEEEeeeC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQK------EFAQEVFIMRKVR---HKNVVQFIGACTK  289 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~-~~~------~~~~Ei~iL~~l~---HpnIv~l~~~~~~  289 (504)
                      ..+|++.+.+-......|.+....++.+.+|..+......+ ...      ...+.+..+.+++   .-....++-+...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            45778888888777888888888999999999876532211 111      1223444444443   2333333333222


Q ss_pred             -----CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          290 -----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       290 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                           ....+++|||++|..|.++..     ++.    .++..|.++|.-||+.|++|+|..|.|++++.++ ++++||+
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~  179 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ  179 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence                 233568999999988876542     222    2556778889999999999999999999999655 9999998


Q ss_pred             ccee
Q 010680          365 VARV  368 (504)
Q Consensus       365 la~~  368 (504)
                      ..+.
T Consensus       180 ~k~~  183 (229)
T PF06176_consen  180 GKRM  183 (229)
T ss_pred             cccc
Confidence            7653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=2.7e-06  Score=81.39  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=85.4

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEeeeC---CCCceeEEEec
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTK---PPSLCIVTEFM  300 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~---~~~~~lV~E~~  300 (504)
                      ++.|+.|..+.||+.+..+..+++|+....    .....+.+|..+++.+....  +++++.....   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            467999999999999998889999997643    34567788999998886433  5677764422   23368999999


Q ss_pred             CCCchHH----------------HHH---hhccc---CChHH---------HHHH------------HHHHHH-HHHHHH
Q 010680          301 SGGSVYD----------------YLH---KLKGV---FKLPS---------LLKV------------AIDVSK-GMNYLH  336 (504)
Q Consensus       301 ~ggsL~~----------------~l~---~~~~~---l~~~~---------~~~i------------~~qI~~-gL~yLH  336 (504)
                      +|..+..                .+.   .....   +....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                111   11000   00000         0000            111222 333333


Q ss_pred             H-------CCceeccCCCCcEEEC-CCCcEEEEeecccee
Q 010680          337 Q-------NNIIHRDLKAANLLMD-ENEVVKVADFGVARV  368 (504)
Q Consensus       337 ~-------~~IiHrDLkp~NILl~-~~~~vkL~DFGla~~  368 (504)
                      .       ..++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2       3599999999999999 666678999998854

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains

Probab=98.42  E-value=7.9e-07  Score=70.85  Aligned_cols=50  Identities=42%  Similarity=0.682  Sum_probs=47.1

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCC
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW  158 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~  158 (504)
                      .||.+.+.|+|+|+++++.+|+++|+||..|.+|.+.+|+.+|+|.|..+
T Consensus         2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~   51 (73)
T cd04900           2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDP   51 (73)
T ss_pred             EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECC
Confidence            58999999999999999999999999999999999999999999999543

This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=4.1e-06  Score=82.04  Aligned_cols=135  Identities=16%  Similarity=0.161  Sum_probs=85.9

Q ss_pred             eeeeeCc-eEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecCCCch
Q 010680          228 KVASGSY-GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSV  305 (504)
Q Consensus       228 ~LG~G~f-G~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  305 (504)
                      .|..|.+ ..||+....+..+.||+.....     ...+.+|+.+++.+. +--+++++++....+..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455655 7799998777788888876542     234667898888885 34467788877766678999999999877


Q ss_pred             HHHH-------------------Hhhcc-cCChH----HHH-HHHH-------------------HHHHHHHHHH-----
Q 010680          306 YDYL-------------------HKLKG-VFKLP----SLL-KVAI-------------------DVSKGMNYLH-----  336 (504)
Q Consensus       306 ~~~l-------------------~~~~~-~l~~~----~~~-~i~~-------------------qI~~gL~yLH-----  336 (504)
                      ....                   +.... ..+..    ... ....                   .+...+..|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   11000 00100    000 0000                   0111122221     


Q ss_pred             --HCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          337 --QNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       337 --~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                        ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              2348999999999999998888999999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=6.6e-06  Score=76.33  Aligned_cols=136  Identities=18%  Similarity=0.223  Sum_probs=98.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEEEe
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~  299 (504)
                      -..+..+.|++|.+|.||+|.|.|..+|+|+-+.+..    ...+..|+++|..+.-.++ .++|.+...    ++.|||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            3455567899999999999999999999999776532    4668889999999987666 445554443    356999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEECCCCcEEEEeeccceeccCC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK-AANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLk-p~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +.|.+|.+.-...    +..    -...++..---|-..||-|..|. |...++..++.+.|+||..|+....+
T Consensus        94 i~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112          94 IDGRPLGKLEIGG----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hcCcchhhhhhcc----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            9998887765421    222    23444555555677899999885 44455555558999999999855544

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.26  E-value=9.3e-06  Score=79.22  Aligned_cols=137  Identities=18%  Similarity=0.172  Sum_probs=91.4

Q ss_pred             eeeeeCceEEEEEEE-CCccEEEEEecCCCCChHH----------------------HHHHHHHHHHHHhcCC--CCceE
Q 010680          228 KVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM----------------------QKEFAQEVFIMRKVRH--KNVVQ  282 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~----------------------~~~~~~Ei~iL~~l~H--pnIv~  282 (504)
                      .|.+|--+.||+|.. .+..+|+|+.+........                      ..-...|+..|+++..  =.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            455666667999875 5788999998754221110                      0113347777777643  33444


Q ss_pred             EEEeeeCCCCceeEEEecCCCc-hHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEE
Q 010680          283 FIGACTKPPSLCIVTEFMSGGS-VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKV  360 (504)
Q Consensus       283 l~~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL  360 (504)
                      -+.+.    ...|||||++... -.-.|..  -.+....+..+..++++.|.-|-. .++||+||..-|||+. ++.+.|
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            44433    2469999995431 1111211  123333678888999999999888 8999999999999999 889999


Q ss_pred             EeeccceeccC
Q 010680          361 ADFGVARVKAQ  371 (504)
Q Consensus       361 ~DFGla~~~~~  371 (504)
                      +|||-|.....
T Consensus       208 ID~~QaV~~~h  218 (268)
T COG1718         208 IDVSQAVTIDH  218 (268)
T ss_pred             EECccccccCC
Confidence            99999865543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.18  E-value=8.3e-06  Score=93.21  Aligned_cols=231  Identities=18%  Similarity=0.202  Sum_probs=161.6

Q ss_pred             eeeeCceEEEEEEECCc------cEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC----ceeEE
Q 010680          229 VASGSYGDLYRGTYCSQ------DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----LCIVT  297 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~g~------~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~  297 (504)
                      +..-++|+++..++.-+      ++-++.-..... .+.......-|...+.++.|+|++.++.+......    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            44556788888776432      121111110000 11223334457778889999999999988654332    33456


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC---cEEECCCCcEEEE--eeccceeccCC
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA---NLLMDENEVVKVA--DFGVARVKAQS  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~---NILl~~~~~vkL~--DFGla~~~~~~  372 (504)
                      |+++..++...+.. -+.++...++.+..++.+|+.|+|+....|.-+...   +..++.++.+.++  ||+..+.....
T Consensus       266 ~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  266 EICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             hhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence            88988899888876 678899999999999999999999997766666655   5555667778887  99998877776


Q ss_pred             CccccCCCCCCccCcccccCCCCCch--hHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHK--ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~k--sDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .......-+..|.+||......++.+  .|+|.+|.....+..|..+-.....       ..    +..+......+.+.
T Consensus       345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------~~----~~l~~~~~~~~~d~  413 (1351)
T KOG1035|consen  345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------PV----SLLDVLSTSELLDA  413 (1351)
T ss_pred             ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------hh----hhhccccchhhhhh
Confidence            66666667778899999887766654  7999999999999987644221110       00    11222222378899


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~  471 (504)
                      +.+|+..++++|+++.+++..
T Consensus       414 ~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  414 LPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhcchhhhhccchhhhhhc
Confidence            999999999999999998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=5.5e-06  Score=78.50  Aligned_cols=100  Identities=17%  Similarity=0.301  Sum_probs=81.0

Q ss_pred             HHHHHHHHhcCC-CCceEEEEeeeCCCCceeEEEecCCCchHHH---HHhhcccCChHHHHHHHHHHHHHHHHHHH---C
Q 010680          266 AQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---N  338 (504)
Q Consensus       266 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~~l~~~~~~~i~~qI~~gL~yLH~---~  338 (504)
                      ..|.-+|+.+++ +++++++|+|..    ++|+||.+.+++...   +.. --..+|..+.+|+.+++..+.+|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358889999987 799999999954    579999987765421   111 1235899999999999999999998   4


Q ss_pred             CceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          339 NIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       339 ~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+.-.|++++|+-+++++.+|++|...+....
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            58889999999999999999999999875443

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.17  E-value=2.6e-07  Score=99.44  Aligned_cols=185  Identities=21%  Similarity=0.204  Sum_probs=134.1

Q ss_pred             eeeeeeeeeeCceEEEEEEECCcc-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g~~-VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~  300 (504)
                      +.+...+++|+++.+++.+...+. ...+.+...       ....-++++|.+++||| .+..++-++.++...++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            344456789999999986654322 223443322       34456889999999999 777777778888899999999


Q ss_pred             CCC-chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCC
Q 010680          301 SGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET  379 (504)
Q Consensus       301 ~gg-sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  379 (504)
                      .++ +-........-.+.......+...-.++++++|+.-=+|||    ||+..+ +..|..||+...............
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence            877 22222211112233334455666778899999998778998    777665 679999999987665544456678


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  419 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~  419 (504)
                      +|+.|+|||+.....++...|.|++|.--.+|--|.+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            9999999999999999999999999987777777776654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=1e-05  Score=87.50  Aligned_cols=140  Identities=19%  Similarity=0.261  Sum_probs=92.5

Q ss_pred             eeeeeeCceEEEEEEEC-CccEEEEEecCCCCCh-----------------------------HHHH------HHHHHHH
Q 010680          227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS-----------------------------DMQK------EFAQEVF  270 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~-----------------------------~~~~------~~~~Ei~  270 (504)
                      +.||.-+.|.||+|+.. |+.||||+-++.....                             +..+      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            46899999999999875 6789999977542111                             0011      2455554


Q ss_pred             HHHhc----CCCC------ceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCc
Q 010680          271 IMRKV----RHKN------VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI  340 (504)
Q Consensus       271 iL~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~I  340 (504)
                      ...+.    .|-+      |+++|..++.  .-.|+||||.|..+.|.-.-....++...+..-+.++..-  -|=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcCC
Confidence            44433    3444      6666654443  3579999999998887654334556666444433333222  2234679


Q ss_pred             eeccCCCCcEEECC----CCcEEEEeeccceecc
Q 010680          341 IHRDLKAANLLMDE----NEVVKVADFGVARVKA  370 (504)
Q Consensus       341 iHrDLkp~NILl~~----~~~vkL~DFGla~~~~  370 (504)
                      +|.|=.|.||++..    ++.+.+-|||+.....
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999999984    5689999999986544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.14  E-value=6.9e-05  Score=71.43  Aligned_cols=127  Identities=19%  Similarity=0.321  Sum_probs=92.0

Q ss_pred             CceeeeeeeeeeCc-eEEEEEEECCccEEEEEecC---CC-------CCh---------HHHHHHHHHHHHHHhcC---C
Q 010680          221 KHLKFGSKVASGSY-GDLYRGTYCSQDVAIKVLKP---ER-------INS---------DMQKEFAQEVFIMRKVR---H  277 (504)
Q Consensus       221 ~~~~i~~~LG~G~f-G~Vy~~~~~g~~VAvK~lk~---~~-------~~~---------~~~~~~~~Ei~iL~~l~---H  277 (504)
                      .++++.+.||.|.- |.||+++..|+.+|+|+.+.   ..       ...         ....-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            67899999999999 99999999999999999432   10       000         12235778887766554   5


Q ss_pred             CCc--eEEEEeeeCC------------------CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH
Q 010680          278 KNV--VQFIGACTKP------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ  337 (504)
Q Consensus       278 pnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~  337 (504)
                      .++  |+.+|+..-.                  ....||.||++...          .++    ..-+.+|.+-|..+|.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHHH
Confidence            566  9999986211                  12357888886543          122    2345677888889999


Q ss_pred             CCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          338 NNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       338 ~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      .||+-+|+++.|..   +  -||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc---C--CEEEecccC
Confidence            99999999999987   2  389999865

>PLN02876 acyl-CoA dehydrogenase

Probab=98.14  E-value=2.9e-05  Score=89.54  Aligned_cols=79  Identities=14%  Similarity=0.256  Sum_probs=57.4

Q ss_pred             eeeeeeeCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCc--eEEEEeeeCC---CCcee
Q 010680          226 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNV--VQFIGACTKP---PSLCI  295 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~~l  295 (504)
                      .+.|+.|.+..+|+.+..+    ..+++|+........ ....+.+|+.+|+.+. |.+|  ++++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3578999999999987754    357777755432211 2346789999999996 6665  8888888764   45789


Q ss_pred             EEEecCCCch
Q 010680          296 VTEFMSGGSV  305 (504)
Q Consensus       296 V~E~~~ggsL  305 (504)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988643

>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=98.03  E-value=1.4e-05  Score=64.32  Aligned_cols=47  Identities=28%  Similarity=0.492  Sum_probs=43.9

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecC
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG  157 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~  157 (504)
                      +.+.+.|+|+|+++++.+|++.|+||..|.++.|.+|+.+|+|.|..
T Consensus         3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d   49 (76)
T cd04927           3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITD   49 (76)
T ss_pred             EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeC
Confidence            56778899999999999999999999999999999999999999954

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.97  E-value=6.2e-05  Score=73.46  Aligned_cols=73  Identities=15%  Similarity=0.218  Sum_probs=47.0

Q ss_pred             eeeeeeCce-EEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---CceEEEEeeeCC---CCceeEEEe
Q 010680          227 SKVASGSYG-DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACTKP---PSLCIVTEF  299 (504)
Q Consensus       227 ~~LG~G~fG-~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~  299 (504)
                      +.|+.|+.. .||+.   +..+++|+.+...    ....+.+|..+|+.+...   -++++++.+...   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 48875   4567778755321    234688899999888632   355566554432   234789999


Q ss_pred             cCCCchH
Q 010680          300 MSGGSVY  306 (504)
Q Consensus       300 ~~ggsL~  306 (504)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.00021  Score=68.24  Aligned_cols=129  Identities=21%  Similarity=0.386  Sum_probs=91.9

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCC--------------CChHHHHHHHHHHHHHHhcC------CCCceEEEEe
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPER--------------INSDMQKEFAQEVFIMRKVR------HKNVVQFIGA  286 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~--------------~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~~  286 (504)
                      ..||+|+.=.||.-- .+....||+.++..              .......+..+|+.-...+.      +.+|.+++|+
T Consensus         7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            468999998888733 24457889988765              01112355666666655555      7899999999


Q ss_pred             eeCCCCceeEEEecCC------CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----
Q 010680          287 CTKPPSLCIVTEFMSG------GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----  356 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----  356 (504)
                      ..++--.-+|+|.+.+      .+|.+++..  +.++.    .+...+-.-..||-..+|+.+|++|.||++....    
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~  159 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF  159 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence            9998888999998753      378888843  44554    3334444556788999999999999999996432    


Q ss_pred             cEEEEe
Q 010680          357 VVKVAD  362 (504)
Q Consensus       357 ~vkL~D  362 (504)
                      .+.|+|
T Consensus       160 ~lvlID  165 (199)
T PF10707_consen  160 RLVLID  165 (199)
T ss_pred             EEEEEe
Confidence            477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.89  E-value=3.8e-05  Score=61.38  Aligned_cols=45  Identities=40%  Similarity=0.536  Sum_probs=41.7

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      |++.+.|+|.|++.++.+|++.|+||..|+++ |.+|+.+|+|.|.
T Consensus         3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~   47 (74)
T cd04925           3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVR   47 (74)
T ss_pred             EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEE
Confidence            56778899999999999999999999999999 5699999999984

This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>PRK10593 hypothetical protein; Provisional

Probab=97.81  E-value=0.00035  Score=70.96  Aligned_cols=76  Identities=14%  Similarity=0.125  Sum_probs=57.8

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CCceEEEEeeeC---CCCceeEEEe
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK---PPSLCIVTEF  299 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~lV~E~  299 (504)
                      .+.||.|..+.||+....+..+.+|..+... .   ...+..|...|+.+.-   -.++++++.+..   .+..+||||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3579999999999998766678888855311 1   2468889999998863   368889987754   3567999999


Q ss_pred             cCCCch
Q 010680          300 MSGGSV  305 (504)
Q Consensus       300 ~~ggsL  305 (504)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.52  E-value=0.00096  Score=64.71  Aligned_cols=73  Identities=12%  Similarity=0.195  Sum_probs=48.3

Q ss_pred             eeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      +.|..|-...+|+.+..   ++.|++|+.......   .....+|+.+++.+...+ .+++++....    .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence            56778888999998865   467999986643211   122346888888885433 4555554331    379999998


Q ss_pred             CchH
Q 010680          303 GSVY  306 (504)
Q Consensus       303 gsL~  306 (504)
                      .++.
T Consensus        77 ~~l~   80 (235)
T cd05157          77 RTLE   80 (235)
T ss_pred             CcCC
Confidence            7653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.50  E-value=9.1e-05  Score=74.85  Aligned_cols=134  Identities=18%  Similarity=0.238  Sum_probs=95.4

Q ss_pred             eeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChH--------------------HHHHHHHHHHHHHhcCC--CC
Q 010680          223 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSD--------------------MQKEFAQEVFIMRKVRH--KN  279 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~--------------------~~~~~~~Ei~iL~~l~H--pn  279 (504)
                      +.+++.||-|--+.||.+-+. |++.++|+-+..+.+-.                    .+-...+|...|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            345678999999999999875 88899987654332211                    01234568888888863  23


Q ss_pred             ceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEE
Q 010680          280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       280 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vk  359 (504)
                      |++.++    .+..|+|||++.|..|....+-    ..   +-.+...+..-+--|-..|+||+|+.-=||+|++++.++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHV----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeec----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            445553    3456899999999887654422    12   233445555566677889999999999999999999999


Q ss_pred             EEeeccce
Q 010680          360 VADFGVAR  367 (504)
Q Consensus       360 L~DFGla~  367 (504)
                      ++||--+.
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.49  E-value=2.4e-05  Score=91.29  Aligned_cols=232  Identities=11%  Similarity=0.060  Sum_probs=148.1

Q ss_pred             EEEEEEECCc---cEEEEEecCC---CCChHHHHHHHHHHHHHHhcCCCCceEEEEeee--CCCCceeEEEecCCCchHH
Q 010680          236 DLYRGTYCSQ---DVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIVTEFMSGGSVYD  307 (504)
Q Consensus       236 ~Vy~~~~~g~---~VAvK~lk~~---~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~  307 (504)
                      ..+++++-+.   .+-+|+.+.-   ...+...+-...|..-+++..|+++.....-..  .....+.+++|+.+|.+.+
T Consensus      1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~ 1320 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFS 1320 (2724)
T ss_pred             eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHH
Confidence            3445555332   2345554432   223334455566777777788998877665432  2234588999999999999


Q ss_pred             HHHhhccc---CChHHHHHHHHHHHHHHHHHHHC-----CceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccC
Q 010680          308 YLHKLKGV---FKLPSLLKVAIDVSKGMNYLHQN-----NIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  378 (504)
Q Consensus       308 ~l~~~~~~---l~~~~~~~i~~qI~~gL~yLH~~-----~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~  378 (504)
                      .+-+.-..   +....+.....+.+.+..-+|+.     -.+|+++|+.|.+|..+..+|++++|+.+..... ......
T Consensus      1321 iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~ 1400 (2724)
T KOG1826|consen 1321 IIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLE 1400 (2724)
T ss_pred             HHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhh
Confidence            98653222   33333444444546677777764     2699999999999999999999999999843332 334456


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD  458 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d  458 (504)
                      .+++.|++|++.+.-.++.++|+|..|+.+|++-.|..+|..... ....+.++.+..-.++...|.+.......++-..
T Consensus      1401 l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq-~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K 1479 (2724)
T KOG1826|consen 1401 LCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQ-PALKGIIDNHTFFSIEKLKPGDANVEALHRLLWK 1479 (2724)
T ss_pred             hCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHH-HHHcCcccccccccccccCCCcccHHHHHHHHHH
Confidence            788899999999999999999999999999999888877642211 1111222222223344444444444444444444


Q ss_pred             CCCCCCHHHH
Q 010680          459 PALRPDFSEI  468 (504)
Q Consensus       459 P~~RPs~~el  468 (504)
                      -..||.-...
T Consensus      1480 ~~~rp~q~is 1489 (2724)
T KOG1826|consen 1480 YMERPGQYIS 1489 (2724)
T ss_pred             hhhcchhhhh
Confidence            4566654443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0026  Score=67.19  Aligned_cols=76  Identities=13%  Similarity=0.023  Sum_probs=53.5

Q ss_pred             eeeeeeCceEEEEEEECCc--cEEEEEecCCCC----C-hHHHHHHHHHHHHHHhcC---CCCceEEEEeeeCCCCceeE
Q 010680          227 SKVASGSYGDLYRGTYCSQ--DVAIKVLKPERI----N-SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~--~VAvK~lk~~~~----~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.||.|.+..||+++..+.  .|.||.-.+...    . .-...++..|...|+.+.   ..++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            5789999999999988653  799998542211    0 113456677888888764   356788887643  557899


Q ss_pred             EEecCCCc
Q 010680          297 TEFMSGGS  304 (504)
Q Consensus       297 ~E~~~ggs  304 (504)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.47  E-value=0.00089  Score=66.13  Aligned_cols=133  Identities=14%  Similarity=0.129  Sum_probs=79.1

Q ss_pred             eeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEEEecCCCchHH
Q 010680          229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGSVYD  307 (504)
Q Consensus       229 LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggsL~~  307 (504)
                      +..|-...+|+.+..++.+++|+.......-  .....+|..+++.+...++ ++++....    -++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            4567788899988778889999855431111  0134678889988864333 45555432    368999999876542


Q ss_pred             H--------------H---Hhhc---ccCChH-HHHHHHHHH---------HHHHHHHHH--------CCceeccCCCCc
Q 010680          308 Y--------------L---HKLK---GVFKLP-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKAAN  349 (504)
Q Consensus       308 ~--------------l---~~~~---~~l~~~-~~~~i~~qI---------~~gL~yLH~--------~~IiHrDLkp~N  349 (504)
                      .              +   +...   ..++.. .+..+..++         ...+..+-.        ..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1              1   1111   011111 111221111         111222221        258999999999


Q ss_pred             EEECCCCcEEEEeecccee
Q 010680          350 LLMDENEVVKVADFGVARV  368 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~  368 (504)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998853

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.44  E-value=0.0025  Score=64.98  Aligned_cols=136  Identities=15%  Similarity=0.225  Sum_probs=76.6

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEEe------eeCCCCceeEEE
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA------CTKPPSLCIVTE  298 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~~~~lV~E  298 (504)
                      +.|+.|....+|+.+..+..+++|+.. . ...   ..+..|+.+++.|...  .+++.+..      ....+..++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            457778878899987767789999876 2 222   2333455666555321  23444421      122345689999


Q ss_pred             ecCCCchH-----------HHH---HhhcccC--------C--h-HHH-HH-----------HHHH-HHHHHHHHH----
Q 010680          299 FMSGGSVY-----------DYL---HKLKGVF--------K--L-PSL-LK-----------VAID-VSKGMNYLH----  336 (504)
Q Consensus       299 ~~~ggsL~-----------~~l---~~~~~~l--------~--~-~~~-~~-----------i~~q-I~~gL~yLH----  336 (504)
                      |++|..+.           ..+   +.....+        .  + ... .+           ...+ +...++.+.    
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99887431           111   1111111        0  0 000 00           1111 111223332    


Q ss_pred             ---HCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          337 ---QNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       337 ---~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                         ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence               2389999999999999977666899999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.40  E-value=0.002  Score=64.89  Aligned_cols=137  Identities=18%  Similarity=0.204  Sum_probs=85.2

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEe------eeCCCCceeEE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA------CTKPPSLCIVT  297 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~lV~  297 (504)
                      .+.|..|....+|+....+..+++|+...  ..   ......|+.+++.+.+.+  +++++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            34677788788999877777899998764  11   245667888888885432  4555542      12234568999


Q ss_pred             EecCCCchHH----H-------H---HhhcccCC----------hHHH----------HHHHHHHHHHHHHHHH------
Q 010680          298 EFMSGGSVYD----Y-------L---HKLKGVFK----------LPSL----------LKVAIDVSKGMNYLHQ------  337 (504)
Q Consensus       298 E~~~ggsL~~----~-------l---~~~~~~l~----------~~~~----------~~i~~qI~~gL~yLH~------  337 (504)
                      +|++|..+..    .       +   +.....+.          +...          ......+..++.++..      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876532    1       1   11110110          0000          0011123334455543      


Q ss_pred             -CCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          338 -NNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       338 -~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                       .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             379999999999999998778999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.40  E-value=0.0022  Score=65.16  Aligned_cols=138  Identities=22%  Similarity=0.277  Sum_probs=83.0

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEEee------eCCCCceeEE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGAC------TKPPSLCIVT  297 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~------~~~~~~~lV~  297 (504)
                      .+.++.|....+|+....+..+++|+..... .   ......|+.++..|...  .+++++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4567778778899987666678889876432 1   23345567777777432  245555422      1234568999


Q ss_pred             EecCCCchH-----------HH---HHhhcccCC--------hHH---HH------------HHHHHHHHHHHHHHH---
Q 010680          298 EFMSGGSVY-----------DY---LHKLKGVFK--------LPS---LL------------KVAIDVSKGMNYLHQ---  337 (504)
Q Consensus       298 E~~~ggsL~-----------~~---l~~~~~~l~--------~~~---~~------------~i~~qI~~gL~yLH~---  337 (504)
                      ||++|..+.           ..   ++.....++        ...   ..            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885432           11   111111110        010   00            011123345555543   


Q ss_pred             ----CCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          338 ----NNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       338 ----~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                          .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                589999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.29  E-value=0.00095  Score=53.40  Aligned_cols=64  Identities=23%  Similarity=0.354  Sum_probs=50.0

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEee---cCCCh---hhHHHHHHHHHHHHH
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---EETEQLRAALEKEVL  175 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v---~~~~~---~~~~~l~~~l~~~~~  175 (504)
                      |.+.+.|+|+||..+..+|+++|++|.-|++ +|..+...|+|-|   +|-+.   +..+.++++|...+.
T Consensus         4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I-~T~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al~   73 (75)
T cd04897           4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATI-DTDGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAIE   73 (75)
T ss_pred             EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEE-eecCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHHh
Confidence            6788999999999999999999999999976 4455689999998   44332   344566777766553

This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.16  E-value=0.0026  Score=64.35  Aligned_cols=73  Identities=15%  Similarity=0.299  Sum_probs=47.6

Q ss_pred             eeeeeeCceEEEEEEEC--------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCCCceeEE
Q 010680          227 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~  297 (504)
                      +.|..|-...+|+.+..        ++.+++|+......   ......+|..+++.+...+ .+++++.+..    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            45566777788888764        36799999665321   1234567888888886433 3456665542    3589


Q ss_pred             EecCCCchH
Q 010680          298 EFMSGGSVY  306 (504)
Q Consensus       298 E~~~ggsL~  306 (504)
                      ||++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.08  E-value=0.0022  Score=51.37  Aligned_cols=64  Identities=20%  Similarity=0.208  Sum_probs=49.7

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccc-cCCCceeeeEeecCCCh-----hhHHHHHHHHHHHH
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPY-----EETEQLRAALEKEV  174 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~-t~dg~~ldv~~v~~~~~-----~~~~~l~~~l~~~~  174 (504)
                      +.+.+.|+|+||..+..++.++|++|+-|++=+ |..+-..|+|.|+..+.     +..+.+++++.+.+
T Consensus         3 lev~a~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D~Fyv~~~g~kl~d~~~~~~L~~~L~~~l   72 (75)
T cd04896           3 LQIRCVDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVDLFIVQSDGKKIMDPKKQAALCARLREEM   72 (75)
T ss_pred             EEEEeCCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEEEEEEeCCCCccCCHHHHHHHHHHHHHHh
Confidence            467889999999999999999999999998874 55566779999976552     33455666665543

This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.

>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=97.00  E-value=0.002  Score=51.03  Aligned_cols=46  Identities=26%  Similarity=0.476  Sum_probs=42.5

Q ss_pred             eeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      ++++...|+|.+|.+++.+|++.|+||..|.+|.+ +++.+|+|.|.
T Consensus         3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~-~~~~~d~f~v~   48 (72)
T cd04926           3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEISTQ-GDMAVNVFYVT   48 (72)
T ss_pred             EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEecC-CCeEEEEEEEE
Confidence            68899999999999999999999999999999855 88999999984

This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.99  E-value=0.0078  Score=61.58  Aligned_cols=143  Identities=19%  Similarity=0.311  Sum_probs=85.0

Q ss_pred             eeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCCC--CceeEEEecCCC
Q 010680          228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP--SLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~--~~~lV~E~~~gg  303 (504)
                      .+-.|..-.+|.....++.+++. ...............+|..+++.+.-  --+...++.|..+.  ..+.||+|++|.
T Consensus        32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            33334444466666667778888 33222233445667788888888763  33455666776655  679999999883


Q ss_pred             c------------------hHHHHHhhc----------c---cCChHHHHHHHH--------------HHHHHHHHHHHC
Q 010680          304 S------------------VYDYLHKLK----------G---VFKLPSLLKVAI--------------DVSKGMNYLHQN  338 (504)
Q Consensus       304 s------------------L~~~l~~~~----------~---~l~~~~~~~i~~--------------qI~~gL~yLH~~  338 (504)
                      .                  |.++|....          +   ......+..+..              ....-..+|+.+
T Consensus       111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            2                  122221110          0   001111112221              222334555543


Q ss_pred             --------CceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          339 --------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       339 --------~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                              .++|+|+.+.||+++.++.+=|.||+++...+.
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                    489999999999999998899999999875443

>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein)

Probab=96.98  E-value=0.002  Score=51.12  Aligned_cols=45  Identities=31%  Similarity=0.507  Sum_probs=40.5

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      |.+.+.|+|+||..++.+|.++|++|+-|++ +|..+...|+|-|.
T Consensus         4 iev~a~DRpGLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~   48 (72)
T cd04895           4 VKVDSARKPGILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVT   48 (72)
T ss_pred             EEEEECCcCCHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEE
Confidence            5688999999999999999999999999976 66667999999994

This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.88  E-value=0.01  Score=60.08  Aligned_cols=29  Identities=28%  Similarity=0.460  Sum_probs=25.7

Q ss_pred             CCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          338 NNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       338 ~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999998 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold

Probab=96.86  E-value=0.002  Score=49.21  Aligned_cols=63  Identities=33%  Similarity=0.410  Sum_probs=50.7

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK  172 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~  172 (504)
                      |.|.+...|+|++|..++++|++.|+||..++.+++.++ ...++++......+.+.+.+++++
T Consensus         1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~   63 (66)
T PF01842_consen    1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDG-VGIVFIVIVVDEEDLEKLLEELEA   63 (66)
T ss_dssp             EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESST-TEEEEEEEEEEGHGHHHHHHHHHH
T ss_pred             CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCC-ceEEEEEEECCCCCHHHHHHHHHc
Confidence            467888999999999999999999999999999999985 444444445556677777777765

ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.85  E-value=0.003  Score=67.52  Aligned_cols=155  Identities=23%  Similarity=0.296  Sum_probs=95.8

Q ss_pred             HHHHHHHHHHHhcCCCCceEEEEeeeC-CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCce
Q 010680          263 KEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII  341 (504)
Q Consensus       263 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~Ii  341 (504)
                      ..+.-...+++.+.|+|..+.+++-.. ..+..+|||++ +.||++++....  +......              .+++.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc--------------ccccc
Confidence            445667888999999999999987644 34578899999 889999986532  2211111              22222


Q ss_pred             eccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 010680          342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL  421 (504)
Q Consensus       342 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~  421 (504)
                      |-     |       .++++| -++   ...              |-.     ..+|+|||++|.++.++.-|..-|...
T Consensus        90 ~~-----~-------~~~~td-~~~---t~~--------------~~~-----~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   90 HL-----N-------IIYITD-HFL---TKY--------------PSP-----IGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             ee-----h-------hhhccc-ccc---ccC--------------CCC-----CCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            21     1       233333 000   000              111     114999999999999999998777655


Q ss_pred             CHHHHHHHHHhcCCCC----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          422 TPLQAAVGVVQKGLRP----------TIPKNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       422 ~~~~~~~~v~~~~~~p----------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      ...+....+..-...+          .+-..++..+.++..+|+...|..||.+.++.
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            5444433332211111          11234566778889999999999988776654

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.81  E-value=0.019  Score=60.67  Aligned_cols=75  Identities=15%  Similarity=0.045  Sum_probs=51.5

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCC--Ch---HHHHHHHHHHHHHHhcC---CCCceEEEEeeeCCCCceeEE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERI--NS---DMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~--~~---~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+.||-|....||+....+..++||.-.+...  ..   -...+-..|...|+.+.   ...+++++.++.+  ..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            45789999999999988777899998652211  10   11233344566666554   3588899988874  467899


Q ss_pred             EecCC
Q 010680          298 EFMSG  302 (504)
Q Consensus       298 E~~~g  302 (504)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>PRK05092 PII uridylyl-transferase; Provisional

Probab=96.79  E-value=0.0024  Score=74.66  Aligned_cols=68  Identities=32%  Similarity=0.480  Sum_probs=56.2

Q ss_pred             cceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEee---cCCCh---hhHHHHHHHHHHHH
Q 010680          107 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---EETEQLRAALEKEV  174 (504)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v---~~~~~---~~~~~l~~~l~~~~  174 (504)
                      ..-+|++.+.|+|+|+++++.+|+..|+||..|++|.+.||+.+|+|.|   +|.+.   +..+.++++|+..+
T Consensus       731 ~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l  804 (931)
T PRK05092        731 GVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDAL  804 (931)
T ss_pred             CeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence            4569999999999999999999999999999999999999999999998   55432   23445555555443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.70  E-value=0.011  Score=60.99  Aligned_cols=141  Identities=13%  Similarity=0.237  Sum_probs=80.9

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPS  292 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~  292 (504)
                      +.+.+++. .|..|-.-.+|+....+.     .|++|+......   ..-.-.+|..+++.+..-++ +++++++.. + 
T Consensus        13 ~~~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G-   86 (330)
T PLN02421         13 DDSDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G-   86 (330)
T ss_pred             CcCceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeCC-c-
Confidence            33455554 444477788998876542     688888764321   12233578888888875555 456665532 2 


Q ss_pred             ceeEEEecCCCchHH-------HH----------Hhhccc----C-ChHHHHHHHHHH----------------------
Q 010680          293 LCIVTEFMSGGSVYD-------YL----------HKLKGV----F-KLPSLLKVAIDV----------------------  328 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~-------~l----------~~~~~~----l-~~~~~~~i~~qI----------------------  328 (504)
                        +|.+|++|.+|..       .+          |....+    . .+..+..+..++                      
T Consensus        87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l  164 (330)
T PLN02421         87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL  164 (330)
T ss_pred             --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence              5899998765532       11          111100    1 112222222221                      


Q ss_pred             HHHHHHHH----HC----CceeccCCCCcEEECC-CCcEEEEeeccce
Q 010680          329 SKGMNYLH----QN----NIIHRDLKAANLLMDE-NEVVKVADFGVAR  367 (504)
Q Consensus       329 ~~gL~yLH----~~----~IiHrDLkp~NILl~~-~~~vkL~DFGla~  367 (504)
                      ..-+..+.    ..    -++|.|+.+.|||+++ ++.++++||..|.
T Consensus       165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            11122222    11    2799999999999975 5789999999884

>PRK04374 PII uridylyl-transferase; Provisional

Probab=96.69  E-value=0.0033  Score=72.72  Aligned_cols=69  Identities=23%  Similarity=0.285  Sum_probs=55.5

Q ss_pred             CcceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCCh---hhHHHHHHHHHHHH
Q 010680          106 RPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPY---EETEQLRAALEKEV  174 (504)
Q Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~---~~~~~l~~~l~~~~  174 (504)
                      +..-||++.+.|+|+|+++++.+|+..|+||..|.+|+|.||+.+|+|.|.....   +..++++.++++.+
T Consensus       688 ~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~i~~~l~~~l  759 (869)
T PRK04374        688 NDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLPQDTYADGDPQRLAAALRQVL  759 (869)
T ss_pred             CCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeCCCCCChHHHHHHHHHHHHHH
Confidence            3456999999999999999999999999999999999999999999999954333   23333444444433

>PRK00275 glnD PII uridylyl-transferase; Provisional

Probab=96.64  E-value=0.0036  Score=72.76  Aligned_cols=50  Identities=20%  Similarity=0.384  Sum_probs=47.5

Q ss_pred             cceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          107 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      ..-||++.+.|+|+|++.++.+|+..|+||..|.+|+|.||+.+|+|.|.
T Consensus       703 ~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~  752 (895)
T PRK00275        703 GGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVL  752 (895)
T ss_pred             CeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEe
Confidence            34599999999999999999999999999999999999999999999994

>TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase

Probab=96.63  E-value=0.0081  Score=69.73  Aligned_cols=69  Identities=26%  Similarity=0.356  Sum_probs=56.2

Q ss_pred             CcceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCC---hh---hHHHHHHHHHHHH
Q 010680          106 RPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP---YE---ETEQLRAALEKEV  174 (504)
Q Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~---~~---~~~~l~~~l~~~~  174 (504)
                      ...-+|++.+.|+|+|+++++.+|+..|+||..|++|+|.+|+.+|+|.|....   ..   ..+.+++++.+.+
T Consensus       666 ~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L  740 (850)
T TIGR01693       666 SGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQGLVDVL  740 (850)
T ss_pred             CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHHHHHHHH
Confidence            345699999999999999999999999999999999999999999999994322   21   2444566665555

This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.63  E-value=0.014  Score=60.68  Aligned_cols=74  Identities=12%  Similarity=-0.029  Sum_probs=46.4

Q ss_pred             eeeeeCceEEEEEEECC--ccEEEEEecCCC-----CChHHHHHHHHHHHHHHhcC--CC-CceEEEEeeeCCCCceeEE
Q 010680          228 KVASGSYGDLYRGTYCS--QDVAIKVLKPER-----INSDMQKEFAQEVFIMRKVR--HK-NVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~-----~~~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lV~  297 (504)
                      .||-|....||++...+  +.|.||.-.+..     ...-...+..-|...|+...  .| .++++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999998754  479999743210     11112344456777776654  34 55666643  334456899


Q ss_pred             EecCCC
Q 010680          298 EFMSGG  303 (504)
Q Consensus       298 E~~~gg  303 (504)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.62  E-value=0.02  Score=57.58  Aligned_cols=30  Identities=30%  Similarity=0.573  Sum_probs=25.4

Q ss_pred             CceeccCCCCcEEECCCCc-EEEEeecccee
Q 010680          339 NIIHRDLKAANLLMDENEV-VKVADFGVARV  368 (504)
Q Consensus       339 ~IiHrDLkp~NILl~~~~~-vkL~DFGla~~  368 (504)
                      .++|+|++|.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997554 56999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.62  E-value=0.014  Score=60.27  Aligned_cols=138  Identities=18%  Similarity=0.214  Sum_probs=91.4

Q ss_pred             eeeeeCceEEEEEEE-CCccEEEEEecCCCC----------------------C-hHHHH-HHHHHHHHHHhcCCCCceE
Q 010680          228 KVASGSYGDLYRGTY-CSQDVAIKVLKPERI----------------------N-SDMQK-EFAQEVFIMRKVRHKNVVQ  282 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~----------------------~-~~~~~-~~~~Ei~iL~~l~HpnIv~  282 (504)
                      .|..|--+.||.++. .|..+|||+.+....                      + ..+.+ -...|++-|++++...|+-
T Consensus       151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~  230 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC  230 (520)
T ss_pred             ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            566677778999976 477799999763211                      0 11122 2335888888887555432


Q ss_pred             EEEeeeCCCCceeEEEecCCCch-HHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEE
Q 010680          283 FIGACTKPPSLCIVTEFMSGGSV-YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKV  360 (504)
Q Consensus       283 l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL  360 (504)
                      ---...  ....|||+|+.+... .-.|.  .-.++...+..+-.+++.-|.-|-+ .++||.||.--|+|+.+ |.+.|
T Consensus       231 PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyi  305 (520)
T KOG2270|consen  231 PEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYI  305 (520)
T ss_pred             CCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEE
Confidence            111111  134689999953211 11121  3457777888999999999998865 58999999999999974 68999


Q ss_pred             Eeeccceecc
Q 010680          361 ADFGVARVKA  370 (504)
Q Consensus       361 ~DFGla~~~~  370 (504)
                      +|.+-+....
T Consensus       306 IDVSQSVE~D  315 (520)
T KOG2270|consen  306 IDVSQSVEHD  315 (520)
T ss_pred             EEccccccCC
Confidence            9998775433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	504
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-59
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-59
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-49
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-49
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-48
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-48
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-48
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-48
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-48
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-47
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-47
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-47
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-47
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-47
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-47
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-47
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-46
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-46
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-46
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-46
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-46
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-46
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-45
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-45
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-45
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-45
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-45
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-45
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-45
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-45
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-45
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-45
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-45
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-45
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-44
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-44
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-44
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-44
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-44
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-44
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-44
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-44
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-44
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-44
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-44
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-44
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-44
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-44
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-44
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-44
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-44
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-44
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-43
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-43
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-43
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-43
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-43
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-43
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-43
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-43
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-43
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-43
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-43
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-43
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-43
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-43
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-43
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-43
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-43
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-43
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-42
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-42
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-42
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-42
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-42
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-42
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-42
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-41
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-41
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-41
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-41
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-41
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-41
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-41
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-40
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-40
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-38
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-38
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-38
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-38
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-38
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-38
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-38
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-38
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-38
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-38
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-38
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-38
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-38
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-38
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-38
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-38
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-38
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-37
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-37
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-37
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-37
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-37
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-37
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-37
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-37
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-37
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-37
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-37
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-37
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-37
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-37
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-36
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-36
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-36
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-36
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-36
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-36
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-36
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-36
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-36
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-36
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-36
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-36
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-36
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-35
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-35
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-35
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-35
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-35
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-35
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-35
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-35
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-35
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-35
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-35
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-35
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-35
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-35
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-35
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-35
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-35
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-35
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-35
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-35
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-35
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-35
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-35
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-35
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-35
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-35
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-35
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-35
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-35
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-35
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-35
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-35
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-35
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-35
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-35
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-35
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-35
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-35
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-35
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-34
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-34
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-34
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-34
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-34
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-34
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-34
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-34
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-34
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-34
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-34
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-34
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-34
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-34
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-34
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-34
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-34
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-33
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-33
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-33
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-33
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-33
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-33
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-33
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-33
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-33
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-33
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-33
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-33
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-33
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-33
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-33
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-33
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-33
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-32
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-32
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-32
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-32
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-32
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-32
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-32
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-32
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-32
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-32
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-32
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-32
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-32
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-32
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-32
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-32
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-32
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-32
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-32
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-32
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-32
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-32
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-32
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-32
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-32
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-32
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-32
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-32
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-32
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-32
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-32
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-32
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-32
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-32
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-32
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-32
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-32
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-32
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-32
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-32
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-31
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-31
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-31
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-31
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-31
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-31
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-31
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-31
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-31
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-30
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-30
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-30
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-30
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-30
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-30
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-30
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-30
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-30
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-30
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-30
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-30
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-30
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-30
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-30
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-30
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-30
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-30
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-30
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-30
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-30
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-30
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-30
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-30
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-30
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-30
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-30
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-30
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-30
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-30
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-29
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-29
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-29
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-29
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-29
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-29
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-29
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-29
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-29
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-29
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-29
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-29
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-29
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-29
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-29
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-28
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-28
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-28
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-28
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-28
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-28
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-28
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-28
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-28
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-28
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-28
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-28
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-27
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-27
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-27
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-27
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-27
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-27
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-27
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-27
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-26
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-26
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-26
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-26
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-26
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-26
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-26
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-26
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-26
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-25
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-25
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-25
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-25
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-25
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-25
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-25
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-25
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-25
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-25
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-25
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-25
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-25
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-25
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-25
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-25
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-25
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-25
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-25
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-25
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-25
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-25
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-25
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-25
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-25
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-25
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-24
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-24
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-24
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-24
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-24
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-24
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-24
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-24
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-24
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-24
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-24
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-24
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-24
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-24
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-24
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-24
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-24
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-23
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-23
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-23
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-23
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-23
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-23
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-23
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-23
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-23
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-23
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-23
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-22
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-22
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-22
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-22
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-21
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-21
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-21
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-21
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-20
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-20
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-20
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-19
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-18
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-18
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-18
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-17
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-16
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-15
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-15
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-15
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-15
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-15
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-15
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-15
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-15
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-15
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-15
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-14
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
3soa_A	444	Full-Length Human Camkii Length = 444		8e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-11
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-11

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  227 bits (578), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 117/272 (43%), Positives = 175/272 (64%), Gaps = 6/272 (2%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           DG D+ +I    L    K+ +GS+G ++R  +   DVA+K+L  +  +++   EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL--LKVAIDV 328
           IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y  LHK     +L     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 329 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT-AETGTYRWM 385
           +KGMNYLH  N  I+HRDLK+ NLL+D+   VKV DFG++R+KA   + +    GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWM 206
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           APEV+  +P + K+DV+SFG++LWEL T + P+  L P Q    V  K  R  IP+N  P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           ++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 116/272 (42%), Positives = 177/272 (65%), Gaps = 6/272 (2%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           DG D+ +I    L    K+ +GS+G ++R  +   DVA+K+L  +  +++   EF +EV 
Sbjct: 28  DGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL--LKVAIDV 328
           IM+++RH N+V F+GA T+PP+L IVTE++S GS+Y  LHK     +L     L +A DV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 329 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT-AETGTYRWM 385
           +KGMNYLH  N  I+HR+LK+ NLL+D+   VKV DFG++R+KA + + + +  GT  WM
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           APEV+  +P + K+DV+SFG++LWEL T + P+  L P Q    V  K  R  IP+N  P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           ++A ++E CW  +P  RP F+ I+++L+ + K
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 2   DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 61  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 119
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 120 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 239
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 14  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 25  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 84  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 142
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 143 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 262
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 263 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 167/277 (60%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 104/278 (37%), Positives = 168/278 (60%), Gaps = 12/278 (4%)
Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           +D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMA 386
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 387 PEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK- 441
           PEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 442 --NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  189 bits (480), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 164/277 (59%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D  D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  T  P L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 73  VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N   ++  L+  C ++    RP F  I+  ++++A+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  189 bits (480), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 104/278 (37%), Positives = 168/278 (60%), Gaps = 12/278 (4%)
Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           +D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   +
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMA 386
           +GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMA
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 387 PEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK- 441
           PEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K 
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 239
Query: 442 --NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  187 bits (476), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRK 274
           W IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMK 59
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H  +VQ  G C +   +C+VTEFM  G + DYL   +G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 391
           L +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFS 178
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQI 237
Query: 451 LERCWQQDPALRPDFSEIIEILQQIAK 477
           +  CW++ P  RP FS ++  L +IA+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  187 bits (474), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/275 (37%), Positives = 166/275 (60%), Gaps = 12/275 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEV 389
           +YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 390 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---N 442
           I   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
               +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 160/271 (59%), Gaps = 10/271 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVF 270
           G+  W IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  
Sbjct: 1   GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAE 57
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +M K+ H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
           GM YL +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +P
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASP 176
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           EV     Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTH 235
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           + +++  CW++ P  RP FS ++  L +IA+
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 18  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 77  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 135
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 136 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 255
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 256 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 166/277 (59%), Gaps = 12/277 (4%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV 
Sbjct: 26  DSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 143
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAP
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK-- 441
           EVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K  
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 263
Query: 442 -NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            N    +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 264 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 103/274 (37%), Positives = 165/274 (60%), Gaps = 12/274 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           K RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 390
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 391 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 443
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  184 bits (468), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 156/265 (58%), Gaps = 10/265 (3%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G + ++D VAIK +K   ++ D   +F +E  +M K+ 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLS 80
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 81  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 199
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 258
Query: 453 RCWQQDPALRPDFSEIIEILQQIAK 477
            CW++ P  RP FS ++  L +IA+
Sbjct: 259 HCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 103/276 (37%), Positives = 166/276 (60%), Gaps = 15/276 (5%)
Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 270
           D +  WEI+   +   +++ SGS+G +Y+G +   DVA+K+LK      +  + F  EV 
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           ++RK RH N++ F+G  TK  +L IVT++  G S+Y +LH  +  F++  L+ +A   ++
Sbjct: 85  VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAP 387
           GM+YLH  NIIHRD+K+ N+ + E   VK+ DFG+A VK++ SG    E  TG+  WMAP
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 388 EVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIP 440
           EVI   ++ P+  ++DV+S+GIVL+EL+TG+LPY ++      + +V +G        + 
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263
Query: 441 KNSQPKLAELLERCWQQDPALRPDFSEI---IEILQ 473
           KN    +  L+  C ++    RP F +I   IE+LQ
Sbjct: 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 164/274 (59%), Gaps = 12/274 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           K RH N++ F+G  T  P L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 390
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 391 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 443
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 164/274 (59%), Gaps = 12/274 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           K RH N++ F+G  TKP  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAE--TGTYRWMAPEVI 390
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++ SG    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 391 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK---NS 443
              +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G L P + K   N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              +  L+  C ++    RP F +I+  ++ +A+
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  182 bits (462), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 157/265 (59%), Gaps = 10/265 (3%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 453 RCWQQDPALRPDFSEIIEILQQIAK 477
            CW++ P  RP FS ++  L +IA+
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 156/264 (59%), Gaps = 10/264 (3%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
           + ++IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 453 RCWQQDPALRPDFSEIIEILQQIA 476
            CW++ P  RP FS ++  L  IA
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAAIA 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 157/265 (59%), Gaps = 10/265 (3%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 393
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV    
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV+SFG+++WE+ + GK+PYE  +  +  V  +  G R   P+ +   + +++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 238
Query: 453 RCWQQDPALRPDFSEIIEILQQIAK 477
            CW++ P  RP FS ++  L +IA+
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 155/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAP 179
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 154/265 (58%), Gaps = 14/265 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 71
Query: 276 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 187
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 246
Query: 451 LERCWQQDPALRPDFSEIIEILQQI 475
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 154/265 (58%), Gaps = 14/265 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 276 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 172
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 231
Query: 451 LERCWQQDPALRPDFSEIIEILQQI 475
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 232 MKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 156/274 (56%), Gaps = 12/274 (4%)
Query: 209 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 266
           P+   D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF 
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 61
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVA 325
           +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 382
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 239
Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               K+ EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 155/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G +G++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 14/265 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 62
Query: 276 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 178
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + E+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEV 237
Query: 451 LERCWQQDPALRPDFSEIIEILQQI 475
           ++ CW  D A+RP F ++ E L+ I
Sbjct: 238 MKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 60
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  + P Q    +++K  R   P+    K
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-VYELLEKDYRMERPEGCPEK 238
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 186
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 75
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 194
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 253
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 254 VYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 152/269 (56%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 81
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT  P   IVTE+M  G++ DYL +  +       LL +A  +S 
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN VVKVADFG++R+       TA  G     +W AP
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 200
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++KG R   P+   PK
Sbjct: 201 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYDLLEKGYRMEQPEGCPPK 259
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CW+  PA RP F+E  +  + +
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 14/265 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 243
Query: 276 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ + +A S   T +TG    +W APE + 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAPEALR 359
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
            K +  K+DV+SFGI+LWE+ + G++PY  + PL+  V  V+KG +   P    P + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 451 LERCWQQDPALRPDFSEIIEILQQI 475
           ++ CW  D A RP F ++ E L+ I
Sbjct: 419 MKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 63
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 182
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 241
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 242
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 155/274 (56%), Gaps = 12/274 (4%)
Query: 209 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 266
           P+   D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF 
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFL 58
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVA 325
           +E  +M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 382
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPI 177
Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPE 236
Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               K+ EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 237 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 269
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHR+L A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 447
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 308
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHR+L A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 427
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 486
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 240
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 12/269 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +  +   EF +E  +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 67
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+ EFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAP 387
            M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     +W AP
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++K  R   P+    K
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEK 245
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           + EL+  CWQ +P+ RP F+EI +  + +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 151/274 (55%), Gaps = 20/274 (7%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRK 274
           EID   L     +  G +G +YR  +   +VA+K  +  P+   S   +   QE  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGM 332
           ++H N++   G C K P+LC+V EF  GG     L+++    ++P   L+  A+ +++GM
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGP----LNRVLSGKRIPPDILVNWAVQIARGM 118
Query: 333 NYLHQNNI---IHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 381
           NYLH   I   IHRDLK++N+L+ +        N+++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           Y WMAPEVI    +   +DV+S+G++LWELLTG++P+  +  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                 A+L+E CW  DP  RP F+ I++ L  I
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 185 HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 301
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 261
Query: 302 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 360
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 361 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 416
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 161/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 185 HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 301
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 261
Query: 302 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 360
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 361 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 416
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 169/297 (56%), Gaps = 26/297 (8%)
Query: 185 HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 159 HRLTNVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 206
Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 301
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 207 NGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 262
Query: 302 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 360
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 263 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 322
Query: 361 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 416
           ADFG+ R+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 323 ADFGLGRL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           PY  +   +  +  V++G R   P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 382 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 270
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 6   GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 62
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 388
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 182
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 183 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 241
Query: 448 AELLERCWQQDPALRPDF----SEIIEILQQ 474
             ++  CW +    RP F    S I++++ +
Sbjct: 242 YTIMYSCWHEKADERPTFKILLSNILDVMDE 272

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 170/297 (57%), Gaps = 26/297 (8%)
Query: 185 HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 241 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 301
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS
Sbjct: 289 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMS 344
Query: 302 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 360
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 404
Query: 361 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 416
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 405 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 464 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 270
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 388
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 191
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 448 AELLERCWQQDPALRPDF----SEIIEILQQ 474
             ++  CW +    RP F    S I++++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 161/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 392
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 452 ERCWQQDPALRPDF----SEIIEIL 472
             CW +    RP F    S I++++
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVM 264

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVF 270
           G   WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  
Sbjct: 15  GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAK 71
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +M  + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV +
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 388
            M YL     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PE
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPE 191
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           V+ +  +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250
Query: 448 AELLERCWQQDPALRPDF----SEIIEILQQ 474
             ++  CW +    RP F    S I++++ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 154/267 (57%), Gaps = 12/267 (4%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 59
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 392
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 238
Query: 452 ERCWQQDPALRPDF----SEIIEILQQ 474
             CW +    RP F    S I++++ +
Sbjct: 239 YSCWHEKADERPTFKILLSNILDVMDE 265

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 154/267 (57%), Gaps = 12/267 (4%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMN 60
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M Y
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 392
           L     +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 239
Query: 452 ERCWQQDPALRPDF----SEIIEILQQ 474
             CW +    RP F    S I++++ +
Sbjct: 240 YSCWHEKADERPTFKILLSNILDVMDE 266

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 105/297 (35%), Positives = 169/297 (56%), Gaps = 26/297 (8%)
Query: 185 HRSSS--PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           HR ++  PTS+P+  G+              D WEI  + L+   K+  G +G+++ GT+
Sbjct: 158 HRLTTVCPTSKPQTQGL------------AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 301
             +  VAIK LKP  ++ +    F QE  +M+K+RH+ +VQ     ++ P + IV E+MS
Sbjct: 206 NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMS 261
Query: 302 GGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 360
            GS+ D+L    G + +LP L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KV
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321
Query: 361 ADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKL 416
           ADFG+AR+  +    TA  G     +W APE   +  +  K+DV+SFGI+L EL T G++
Sbjct: 322 ADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           PY  +   +  +  V++G R   P      L +L+ +CW+++P  RP F  +   L+
Sbjct: 381 PYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  171 bits (434), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS G + D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  171 bits (433), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS GS+ D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  171 bits (433), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 58
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 59  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 235
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            +L+ +CW++DP  RP F  +   L+
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 57
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 58  KKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 116
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 117 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 175
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 234
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            +L+ +CW+++P  RP F  +   L+
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 60
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ G
Sbjct: 61  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 120 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 178
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 237
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            +L+ +CW+++P  RP F  +   L+
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  169 bits (429), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 159/275 (57%), Gaps = 12/275 (4%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQK 263
           H++      D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +   
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-- 59
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLL 322
            F QE  +M+K+RH+ +VQ     ++ P + IV E+MS G + D+L    G + +LP L+
Sbjct: 60  -FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
            +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G  
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 176
Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 438
              +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 235
Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            P      L +L+ +CW++DP  RP F  +   L+
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 168/315 (53%), Gaps = 22/315 (6%)
Query: 176 KLERQGWPS------HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV 229
           +LE +G+PS      H  S+     + +G+     H  +P D    W ++ + L  G ++
Sbjct: 69  RLEGEGFPSIPLLIDHLLSTQQPLTKKSGVV---LHRAVPKDK---WVLNHEDLVLGEQI 122
Query: 230 ASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
             G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
           T+   + IV E + GG    +L       ++ +LL++  D + GM YL     IHRDL A
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 348 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVFS 403
            N L+ E  V+K++DFG++R +A  GV  A  G      +W APE + +  Y  ++DV+S
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 404 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           FGI+LWE  + G  PY  L+  Q     V+KG R   P+     +  L+E+CW  +P  R
Sbjct: 301 FGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
Query: 463 PDFSEIIEILQQIAK 477
           P FS I + LQ I K
Sbjct: 360 PSFSTIYQELQSIRK 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 168/315 (53%), Gaps = 22/315 (6%)
Query: 176 KLERQGWPS------HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV 229
           +LE +G+PS      H  S+     + +G+     H  +P D    W ++ + L  G ++
Sbjct: 69  RLEGEGFPSIPLLIDHLLSTQQPLTKKSGVV---LHRAVPKDK---WVLNHEDLVLGEQI 122
Query: 230 ASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
             G++G+++ G   + +  VA+K  + E +  D++ +F QE  I+++  H N+V+ IG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
           T+   + IV E + GG    +L       ++ +LL++  D + GM YL     IHRDL A
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 348 ANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVFS 403
            N L+ E  V+K++DFG++R +A  GV  A  G      +W APE + +  Y  ++DV+S
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 404 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           FGI+LWE  + G  PY  L+  Q     V+KG R   P+     +  L+E+CW  +P  R
Sbjct: 301 FGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
Query: 463 PDFSEIIEILQQIAK 477
           P FS I + LQ I K
Sbjct: 360 PSFSTIYQELQSIRK 374

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 157/264 (59%), Gaps = 12/264 (4%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M+K
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 58
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 333
           +RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G + +LP L+ +A  ++ GM 
Sbjct: 59  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 390
           Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE  
Sbjct: 118 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 176
Query: 391 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
            +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L +
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 235
Query: 450 LLERCWQQDPALRPDFSEIIEILQ 473
           L+ +CW++DP  RP F  +   L+
Sbjct: 236 LMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+M+ GS+ D+L    G + +LP L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTARQGAKFPIKWTAPE 182
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            +L+ +CW+++P  RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+  +  VAIK LKP  ++ +    F QE  +M
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 64
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+M+ GS+ D+L    G + +LP L+ ++  ++ G
Sbjct: 65  KKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 182
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESL 241
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            +L+ +CW+++P  RP F  +   L+
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 160/266 (60%), Gaps = 12/266 (4%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           DVWEI  + L+   ++ +G +G+++ GT+  +  VAIK LKP  ++ +    F +E  IM
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIM 58
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           +K++H  +VQ     ++ P + IVTE+M+ GS+ D+L   +G   KLP+L+ +A  V+ G
Sbjct: 59  KKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 117
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N IHRDL++AN+L+    + K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL+T G++PY  +   +  +  V++G R   P++    L
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISL 235
Query: 448 AELLERCWQQDPALRPDFSEIIEILQ 473
            EL+  CW++DP  RP F  +   L+
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 152/265 (57%), Gaps = 12/265 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDPK L F  ++ +G +G +  G +  Q DVAIK++K   ++ D   EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 394
               +HRDL A N L+++  VVKV+DFG++R        ++    +  RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           +  K+D+++FG+++WE+ + GK+PYE  T  + A  + Q GLR   P  +  K+  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYS 236
Query: 454 CWQQDPALRPDF----SEIIEILQQ 474
           CW +    RP F    S I++++ +
Sbjct: 237 CWHEKADERPTFKILLSNILDVMDE 261

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 154/264 (58%), Gaps = 10/264 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 237
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 331
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I    +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 415
Query: 449 ELLERCWQQDPALRPDFSEIIEIL 472
            ++ RCW+  P  RP F  I  +L
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 154/264 (58%), Gaps = 10/264 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 64
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 331
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 65  KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 124 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I    +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L 
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELY 242
Query: 449 ELLERCWQQDPALRPDFSEIIEIL 472
            ++ RCW+  P  RP F  I  +L
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  166 bits (419), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 154/262 (58%), Gaps = 16/262 (6%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP  ++ +    F  E  +M
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVM 231
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-LPSLLKVAIDVSKG 331
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G  + LP L+  +  +++G
Sbjct: 232 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV A+  +        +W APE I 
Sbjct: 291 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI--------KWTAPEAIN 342
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              +  K+DV+SFGI+L E++T G++PY  ++  +  +  +++G R   P+N   +L  +
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 401
Query: 451 LERCWQQDPALRPDFSEIIEIL 472
           + RCW+  P  RP F  I  +L
Sbjct: 402 MMRCWKNRPEERPTFEYIQSVL 423

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 15/267 (5%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +V H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 60
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV--FKLPSLLKVAIDVSKGMNYL 335
            N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 336 HQ---NNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           H      +IHRDLK  NLL+     V+K+ DFG A    Q+  MT   G+  WMAPEV E
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAAWMAPEVFE 176
Query: 392 HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +  L
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 451 LERCWQQDPALRPDFSEIIEILQQIAK 477
           + RCW +DP+ RP   EI++I+  + +
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 15/267 (5%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +V H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 61
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV--FKLPSLLKVAIDVSKGMNYL 335
            N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +  +     +   +  S+G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 336 HQ---NNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           H      +IHRDLK  NLL+     V+K+ DFG A    Q+  MT   G+  WMAPEV E
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAAWMAPEVFE 177
Query: 392 HKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +  L
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 451 LERCWQQDPALRPDFSEIIEILQQIAK 477
           + RCW +DP+ RP   EI++I+  + +
Sbjct: 238 MTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 152/264 (57%), Gaps = 9/264 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + +K   ++ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           + ++H  +V+     T+   + I+TE+M+ GS+ D+L   +G    LP L+  +  +++G
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 122
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE 
Sbjct: 123 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I    +  K+DV+SFGI+L+E++T GK+PY   T       + Q G R    +N   +L 
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ-GYRMPRVENCPDELY 241
Query: 449 ELLERCWQQDPALRPDFSEIIEIL 472
           ++++ CW++    RP F  +  +L
Sbjct: 242 DIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 70
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 71  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 248
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 249 QLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 63
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 64  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 241
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 242 QLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 57
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 235
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 68
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 246
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 247 QLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 67
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 68  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 126
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 245
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 246 QLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 71
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 72  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 130
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 131 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 249
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 250 QLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 72
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 73  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 250
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 251 QLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 154/265 (58%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 64
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 65  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 242
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 243 QLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 153/265 (57%), Gaps = 10/265 (3%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G  G+++ G Y     VA+K LK   ++ D    F  E  +M
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           I +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELY 240
Query: 449 ELLERCWQQDPALRPDFSEIIEILQ 473
           +L+  CW++ P  RP F  +  +L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 172/344 (50%), Gaps = 29/344 (8%)
Query: 154 VVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 213
           ++DG+       +  A +  +++ +++G  +  S    +  E  G++SH   +   +D  
Sbjct: 313 LIDGY----CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYA 368
Query: 214 DV--------------WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP 254
           ++              +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K 
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN 428
Query: 255 ERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 314
              +S ++++F QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K 
Sbjct: 429 CTSDS-VREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF 486
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
              L SL+  A  +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S  
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 375 MTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 431
             A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRI 605
Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           + G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 146/272 (53%), Gaps = 13/272 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVF 270
           EI P  +     + +G +G++Y+G   +        VAIK LK        + +F  E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAG 98
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   ++ 
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMA 386
           GM YL   N +HRDL A N+L++ N V KV+DFG++RV       T  T       RW A
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           PE I ++ +   +DV+SFGIV+WE++T G+ PY  L+     +  +  G R   P +   
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPS 277
Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 278 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WEI  + +K   K+ +G +G+++ G Y  S  VA+K LKP  ++    + F +E  +M+ 
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 63
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 333
           ++H  +V+     TK   + I+TEFM+ GS+ D+L   +G    LP L+  +  +++GM 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV   +     E   +  +W APE I 
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              +  K++V+SFGI+L+E++T GK+PY   T     +  + +G R    +N   +L ++
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNAD-VMSALSQGYRMPRMENCPDELYDI 242
Query: 451 LERCWQQDPALRPDFSEIIEIL 472
           ++ CW++    RP F  +  +L
Sbjct: 243 MKMCWKEKAEERPTFDYLQSVL 264

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFL 59
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 153/263 (58%), Gaps = 10/263 (3%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++ D    F  E  +M++
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQ 60
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 333
           ++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++GM 
Sbjct: 61  LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 391
           ++ + N IHR+L+AAN+L+ +    K+ADFG+AR+   +     E   +  +W APE I 
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           +  +  K+DV+SFGI+L E++T G++PY  +T  +  +  +++G R   P N   +L +L
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQL 238
Query: 451 LERCWQQDPALRPDFSEIIEILQ 473
           +  CW++ P  RP F  +  +L+
Sbjct: 239 MRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 153/281 (54%), Gaps = 25/281 (8%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W+I  + L+ G  +  G +G +Y G +   +VAI+++  ER N D  K F +EV   R+ 
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH+NVV F+GAC  PP L I+T    G ++Y  +   K V  +    ++A ++ KGM YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA---------ETGTYRWMA 386
           H   I+H+DLK+ N+  D  +VV + DFG+  +   SGV+ A         + G    +A
Sbjct: 147 HAKGILHKDLKSKNVFYDNGKVV-ITDFGLFSI---SGVLQAGRREDKLRIQNGWLCHLA 202
Query: 387 PEVI---------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 437
           PE+I         +  P+   +DVF+ G + +EL   + P++   P +A +  +  G++P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKP 261
Query: 438 TIPKNSQPK-LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            + +    K ++++L  CW  +   RP F++++++L+++ K
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 30  TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 87
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 146
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 147 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 206
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 265
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 266 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 5   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 62
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 63  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 121
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 240
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 241 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 64
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 242
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 59
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 4   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFL 61
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 120
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 239
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 240 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFL 59
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 141/269 (52%), Gaps = 13/269 (4%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FAQEV 269
           +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F QE 
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEA 59
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
             MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A  +S
Sbjct: 60  LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAP 387
             + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +WMAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N  P 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPT 237
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 171/344 (49%), Gaps = 29/344 (8%)
Query: 154 VVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT 213
           ++DG+       +  A +  +++ +++G  +  S    +  E  G++SH   +   +D  
Sbjct: 313 LIDGY----CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYA 368
Query: 214 DV--------------WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP 254
           ++              +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K 
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN 428
Query: 255 ERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 314
              +S ++++F QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K 
Sbjct: 429 CTSDS-VREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF 486
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
              L SL+  A  +S  + YL     +HRD+ A N+L+   + VK+ DFG++R    S  
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546
Query: 375 MTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 431
             A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRI 605
Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           + G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 151/266 (56%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 278 KNVVQFIGACTKPPSL--CIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNY 334
            NV+  +GAC  PP+    ++T +M  GS+Y+ LH+    V      +K A+D+++GM +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 335 LH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 392
           LH  +  I    L + ++++DE+   +++   V       G M A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 393 KPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
           KP D     AD++SF ++LWEL+T ++P+  L+ ++  + V  +GLRPTIP    P +++
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 450 LLERCWQQDPALRPDFSEIIEILQQI 475
           L++ C  +DPA RP F  I+ IL+++
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 145/261 (55%), Gaps = 8/261 (3%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           E+  + +    ++ SG +G +  G +  Q DVA+K++K   ++ D   EF QE   M K+
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H  +V+F G C+K   + IVTE++S G + +YL       +   LL++  DV +GM +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHK 393
             +  IHRDL A N L+D +  VKV+DFG+ R       +++    +  +W APEV  + 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            Y  K+DV++FGI++WE+ + GK+PY+  T  +  + V Q G R   P  +   + +++ 
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHLASDTIYQIMY 239
Query: 453 RCWQQDPALRPDFSEIIEILQ 473
            CW + P  RP F +++  ++
Sbjct: 240 SCWHELPEKRPTFQQLLSSIE 260

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 141/272 (51%), Gaps = 13/272 (4%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKE-FA 266
           T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K     SD  +E F 
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK--NCTSDSVREKFL 59
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+   + VK+ DFG++R    S    A  G    +W
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNC 237
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P L  L+ +CW  DP+ RP F+E+   L  I
Sbjct: 238 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/322 (29%), Positives = 160/322 (49%), Gaps = 33/322 (10%)
Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           P  R ++  S   DT M +     ++P D    WE     L  G  +  G +G +     
Sbjct: 45  PLVRITTRLSSTADTPMLAGVSEYELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 243 CSQD---------VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 292
              D         VA+K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 103 VGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 293 LCIVTEFMSGGSVYDYLHKLK--------GVFKLPS-------LLKVAIDVSKGMNYLHQ 337
           L ++ E+ S G++ +YL   +         + ++P        L+     +++GM YL  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 394
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y H++DV+SFG+++WE+ T G  PY  + P++    ++++G R   P N   +L  ++  
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRD 340
Query: 454 CWQQDPALRPDFSEIIEILQQI 475
           CW   P+ RP F +++E L +I
Sbjct: 341 CWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 153/296 (51%), Gaps = 18/296 (6%)
Query: 198 GMKSH--PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VA 248
           GMK    P+  + PN+    +  EID   +K    + +G +G++  G           VA
Sbjct: 6   GMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA 65
Query: 249 IKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY 308
           IK LK        +++F  E  IM +  H NV+   G  TK   + I+TEFM  GS+  +
Sbjct: 66  IKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 124
Query: 309 LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 368
           L +  G F +  L+ +   ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R 
Sbjct: 125 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 369 ---KAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
                     T+  G     RW APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           T  Q  +  +++  R   P +    L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 245 TN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG+ARV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  149 bits (375), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 153/271 (56%), Gaps = 22/271 (8%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 275
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 336 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 388
              N  I+HRDL++ N+ +   DEN  V  KVADFG+++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 389 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 444
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 87
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 266
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 70
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 97
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 276
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 277 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 152/271 (56%), Gaps = 22/271 (8%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 275
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 336 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 388
              N  I+HRDL++ N+ +   DEN  V  KVADFG ++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS--VSGLLGNFQWMAPE 196
Query: 389 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 444
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG+ RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/312 (29%), Positives = 157/312 (50%), Gaps = 43/312 (13%)
Query: 198 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VA 248
           GM +     ++P D    WE+    L  G  +  G++G +        D         VA
Sbjct: 48  GMLAGVSEYELPEDPR--WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA 105
Query: 249 IKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 307
           +K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +
Sbjct: 106 VKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 308 YL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           YL               H  +       L+  A  V++GM YL     IHRDL A N+L+
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 353 DENEVVKVADFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
            E+ V+K+ADFG+AR         K  +G +       +WMAPE +  + Y H++DV+SF
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSF 279
Query: 405 GIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 463
           G++LWE+ T G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP
Sbjct: 280 GVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 338
Query: 464 DFSEIIEILQQI 475
            F +++E L +I
Sbjct: 339 TFKQLVEDLDRI 350

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDVA--IKVLKPERINSDMQKEFAQEVFI 271
           E+D   +K    + +G +G++  G       +DVA  IK LK        +++F  E  I
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-YTEKQRRDFLCEASI 97
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H NVV   G  T+   + IV EFM  G++  +L K  G F +  L+ +   ++ G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV       V T   G    RW AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I+++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P +    
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAG 276
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ++ A RP F +I+ IL ++ +
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/309 (29%), Positives = 155/309 (50%), Gaps = 33/309 (10%)
Query: 196 DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--------- 246
           DT M +     ++P D    WE     L  G  +  G +G +        D         
Sbjct: 4   DTPMLAGVSEYELPEDPK--WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT 61
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           VA+K+LK +    D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++
Sbjct: 62  VAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 306 YDYLHKLK--------GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 350
            +YL   +         + ++P        L+     +++GM YL     IHRDL A N+
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 180
Query: 351 LMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIV 407
           L+ EN V+K+ADFG+AR           T      +WMAPE +  + Y H++DV+SFG++
Sbjct: 181 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 240
Query: 408 LWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 466
           +WE+ T G  PY  + P++    ++++G R   P N   +L  ++  CW   P+ RP F 
Sbjct: 241 MWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 299
Query: 467 EIIEILQQI 475
           +++E L +I
Sbjct: 300 QLVEDLDRI 308

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 151/290 (52%), Gaps = 20/290 (6%)
Query: 203 PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVL 252
           P+  + PN     +  EID   +K    +  G +G++  G          C   VAIK L
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTL 65
Query: 253 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL 312
           K    +   +++F  E  IM +  H N++   G  TK   + I+TE+M  GS+  +L K 
Sbjct: 66  KAGYTDKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 124
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 371
            G F +  L+ +   +  GM YL   + +HRDL A N+L++ N V KV+DFG++RV    
Sbjct: 125 DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 372 -SGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
                T   G    RW APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDV 243
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           +  +++G R   P +    L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 73
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 74  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 252
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 253 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 74
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 75  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 253
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 254 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 66
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 245
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 81
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 260
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE+    L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLI 70
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 310
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL               H
Sbjct: 71  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
             +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+ADFG+AR   
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG++LWE+ T G  PY  + P++ 
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 249
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 250 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++TEF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 70
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 249
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRG-----TYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           E+D  ++     V +G +G++  G     +     VAIK LK        +++F  E  I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASI 99
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  TK   + IVTE M  GS+  +L K    F +  L+ +   ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L++ N V KV+DFG++RV         T   G    RW +P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P +    
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAA 278
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 152/271 (56%), Gaps = 22/271 (8%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD--VAIK--VLKPERINSDMQ---KEFAQEVFIMRKV 275
           +++  ++  G +G +++G        VAIK  +L      ++M    +EF +EVFIM  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H N+V+  G    PP +  V EF+  G +Y  L       K    L++ +D++ G+ Y+
Sbjct: 81  NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 336 HQNN--IIHRDLKAANLLM---DENEVV--KVADFGVARVKAQSGVMTAETGTYRWMAPE 388
              N  I+HRDL++ N+ +   DEN  V  KVADF +++    S  ++   G ++WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 389 VI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQ 444
            I  E + Y  KAD +SF ++L+ +LTG+ P++  +   ++    + ++GLRPTIP++  
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 147/294 (50%), Gaps = 26/294 (8%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 16  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 317 -----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                       L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 366 AR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVLKPERINSDMQKEFAQE 268
           EID   +K    +  G +G++  G          C   VAIK LK    +   +++F  E
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTLKAGYTDKQ-RRDFLSE 59
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             IM +  H N++   G  TK   + I+TE+M  GS+  +L K  G F +  L+ +   +
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 119
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRW 384
             GM YL   + +HRDL A N+L++ N V KV+DFG++RV         T   G    RW
Sbjct: 120 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
            APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P + 
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDC 238
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 239 PIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 17  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 75
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 76  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 254
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 255 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 145/273 (53%), Gaps = 14/273 (5%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFI 271
           EID  ++K    + +G +G++ RG   +       VAIK LK        ++EF  E  I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASI 70
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  T    + I+TEFM  G++  +L    G F +  L+ +   ++ G
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 130
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWM 385
           M YL + + +HRDL A N+L++ N V KV+DFG++R   ++     ET +       RW 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           APE I  + +   +D +S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P +  
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 249
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             L +L+  CWQ+D   RP F +++  L ++ +
Sbjct: 250 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G +G +        D         VA+K+LK +    D+  +  
Sbjct: 19  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 77
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 78  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 256
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 257 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 92/287 (32%), Positives = 147/287 (51%), Gaps = 14/287 (4%)
Query: 203 PYHLKIPNDGTDVW--EIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPE 255
           P+  + PN     +  EI+   +     + +G +G++  G           VAIK LK  
Sbjct: 2   PHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG 61
Query: 256 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 315
                 +++F  E  IM +  H N++   G  TK   + IVTE+M  GS+  +L K  G 
Sbjct: 62  -YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ 120
Query: 316 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SG 373
           F +  L+ +   +S GM YL     +HRDL A N+L++ N V KV+DFG++RV       
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 180
Query: 374 VMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
             T   G    RW APE I  + +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +  
Sbjct: 181 AYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKA 239
Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V++G R   P +    L +L+  CWQ++   RP F EI+ +L ++ +
Sbjct: 240 VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY--------CSQDVAIKVLKPERINSDMQKEFAQE 268
           EID   +K    +  G +G++  G          C   VAIK LK    +   +++F  E
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC---VAIKTLKAGYTDKQ-RRDFLSE 65
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             IM +  H N++   G  TK   + I+TE+M  GS+  +L K  G F +  L+ +   +
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 125
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRW 384
             GM YL   + +HRDL A N+L++ N V KV+DFG++RV         T   G    RW
Sbjct: 126 GSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
            APE I ++ +   +DV+S+GIV+WE+++ G+ PY  ++  Q  +  +++G R   P + 
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDC 244
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              L +L+  CWQ++ + RP F +I+ +L ++ +
Sbjct: 245 PIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 148/289 (51%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+++ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 5   RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 123
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 244 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDV--AIKVLKPERINSDMQKEFAQEVFI 271
           EI+   +     + SG  G++  G       +DV  AIK LK        +++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMTAETGTYRWMAP 387
           M YL     +HRDL A N+L+D N V KV+DFG++RV       +   T      RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDV--AIKVLKPERINSDMQKEFAQEVFI 271
           EI+   +     + SG  G++  G       +DV  AIK LK        +++F  E  I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 387
           M YL     +HRDL A N+L+D N V KV+DFG++RV         T   G    RW AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P      
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 16  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 194
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 195 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 254
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 255 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     LK G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 51  RLPYDASK-WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 317 -------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
                         L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DF
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 229
Query: 364 GVAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           G+AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY 
Sbjct: 230 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 14/273 (5%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFI 271
           EID   +K    + +G +G++  G           VAIK LK        +++F  E  I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 61
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H NV+   G  TK   + I+TEFM  GS+  +L +  G F +  L+ +   ++ G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGT---YRWM 385
           M YL   N +HR L A N+L++ N V KV+DFG++R           T+  G     RW 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +  +++  R   P +  
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCP 240
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 146/292 (50%), Gaps = 24/292 (8%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 317 ---------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
                     L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192
Query: 368 --VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 423
              K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +  
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 252
Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 DEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++  + S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 146/295 (49%), Gaps = 27/295 (9%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 15  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 317 ------------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
                        L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 365 VAR--VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY 420
           +AR   K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 421 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 147/289 (50%), Gaps = 31/289 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 266
           WE     L  G  +  G++G +        D         VA+K+LK +    D+  +  
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV 88
Query: 267 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 317
            E+ +M+ + +HKN++  +GACT+   L ++  + S G++ +YL   +         + +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 318 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 370
           +P        L+     +++GM YL     IHRDL A N+L+ EN V+K+ADFG+AR   
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 371 QSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 426
                   T      +WMAPE +  + Y H++DV+SFG+++WE+ T G  PY  + P++ 
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 267
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG +      +  VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R   Q+    VM       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
           +  ++ +CW   P  RP F  + + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 146/292 (50%), Gaps = 24/292 (8%)
Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINS 259
           ++P D +  WE     L  G  +  G++G +          T   + VA+K+LK    +S
Sbjct: 14  RLPYDASK-WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF-- 316
           + +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL   +  F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 317 ---------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
                     L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192
Query: 368 --VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 423
              K    V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +  
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 252
Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 253 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 145/273 (53%), Gaps = 14/273 (5%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFI 271
           EID  ++K    + +G +G++ RG   +       VAIK LK        ++EF  E  I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASI 68
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M +  H N+++  G  T    + I+TEFM  G++  +L    G F +  L+ +   ++ G
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT---YRWM 385
           M YL + + +HRDL A N+L++ N V KV+DFG++R   ++      T+  G     RW 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           APE I  + +   +D +S+GIV+WE+++ G+ PY  ++  Q  +  +++  R   P +  
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCP 247
Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             L +L+  CWQ+D   RP F +++  L ++ +
Sbjct: 248 TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 70
Query: 274 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 320
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 321 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 249
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 250 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 80
Query: 274 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 320
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 321 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
              LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 259
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 141/265 (53%), Gaps = 12/265 (4%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 278 KNVVQFIGACTKPPSL--CIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNY 334
            NV+  +GAC  PP+    ++T +   GS+Y+ LH+    V      +K A+D ++G  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 335 LH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 392
           LH  +  I    L + ++ +DE+   +++   V       G   A      W+APE ++ 
Sbjct: 127 LHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----WVAPEALQK 182
Query: 393 KPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
           KP D     AD +SF ++LWEL+T ++P+  L+  +    V  +GLRPTIP    P +++
Sbjct: 183 KPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSK 242
Query: 450 LLERCWQQDPALRPDFSEIIEILQQ 474
           L + C  +DPA RP F  I+ IL++
Sbjct: 243 LXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 140/274 (51%), Gaps = 20/274 (7%)
Query: 220 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
           P  L  G  +  G +G   + T+      + + +  R + + Q+ F +EV +MR + H N
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V++FIG   K   L  +TE++ GG++   +  +   +     +  A D++ GM YLH  N
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV----KAQ-SGVMTAE----------TGTYRW 384
           IIHRDL + N L+ EN+ V VADFG+AR+    K Q  G+ + +           G   W
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKG-LRPTIPK 441
           MAPE+I  + YD K DVFSFGIVL E++ G++    +YL P     G+  +G L    P 
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYL-PRTMDFGLNVRGFLDRYCPP 246
Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           N  P    +  RC   DP  RP F ++   L+ +
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 142/265 (53%), Gaps = 13/265 (4%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           LK    + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + 
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMD 75
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H ++V+ +G C  P ++ +VT+ M  G + +Y+H+ K       LL   + ++KGM YL 
Sbjct: 76  HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 393
           +  ++HRDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            + H++DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ 
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMV 253
Query: 453 RCWQQDPALRPDFSEIIEILQQIAK 477
           +CW  D   RP F E+     ++A+
Sbjct: 254 KCWMIDADSRPKFKELAAEFSRMAR 278

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 142/265 (53%), Gaps = 13/265 (4%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           LK    + SG++G +Y+G +  +       VAIK+L  E        EF  E  IM  + 
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMD 98
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H ++V+ +G C  P ++ +VT+ M  G + +Y+H+ K       LL   + ++KGM YL 
Sbjct: 99  HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 393
           +  ++HRDL A N+L+     VK+ DFG+AR ++       A+ G    +WMA E I ++
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 394 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
            + H++DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ 
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMV 276
Query: 453 RCWQQDPALRPDFSEIIEILQQIAK 477
           +CW  D   RP F E+     ++A+
Sbjct: 277 KCWMIDADSRPKFKELAAEFSRMAR 301

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 322
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 323 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 370
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 371 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 229 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 91  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 401
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 268
Query: 461 LRPDFSEIIEILQQI 475
            RP F+E++  L  +
Sbjct: 269 DRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 229 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 75  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 401
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 252
Query: 461 LRPDFSEIIEILQQI 475
            RP F+E++  L  +
Sbjct: 253 DRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 11/255 (4%)
Query: 229 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           +  G +G++Y G Y +      +VA+K  K +    D +++F  E  IM+ + H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG   + P+  I+ E    G +  YL + K   K+ +L+  ++ + K M YL   N +HR
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADV 401
           D+   N+L+   E VK+ DFG++R         A       +WM+PE I  + +   +DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           + F + +WE+L+ GK P+ +L   +  +GV++KG R   P    P L  L+ RCW  DP+
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPS 256
Query: 461 LRPDFSEIIEILQQI 475
            RP F+E++  L  +
Sbjct: 257 DRPRFTELVCSLSDV 271

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 34  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 93
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 322
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 323 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 370
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 371 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 322
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 323 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 370
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 371 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 100
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 322
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 160
Query: 323 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 370
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 371 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 147/279 (52%), Gaps = 23/279 (8%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           +D   +KF   +  G++G + +          D AIK +K E  + D  ++FA E+ ++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 77
Query: 274 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 320
           K+  H N++  +GAC     L +  E+   G++ D+L K + +   P+            
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 321 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
              LL  A DV++GM+YL Q   IHR+L A N+L+ EN V K+ADFG++R +      T 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                RWMA E + +  Y   +DV+S+G++LWE+++ G  PY  +T  +    + Q G R
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 256
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P N   ++ +L+ +CW++ P  RP F++I+  L ++
Sbjct: 257 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 28/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 268
           WE     L FG  + +G++G +   T         +  VA+K+LKP    ++ +   ++ 
Sbjct: 36  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 95
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL----PSLL-- 322
             +     H N+V  +GACT      ++TE+   G + ++L + +  F      P+++  
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 155
Query: 323 -----------KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKA 370
                        +  V+KGM +L   N IHRDL A N+L+    + K+ DFG+AR +K 
Sbjct: 156 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 371 QSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 427
            S  +         +WMAPE I +  Y  ++DV+S+GI LWEL + G  PY  +      
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 262
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 92  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 210
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 211 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 269
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 270 ADSRPKFRELIIEFSKMAR 288

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 88  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 206
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 207 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 265
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 266 ADSRPKFRELIIEFSKMAR 284

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 107 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 225
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 226 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 284
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 285 ADSRPKFRELIIEFSKMAR 303

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 76  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 253
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 254 ADSRPKFRELIIEFSKMAR 272

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 61
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 182 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 237 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 67
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 188 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 243 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 70
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 69
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 142/280 (50%), Gaps = 29/280 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           W I+    +    + SG+   + +  YC+   + VAIK +  E+  + M  E  +E+  M
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAM 67
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVA 325
            +  H N+V +  +      L +V + +SGGSV D +  +        GV    ++  + 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------T 379
            +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 380 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
           GT  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++  +  +Q    P+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPS 246
Query: 439 IPKNSQPK---------LAELLERCWQQDPALRPDFSEII 469
           +    Q K           +++  C Q+DP  RP  +E++
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 63
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 239 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 98
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 219 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 274 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 70
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 191 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 246 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 66
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF---------K 317
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+             
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 187 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 242 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 7/246 (2%)
Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +     V ++ G
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 87
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 404
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 205
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 206 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 465 FSEIIE 470
             E+++
Sbjct: 265 AKELLK 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 142/280 (50%), Gaps = 29/280 (10%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           W I+    +    + SG+   + +  YC+   + VAIK +  E+  + M  E  +E+  M
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVA 325
            +  H N+V +  +      L +V + +SGGSV D +  +        GV    ++  + 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------T 379
            +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 380 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
           GT  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++  +  +Q    P+
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPS 241
Query: 439 IPKNSQPK---------LAELLERCWQQDPALRPDFSEII 469
           +    Q K           +++  C Q+DP  RP  +E++
Sbjct: 242 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 69
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 245 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 139/257 (54%), Gaps = 8/257 (3%)
Query: 218 IDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +DP+ L     K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQ 61
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
                V ++ G+  K   L I+ E++ GGS  D L    G      +  +  ++ KG++Y
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY 119
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHK 393
           LH    IHRD+KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+  
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            YD KAD++S GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEA 238
Query: 454 CWQQDPALRPDFSEIIE 470
           C  ++P+ RP   E+++
Sbjct: 239 CLNKEPSFRPTAKELLK 255

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 145/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R         K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 197 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 252 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + +++GMNYL    ++H
Sbjct: 79  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 197
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 198 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 256
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 257 ADSRPKFRELIIEFSKMAR 275

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 134/246 (54%), Gaps = 7/246 (2%)
Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +     V ++ G
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYYG 92
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L I+ E++ GGS  D L    G      +  +  ++ KG++YLH    IHRD+
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 150
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+   YD KAD++S 
Sbjct: 151 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 210
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E C  ++P+ RP 
Sbjct: 211 GITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 269
Query: 465 FSEIIE 470
             E+++
Sbjct: 270 AKELLK 275

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           ++SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 89  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 207
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 208 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 266
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 267 ADSRPKFRELIIEFSKMAR 285

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 139/257 (54%), Gaps = 8/257 (3%)
Query: 218 IDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +DP+ L     K+  GS+G++++G      + VAIK++  E    +++    QE+ ++ +
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQ 61
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
                V ++ G+  K   L I+ E++ GGS  D L    G      +  +  ++ KG++Y
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY 119
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHK 393
           LH    IHRD+KAAN+L+ E+  VK+ADFGVA     + +      GT  WMAPEVI+  
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            YD KAD++S GI   EL  G+ P+  L P++    ++ K   PT+  N    L E +E 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEA 238
Query: 454 CWQQDPALRPDFSEIIE 470
           C  ++P+ RP   E+++
Sbjct: 239 CLNKEPSFRPTAKELLK 255

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 205 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 263
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 264 ADSRPKFRELIIEFSKMAR 282

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 202 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 260
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 261 ADSRPKFRELIIEFSKMAR 279

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 85  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 203
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 204 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 262
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 263 ADSRPKFRELIIEFSKMAR 281

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 82  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 259
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 260 ADSRPKFRELIIEFSKMAR 278

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAI  L+ E  +    KE   E ++M  V + +V +
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 116 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 174
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 234
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 235 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 293
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 294 ADSRPKFRELIIEFSKMAR 312

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG+A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 201
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 202 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 260
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 261 ADSRPKFRELIIEFSKMAR 279

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 135/261 (51%), Gaps = 16/261 (6%)
Query: 229 VASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ 282
           +  G +G +Y G Y  Q       AIK L   RI    Q E F +E  +MR + H NV+ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 283 FIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
            IG    P  L  ++  +M  G +  ++   +    +  L+   + V++GM YL +   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----RWMAPEVIEHKPYD 396
           HRDL A N ++DE+  VKVADFG+AR        + +   +     +W A E ++   + 
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 397 HKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
            K+DV+SFG++LWELLT G  PY ++ P      + Q G R   P+     L +++++CW
Sbjct: 207 TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQVMQQCW 265
Query: 456 QQDPALRPDFSEIIEILQQIA 476
           + DPA+RP F  ++  ++QI 
Sbjct: 266 EADPAVRPTFRVLVGEVEQIV 286

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 32/286 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 63
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPS 320
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+       V   PS
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 321 L---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L   +++A +++ GM YL+ N  +HRDL A N  + E+  VK+ DFG+ R         K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q   
Sbjct: 184 GGKGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
            V++ GL    P N    L EL+  CWQ +P +RP F EII  +++
Sbjct: 239 FVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 27/257 (10%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K+LK E  ++DMQ +F +E  +M +  + N+V+ +G C     +C++ E+M+ G + 
Sbjct: 80  VAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 307 DYLHKLK--GVFKL----------------PSL-----LKVAIDVSKGMNYLHQNNIIHR 343
           ++L  +    V  L                P L     L +A  V+ GM YL +   +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKAD 400
           DL   N L+ EN VVK+ADFG++R    +    A+       RWM PE I +  Y  ++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           V+++G+VLWE+ +  L   Y    +  +  V+ G     P+N   +L  L+  CW + PA
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 318
Query: 461 LRPDFSEIIEILQQIAK 477
            RP F  I  ILQ++ +
Sbjct: 319 DRPSFCSIHRILQRMCE 335

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 262 ADSRPKFRELIIEFSKMAR 280

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 139/259 (53%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++M  V + +V +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ ++ + M  G + DY+ + K       LL   + ++KGMNYL    ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+   + VK+ DFG A+ + A+     AE G    +WMA E I H+ Y H++
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 204
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P      +++KG R   P      +  ++ +CW  D
Sbjct: 205 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 263
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E+I    ++A+
Sbjct: 264 ADSRPKFRELIIEFSKMAR 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 147/277 (53%), Gaps = 12/277 (4%)
Query: 199 MKSHPYHLKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPE 255
           M   P  +++P    ++   DP+ L     ++  GS+G++++G      Q VAIK++  E
Sbjct: 2   MAHSPVAVQVPGMQNNI--ADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE 59
Query: 256 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-G 314
               +++    QE+ ++ +     V ++ G+  K   L I+ E++ GGS  D L      
Sbjct: 60  EAEDEIEDI-QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD 118
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
            F++ ++LK   ++ KG++YLH    IHRD+KAAN+L+ E   VK+ADFGVA     + +
Sbjct: 119 EFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175
Query: 375 -MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 433
                 GT  WMAPEVI+   YD KAD++S GI   EL  G+ P   + P++    ++ K
Sbjct: 176 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPK 234
Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
              PT+  +      E ++ C  +DP+ RP   E+++
Sbjct: 235 NNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 136/257 (52%), Gaps = 8/257 (3%)
Query: 218 IDPKHLKFG-SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +DP+ L     ++  GS+G++Y+G   +  + VAIK++  E    +++    QE+ ++ +
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQ 73
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
                + ++ G+  K   L I+ E++ GGS  D L    G  +   +  +  ++ KG++Y
Sbjct: 74  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDY 131
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHK 393
           LH    IHRD+KAAN+L+ E   VK+ADFGVA     + +      GT  WMAPEVI+  
Sbjct: 132 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            YD KAD++S GI   EL  G+ P   L P++    ++ K   PT+         E +E 
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQHSKPFKEFVEA 250
Query: 454 CWQQDPALRPDFSEIIE 470
           C  +DP  RP   E+++
Sbjct: 251 CLNKDPRFRPTAKELLK 267

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 63  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 121
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++G   
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 300
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 40  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 98
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 99  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++G   
Sbjct: 159 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 218
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 277
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 278 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 121/198 (61%), Gaps = 12/198 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 341
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 396
           HRD+K+AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  E  P  
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP-- 213
Query: 397 HKADVFSFGIVLWELLTG 414
            K+D++SFG+VL E++TG
Sbjct: 214 -KSDIYSFGVVLLEIITG 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 22/283 (7%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 33  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 91
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---------FKL 318
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +              +L
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTA 377
             LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S  +  
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 378 ETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 434
                  +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +V+ G
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 272 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 120/198 (60%), Gaps = 12/198 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 341
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 396
           HRD+K+AN+L+DE    K++DFG+AR     AQ+ +     GT  +MAPE +  E  P  
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP-- 213
Query: 397 HKADVFSFGIVLWELLTG 414
            K+D++SFG+VL E++TG
Sbjct: 214 -KSDIYSFGVVLLEIITG 230

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 22/283 (7%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---------FKL 318
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +              +L
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTA 377
             LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S  +  
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 378 ETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 434
                  +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +V+ G
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K+ H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 139/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 95
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K+ H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 49  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 107
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 168 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 286
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 287 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 95
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 268
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 315
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 316 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                       +  L+  A  +S+GM YL + +++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 366 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 73/198 (36%), Positives = 119/198 (60%), Gaps = 12/198 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           G+K+  G +G +Y+G   +  VA+K L    +    +++++F QE+ +M K +H+N+V+ 
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 341
           +G  +    LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 396
           HRD+K+AN+L+DE    K++DFG+AR     AQ  +     GT  +MAPE +  E  P  
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP-- 207
Query: 397 HKADVFSFGIVLWELLTG 414
            K+D++SFG+VL E++TG
Sbjct: 208 -KSDIYSFGVVLLEIITG 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 80
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 259
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 29  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 87
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 88  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 148 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 266
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 267 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 39  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 97
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 98  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 157
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 158 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 276
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 277 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 14  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 72
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 133 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 251
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 252 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 142/287 (49%), Gaps = 26/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-------- 319
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 320 -----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSG 373
                 LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 374 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
            +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 80
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 259
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 142/287 (49%), Gaps = 26/287 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-------- 319
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V +          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 320 -----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSG 373
                 LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   S 
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 374 VMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
            +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +        +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVYSEQDELDF 95
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+AR   ++    
Sbjct: 156 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 274
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 275 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 36/294 (12%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 268
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 315
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 316 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                       +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 366 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 36/294 (12%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 268
           WE   K+L  G  +  G +G + + T            VA+K+LK     S++ ++   E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSE 76
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV------------- 315
             ++++V H +V++  GAC++   L ++ E+   GS+  +L + + V             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 316 ----------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                       +  L+  A  +S+GM YL +  ++HRDL A N+L+ E   +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 366 AR-VKAQSGVMTAETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           +R V  +   +    G    +WMA E +    Y  ++DV+SFG++LWE++T G  PY  +
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L+++
Sbjct: 257 PP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 269
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 270 LKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 109
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 288
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 289 LKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 265
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 266 LKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 269
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 270 LKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 268
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 269 LKCWHPKAEMRPSFSELVSRISAI 292

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 110
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 289
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 290 LKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 262
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 263 LKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM YL  
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-----YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR        +    T      +WMA E ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 267
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 268 LKCWHPKAEMRPSFSELVSRISAI 291

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 142/292 (48%), Gaps = 32/292 (10%)
Query: 217 EIDPKH-----LKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEF 265
           E+DP H     LK    +  G +G  +L R    G    + VA+K LKPE   + +  + 
Sbjct: 12  EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DL 70
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
            +E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 379
            A+ + KGM+YL     +HRDL A N+L++    VK+ DFG+ +     K    V     
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--------GKLPYEYLTPLQAA---- 427
               W APE +    +   +DV+SFG+ L ELLT          L  + + P        
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 428 --VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEF 265
           +D+ E+  K++     +  G++G++Y G             VA+K L PE  +   + +F
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDF 81
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS----- 320
             E  I+ K  H+N+V+ IG   +     I+ E M+GG +  +L + +     PS     
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMT 376
            LL VA D++ G  YL +N+ IHRD+ A N L+       V K+ DFG+A+   ++    
Sbjct: 142 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 377 AETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    +WM PE      +  K D +SFG++LWE+ + G +PY   +  Q  +  V 
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 260
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            G R   PKN    +  ++ +CWQ  P  RP+F+ I+E ++
Sbjct: 261 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR  +  +   +  +TG     +WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 271
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 272 LKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG++G +Y+G +          VAIKVL+ E  +    KE   E ++M  V    V +
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    ++ +VT+ M  G + D++ + +G      LL   + ++KGM+YL    ++H
Sbjct: 84  LLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 399
           RDL A N+L+     VK+ DFG+AR +        A+ G    +WMA E I  + + H++
Sbjct: 143 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQS 202
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY+ + P +    +++KG R   P      +  ++ +CW  D
Sbjct: 203 DVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 261
Query: 459 PALRPDFSEIIEILQQIAK 477
              RP F E++    ++A+
Sbjct: 262 SECRPRFRELVSEFSRMAR 280

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 142/296 (47%), Gaps = 35/296 (11%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 26  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 84
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------ 321
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L +       PSL      
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 322 ----------------LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                           L  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 366 AR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           AR +   S  +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 264
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
                   +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 265 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 320

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 65
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 186 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 241 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 268
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 269 LKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 271
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 272 LKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 96
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 275
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 276 LKCWHPKAEMRPSFSELVSRISAI 299

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK 188
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 141/289 (48%), Gaps = 28/289 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQE 268
           WE    +L+FG  + +G++G +   T            VA+K+LK    ++D ++    E
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSE 99
Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 312
           + IM  + +H+N+V  +GACT    + ++TE+   G + ++L               H  
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 371
           +       LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+AR +   
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 372 SGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
           S  +         +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +       
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 328

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 270
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 271 LKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 225 FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK 278
           F   +  G +G +Y GT    D      A+K L   RI    +  +F  E  IM+   H 
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 279 NVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           NV+  +G C +   S  +V  +M  G + +++        +  L+   + V+KGM +L  
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIEH 392
              +HRDL A N ++DE   VKVADFG+AR     +   +  +TG     +WMA E ++ 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 393 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
           + +  K+DV+SFG++LWEL+T G  PY  +      V ++Q G R   P+     L E++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVM 329
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
            +CW     +RP FSE++  +  I
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 141/291 (48%), Gaps = 32/291 (10%)
Query: 218 IDPKH-----LKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFA 266
           +DP H     LK    +  G +G  +L R    G    + VA+K LKPE   + +  +  
Sbjct: 1   VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLK 59
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
           +E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK 
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 119
Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETG 380
           A+ + KGM+YL     +HRDL A N+L++    VK+ DFG+ +     K    V      
Sbjct: 120 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 381 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--------GKLPYEYLTPLQAA----- 427
              W APE +    +   +DV+SFG+ L ELLT          L  + + P         
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 239
Query: 428 -VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 240 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 290

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/335 (27%), Positives = 155/335 (46%), Gaps = 43/335 (12%)
Query: 172 KEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 231
           K+  + E Q      + S  +E      + + Y LK        WE   ++L+FG  + S
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK--------WEFPRENLEFGKVLGS 55
Query: 232 GSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 283
           G++G +   T         S  VA+K+LK E+ +S  ++    E+ +M ++  H+N+V  
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNL 114
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSL 321
           +GACT    + ++ E+   G + +YL   +                       V     L
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 380
           L  A  V+KGM +L   + +HRDL A N+L+   +VVK+ DFG+AR + + S  +     
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234
Query: 381 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 437
               +WMAPE +    Y  K+DV+S+GI+LWE+ + G  PY  +        ++Q G + 
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294
Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
             P  +  ++  +++ CW  D   RP F  +   L
Sbjct: 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 161/322 (50%), Gaps = 35/322 (10%)
Query: 184 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGT 241
           S  S SPT E + +G++ H   ++ P   +D  V  I  + +    ++  G++G ++   
Sbjct: 5   SGSSLSPT-EGKGSGLQGHI--IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAE 61
Query: 242 YC-----SQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 293
            C      QD   VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L
Sbjct: 62  -CHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 294 CIVTEFMSGGSVYDYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            +V E+M  G +  +L                  G   L  LL VA  V+ GM YL   +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYD 396
            +HRDL   N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ + 
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 397 HKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
            ++DV+SFG+VLWE+ T GK P+  L+  + A+  + +G     P+   P++  ++  CW
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCW 297
Query: 456 QQDPALRPDFSEIIEILQQIAK 477
           Q++P  R    ++   LQ +A+
Sbjct: 298 QREPQQRHSIKDVHARLQALAQ 319

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 68
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HR+L A N ++  +  VK+ DFG+ R         K
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 189 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 244 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF 
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFL 69
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VK 369
           L  ++++A +++ GM YL+    +HR+L A N ++  +  VK+ DFG+ R         K
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q   
Sbjct: 190 GGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            V+  G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 245 FVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 145/288 (50%), Gaps = 26/288 (9%)
Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRG---TYC-SQD---VAIKVLKPERINSDMQKEF 265
           T V  I   ++    ++  G++G ++       C  QD   VA+K LK    N+  +K+F
Sbjct: 5   TFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--RKDF 62
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPS--- 320
            +E  ++  ++H+++V+F G C +   L +V E+M  G +  +L  H    V        
Sbjct: 63  HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 321 -------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 373
                  +L +A  ++ GM YL   + +HRDL   N L+ EN +VK+ DFG++R    + 
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 374 VMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 429
                  T    RWM PE I ++ +  ++DV+S G+VLWE+ T GK P+  L+     + 
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIE 241
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            + +G     P+    ++ EL+  CWQ++P +R +   I  +LQ +AK
Sbjct: 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 129/249 (51%), Gaps = 21/249 (8%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 45  VAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 307 DYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
            +L                  G   L  LL VA  V+ GM YL   + +HRDL   N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 353 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 409
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+VLW
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 222
Query: 410 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           E+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P  R    ++
Sbjct: 223 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281
Query: 469 IEILQQIAK 477
              LQ +A+
Sbjct: 282 HARLQALAQ 290

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 129/249 (51%), Gaps = 21/249 (8%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V E+M  G + 
Sbjct: 51  VAVKALK--EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 307 DYLHK--------------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
            +L                  G   L  LL VA  V+ GM YL   + +HRDL   N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 353 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 409
            +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++DV+SFG+VLW
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 228
Query: 410 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           E+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P  R    ++
Sbjct: 229 EIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287
Query: 469 IEILQQIAK 477
              LQ +A+
Sbjct: 288 HARLQALAQ 296

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 133/247 (53%), Gaps = 12/247 (4%)
Query: 228 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           ++  G++G + +G Y  +    DVAIKVLK     +D + E  +E  IM ++ +  +V+ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRL 75
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           IG C +  +L +V E   GG ++ +L   +    + ++ ++   VS GM YL + N +HR
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 344 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKA 399
           DL A N+L+      K++DFG+++ + A     TA +      +W APE I  + +  ++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WE L+ G+ PY+ +   +  +  +++G R   P    P+L  L+  CW   
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYK 253
Query: 459 PALRPDF 465
              RPDF
Sbjct: 254 WEDRPDF 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 145/294 (49%), Gaps = 29/294 (9%)
Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQ 262
           + G  V  I  + +    ++  G++G ++         T     VA+K LK   + +  +
Sbjct: 4   HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--R 61
Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------------ 310
           K+F +E  ++  ++H+++V+F G C     L +V E+M  G +  +L             
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 311 ---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
              + KG   L  +L +A  ++ GM YL   + +HRDL   N L+  N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 368 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 423
               +        T    RWM PE I ++ +  ++DV+SFG++LWE+ T GK P+  L+ 
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            +  +  + +G     P+    ++ +++  CWQ++P  R +  EI +IL  + K
Sbjct: 242 TE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 37/267 (13%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 285
           V +G+YG +Y+G +    Q  AIKV+    +  D ++E  QE+ +++K   H+N+  + G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 286 ACTK--PPS----LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 338
           A  K  PP     L +V EF   GSV D +   KG   K   +  +  ++ +G+++LHQ+
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 339 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 394
            +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMAPEVI  +  P 
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 395 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---- 448
             YD K+D++S GI   E+  G  P   + P++A            IP+N  P+L     
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 259
Query: 449 -----ELLERCWQQDPALRPDFSEIIE 470
                  +E C  ++ + RP   ++++
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 147/286 (51%), Gaps = 25/286 (8%)
Query: 189 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ--- 245
           SP S+PE+   K     L +  D   + +I+         +  G++G + +G Y  +   
Sbjct: 317 SPFSDPEELKDKK----LFLKRDNLLIADIE---------LGCGNFGSVRQGVYRMRKKQ 363
Query: 246 -DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
            DVAIKVLK     +D + E  +E  IM ++ +  +V+ IG C +  +L +V E   GG 
Sbjct: 364 IDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           ++ +L   +    + ++ ++   VS GM YL + N +HR+L A N+L+      K++DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 365 VAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           +++ + A     TA +      +W APE I  + +  ++DV+S+G+ +WE L+ G+ PY+
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
            +   +  +  +++G R   P    P+L  L+  CW      RPDF
Sbjct: 542 KMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDF 586

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 31  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDIL 87
Query: 273 RKVRHKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 145
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 386
           GM YLH  + IHRDL A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA 205
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 432
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 115/198 (58%), Gaps = 12/198 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKP--ERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           G+K   G +G +Y+G   +  VA+K L    +    +++++F QE+ +  K +H+N+V+ 
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNNII 341
           +G  +    LC+V  +   GS+ D L  L G   L      K+A   + G+N+LH+N+ I
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVI--EHKPYD 396
           HRD+K+AN+L+DE    K++DFG+AR     AQ    +   GT  + APE +  E  P  
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP-- 204
Query: 397 HKADVFSFGIVLWELLTG 414
            K+D++SFG+VL E++TG
Sbjct: 205 -KSDIYSFGVVLLEIITG 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG +G +++G +  +       V IKV++ +      Q      +  +  + H ++V+
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 97
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    SL +VT+++  GS+ D++ + +G      LL   + ++KGM YL ++ ++H
Sbjct: 98  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 156
Query: 343 RDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT-YRWMAPEVIEHKPYDHKA 399
           R+L A N+L+     V+VADFGVA +       ++ +E  T  +WMA E I    Y H++
Sbjct: 157 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 216
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY  L  L     +++KG R   P+     +  ++ +CW  D
Sbjct: 217 DVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMID 275
Query: 459 PALRPDFSEIIEILQQIAK 477
             +RP F E+     ++A+
Sbjct: 276 ENIRPTFKELANEFTRMAR 294

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 140/247 (56%), Gaps = 5/247 (2%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS+G   L + T   +   IK +   R++S  ++E  +EV ++  ++H N+VQ+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           +  +  SL IV ++  GG ++  ++  KGV F+   +L   + +   + ++H   I+HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           +K+ N+ + ++  V++ DFG+ARV  +   +  A  GT  +++PE+ E+KPY++K+D+++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 463
            G VL+EL T K  +E    ++  V  +  G  P +  +    L  L+ + ++++P  RP
Sbjct: 211 LGCVLYELCTLKHAFE-AGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 464 DFSEIIE 470
             + I+E
Sbjct: 270 SVNSILE 276

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 229 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           + SG +G +++G +  +       V IKV++ +      Q      +  +  + H ++V+
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 79
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +G C    SL +VT+++  GS+ D++ + +G      LL   + ++KGM YL ++ ++H
Sbjct: 80  LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138
Query: 343 RDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT-YRWMAPEVIEHKPYDHKA 399
           R+L A N+L+     V+VADFGVA +       ++ +E  T  +WMA E I    Y H++
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198
Query: 400 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           DV+S+G+ +WEL+T G  PY  L  L     +++KG R   P+     +  ++ +CW  D
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMID 257
Query: 459 PALRPDFSEIIEILQQIAK 477
             +RP F E+     ++A+
Sbjct: 258 ENIRPTFKELANEFTRMAR 276

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 155/304 (50%), Gaps = 28/304 (9%)
Query: 182 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGS 233
           W + +     + P DT +   PY         D  EI PK +    K+         SG+
Sbjct: 331 WAADKGPQREALPMDTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGN 382
Query: 234 YGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 289
           +G + +G Y      + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +
Sbjct: 383 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 441
Query: 290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
             S  +V E    G +  YL + + V K  +++++   VS GM YL ++N +HRDL A N
Sbjct: 442 AESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 500
Query: 350 LLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFG 405
           +L+      K++DFG+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG
Sbjct: 501 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 560
Query: 406 IVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           +++WE  + G+ PY  +   +    +++KG R   P     ++ +L+  CW  D   RP 
Sbjct: 561 VLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 619
Query: 465 FSEI 468
           F+ +
Sbjct: 620 FAAV 623

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 32/282 (11%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEV 269
           E+  + +    ++  GS+G +Y G             VA+K +  E  +   + EF  E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEA 70
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---------LPS 320
            +M+     +VV+ +G  +K     +V E M+ G +  YL  L+   +         L  
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 372
           ++++A +++ GM YL+    +HRDL A N ++  +  VK+ DFG+ R         K   
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 431
           G++       RWMAPE ++   +   +D++SFG+VLWE+ +  + PY+ L+  Q    V+
Sbjct: 191 GLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
             G     P N   ++ +L+  CWQ +P +RP F EI+ +L+
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 133/269 (49%), Gaps = 22/269 (8%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 272
           ID   L  G  +  G +G +  G    +D     VA+K +K +  +    +EF  E   M
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 273 RKVRHKNVVQFIGACTKP-----PSLCIVTEFMSGGSVYDYL--HKLKGVFK---LPSLL 322
           +   H NV++ +G C +      P   ++  FM  G ++ YL   +L+   K   L +LL
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT- 381
           K  +D++ GM YL   N +HRDL A N ++ ++  V VADFG+++ K  SG    +    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIYSGDYYRQGRIA 209
Query: 382 ---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 437
               +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY  +         +  G R 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHGHRL 268
Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFS 466
             P++   +L E++  CW+ DP  RP FS
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 145/262 (55%), Gaps = 15/262 (5%)
Query: 213 TDVWEIDPKHLKFGSKV--ASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEV 269
           +D+ E D ++ + G +V    G+YG +Y G   S  V I + + PER +S   +   +E+
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEI 70
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAID 327
            + + ++HKN+VQ++G+ ++   + I  E + GGS+   L    G  K    ++      
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVA-RVKAQSGVMTAETGTYRWM 385
           + +G+ YLH N I+HRD+K  N+L++  + V+K++DFG + R+   +      TGT ++M
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 386 APEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIP 440
           APE+I+  P  Y   AD++S G  + E+ TGK P+  L   QAA   VG+ +  + P IP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIP 248
Query: 441 KNSQPKLAELLERCWQQDPALR 462
           ++   +    + +C++ DP  R
Sbjct: 249 ESMSAEAKAFILKCFEPDPDKR 270

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 14  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDIL 70
Query: 273 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 128
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 386
           GM YLH  + IHR+L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 432
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ++LK    +  G +G +    YC         + VA+K LK +      +  + QE+ I+
Sbjct: 14  RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDIL 70
Query: 273 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           R + H++++++ G C      SL +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 128
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 386
           GM YLH  + IHR+L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVG---------VVQ 432
           PE ++   + + +DV+SFG+ L+ELLT        P ++L  +  A G         +++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           +G R   P     ++  L++ CW+ + + RP F  +I IL+ +
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 155/304 (50%), Gaps = 28/304 (9%)
Query: 182 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGS 233
           W + +     + P DT +   P+         D  EI PK +    K+         SG+
Sbjct: 330 WAADKGPQREALPMDTEVFESPF--------ADPEEIRPKEVYLDRKLLTLEDKELGSGN 381
Query: 234 YGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 289
           +G + +G Y      + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +
Sbjct: 382 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 440
Query: 290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
             S  +V E    G +  YL + + V K  +++++   VS GM YL ++N +HRDL A N
Sbjct: 441 AESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499
Query: 350 LLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFG 405
           +L+      K++DFG+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG
Sbjct: 500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 559
Query: 406 IVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 464
           +++WE  + G+ PY  +   +    +++KG R   P     ++ +L+  CW  D   RP 
Sbjct: 560 VLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 618
Query: 465 FSEI 468
           F+ +
Sbjct: 619 FAAV 622

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 142/281 (50%), Gaps = 33/281 (11%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ++LK    +  G +G +    YC         + VA+K LK E     ++  + +E+ I+
Sbjct: 9   RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALK-EGCGPQLRSGWQREIEIL 65
Query: 273 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           R + H+++V++ G C      S+ +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLAQLLLFAQQICE 123
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 386
           GM YLH  + IHR L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 124 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT----GKLPYEYLTPL----QAAVGV------VQ 432
           PE ++   + + +DV+SFG+ L+ELLT     + P+   T L    Q  + V      ++
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           +G R   P     ++  L++ CW+ + + RP F  ++ ILQ
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 142/281 (50%), Gaps = 33/281 (11%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           ++LK    +  G +G +    YC         + VA+K LK E     ++  + +E+ I+
Sbjct: 8   RYLKKIRDLGEGHFGKV--SLYCYDPTNDGTGEMVAVKALK-EGCGPQLRSGWQREIEIL 64
Query: 273 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           R + H+++V++ G C      S+ +V E++  GS+ DYL +      L  LL  A  + +
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLAQLLLFAQQICE 122
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRWMA 386
           GM YLH  + IHR L A N+L+D + +VK+ DFG+A+   +        E G     W A
Sbjct: 123 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT----GKLPYEYLTPL----QAAVGV------VQ 432
           PE ++   + + +DV+SFG+ L+ELLT     + P+   T L    Q  + V      ++
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
           +G R   P     ++  L++ CW+ + + RP F  ++ ILQ
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 150/290 (51%), Gaps = 28/290 (9%)
Query: 196 DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGSYGDLYRGTY----C 243
           DT +   PY         D  EI PK +    K+         SG++G + +G Y     
Sbjct: 2   DTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV 53
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
            + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +  S  +V E    G
Sbjct: 54  VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 112
Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
            +  YL + + V K  +++++   VS GM YL ++N +HRDL A N+L+      K++DF
Sbjct: 113 PLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 171
Query: 364 GVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 418
           G+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG+++WE  + G+ PY
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 419 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
             +   +    +++KG R   P     ++ +L+  CW  D   RP F+ +
Sbjct: 232 RGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 150/290 (51%), Gaps = 28/290 (9%)
Query: 196 DTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV--------ASGSYGDLYRGTY----C 243
           DT +   PY         D  EI PK +    K+         SG++G + +G Y     
Sbjct: 2   DTEVYESPY--------ADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV 53
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
            + VA+K+LK E  +  ++ E   E  +M+++ +  +V+ IG C +  S  +V E    G
Sbjct: 54  VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 112
Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
            +  YL + + V K  +++++   VS GM YL ++N +HRDL A N+L+      K++DF
Sbjct: 113 PLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 171
Query: 364 GVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 418
           G+++ ++A      A+T G +  +W APE I +  +  K+DV+SFG+++WE  + G+ PY
Sbjct: 172 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 419 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
             +   +    +++KG R   P     ++ +L+  CW  D   RP F+ +
Sbjct: 232 RGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 217 EIDPKHLKFGSKV--------ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKE 264
           EI PK +    K+         SG++G + +G Y      + VA+K+LK E  +  ++ E
Sbjct: 13  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 72
Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
              E  +M+++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++
Sbjct: 73  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIEL 130
Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY 382
              VS GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 383 --RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 439
             +W APE I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGC 249
Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEI 468
           P     ++ +L+  CW  D   RP F+ +
Sbjct: 250 PAGCPREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 63/170 (37%), Positives = 99/170 (58%), Gaps = 8/170 (4%)
Query: 314 GVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-- 367
           G +K P     L+  +  V++GM +L     IHRDL A N+L+ EN VVK+ DFG+AR  
Sbjct: 190 GFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 368 VKAQSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 425
            K    V   +T    +WMAPE I  K Y  K+DV+S+G++LWE+ + G  PY  +   +
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                +++G+R   P+ S P++ +++  CW +DP  RP F+E++E L  +
Sbjct: 310 DFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 218 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 118
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 388
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 237
Query: 448 AELLERCWQQDPALRPDFSEI 468
            +L+  CW  D   RP F+ +
Sbjct: 238 YDLMNLCWTYDVENRPGFAAV 258

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 217 EIDPKHLKFGSKV--------ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKE 264
           EI PK +    K+         SG++G + +G Y      + VA+K+LK E  +  ++ E
Sbjct: 5   EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
              E  +M+++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIEL 122
Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY 382
              VS GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 383 --RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 439
             +W APE I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGC 241
Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEI 468
           P     ++ +L+  CW  D   RP F+ +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 218 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 120
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 388
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 239
Query: 448 AELLERCWQQDPALRPDFSEI 468
            +L+  CW  D   RP F+ +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAV 260

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 142/258 (55%), Gaps = 15/258 (5%)
Query: 217 EIDPKHLKFGSKV--ASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMR 273
           E D ++ + G +V    G+YG +Y G   S  V I + + PER +S   +   +E+ + +
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHK 60
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKG 331
            ++HKN+VQ++G+ ++   + I  E + GGS+   L    G  K    ++      + +G
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 332 MNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEV 389
           + YLH N I+HRD+K  N+L++  + V+K++DFG + R+   +      TGT ++MAPE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 180
Query: 390 IEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIPKNSQ 444
           I+  P  Y   AD++S G  + E+ TGK P+  L   QAA   VG+ +  + P IP++  
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMS 238
Query: 445 PKLAELLERCWQQDPALR 462
            +    + +C++ DP  R
Sbjct: 239 AEAKAFILKCFEPDPDKR 256

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 218 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 388
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 448 AELLERCWQQDPALRPDFSEI 468
            +L+  CW  D   RP F+ +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAV 264

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 218 IDPKHLKFGSK-VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D K L    K + SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +++ +  +V+ IG C +  S  +V E    G +  YL + + V K  +++++   VS GM
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPE 388
            YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T G +  +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREM 243
Query: 448 AELLERCWQQDPALRPDFSEI 468
            +L+  CW  D   RP F+ +
Sbjct: 244 YDLMNLCWTYDVENRPGFAAV 264

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 23/279 (8%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 272
           I  +    G  +  G +G +       +D     VA+K+LK + I S   +EF +E   M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 273 RKVRHKNVVQFIGACTKP------PSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SL 321
           ++  H +V + +G   +       P   ++  FM  G ++ +L   +     F LP  +L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----TA 377
           ++  +D++ GM YL   N IHRDL A N ++ E+  V VADFG++R K  SG       A
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYYRQGCA 198
Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 436
                +W+A E +    Y   +DV++FG+ +WE++T G+ PY  +   +    ++  G R
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNR 257
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P     ++ +L+ +CW  DP  RP F+ +   L+ I
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 127/248 (51%), Gaps = 10/248 (4%)
Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GSYG +Y+  +    Q VAIK +    + SD+Q E  +E+ IM++    +VV++ G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQ-EIIKEISIMQQCDSPHVVKYYG 91
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +  K   L IV E+   GSV D +           +  +     KG+ YLH    IHRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           KA N+L++     K+ADFGVA ++           GT  WMAPEVI+   Y+  AD++S 
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALR 462
           GI   E+  GK PY  + P++ A+ ++     PT   P+       + +++C  + P  R
Sbjct: 212 GITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 463 PDFSEIIE 470
              +++++
Sbjct: 271 ATATQLLQ 278

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 221 KHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I++ 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 64
Query: 275 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +    +V++ G    P  P L +V E++  G + D+L + +       LL  +  + KGM
Sbjct: 65  LHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 388
            YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W APE
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------VQKG 434
            +    +  ++DV+SFG+VL+EL T          E+L  +     V         +++G
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 244
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
            R   P     ++ EL++ CW   P  RP FS +
Sbjct: 245 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 29/291 (9%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 265
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDF 58
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 379
               + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V     
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA-------- 426
               W APE +    +   +DV+SFG+VL+EL T        P E++  +          
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 427 --AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 157/331 (47%), Gaps = 54/331 (16%)
Query: 195 EDTGMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIK 250
           E T +K   Y +     G+     V     + +     +  G +G+++RG +  ++VA+K
Sbjct: 12  EGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVK 71
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVY 306
           +       S  ++    E++    +RH+N++ FI A  K       L +V+++   GS++
Sbjct: 72  IFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVV 358
           DYL++      +  ++K+A+  + G+ +LH           I HRDLK+ N+L+ +N   
Sbjct: 129 DYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
Query: 359 KVADFGVARVKAQSGVMTAE------TGTYRWMAPEVIE------HKPYDHKADVFSFGI 406
            +AD G+A V+  S   T +       GT R+MAPEV++      H     +AD+++ G+
Sbjct: 187 CIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245
Query: 407 VLWEL-----LTG-----KLPYEYLTPLQAAVG-----VVQKGLRPTIPKNSQP-----K 446
           V WE+     + G     +LPY  L P   +V      V ++ LRP IP   Q       
Sbjct: 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305
Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           +A+++  CW  + A R     I + L Q+++
Sbjct: 306 MAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 136/291 (46%), Gaps = 29/291 (9%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 265
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDF 58
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----GVMTAET 379
               + KGM YL     IHRDL   N+L++    VK+ DFG+ +V  Q      V     
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA-------- 426
               W APE +    +   +DV+SFG+VL+EL T        P E++  +          
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 427 --AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 68
Query: 289 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 338
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 339 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 390
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 391 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 429
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 245
Query: 430 VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 246 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 298

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 123/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VAIK++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL+R    +P  R   
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 259
Query: 466 SEIIE 470
            +I++
Sbjct: 260 EQIMK 264

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 93
Query: 289 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 338
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 339 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 390
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 391 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 429
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 270
Query: 430 VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 271 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 323

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 142/288 (49%), Gaps = 12/288 (4%)
Query: 187 SSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQ 245
            SSP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S 
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSS 55
Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
              + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++
Sbjct: 56  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG- 364
            D +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG 
Sbjct: 116 TDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 365 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
            A+V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL
Sbjct: 174 CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 233
Query: 425 QAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPDFSEIIE 470
           + A+ +++  L P +       P L   L+R   +DPA R   +E+++
Sbjct: 234 K-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 280

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 29/295 (9%)
Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDM 261
           +P    ++ + + +HLKF  ++  G++G +    Y        + VA+K L  +    + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEH 72
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLP 319
            ++F +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVM 375
            LL+    + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V 
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---- 426
                   W APE +    +   +DV+SFG+VL+EL T        P E++  +      
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 427 ------AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                  + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 70
Query: 289 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 338
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 339 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 390
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 391 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 429
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 247
Query: 430 VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 248 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 300

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 29/295 (9%)
Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDM 261
           +P    ++ + + +HLKF  ++  G++G +    Y        + VA+K L  +    + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEH 72
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLP 319
            ++F +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K      
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVM 375
            LL+    + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V 
Sbjct: 133 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---- 426
                   W APE +    +   +DV+SFG+VL+EL T        P E++  +      
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 252
Query: 427 ------AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                  + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 253 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 73
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 131
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 132 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 191
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 250
Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC + D   R    E+I+
Sbjct: 251 LNRCLEMDVEKRGSAKELIQ 270

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 73
Query: 289 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 338
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 339 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 390
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 391 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 429
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 250
Query: 430 VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 251 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 303

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 50/293 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  G +G+++RG +  ++VA+K+       S  ++    E++    +RH+N++ FI A  
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADN 67
Query: 289 KP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------ 338
           K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH        
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 339 --NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGTYRWMAPEVI 390
              I HRDLK+ N+L+ +N    +AD G+A V+  S   T +       GT R+MAPEV+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 391 E------HKPYDHKADVFSFGIVLWEL-----LTG-----KLPYEYLTPLQAAVG----- 429
           +      H     +AD+++ G+V WE+     + G     +LPY  L P   +V      
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 430 VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 123/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VAIK++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 138
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +      G +    G+  + APE+ + K YD  + DV+S G
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL+R    +P  R   
Sbjct: 199 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTL 256
Query: 466 SEIIE 470
            +I++
Sbjct: 257 EQIMK 261

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 135/277 (48%), Gaps = 28/277 (10%)
Query: 218 IDPKHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
            + +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 64
Query: 272 MRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
           ++ +    +V++ G    P   SL +V E++  G + D+L + +       LL  +  + 
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 385
           KGM YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W 
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------V 431
           APE +    +  ++DV+SFG+VL+EL T          E+L  + +   V         +
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           ++G R   P     ++ EL++ CW   P  RP FS +
Sbjct: 245 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 269
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 387
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 204
Query: 388 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 440
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 441 KNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 190
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC + D   R    E+++
Sbjct: 250 LNRCLEMDVEKRGSAKELLQ 269

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 31/286 (10%)
Query: 209 PNDGTDVWEIDPKHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQ 262
           P D T   E   +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q
Sbjct: 2   PQDPTIFEE---RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQ 56
Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 320
           ++F +E+ I++ +    +V++ G    P   SL +V E++  G + D+L + +       
Sbjct: 57  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 116
Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMT 376
           LL  +  + KGM YL     +HRDL A N+L++    VK+ADFG+A++    K    V  
Sbjct: 117 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV- 430
                  W APE +    +  ++DV+SFG+VL+EL T          E+L  +     V 
Sbjct: 177 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 236
Query: 431 --------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
                   +++G R   P     ++ EL++ CW   P  RP FS +
Sbjct: 237 ALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 269
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 387
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   ++  GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDSFIGTPYWMAP 204
Query: 388 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 440
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 441 KNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 218 IDPKHLKFGSKVASGSYG--DLYR----GTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
            + +HLK+ S++  G++G  +L R    G      VA+K L  +    D Q++F +E+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 77
Query: 272 MRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
           ++ +    +V++ G    P   SL +V E++  G + D+L + +       LL  +  + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 385
           KGM YL     +HRDL A N+L++    VK+ADFG+A++    K    V         W 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQAAVGV---------V 431
           APE +    +  ++DV+SFG+VL+EL T          E+L  +     V         +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           ++G R   P     ++ EL++ CW   P  RP FS +
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 132/253 (52%), Gaps = 7/253 (2%)
Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 278
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++++     + P  + +V E++SGG ++DY+ K  G        ++   +  G++Y H++
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH- 397
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 457
           + D++S G++L+ LL G LP++    +      +  G+  T P+   P +  LL+   Q 
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYT-PQYLNPSVISLLKHMLQV 253
Query: 458 DPALRPDFSEIIE 470
           DP  R    +I E
Sbjct: 254 DPMKRATIKDIRE 266

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 17/280 (6%)
Query: 200 KSHPY-HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN 258
           KS  Y H++   D  +VWEI         ++  G++G +Y+               E  +
Sbjct: 4   KSREYEHVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETKS 56
Query: 259 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
            +  +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      
Sbjct: 57  EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 377
           P +  V   + + +N+LH   IIHRDLKA N+LM     +++ADFGV+    ++     +
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 378 ETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 432
             GT  WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA- 235
Query: 433 KGLRPTI--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           K   PT+  P     +  + L+    ++P  RP  ++++E
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 141/286 (49%), Gaps = 12/286 (4%)
Query: 189 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDV 247
           SP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S   
Sbjct: 1   SPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSSGK 55
Query: 248 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 307
            + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++ D
Sbjct: 56  LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 115
Query: 308 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VA 366
            +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG  A
Sbjct: 116 IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 173
Query: 367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 426
           +V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL+ 
Sbjct: 174 QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK- 232
Query: 427 AVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPDFSEIIE 470
           A+ +++  L P +       P L   L+R   +DPA R   +E+++
Sbjct: 233 AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 278

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 28/278 (10%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 269
           EI    ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 80
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 314
            +  +++H NVV  +G  TK   L ++  + S G ++++L                 +K 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQ 371
             + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R       
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
             ++       RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +       +
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260
Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
             + + P  P +    +  L+  CW + P+ RP F +I
Sbjct: 261 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 73
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 131
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHR++K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 132 FLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 191
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 250
Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC + D   R    E+I+
Sbjct: 251 LNRCLEMDVEKRGSAKELIQ 270

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 137/270 (50%), Gaps = 26/270 (9%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 269
           D WEI         ++  G++G +Y+    +Q+    VL   ++    + +  +++  E+
Sbjct: 37  DFWEI-------IGELGDGAFGKVYK----AQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+    H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V     
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 387
             +NYLH N IIHRDLKA N+L   +  +K+ADFGV+  K    +   +   GT  WMAP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDXFIGTPYWMAP 204
Query: 388 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 440
           EV+     + +PYD+KADV+S GI L E+   + P+  L P++  + +  K   PT+  P
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQP 263
Query: 441 KNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                   + L++C +++   R   S++++
Sbjct: 264 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 59
Query: 268 EVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 240 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 143/287 (49%), Gaps = 14/287 (4%)
Query: 189 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDV 247
           SP  EP+    +     L++  D  D     P+ +L    K+  GS G +   T  S   
Sbjct: 46  SPQREPQRVSHEQFRAALQLVVDPGD-----PRSYLDNFIKIGEGSTGIVCIATVRSSGK 100
Query: 248 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 307
            + V K +      ++    EV IMR  +H+NVV+   +      L +V EF+ GG++ D
Sbjct: 101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160
Query: 308 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VA 366
            +   +       +  V + V + ++ LH   +IHRD+K+ ++L+  +  VK++DFG  A
Sbjct: 161 IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218
Query: 367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 426
           +V  +        GT  WMAPE+I   PY  + D++S GI++ E++ G+ PY    PL+ 
Sbjct: 219 QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK- 277
Query: 427 AVGVVQKGLRPTIPKN---SQPKLAELLERCWQQDPALRPDFSEIIE 470
           A+ +++  L P + KN     P L   L+R   +DPA R   +E+++
Sbjct: 278 AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 131/256 (51%), Gaps = 7/256 (2%)
Query: 219 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 21  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 80
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V + ++ LH 
Sbjct: 81  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHA 138
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY 
Sbjct: 139 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERC 454
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P +       P L   L+R 
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 257
Query: 455 WQQDPALRPDFSEIIE 470
             +DPA R   +E+++
Sbjct: 258 LVRDPAQRATAAELLK 273

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 10  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 67
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 248 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 131/256 (51%), Gaps = 7/256 (2%)
Query: 219 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 277
           DP+ +L    K+  GS G +   T  S    + V K +      ++    EV IMR  +H
Sbjct: 17  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           +NVV+   +      L +V EF+ GG++ D +   +       +  V + V + ++ LH 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHA 134
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
             +IHRD+K+ ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERC 454
            + D++S GI++ E++ G+ PY    PL+ A+ +++  L P +       P L   L+R 
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 253
Query: 455 WQQDPALRPDFSEIIE 470
             +DPA R   +E+++
Sbjct: 254 LVRDPAQRATAAELLK 269

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 63
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 133/278 (47%), Gaps = 28/278 (10%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 269
           EI    ++F  ++    +G +Y+G          +Q VAIK LK ++    +++EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 63
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 314
            +  +++H NVV  +G  TK   L ++  + S G ++++L                 +K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQ 371
             + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R       
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 430
             ++       RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +       +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
             + + P  P +    +  L+  CW + P+ RP F +I
Sbjct: 244 RNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        + A  G   + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 466 SEIIE 470
            +I++
Sbjct: 259 EQIMK 263

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 60
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 58
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 128/247 (51%), Gaps = 8/247 (3%)
Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           K+  GS G +   T  S    + V K +      ++    EV IMR  +H+NVV+   + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
                L +V EF+ GG++ D +   +       +  V + V + ++ LH   +IHRD+K+
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 348 ANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 406
            ++L+  +  VK++DFG  A+V  +        GT  WMAPE+I   PY  + D++S GI
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 335
Query: 407 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN---SQPKLAELLERCWQQDPALRP 463
           ++ E++ G+ PY    PL+ A+ +++  L P + KN     P L   L+R   +DPA R 
Sbjct: 336 MVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRA 393
Query: 464 DFSEIIE 470
             +E+++
Sbjct: 394 TAAELLK 400

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 9   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 66
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 247 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 34  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 91
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 8   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 65
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 246 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 219 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 273
           DPK  + +F  K+  G+ G +Y        Q+VAI+ +    +    +KE    E+ +MR
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           + ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 130
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +LH N +IHRD+K+ N+L+  +  VK+ DFG  A++  +    +   GT  WMAPEV+  
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR 190
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 450
           K Y  K D++S GI+  E++ G+ PY    PL+A   +   G  P +  P+       + 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 451 LERCWQQDPALRPDFSEIIE 470
           L RC   D   R    E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 7   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 64
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 245 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H++   D  +VWEI         ++  G++G +Y+               E  + +  ++
Sbjct: 2   HVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 54
Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
           +  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P +  V
Sbjct: 55  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 114
Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYR 383
              + + +N+LH   IIHRDLKA N+LM     +++ADFGV+    ++     +  GT  
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 384 WMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
           WMAPEV+     +  PYD+KAD++S GI L E+   + P+  L P++  + +  K   PT
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPT 233
Query: 439 I--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           +  P     +  + L+    ++P  RP  ++++E
Sbjct: 234 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 272
           W+   + LK   ++  G+YG + +  +    Q +A+K ++   ++   QK+   ++  +M
Sbjct: 17  WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVM 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHK-LKGVFKLPSLLKVAIDVS 329
           R      +VQF GA  +     I  E MS      Y Y++  L  V     L K+ +   
Sbjct: 76  RSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 330 KGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           K +N+L +N  IIHRD+K +N+L+D +  +K+ DFG++     S   T + G   +MAPE
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 389 VIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
            I+     + YD ++DV+S GI L+EL TG+ PY     +   +  V KG  P +  + +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 445 ----PKLAELLERCWQQDPALRPDFSEIIE 470
               P     +  C  +D + RP + E+++
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 63
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ EF+  GS+ +YL K K       LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 134/255 (52%), Gaps = 11/255 (4%)
Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 278
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++++     + P    +V E++SGG ++DY+ K   V ++ +  ++   +   ++Y H++
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRH 130
Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH- 397
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 398 KADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
           + D++S G++L+ LL G LP+  E++  L   +    +G    IP+     +A LL    
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHML 246
Query: 456 QQDPALRPDFSEIIE 470
           Q DP  R    +I E
Sbjct: 247 QVDPLKRATIKDIRE 261

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 466 SEIIE 470
            +I++
Sbjct: 259 EQIMK 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 466 SEIIE 470
            +I++
Sbjct: 259 EQIMK 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G+  W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE 179
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 237
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 238 DLISRLLKHNPSQRPMLREVLE 259

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 134/255 (52%), Gaps = 11/255 (4%)
Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHK 278
           H   G  +  G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++++     + P    +V E++SGG ++DY+ K   V ++ +  ++   +   ++Y H++
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRH 130
Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH- 397
            ++HRDLK  N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 398 KADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
           + D++S G++L+ LL G LP+  E++  L   +    +G    IP+     +A LL    
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----RGGVFYIPEYLNRSVATLLMHML 246
Query: 456 QQDPALRPDFSEIIE 470
           Q DP  R    +I E
Sbjct: 247 QVDPLKRATIKDIRE 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVA-HGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 133
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 134 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 193
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 194 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 251
Query: 466 SEIIE 470
            +I++
Sbjct: 252 EQIMK 256

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKV 192
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 251 SQRPXLREVLE 261

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA++++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 466 SEIIE 470
            +I++
Sbjct: 259 EQIMK 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 265 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 314
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                  ++V  D  + +N+ HQN IIHRD+K AN+L+     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGN 171
Query: 375 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 427
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 141/292 (48%), Gaps = 50/292 (17%)
Query: 230 ASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 289
           A G +G +++    ++ VA+K+  P +     Q E+  EV+ +  ++H+N++QFIGA  +
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 290 PPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN------- 338
             S    L ++T F   GS+ D+L     V     L  +A  +++G+ YLH++       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 339 ---NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIE 391
               I HRD+K+ N+L+  N    +ADFG+A +K ++G    +T    GT R+MAPEV+E
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 392 -----HKPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPLQAAVG-----------V 430
                 +    + D+++ G+VLWEL +          EY+ P +  +G           V
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV 266
Query: 431 VQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           V K  RP +    Q       L E +E CW  D   R     + E + Q+ +
Sbjct: 267 VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 229 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G C
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN---NII 341
             P    +V  +M+ GSV   L +    +     P   ++A+  ++G+ YLH +    II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           HRD+KAAN+L+DE     V DFG+A++       V  A  GT   +APE +       K 
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKT 224
Query: 400 DVFSFGIVLWELLTGKLPYEY-----------------LTPLQAAVGVVQKGLRPTIPKN 442
           DVF +G++L EL+TG+  ++                  L   +    +V   L+      
Sbjct: 225 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 284
Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
              +L ++   C Q  P  RP  SE++ +L+
Sbjct: 285 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 125/246 (50%), Gaps = 12/246 (4%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G +   T+    Q VA+K +  + +  SDM     +E+  ++ +RH ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
             T P  + +V E+ +GG ++DY+ + K + +     +    +   + Y H++ I+HRDL
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRHKIVHRDL 134
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 404
           K  NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 405 GIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           GIVL+ +L G+LP+  E++  L   V          +P    P    L+ R    DP  R
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQR 250
Query: 463 PDFSEI 468
               EI
Sbjct: 251 ITIQEI 256

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 154
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 213
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 271
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 272 SQRPMLREVLE 282

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR-----ADLARD 52
Query: 265 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 314
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 375 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 427
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 124/245 (50%), Gaps = 6/245 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA++++   ++NS   ++  +EV IM+ + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 465
           ++L+ L++G LP++     +    V++   R  IP         LL++    +P+ R   
Sbjct: 201 VILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTL 258
Query: 466 SEIIE 470
            +I++
Sbjct: 259 EQIMK 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 127
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 186
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 187 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 244
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 245 SQRPMLREVLE 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 145
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 204
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 205 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 262
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 263 SQRPMLREVLE 273

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR-----ADLARD 52
Query: 265 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 314
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 375 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 427
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GPRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 132
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 192 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 249
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 250 SQRPMLREVLE 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 4   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 61
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----GVMTAETGT 381
             + KGM YL     IHR+L   N+L++    VK+ DFG+ +V  Q      V       
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 242 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++NS   ++  +EV I + + H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVA-HGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        + A  G   + APE+ + K YD  + DV+S G
Sbjct: 141 AENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 406 IVLWELLTGKLPYE 419
           ++L+ L++G LP++
Sbjct: 201 VILYTLVSGSLPFD 214

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 192
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 25/244 (10%)
Query: 198 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI 257
           G+     H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+    
Sbjct: 13  GLVPRGSHMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRLHRDVAVKVLR---- 63
Query: 258 NSDMQKE------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYD 307
            +D+ ++      F +E      + H  +V     G    P  P   IV E++ G ++ D
Sbjct: 64  -ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 122
Query: 308 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
            +H  +G       ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR
Sbjct: 123 IVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 368 VKAQSGVMTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
             A SG    +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
Query: 424 LQAA 427
           +  A
Sbjct: 242 VSVA 245

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLYRGTYCSQD--VAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y      +   +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 125
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 184
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 185 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 242
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 243 SQRPMLREVLE 253

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 265 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 314
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 375 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 427
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG +   A S   T  +GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKV 188
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 145/293 (49%), Gaps = 54/293 (18%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 287
           V  G YG+++RG++  ++VA+K+        D +  F + E++    +RH+N++ FI + 
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 288 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 336
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 337 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 390
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 391 EHK----PYD--HKADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 427
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 278
Query: 428 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 475
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 279 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 53/279 (18%)
Query: 230 ASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 289
           A G +G +++    +  VA+K+  P +     Q E  +E+F    ++H+N++QFI A  +
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIF-PLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKR 80
Query: 290 PPSL----CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN------ 338
             +L     ++T F   GS+ DYL   KG +     L  VA  +S+G++YLH++      
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 339 -----NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEV 389
                +I HRD K+ N+L+  +    +ADFG+A V+ + G    +T    GT R+MAPEV
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 390 IE-----HKPYDHKADVFSFGIVLWELLT----GKLPY-EYLTPLQAAVG---------- 429
           +E      +    + D+++ G+VLWEL++       P  EY+ P +  +G          
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQE 256
Query: 430 -VVQKGLRPTIPKN--SQPKLAEL---LERCWQQDPALR 462
            VV K +RPTI  +    P LA+L   +E CW  D   R
Sbjct: 257 VVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 53  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 106
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 107 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 225
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 226 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 370
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 371 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKK 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S    A  GT  ++ PE+IE + +D K 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  Q     + + +  T P        +L+ R  + +P
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANT-YQDTYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 245
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 246 SQRPMLREVLE 256

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 55  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 108
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 109 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 168
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 227
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 228 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 55  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 108
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 109 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 168
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 169 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 227
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 228 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 284
           K+  GS G   L R  +  + VA+K++    +    ++E    EV IMR  +H NVV+  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +      L ++ EF+ GG++ D + +++       +  V   V + + YLH   +IHRD
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 345 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           +K+ ++L+  +  VK++DFG  A++           GT  WMAPEVI    Y  + D++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQ---PKLAELLERCWQQ 457
            GI++ E++ G+ PY   +P+QA      K LR + P   KNS    P L + LER   +
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 458 DPALRPDFSEIIE 470
           DP  R    E+++
Sbjct: 282 DPQERATAQELLD 294

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 133/272 (48%), Gaps = 14/272 (5%)
Query: 206 LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDM 261
           LK P+     ++ DP+ L F    ++  GS+G +Y  R    S+ VAIK +      S+ 
Sbjct: 38  LKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 96
Query: 262 Q-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 320
           + ++  +EV  ++K+RH N +Q+ G   +  +  +V E+  G S  D L   K   +   
Sbjct: 97  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 155
Query: 321 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
           +  V     +G+ YLH +N+IHRD+KA N+L+ E  +VK+ DFG A + A +       G
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VG 212
Query: 381 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 437
           T  WMAPEVI   +   YD K DV+S GI   EL   K P   +  + A   + Q     
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 272
Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
               +        ++ C Q+ P  RP  SE++
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVL 303

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 370
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 371 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 59  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 112
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 113 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 172
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 173 YDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 231
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 232 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 370
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 371 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 146/293 (49%), Gaps = 54/293 (18%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 287
           V  G YG+++RG++  ++VA+K+      + D +  F + E++    +RH+N++ FI + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 288 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 336
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 337 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 390
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 391 EHK----PYD--HKADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 427
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 428 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 475
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 250 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 77  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 130
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 131 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 190
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 191 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 249
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 250 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 4/167 (2%)
Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 370
           K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR   K 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 371 QSGVMTAETGT-YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              V   +     +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +   
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  +
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 146/293 (49%), Gaps = 54/293 (18%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGAC 287
           V  G YG+++RG++  ++VA+K+      + D +  F + E++    +RH+N++ FI + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 288 T----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 336
                    L ++T +   GS+YDYL          S L++ + ++ G+ +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 337 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 390
            +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R+MAPEV+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 391 EHK----PYD--HKADVFSFGIVLWE----LLTGKLPYEYLTP-------------LQAA 427
           +       +D   + D+++FG+VLWE    +++  +  +Y  P             ++  
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 428 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQI 475
           V V Q+  RP IP    S P    LA+L++ CW Q+P+ R     I + L +I
Sbjct: 250 VCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G++    L R     ++VA+K++   ++N    ++  +EV IM+ + H N+V+    
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                +L +V E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLK
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLK 141
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFG 405
           A NLL+D +  +K+ADFG +        +    G+  + APE+ + K YD  + DV+S G
Sbjct: 142 AENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 406 IVLWELLTGKLPYE 419
           ++L+ L++G LP++
Sbjct: 202 VILYTLVSGSLPFD 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 251 VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
           +LKP +     +++ + E+ I R + H++VV F G       + +V E     S+ + LH
Sbjct: 79  LLKPHQ-----REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LH 132
Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVK 369
           K +     P        +  G  YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
                     GT  ++APEV+  K +  + DV+S G +++ LL GK P+E  + L+    
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL 251
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 469
            ++K    +IPK+  P  A L+++  Q DP  RP  +E++
Sbjct: 252 RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+A+FG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 131/253 (51%), Gaps = 15/253 (5%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+ SG+YG+  L R      + AIK+++   +++    +  +EV +++ + H N+++   
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 286 ACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                 +  +V E   GG ++D  +H++K  F       +   V  G+ YLH++NI+HRD
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 345 LKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
           LK  NLL++  E   ++K+ DFG++ V      M    GT  ++APEV+  K YD K DV
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP----KNSQPKLAELLERCWQQ 457
           +S G++L+ LL G  P+   T  Q  +  V+KG + T      KN      +L+++  Q 
Sbjct: 221 WSIGVILFILLAGYPPFGGQTD-QEILRKVEKG-KYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 458 DPALRPDFSEIIE 470
           D   R    + +E
Sbjct: 279 DSQRRISAQQALE 291

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 130
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+A+FG + V A S   T   GT  ++ PE+IE + +D K 
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 189
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 247
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 248 SQRPMLREVLE 258

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G+  W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 4   GSRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE 179
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 237
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 238 DLISRLLKHNPSQRPMLREVLE 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 129/262 (49%), Gaps = 9/262 (3%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQE 268
           G   W ++    + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +E
Sbjct: 1   GKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           V I   +RH N+++  G       + ++ E+   G+VY  L KL   F          ++
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           +  ++Y H   +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE 176
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           +IE + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGAR 234
Query: 449 ELLERCWQQDPALRPDFSEIIE 470
           +L+ R  + +P+ RP   E++E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLE 256

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 132/289 (45%), Gaps = 29/289 (10%)
Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D  + + +HLKF  ++  G++G +    Y        + VA+K L  +    +  ++F +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER 63
Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL           LL+  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGT 381
             + KGM YL     IHRDL   N+L++    VK+ DFG+ +V    K    V       
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYLTPLQA---------- 426
             W APE +    +   +DV+SFG+VL+EL T        P E++  +            
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 244 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 229 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G C
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN---NII 341
             P    +V  +M+ GSV   L +    +     P   ++A+  ++G+ YLH +    II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           HRD+KAAN+L+DE     V DFG+A++       V  A  G    +APE +       K 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKT 216
Query: 400 DVFSFGIVLWELLTGKLPYEY-----------------LTPLQAAVGVVQKGLRPTIPKN 442
           DVF +G++L EL+TG+  ++                  L   +    +V   L+      
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
              +L ++   C Q  P  RP  SE++ +L+
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 188
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 247 SQRPMLREVLE 257

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 124/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G VY  L KL   F          +++  ++Y H   
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCHSKR 133
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKV 192
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 250
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 251 SQRPMLREVLE 261

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 25/233 (10%)
Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE 264
           H+  P+  +D +E+  + L FG      S   L R     +DVA+KVL+     +D+ ++
Sbjct: 3   HMTTPSHLSDRYELG-EILGFGGM----SEVHLARDLRDHRDVAVKVLR-----ADLARD 52
Query: 265 ------FAQEVFIMRKVRHKNVVQF--IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKG 314
                 F +E      + H  +V     G    P  P   IV E++ G ++ D +H  +G
Sbjct: 53  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG 111
Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                  ++V  D  + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 375 MTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
              +T    GT ++++PE       D ++DV+S G VL+E+LTG+ P+   +P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 130
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 189
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 247
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 248 SQRPMLREVLE 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 131
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 190
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ R  + +P
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 249 SQRPMLREVLE 259

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 122/248 (49%), Gaps = 11/248 (4%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 284
           ++  GS+G +Y  R    S+ VAIK +      S+ + ++  +EV  ++K+RH N +Q+ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
           G   +  +  +V E+  G S  D L   K   +   +  V     +G+ YLH +N+IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 401
           +KA N+L+ E  +VK+ DFG A + A +       GT  WMAPEVI   +   YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 461
           +S GI   EL   K P   +  + A   + Q         +        ++ C Q+ P  
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 462 RPDFSEII 469
           RP  SE++
Sbjct: 258 RPT-SEVL 264

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 7/251 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++  G       + ++ E+   G+VY  L KL   F          +++  ++Y H   
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR 154
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + +D K 
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 213
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           D++S G++ +E L GK P+E  T  Q     + + +  T P        +L+ R  + +P
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANT-YQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 271
Query: 460 ALRPDFSEIIE 470
           + RP   E++E
Sbjct: 272 SQRPMLREVLE 282

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 13/261 (4%)
Query: 219 DPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           D + LKF  ++  GS+  +Y+G  T  + +VA   L+  ++    ++ F +E   ++ ++
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 277 HKNVVQFIGA--CTKPPSLCIV--TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           H N+V+F  +   T     CIV  TE  + G++  YL + K V K+  L      + KG+
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGL 142
Query: 333 NYLHQNN--IIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
            +LH     IIHRDLK  N+ +      VK+ D G+A +K ++    A  GT  + APE 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFXAPEX 201
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLA 448
            E K YD   DV++FG    E  T + PY            V  G++P +  K + P++ 
Sbjct: 202 YEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 449 ELLERCWQQDPALRPDFSEII 469
           E++E C +Q+   R    +++
Sbjct: 261 EIIEGCIRQNKDERYSIKDLL 281

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 135/287 (47%), Gaps = 52/287 (18%)
Query: 221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
           K ++   ++  G YG+++ G +  + VA+KV    E  +   + E  Q V +    RH+N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM----RHEN 92
Query: 280 VVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           ++ FI A  K       L ++T++   GS+YDYL          S+LK+A     G+ +L
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHL 150
Query: 336 HQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE------TGT 381
           H           I HRDLK+ N+L+ +N    +AD G+A VK  S     +       GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVGT 209
Query: 382 YRWMAPEVIE------HKPYDHKADVFSFGIVLWEL----LTG------KLPYEYLTPLQ 425
            R+M PEV++      H      AD++SFG++LWE+    ++G      +LPY  L P  
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 426 AAVG-----VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALR 462
            +       V  K LRP+ P          ++ +L+  CW  +PA R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + +V E+ +G  ++DY+ +   + +  +  +    +   + Y H++ I+HRDL
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKIVHRDL 138
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 404
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 139 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 461
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 199 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253
Query: 462 RPDFSEIIE 470
           R    EI++
Sbjct: 254 RISIHEIMQ 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + +V E+ +G  ++DY+ +   + +  +  +    +   + Y H++ I+HRDL
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKIVHRDL 139
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 404
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 140 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 199
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 461
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 200 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 254
Query: 462 RPDFSEIIE 470
           R    EI++
Sbjct: 255 RISIHEIMQ 263

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 128/249 (51%), Gaps = 14/249 (5%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + +V E+ +G  ++DY+ + +         +    +   + Y H++ I+HRDL
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 133
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 404
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 134 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 193
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 461
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 194 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 248
Query: 462 RPDFSEIIE 470
           R    EI++
Sbjct: 249 RISIHEIMQ 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G   L   T   Q VA+K++  + +  SDMQ    +E+  +R +RH ++++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + +V E+ +G  ++DY+ +   + +  +  +    +   + Y H++ I+HRDL
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKIVHRDL 129
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSF 404
           K  NLL+DE+  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S 
Sbjct: 130 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 189
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELLERCWQQDPAL 461
           G++L+ +L  +LP++       ++ V+ K +     T+PK   P  A L++R    +P  
Sbjct: 190 GVILYVMLCRRLPFD-----DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 462 RPDFSEIIE 470
           R    EI++
Sbjct: 245 RISIHEIMQ 253

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 119/237 (50%), Gaps = 8/237 (3%)
Query: 229 VASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           + +GS+G   L R  +  +  A+KVLK E +    Q E    E  ++  V H  +++  G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + ++ +++ GG ++  L K +  F  P     A +V   + YLH  +II+RDL
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDL 132
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 405
           K  N+L+D+N  +K+ DFG A  K    V     GT  ++APEV+  KPY+   D +SFG
Sbjct: 133 KPENILLDKNGHIKITDFGFA--KYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           I+++E+L G  P+     ++    ++   LR   P      + +LL R   +D + R
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 229 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 347 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 404 FGIVLWELLTGKLPY 418
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 219 DPK-HLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRK 274
           DP+ +L    K+  GS G +   T  +  + VA+K +    +    ++E    EV IMR 
Sbjct: 42  DPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 98
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
             H NVV    +      L +V EF+ GG++ D +   +       +  V + V + ++Y
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSY 156
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           LH   +IHRD+K+ ++L+  +  +K++DFG  A+V  +        GT  WMAPEVI   
Sbjct: 157 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL 216
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 426
           PY  + D++S GI++ E++ G+ PY    PLQA
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 249

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 15/260 (5%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D     F   + SG++G   L R     + VA+K + +   I+ ++Q+E        R +
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSL 73
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L I+ E+ SGG +Y+ +    G F           +  G++Y 
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYC 132
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   I HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  +
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQ--PKLA 448
            YD K ADV+S G+ L+ +L G  P+E     +     +Q+   ++ +IP + +  P+  
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 449 ELLERCWQQDPALRPDFSEI 468
            L+ R +  DPA R    EI
Sbjct: 253 HLISRIFVADPATRISIPEI 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 124/248 (50%), Gaps = 7/248 (2%)
Query: 226 GSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
             G       + ++ E+   G+VY  L KL   F          +++  ++Y H   +IH
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           RD+K  NLL+  N  +K+ADFG + V A S   T   GT  ++ PE+IE + +D K D++
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 194
Query: 403 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           S G++ +E L G  P+E  T  +    + +  +  T P        +L+ R  + + + R
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 463 PDFSEIIE 470
              +E++E
Sbjct: 253 LTLAEVLE 260

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 129/260 (49%), Gaps = 17/260 (6%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIK-VLKPERINSDMQKEFAQEVFI 271
           + +I  +  K   K+  G    +Y    T  +  VAIK +  P R   +  K F +EV  
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
             ++ H+N+V  I    +     +V E++ G ++ +Y+    G   + + +     +  G
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDG 123
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEV 389
           + + H   I+HRD+K  N+L+D N+ +K+ DFG+A+  +++ +       GT ++ +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------LRPTIPKN 442
            + +  D   D++S GIVL+E+L G+ P+   T +  A+  +Q         +R  IP++
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 443 SQPKLAELLERCWQQDPALR 462
               L+ ++ R  ++D A R
Sbjct: 244 ----LSNVILRATEKDKANR 259

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 229 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 347 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 404 FGIVLWELLTGKLPY 418
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 229 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                S  IV E  +GG ++D + K K  F      ++   V  G+ Y+H++NI+HRDLK
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 347 AANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
             N+L++  E    +K+ DFG++    Q+  M    GT  ++APEV+    YD K DV+S
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWS 207
Query: 404 FGIVLWELLTGKLPY 418
            G++L+ LL+G  P+
Sbjct: 208 AGVILYILLSGTPPF 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 221 KHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVR 276
           K   F   + SG++ +++  +     +  A+K +K  P   +S ++ E A    +++K++
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA----VLKKIK 64
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H+N+V             +V + +SGG ++D + + +GV+       V   V   + YLH
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLH 123
Query: 337 QNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           +N I+HRDLK  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  K
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQK 182
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
           PY    D +S G++ + LL G  P+
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 221 KHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           K  +F   + +G++ +  L       +  A+K + P++     +     E+ ++RK++H+
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCI-PKKALKGKESSIENEIAVLRKIKHE 80
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+V        P  L +V + +SGG ++D + + KG +       +   V   + YLH+ 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVE-KGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 339 NIIHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
            I+HRDLK  NLL    DE   + ++DFG+++++ +  VM+   GT  ++APEV+  KPY
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 396 DHKADVFSFGIVLWELLTGKLPY 418
               D +S G++ + LL G  P+
Sbjct: 200 SKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 219 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 267
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 78
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 79  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 386
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 252
Query: 447 LAELLERCWQQDPALR 462
              LL   ++++PA R
Sbjct: 253 AQSLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 219 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 267
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 78
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 79  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 386
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 252
Query: 447 LAELLERCWQQDPALR 462
              LL   ++++PA R
Sbjct: 253 AQSLLRMLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 219 DPKHLKFGSKVASGSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQ 267
           DP   +    +  GS+G ++      G+   Q  A+KVLK       +R+ + M+++   
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--- 79
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
              I+ +V H  +V+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 80  ---ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 135
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 386
           ++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PEV+  + +   AD +SFG++++E+LTG LP++     +    +++  L   +P+   P+
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--GMPQFLSPE 253
Query: 447 LAELLERCWQQDPALR 462
              LL   ++++PA R
Sbjct: 254 AQSLLRMLFKRNPANR 269

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 123/248 (49%), Gaps = 7/248 (2%)
Query: 226 GSKVASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           G  +  G +G++Y  R       +A+KVL K +   + ++ +  +EV I   +RH N+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
             G       + ++ E+   G+VY  L KL   F          +++  ++Y H   +IH
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           RD+K  NLL+  N  +K+ADFG + V A S       GT  ++ PE+IE + +D K D++
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLW 194
Query: 403 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           S G++ +E L G  P+E  T  +    + +  +  T P        +L+ R  + + + R
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 463 PDFSEIIE 470
              +E++E
Sbjct: 253 LTLAEVLE 260

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 10/259 (3%)
Query: 218 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 271
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 390
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL 214
Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 272
Query: 451 LERCWQQDPALRPDFSEII 469
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 138/268 (51%), Gaps = 25/268 (9%)
Query: 219 DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKP------ERINSDMQKEFAQ 267
           DP H +    +  GS+G ++     ++       A+KVLK       +R+ + M+++   
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD--- 82
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
              I+  V H  VV+   A      L ++ +F+ GG ++  L K + +F    +     +
Sbjct: 83  ---ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 138
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMA 386
           ++ G+++LH   II+RDLK  N+L+DE   +K+ DFG+++          +  GT  +MA
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PEV+  + + H AD +S+G++++E+LTG LP++     +    +++  L   +P+    +
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKL--GMPQFLSTE 256
Query: 447 LAELLERCWQQDPALR----PDFSEIIE 470
              LL   ++++PA R    PD +E I+
Sbjct: 257 AQSLLRALFKRNPANRLGSGPDGAEEIK 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 10/259 (3%)
Query: 218 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 271
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 390
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A +++          GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL 214
Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 272
Query: 451 LERCWQQDPALRPDFSEII 469
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 10/259 (3%)
Query: 218 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 271
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 20  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 80  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 138
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVI 390
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A      G    +  GT  ++APEV+
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 198
Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 256
Query: 451 LERCWQQDPALRPDFSEII 469
           + R    DP LRP  +E++
Sbjct: 257 IRRMLHADPTLRPSVAELL 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 10/259 (3%)
Query: 218 IDPKHLKF---GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKE-FAQEVFI 271
           +DP+ +K    G  +  G +   Y  T     +  A KV+    +    QKE  + E+ I
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            + + + +VV F G       + +V E     S+ + LHK +     P          +G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQG 154
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVI 390
           + YLH N +IHRDLK  NL ++++  VK+ DFG+A      G    +  GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 214
Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K +  + D++S G +L+ LL GK P+E  T       +  K    ++P++  P  + L
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFE--TSCLKETYIRIKKNEYSVPRHINPVASAL 272
Query: 451 LERCWQQDPALRPDFSEII 469
           + R    DP LRP  +E++
Sbjct: 273 IRRMLHADPTLRPSVAELL 291

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 129/256 (50%), Gaps = 8/256 (3%)
Query: 220 PKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKV 275
           P    F   +  GS+G +    + +++V  A+KVL+ + I    +++   ++   +++ V
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           +H  +V    +      L  V ++++GG ++ +L + +  F  P     A +++  + YL
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL 155
Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP 394
           H  NI++RDLK  N+L+D    + + DFG+ +   +    T+   GT  ++APEV+  +P
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLE 452
           YD   D +  G VL+E+L G  P+      +    ++ K   L+P I  +++  L  LL+
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 275
Query: 453 RCWQQDPALRPDFSEI 468
           +   +    + DF EI
Sbjct: 276 KDRTKRLGAKDDFMEI 291

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 32/267 (11%)
Query: 229 VASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           +  G +G +Y+G       VA+K   PE  +S   +EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL-------LKVAIDVSKGMNYLHQNNI 340
            +   + ++ ++M  G++  +L+       LP++       L++ I  ++G++YLH   I
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDH 397
           IHRD+K+ N+L+DEN V K+ DFG+++   + G   +     GT  ++ PE         
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 398 KADVFSFGIVLWELLTGK------LPYEYLTPLQAAV-----GVVQKGLRPTIPKNSQP- 445
           K+DV+SFG+VL+E+L  +      LP E +   + AV     G +++ + P +    +P 
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 446 ---KLAELLERCWQQDPALRPDFSEII 469
              K  +   +C       RP   +++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 32/267 (11%)
Query: 229 VASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 287
           +  G +G +Y+G       VA+K   PE  +S   +EF  E+  +   RH ++V  IG C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL-------LKVAIDVSKGMNYLHQNNI 340
            +   + ++ ++M  G++  +L+       LP++       L++ I  ++G++YLH   I
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKA---QSGVMTAETGTYRWMAPEVIEHKPYDH 397
           IHRD+K+ N+L+DEN V K+ DFG+++      Q+ +     GT  ++ PE         
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 398 KADVFSFGIVLWELLTGK------LPYEYLTPLQAAV-----GVVQKGLRPTIPKNSQP- 445
           K+DV+SFG+VL+E+L  +      LP E +   + AV     G +++ + P +    +P 
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 446 ---KLAELLERCWQQDPALRPDFSEII 469
              K  +   +C       RP   +++
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 127/268 (47%), Gaps = 31/268 (11%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D    +    + +G++G   L R    ++ VA+K + + E+I+ ++++E        R +
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSL 72
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYA 131
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   + HRDLK  N L+D +    +K+ADFG ++         +  GT  ++APEV+  K
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQ------ 444
            YD K ADV+S G+ L+ +L G  P+E   P +       K  R TI +  N Q      
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEP------KNFRKTIHRILNVQYAIPDY 243
Query: 445 ----PKLAELLERCWQQDPALRPDFSEI 468
               P+   L+ R +  DPA R    EI
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 126/268 (47%), Gaps = 31/268 (11%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D    +    + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 71
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 130
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQ------ 444
            YD K ADV+S G+ L+ +L G  P+E   P +       K  R TI +  N Q      
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFE--DPEEP------KNFRKTIHRILNVQYAIPDY 242
Query: 445 ----PKLAELLERCWQQDPALRPDFSEI 468
               P+   L+ R +  DPA R    EI
Sbjct: 243 VHISPECRHLISRIFVADPAKRISIPEI 270

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 15/260 (5%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D    +    + SG++G   L R    ++ VA+K + + E+I +++++E        R +
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSL 72
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 131
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   + HRDLK  N L+D +    +K+ DFG ++         +  GT  ++APEV+  K
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLA 448
            YD K ADV+S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+  
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 449 ELLERCWQQDPALRPDFSEI 468
            L+ R +  DPA R    EI
Sbjct: 252 HLISRIFVADPAKRISIPEI 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQK-EFAQEVFIMRKVRHKNVVQFI 284
           K+ SG+YG+  L +      + AIK++K   + +         EV +++++ H N+++  
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  +  +V E   GG ++D +  L+  F       +   V  G  YLH++NI+HRD
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 345 LKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
           LK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K DV
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 188
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 434
           +S G++L+ LL G  P+   T  Q  +  V+KG
Sbjct: 189 WSCGVILYILLCGYPPFGGQTD-QEILKRVEKG 220

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 346 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 234
Query: 403 SFGIVLWELLTGKLPY 418
           S G++L+ LL+G  P+
Sbjct: 235 STGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 346 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 235
Query: 403 SFGIVLWELLTGKLPY 418
           S G++L+ LL+G  P+
Sbjct: 236 STGVILYILLSGCPPF 251

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYR-----GTYCSQDVAIKVLKPERI--NSDMQKEFAQEV 269
           +I P+  +    +  G YG +++     G    +  A+KVLK   I  N+        E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+ +V+H  +V  I A      L ++ E++SGG ++  L + +G+F   +      ++S
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEIS 131
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPE 388
             + +LHQ  II+RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++    ++   D +S G +++++LTG  P+
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 135 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 194
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-- 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R  
Sbjct: 195 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLG 252
Query: 463 ---PDFSEIIE 470
               D  E++E
Sbjct: 253 GGPSDAKEVME 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 346 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 403 SFGIVLWELLTGKLPY 418
           S G++L+ LL+G  P+
Sbjct: 212 STGVILYILLSGCPPF 227

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYR-----GTYCSQDVAIKVLKPERI--NSDMQKEFAQEV 269
           +I P+  +    +  G YG +++     G    +  A+KVLK   I  N+        E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            I+ +V+H  +V  I A      L ++ E++SGG ++  L + +G+F   +      ++S
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEIS 131
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPE 388
             + +LHQ  II+RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++    ++   D +S G +++++LTG  P+
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 9/213 (4%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQK-EFAQEVFIMRKVRHKNVVQFI 284
           K+ SG+YG+  L +      + AIK++K   + +         EV +++++ H N+++  
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  +  +V E   GG ++D +  L+  F       +   V  G  YLH++NI+HRD
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 345 LKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
           LK  NLL++    + ++K+ DFG++      G M    GT  ++APEV+  K YD K DV
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 205
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 434
           +S G++L+ LL G  P+   T  Q  +  V+KG
Sbjct: 206 WSCGVILYILLCGYPPFGGQTD-QEILKRVEKG 237

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 111/198 (56%), Gaps = 10/198 (5%)
Query: 229 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 282
           +  GS+G +     +GT   +  AIK+LK + +  + D++    ++  +    +   + Q
Sbjct: 27  LGKGSFGKVMLADRKGT--EELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                     L  V E+++GG +  ++ ++ G FK P  +  A ++S G+ +LH+  II+
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+++D    +K+ADFG+ +     GV T E  GT  ++APE+I ++PY    D 
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 402 FSFGIVLWELLTGKLPYE 419
           +++G++L+E+L G+ P++
Sbjct: 204 WAYGVLLYEMLAGQPPFD 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-- 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R  
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 463 ---PDFSEIIE 470
               D  E++E
Sbjct: 250 GGPSDAKEVME 260

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 363
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-- 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R  
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 463 ---PDFSEIIE 470
               D  E++E
Sbjct: 250 GGPSDAKEVME 260

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 222 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 275
           H + G ++ SG +  +   R     ++ A K +K  R++S  +    +E  +EV I+R++
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 333
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 122
Query: 334 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 443
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 238
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIE 470
                + + R   +DP  R   ++ +E
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLE 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 222 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 275
           H + G ++ SG +  +   R     ++ A K +K  R++S  +    +E  +EV I+R++
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 333
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 129
Query: 334 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 443
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 245
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIE 470
                + + R   +DP  R   ++ +E
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLE 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+++   
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                    +V E  +GG ++D +   K  F      ++   V  G+ Y+H+N I+HRDL
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDL 158
Query: 346 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           K  NLL++   ++  +++ DFG++     S  M  + GT  ++APEV+ H  YD K DV+
Sbjct: 159 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVW 217
Query: 403 SFGIVLWELLTGKLPY 418
           S G++L+ LL+G  P+
Sbjct: 218 STGVILYILLSGCPPF 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+M GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-- 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R  
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 463 ---PDFSEIIE 470
               D  E++E
Sbjct: 250 GGPSDAKEVME 260

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 137 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 197 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+M GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 147/309 (47%), Gaps = 18/309 (5%)
Query: 161 EETEQLRAALEKEVLKLERQGWPS--HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 218
           EE E+   A++     L++Q       RS SP+   +++G +     L  P     + E 
Sbjct: 94  EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPS---DNSGAEEMEVSLAKPKHRVTMNEF 150
Query: 219 DPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV 275
           +  +LK    +  G++G   L +     +  A+K+LK E I   D       E  +++  
Sbjct: 151 E--YLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH  +     +      LC V E+ +GG ++ +L + + VF          ++   ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL 264
Query: 336 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHK 393
           H + N+++RDLK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL  
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSG 382
Query: 454 CWQQDPALR 462
             ++DP  R
Sbjct: 383 LLKKDPKQR 391

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L R     +  A+K+L+ E I   D       E  +++  RH  +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      LC V E+ +GG ++ +L + + VF          ++   + YLH  ++++RD+
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y    D +  
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 363
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VAIK +  E +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKEALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 363
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 148/309 (47%), Gaps = 18/309 (5%)
Query: 161 EETEQLRAALEK--EVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 218
           EE E+   A++   + LK + +     RS SP+   +++G +     L  P     + E 
Sbjct: 97  EEREEWTTAIQTVADGLKKQEEEEMDFRSGSPS---DNSGAEEMEVSLAKPKHRVTMNEF 153
Query: 219 DPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV 275
           +  +LK    +  G++G   L +     +  A+K+LK E I   D       E  +++  
Sbjct: 154 E--YLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH  +     +      LC V E+ +GG ++ +L + + VF          ++   ++YL
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL 267
Query: 336 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHK 393
           H + N+++RDLK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E  
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL  
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSG 385
Query: 454 CWQQDPALR 462
             ++DP  R
Sbjct: 386 LLKKDPKQR 394

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 128/267 (47%), Gaps = 25/267 (9%)
Query: 222 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ----KEFAQEVFIMRKV 275
           H + G ++ SG +  +   R     ++ A K +K  R+ S  +    +E  +EV I+R++
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMN 333
           RH N++           + ++ E +SGG ++D+L + + + +      LK  +D   G++
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVH 143
Query: 334 YLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           YLH   I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE+
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLRPTIPKNS 443
           + ++P   +AD++S G++ + LL+G  P+      E LT + A    V          N+
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA----VNYDFDEEYFSNT 259
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIE 470
                + + R   +DP  R   ++ +E
Sbjct: 260 SELAKDFIRRLLVKDPKRRMXIAQSLE 286

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI-- 284
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 285 --GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
              A   P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 401
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 373
Query: 402 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 431

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI-- 284
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 285 --GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
              A   P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 401
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 402 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 54/294 (18%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA- 286
           V  G YG+++RG +  + VA+K+      + D Q  F + E++    +RH N++ FI + 
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFS----SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 287 ---CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH------- 336
                    L ++T +   GS+YD+L +     +    L++A+  + G+ +LH       
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQR--QTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 337 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYRWMAPEVI 390
            +  I HRD K+ N+L+  N    +AD G+A + +Q             GT R+MAPEV+
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 391 EHKPYD------HKADVFSFGIVLWELLTGKL----------PYEYLTP-------LQAA 427
           + +            D+++FG+VLWE+    +          P+  + P       ++  
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKV 249
Query: 428 VGVVQKGLRPTIPKN--SQP---KLAELLERCWQQDPALRPDFSEIIEILQQIA 476
           V V Q+   PTIP    + P    LA+++  CW  +P+ R     I + LQ+I+
Sbjct: 250 VCVDQQT--PTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKIS 301

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 27/227 (11%)
Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEF 265
           +P      WE+         ++ +G +G + R  +    + VAIK  + E ++   ++ +
Sbjct: 8   LPTQTCGPWEMK-------ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 59
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSL---------CIVTEFMSGGSVYDYLHKLKGVF 316
             E+ IM+K+ H NVV    A   P  L          +  E+  GG +  YL++ +   
Sbjct: 60  CLEIQIMKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 317 KLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQ 371
            L    +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
             + T   GT +++APE++E K Y    D +SFG + +E +TG  P+
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 27/227 (11%)
Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEF 265
           +P      WE+         ++ +G +G + R  +    + VAIK  + E ++   ++ +
Sbjct: 9   LPTQTCGPWEMK-------ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERW 60
Query: 266 AQEVFIMRKVRHKNVVQFIGACTKPPSL---------CIVTEFMSGGSVYDYLHKLKGVF 316
             E+ IM+K+ H NVV    A   P  L          +  E+  GG +  YL++ +   
Sbjct: 61  CLEIQIMKKLNHPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 117
Query: 317 KLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQ 371
            L    +  +  D+S  + YLH+N IIHRDLK  N+++    +  + K+ D G A+   Q
Sbjct: 118 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
             + T   GT +++APE++E K Y    D +SFG + +E +TG  P+
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 15/260 (5%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D    +    + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 72
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 131
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   + HRDLK  N L+D +    +K+  FG ++         +  GT  ++APEV+  K
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLA 448
            YD K ADV+S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+  
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 449 ELLERCWQQDPALRPDFSEI 468
            L+ R +  DPA R    EI
Sbjct: 252 HLISRIFVADPAKRISIPEI 271

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 287 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 401
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 402 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G +G++Y  R     +  A+K L  +RI     +  A    IM  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 287 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +     P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H   +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADV 401
           RDLK AN+L+DE+  V+++D G+A          A  GT+ +MAPEV++    YD  AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 402 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           FS G +L++LL G  P+ ++ T  +  +  +   +   +P +  P+L  LLE   Q+D
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSLLKVAID 327
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 386
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 442
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 443 SQPKLAELLERCWQQDPALRPDFSE 467
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSLLKVAID 327
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 386
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 442
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 443 SQPKLAELLERCWQQDPALRPDFSE 467
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSLLKVAID 327
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 386
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 442
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 443 SQPKLAELLERCWQQDPALRPDFSE 467
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSLLKVAID 327
           I+ KV  + +V    A      LC+V   M+GG +  +++ +      F+ P  +     
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 386
           +  G+ +LHQ NII+RDLK  N+L+D++  V+++D G+A  +KA         GT  +MA
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQKGLRPTIPKN 442
           PE++  + YD   D F+ G+ L+E++  + P+    E +   +    V+++ +  T P  
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415
Query: 443 SQPKLAELLERCWQQDPALRPDFSE 467
             P   +  E   Q+DP  R  F +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 94/175 (53%), Gaps = 5/175 (2%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VAIK +  + +    +     E+ ++ K++H N+V           L ++ + +SGG ++
Sbjct: 46  VAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL---MDENEVVKVADF 363
           D + + KG +      ++   V   + YLH   I+HRDLK  NLL   +DE+  + ++DF
Sbjct: 105 DRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           G+++++    V++   GT  ++APEV+  KPY    D +S G++ + LL G  P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 130/264 (49%), Gaps = 11/264 (4%)
Query: 222 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRH 277
           + +   K+  G + ++YR   C  D     LK  +I    ++  + +  +E+ +++++ H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
            NV+++  +  +   L IV E    G +     +  K K +    ++ K  + +   + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHK 393
           +H   ++HRD+K AN+ +    VVK+ D G+ R   +++    +  GT  +M+PE I   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 394 PYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELL 451
            Y+ K+D++S G +L+E+   + P Y     L +    +++   P +P +    +L +L+
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 452 ERCWQQDPALRPDFSEIIEILQQI 475
             C   DP  RPD + + ++ +++
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRM 295

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 127/266 (47%), Gaps = 37/266 (13%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG--- 285
           + SG +G +++  +   D    V+K  + N++  +   +EV  + K+ H N+V + G   
Sbjct: 19  IGSGGFGQVFKAKH-RIDGKTYVIKRVKYNNEKAE---REVKALAKLDHVNIVHYNGCWD 74
Query: 286 -------------ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSK 330
                        + +K   L I  EF   G++  ++ K +G  KL  +L + +   ++K
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQITK 133
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           G++Y+H   +I+RDLK +N+ + + + VK+ DFG+       G      GT R+M+PE I
Sbjct: 134 GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 391 EHKPYDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
             + Y  + D+++ G++L ELL    T     ++ T L+  +          I      K
Sbjct: 194 SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI----------ISDIFDKK 243
Query: 447 LAELLERCWQQDPALRPDFSEIIEIL 472
              LL++   + P  RP+ SEI+  L
Sbjct: 244 EKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  GSY    R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + +VTE M GG + D + + K  F       V   ++K + YLH   ++HRDLK +
Sbjct: 87  DGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145
Query: 349 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV+E + YD   D++S
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 404 FGIVLWELLTGKLPY 418
            G++L+ +LTG  P+
Sbjct: 206 LGVLLYTMLTGYTPF 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 15/260 (5%)
Query: 219 DPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKV 275
           D    +    + SG++G   L R    ++ VA+K + + E+I+ ++++E        R +
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 72
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH N+V+F      P  L IV E+ SGG +++ +    G F           +  G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 131
Query: 336 HQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           H   + HRDLK  N L+D +    +K+  FG ++            GT  ++APEV+  K
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 394 PYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK--NSQPKLA 448
            YD K ADV+S G+ L+ +L G  P+E     +     + +   ++  IP   +  P+  
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 449 ELLERCWQQDPALRPDFSEI 468
            L+ R +  DPA R    EI
Sbjct: 252 HLISRIFVADPAKRISIPEI 271

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 191 SCGIVLTAMLAGELPWD 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 50/279 (17%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG--- 285
           + SG +G +++  +   D    V++  + N++  +   +EV  + K+ H N+V + G   
Sbjct: 20  IGSGGFGQVFKAKH-RIDGKTYVIRRVKYNNEKAE---REVKALAKLDHVNIVHYNGCWD 75
Query: 286 --------------------------ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 319
                                     + +K   L I  EF   G++  ++ K +G  KL 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLD 134
Query: 320 SLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
            +L + +   ++KG++Y+H   +IHRDLK +N+ + + + VK+ DFG+       G  T 
Sbjct: 135 KVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQK 433
             GT R+M+PE I  + Y  + D+++ G++L ELL    T     ++ T L+  +     
Sbjct: 195 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI----- 249
Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
                I      K   LL++   + P  RP+ SEI+  L
Sbjct: 250 -----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 109/197 (55%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I + + H+NVV+F G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 192 SCGIVLTAMLAGELPWD 208

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 105/196 (53%), Gaps = 6/196 (3%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +        D   A+K+LK + +  + D++    ++  +    +   + Q  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                   L  V E+++GG +  ++ ++ G FK P  +  A +++ G+ +L    II+RD
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 404 FGIVLWELLTGKLPYE 419
           FG++L+E+L G+ P+E
Sbjct: 528 FGVLLYEMLAGQAPFE 543

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 118/239 (49%), Gaps = 8/239 (3%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L +     +  A+K+LK E I   D       E  +++  RH  +     
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 344
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 137 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 196
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 197 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 118/239 (49%), Gaps = 8/239 (3%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L +     +  A+K+LK E I   D       E  +++  RH  +     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 344
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 135 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 194
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 195 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 8/196 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIG 285
           +  GS+G+  L +     Q+ A+KV+   ++     KE   +EV +++++ H N+ +   
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                    +V E  +GG ++D +   K  F      ++   V  G+ Y H+N I+HRDL
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 346 KAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           K  NLL++   ++  +++ DFG++     S     + GT  ++APEV+ H  YD K DV+
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVW 211
Query: 403 SFGIVLWELLTGKLPY 418
           S G++L+ LL+G  P+
Sbjct: 212 STGVILYILLSGCPPF 227

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 118/239 (49%), Gaps = 8/239 (3%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G   L +     +  A+K+LK E I   D       E  +++  RH  +     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRD 344
           +      LC V E+ +GG ++ +L + + VF          ++   ++YLH + N+++RD
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  NL++D++  +K+ DFG+ +   + G  M    GT  ++APEV+E   Y    D + 
Sbjct: 136 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWG 195
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
            G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL    ++DP  R
Sbjct: 196 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 154
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+DE   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 211
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 212 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 105/196 (53%), Gaps = 6/196 (3%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +  GS+G +        D   A+K+LK + +  + D++    ++  +    +   + Q  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                   L  V E+++GG +  ++ ++ G FK P  +  A +++ G+ +L    II+RD
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+++D    +K+ADFG+ +     GV T    GT  ++APE+I ++PY    D ++
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 404 FGIVLWELLTGKLPYE 419
           FG++L+E+L G+ P+E
Sbjct: 207 FGVLLYEMLAGQAPFE 222

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 108/197 (54%), Gaps = 8/197 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G+YG+  L       + VA+K++  +R   D  +   +E+ I   + H+NVV+F G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
             +     +  E+ SGG ++D +    G+ + P   +    +  G+ YLH   I HRD+K
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 347 AANLLMDENEVVKVADFGVA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVF 402
             NLL+DE + +K++DFG+A   R   +  ++    GT  ++APE+++ + +  +  DV+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 403 SFGIVLWELLTGKLPYE 419
           S GIVL  +L G+LP++
Sbjct: 193 SCGIVLTAMLAGELPWD 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 102/195 (52%), Gaps = 6/195 (3%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +  GS+G ++   +   +Q  AIK LK + +  + D++    ++  +     H  +    
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  +L  V E+++GG +  ++      F L      A ++  G+ +LH   I++RD
Sbjct: 86  CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRD 144
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+L+D++  +K+ADFG+ +        T E  GT  ++APE++  + Y+H  D +S
Sbjct: 145 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWS 204
Query: 404 FGIVLWELLTGKLPY 418
           FG++L+E+L G+ P+
Sbjct: 205 FGVLLYEMLIGQSPF 219

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I + V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   +KVADFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 14/271 (5%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           G   +E+    L+   ++  G+YG  +  R     Q +A+K ++   +NS  QK    ++
Sbjct: 42  GNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL 100
Query: 270 FI-MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAI 326
            I MR V     V F GA  +   + I  E M       Y   +     +P   L K+A+
Sbjct: 101 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 160
Query: 327 DVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 385
            + K + +LH   ++IHRD+K +N+L++    VK+ DFG++     S   T + G   +M
Sbjct: 161 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 386 APEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIP 440
           APE I      K Y  K+D++S GI + EL   + PY+ + TP Q    VV++   P +P
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLP 279
Query: 441 KNS-QPKLAELLERCWQQDPALRPDFSEIIE 470
            +    +  +   +C +++   RP + E+++
Sbjct: 280 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 162
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 219
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 220 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 153
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 211 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK  +  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFAEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 10/234 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVD 276

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 228 KVASGSYGD--LYRGTYCSQDVAIKVLKPERI--------NSDMQK---EFAQEVFIMRK 274
           K+ SG+YG+  L +      + AIKV+K  +         N +++K   E   E+ +++ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKG 331
           + H N+++            +VTEF  GG +++ +   HK    F       +   +  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSG 158
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           + YLH++NI+HRD+K  N+L++       +K+ DFG++   ++   +    GT  ++APE
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218
Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           V++ K Y+ K DV+S G++++ LL G  P+
Sbjct: 219 VLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 160
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  GSY +  R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYD 91
Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + +VTE M GG + D + + K  F       V   + K + YLH   ++HRDLK +
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPS 150
Query: 349 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D++S
Sbjct: 151 NILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWS 210
Query: 404 FGIVLWELLTGKLPY 418
            GI+L+ +L G  P+
Sbjct: 211 LGILLYTMLAGYTPF 225

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  GSY +  R  + + ++   V   ++   D  +E      ++R  +H N++       
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYD 91
Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + +VTE M GG + D + + K  F       V   + K + YLH   ++HRDLK +
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPS 150
Query: 349 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV++ + YD   D++S
Sbjct: 151 NILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWS 210
Query: 404 FGIVLWELLTGKLPY 418
            GI+L+ +L G  P+
Sbjct: 211 LGILLYTMLAGYTPF 225

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E++ GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 101/177 (57%), Gaps = 6/177 (3%)
Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           VA+K++  +R   D  +   +E+ I + + H+NVV+F G   +     +  E+ SGG ++
Sbjct: 34  VAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
           D +    G+ + P   +    +  G+ YLH   I HRD+K  NLL+DE + +K++DFG+A
Sbjct: 93  DRIEPDIGMPE-PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 367 ---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYE 419
              R   +  ++    GT  ++APE+++ + +  +  DV+S GIVL  +L G+LP++
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 244 SQDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 300
            Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 301 SGGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEV 357
            G  + ++ + +    F     +       + + + Y H NNIIHRD+K  N+L+   E 
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKEN 168
Query: 358 ---VKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
              VK+ DFGVA    +SG V     GT  +MAPEV++ +PY    DV+  G++L+ LL+
Sbjct: 169 SAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 414 GKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 229 GCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           +  GSY    R  + + +    V   ++   D  +E      ++R  +H N++       
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + +VTE   GG + D + + K  F       V   ++K + YLH   ++HRDLK +
Sbjct: 87  DGKYVYVVTELXKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145
Query: 349 NLL-MDEN---EVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
           N+L +DE+   E +++ DFG A+ ++A++G++     T  ++APEV+E + YD   D++S
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 404 FGIVLWELLTGKLPY 418
            G++L+  LTG  P+
Sbjct: 206 LGVLLYTXLTGYTPF 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 119/238 (50%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++++  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 7/231 (3%)
Query: 226 GSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQ 282
           G  +  G +G++Y  R       +A+KVL   ++  + ++ +  +E+ I   +RH N+++
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 79
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                     + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IH
Sbjct: 80  MYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIH 138
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           RD+K  NLLM     +K+ADFG + V A S       GT  ++ PE+IE K +D K D++
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLW 197
Query: 403 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELL 451
             G++ +E L G  P++  +  +    +V   L+  P +   S+  +++LL
Sbjct: 198 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    + E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG+A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 144
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 145 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 204
Query: 402 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 205 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSMSVKAASVLK 262
Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 263 SFLNKDPKER 272

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 133
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 402 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 251
Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 252 SFLNKDPKER 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     +  A+KV+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 129
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 130 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 189
Query: 402 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 190 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 247
Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 248 SFLNKDPKER 257

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +  GS+G ++   +   +Q  AIK LK + +  + D++    ++  +     H  +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  +L  V E+++GG +  ++      F L      A ++  G+ +LH   I++RD
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRD 143
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 403
           LK  N+L+D++  +K+ADFG+ +        T    GT  ++APE++  + Y+H  D +S
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWS 203
Query: 404 FGIVLWELLTGKLPY 418
           FG++L+E+L G+ P+
Sbjct: 204 FGVLLYEMLIGQSPF 218

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           G +   G YG L+       +V +KVL  ++ + +  + F +   +M K+ HK++V   G
Sbjct: 27  GVRREVGDYGQLHE-----TEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVLNYG 79
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            C       +V EF+  GS+  YL K K    +   L+VA  ++  M++L +N +IH ++
Sbjct: 80  VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139
Query: 346 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 396
            A N+L+   E         +K++D G++       ++        W+ PE IE+ K  +
Sbjct: 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLN 196
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
              D +SFG  LWE+ +G    + L+ L +   +     R  +P     +LA L+  C  
Sbjct: 197 LATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMD 254
Query: 457 QDPALRPDFSEIIEILQQI 475
            +P  RP F  II  L  +
Sbjct: 255 YEPDHRPSFRAIIRDLNSL 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 16/256 (6%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 285
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 286 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--- 337
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+   
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 338 --NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKP 394
             + ++HRDLK AN+ +D  + VK+ DFG+AR+    +    A  GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 454
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 455 WQQDPALRPDFSEIIE 470
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT   +APE+I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 117/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   ++V DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+++GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NLL+D+   ++V DFG A RVK ++  +    GT  ++AP +I  K Y+   D ++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    Q E    E  I++ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   +KV DFG A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 285
           +  GSY    L R     +  A++V+K E +N D   ++ Q E  +  +  +   +  + 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 286 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIH 342
           +C +  S L  V E+++GG +  ++ + +   KLP       + ++S  +NYLH+  II+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 176
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 401
           RDLK  N+L+D    +K+ D+G+ +   + G  T+   GT  ++APE++  + Y    D 
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236
Query: 402 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 452
           ++ G++++E++ G+ P++ +     P Q         +++K +R  IP++   K A +L+
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 294
Query: 453 RCWQQDPALR 462
               +DP  R
Sbjct: 295 SFLNKDPKER 304

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 6/203 (2%)
Query: 222 HLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH 277
           + +F   +  GS+G   L R        A+KVLK + I  + D++    ++  +     H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             + Q       P  L  V EF++GG +  ++ K +  F        A ++   + +LH 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHD 142
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYD 396
             II+RDLK  N+L+D     K+ADFG+ +    +GV TA   GT  ++APE+++   Y 
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 397 HKADVFSFGIVLWELLTGKLPYE 419
              D ++ G++L+E+L G  P+E
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 10/238 (4%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 285
           + +GS+G   L +        A+K+L  +++    + E    E  I++ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +     +L +V E+  GG ++ +L ++ G F  P     A  +     YLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 346 KAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           K  NL++D+   ++V DFG+A RVK ++  +    GT  ++APE+I  K Y+   D ++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G++++E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 285
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 286 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--- 337
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+   
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 338 --NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP 394
             + ++HRDLK AN+ +D  + VK+ DFG+AR+         E  GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 454
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 455 WQQDPALRPDFSEIIE 470
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 114/228 (50%), Gaps = 7/228 (3%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G +G++Y  R       +A+KVL   ++  + ++ +  +E+ I   +RH N+++   
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IHRD+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 405
           K  NLLM     +K+ADFG + V A S       GT  ++ PE+IE K +D K D++  G
Sbjct: 141 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELL 451
           ++ +E L G  P++  +  +    +V   L+  P +   S+  +++LL
Sbjct: 200 VLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           G +   G YG L+       +V +KVL  ++ + +  + F +   +M K+ HK++V   G
Sbjct: 27  GVRREVGDYGQLHE-----TEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVLNYG 79
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            C       +V EF+  GS+  YL K K    +   L+VA  ++  M++L +N +IH ++
Sbjct: 80  VCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNV 139
Query: 346 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 396
            A N+L+   E         +K++D G++       ++        W+ PE IE+ K  +
Sbjct: 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---WVPPECIENPKNLN 196
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
              D +SFG  LWE+ +G    + L+ L +   +     R  +P     +LA L+  C  
Sbjct: 197 LATDKWSFGTTLWEICSGG--DKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMD 254
Query: 457 QDPALRPDFSEIIEILQQI 475
            +P  RP F  II  L  +
Sbjct: 255 YEPDHRPSFRAIIRDLNSL 273

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 127/257 (49%), Gaps = 15/257 (5%)
Query: 219 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRK 274
           DPK +  G  V+S     ++R T     V I  +  ER++ +  +E  +    E  I+R+
Sbjct: 97  DPKDV-IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 275 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           V  H +++  I +      + +V + M  G ++DYL + K          +   + + ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVS 214
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 391
           +LH NNI+HRDLK  N+L+D+N  ++++DFG +        +    GT  ++APE+++  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 392 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP 445
               H  Y  + D+++ G++L+ LL G  P+ +   +     +++   + + P+  +   
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSS 334
Query: 446 KLAELLERCWQQDPALR 462
            + +L+ R  Q DP  R
Sbjct: 335 TVKDLISRLLQVDPEAR 351

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVFIMRKVRHKNVVQFIG 285
           + +GSYG   +    S D  I V K     S  + E      EV ++R+++H N+V++  
Sbjct: 14  IGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 286 ACT--KPPSLCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--- 337
                   +L IV E+  GG   SV     K +       +L+V   ++  +   H+   
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 338 --NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKP 394
             + ++HRDLK AN+ +D  + VK+ DFG+AR+    +       GT  +M+PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 454
           Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E++ R 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 455 WQQDPALRPDFSEIIE 470
                  RP   EI+E
Sbjct: 252 LNLKDYHRPSVEEILE 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 6/252 (2%)
Query: 223 LKFGSKVASGSYGDLYRG--TYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKN 279
            K G+ +  GS+  +YR    +   +VAIK++ K     + M +    EV I  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++          + +V E    G +  YL      F           +  GM YLH + 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           I+HRDL  +NLL+  N  +K+ADFG+A ++K          GT  +++PE+     +  +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
           +DV+S G + + LL G+ P++  T       VV       +P     +  +L+ +  +++
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKDLIHQLLRRN 250
Query: 459 PALRPDFSEIIE 470
           PA R   S +++
Sbjct: 251 PADRLSLSSVLD 262

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 220 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 276
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 8   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 67
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 126
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 393
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 447
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 238
Query: 448 AELLERCWQQDPALR 462
            +L+E+    D   R
Sbjct: 239 RDLVEKLLVLDATKR 253

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 220 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 276
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 6   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 65
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 124
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 393
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 447
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 236
Query: 448 AELLERCWQQDPALR 462
            +L+E+    D   R
Sbjct: 237 RDLVEKLLVLDATKR 251

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 220 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 276
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 9   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 68
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 69  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 127
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 393
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 447
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 239
Query: 448 AELLERCWQQDPALR 462
            +L+E+    D   R
Sbjct: 240 RDLVEKLLVLDATKR 254

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 119/255 (46%), Gaps = 21/255 (8%)
Query: 220 PKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVR 276
           P+  KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ 
Sbjct: 7   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H   V+          L     +   G +  Y+ K+ G F          ++   + YLH
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 125
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHK 393
              IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKL 447
                +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA 237
Query: 448 AELLERCWQQDPALR 462
            +L+E+    D   R
Sbjct: 238 RDLVEKLLVLDATKR 252

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     A  GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 83/150 (55%), Gaps = 1/150 (0%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV-YDYLHKLKGVFKLPSLLKVAIDVS 329
           I+ KV  + VV    A     +LC+V   M+GG + +   H  +  F     +  A ++ 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
            G+  LH+  I++RDLK  N+L+D++  ++++D G+A    +   +    GT  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           ++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 83/150 (55%), Gaps = 1/150 (0%)
Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV-YDYLHKLKGVFKLPSLLKVAIDVS 329
           I+ KV  + VV    A     +LC+V   M+GG + +   H  +  F     +  A ++ 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
            G+  LH+  I++RDLK  N+L+D++  ++++D G+A    +   +    GT  +MAPEV
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           ++++ Y    D ++ G +L+E++ G+ P++
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 124/254 (48%), Gaps = 11/254 (4%)
Query: 225 FGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           F  K+ SG++GD++     S  +   IK +  +R    M+ +   E+ +++ + H N+++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNIIK 84
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN---YLHQNN 339
                    ++ IV E   GG + + +   +   K  S   VA  + + MN   Y H  +
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 340 IIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           ++H+DLK  N+L  +   +  +K+ DFG+A +       T   GT  +MAPEV + +   
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-KNSQPKLAELLERCW 455
            K D++S G+V++ LLTG LP+   +  +       K     +  +   P+  +LL++  
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML 263
Query: 456 QQDPALRPDFSEII 469
            +DP  RP  ++++
Sbjct: 264 TKDPERRPSAAQVL 277

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 14/255 (5%)
Query: 228 KVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFI 284
           ++  G+YG  +  R     Q +A+K ++   +NS  QK    ++ I MR V     V F 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NII 341
           GA  +   + I  E M       Y   +     +P   L K+A+ + K + +LH   ++I
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDH 397
           HRD+K +N+L++    VK+ DFG++           + G   +MAPE I      K Y  
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 398 KADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCW 455
           K+D++S GI + EL   + PY+ + TP Q    VV++   P +P +    +  +   +C 
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTSQCL 251
Query: 456 QQDPALRPDFSEIIE 470
           +++   RP + E+++
Sbjct: 252 KKNSKERPTYPELMQ 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 227 SKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           S++  G+   +YR   C Q       A+KVLK     +  +K    E+ ++ ++ H N++
Sbjct: 59  SELGRGATSIVYR---CKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +       P  + +V E ++GG ++D + + KG +           + + + YLH+N I+
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 342 HRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           HRDLK  NLL      +  +K+ADFG++++     +M    GT  + APE++    Y  +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 399 ADVFSFGIVLWELLTGKLPY 418
            D++S GI+ + LL G  P+
Sbjct: 231 VDMWSVGIITYILLCGFEPF 250

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H NV+           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 34/274 (12%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V  GSYG +   R     + VAIK       +  ++K   +E+ +++++RH+N+V  +  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
           C K     +V EF+   ++ D L           + K    +  G+ + H +NIIHRD+K
Sbjct: 93  CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 347 AANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPE-VIEHKPYDHKADVFSF 404
             N+L+ ++ VVK+ DFG AR  A  G V   E  T  + APE ++    Y    DV++ 
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211
Query: 405 GIVLWELLTGKLPY------EYLTPLQAAVGV-------------VQKGLR-PTIPKNS- 443
           G ++ E+  G+  +      + L  +   +G              V  G+R P I +   
Sbjct: 212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP 271
Query: 444 ----QPKLAE----LLERCWQQDPALRPDFSEII 469
                PKL+E    L ++C   DP  RP  +E++
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 94/164 (57%), Gaps = 11/164 (6%)
Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LP 319
           ++E  +EV I+R+V H N++           + ++ E +SGG ++D+L + + + +    
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVM 375
           S +K  +D   G+NYLH   I H DLK  N+++ +  +    +K+ DFG+A  + + GV 
Sbjct: 119 SFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVE 174
Query: 376 TAET-GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
                GT  ++APE++ ++P   +AD++S G++ + LL+G  P+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 265
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 266 VEKLLVLDATKR 277

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 128/303 (42%), Gaps = 67/303 (22%)
Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--V 275
           +D  +LK    +  G YG +Y+G+   + VA+KV          ++ F  E  I R   +
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLM 64
Query: 276 RHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDV 328
            H N+ +FI    +  +       +V E+   GS+  Y  LH    V    S  ++A  V
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV----SSCRLAHSV 120
Query: 329 SKGMNYLHQN---------NIIHRDLKAANLLMDENEVVKVADFGVA---------RVKA 370
           ++G+ YLH            I HRDL + N+L+  +    ++DFG++         R   
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 371 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWE-------LLTGKL 416
           +     +E GT R+MAPEV+E        +    + D+++ G++ WE       L  G+ 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 417 PYEYLTPLQAAVG-----------VVQKGLRPTIP----KNSQP--KLAELLERCWQQDP 459
             EY    Q  VG           V ++  RP  P    +NS     L E +E CW QD 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 460 ALR 462
             R
Sbjct: 301 EAR 303

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++     +  GT ++++PE++  K   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 261
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 262 VEKLLVLDATKR 273

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 13/231 (5%)
Query: 244 SQDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 300
            Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM
Sbjct: 51  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 301 SGGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENE- 356
            G  + ++ + +    F     +       + + + Y H NNIIHRD+K   +L+   E 
Sbjct: 111 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 170
Query: 357 --VVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
              VK+  FGVA    +SG V     GT  +MAPEV++ +PY    DV+  G++L+ LL+
Sbjct: 171 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 230
Query: 414 GKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 231 GCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 280

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 13/231 (5%)
Query: 244 SQDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 300
            Q  A+K++   +  S      ++  +E  I   ++H ++V+ +   +    L +V EFM
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 301 SGGSV-YDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENE- 356
            G  + ++ + +    F     +       + + + Y H NNIIHRD+K   +L+   E 
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 168
Query: 357 --VVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
              VK+  FGVA    +SG V     GT  +MAPEV++ +PY    DV+  G++L+ LL+
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 414 GKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPALR 462
           G LP+ Y T  +   G+++    + P    +      +L+ R    DPA R
Sbjct: 229 GCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 269
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 270 VEKLLVLDATKR 281

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           WE+ PK     + V SG+YG +         + VAIK L     +    K   +E+ +++
Sbjct: 20  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 274 KVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAI 326
            ++H+NV+  +   T   SL       +V  FM        L K+ G+ F    +  +  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEEKIQYLVY 133
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 386
            + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRA 191
Query: 387 PEVI-EHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           PEVI     Y+   D++S G ++ E+LTGK  +   +YL  L   + V 
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 265
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 266 VEKLLVLDATKR 277

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 264
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 265 VEKLLVLDATKR 276

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           WE+ PK     + V SG+YG +         + VAIK L     +    K   +E+ +++
Sbjct: 38  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 274 KVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAI 326
            ++H+NV+  +   T   SL       +V  FM        L K+ G+ F    +  +  
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGMEFSEEKIQYLVY 151
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 386
            + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T  + A
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRA 209
Query: 387 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           PEVI     Y+   D++S G ++ E+LTGK
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 262
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 263 VEKLLVLDATKR 274

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 246
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 247 VEKLLVLDATKR 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P+   PK  +L
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKARDL 261
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 262 VEKLLVLDATKR 273

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 114/246 (46%), Gaps = 9/246 (3%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
             +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L+E+   
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLVEKLLV 270
Query: 457 QDPALR 462
            D   R
Sbjct: 271 LDATKR 276

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 83  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR  A    MT    T  
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRW 194
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 21/252 (8%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 397 HKADVFSFGIVLWELLTGKLPY----EYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAEL 450
             +D+++ G ++++L+ G  P+    EYL        + QK   L    P    PK  +L
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPAAFFPKARDL 267
Query: 451 LERCWQQDPALR 462
           +E+    D   R
Sbjct: 268 VEKLLVLDATKR 279

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 100/179 (55%), Gaps = 5/179 (2%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
           +Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG
Sbjct: 56  TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKV 360
            +++ +   +  +           + + +N++HQ++I+HRDLK  NLL+    +   VK+
Sbjct: 116 ELFEDI-VAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 361 ADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 126/251 (50%), Gaps = 16/251 (6%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 75  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 133
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKA 399
           +K +N+L++    +K+ DFGV      SG +  E      GT  +M+PE ++   Y  ++
Sbjct: 134 VKPSNILVNSRGEIKLCDFGV------SGQLIDEMANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQD 458
           D++S G+ L E+  G+ P   +   +    +V +   P +P      +  + + +C  ++
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEP-PPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 459 PALRPDFSEII 469
           PA R D  +++
Sbjct: 247 PAERADLKQLM 257

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 114/246 (46%), Gaps = 9/246 (3%)
Query: 223 LKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEF-AQEVFIMRKVRHKN 279
            KFG  +  GS+    L R    S++ AIK+L+   I  + +  +  +E  +M ++ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
            V+          L     +   G +  Y+ K+ G F          ++   + YLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           IIHRDLK  N+L++E+  +++ DFG A+V   +++        GT ++++PE++  K   
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
             +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L+E+   
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDLVEKLLV 270
Query: 457 QDPALR 462
            D   R
Sbjct: 271 LDATKR 276

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+ +G+Y  +Y+G   +  V +  LK  +++S+        +E+ +M++++H+N+V+   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYV-ALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DVSKGMNYLHQNN 339
                  L +V EFM    +  Y+   + V   P  L++ +       + +G+ + H+N 
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDH 397
           I+HRDLK  NLL+++   +K+ DFG+AR         ++E  T  + AP+V+   + Y  
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 398 KADVFSFGIVLWELLTGK 415
             D++S G +L E++TGK
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 116/234 (49%), Gaps = 7/234 (2%)
Query: 223 LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHKN 279
            + G  +  G +G++Y  R       VA+KVL   +I  + ++ +  +E+ I   + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +++          + ++ E+   G +Y  L K    F       +  +++  + Y H   
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQK-SCTFDEQRTATIMEELADALMYCHGKK 143
Query: 340 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           +IHRD+K  NLL+     +K+ADFG + V A S       GT  ++ PE+IE + ++ K 
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELL 451
           D++  G++ +ELL G  P+E  +  +    +V+  L+   ++P  +Q  +++LL
Sbjct: 203 DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL 256

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNVVQ 282
           KV  G+YG +Y+    ++D   +++  +RI  D + E       +E+ +++++ H N+V 
Sbjct: 28  KVGEGTYGVVYK----AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            I        L +V EFM    +   L + K   +   +      + +G+ + HQ+ I+H
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 398
           RDLK  NLL++ +  +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 399 ADVFSFGIVLWELLTGK 415
            D++S G +  E++TGK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNVVQ 282
           KV  G+YG +Y+    ++D   +++  +RI  D + E       +E+ +++++ H N+V 
Sbjct: 28  KVGEGTYGVVYK----AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            I        L +V EFM    +   L + K   +   +      + +G+ + HQ+ I+H
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 343 RDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 398
           RDLK  NLL++ +  +K+ADFG+AR   +  +S   T E  T  + AP+V+   K Y   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 399 ADVFSFGIVLWELLTGK 415
            D++S G +  E++TGK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 126/249 (50%), Gaps = 8/249 (3%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 91  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 149
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 150 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 208
Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS-QPKLAELLERCWQQDPA 460
           G+ L E+  G+ P    +   A   ++   +    P +P      +  + + +C  ++PA
Sbjct: 209 GLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 268
Query: 461 LRPDFSEII 469
            R D  +++
Sbjct: 269 ERADLKQLM 277

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 129
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYVAT 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKXQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 147
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 205
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 138
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 196
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCAKLTDDHV 123
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 190
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 146
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 204
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 229 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           + SG+ G +         ++VAIK L     N    K   +E+ +M+ V HKN++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 287 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK---------- 330
            T   SL       IV E M                 L  ++++ +D  +          
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDAN--------------LSQVIQMELDHERMSYLLYQMLV 137
Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  + APEVI
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 391 EHKPYDHKADVFSFGIVLWELLTG 414
               Y    D++S G+++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 38  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 90
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       +VT  M        L+KL     L + 
Sbjct: 91  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYLVTHLMGAD-----LYKLLKTQHLSND 144
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 145 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 29/238 (12%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +         + I V K  R    +   K   +E+ ++
Sbjct: 46  IWEV-PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 156
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 157 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 214
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
             + APE++ +   Y+   D++S G ++ ELLTG+     L P    +  +Q+ +R T
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT----LFPGTDHINQLQQIMRLT 268

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 123
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S + SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYVAT 190
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 30/188 (15%)
Query: 243 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIV 296
             ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV
Sbjct: 48  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107
Query: 297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLK 346
            E M                 L  ++++ +D  +          G+ +LH   IIHRDLK
Sbjct: 108 MELMDAN--------------LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLK 153
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 406
            +N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G+
Sbjct: 154 PSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGV 213
Query: 407 VLWELLTG 414
           ++ E++ G
Sbjct: 214 IMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT E  T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 139
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 197
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 106/192 (55%), Gaps = 20/192 (10%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 302
           SQ+ A+K++  E+    ++    +EV ++ + + H+NV++ I    +     +V E M G
Sbjct: 38  SQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEV--VK 359
           GS+  ++HK +   +L + + V  DV+  +++LH   I HRDLK  N+L +  N+V  VK
Sbjct: 96  GSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154
Query: 360 VADFGVARVKAQSG----VMTAE----TGTYRWMAPEVI-----EHKPYDHKADVFSFGI 406
           + DFG+      +G    + T E     G+  +MAPEV+     E   YD + D++S G+
Sbjct: 155 ICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 407 VLWELLTGKLPY 418
           +L+ LL+G  P+
Sbjct: 215 ILYILLSGYPPF 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 90/179 (50%), Gaps = 5/179 (2%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGG 303
           Q+ A K LK  R   D + E   E+ ++   +    V+           + ++ E+ +GG
Sbjct: 55  QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 304 SVYDY-LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVK 359
            ++   L +L  +     ++++   + +G+ YLHQNNI+H DLK  N+L+        +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 360 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           + DFG++R    +  +    GT  ++APE++ + P     D+++ GI+ + LLT   P+
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
           QE+ I++K+ H NVV+ +     P    L +V E ++ G V + +  LK + +  +    
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYF 143
Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYR 383
             D+ KG+ YLH   IIHRD+K +NLL+ E+  +K+ADFGV+   K    +++   GT  
Sbjct: 144 Q-DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202
Query: 384 WMAPEVIEH--KPYDHKA-DVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPT 438
           +MAPE +    K +  KA DV++ G+ L+  + G+ P+  E +  L + +    K     
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI----KSQALE 258
Query: 439 IPKNSQPKLAE----LLERCWQQDPALRPDFSEI 468
            P   QP +AE    L+ R   ++P  R    EI
Sbjct: 259 FP--DQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 415
           + APE+ +    Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKV------LKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           +  G+  +++RG +       AIKV      L+P     D+Q    +E  +++K+ HKN+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP----VDVQ---MREFEVLKKLNHKNI 69
Query: 281 VQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLH 336
           V+   I   T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 337 QNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 391
           +N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 392 -------HKPYDHKADVFSFGIVLWELLTGKLPY 418
                   K Y    D++S G+  +   TG LP+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 132
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 190
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 139
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 197
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 29  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 139
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 197
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 150
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 208
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 129
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 23  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 129
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQ- 337
           +VQ  G       + I  E M  G+  + L K ++G      L K+ + + K + YL + 
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE----HK 393
           + +IHRD+K +N+L+DE   +K+ DFG++             G   +MAPE I+     K
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 394 P-YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNS--QPKLAE 449
           P YD +ADV+S GI L EL TG+ PY+   T  +    V+Q+   P +P +         
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSGDFQS 262
Query: 450 LLERCWQQDPALRPDFSEIIE 470
            ++ C  +D   RP +++++E
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLE 283

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 22  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 132
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 190
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 19  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 129
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 16  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 126
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 127 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 184
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 36  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 146
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 204
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 124
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 182
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 147
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 205
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 222 HLKFGSKVASGSYGDLYRGT--YCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHK 278
           H     ++ +G++G ++R T      + A K V+ P   + +  +   +E+  M  +RH 
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHP 108
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            +V    A      + ++ EFMSGG +++ +            ++    V KG+ ++H+N
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 339 NIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           N +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 397 HKADVFSFGIVLWELLTGKLPY 418
           +  D++S G++ + LL+G  P+
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPF 250

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 24  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 134
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 192
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 222 HLKFGSKVASGSYGDLYRGT--YCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHK 278
           H     ++ +G++G ++R T      + A K V+ P   + +  +   +E+  M  +RH 
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHP 214
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            +V    A      + ++ EFMSGG +++ +            ++    V KG+ ++H+N
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 339 NIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
           N +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV E KP  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 397 HKADVFSFGIVLWELLTGKLPY 418
           +  D++S G++ + LL+G  P+
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF 356

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 28  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 138
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 196
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 229 VASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  G +G +++   T     +A K++K   +    ++E   E+ +M ++ H N++Q   A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDA 154
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLHQNNIIHRD 344
                 + +V E++ GG ++D +  +   + L  L  +     + +G+ ++HQ  I+H D
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 345 LKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           LK  N+L    +   +K+ DFG+AR       +    GT  ++APEV+ +       D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 403 SFGIVLWELLTGKLPY 418
           S G++ + LL+G  P+
Sbjct: 273 SVGVIAYMLLSGLSPF 288

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKXQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 123
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 181
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  + V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 27  IWEV-PERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 137
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 138 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 195
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 14  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 124
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 182
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 15  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 125
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 126 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVAT 183
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 127/255 (49%), Gaps = 14/255 (5%)
Query: 227 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 405 GIVLWELLTGKLPY------EYLTPLQAAVGVVQKGLR---PTIPKNS-QPKLAELLERC 454
           G+ L E+  G+ P       E   P  A   ++   +    P +P      +  + + +C
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 249
Query: 455 WQQDPALRPDFSEII 469
             ++PA R D  +++
Sbjct: 250 LIKNPAERADLKQLM 264

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKCQALSDEHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 229 VASGSYGDLYRGTY--CSQDVAIKV------LKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           +  G+  +++RG +       AIKV      L+P     D+Q    +E  +++K+ HKN+
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP----VDVQ---MREFEVLKKLNHKNI 69
Query: 281 VQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLH 336
           V+   I   T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 337 QNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 391
           +N I+HR++K  N++     D   V K+ DFG AR            GT  ++ P++ E 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189
Query: 392 -------HKPYDHKADVFSFGIVLWELLTGKLPY 418
                   K Y    D++S G+  +   TG LP+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 37  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 147
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVAT 205
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 120/233 (51%), Gaps = 17/233 (7%)
Query: 221 KHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           K+ K G K+  GSYG ++  R     Q VAIK       +  ++K   +E+ ++++++H 
Sbjct: 4   KYEKIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLH 336
           N+V  +    +   L +V E+     +++     +GV   P  L  +I     + +N+ H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV---PEHLVKSITWQTLQAVNFCH 119
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPE-VIEHKP 394
           ++N IHRD+K  N+L+ ++ V+K+ DFG AR +   S     E  T  + +PE ++    
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG---VVQKGLRPTIPKNSQ 444
           Y    DV++ G V  ELL+G +P   L P ++ V    +++K L   IP++ Q
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VP---LWPGKSDVDQLYLIRKTLGDLIPRHQQ 228

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 31/251 (12%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQK----------EFAQEVFIMRKVRHK 278
           +  GS+G+          V I V K  RI    +K           F QE+ IM+ + H 
Sbjct: 34  IGRGSWGE----------VKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 83
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H+ 
Sbjct: 84  NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y 201
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK----NSQPKLAELL 451
             + D +S G++++ LL G  P+   T  +  + + +     T P+    N  P+   L+
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLI 259
Query: 452 ERCWQQDPALR 462
            R   + P  R
Sbjct: 260 RRLLTKSPKQR 270

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V+           + ++ E ++GG ++D+L + K         +    +  G+ YLH   
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 340 IIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++P 
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELLER 453
             +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + + R
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 454 CWQQDPALR 462
              +DP  R
Sbjct: 254 LLVKDPKKR 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 134 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 192
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 193 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 251
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 252 GLSLVEMAVGRYP 264

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 285 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 333
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKASIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 388
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 389 -VIEHKPYDHKADVFSFGIVLWELLT 413
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 31/251 (12%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQK----------EFAQEVFIMRKVRHK 278
           +  GS+G+          V I V K  RI    +K           F QE+ IM+ + H 
Sbjct: 17  IGRGSWGE----------VKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H+ 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+E   Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y 184
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK----NSQPKLAELL 451
             + D +S G++++ LL G  P+   T  +  + + +     T P+    N  P+   L+
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF--TFPEKDWLNVSPQAESLI 242
Query: 452 ERCWQQDPALR 462
            R   + P  R
Sbjct: 243 RRLLTKSPKQR 253

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 23  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 75
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 76  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 129
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 130 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 189
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 190 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 24  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 76
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 77  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 130
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 131 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 190
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 191 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 15  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 67
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 68  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 121
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 122 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 181
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 182 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 298
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 348
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155
Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 409 WELLTG 414
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V+           + ++ E ++GG ++D+L + K         +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 340 IIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++P 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELLER 453
             +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + + R
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254
Query: 454 CWQQDPALR 462
              +DP  R
Sbjct: 255 LLVKDPKKR 263

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V+           + ++ E ++GG ++D+L + K         +    +  G+ YLH   
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 340 IIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++P 
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELLER 453
             +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + + R
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 454 CWQQDPALR 462
              +DP  R
Sbjct: 254 LLVKDPKKR 262

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 38  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 90
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 91  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 144
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 145 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKSQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+ R       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V+           + ++ E ++GG ++D+L + K         +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 340 IIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++P 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELLER 453
             +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + + R
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254
Query: 454 CWQQDPALR 462
              +DP  R
Sbjct: 255 LLVKDPKKR 263

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 26  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 78
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 79  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 132
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 133 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 193 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 18  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 70
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 71  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 124
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 125 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 16  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 68
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 69  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 122
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 123 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 182
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 183 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 23  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKSQALSDEHV 133
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 298
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 348
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPS 155
Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 409 WELLTG 414
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 16  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 68
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 69  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 122
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 123 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 182
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 183 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 316
           I   ++ +  +E+ ++ +     +V F GA      + I  E M GGS+   L + K   
Sbjct: 53  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 109
Query: 317 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 373
           ++P   L KV+I V +G+ YL + + I+HRD+K +N+L++    +K+ DFGV+     S 
Sbjct: 110 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 168
Query: 374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
           +  +  GT  +MAPE ++   Y  ++D++S G+ L EL  G+ P
Sbjct: 169 MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D+G+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 298
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL       IV E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAA 348
            M                 L  ++++ +D  +          G+ +LH   IIHRDLK +
Sbjct: 110 LMDAN--------------LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155
Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           N+++  +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++
Sbjct: 156 NIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 409 WELLTG 414
            E++ G
Sbjct: 216 GEMIKG 221

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           YR  APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YR--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW 187
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           YR  APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YR--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 99  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 217 GLSLVEMAVGRYP 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+   RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLAFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFL 186
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 285 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 333
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 388
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 389 -VIEHKPYDHKADVFSFGIVLWELLT 413
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 118/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK    +  G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK---QILNGVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 4/193 (2%)
Query: 227 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           S++ +G+ G +++ ++  S  V  + L    I   ++ +  +E+ ++ +     +V F G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRD 344
           A      + I  E M GGS+ D + K  G      L KV+I V KG+ YL + + I+HRD
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           +K +N+L++    +K+ DFGV+     S +  +  GT  +M+PE ++   Y  ++D++S 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 405 GIVLWELLTGKLP 417
           G+ L E+  G+ P
Sbjct: 190 GLSLVEMAVGRYP 202

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 13  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 123
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR           T  
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW 183
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           YR  APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 184 YR--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 115/249 (46%), Gaps = 13/249 (5%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           V+           + ++ E ++GG ++D+L + K         +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 340 IIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++P 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELLER 453
             +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + + R
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254
Query: 454 CWQQDPALR 462
              +DP  R
Sbjct: 255 LLVKDPKKR 263

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 228 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDM---QKEFAQEVFIMRKVRHKNVVQFI 284
           ++ SG++G ++R   C +    +V   + IN+     +     E+ IM ++ H  ++   
Sbjct: 58  ELGSGAFGVVHR---CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            A      + ++ EF+SGG ++D +           ++       +G+ ++H+++I+H D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 345 LKAANLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           +K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P     D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 403 SFGIVLWELLTGKLPY 418
           + G++ + LL+G  P+
Sbjct: 235 AIGVLGYVLLSGLSPF 250

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 105/192 (54%), Gaps = 20/192 (10%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 302
           SQ+ A+K++  E+    ++    +EV ++ + + H+NV++ I    +     +V E M G
Sbjct: 38  SQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEV--VK 359
           GS+  ++HK +   +L + + V  DV+  +++LH   I HRDLK  N+L +  N+V  VK
Sbjct: 96  GSILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154
Query: 360 VADF----GVARVKAQSGVMTAE----TGTYRWMAPEVI-----EHKPYDHKADVFSFGI 406
           + DF    G+      S + T E     G+  +MAPEV+     E   YD + D++S G+
Sbjct: 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 407 VLWELLTGKLPY 418
           +L+ LL+G  P+
Sbjct: 215 ILYILLSGYPPF 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 8/166 (4%)
Query: 260 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 123
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        + + 
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV 183
Query: 379 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 418
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 95/179 (53%), Gaps = 5/179 (2%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
            Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKV 360
            +++ +   +  +           + + +N+ H N I+HRDLK  NLL+    +   VK+
Sbjct: 89  ELFEDI-VAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 361 ADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ADFG+A  V+          GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 148 ADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           VWE+ P+ L+    V SG+YG +         Q VA+K L     +    +   +E+ ++
Sbjct: 15  VWEV-PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   S+       +VT  M           L  + K  +L     
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA--------DLNNIVKCQALSDEHV 125
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H   IIHRDLK +N+ ++E+  +++ DFG+AR   +   MT    T
Sbjct: 126 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVAT 183
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
             + APE++ +   Y+   D++S G ++ ELL GK  +   +Y+  L+  + VV
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAI+ + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 285 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 333
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 84  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 388
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 389 -VIEHKPYDHKADVFSFGIVLWELLT 413
            ++  + Y    D++  G ++ E+ T
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 119/251 (47%), Gaps = 17/251 (6%)
Query: 226 GSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ----KEFAQEVFIMRKVRHKN 279
           G ++ SG +  + +    S  +  A K +K  R  S  +    ++  +EV I+++++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAIDVSKGMNYLHQ 337
           V+           + ++ E ++GG ++D+L + + + +      LK  ++   G+ YLH 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 452 ERCWQQDPALR 462
            R   +DP  R
Sbjct: 253 RRLLVKDPKKR 263

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 227 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV  I
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 285 GAC---TKPPSLCIVTEFMSGGSVYDYL-HKLKGV-------FKLPSLLKVAIDVSKGMN 333
             C     P + C  + ++    V+D+  H L G+       F L  + +V   +  G+ 
Sbjct: 83  EICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 388
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q         T  +  PE
Sbjct: 139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 198
Query: 389 -VIEHKPYDHKADVFSFGIVLWELLT 413
            ++  + Y    D++  G ++ E+ T
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 95/178 (53%), Gaps = 5/178 (2%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     +V + ++GG 
Sbjct: 30  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVA 361
           +++ +   +  +           + + +N+ H N I+HRDLK  NLL+    +   VK+A
Sbjct: 90  LFEDI-VAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 362 DFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           DFG+A  V+          GT  +++PEV+   PY    D+++ G++L+ LL G  P+
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 229 VASGSYGDLY--RGTYCSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           +  G +  +Y  R    +Q VAIK +K          + +   +E+ +++++ H N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-KGMNYLHQNNIIH 342
           + A     ++ +V +FM   +  + + K   +   PS +K  + ++ +G+ YLHQ+ I+H
Sbjct: 78  LDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKAD 400
           RDLK  NLL+DEN V+K+ADFG+A+               RW  APE++   + Y    D
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVD 195
Query: 401 VFSFGIVLWELLTGKLPY 418
           +++ G +L ELL  ++P+
Sbjct: 196 MWAVGCILAELLL-RVPF 212

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 40  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 150
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR       M     T
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVAT 208
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                  L +V EF+S   + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 73  VIHTENKLYLVFEFLSM-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 344 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 401
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 402 FSFGIVLWELLTGK 415
           +S G +  E++T +
Sbjct: 191 WSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                  L +V EF+S   + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 72  VIHTENKLYLVFEFLSM-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 344 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 401
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 402 FSFGIVLWELLTGK 415
           +S G +  E++T +
Sbjct: 190 WSLGCIFAEMVTRR 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 20  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-R 72
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+   RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 73  EIKILLAFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 126
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 127 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
           T    T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 8/166 (4%)
Query: 260 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 52  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 110
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +   
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 170
Query: 379 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 418
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--------LNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DF +AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 266
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 11  PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 69
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 70  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 127
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 187
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 8/166 (4%)
Query: 260 DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
           ++++   +EV I+RKV  H N++Q            +V + M  G ++DYL + K     
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE 123
Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
               K+   + + +  LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 379 TGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPY 418
            GT  ++APE+IE      H  Y  + D++S G++++ LL G  P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 266
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 4   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 62
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 63  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 120
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 180
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 104
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERINSDMQKE------FA 266
           PK L+        + SG+ G++   +    C + VAIK++   +      +E        
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 266
           PK L+        + SG+ G++   +    C + VAIK++   +        +D      
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERINSDMQKE------FA 266
           PK L+        + SG+ G++   +    C + VAIK++   +      +E        
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVE 63
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 64  TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 121
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           ++APEV   +    Y+   D +S G++L+  L+G  P+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 22  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 74
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 75  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
                T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 189 XEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 267
           V+++ P++    S +  G+YG       CS         VAIK + P    +  Q+   +
Sbjct: 23  VFDVGPRYTNL-SYIGEGAYG-----MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-R 75
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 320
           E+ I+ + RH+N++  I    + P++       IV + M        L+KL     L + 
Sbjct: 76  EIKILLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 129
Query: 321 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVM 375
            +      + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +
Sbjct: 130 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 189
Query: 376 TAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
                T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 190 XEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KL 416
           K+
Sbjct: 222 KI 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--- 323
           + ++H+NV+  +   T   SL       +VT  M           L  + K   L     
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHV 127
Query: 324 --VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
             +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+  FG+AR       MT    T
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYVAT 185
Query: 382 YRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
             + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 362
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 92  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 363 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 151 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 362
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 363 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 6/203 (2%)
Query: 218 IDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           +D ++ +   K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
            H N+V+ +        L +V EF+      +     L G+  LP +      + +G+ +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAF 122
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEH 392
            H + ++HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 393 KPYDHKADVFSFGIVLWELLTGK 415
           K Y    D++S G +  E++T +
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 362
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 93  FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 363 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 97/193 (50%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+++ H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           +  +N V+ + A  K  +L I  E+   G++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 379
           +H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 380 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 434
           GT  ++A EV++    Y+ K D++S GI+ +E++    TG      L  L++    V   
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSIE 247
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRP 463
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 126/265 (47%), Gaps = 25/265 (9%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 266
           PK L+        + SG+ G++   +    C + VAI+++   +        +D      
Sbjct: 144 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVE 202
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 203 TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 260
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 320
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY-EYLT--PLQAAVGVVQKGLRP 437
           ++APEV   +    Y+   D +S G++L+  L+G  P+ E+ T   L+  +   +    P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 438 TIPKNSQPKLAELLERCWQQDPALR 462
            +      K  +L+++    DP  R
Sbjct: 381 EVWAEVSEKALDLVKKLLVVDPKAR 405

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 126/265 (47%), Gaps = 25/265 (9%)
Query: 220 PKHLK----FGSKVASGSYGDL---YRGTYCSQDVAIKVLKPERI------NSDMQKEFA 266
           PK L+        + SG+ G++   +    C + VAI+++   +        +D      
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVE 188
Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E+ I++K+ H  +++ I          IV E M GG ++D +   K + +    L    
Sbjct: 189 TEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-Y 246
Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   + YLH+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 384 WMAPEV---IEHKPYDHKADVFSFGIVLWELLTGKLPY-EYLT--PLQAAVGVVQKGLRP 437
           ++APEV   +    Y+   D +S G++L+  L+G  P+ E+ T   L+  +   +    P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 438 TIPKNSQPKLAELLERCWQQDPALR 462
            +      K  +L+++    DP  R
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKAR 391

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 93/176 (52%), Gaps = 4/176 (2%)
Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           + A K++  +++++   ++  +E  I RK++H N+V+   +  +     +V + ++GG +
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVAD 362
           ++ +   +  +           + + + Y H N I+HR+LK  NLL+    +   VK+AD
Sbjct: 116 FEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 363 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           FG+A     S       GT  +++PEV++  PY    D+++ G++L+ LL G  P+
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 195
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 196 SLGCIFAEMVTRR 208

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KL 416
           K+
Sbjct: 222 KI 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +M  E  T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 96
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 415 KL 416
           K+
Sbjct: 215 KI 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 229 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           + SG+ G +     T    +VA+K L     N    K   +E+ +++ V HKN++  +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 287 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            T   +L       +V E M   ++   +H      ++  LL   +    G+ +LH   I
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQML---CGIKHLHSAGI 145
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 400
           IHRDLK +N+++  +  +K+ DFG+AR  + + +MT    T  + APEVI    Y    D
Sbjct: 146 IHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVD 205
Query: 401 VFSFGIVLWELLTGKLPYE 419
           ++S G ++ EL+ G + ++
Sbjct: 206 IWSVGCIMGELVKGSVIFQ 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +WE+ P+  +  S V SG+YG +     T     VA+K L     +    K   +E+ ++
Sbjct: 17  IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 323
           + ++H+NV+  +   T   SL    EF     VY   H     L  + K   L       
Sbjct: 76  KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ D G+AR       MT    T  
Sbjct: 130 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYVATRW 187
Query: 384 WMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           + APE++ +   Y+   D++S G ++ ELLTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 141
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 142 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 415 KL 416
           K+
Sbjct: 260 KI 261

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 101/208 (48%), Gaps = 7/208 (3%)
Query: 217 EIDPKHLKFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER-INSDMQKEFAQEVFIMR 273
           +++  H +    +  GS+G   + +     +  A+K +  ++ +  +  +   +E+ IM+
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
            + H  +V    +      + +V + + GG +  +L +    FK  ++     ++   ++
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALD 129
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           YL    IIHRD+K  N+L+DE+  V + DF +A +  +   +T   GT  +MAPE+   +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189
Query: 394 P---YDHKADVFSFGIVLWELLTGKLPY 418
               Y    D +S G+  +ELL G+ PY
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 228 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+Y  +Y+G     D  VA+K ++ E           +EV +++ ++H N+V    
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                 SL +V E++    +  YL     +  + ++      + +G+ Y H+  ++HRDL
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 403
           K  NLL++E   +K+ADFG+AR K+  +     E  T  +  P++ +    Y  + D++ 
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186
Query: 404 FGIVLWELLTGK 415
            G + +E+ TG+
Sbjct: 187 VGCIFYEMATGR 198

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
                  L +V EF+    + D++    L G+  LP +      + +G+ + H + ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKDFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 344 DLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 401
           DLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D+
Sbjct: 128 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 402 FSFGIVLWELLTGK 415
           +S G +  E++T +
Sbjct: 188 WSLGCIFAEMVTRR 201

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 17/197 (8%)
Query: 229 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 280
           +  GS+G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +  +   T    +C+  E +S  ++Y+ + K K   F LP + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 340 IIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 398 KADVFSFGIVLWELLTG 414
             D++S G +L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMT- 376
           L + I +++ + +LH   ++HRDLK +N+    ++VVKV DFG+     Q      V+T 
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 377 --------AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA- 427
                    + GT  +M+PE I    Y HK D+FS G++L+ELL     Y + T ++   
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERVR 281
Query: 428 -VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            +  V+    P +     P+   +++      P  RP+ ++IIE
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 108
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 109 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 166
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 167 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 226
Query: 415 KLPY 418
           K+ +
Sbjct: 227 KILF 230

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 17/197 (8%)
Query: 229 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 280
           +  GS+G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +  +   T    +C+  E +S  ++Y+ + K K   F LP + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 340 IIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 398 KADVFSFGIVLWELLTG 414
             D++S G +L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 195
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 196 SLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  L +V EF     +  Y     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 403
           K  NLL++ N  +K+ADFG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 404 FGIVLWELLTGKLP 417
            G +  EL     P
Sbjct: 188 AGCIFAELANAARP 201

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 97
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 98  VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 215
Query: 415 KLPY 418
           K+ +
Sbjct: 216 KILF 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 141
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 142 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 415 KL 416
           K+
Sbjct: 260 KI 261

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+S     +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 104
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 415 KLPY 418
           K+ +
Sbjct: 223 KILF 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 96
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 97  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 415 KL 416
           K+
Sbjct: 215 KI 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 104
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 105 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 222
Query: 415 KLPY 418
           K+ +
Sbjct: 223 KILF 226

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 103
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 104 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 221
Query: 415 KLPY 418
           K+ +
Sbjct: 222 KILF 225

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 102
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 103 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 220
Query: 415 KLPY 418
           K+ +
Sbjct: 221 KILF 224

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 97
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 98  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 415 KL 416
           K+
Sbjct: 216 KI 217

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   +L    EF     
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL---EEFQD--- 97
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 98  VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +MT    T  + APEVI    Y    D++S G ++ E++  
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 215
Query: 415 KL 416
           K+
Sbjct: 216 KI 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 227 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 280
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 281 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 333
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+S     +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 18/180 (10%)
Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           ++VAIK L     N    K   +E+ +M+ V HKN++  +   T   SL    EF     
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 105
Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 354
           VY  +  +     L  ++++ +D  +          G+ +LH   IIHRDLK +N+++  
Sbjct: 106 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 163
Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
           +  +K+ DFG+AR    S +M     T  + APEVI    Y    D++S G ++ E++ G
Sbjct: 164 DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 95/180 (52%), Gaps = 9/180 (5%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
           +Q  A+K++  +R+ ++ QKE      +     H N+V+            +V E ++GG
Sbjct: 36  NQAFAVKII-SKRMEANTQKEITA---LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91
Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENE--VVKV 360
            +++ + K K  F       +   +   ++++H   ++HRDLK  NLL  DEN+   +K+
Sbjct: 92  ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 361 ADFGVARVKA-QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
            DFG AR+K   +  +     T  + APE++    YD   D++S G++L+ +L+G++P++
Sbjct: 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 227 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 280
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 281 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 333
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 120/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E M     ++D++ + +G  +          V + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 129
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 188
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 240
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 241 WCLALRPSDRPTFEEI 256

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 227 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 280
           +++  G+YG +++          VA+K ++ +     M     +EV ++R +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 281 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMN 333
           V+    CT     +   L +V E +    +  YL K+   GV    ++  +   + +G++
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQLLRGLD 134
Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           +LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    D++S G +  E+   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 96/185 (51%), Gaps = 17/185 (9%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
            Q+ A K++  +++++   ++  +E  I R ++H N+V+   + ++     ++ + ++GG
Sbjct: 47  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 106
Query: 304 SVYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---E 354
            +++      Y  +      +  +L+  +       + HQ  ++HRDLK  NLL+    +
Sbjct: 107 ELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRDLKPENLLLASKLK 159
Query: 355 NEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
              VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL 
Sbjct: 160 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 219
Query: 414 GKLPY 418
           G  P+
Sbjct: 220 GYPPF 224

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 14/267 (5%)
Query: 216 WEIDPKHLKFGSKVASGSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI-M 272
           +E+    L+   ++  G+YG  +  R     Q  A+K ++   +NS  QK    ++ I  
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISX 87
Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSK 330
           R V     V F GA  +   + I  E         Y   +     +P   L K+A+ + K
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 331 GMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
            + +LH   ++IHRD+K +N+L++    VK  DFG++           + G   + APE 
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 390 I----EHKPYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS- 443
           I      K Y  K+D++S GI   EL   + PY+ + TP Q    VV++   P +P +  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKF 266
Query: 444 QPKLAELLERCWQQDPALRPDFSEIIE 470
             +  +   +C +++   RP + E+ +
Sbjct: 267 SAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 229 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NV 280
           +  G +G + +       Q VA+K+++ E+      ++ A+E+ I+  +R +      NV
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +  +   T    +C+  E +S  ++Y+ + K K   F LP + K A  + + ++ LH+N 
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 340 IIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           IIH DLK  N+L+ +     +KV DFG +  + Q      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGARYGM 278
Query: 398 KADVFSFGIVLWELLTG 414
             D++S G +L ELLTG
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 5/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L I+ E M GG ++  +  +    F      ++  D+   + +LH +NI HRD+K  NLL
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 352 MDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
               E   V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G+++
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 201 YILLCGFPPF 210

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 116/237 (48%), Gaps = 32/237 (13%)
Query: 216 WEIDPKHLKFGSKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 269
           +++ P++ +    +  G+YG      D  R T     VAIK + P    +  Q+   +E+
Sbjct: 39  FDVGPRYTQL-QYIGEGAYGMVSSAYDHVRKT----RVAIKKISPFEHQTYCQRTL-REI 92
Query: 270 FIMRKVRHKNVV---QFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LL 322
            I+ + RH+NV+     + A T      + IV + M        L+KL    +L +  + 
Sbjct: 93  QILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETD-----LYKLLKSQQLSNDHIC 147
Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK----AQSGVMTAE 378
                + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+AR+       +G +T  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 379 TGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 431
             T  + APE+ +  K Y    D++S G +L E+L+ +  +    YL  L   +G++
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 7/131 (5%)
Query: 293 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 350
           L I+ E M GG ++  + + +G   F      ++  D+   + +LH +NI HRD+K  NL
Sbjct: 101 LLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159
Query: 351 LMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 407
           L    E   V+K+ DFG A+   Q+ + T     Y ++APEV+  + YD   D++S G++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVI 218
Query: 408 LWELLTGKLPY 418
           ++ LL G  P+
Sbjct: 219 MYILLCGFPPF 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 229 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           + SG+ G +     T    +VA+K L     N    K   +E+ +++ V HKN++  +  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 287 CTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            T   +L       +V E M   ++   +H      ++  LL     +  G+ +LH   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGI 147
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 400
           IHRDLK +N+++  +  +K+ DFG+AR    + +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVD 207
Query: 401 VFSFGIVLWELLTGKLPYE 419
           ++S G ++ EL+ G + ++
Sbjct: 208 IWSVGCIMGELVKGCVIFQ 226

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+  ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+  ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 193 SLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 192 SLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 228 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V+   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
                  L +V EF     +  Y     G      +      + KG+ + H  N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 403
           K  NLL++ N  +K+A+FG+AR         +AE  T  +  P+V+   K Y    D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 404 FGIVLWELLTGKLP 417
            G +  EL     P
Sbjct: 188 AGCIFAELANAGRP 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 190 SLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 191 SLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 188 SLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 228 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVI-EHKPYDHKADV 401
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
           +S G +  E++ G       TPL   V    + +R
Sbjct: 185 WSVGCIFAEMVNG-------TPLFPGVSEADQLMR 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 286 ACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                  L +V EF+      +     L G+  LP +      + +G+ + H + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 345 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVF 402
           LK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y    D++
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 403 SFGIVLWELLTGK 415
           S G +  E++T +
Sbjct: 189 SLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 286 ACTKPPSLCIVTE--------FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
                  L +V E        FM   +       L G+  LP +      + +G+ + H 
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASA-------LTGI-PLPLIKSYLFQLLQGLAFCHS 120
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPY 395
           + ++HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE+ +  K Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 396 DHKADVFSFGIVLWELLTGK 415
               D++S G +  E++T +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           +  +N V+ + A  K  +L I  E+    ++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 379
           +H   IIHRDLK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 380 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 434
           GT  ++A EV++    Y+ K D++S GI+ +E++    TG      L  L++    V   
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS----VSIE 247
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRP 463
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 228 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVI-EHKPYDHKADV 401
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 402 FSFGIVLWELLTG 414
           +S G +  E++ G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 66/283 (23%)
Query: 212 GTDVWEIDPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKP------ERINSDMQKE 264
           G  + E+  K HLK    +  GSYG + R    +Q  AI+ +K        +IN    + 
Sbjct: 18  GGSLLELQKKYHLK--GAIGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER 74
Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
              EV +M+K+ H N+ +          +C+V E   GG + D L+    VF   S  K 
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN----VFIDDSTGKC 130
Query: 325 AIDVSK-------------------------------------------GMNYLHQNNII 341
           A+DV K                                            ++YLH   I 
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190
Query: 342 HRDLKAANLLMDENEV--VKVADFGVAR--VKAQSGV---MTAETGTYRWMAPEVIE--H 392
           HRD+K  N L   N+   +K+ DFG+++   K  +G    MT + GT  ++APEV+   +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 435
           + Y  K D +S G++L  LL G +P+  +        V+ K L
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 228 KVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                 L +V E +    +   L   +G  +  +     + +  G+ Y H   ++HRDLK
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 347 AANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEVI-EHKPYDHKADV 401
             NLL++    +K+ADFG+AR     G+     T E  T  + AP+V+   K Y    D+
Sbjct: 128 PQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 402 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
           +S G +  E++ G       TPL   V    + +R
Sbjct: 185 WSVGCIFAEMVNG-------TPLFPGVSEADQLMR 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 281
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 282 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 334
           + +  C      +   + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 281
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 282 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 334
           + +  C      +   + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 229 VASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
           V SG+YG +           VAIK L     +    K   +E+ +++ +RH+NV+  +  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 287 CTKPPSLCIVTEF-----MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
            T   +L   T+F       G  +   + H+  G  ++  L+     + KG+ Y+H   I
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV---YQMLKGLRYIHAAGI 149
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKA 399
           IHRDLK  NL ++E+  +K+ DFG+AR +A S  M     T  + APEVI +   Y    
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLAR-QADSE-MXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 400 DVFSFGIVLWELLTGK 415
           D++S G ++ E++TGK
Sbjct: 208 DIWSVGCIMAEMITGK 223

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 236
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 269
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 268
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 281
           +++  G+YG +Y  R  +    VA+K ++       +     +EV ++R++    H NVV
Sbjct: 10  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVV 69
Query: 282 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNY 334
           + +  C      +   + +V E +    +  YL K      LP  ++  +     +G+++
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDF 127
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +     T  + APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E+   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 269
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSSECQ----HLIR 268
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 13/104 (12%)
Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--------- 372
           L + + +++ + +LH   ++HRDLK +N+    ++VVKV DFG+     Q          
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 373 ----GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
                  T + GT  +M+PE I    Y HK D+FS G++L+ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 269
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 158
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 217
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 269
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 270 WCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG----QVFFRQRVSXECQ----HLIR 268
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 29/283 (10%)
Query: 218 IDPKHLKFGSKVASG--SYGDLYRGTYCSQDVAIK-VLKPERINSDMQKEFAQEVFIMRK 274
           ID KH  F  K+  G  SY DL  G +     A+K +L  E+ +   ++E  +E  + R 
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRL 82
Query: 275 VRHKNVVQFIGACTKPPSL----CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAID 327
             H N+++ +  C +         ++  F   G++++ + +LK          +L + + 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-----VARVKAQSGVMT-----A 377
           + +G+  +H     HRDLK  N+L+ +     + D G        V+     +T     A
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 378 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV-VQK 433
           +  T  + APE+     H   D + DV+S G VL+ ++ G+ PY+ +     +V + VQ 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 434 GLR-PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            L  P  P++S   L +LL      DP  RP    ++  L+ +
Sbjct: 263 QLSIPQSPRHSS-ALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 120/248 (48%), Gaps = 15/248 (6%)
Query: 229 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHK-NV 280
           + +G+YG ++      G    +  A+KVLK   I   +   +    E  ++  +R    +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V    A      L ++ ++++GG ++ +L + +   +    + V  ++   + +LH+  I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGI 180
Query: 341 IHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIE--HKPYD 396
           I+RD+K  N+L+D N  V + DFG+++  V  ++       GT  +MAP+++      +D
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 454
              D +S G++++ELLTG  P+       +   + ++ L+  P  P+       +L++R 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 455 WQQDPALR 462
             +DP  R
Sbjct: 301 LMKDPKKR 308

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 236
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 48/296 (16%)
Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDV------AIKVLKPERINSDMQKEFAQEVF 270
           E+    L+    +A G +  +Y     +QDV      A+K L       +  +   QEV 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYE----AQDVGSGREYALKRLLSN--EEEKNRAIIQEVC 77
Query: 271 IMRKVR-HKNVVQFIGAC--------TKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLP 319
            M+K+  H N+VQF  A         T      ++TE +  G + ++L K+  +G     
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCD 136
Query: 320 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARV--------- 368
           ++LK+     + + ++H+    IIHRDLK  NLL+     +K+ DFG A           
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 369 KAQSGVMTAE----TGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYL 421
            AQ   +  E      T  +  PE+I+   + P   K D+++ G +L+ L   + P+E  
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ-DPALRPDFSEIIEILQQIA 476
             L+     +  G     P ++Q  +   L R   Q +P  R   +E++  LQ+IA
Sbjct: 257 AKLR-----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 125
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 236
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 237 WCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 10  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 128
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 187
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 239
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 240 WCLALRPSDRPTFEEI 255

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 164
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 223
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 275
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 276 WCLALRPSDRPTFEEI 291

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 144
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 203
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 255
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 256
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 157
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 216
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 268
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 172
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 231
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 283
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 130
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 189
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 241
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 242 WCLALRPSDRPTFEEI 257

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A      L +V E+M GG + + +       K         +V   ++ +H   +IHRD+
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 200
Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 399
           K  N+L+D++  +K+ADFG      ++G++  +T  GT  +++PEV++ +     Y  + 
Sbjct: 201 KPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGREC 260
Query: 400 DVFSFGIVLWELLTGKLPY 418
           D +S G+ L+E+L G  P+
Sbjct: 261 DWWSVGVFLFEMLVGDTPF 279

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 129
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 188
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSECQ----HLIR 240
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 241 WCLALRPSDRPTFEEI 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 59  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 118
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 119 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 177
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 236
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 288
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 289 WCLALRPSDRPTFEEI 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 34  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 152
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 211
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 263
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 264 WCLALRPSDRPTFEEI 279

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 214 YILLCGYPPF 223

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 144
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 203
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 255
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 256
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 172
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 231
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 283
Query: 453 RCWQQDPALRPDFSEI 468
            C    P+ RP F EI
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 216 YILLCGYPPF 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 215 YILLCGYPPF 224

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 210 YILLCGYPPF 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 254 YILLCGYPPF 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 260 YILLCGYPPF 269

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 210 YILLCGYPPF 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 224 YILLCGYPPF 233

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 208 YILLCGYPPF 217

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 209 YILLCGYPPF 218

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 228 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+YG +Y  R     + VA+K ++ +     +     +E+ +++++ H N+V+ + 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 286 ACTKPPSLCIVTE--------FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
                  L +V E        FM   +       L G+  LP +      + +G+ + H 
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASA-------LTGI-PLPLIKSYLFQLLQGLAFCHS 124
Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEV-IEHKPY 395
           + ++HRDLK  NLL++    +K+ADFG+AR           E  T  + APE+ +  K Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 396 DHKADVFSFGIVLWELLTGK 415
               D++S G +  E++T +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G+++
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 208 YILLCGYPPF 217

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 21/256 (8%)
Query: 224 KFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S +  VAIK ++ +RI+   +         EV +++KV  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
               V++ +    +P S  ++ E       ++D++ + +G  +          V + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRH 145
Query: 335 LHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-H 392
            H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 204
Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +   A V+S GI+L++++ G +P+E+   +       Q   R  +    Q     L+ 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSXECQ----HLIR 256
Query: 453 RCWQQDPALRPDFSEI 468
            C    P  RP F EI
Sbjct: 257 WCLALRPXDRPTFEEI 272

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVR---HK 278
           +++  G+YG +Y  R  +    VA+K ++          +     +EV ++R++    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 279 NVVQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKG 331
           NVV+ +  C      +   + +V E +    +  YL K      LP  ++  +     +G
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-GLPAETIKDLMRQFLRG 132
Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
           +++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  + APEV+ 
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192
Query: 392 HKPYDHKADVFSFGIVLWELLTGK 415
              Y    D++S G +  E+   K
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 234 YGDLYRGTY---------CS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
           Y D+ +G +         C+  + A K++  +++++   ++  +E  I R ++H N+V+ 
Sbjct: 9   YEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 284 IGACTKPPSLCIVTEFMSGGSVYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             + ++     +V + ++GG +++      Y  +      +  +L+  +       + HQ
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ 121
Query: 338 NNIIHRDLKAANLLMD---ENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHK 393
             ++HRDLK  NLL+    +   VK+ADFG+A  V+          GT  +++PEV+  +
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
            Y    D+++ G++L+ LL G  P+
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 95/185 (51%), Gaps = 17/185 (9%)
Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 303
            Q+ A  ++  +++++   ++  +E  I R ++H N+V+   + ++     ++ + ++GG
Sbjct: 36  GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95
Query: 304 SVYD------YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---E 354
            +++      Y  +      +  +L+  +       + HQ  ++HR+LK  NLL+    +
Sbjct: 96  ELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRNLKPENLLLASKLK 148
Query: 355 NEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
              VK+ADFG+A  V+ +        GT  +++PEV+   PY    D+++ G++L+ LL 
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 414 GKLPY 418
           G  P+
Sbjct: 209 GYPPF 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           +KN+++ I          +V E + GGS+  ++ K K  F      +V  DV+  +++LH
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH 128
Query: 337 QNNIIHRDLKAANLLMDENEV---VKVADF----GVARVKAQSGVMTAE----TGTYRWM 385
              I HRDLK  N+L +  E    VK+ DF    G+    + + + T E     G+  +M
Sbjct: 129 TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 386 APEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPY 418
           APEV+E        YD + D++S G+VL+ +L+G  P+
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 343
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 137 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 397
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 398 KADVFSFGIVLWELLTGKLPY 418
           + D +S G+ L+E+L G  P+
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPF 273

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 4/130 (3%)
Query: 293 LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
           L IV E + GG ++  +  +    F      ++   + + + YLH  NI HRD+K  NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 352 MDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
                 N ++K+ DFG A+       +T    T  ++APEV+  + YD   D +S G++ 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIX 253
Query: 409 WELLTGKLPY 418
           + LL G  P+
Sbjct: 254 YILLCGYPPF 263

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 343
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 142 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 397
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 398 KADVFSFGIVLWELLTGKLPY 418
           + D +S G+ L+E+L G  P+
Sbjct: 258 ECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 229 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           +  G++G+  L R     +  A+K+L K E I       F +E  IM       VVQ   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHR 343
           A      L +V E+M GG     L  L   + +P         +V   ++ +H    IHR
Sbjct: 142 AFQDDRYLYMVMEYMPGGD----LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDH 397
           D+K  N+L+D++  +K+ADFG      + G++  +T  GT  +++PEV++ +     Y  
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 257
Query: 398 KADVFSFGIVLWELLTGKLPY 418
           + D +S G+ L+E+L G  P+
Sbjct: 258 ECDWWSVGVFLYEMLVGDTPF 278

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           +  +N V+   A  K  +L I  E+    ++YD +H      +     ++   + + ++Y
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------------VKAQSGVMTAET 379
           +H   IIHR+LK  N+ +DE+  VK+ DFG+A+               +   S  +T+  
Sbjct: 132 IHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 380 GTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELL----TGKLPYEYLTPLQAAVGVVQKG 434
           GT  ++A EV++    Y+ K D +S GI+ +E +    TG      L  L++    V   
Sbjct: 192 GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRS----VSIE 247
Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRP 463
             P    N      +++      DP  RP
Sbjct: 248 FPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 225 FGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
            G  +  GSYG     L   T C + V I   K  R   + +    +E+ ++R++RHKNV
Sbjct: 9   MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 281 VQFIGAC--TKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           +Q +      +   + +V E+   G   + D + + +  F +         +  G+ YLH
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLH 126
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGVMTAETGTYRWMAPEVIE-- 391
              I+H+D+K  NLL+     +K++  GVA      A         G+  +  PE+    
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 392 HKPYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
                 K D++S G+ L+ + TG  P+E   +  L   +G   KG    IP +  P L++
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG---KGSY-AIPGDCGPPLSD 242
Query: 450 LLERCWQQDPALRPDFSEI 468
           LL+   + +PA R    +I
Sbjct: 243 LLKGMLEYEPAKRFSIRQI 261

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 228 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           ++  GS+G+++R      G  C+ + V ++V +            A+E+     +    +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR------------AEELMACAGLTSPRI 147
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V   GA  + P + I  E + GGS+   L K +G       L       +G+ YLH   I
Sbjct: 148 VPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRI 206
Query: 341 IHRDLKAANLLM-DENEVVKVADFGVARVKAQSG----VMTAE--TGTYRWMAPEVIEHK 393
           +H D+KA N+L+  +     + DFG A      G    ++T +   GT   MAPEV+  +
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             D K DV+S   ++  +L G  P+   +  PL   +      +R  IP +  P  A+ +
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAI 325
Query: 452 ERCWQQDPALRPDFSE----IIEILQQIA 476
           +   +++P  R   +E    +   LQQ+ 
Sbjct: 326 QEGLRKEPIHRVSAAELGGKVNRALQQVG 354

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 39/200 (19%)
Query: 243 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 286
           C + VAIK +    + +D Q  K   +E+ I+R++ H N+V+               +G+
Sbjct: 35  CDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 341
            T+  S+ IV E+M           L  V +   LL+         + +G+ Y+H  N++
Sbjct: 91  LTELNSVYIVQEYMET--------DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVL 142
Query: 342 HRDLKAANLLMD-ENEVVKVADFGVARVK----AQSGVMTAETGTYRWMAPE-VIEHKPY 395
           HRDLK ANL ++ E+ V+K+ DFG+AR+     +  G ++    T  + +P  ++    Y
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202
Query: 396 DHKADVFSFGIVLWELLTGK 415
               D+++ G +  E+LTGK
Sbjct: 203 TKAIDMWAAGCIFAEMLTGK 222

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 228 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           ++  GS+G+++R      G  C+ + V ++V +            A+E+     +    +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR------------AEELMACAGLTSPRI 128
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V   GA  + P + I  E + GGS+   L K +G       L       +G+ YLH   I
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRI 187
Query: 341 IHRDLKAANLLM-DENEVVKVADFGVARVKAQSG----VMTAE--TGTYRWMAPEVIEHK 393
           +H D+KA N+L+  +     + DFG A      G    ++T +   GT   MAPEV+  +
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 394 PYDHKADVFSFGIVLWELLTGKLPYE--YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 451
             D K DV+S   ++  +L G  P+   +  PL   +      +R  IP +  P  A+ +
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVR-EIPPSCAPLTAQAI 306
Query: 452 ERCWQQDPALRPDFSE----IIEILQQIA 476
           +   +++P  R   +E    +   LQQ+ 
Sbjct: 307 QEGLRKEPIHRVSAAELGGKVNRALQQVG 335

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 264 EFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY------LHKLKGVFK 317
           +F  E+ I+  ++++  +   G  T    + I+ E+M   S+  +      L K    F 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 318 LPSLLKVAI-DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
              ++K  I  V    +Y+H + NI HRD+K +N+LMD+N  VK++DFG +       + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI- 207
Query: 376 TAETGTYRWMAPEVIEHK-PYD-HKADVFSFGIVLWELLTGKLPY 418
               GTY +M PE   ++  Y+  K D++S GI L+ +    +P+
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 227 SKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 284
           +K+  G+YG++Y+   T  ++ VAIK ++ E     +     +EV ++++++H+N+++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
                   L ++ E+ +   +  Y+ K   V  +  +      +  G+N+ H    +HRD
Sbjct: 100 SVIHHNHRLHLIFEY-AENDLKKYMDKNPDV-SMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 345 LKAANLLM-----DENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKP 394
           LK  NLL+      E  V+K+ DFG+AR     G+     T E  T  +  PE+ +  + 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 395 YDHKADVFSFGIVLWELL 412
           Y    D++S   +  E+L
Sbjct: 215 YSTSVDIWSIACIWAEML 232

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 228 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 281
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 16  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 339 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 378
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 188
Query: 379 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 189 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 243
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRP 463
           P IP+    +  ELL+     DP  RP
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRP 270

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 228 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 281
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 16  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 339 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 378
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 188
Query: 379 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 189 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 243
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRP 463
           P IP+    +  ELL+     DP  RP
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRP 270

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 228 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 281
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 14  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 70
Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 71  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 130
Query: 339 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 378
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 131 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 186
Query: 379 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 187 EGDSRFLANEVLQEN-YTHLPKADIFALALTVVX-AAGAEP---LPRNGDQWHEIRQGRL 241
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRP 463
           P IP+    +  ELL+     DP  RP
Sbjct: 242 PRIPQVLSQEFTELLKVMIHPDPERRP 268

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 126/274 (45%), Gaps = 43/274 (15%)
Query: 228 KVASGSYGDLYRGTYCSQDV-----AIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 281
           K+ SG +G +++   C + +     AIK  K     S  ++   +EV+    + +H +VV
Sbjct: 18  KIGSGEFGSVFK---CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           ++  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 339 NIIHRDLKAANLLM-------------DENE------VVKVADFG-VARVKAQSGVMTAE 378
           +++H D+K +N+ +             DE++      + K+ D G V R+ +       E
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VE 190
Query: 379 TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
            G  R++A EV++   Y H  KAD+F+  + +     G  P   L         +++G  
Sbjct: 191 EGDSRFLANEVLQEN-YTHLPKADIFALALTVV-CAAGAEP---LPRNGDQWHEIRQGRL 245
Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           P IP+    +  ELL+     DP  RP    +++
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 128/264 (48%), Gaps = 34/264 (12%)
Query: 229 VASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKV-RHKNVVQFIG 285
           +  G+ G + YRG + ++DVA+K + PE  +      FA +EV ++R+   H NV+++  
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYF- 84
Query: 286 ACT-KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
            CT K      +   +   ++ +Y+ +          + +    + G+ +LH  NI+HRD
Sbjct: 85  -CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 345 LKAANLLM---DENEVVK--VADFGVARVKA--------QSGVMTAETGTYRWMAPEVIE 391
           LK  N+L+   + +  +K  ++DFG+ +  A        +SGV     GT  W+APE++ 
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV----PGTEGWIAPEMLS 199
Query: 392 HKPYD---HKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
               +   +  D+FS G V + +++ G  P+      QA + +    L    P+  +  +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 448 A-ELLERCWQQDPALRPDFSEIIE 470
           A EL+E+    DP  RP    +++
Sbjct: 260 ARELIEKMIAMDPQKRPSAKHVLK 283

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 228 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           +V  GS+G+++R      G  C+ + V ++V + E            E+     +    +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACAGLSSPRI 112
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V   GA  + P + I  E + GGS+   + ++ G       L       +G+ YLH   I
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 341 IHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV----MTAE--TGTYRWMAPEVIEHK 393
           +H D+KA N+L+  +     + DFG A      G+    +T +   GT   MAPEV+  K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
           P D K D++S   ++  +L G  P+
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKV--LKPERINSDMQKEFAQ 267
           G+ V  + P + + G K+  G++G+L  G   Y ++ VAIK+  +K       ++  F +
Sbjct: 1   GSGVLMVGP-NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59
Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           ++     +     V + G C K  ++  V E + G S+ D        F L ++L +AI 
Sbjct: 60  QLGSGDGIPQ---VYYFGPCGKYNAM--VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARV----KAQSGVMTAE 378
           +   M Y+H  N+I+RD+K  N L+        +V+ + DFG+A+     + +  +   E
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYRE 173
Query: 379 ----TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-----YLTPLQAAVG 429
               TGT R+M+      K    + D+ + G +    L G LP++      L      +G
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
Query: 430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
             ++     +   + P++A  L    + D   +PD+  + ++   +
Sbjct: 234 DTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 228 KVASGSYGDLYR------GTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           +V  GS+G+++R      G  C+ + V ++V + E            E+     +    +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACAGLSSPRI 128
Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V   GA  + P + I  E + GGS+   + ++ G       L       +G+ YLH   I
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRI 187
Query: 341 IHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGV----MTAE--TGTYRWMAPEVIEHK 393
           +H D+KA N+L+  +     + DFG A      G+    +T +   GT   MAPEV+  K
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
           P D K D++S   ++  +L G  P+
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 227 SKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHK 278
           S + SG++G ++       +++V +K +K E++  D   E         E+ I+ +V H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--DVSKGMNYLH 336
           N+++ +          +V E    GS  D    +    +L   L   I   +   + YL 
Sbjct: 90  NIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 396
             +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   PY 
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 397 H-KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVG---VVQKGLRPTIPKNSQP------ 445
             + +++S G+ L+ L+  + P+ E    ++AA+    +V K L   +    QP      
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRT 267
Query: 446 KLAELLERCWQQDPALRPDFS 466
            L +L+   W   P    D++
Sbjct: 268 TLEKLVTDPWVTQPVNLADYT 288

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 88
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 206
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 232
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 99
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 217
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 210
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 81
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 199
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 236 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 295
           +L R     + V ++ +  E  +++M      E+ + +   H N+V +         L +
Sbjct: 28  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 87
Query: 296 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 353
           VT FM+ GS  D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+ 
Sbjct: 88  VTSFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 146
Query: 354 ENEVVKVADFG-----VARVKAQSGVMTAETGTYR---WMAPEVIEH--KPYDHKADVFS 403
            +  V ++        ++  + Q  V      + +   W++PEV++   + YD K+D++S
Sbjct: 147 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 206
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAV---------------------------GVVQKGLR 436
            GI   EL  G +P++ +   Q  +                            V   GL 
Sbjct: 207 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 266
Query: 437 PTI------PKNS-----------QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 477
            ++      P N             P     +E+C Q++P  RP  S ++     +QI +
Sbjct: 267 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 326

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 229 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEVFIMRKVRHKNVVQFIGA 286
           +  GSYG +Y     + +  + + K  R+  D+   K   +E+ I+ +++   +++    
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLHQNNI 340
              P  L    E      + D    LK +FK P  L       +  ++  G N++H++ I
Sbjct: 94  II-PDDLLKFDELYIVLEIAD--SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 341 IHRDLKAANLLMDENEVVKVADFGVARV-----------------------KAQSGVMTA 377
           IHRDLK AN L++++  VKV DFG+AR                        K     +T+
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 378 ETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 413
              T  + APE+I   + Y    D++S G +  ELL 
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 198
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/300 (21%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 236 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 295
           +L R     + V ++ +  E  +++M      E+ + +   H N+V +         L +
Sbjct: 44  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103
Query: 296 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 353
           VT FM+ GS  D +  H + G+ +L ++  +   V K ++Y+H    +HR +KA+++L+ 
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162
Query: 354 ENEVVKVADFG-----VARVKAQSGVMTAETGTYR---WMAPEVIEH--KPYDHKADVFS 403
            +  V ++        ++  + Q  V      + +   W++PEV++   + YD K+D++S
Sbjct: 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 404 FGIVLWELLTGKLPYEYLTPLQAAV---------------------------GVVQKGLR 436
            GI   EL  G +P++ +   Q  +                            V   GL 
Sbjct: 223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 282
Query: 437 PTI------PKNS-----------QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 477
            ++      P N             P     +E+C Q++P  RP  S ++     +QI +
Sbjct: 283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 223 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA----QEVFIMRKVR 276
            +  S +  G+YG +   T+    + VAIK ++P       +  FA    +E+ I++  +
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-----KPLFALRTLREIKILKHFK 67
Query: 277 HKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDV 328
           H+N++  I    +P S      + I+ E M        LH++     L    +       
Sbjct: 68  HENIIT-IFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQT 121
Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-----------MTA 377
            + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+  +S             MT 
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 378 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELL 412
              T  + APEV +    Y    DV+S G +L EL 
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 84
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR--APELIFGAT 202
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 232
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 108
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 226
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 85
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 203
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 118
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 179 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 236
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 237 DYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 116
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 177 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 234
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 235 DYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 229 VASGSYGDLYRGTYCSQD--VAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ--- 282
           + +GS+G +Y+   C     VAIK VL+ +R  +       +E+ IMRK+ H N+V+   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 93
Query: 283 -FIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKLPSL-LKVAI-DVSKGMNYLHQ 337
            F  +  K     L +V +++         H  +    LP + +K+ +  + + + Y+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 338 NNIIHRDLKAANLLMD-ENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVI-EHK 393
             I HRD+K  NLL+D +  V+K+ DFG A+  V+ +  V    +  YR  APE+I    
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGAT 211
Query: 394 PYDHKADVFSFGIVLWELLTGK 415
            Y    DV+S G VL ELL G+
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQ 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	504
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-159
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-151
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-150
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-149
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-149
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-147
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-145
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-143
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-141
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-122
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-118
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-118
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-116
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-113
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-102
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-93
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-91
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-91
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-91
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-90
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-90
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-90
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-89
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-89
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-88
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-88
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-88
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-87
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-87
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-86
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-86
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-85
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-85
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-85
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-85
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-84
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-84
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-84
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-84
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-83
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-83
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-82
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-82
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-80
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-80
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-80
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-80
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-79
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-79
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-79
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-79
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-79
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-79
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-79
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-79
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-78
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-78
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-78
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-78
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-78
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-78
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-77
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-77
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-77
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-77
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-75
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-70
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-64
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-64
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-63
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-62
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-62
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-61
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-61
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-60
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-59
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-58
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-58
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-56
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-56
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-56
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-56
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-55
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-55
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-55
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-55
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-54
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-54
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-54
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-54
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-54
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-53
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-53
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-52
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-50
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-49
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-48
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-47
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-46
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-45
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-44
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-43
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-40
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-39
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-38
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-38
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-38
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-38
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-38
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-37
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-36
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-36
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-36
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-35
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-35
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-35
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-35
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-35
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-34
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-34
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-34
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-34
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-34
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-30
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-30
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-29
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-29
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-29
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-28
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-28
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-27
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-27
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-27
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-27
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-25
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-24
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-23
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-20
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-18
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-18
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1u8s_A	192	Glycine cleavage system transcriptional repressor,	4e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  454 bits (1169), Expect = e-159
 Identities = 117/300 (39%), Positives = 182/300 (60%), Gaps = 8/300 (2%)

Query: 185 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 244
           H    P S+ +    ++  +   +  D     +I    L    K+ +GS+G ++R  +  
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGD---DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
            DVA+K+L  +  +++   EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 305 VYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV 360
           +Y  LHK     +L     L +A DV+KGMNYLH  N  I+HR+LK+ NLL+D+   VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 361 ADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
            DFG++R+KA + +   +  GT  WMAPEV+  +P + K+DV+SFG++LWEL T + P+ 
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 479
            L P Q    V  K  R  IP+N  P++A ++E CW  +P  RP F+ I+++L+ + K  
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  431 bits (1111), Expect = e-151
 Identities = 101/289 (34%), Positives = 164/289 (56%), Gaps = 12/289 (4%)

Query: 200 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS 259
           K H +H     D  D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L       
Sbjct: 3   KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTP 61

Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 319
              + F  EV ++RK RH N++ F+G  T P  L IVT++  G S+Y +LH  +  F++ 
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK 120

Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMT 376
            L+ +A   ++GM+YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A  K++   S    
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180

Query: 377 AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 433
             +G+  WMAPEVI   +  PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240

Query: 434 GLR----PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           G        +  N   ++  L+  C ++    RP F  I+  ++++A+E
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  428 bits (1102), Expect = e-149
 Identities = 92/304 (30%), Positives = 137/304 (45%), Gaps = 17/304 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
               P  L  G  +  G +G   + T+      + + +  R + + Q+ F +EV +MR +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H NV++FIG   K   L  +TE++ GG++   +  +   +     +  A D++ GM YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA---------------QSGVMTAETG 380
           H  NIIHRDL + N L+ EN+ V VADFG+AR+                          G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 381 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV-VQKGLRPTI 439
              WMAPE+I  + YD K DVFSFGIVL E++          P     G+ V+  L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK-EKSSGGFLSV 498
           P N  P    +  RC   DP  RP F ++   L+ +   +        + E+   GF   
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304

Query: 499 LRRG 502
            RRG
Sbjct: 305 YRRG 308

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  425 bits (1096), Expect = e-149
 Identities = 95/274 (34%), Positives = 147/274 (53%), Gaps = 16/274 (5%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIM 272
           + EID   L     +  G +G +YR  +   +VA+K  + +     S   +   QE  + 
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
             ++H N++   G C K P+LC+V EF  GG +   L   +       L+  A+ +++GM
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118

Query: 333 NYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 381
           NYLH      IIHRDLK++N+L+ +        N+++K+ DFG+AR   ++  M+A  G 
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177

Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           Y WMAPEVI    +   +DV+S+G++LWELLTG++P+  +  L  A GV    L   IP 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                 A+L+E CW  DP  RP F+ I++ L  I
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  420 bits (1083), Expect = e-147
 Identities = 83/271 (30%), Positives = 149/271 (54%), Gaps = 12/271 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
             ID K L F +K+     G+L++G +   D+ +KVLK    ++   ++F +E   +R  
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 276 RHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 332
            H NV+  +GAC  PP+    ++T +M  GS+Y+ LH+    V      +K A+D+++GM
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 333 NYLH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
            +LH  +  I    L + ++++DE+   +++   V                  W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180

Query: 391 EHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
           + KP D     AD++SF ++LWEL+T ++P+  L+ ++  + V  +GLRPTIP    P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           ++L++ C  +DPA RP F  I+ IL+++  +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  419 bits (1078), Expect = e-145
 Identities = 83/305 (27%), Positives = 150/305 (49%), Gaps = 19/305 (6%)

Query: 190 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAI 249
           P         +S P      +     W+I  + L+ G  +  G +G +Y G +   +VAI
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAI 60

Query: 250 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 309
           +++  ER N D  K F +EV   R+ RH+NVV F+GAC  PP L I+T    G ++Y  +
Sbjct: 61  RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120

Query: 310 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 369
              K V  +    ++A ++ KGM YLH   I+H+DLK+ N+  D    V + DFG+  + 
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSIS 179

Query: 370 A------QSGVMTAETGTYRWMAPEVI---------EHKPYDHKADVFSFGIVLWELLTG 414
                  +   +  + G    +APE+I         +  P+   +DVF+ G + +EL   
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239

Query: 415 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQQDPALRPDFSEIIEILQ 473
           + P++        +  +  G++P + +    K ++++L  CW  +   RP F++++++L+
Sbjct: 240 EWPFKTQPAEA-IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

Query: 474 QIAKE 478
           ++ K 
Sbjct: 299 KLPKR 303

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  410 bits (1057), Expect = e-143
 Identities = 85/285 (29%), Positives = 150/285 (52%), Gaps = 22/285 (7%)

Query: 209 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ---- 262
               + +  +    +++  ++  G +G +++G        VAIK L       + +    
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 263 -KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 321
            +EF +EVFIM  + H N+V+  G    PP   +V EF+  G +Y  L       K    
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 322 LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGV 374
           L++ +D++ G+ Y+   N  I+HRDL++ N+ +   +       KVADFG+++    S  
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182

Query: 375 MTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--GV 430
           ++   G ++WMAPE I  E + Y  KAD +SF ++L+ +LTG+ P++  +  +      +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            ++GLRPTIP++  P+L  ++E CW  DP  RP FS I++ L ++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  407 bits (1048), Expect = e-141
 Identities = 94/285 (32%), Positives = 149/285 (52%), Gaps = 15/285 (5%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           +  ID K ++    V  G++G + +  + ++DVAIK ++ E      +K F  E+  + +
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGM 332
           V H N+V+  GAC  P  +C+V E+  GGS+Y+ LH  + +        +   +  S+G+
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 333 NYLHQ---NNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
            YLH      +IHRDLK  NLL+     V+K+ DFG A        MT   G+  WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKL 447
           V E   Y  K DVFS+GI+LWE++T + P++ +  P    +  V  G RP + KN    +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 492
             L+ RCW +DP+ RP   EI++I+  + +     +E  +     
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  360 bits (926), Expect = e-122
 Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 48/307 (15%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           V     K ++   ++  G YG+++ G +  + VA+KV       S  ++    E++    
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87

Query: 275 VRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +RH+N++ FI A  K       L ++T++   GS+YDYL          S+LK+A     
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145

Query: 331 GMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 377
           G+ +LH        +  I HRDLK+ N+L+ +N    +AD G+A                
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 378 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 421
             GT R+M PEV++      H      AD++SFG++LWE+             +LPY  L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 422 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 471
            P   +       V  K LRP+ P          ++ +L+  CW  +PA R     + + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 472 LQQIAKE 478
           L ++++ 
Sbjct: 326 LAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  349 bits (897), Expect = e-118
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           + +     V  G YG+++RG++  ++VA+K+       S  ++    E++    +RH+N+
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64

Query: 281 VQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           + FI +          L ++T +   GS+YDYL          S L++ + ++ G+ +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH 122

Query: 337 --------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYR 383
                   +  I HRDLK+ N+L+ +N    +AD G+A + +QS            GT R
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 384 WMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLTPLQAA 427
           +MAPEV++            + D+++FG+VLWE+             K P+  + P   +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 428 V-----GVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                  V     RP IP           LA+L++ CW Q+P+ R     I + L +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  345 bits (887), Expect = e-116
 Identities = 79/309 (25%), Positives = 145/309 (46%), Gaps = 48/309 (15%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           V     + +     +  G +G+++RG +  ++VA+K+       S  ++    E++    
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92

Query: 275 VRHKNVVQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           +RH+N++ FI A  K       L +V+++   GS++DYL++      +  ++K+A+  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150

Query: 331 GMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 377
           G+ +LH           I HRDLK+ N+L+ +N    +AD G+A     +          
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 378 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 421
             GT R+MAPEV++      H     +AD+++ G+V WE+             +LPY  L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 422 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 471
            P   +V      V ++ LRP IP   Q       +A+++  CW  + A R     I + 
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 472 LQQIAKEVG 480
           L Q++++ G
Sbjct: 331 LSQLSQQEG 339

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  337 bits (867), Expect = e-113
 Identities = 82/309 (26%), Positives = 139/309 (44%), Gaps = 48/309 (15%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           GT+        L+     A G +G +++    ++ VA+K+   +        +   EV+ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYS 71

Query: 272 MRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           +  ++H+N++QFIGA  +  S    L ++T F   GS+ D+L     V     L  +A  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129

Query: 328 VSKGMNYLHQN----------NIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGV 374
           +++G+ YLH++           I HRD+K+ N+L+  N    +ADFG+A        +G 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 375 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPL 424
              + GT R+MAPEV+E      +    + D+++ G+VLWEL +          EY+ P 
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 425 QAAVG-----------VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEI 468
           +  +G           VV K  RP +    Q       L E +E CW  D   R     +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 469 IEILQQIAK 477
            E + Q+ +
Sbjct: 310 GERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  308 bits (790), Expect = e-102
 Identities = 74/320 (23%), Positives = 129/320 (40%), Gaps = 63/320 (19%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMR 273
             +D  +LK    +  G YG +Y+G+   + VA+KV        + Q  F  E  ++ + 
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQ-NFINEKNIYRVP 62

Query: 274 KVRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
            + H N+ +FI    +  +       +V E+   GS+  YL          S  ++A  V
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120

Query: 329 SKGMNYLH---------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--------- 370
           ++G+ YLH         +  I HRDL + N+L+  +    ++DFG++             
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 371 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGK---LPYEY 420
           +     +E GT R+MAPEV+E        +    + D+++ G++ WE+        P E 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 421 LTPLQAA---------------VGVVQKGLRPTIPKN------SQPKLAELLERCWQQDP 459
           +   Q A               V V ++  RP  P+       +   L E +E CW QD 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300

Query: 460 ALRPDFSEIIEILQQIAKEV 479
             R       E + ++    
Sbjct: 301 EARLTAQXAEERMAELMMIW 320

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  287 bits (736), Expect = 3e-93
 Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 10/272 (3%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D W ++ + L  G ++  G++G+++ G     +  VA+K  + E +  D++ +F QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           +++  H N+V+ IG CT+   + IV E + GG    +L       ++ +LL++  D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAP 387
           M YL     IHRDL A N L+ E  V+K++DFG++R     GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E + +  Y  ++DV+SFGI+LWE  + G  PY  L+  Q     V+KG R   P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           +  L+E+CW  +P  RP FS I + LQ I K 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  278 bits (714), Expect = 3e-91
 Identities = 96/267 (35%), Positives = 156/267 (58%), Gaps = 10/267 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           W IDP  L F  ++ SG +G ++ G + ++  VAIK ++     +  +++F +E  +M K
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H  +VQ  G C +   +C+VTEFM  G + DYL   +G+F   +LL + +DV +GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 391
           L +  +IHRDL A N L+ EN+V+KV+DFG+ R        T+ TGT    +W +PEV  
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              Y  K+DV+SFG+++WE+ + GK+PYE  +     V  +  G R   P+ +   + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237

Query: 451 LERCWQQDPALRPDFSEIIEILQQIAK 477
           +  CW++ P  RP FS ++  L +IA+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  279 bits (715), Expect = 3e-91
 Identities = 102/292 (34%), Positives = 162/292 (55%), Gaps = 14/292 (4%)

Query: 209 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 266
           PN   D WE++   +    K+  G YG++Y G +   S  VA+K LK    ++   +EF 
Sbjct: 3   PNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL 57

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVA 325
           +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +          LL +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 382
             +S  M YL + N IHRDL A N L+ EN +VKVADFG++R+       TA  G     
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPI 176

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           +W APE + +  +  K+DV++FG++LWE+ T G  PY  +   Q    +++K  R   P+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 235

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSG 493
               K+ EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++    G
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  278 bits (713), Expect = 4e-91
 Identities = 94/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
             W ++ K LK    +  G +GD+  G Y    VA+K +K         + F  E  +M 
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69

Query: 274 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           ++RH N+VQ +G   +    L IVTE+M+ GS+ DYL      V     LLK ++DV + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M YL  NN +HRDL A N+L+ E+ V KV+DFG+ +        + +       +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 184

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            +  K +  K+DV+SFGI+LWE+ + G++PY  +  L+  V  V+KG +   P    P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKE 478
            E+++ CW  D A+RP F ++ E L+ I   
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  278 bits (713), Expect = 6e-91
 Identities = 90/270 (33%), Positives = 150/270 (55%), Gaps = 10/270 (3%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
             WEIDPK L F  ++ +G +G +  G +  Q DVAIK++K     S  + EF +E  +M
Sbjct: 17  GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
             + H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 389
            YL     +HRDL A N L+++  VVKV+DFG++R        T+  G+    RW  PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192

Query: 390 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
           + +  +  K+D+++FG+++WE+ + GK+PYE  T        + +GLR   P  +  K+ 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251

Query: 449 ELLERCWQQDPALRPDFSEIIEILQQIAKE 478
            ++  CW +    RP F  ++  +  +  E
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  275 bits (706), Expect = 3e-90
 Identities = 87/268 (32%), Positives = 145/268 (54%), Gaps = 10/268 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 274
            E+  + +    ++ SG +G +  G +  Q DVA+K++K     S  + EF QE   M K
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           + H  +V+F G C+K   + IVTE++S G + +YL       +   LL++  DV +GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 391
           L  +  IHRDL A N L+D +  VKV+DFG+ R         +  GT    +W APEV  
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 392 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
           +  Y  K+DV++FGI++WE+ + GK+PY+  T     V  V +G R   P  +   + ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQI 237

Query: 451 LERCWQQDPALRPDFSEIIEILQQIAKE 478
           +  CW + P  RP F +++  ++ + ++
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  276 bits (707), Expect = 6e-90
 Identities = 83/277 (29%), Positives = 140/277 (50%), Gaps = 12/277 (4%)

Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFA 266
           +    I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++      +F 
Sbjct: 10  SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           +EV  M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---Y 382
            V++GM YL     IHRDL A NLL+   ++VK+ DFG+ R +         +      +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
            W APE ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           +    +  ++ +CW   P  RP F  + + L +    
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  281 bits (720), Expect = 9e-90
 Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
             W ++ K LK    +  G +GD+  G Y    VA+K +K +       + F  E  +M 
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 241

Query: 274 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           ++RH N+VQ +G   +    L IVTE+M+ GS+ DYL      V     LLK ++DV + 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M YL  NN +HRDL A N+L+ E+ V KV+DFG+ +        + +       +W APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 356

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            +  K +  K+DV+SFGI+LWE+ + G++PY  +  L+  V  V+KG +   P    P +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 415

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKE 478
            ++++ CW  D A RP F ++ E L+ I   
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  274 bits (703), Expect = 2e-89
 Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 11/282 (3%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 266
           G   + I  + +     +  G +G++Y G Y +       VA+K  K +    D +++F 
Sbjct: 3   GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFM 61

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            E  IM+ + H ++V+ IG   + P   I+ E    G +  YL + K   K+ +L+  ++
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            + K M YL   N +HRD+   N+L+   E VK+ DFG++R         A       +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           M+PE I  + +   +DV+ F + +WE+L+ GK P+ +L      +GV++KG R   P   
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 485
            P L  L+ RCW  DP+ RP F+E++  L  + +   +   E
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  280 bits (719), Expect = 3e-89
 Identities = 100/301 (33%), Positives = 164/301 (54%), Gaps = 12/301 (3%)

Query: 200 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI 257
           K +   +   +   D WE++   +    K+  G YG++Y G +   S  VA+K LK    
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--- 255

Query: 258 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VF 316
           ++   +EF +E  +M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +      
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 317 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 376
               LL +A  +S  M YL + N IHR+L A N L+ EN +VKVADFG++R+       T
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYT 374

Query: 377 AETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
           A  G     +W APE + +  +  K+DV++FG++LWE+ T G  PY  +  L     +++
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLE 433

Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 492
           K  R   P+    K+ EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++    
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 493

Query: 493 G 493
           G
Sbjct: 494 G 494

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  271 bits (695), Expect = 3e-88
 Identities = 88/268 (32%), Positives = 151/268 (56%), Gaps = 12/268 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK     S     F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G    +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+  +    TA  G     +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFGI+L E++T G++PY  +T     +  +++G R   P N   +L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQI 475
            +L+  CW++ P  RP F  +  +L+  
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  271 bits (696), Expect = 8e-88
 Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)

Query: 209 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 261
           PN    +   +     K    + SG++G +Y+G +  +       VAIK L+        
Sbjct: 4   PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61

Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 321
            KE   E ++M  V + +V + +G C     + ++T+ M  G + DY+ + K       L
Sbjct: 62  -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119

Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 380
           L   + ++KGMNYL    ++HRDL A N+L+   + VK+ DFG+A+ + A+     AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 381 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 437
               +WMA E I H+ Y H++DV+S+G+ +WEL+T G  PY+ +   +    +++KG R 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238

Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
             P      +  ++ +CW  D   RP F E+I    ++A++
Sbjct: 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  269 bits (691), Expect = 9e-88
 Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 11/275 (4%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 266
            T  +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K    +  ++++F 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFL 64

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           QE   MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 384
            +S  + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A  G    +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
           MAPE I  + +   +DV+ FG+ +WE+L  G  P++ +      +G ++ G R  +P N 
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNC 242

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
            P L  L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  269 bits (691), Expect = 4e-87
 Identities = 72/274 (26%), Positives = 137/274 (50%), Gaps = 15/274 (5%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQ-KEFAQE 268
                  L+    + SG +G +++G +  +       V IKV++ +  +     +     
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDH 65

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           +  +  + H ++V+ +G C     L +VT+++  GS+ D++ + +G      LL   + +
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWM 385
           +KGM YL ++ ++HR+L A N+L+     V+VADFGVA +          +      +WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           A E I    Y H++DV+S+G+ +WEL+T G  PY  L   +    +++KG R   P+   
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICT 243

Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
             +  ++ +CW  D  +RP F E+     ++A++
Sbjct: 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  268 bits (688), Expect = 4e-87
 Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 13/286 (4%)

Query: 214 DVWEIDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQE 268
               +D K L    K   SG++G + +G Y      + VA+K+LK E  +  ++ E   E
Sbjct: 9   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             +M+++ +  +V+ IG C       +V E    G +  YL +     K  +++++   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 384
           S GM YL ++N +HRDL A N+L+      K++DFG+++ ++A      A+T      +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
            APE I +  +  K+DV+SFG+++WE  + G+ PY  +        +++KG R   P   
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKE 489
             ++ +L+  CW  D   RP F+ +   L+    +V  E       
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  267 bits (685), Expect = 3e-86
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 12/274 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQE 268
              EI+   +     + SG  G++  G           VAIK LK        +++F  E
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             IM +  H N+++  G  T+     IVTE+M  GS+  +L    G F +  L+ +   V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 384
             GM YL     +HRDL A N+L+D N V KV+DFG++R ++         TG     RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
            APE I  + +   +DV+SFG+V+WE+L  G+ PY  +T  +  +  V++G R   P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              L +L+  CW +D A RP FS+I+ +L  + +
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  267 bits (685), Expect = 4e-86
 Identities = 86/275 (31%), Positives = 146/275 (53%), Gaps = 13/275 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
              EI P  +     + +G +G++Y+G            VAIK LK        + +F  
Sbjct: 37  FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLG 95

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E  IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 383
           ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R ++         +G     R
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           W APE I ++ +   +DV+SFGIV+WE++T G+ PY  L+     +  +  G R   P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPMD 274

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
               + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  270 bits (692), Expect = 1e-85
 Identities = 97/278 (34%), Positives = 155/278 (55%), Gaps = 12/278 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + LK   K+ +G +G+++  TY     VA+K +KP    S   + F  E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           + ++H  +V+     TK P + I+TEFM+ GS+ D+L   +G    LP L+  +  +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M ++ Q N IHRDL+AAN+L+  + V K+ADFG+ARV  +    TA  G     +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I    +  K+DV+SFGI+L E++T G++PY  ++     +  +++G R   P+N   +L
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEEL 414

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 485
             ++ RCW+  P  RP F  I  +L         + EE
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  263 bits (675), Expect = 3e-85
 Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 15/284 (5%)

Query: 214 DVWEIDPKHLKFG-SKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQK-EFAQ 267
               +   +L     ++  G++G + +G Y  +    DVAIKVLK           E  +
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 59

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E  IM ++ +  +V+ IG C     L +V E   GG ++ +L   +    + ++ ++   
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 383
           VS GM YL + N +HRDL A N+L+      K++DFG+++ + A     TA +      +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           W APE I  + +  ++DV+S+G+ +WE L+ G+ PY+ +      +  +++G R   P  
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPE 237

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 486
             P+L  L+  CW      RPDF  + + ++     +  + E  
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  263 bits (675), Expect = 4e-85
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 31/292 (10%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 265
           G+D  + + +HLKF  ++  G++G +    Y        + VA+K L+      +  ++F
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDF 58

Query: 266 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
            +E+ I++ ++H N+V++ G C      +L ++ E++  GS+ DYL K K       LL+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT- 381
               + KGM YL     IHRDL   N+L++    VK+ DFG+ + +         +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 382 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT----------------GKLPYEYLTP 423
               W APE +    +   +DV+SFG+VL+EL T                G      +  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               + +++   R   P     ++  ++  CW  +   RP F ++   + QI
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  264 bits (677), Expect = 6e-85
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 28/303 (9%)

Query: 199 MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVL 252
           M  H +H        D    + +HLK+ S++  G++G +    Y          VA+K L
Sbjct: 1   MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60

Query: 253 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLH 310
           +      D Q++F +E+ I++ +    +V++ G    P   SL +V E++  G + D+L 
Sbjct: 61  QHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118

Query: 311 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VK 369
           + +       LL  +  + KGM YL     +HRDL A N+L++    VK+ADFG+A+ + 
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

Query: 370 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 425
                            W APE +    +  ++DV+SFG+VL+EL T             
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238

Query: 426 AAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
             +G              +++G R   P     ++ EL++ CW   P  RP FS +   L
Sbjct: 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 473 QQI 475
             +
Sbjct: 299 DML 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  263 bits (674), Expect = 2e-84
 Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 31/323 (9%)

Query: 185 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 242
           H       +   T        +    +  D  + + +HLKF  ++  G++G +    Y  
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64

Query: 243 ----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 296
                 + VA+K L+      +  ++F +E+ I++ ++H N+V++ G C      +L ++
Sbjct: 65  LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122

Query: 297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            E++  GS+ DYL K K       LL+    + KGM YL     IHRDL   N+L++   
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182

Query: 357 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
            VK+ DFG+ + +         +        W APE +    +   +DV+SFG+VL+EL 
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

Query: 413 T----------------GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
           T                G      +      + +++   R   P     ++  ++  CW 
Sbjct: 243 TYIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWN 301

Query: 457 QDPALRPDFSEIIEILQQIAKEV 479
            +   RP F ++   + QI  ++
Sbjct: 302 NNVNQRPSFRDLALRVDQIRDQM 324

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  267 bits (683), Expect = 2e-84
 Identities = 99/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)

Query: 202 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSD 260
                +      D WEI  + L+   K+  G +G+++ GT+     VAIK LKP    + 
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTM 221

Query: 261 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLP 319
             + F QE  +M+K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 280

Query: 320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 379
            L+ +A  ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339

Query: 380 GT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 435
           G     +W APE   +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G 
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGY 398

Query: 436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           R   P      L +L+ +CW+++P  RP F  +   L+  
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  272 bits (697), Expect = 4e-84
 Identities = 100/357 (28%), Positives = 173/357 (48%), Gaps = 20/357 (5%)

Query: 135 NIQEAHAFST-VDGY----SLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSS 189
           ++  A   +  +DGY    +         P +E E+   ++ K     ++       S S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362

Query: 190 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--- 246
            T +  +   +   Y   +P+     +EI  + ++ G  +  G +GD+++G Y S +   
Sbjct: 363 ETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418

Query: 247 --VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
             VAIK  K    +  ++++F QE   MR+  H ++V+ IG  T+ P + I+ E  + G 
Sbjct: 419 MAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGE 476

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           +  +L   K    L SL+  A  +S  + YL     +HRD+ A N+L+  N+ VK+ DFG
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 365 VARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           ++R    S    A  G    +WMAPE I  + +   +DV+ FG+ +WE+L  G  P++ +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
                 +G ++ G R  +P N  P L  L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 597 KNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  263 bits (674), Expect = 5e-84
 Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 12/274 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQE 268
              E+D  ++     V +G +G++  G           VAIK LK        +++F  E
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGE 96

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             IM +  H N+++  G  TK   + IVTE+M  GS+  +L K    F +  L+ +   +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 384
           + GM YL     +HRDL A N+L++ N V KV+DFG+ R ++          G     RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 443
            +PE I ++ +   +DV+S+GIVLWE+++ G+ PY  ++  Q  +  V +G R   P + 
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
              L +L+  CWQ+D   RP F +I+ IL ++ +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  266 bits (681), Expect = 4e-83
 Identities = 99/268 (36%), Positives = 155/268 (57%), Gaps = 12/268 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+     VAIK LKP    +   + F QE  +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP L+ +A  ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 388
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+  +    TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
              +  +  K+DV+SFGI+L EL T G++PY  +   +  +  V++G R   P      L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQI 475
            +L+ +CW+++P  RP F  +   L+  
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  258 bits (661), Expect = 6e-83
 Identities = 81/291 (27%), Positives = 139/291 (47%), Gaps = 29/291 (9%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 267
           D    + + LK    +  G +G +    Y        + VA+K LKPE    +   +  +
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKK 72

Query: 268 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 325
           E+ I+R + H+N+V++ G CT+     + ++ EF+  GS+ +YL K K    L   LK A
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--- 381
           + + KGM+YL     +HRDL A N+L++    VK+ DFG+ + ++      T +      
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT---------------GKLPYEYLTPLQA 426
             W APE +    +   +DV+SFG+ L ELLT                   +  +T  + 
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR- 251

Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            V  +++G R   P N   ++ +L+ +CW+  P+ R  F  +IE  + + K
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  258 bits (662), Expect = 1e-82
 Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)

Query: 209 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 261
           PN    +   +     K    + SG++G +Y+G +  +       VAIK L+        
Sbjct: 4   PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61

Query: 262 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 321
            KE   E ++M  V + +V + +G C     + ++T+ M  G + DY+ + K       L
Sbjct: 62  -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119

Query: 322 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 380
           L   + ++KGMNYL    ++HRDL A N+L+   + VK+ DFG+A+ + A+     AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 381 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 437
               +WMA E I H+ Y H++DV+S+G+ +WEL+T G  PY+ +   +    +++KG R 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238

Query: 438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
             P      +  ++ +CW  D   RP F E+I    ++A++
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  254 bits (652), Expect = 8e-82
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY---------CSQDVAIKVLKPERINSDMQKEFA 266
            +I  + L F   +  G++  +++G              +V +KVL     + +  + F 
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFF 60

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           +   +M K+ HK++V   G C       +V EF+  GS+  YL K K    +   L+VA 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMD--------ENEVVKVADFGVARVKAQSGVMTAE 378
            ++  M++L +N +IH ++ A N+L+             +K++D G++            
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173

Query: 379 TGTY----RWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 432
                    W+ PE IE+ K  +   D +SFG  LWE+ + G  P   L   Q  +   +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232

Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              +  +P     +LA L+  C   +P  RP F  II  L  +
Sbjct: 233 DRHQ--LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  251 bits (643), Expect = 2e-80
 Identities = 78/294 (26%), Positives = 142/294 (48%), Gaps = 29/294 (9%)

Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQ 262
           + G  V  I  + +    ++  G++G ++               VA+K LK        +
Sbjct: 4   HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR 61

Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------------- 309
           K+F +E  ++  ++H+++V+F G C     L +V E+M  G +  +L             
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121

Query: 310 --HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
              + KG   L  +L +A  ++ GM YL   + +HRDL   N L+  N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

Query: 368 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 423
               +        T    RWM PE I ++ +  ++DV+SFG++LWE+ T GK P+  L+ 
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241

Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            +  +  + +G     P+    ++ +++  CWQ++P  R +  EI +IL  + K
Sbjct: 242 TE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  252 bits (645), Expect = 3e-80
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 21/293 (7%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 268
           +   I  +    G  +  G +G +       +D     VA+K+LK + I S   +EF +E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 269 VFIMRKVRHKNVVQFIGACTK------PPSLCIVTEFMSGGSVYDYLHKLK-----GVFK 317
              M++  H +V + +G   +       P   ++  FM  G ++ +L   +         
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
           L +L++  +D++ GM YL   N IHRDL A N ++ E+  V VADFG++R          
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 378 ETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 433
              +    +W+A E +    Y   +DV++FG+ +WE++T G+ PY  +   +     +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG 254

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 486
           G R   P     ++ +L+ +CW  DP  RP F+ +   L+ I   +   +  +
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  251 bits (643), Expect = 3e-80
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 268
           +   ID   L  G  +  G +G +  G    +D     VA+K +K +  +    +EF  E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 269 VFIMRKVRHKNVVQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKLK-----GVFKL 318
              M+   H NV++ +G C +      P   ++  FM  G ++ YL   +         L
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 378
            +LLK  +D++ GM YL   N +HRDL A N ++ ++  V VADFG+++           
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206

Query: 379 TGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 434
                  +W+A E +  + Y  K+DV++FG+ +WE+ T G  PY  +   +     +  G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHG 265

Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
            R   P++   +L E++  CW+ DP  RP FS +   L+++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  251 bits (643), Expect = 5e-80
 Identities = 83/312 (26%), Positives = 144/312 (46%), Gaps = 38/312 (12%)

Query: 202 HPYHLKIPNDG---------TDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQD 246
           H +H    + G          D      ++LK    +  G +G +    Y        + 
Sbjct: 3   HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGS 304
           VA+K LK +      +  + QE+ I+R + H++++++ G C      SL +V E++  GS
Sbjct: 63  VAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           + DYL +      L  LL  A  + +GM YLH  + IHRDL A N+L+D + +VK+ DFG
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 365 VAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 419
           +A+ V                  W APE ++   + + +DV+SFG+ L+ELLT       
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239

Query: 420 YLTPLQAAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 466
             T     +G+             +++G R   P     ++  L++ CW+ + + RP F 
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299

Query: 467 EIIEILQQIAKE 478
            +I IL+ + ++
Sbjct: 300 NLIPILKTVHEK 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  250 bits (640), Expect = 2e-79
 Identities = 93/315 (29%), Positives = 154/315 (48%), Gaps = 29/315 (9%)

Query: 202 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERI 257
           H +H K   D T    +D   +KF   +  G++G + +          D AIK +K E  
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYA 64

Query: 258 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------- 309
           + D  ++FA E+ ++ K+  H N++  +GAC     L +  E+   G++ D+L       
Sbjct: 65  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 310 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 361
                   +          LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 362 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 417
           DFG++R      V   +T      RWMA E + +  Y   +DV+S+G++LWE+++ G  P
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

Query: 418 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           Y  +T        + +G R   P N   ++ +L+ +CW++ P  RP F++I+  L ++ +
Sbjct: 242 YCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

Query: 478 EVGEENEERRKEKSS 492
           E          EK +
Sbjct: 301 ERKTYVNTTLYEKFT 315

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  249 bits (637), Expect = 2e-79
 Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 14/273 (5%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 269
           V       + F   +  G +G +Y GT    D      A+K L     +     +F  E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77

Query: 270 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
            IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 383
           +KGM YL     +HRDL A N ++DE   VKVADFG+AR        +    T      +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           WMA E ++ + +  K+DV+SFG++LWEL+T G  PY  +         + +G R   P+ 
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               L E++ +CW     +RP FSE++  +  I
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  249 bits (638), Expect = 2e-79
 Identities = 81/305 (26%), Positives = 144/305 (47%), Gaps = 32/305 (10%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 259
           ++P D    WE     L FG  + +G++G +   T         +  VA+K+LK    + 
Sbjct: 11  QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHL 67

Query: 260 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--------- 309
             ++    E+ ++  +  H N+V  +GACT      ++TE+   G + ++L         
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 310 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 361
                      +    L  LL  +  V+KGM +L   N IHRDL A N+L+    + K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 362 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 417
           DFG+AR          +       +WMAPE I +  Y  ++DV+S+GI LWEL + G  P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 418 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           Y  +        ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++   
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 478 EVGEE 482
           E    
Sbjct: 308 ESTNH 312

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  250 bits (640), Expect = 2e-79
 Identities = 88/322 (27%), Positives = 151/322 (46%), Gaps = 37/322 (11%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
            SH     + +P   G+       ++P D    WE     L  G  +  G++G +     
Sbjct: 3   SSHHHHHHSQDPMLAGVS----EYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEA 56

Query: 243 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 292
                     +  VA+K+LK +        +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 57  VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115

Query: 293 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           L ++ E+ S G++ +YL                  +       L+     +++GM YL  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 394
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y H++DV+SFG+++WE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 294

Query: 454 CWQQDPALRPDFSEIIEILQQI 475
           CW   P+ RP F +++E L +I
Sbjct: 295 CWHAVPSQRPTFKQLVEDLDRI 316

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  249 bits (639), Expect = 2e-79
 Identities = 86/318 (27%), Positives = 150/318 (47%), Gaps = 30/318 (9%)

Query: 187 SSSPTSEPEDTGMKSHPYHLKIPN--DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 242
           S S  S  E  G     + ++ P       V  I  + +    ++  G++G ++      
Sbjct: 5   SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64

Query: 243 -----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 297
                    VA+K LK    +   +++F +E  ++  ++H+++V+F G CT+   L +V 
Sbjct: 65  LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122

Query: 298 EFMSGGSVYDYL--------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           E+M  G +  +L                  G   L  LL VA  V+ GM YL   + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182

Query: 344 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKAD 400
           DL   N L+ +  VVK+ DFG++R    +        T    RWM PE I ++ +  ++D
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242

Query: 401 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 459
           V+SFG+VLWE+ T GK P+  L+  + A+  + +G     P+   P++  ++  CWQ++P
Sbjct: 243 VWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREP 301

Query: 460 ALRPDFSEIIEILQQIAK 477
             R    ++   LQ +A+
Sbjct: 302 QQRHSIKDVHARLQALAQ 319

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  248 bits (635), Expect = 4e-79
 Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)

Query: 216 WEI--DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 268
             I  +         +  G +G +Y G Y  Q       AIK L        ++  F +E
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLRE 72

Query: 269 VFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
             +MR + H NV+  IG    P     ++  +M  G +  ++   +    +  L+   + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY----- 382
           V++GM YL +   +HRDL A N ++DE+  VKVADFG+AR        + +   +     
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           +W A E ++   +  K+DV+SFG++LWELLT G  PY ++ P       + +G R   P+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPE 251

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                L +++++CW+ DPA+RP F  ++  ++QI
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  249 bits (637), Expect = 5e-79
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 30/306 (9%)

Query: 201 SHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQ 245
           +H +H   PN          +D+ E+  K++     +  G++G++Y G            
Sbjct: 2   AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61

Query: 246 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
            VA+K L  E  +   + +F  E  I+ K  H+N+V+ IG   +     I+ E M+GG +
Sbjct: 62  QVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120

Query: 306 YDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENE 356
             +L + +          +  LL VA D++ G  YL +N+ IHRD+ A N L+       
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180

Query: 357 VVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
           V K+ DFG+AR   ++             +WM PE      +  K D +SFG++LWE+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

Query: 414 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
            G +PY   +  +  +  V  G R   PKN    +  ++ +CWQ  P  RP+F+ I+E +
Sbjct: 241 LGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

Query: 473 QQIAKE 478
           +   ++
Sbjct: 300 EYCTQD 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  250 bits (640), Expect = 5e-79
 Identities = 91/329 (27%), Positives = 153/329 (46%), Gaps = 33/329 (10%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           P  R ++  S   DT M +     ++P D    WE     L  G  +  G +G +     
Sbjct: 45  PLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102

Query: 243 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 292
                     +  VA+K+LK +        +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 103 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161

Query: 293 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           L ++ E+ S G++ +YL                  +       L+     +++GM YL  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 394
              IHRDL A N+L+ EN V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y H++DV+SFG+++WE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 340

Query: 454 CWQQDPALRPDFSEIIEILQQIAKEVGEE 482
           CW   P+ RP F +++E L +I      E
Sbjct: 341 CWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  249 bits (638), Expect = 1e-78
 Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 14/273 (5%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 269
           V       + F   +  G +G +Y GT    D      A+K L       ++  +F  E 
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEG 141

Query: 270 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
            IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 383
           +KGM +L     +HRDL A N ++DE   VKVADFG+AR        +    T      +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           WMA E ++ + +  K+DV+SFG++LWEL+T G  PY  +         + +G R   P+ 
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 320

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
               L E++ +CW     +RP FSE++  +  I
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  246 bits (630), Expect = 2e-78
 Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 28/285 (9%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQ 267
           + EI    ++F  ++    +G +Y+G          +Q VAIK LK +     +++EF  
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRH 61

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 312
           E  +  +++H NVV  +G  TK   L ++  + S G ++++L                 +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 313 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 372
           K   + P  + +   ++ GM YL  ++++H+DL   N+L+ +   VK++D G+ R    +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 373 GVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
                   +    RWMAPE I +  +   +D++S+G+VLWE+ + G  PY   +     V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240

Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
            +++       P +    +  L+  CW + P+ RP F +I   L+
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  247 bits (632), Expect = 2e-78
 Identities = 93/325 (28%), Positives = 147/325 (45%), Gaps = 38/325 (11%)

Query: 189 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------ 242
            P   P D   +  PY           WE     LK G  +  G++G +           
Sbjct: 2   DPDELPLDEHCERLPYD-------ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT 54

Query: 243 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-PSLCIVTEF 299
              + VA+K+LK E       +    E+ I+  +  H NVV  +GACTKP   L ++ EF
Sbjct: 55  ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113

Query: 300 MSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 344
              G++  YL                  K    L  L+  +  V+KGM +L     IHRD
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADV 401
           L A N+L+ E  VVK+ DFG+AR   +      +       +WMAPE I  + Y  ++DV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233

Query: 402 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           +SFG++LWE+ + G  PY  +   +     +++G R   P  + P++ + +  CW  +P+
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293

Query: 461 LRPDFSEIIEILQQIAKEVGEENEE 485
            RP FSE++E L  + +      ++
Sbjct: 294 QRPTFSELVEHLGNLLQA--NAQQD 316

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  247 bits (632), Expect = 2e-78
 Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 22/282 (7%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +  E  +   + EF 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFK 317
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+             
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
           L  ++++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R   ++     
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 378 ETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 433
                   RWM+PE ++   +   +DV+SFG+VLWE+ T  + PY+ L+  Q  +  V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVME 255

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
           G     P N    L EL+  CWQ +P +RP F EII  +++ 
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  254 bits (651), Expect = 6e-78
 Identities = 81/314 (25%), Positives = 145/314 (46%), Gaps = 14/314 (4%)

Query: 182 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV-ASGSYGDLYRG 240
                   P   P DT +   P+             +   +L         G++G + +G
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRDNLLIADIELGCGNFGSVRQG 355

Query: 241 TYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 296
            Y  +    DVAIKVLK     +D  +E  +E  IM ++ +  +V+ IG C     L +V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLV 413

Query: 297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            E   GG ++ +L   +    + ++ ++   VS GM YL + N +HR+L A N+L+    
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473

Query: 357 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
             K++DFG+++ + A     TA +      +W APE I  + +  ++DV+S+G+ +WE L
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

Query: 413 T-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 471
           + G+ PY+ +      +  +++G R   P    P+L  L+  CW      RPDF  + + 
Sbjct: 534 SYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592

Query: 472 LQQIAKEVGEENEE 485
           ++     +  + E 
Sbjct: 593 MRACYYSLASKVEG 606

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  245 bits (628), Expect = 7e-78
 Identities = 82/303 (27%), Positives = 149/303 (49%), Gaps = 38/303 (12%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 259
           KI  D    WE   K+L  G  +  G +G + + T            VA+K+LK E  + 
Sbjct: 11  KILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASP 67

Query: 260 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 309
              ++   E  ++++V H +V++  GAC++   L ++ E+   GS+  +L          
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 310 -------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
                        H  +    +  L+  A  +S+GM YL +  ++HRDL A N+L+ E  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187

Query: 357 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
            +K++DFG++R   +       +      +WMA E +    Y  ++DV+SFG++LWE++T
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

Query: 414 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
            G  PY  + P +    +++ G R   P N   ++  L+ +CW+Q+P  RP F++I + L
Sbjct: 248 LGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

Query: 473 QQI 475
           +++
Sbjct: 307 EKM 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  247 bits (632), Expect = 1e-77
 Identities = 84/316 (26%), Positives = 147/316 (46%), Gaps = 22/316 (6%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           P ++ S   +    T    +       +  +D+ E+  K++     +  G++G++Y G  
Sbjct: 33  PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92

Query: 243 -------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 295
                      VA+K L  E  +   + +F  E  I+ K  H+N+V+ IG   +     I
Sbjct: 93  SGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151

Query: 296 VTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
           + E M+GG +  +L + +          +  LL VA D++ G  YL +N+ IHRD+ A N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211

Query: 350 LLMD---ENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFS 403
            L+       V K+ DFG+AR   ++G            +WM PE      +  K D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271

Query: 404 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           FG++LWE+ + G +PY   +  +  +  V  G R   PKN    +  ++ +CWQ  P  R
Sbjct: 272 FGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

Query: 463 PDFSEIIEILQQIAKE 478
           P+F+ I+E ++   ++
Sbjct: 331 PNFAIILERIEYCTQD 346

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  246 bits (629), Expect = 4e-77
 Identities = 93/322 (28%), Positives = 153/322 (47%), Gaps = 34/322 (10%)

Query: 184 SHRSSSPTSE-PEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
            H    PT+E     GM +     ++P D    WE+    L  G  +  G++G +     
Sbjct: 33  HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90

Query: 243 ---------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 292
                        VA+K+LK          +   E+ +M+ + +HKN++  +GACT+   
Sbjct: 91  IGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 293 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           L ++ E+ S G++ +YL               H  +       L+  A  V++GM YL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 394
              IHRDL A N+L+ E+ V+K+ADFG+AR           T      +WMAPE +  + 
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y H++DV+SFG++LWE+ T G  PY  +   +    ++++G R   P N   +L  ++  
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD 328

Query: 454 CWQQDPALRPDFSEIIEILQQI 475
           CW   P+ RP F +++E L +I
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRI 350

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  244 bits (625), Expect = 4e-77
 Identities = 84/303 (27%), Positives = 148/303 (48%), Gaps = 28/303 (9%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINS 259
           ++P +  + WE    +L+FG  + +G++G +   T            VA+K+LK    ++
Sbjct: 34  QLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHA 90

Query: 260 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK- 317
           D ++    E+ IM  + +H+N+V  +GACT    + ++TE+   G + ++L +   V + 
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 318 ------------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                          LL  +  V++GM +L   N IHRD+ A N+L+    V K+ DFG+
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210

Query: 366 ARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           AR          +       +WMAPE I    Y  ++DV+S+GI+LWE+ + G  PY  +
Sbjct: 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 481
                   +V+ G +   P  +   +  +++ CW  +P  RP F +I   LQ+ A+E   
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330

Query: 482 ENE 484
           E +
Sbjct: 331 ERD 333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  243 bits (623), Expect = 8e-77
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 37/303 (12%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 259
           +   D    WE   ++L+FG  + SG++G +   T         S  VA+K+LK E+ +S
Sbjct: 33  EYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADS 89

Query: 260 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 318
             ++    E+ +M ++  H+N+V  +GACT    + ++ E+   G + +YL   +  F  
Sbjct: 90  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 319 PS----------------------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
                                   LL  A  V+KGM +L   + +HRDL A N+L+   +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209

Query: 357 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 413
           VVK+ DFG+AR                  +WMAPE +    Y  K+DV+S+GI+LWE+ +
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

Query: 414 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
            G  PY  +        ++Q G +   P  +  ++  +++ CW  D   RP F  +   L
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

Query: 473 QQI 475
              
Sbjct: 330 GCQ 332

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  241 bits (616), Expect = 1e-75
 Identities = 87/337 (25%), Positives = 156/337 (46%), Gaps = 39/337 (11%)

Query: 179 RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP---NDGTDVWEIDPKHLKFGSKVASGSYG 235
                +   ++  SE     +  +P + ++P   N      E    ++++   +  G++G
Sbjct: 2   AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61

Query: 236 DLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
            +++              VA+K+LK E  ++DMQ +F +E  +M +  + N+V+ +G C 
Sbjct: 62  RVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKG-----------------------VFKLPSLLKVA 325
               +C++ E+M+ G + ++L  +                                L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--- 382
             V+ GM YL +   +HRDL   N L+ EN VVK+ADFG++R    +    A+       
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           RWM PE I +  Y  ++DV+++G+VLWE+ + G  PY  +   +  +  V+ G     P+
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPE 299

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
           N   +L  L+  CW + PA RP F  I  ILQ++ + 
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  226 bits (577), Expect = 1e-70
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 15/272 (5%)

Query: 208 IPNDGTDVWEIDP--KHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQK 263
           I    T    +    + LKF  ++  GS+  +Y+G  T  + +VA   L+  ++    ++
Sbjct: 11  IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70

Query: 264 EFAQEVFIMRKVRHKNVVQFIGA----CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 319
            F +E  +++ ++H N+V+F  +          + +VTE M+ G++  YL +   V K+ 
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIK 129

Query: 320 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMT 376
            L      + KG+ +LH     IIHRDLK  N+ +      VK+ D G+A +K  S    
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189

Query: 377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
              GT  +MAPE+ E K YD   DV++FG+ + E+ T + PY            V  G++
Sbjct: 190 -VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 437 P-TIPKNSQPKLAELLERCWQQDPALRPDFSE 467
           P +  K + P++ E++E C +Q+   R    +
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  210 bits (537), Expect = 2e-64
 Identities = 60/311 (19%), Positives = 133/311 (42%), Gaps = 16/311 (5%)

Query: 186 RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYC 243
           +S      P             +  +    + I         K+  G + ++YR      
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLD 56

Query: 244 SQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 302
              VA+K ++   +     +    +E+ +++++ H NV+++  +  +   L IV E    
Sbjct: 57  GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116

Query: 303 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 359
           G +   +   K    +    ++ K  + +   + ++H   ++HRD+K AN+ +    VVK
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 176

Query: 360 VADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           + D G+ R   +++    +  GT  +M+PE I    Y+ K+D++S G +L+E+   + P+
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 419 EY-LTPLQAAVGVVQKGLRPTIPKNSQ-PKLAELLERCWQQDPALRPDFSEIIEILQQIA 476
                 L +    +++   P +P +    +L +L+  C   DP  RPD + + ++ +++ 
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

Query: 477 KEVGEENEERR 487
                  E   
Sbjct: 297 ACTASSLEHHH 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  211 bits (539), Expect = 3e-64
 Identities = 75/277 (27%), Positives = 148/277 (53%), Gaps = 10/277 (3%)

Query: 202 HPYHLKIPNDGTDVWEIDPKHLK---FGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER 256
           H +H            +  + ++      K+  GS+G   L + T   +   IK +   R
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61

Query: 257 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 315
           ++S  ++E  +EV ++  ++H N+VQ+  +  +  SL IV ++  GG ++  ++  KGV 
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121

Query: 316 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
           F+   +L   + +   + ++H   I+HRD+K+ N+ + ++  V++ DFG+ARV   S V 
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVE 180

Query: 376 TAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 433
            A    GT  +++PE+ E+KPY++K+D+++ G VL+EL T K  +E  + ++  V  +  
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKIIS 239

Query: 434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           G  P +  +    L  L+ + ++++P  RP  + I+E
Sbjct: 240 GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  207 bits (528), Expect = 8e-63
 Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 19/299 (6%)

Query: 175 LKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 234
           L    + W S  +      PE    +      K+     +  E +   +    +V  GS+
Sbjct: 13  LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSF 71

Query: 235 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 292
           G+++R          A+K +        ++    +E+     +    +V   GA  + P 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           + I  E + GGS+   + K  G       L       +G+ YLH   I+H D+KA N+L+
Sbjct: 125 VNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183

Query: 353 DEN-EVVKVADFGVARVKAQSGVMTAET------GTYRWMAPEVIEHKPYDHKADVFSFG 405
             +     + DFG A      G+  +        GT   MAPEV+  KP D K D++S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 406 IVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQDPALRP 463
            ++  +L G  P+         + +  +      IP +  P  A+ ++   +++P  R 
Sbjct: 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  203 bits (518), Expect = 5e-62
 Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 38/291 (13%)

Query: 218 IDPKHLK---FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D +          + SG +G +++  +    +   IK +K         ++  +EV  +
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58

Query: 273 RKVRHKNVVQFIGA----------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 315
            K+ H N+V + G                  +K   L I  EF   G++  ++ K +G  
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 316 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
                 L++   ++KG++Y+H   +I+RDLK +N+ + + + VK+ DFG+       G  
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 434
           T   GT R+M+PE I  + Y  + D+++ G++L ELL      +E               
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDL 231

Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEEN 483
               I      K   LL++   + P  RP+ SEI+    + + + E  E +
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  203 bits (519), Expect = 9e-62
 Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 8/250 (3%)

Query: 224 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNV 280
           +  S++  GSYG++++       +  A+K           +     EV    KV +H   
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V+   A  +   L + TE   G S+  +            +     D    + +LH   +
Sbjct: 120 VRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 400
           +H D+K AN+ +      K+ DFG+      +G    + G  R+MAPE+++   Y   AD
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAAD 237

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           VFS G+ + E+             Q    + Q  L P        +L  +L    + DP 
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294

Query: 461 LRPDFSEIIE 470
           LR     ++ 
Sbjct: 295 LRATAEALLA 304

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  201 bits (512), Expect = 7e-61
 Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 36/282 (12%)

Query: 199 MKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE 255
           M   P    +P  G    + DP+ L     K+  GS+G++++G      + VAIK++  E
Sbjct: 1   MAHSPVQSGLP--GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58

Query: 256 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 315
               +++ +  QE+ ++ +     V ++ G+  K   L I+ E++ GGS  D L    G 
Sbjct: 59  EAEDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GP 115

Query: 316 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVK 369
                +  +  ++ KG++YLH    IHRD+KAAN+L+ E+  VK+ADFGVA      ++K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175

Query: 370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
             + V     GT  WMAPEVI+   YD KAD++S GI   EL  G+ P+  L P++    
Sbjct: 176 RNTFV-----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF- 229

Query: 430 VVQKGLRPTIPKNSQPKLA--------ELLERCWQQDPALRP 463
                    IPKN+ P L         E +E C  ++P+ RP
Sbjct: 230 --------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  201 bits (512), Expect = 8e-61
 Identities = 86/285 (30%), Positives = 131/285 (45%), Gaps = 43/285 (15%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           W I+    +    + SG+   +         + VAIK +  E+  + M  E  +E+  M 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLK---VAI--- 326
           +  H N+V +  +      L +V + +SGGSV D   H +        +L    +A    
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------G 380
           +V +G+ YLH+N  IHRD+KA N+L+ E+  V++ADFGV+   A  G +T         G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 381 TYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 439
           T  WMAPEV+E  + YD KAD++SFGI   EL TG  PY    P++              
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLT 239

Query: 440 PKNSQPKLA-----------------ELLERCWQQDPALRPDFSE 467
            +N  P L                  +++  C Q+DP  RP  +E
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  199 bits (509), Expect = 1e-60
 Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 11/247 (4%)

Query: 226 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 283
              +  G+YG +Y G   S    +AIK +     +S   +   +E+ + + ++HKN+VQ+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKV-AIDVSKGMNYLHQNNII 341
           +G+ ++   + I  E + GGS+   L    G  K     +      + +G+ YLH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 342 HRDLKAANLLMDENE-VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKP--YDH 397
           HRD+K  N+L++    V+K++DFG + R+   +      TGT ++MAPE+I+  P  Y  
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 398 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
            AD++S G  + E+ TGK P+ E   P  A   V    + P IP++   +    + +C++
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264

Query: 457 QDPALRP 463
            DP  R 
Sbjct: 265 PDPDKRA 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  196 bits (500), Expect = 3e-59
 Identities = 58/281 (20%), Positives = 119/281 (42%), Gaps = 35/281 (12%)

Query: 226 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 282
             K+ SG +G +++          AIK  K     S  ++   +EV+    + +H +VV+
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +  A  +   + I  E+ +GGS+ D +   +++   FK   L  + + V +G+ Y+H  +
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135

Query: 340 IIHRDLKAANLLMDEN-------------------EVVKVADFGVARVKAQSGVMTAETG 380
           ++H D+K +N+ +                       + K+ D G      +      E G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEG 192

Query: 381 TYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 439
             R++A EV+ E+  +  KAD+F+  + +      +               +++G  P I
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLPRI 248

Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKE 478
           P+    +  ELL+     DP  RP    +++  +L   +++
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  194 bits (496), Expect = 3e-58
 Identities = 80/273 (29%), Positives = 123/273 (45%), Gaps = 37/273 (13%)

Query: 214 DVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVF 270
           D     P+ +     K+  GSYG +Y+  +    Q VAIK +  E       +E  +E+ 
Sbjct: 21  DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEIS 76

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           IM++    +VV++ G+  K   L IV E+   GSV D +           +  +     K
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRW 384
           G+ YLH    IHRD+KA N+L++     K+ADFGVA        K  + +     GT  W
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           MAPEVI+   Y+  AD++S GI   E+  GK PY  + P++A            IP N  
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPTNPP 242

Query: 445 PKLA----------ELLERCWQQDPALRPDFSE 467
           P             + +++C  + P  R   ++
Sbjct: 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  193 bits (492), Expect = 7e-58
 Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 46/289 (15%)

Query: 205 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ 262
           H++   D  +VWEI         ++  G++G +Y+          A KV++ +  + +  
Sbjct: 10  HVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL 60

Query: 263 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           +++  E+ I+    H  +V+ +GA      L I+ EF  GG+V   + +L      P + 
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 323 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMT 376
            V   + + +N+LH   IIHRDLKA N+LM     +++ADFGV+        K  S +  
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178

Query: 377 AETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 431
              GT  WMAPEV+        PYD+KAD++S GI L E+   + P+  L P++  +   
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--- 232

Query: 432 QKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 470
                  I K+  P L           + L+    ++P  RP  ++++E
Sbjct: 233 ------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  190 bits (485), Expect = 7e-57
 Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 20/250 (8%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  G+ G +Y     +  Q+VAI+ +  +      ++    E+ +MR+ ++ N+V ++ 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +      L +V E+++GGS+ D + +         +  V  +  + + +LH N +IHRD+
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142

Query: 346 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           K+ N+L+  +  VK+ DFG        + K  + V     GT  WMAPEV+  K Y  K 
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKV 197

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 457
           D++S GI+  E++ G+ PY    PL+A   +   G  P +    +      + L RC + 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEM 256

Query: 458 DPALRPDFSE 467
           D   R    E
Sbjct: 257 DVEKRGSAKE 266

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  193 bits (491), Expect = 9e-57
 Identities = 54/308 (17%), Positives = 124/308 (40%), Gaps = 21/308 (6%)

Query: 181 GWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG 240
           G     ++    +  D+         K  +   +   +  +      ++ SG    +++ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75

Query: 241 TYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVT 297
                Q  AIK +  E  ++     +  E+  + K++  +  +++          + +V 
Sbjct: 76  LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 357
           E      +  +L K K             ++ + ++ +HQ+ I+H DLK AN L+ +  +
Sbjct: 136 EC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-M 192

Query: 358 VKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP-----------YDHKADVFS 403
           +K+ DFG+A  ++  +  +  ++  G   +M PE I+                 K+DV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252

Query: 404 FGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
            G +L+ +  GK P+ + +  +     ++        P   +  L ++L+ C ++DP  R
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

Query: 463 PDFSEIIE 470
               E++ 
Sbjct: 313 ISIPELLA 320

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (481), Expect = 3e-56
 Identities = 62/311 (19%), Positives = 125/311 (40%), Gaps = 33/311 (10%)

Query: 198 GMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKV 251
           G   H +H     +       +  ID KH  F  K+  G +  +    G +     A+K 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61

Query: 252 LKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVY 306
           +     +    +E A +E  + R   H N+++ +  C +         ++  F   G+++
Sbjct: 62  I---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 307 DYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
           + + +LK          +L + + + +G+  +H     HRDLK  N+L+ +     + D 
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178

Query: 364 GVARVK----------AQSGVMTAETGTYRWMAPEVIEHKPY---DHKADVFSFGIVLWE 410
           G                      A+  T  + APE+   + +   D + DV+S G VL+ 
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238

Query: 411 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEI 468
           ++ G+ PY+ +     +V +  +  + +IP++ +    L +LL      DP  RP    +
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297

Query: 469 IEILQQIAKEV 479
           +  L+ +    
Sbjct: 298 LSQLEALQPPA 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  188 bits (481), Expect = 3e-56
 Identities = 76/265 (28%), Positives = 138/265 (52%), Gaps = 21/265 (7%)

Query: 232 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGACTK 289
           G +G +Y+G   +  VA+K L      +  +  ++F QE+ +M K +H+N+V+ +G  + 
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101

Query: 290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
              LC+V  +M  GS+ D L  L G   L      K+A   + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 348 ANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 404
           AN+L+DE    K++DFG+AR     AQ+ + +   GT  +MAPE +  +    K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220

Query: 405 GIVLWELLTGKLPY----------EYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELL 451
           G+VL E++TG              +    ++     ++  +   +      S   +  + 
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280

Query: 452 ERCWQQDPALRPDFSEIIEILQQIA 476
            +C  +    RPD  ++ ++LQ++ 
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEMT 305

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  189 bits (481), Expect = 4e-56
 Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 20/250 (8%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GS G +         + VA+K++         ++    EV IMR  +H NVV+   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYK 109

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           +      L ++ EF+ GG++ D + +         +  V   V + + YLH   +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167

Query: 346 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           K+ ++L+  +  VK++DFG          K +S V     GT  WMAPEVI    Y  + 
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLYATEV 222

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 457
           D++S GI++ E++ G+ PY   +P+QA   +      P +  + +  P L + LER   +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVR 281

Query: 458 DPALRPDFSE 467
           DP  R    E
Sbjct: 282 DPQERATAQE 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  187 bits (478), Expect = 7e-56
 Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 35/289 (12%)

Query: 231 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 287
            G +G     +      + AIK ++        +++  +EV  + K+ H  +V++  A  
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWL 73

Query: 288 -----------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNY 334
                      +    L I  +     ++ D+++    + +      L + + +++ + +
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------KAQSGVMTAETGT 381
           LH   ++HRDLK +N+    ++VVKV DFG+                       T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
             +M+PE I    Y HK D+FS G++L+ELL    P+         +  V+    P +  
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFT 250

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEENEERRK 488
              P    +++      P  RP+   IIE  + + +         +R +
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  189 bits (481), Expect = 8e-56
 Identities = 52/265 (19%), Positives = 114/265 (43%), Gaps = 21/265 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--V 280
               ++ SG    +++      Q  AIK +  E  ++     +  E+  + K++  +  +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           ++          + +V E      +  +L K K             ++ + ++ +HQ+ I
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGI 129

Query: 341 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP--- 394
           +H DLK AN L+ +  ++K+ DFG+A  ++  +  +  ++  GT  +M PE I+      
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 395 --------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQP 445
                      K+DV+S G +L+ +  GK P+ + +  +     ++        P   + 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248

Query: 446 KLAELLERCWQQDPALRPDFSEIIE 470
            L ++L+ C ++DP  R    E++ 
Sbjct: 249 DLQDVLKCCLKRDPKQRISIPELLA 273

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  186 bits (475), Expect = 3e-55
 Identities = 54/271 (19%), Positives = 114/271 (42%), Gaps = 21/271 (7%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           +  +      ++ SG    +++      Q  AIK +  E  ++     +  E+  + K++
Sbjct: 25  VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84

Query: 277 HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
             +  +++          + +V E      +  +L K K             ++ + ++ 
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHT 142

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 391
           +HQ+ I+H DLK AN L+ +  ++K+ DFG+A        S V  ++ GT  +M PE I+
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 392 HKP-----------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTI 439
                            K+DV+S G +L+ +  GK P+ + +  +     ++        
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           P   +  L ++L+ C ++DP  R    E++ 
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  185 bits (472), Expect = 3e-55
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)

Query: 231 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA-- 286
           +GSYG     R     + +  K L    +    ++    EV ++R+++H N+V++     
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQ-----N 338
                +L IV E+  GG +   + K            +L+V   ++  +   H+     +
Sbjct: 76  DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYD 396
            ++HRDLK AN+ +D  + VK+ DFG+AR+        A+T  GT  +M+PE +    Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYN 194

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
            K+D++S G +L+EL     P+   +  +   G +++G    IP     +L E++ R   
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITRMLN 253

Query: 457 QDPALRPDFSEIIE 470
                RP   EI+E
Sbjct: 254 LKDYHRPSVEEILE 267

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  187 bits (477), Expect = 3e-55
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 29/301 (9%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGT 241
           P+  +       +          LK P+     ++ DP+ L     ++  GS+G +Y   
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74

Query: 242 YCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 298
                + VAIK +      S +  ++  +EV  ++K+RH N +Q+ G   +  +  +V E
Sbjct: 75  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134

Query: 299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 358
           +   GS  D L   K   +   +  V     +G+ YLH +N+IHRD+KA N+L+ E  +V
Sbjct: 135 YC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 193

Query: 359 KVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 415
           K+ DFG A   +      +  GT  WMAPEVI   +   YD K DV+S GI   EL   K
Sbjct: 194 KLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

Query: 416 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------ELLERCWQQDPALRPDFS 466
            P   +  + A            I +N  P L            ++ C Q+ P  RP   
Sbjct: 251 PPLFNMNAMSALY---------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301

Query: 467 E 467
            
Sbjct: 302 V 302

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  186 bits (475), Expect = 4e-55
 Identities = 79/287 (27%), Positives = 135/287 (47%), Gaps = 19/287 (6%)

Query: 211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQE 268
                W+   + LK   ++  G+YG + +  +    Q +A+K ++   ++   QK+   +
Sbjct: 12  SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMD 70

Query: 269 V-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKV 324
           +  +MR      +VQF GA  +     I  E MS      Y      L  V     L K+
Sbjct: 71  LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130

Query: 325 AIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
            +   K +N+L +N  IIHRD+K +N+L+D +  +K+ DFG++     S   T + G   
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190

Query: 384 WMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 439
           +MAPE I+     + YD ++DV+S GI L+EL TG+ PY     +   +  V KG  P +
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250

Query: 440 PKNSQ----PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 479
             + +    P     +  C  +D + RP + E+++   IL    + V
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  187 bits (476), Expect = 1e-54
 Identities = 51/329 (15%), Positives = 108/329 (32%), Gaps = 38/329 (11%)

Query: 184 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG--SYGDLYRGT 241
           +H            GM S                 +    +  + +  G      +    
Sbjct: 2   AHHHHHHMENLYFQGMSSFL--------------PEGGCYELLTVIGKGFEDLMTVNLAR 47

Query: 242 YCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 299
           Y    + V ++ +  E  +++M      E+ + +   H N+V +         L +VT F
Sbjct: 48  YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107

Query: 300 MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 358
           M+ GS  D +           ++  +   V K ++Y+H    +HR +KA+++L+  +  V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167

Query: 359 KVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVL 408
            ++             R +              W++PEV++   + YD K+D++S GI  
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
            EL  G +P++ +   Q  +              + P L +      ++           
Sbjct: 228 CELANGHVPFKDMPATQMLL---------EKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278

Query: 469 IEILQQIAKEVGEENEERRKEKSSGGFLS 497
             +   +       +             S
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  183 bits (467), Expect = 2e-54
 Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 15/277 (5%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMR 273
           E+    L+   ++  G+YG + +  +    Q +A+K ++   +NS  QK    ++   MR
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            V     V F GA  +   + I  E M       Y  +           L K+A+ + K 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 332 MNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           + +LH   ++IHRD+K +N+L++    VK+ DFG++           + G   +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 391 E----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QP 445
                 K Y  K+D++S GI + EL   + PY+        +  V +   P +P +    
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241

Query: 446 KLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 479
           +  +   +C +++   RP + E+++        +K  
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  182 bits (465), Expect = 7e-54
 Identities = 69/301 (22%), Positives = 132/301 (43%), Gaps = 25/301 (8%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 272
           ++ +   L+   ++ SG+ G +++  +      +A+K ++    N +  K    ++  ++
Sbjct: 20  YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVL 78

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +      +VQ  G       + I  E M   +      +++G      L K+ + + K +
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137

Query: 333 NYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
            YL  ++ +IHRD+K +N+L+DE   +K+ DFG++             G   +MAPE I+
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197

Query: 392 -----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 444
                   YD +ADV+S GI L EL TG+ PY+        +  V +   P +P +    
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 445 PKLAELLERCWQQDPALRPDFSEIIE------------ILQQIAKEVGEENEERRKEKSS 492
                 ++ C  +D   RP +++++E             +    K+V  + E  R   SS
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSS 317

Query: 493 G 493
           G
Sbjct: 318 G 318

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  183 bits (466), Expect = 8e-54
 Identities = 87/311 (27%), Positives = 146/311 (46%), Gaps = 49/311 (15%)

Query: 219 DPKHL-KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           DP  + +    V +G+YG +Y+G +    Q  AIKV+       D ++E  QE+ +++K 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKY 77

Query: 276 -RHKNVVQFIGA------CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAID 327
             H+N+  + GA            L +V EF   GSV D +   K    K   +  +  +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 386
           + +G+++LHQ+ +IHRD+K  N+L+ EN  VK+ DFGV A++    G      GT  WMA
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 387 PEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           PEVI         YD K+D++S GI   E+  G  P   + P++A            IP+
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPR 248

Query: 442 NSQPKLA---------ELLERCWQQDPALRPDFSEIIE-----------ILQQIAKEVGE 481
           N  P+L            +E C  ++ + RP   ++++            ++   K+  +
Sbjct: 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308

Query: 482 ENEERRKEKSS 492
             +++R EK  
Sbjct: 309 RTKKKRGEKDE 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  184 bits (468), Expect = 1e-53
 Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 9/272 (3%)

Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ 267
                V E+     +  S++ +G+ G +++ ++      +A K++  E I   ++ +  +
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 80

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E+ ++ +     +V F GA      + I  E M GGS+   L K  G      L KV+I 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139

Query: 328 VSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 386
           V KG+ YL +   I+HRD+K +N+L++    +K+ DFGV+     S   +   GT  +M+
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMS 198

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           PE ++   Y  ++D++S G+ L E+  G+ P     P  A    +  G +        P 
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI---PPPDAKELELMFGCQVEGDAAETPP 255

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
                 R   +          I E+L  I  E
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  182 bits (463), Expect = 1e-53
 Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 34/278 (12%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +  + +  G++G + +       +  AIK ++      +       EV ++  + H+ VV
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 282 QFIGA-------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           ++  A               K  +L I  E+   G++YD +H      +     ++   +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---------------KAQSG 373
            + ++Y+H   IIHRDLK  N+ +DE+  VK+ DFG+A+                   S 
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 374 VMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 432
            +T+  GT  ++A EV++    Y+ K D++S GI+ +E++           +   +  V 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245

Query: 433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
               P    N      +++      DP  RP    ++ 
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  178 bits (455), Expect = 3e-52
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 30/270 (11%)

Query: 231 SGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGAC 287
            G +G +Y+G       VA+K   PE      Q  +EF  E+  +   RH ++V  IG C
Sbjct: 49  HGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104

Query: 288 TKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRD 344
            +   + ++ ++M  G++  +L+        +     L++ I  ++G++YLH   IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164

Query: 345 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE-VIEHKPYDHKAD 400
           +K+ N+L+DEN V K+ DFG+++   +     + T   GT  ++ PE  I+ +  + K+D
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSD 223

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQA------AVGVVQKG---------LRPTIPKNSQP 445
           V+SFG+VL+E+L  +       P +       AV     G         L   I   S  
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQI 475
           K  +   +C       RP   +++  L+  
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  173 bits (440), Expect = 3e-50
 Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 46/292 (15%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                +  G+  +++RG +       AIKV         +  +  +E  +++K+ HKN+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70

Query: 282 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 337
           +       T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 391
           N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 392 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 436
                  K Y    D++S G+  +   TG LP+      +    V+ K +          
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 437 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                              ++ +  Q  L  +L    + D      F +   
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  173 bits (441), Expect = 1e-49
 Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 46/297 (15%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                +  G+  +++RG +       AIKV         +  +  +E  +++K+ HKN+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70

Query: 282 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 337
           +       T      ++ EF   GS+Y  L +    + LP    L V  DV  GMN+L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 391
           N I+HR++K  N++     D   V K+ DFG AR         +  GT  ++ P++ E  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 392 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 436
                  K Y    D++S G+  +   TG LP+      +    V+ K +          
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 437 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                              ++ +  Q  L  +L    + D      F +       I
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  167 bits (425), Expect = 7e-48
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 29/290 (10%)

Query: 228 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 286
            +  G +G +Y+G       VA+K LK ER     + +F  EV ++    H+N+++  G 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQN---NI 340
           C  P    +V  +M+ GSV   L  + +    L  P   ++A+  ++G+ YLH +    I
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           IHRD+KAAN+L+DE     V DFG+A++     + V TA  GT   +APE +       K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQA-----------------AVGVVQKGLRPTIPK 441
            DVF +G++L EL+TG+  ++                           +V   L+     
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD 275

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKS 491
               +L ++   C Q  P  RP  SE++ +L+     + E  EE +KE+ 
Sbjct: 276 EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE--GDGLAERWEEWQKEEM 323

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 9e-48
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 51/324 (15%)

Query: 188 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQ 245
           + P S    +G     +       G  V E+    L+    +A G +  +Y  +     +
Sbjct: 2   AGPGSLGGASGRDQSDF------VGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54

Query: 246 DVAIK-VLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--------LCI 295
           + A+K +L       +  +   QEV  M+K+  H N+VQF  A +              +
Sbjct: 55  EYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111

Query: 296 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLL 351
           +TE    G + ++L   + +G     ++LK+     + + ++H+    IIHRDLK  NLL
Sbjct: 112 LTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAET-------------GTYRWMAPEVIE---HKPY 395
           +     +K+ DFG A   +     +                 T  +  PE+I+   + P 
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230

Query: 396 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLER 453
             K D+++ G +L+ L   + P+E    L+     +  G + +IP +         L+  
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IVNG-KYSIPPHDTQYTVFHSLIRA 284

Query: 454 CWQQDPALRPDFSEIIEILQQIAK 477
             Q +P  R   +E++  LQ+IA 
Sbjct: 285 MLQVNPEERLSIAEVVHQLQEIAA 308

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  166 bits (422), Expect = 1e-47
 Identities = 71/260 (27%), Positives = 127/260 (48%), Gaps = 10/260 (3%)

Query: 218 IDPKHLK---FGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFI 271
           +DP+  +    G  +  G +   +  +     +  A K++    +     +++ + E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
            R + H++VV F G       + +V E     S+ +   K +     P        +  G
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG 127

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 390
             YLH+N +IHRDLK  NL ++E+  VK+ DFG+A +V+          GT  ++APEV+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K +  + DV+S G +++ LL GK P+E  + L+     ++K    +IPK+  P  A L
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASL 245

Query: 451 LERCWQQDPALRPDFSEIIE 470
           +++  Q DP  RP  +E++ 
Sbjct: 246 IQKMLQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  167 bits (424), Expect = 1e-47
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 12/295 (4%)

Query: 183 PSHRSSSPTSEPEDTGMKSH---PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYR 239
           P+         P      +    P   +IP    D      +    G  +  G +   + 
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59

Query: 240 GT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 296
            +     +  A K++    +     +++ + E+ I R + H++VV F G       + +V
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119

Query: 297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            E     S+ +   K +     P        +  G  YLH+N +IHRDLK  NL ++E+ 
Sbjct: 120 LELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178

Query: 357 VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
            VK+ DFG+A +V+          GT  ++APEV+  K +  + DV+S G +++ LL GK
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

Query: 416 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            P+E  + L+     ++K    +IPK+  P  A L+++  Q DP  RP  +E++ 
Sbjct: 239 PPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  161 bits (410), Expect = 3e-46
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 8/244 (3%)

Query: 232 GSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           GS+  +YR        +VAIK++ K     + M +    EV I  +++H ++++      
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + +V E    G +  YL      F           +  GM YLH + I+HRDL  +
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGI 406
           NLL+  N  +K+ADFG+A  + +       T  GT  +++PE+     +  ++DV+S G 
Sbjct: 142 NLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200

Query: 407 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 466
           + + LL G+ P++    ++  +  V       +P     +  +L+ +  +++PA R   S
Sbjct: 201 MFYTLLIGRPPFDT-DTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLS 258

Query: 467 EIIE 470
            +++
Sbjct: 259 SVLD 262

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  161 bits (409), Expect = 5e-46
 Identities = 70/260 (26%), Positives = 125/260 (48%), Gaps = 10/260 (3%)

Query: 232 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           G +G++Y  R       +A+KVL   ++  + ++ +  +EV I   +RH N+++  G   
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + ++ E+   G+VY  L K    F          +++  ++Y H   +IHRD+K  
Sbjct: 80  DATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           NLL+     +K+ADFG +     S       GT  ++ PE+IE + +D K D++S G++ 
Sbjct: 139 NLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           +E L GK P+E  T  Q     + +    T P        +L+ R  + +P+ RP   E+
Sbjct: 198 YEFLVGKPPFEANTY-QETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255

Query: 469 IE---ILQQIAKEVGEENEE 485
           +E   I    +K    +N+E
Sbjct: 256 LEHPWITANSSKPSNCQNKE 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  169 bits (429), Expect = 6e-46
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 14/236 (5%)

Query: 224 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +   ++ +G +G + R       + VAIK  + E    + ++ +  E+ IM+K+ H NVV
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75

Query: 282 QFI------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMN 333
                              +  E+  GG +  YL++ +    L    +  +  D+S  + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 334 YLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 390
           YLH+N IIHRDLK  N+++       + K+ D G A+   Q  + T   GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E K Y    D +SFG + +E +TG  P+          G V++     I       
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  159 bits (404), Expect = 3e-45
 Identities = 60/242 (24%), Positives = 112/242 (46%), Gaps = 7/242 (2%)

Query: 232 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           G +G++Y  R       +A+KVL   ++    ++ +  +E+ I   +RH N+++      
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
               + ++ EF   G +Y  L K  G F          +++  ++Y H+  +IHRD+K  
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           NLLM     +K+ADFG +         T   GT  ++ PE+IE K +D K D++  G++ 
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           +E L G  P++  +  +    +V   L+   P        +L+ +  +  P  R     +
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

Query: 469 IE 470
           +E
Sbjct: 261 ME 262

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (410), Expect = 8e-45
 Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 34/297 (11%)

Query: 188 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQD 246
           SSP+ E +D             ++ T V  +          +  G+ G  +YRG + ++D
Sbjct: 3   SSPSLEQDD------------GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD 50

Query: 247 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           VA+K     RI  +      +EV ++R+   H NV+++           I  E     ++
Sbjct: 51  VAVK-----RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL 104

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKV 360
            +Y+ +          + +    + G+ +LH  NI+HRDLK  N+L+            +
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164

Query: 361 ADFGVARV----KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT 413
           +DFG+ +     +      +   GT  W+APE++     +   +  D+FS G V + +++
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

Query: 414 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA-ELLERCWQQDPALRPDFSEI 468
            G  P+      QA + +    L    P+  +  +A EL+E+    DP  RP    +
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  158 bits (400), Expect = 5e-44
 Identities = 57/173 (32%), Positives = 92/173 (53%), Gaps = 4/173 (2%)

Query: 310 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 369
              K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG+AR  
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 370 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 425
            +      +       +WMAPE I  + Y  ++DV+SFG++LWE+ + G  PY  +   +
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
                +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  + + 
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 15/156 (9%)

Query: 213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEF 265
              WE     LK G  +  G++G +        D       VA+K+LK E       +  
Sbjct: 14  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 72

Query: 266 AQEVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
             E+ I+  +  H NVV  +GACTKP   L ++ EF   G++  YL   +  F       
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 359
                 +G +Y+     I  DLK     +  ++   
Sbjct: 133 A--RFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  157 bits (398), Expect = 6e-44
 Identities = 51/248 (20%), Positives = 100/248 (40%), Gaps = 18/248 (7%)

Query: 238 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 297
           ++       +  +       +       + ++  M     KN V  +   +    L I  
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 298 EFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 355
           +     ++ D++++   +        L + I +++ + +LH   ++HRDLK +N+    +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200

Query: 356 EVVKVADFGVARV-------------KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
           +VVKV DFG+                       T + GT  +M+PE I    Y HK D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 403 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           S G++L+ELL     +         +  V+    P +     P+   +++      P  R
Sbjct: 261 SLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

Query: 463 PDFSEIIE 470
           P+ ++IIE
Sbjct: 318 PEATDIIE 325

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  156 bits (397), Expect = 1e-43
 Identities = 54/314 (17%), Positives = 120/314 (38%), Gaps = 47/314 (14%)

Query: 224 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI---------------NSDMQKEFAQE 268
           +    +  G +  +      ++  A+K  +   +                     +F  E
Sbjct: 34  RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSL 321
           + I+  ++++  +   G  T    + I+ E+M   S+  +                +  +
Sbjct: 94  LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 322 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 380
             +   V    +Y+H + NI HRD+K +N+LMD+N  VK++DFG +        +    G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212

Query: 381 TYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYE----------------YLT 422
           TY +M PE   ++      K D++S GI L+ +    +P+                    
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272

Query: 423 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAK 477
           PL     +     + +   N+    +  + L+   +++PA R    + ++   +     +
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332

Query: 478 EVGEENEERRKEKS 491
           ++ E ++E  K++ 
Sbjct: 333 DLREFSKELYKKRK 346

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  154 bits (391), Expect = 5e-43
 Identities = 72/242 (29%), Positives = 123/242 (50%), Gaps = 6/242 (2%)

Query: 232 GSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 289
           G++  +    +    ++VAIK++   ++N    ++  +EV IM+ + H N+V+       
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85

Query: 290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 349
             +L ++ E+ SGG V+DYL    G  K          +   + Y HQ  I+HRDLKA N
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAEN 144

Query: 350 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVL 408
           LL+D +  +K+ADFG +      G + A  G   + APE+ + K YD  + DV+S G++L
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 468
           + L++G LP++    L+     V +G +  IP         LL+R    +P  R    +I
Sbjct: 205 YTLVSGSLPFDGQN-LKELRERVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

Query: 469 IE 470
           ++
Sbjct: 263 MK 264

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  152 bits (387), Expect = 1e-42
 Identities = 67/266 (25%), Positives = 127/266 (47%), Gaps = 18/266 (6%)

Query: 226 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 282
             K+  G    +Y    T  +  VAIK +    R   +  K F +EV    ++ H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            I    +     +V E++ G ++ +Y+    G   + + +     +  G+ + H   I+H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 400
           RD+K  N+L+D N+ +K+ DFG+A+  +++ +       GT ++ +PE  + +  D   D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------KGLRPTIPKNSQPKLAELLER 453
           ++S GIVL+E+L G+ P+   T +  A+  +Q         +R  IP      L+ ++ R
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP----QSLSNVILR 250

Query: 454 CWQQDPALRP-DFSEIIEILQQIAKE 478
             ++D A R     E+ + L  +  E
Sbjct: 251 ATEKDKANRYKTIQEMKDDLSSVLHE 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  152 bits (385), Expect = 6e-42
 Identities = 52/334 (15%), Positives = 115/334 (34%), Gaps = 67/334 (20%)

Query: 164 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 223
           ++L   L      L     P   SS P +      + +    +K   +    +++  K +
Sbjct: 24  DKLIFKL------LSGLSKPV--SSYPNTFEWQCKLPA----IKPKTE----FQLGSKLV 67

Query: 224 KFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
                +  G++  +Y  T          Q   +KV KP     +      Q +  ++   
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLMERLKPSM 125

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGM 332
               ++F  A        +V E  S G++ + ++  K     V     ++  A+ +   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 333 NYLHQNNIIHRDLKAANLLM-----------DENEVVKVADFGVA---RVKAQSGVMTAE 378
             +H   IIH D+K  N ++           D +  + + D G +   ++  +  + TA+
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 438
             T  +   E++ +KP++++ D F     ++ +L G                        
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-------------------KV 286

Query: 439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 472
             +  + K   L  R    D      ++E   ++
Sbjct: 287 KNEGGECKPEGLFRRLPHLDM-----WNEFFHVM 315

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  149 bits (378), Expect = 3e-41
 Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 23/269 (8%)

Query: 226 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           G  +  G   +++        +DVA+KVL+ +   +      F +E      + H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 283 F--IGACTKPPSLC--IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
               G    P      IV E++ G ++ D +H  +G       ++V  D  + +N+ HQN
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN 135

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKP 394
            IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++++PE      
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195

Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLA 448
            D ++DV+S G VL+E+LTG+ P+   +P+  A   V+            +       L 
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----ADLD 251

Query: 449 ELLERCWQQDPALRP-DFSEIIEILQQIA 476
            ++ +   ++P  R    +E+   L ++ 
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVH 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  147 bits (373), Expect = 6e-41
 Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)

Query: 232 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH ++++     +
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
            P    +V E++SGG ++DY+ K  G  +     ++   +   ++Y H++ ++HRDLK  
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 407
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G++
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200

Query: 408 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 467
           L+ LL G LP++    +      ++ G    IP+     +A LL    Q DP  R    +
Sbjct: 201 LYALLCGTLPFDDEH-VPTLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKD 258

Query: 468 IIE 470
           I E
Sbjct: 259 IRE 261

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (367), Expect = 4e-40
 Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
            G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
           +     +  E+ SGG ++D +         P   +    +  G+ YLH   I HRD+K  
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 349 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 404
           NLL+DE + +K++DFG   V R   +  ++    GT  ++APE+++ + +     DV+S 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 463
           GIVL  +L G+LP++  +         ++      P          LL +   ++P+ R 
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254

Query: 464 DFSEIIE 470
              +I +
Sbjct: 255 TIPDIKK 261

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  145 bits (369), Expect = 4e-40
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 44/284 (15%)

Query: 224 KFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI------------------------ 257
               ++  GSYG   L      +   A+KVL  +++                        
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 258 NSDMQKEFAQEVFIMRKVRHKNVVQF---IGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 314
                ++  QE+ I++K+ H NVV+    +    +   L +V E ++ G V +       
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL--K 132

Query: 315 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 374
                       D+ KG+ YLH   IIHRD+K +NLL+ E+  +K+ADFGV+     S  
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 375 MTAET-GTYRWMAPEVI--EHKPYD-HKADVFSFGIVLWELLTGKLPY--EYLTPLQAAV 428
           + + T GT  +MAPE +    K +     DV++ G+ L+  + G+ P+  E +  L +  
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK- 251

Query: 429 GVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE 470
             ++       P        L +L+ R   ++P  R    EI  
Sbjct: 252 --IKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  142 bits (361), Expect = 1e-38
 Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
            G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV+F G   
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
           +     +  E+ SGG ++D +         P   +    +  G+ YLH   I HRD+K  
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134

Query: 349 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 404
           NLL+DE + +K++DFG   V R   +  ++    GT  ++APE+++ + +     DV+S 
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194

Query: 405 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 463
           GIVL  +L G+LP++  +         ++      P          LL +   ++P+ R 
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254

Query: 464 DFSEIIE 470
              +I +
Sbjct: 255 TIPDIKK 261

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  142 bits (360), Expect = 2e-38
 Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 8/243 (3%)

Query: 232 GSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           GS+G +   T+    Q VA+K +  + +  SDM     +E+  ++ +RH ++++     T
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
            P  + +V E+ +GG ++DY+ + K         +    +   + Y H++ I+HRDLK  
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 407
           NLL+D+N  VK+ADFG++ +      +    G+  + APEVI  K Y   + DV+S GIV
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197

Query: 408 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 467
           L+ +L G+LP++    +      V       +P    P    L+ R    DP  R    E
Sbjct: 198 LYVMLVGRLPFDDEF-IPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255

Query: 468 IIE 470
           I  
Sbjct: 256 IRR 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  140 bits (356), Expect = 2e-38
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           +       +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+++         S  IV E  +GG ++D + K +  F      ++   V  G+ Y+H++
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 396 DHKADVFSFGIVLWELLTGKLP 417
           D K DV+S G++L+ LL+G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  143 bits (361), Expect = 2e-38
 Identities = 41/360 (11%), Positives = 101/360 (28%), Gaps = 51/360 (14%)

Query: 166 LRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 225
           +R  L++E   +      + +  +   E     +        + +  +       + LK 
Sbjct: 11  MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKL 66

Query: 226 GSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
              +  G    ++        +D A+KV       +    +   +  F   ++  ++  +
Sbjct: 67  VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 283 FIGAC--------------------------TKPPSLCIVTEFMSG-----GSVYDYLHK 311
                                              +  ++    S       S  D+++ 
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 312 LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 371
            +G   + +L  +   + +    L    ++H      NL +  +  + + D         
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 372 SGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 429
            G  ++   TY     E +      + H  + +  G+ ++ +    LP+  +TP      
Sbjct: 247 RGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 430 VVQKGLRPTIPKNSQPKLA-------ELLERCWQQDPALRPDFSEIIE--ILQQIAKEVG 480
                  P     +             L+ R    D   R    E +E     Q+  E+ 
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  140 bits (355), Expect = 3e-38
 Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
               ++  G++  + R  + +   + A K++  +++++   ++  +E  I RK++H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +   +  +     +V + ++GG +++ +   +  +           + + + Y H N I+
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 342 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           HR+LK  NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 399 ADVFSFGIVLWELLTGKLP 417
            D+++ G++L+ LL G  P
Sbjct: 188 VDIWACGVILYILLVGYPP 206

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  145 bits (367), Expect = 3e-38
 Identities = 61/239 (25%), Positives = 115/239 (48%), Gaps = 21/239 (8%)

Query: 199 MKSHPYHLKIPNDGTDVWEIDP--------------KHLKFGSKVASGSYGDLYRGTYCS 244
           M  H +H     +     ++                +  +   K+ SG+YG++       
Sbjct: 1   MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60

Query: 245 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 302
              + AIK+++   +++    +  +EV +++ + H N+++         +  +V E   G
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVK 359
           G ++D +   +  F       +   V  G+ YLH++NI+HRDLK  NLL+   +++ ++K
Sbjct: 121 GELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179

Query: 360 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 418
           + DFG++ V      M    GT  ++APEV+  K YD K DV+S G++L+ LL G  P+
Sbjct: 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPF 237

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  144 bits (366), Expect = 4e-38
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           +       +  GS+G++ +       Q+ A+KV+      +       +EV +++K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+++         S  IV E  +GG ++D + K +  F      ++   V  G+ Y+H++
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           NI+HRDLK  N+L+   +++  +K+ DFG++    Q+  M    GT  ++APEV+    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 396 DHKADVFSFGIVLWELLTGKLP 417
           D K DV+S G++L+ LL+G  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  144 bits (365), Expect = 4e-38
 Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)

Query: 232 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           G++G +  G +      VA+K+L  ++I S D+  +  +E+  ++  RH ++++     +
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
            P  + +V E++SGG ++DY+ K  G        ++   +  G++Y H++ ++HRDLK  
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 407
           N+L+D +   K+ADFG++ + +    +    G+  + APEVI  + Y   + D++S G++
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205

Query: 408 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 467
           L+ LL G LP++    +      +  G     P+   P +  LL+   Q DP  R    +
Sbjct: 206 LYALLCGTLPFDDDH-VPTLFKKICDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKD 263

Query: 468 IIE 470
           I E
Sbjct: 264 IRE 266

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 6e-38
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 17/249 (6%)

Query: 226 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 282
              V  G  GD+Y    T   + VA+K++      +   +    +E     +++  +VV 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                     L +    ++G  +   L + +G    P  + +   +   ++  H     H
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH 157

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 400
           RD+K  N+L+  ++   + DFG+A       +       GT  +MAPE        ++AD
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLERC 454
           +++   VL+E LTG  PY+    L      +         +RP IP         ++ R 
Sbjct: 218 IYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIARG 272

Query: 455 WQQDPALRP 463
             ++P  R 
Sbjct: 273 MAKNPEDRY 281

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  140 bits (354), Expect = 6e-38
 Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 19/261 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS--DMQKEFAQEVFIMRKVRHKN 279
             G  +  GSYG +            A+K+LK +++    + +    +E+ ++R++RHKN
Sbjct: 8   LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 280 VVQF---IGACTKPPSLCIVTEFMSGGS--VYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
           V+Q    +    K   + +V E+   G   + D +   +  F +         +  G+ Y
Sbjct: 68  VIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 391
           LH   I+H+D+K  NLL+     +K++  GVA      A         G+  +  PE+  
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 392 -HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
               +   K D++S G+ L+ + TG  P+E    +      + KG    IP +  P L++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSD 242

Query: 450 LLERCWQQDPALRPDFSEIIE 470
           LL+   + +PA R    +I +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQ 263

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  140 bits (355), Expect = 8e-38
 Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 19/257 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA------QEVFIMRKV 275
              S + SG++G ++        ++V +K +K E++  D   E         E+ I+ +V
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 276 RHKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
            H N+++ +          +V E   SG  ++ ++ +       P    +   +   + Y
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGY 145

Query: 335 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           L   +IIHRD+K  N+++ E+  +K+ DFG A    +  +     GT  + APEV+   P
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205

Query: 395 YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y   + +++S G+ L+ L+  + P+  L     A            P     +L  L+  
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLVSG 257

Query: 454 CWQQDPALRPDFSEIIE 470
             Q  P  R    +++ 
Sbjct: 258 LLQPVPERRTTLEKLVT 274

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  140 bits (356), Expect = 1e-37
 Identities = 68/250 (27%), Positives = 115/250 (46%), Gaps = 15/250 (6%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 288
           SG++G           + VA+K ++       + +   +E+   R +RH N+V+F     
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
            P  L I+ E+ SGG +Y+ +    G F           +  G++Y H   I HRDLK  
Sbjct: 87  TPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 349 NLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFG 405
           N L+D +    +K+ DFG ++         +  GT  ++APEV+  + YD   ADV+S G
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

Query: 406 IVLWELLTGKLPYE---YLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPA 460
           + L+ +L G  P+E        +  +  +    + +IP + +  P+   L+ R +  DPA
Sbjct: 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPECCHLISRIFVADPA 264

Query: 461 LRPDFSEIIE 470
            R    EI  
Sbjct: 265 TRISIPEIKT 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  138 bits (350), Expect = 3e-37
 Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 21/298 (7%)

Query: 184 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 243
            H   S    P  + M                 E      + G  + SG +G +Y G   
Sbjct: 6   HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65

Query: 244 S--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCI 295
           S    VAIK ++ +RI+             EV +++KV      V++ +    +P S  +
Sbjct: 66  SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125

Query: 296 VTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 354
           + E       ++D++ + +G  +          V + + + H   ++HRD+K  N+L+D 
Sbjct: 126 ILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184

Query: 355 NEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELL 412
           N   +K+ DFG   +  +  V T   GT  +  PE I +  Y    A V+S GI+L++++
Sbjct: 185 NRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

Query: 413 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            G +P+E           + +G +    +    +   L+  C    P+ RP F EI  
Sbjct: 244 CGDIPFE-------HDEEIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  137 bits (347), Expect = 4e-37
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 10/205 (4%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
               F  K+ SG++GD++     S   +  IK +  +R    M++    E+ +++ + H 
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHP 80

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 335
           N+++         ++ IV E   GG + + +              + ++   +   + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 336 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 392
           H  +++H+DLK  N+L      +  +K+ DFG+A +       T   GT  +MAPEV   
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199

Query: 393 KPYDHKADVFSFGIVLWELLTGKLP 417
           +    K D++S G+V++ LLTG LP
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  141 bits (357), Expect = 6e-37
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 8/204 (3%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRH 277
              K    +  GS+G++         Q+ A+KV+ K +      ++   +EV +++++ H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            N+++            +V E  +GG ++D +   +  F      ++   V  G+ Y+H+
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK 144

Query: 338 NNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           N I+HRDLK  NLL+    ++  +++ DFG++     S  M  + GT  ++APEV+ H  
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203

Query: 395 YDHKADVFSFGIVLWELLTGKLPY 418
           YD K DV+S G++L+ LL+G  P+
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  139 bits (352), Expect = 1e-36
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 275
                + SG+ G++         + VAI+++   +        +D       E+ I++K+
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H  +++            IV E M GG ++D +       K  +       +   + YL
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 255

Query: 336 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 391
           H+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+  
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315

Query: 392 --HKPYDHKADVFSFGIVLWELLTGKLP 417
                Y+   D +S G++L+  L+G  P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  135 bits (341), Expect = 2e-36
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
           ++    + +  GS+G++            A K +    +       F QE+ IM+ + H 
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHP 66

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           N+++          + +V E  +GG +++ +   K VF+     ++  DV   + Y H+ 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           N+ HRDLK  N L      +  +K+ DFG+A       +M  + GT  +++P+V+    Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY 184

Query: 396 DHKADVFSFGIVLWELLTGKLP 417
             + D +S G++++ LL G  P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  137 bits (346), Expect = 2e-36
 Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
               ++  G++  + R  + +   + A K++  +++++   ++  +E  I RK++H N+V
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +   +  +     +V + ++GG +++ +   +  +           + + + Y H N I+
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 342 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           HR+LK  NLL+    +   VK+ADFG+A     S       GT  +++PEV++  PY   
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

Query: 399 ADVFSFGIVLWELLTGKLP 417
            D+++ G++L+ LL G  P
Sbjct: 211 VDIWACGVILYILLVGYPP 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  136 bits (345), Expect = 1e-35
 Identities = 59/287 (20%), Positives = 120/287 (41%), Gaps = 43/287 (14%)

Query: 221 KHLKFGSKVASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHK 278
             +     +  GS G + ++G++  + VA+K     R+  D       E+ ++ +   H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHP 69

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------HKLKGVFKLPSLLKVAIDVSKGM 332
           NV+++  + T    L I  E     ++ D +       +   + K  + + +   ++ G+
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 333 NYLHQNNIIHRDLKAANLLMD-------------ENEVVKVADFGVARV-----KAQSGV 374
            +LH   IIHRDLK  N+L+              EN  + ++DFG+ +       +    
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 375 MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPY--EYLTPL 424
           +   +GT  W APE++E        +      D+FS G V + +L+ GK P+  +Y    
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 425 QAAVGVVQ-KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
               G+     ++    ++   +  +L+ +    DP  RP   +++ 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  133 bits (337), Expect = 1e-35
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNV 280
            F   + SG++ +++        +  A+K + K              E+ +++K++H+N+
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHENI 68

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V             +V + +SGG ++D + + +GV+       V   V   + YLH+N I
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 341 IHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           +HRDLK  NLL    +EN  + + DFG+++++ Q+G+M+   GT  ++APEV+  KPY  
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSK 186

Query: 398 KADVFSFGIVLWELLTGKLP 417
             D +S G++ + LL G  P
Sbjct: 187 AVDCWSIGVITYILLCGYPP 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  133 bits (337), Expect = 2e-35
 Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 23/260 (8%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR- 276
           + G  +  G +G ++ G   +    VAIKV+   R+              EV ++ KV  
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 277 ---HKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
              H  V++ +          +V E  +    ++DY+ + KG             V   +
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAI 152

Query: 333 NYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 391
            + H   ++HRD+K  N+L+D      K+ DFG   +       T   GT  +  PE I 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWIS 211

Query: 392 HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
              Y    A V+S GI+L++++ G +P+E           + +      P +  P    L
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE-------RDQEILEA-ELHFPAHVSPDCCAL 263

Query: 451 LERCWQQDPALRPDFSEIIE 470
           + RC    P+ RP   EI+ 
Sbjct: 264 IRRCLAPKPSSRPSLEEILL 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  136 bits (344), Expect = 2e-35
 Identities = 43/200 (21%), Positives = 101/200 (50%), Gaps = 7/200 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +   ++  G++  + R       Q+ A  ++  +++++   ++  +E  I R ++H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +   + ++     ++ + ++GG +++ +   +  +           + + + + HQ  ++
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 342 HRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           HR+LK  NLL+    +   VK+ADFG+A  V+ +        GT  +++PEV+   PY  
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192

Query: 398 KADVFSFGIVLWELLTGKLP 417
             D+++ G++L+ LL G  P
Sbjct: 193 PVDLWACGVILYILLVGYPP 212

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  134 bits (338), Expect = 2e-35
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 53/247 (21%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL---KPERINSDMQKEFAQEVFIMRKVRHK 278
                +  GSYG +            AIK++   K  +IN    +    EV +M+K+ H 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL---------------- 322
           N+ +          +C+V E   GG + D L+           +                
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 323 -----------------------KVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEV 357
                                   +   +   ++YLH   I HRD+K  N L   +++  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 358 VKVADFGVARV-----KAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWE 410
           +K+ DFG+++        +   MT + GT  ++APEV+   ++ Y  K D +S G++L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 411 LLTGKLP 417
           LL G +P
Sbjct: 269 LLMGAVP 275

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  133 bits (336), Expect = 4e-35
 Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 14/247 (5%)

Query: 176 KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG 235
            L  +       SS T+          P +    ++   +        +  S++  G+  
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL----SDFFEVESELGRGATS 67

Query: 236 DLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 293
            +YR       +  A+KVLK       ++     E+ ++ ++ H N+++       P  +
Sbjct: 68  IVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFETPTEI 123

Query: 294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM- 352
            +V E ++GG ++D + + KG +           + + + YLH+N I+HRDLK  NLL  
Sbjct: 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 353 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
               +  +K+ADFG++++     +M    GT  + APE++    Y  + D++S GI+ + 
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242

Query: 411 LLTGKLP 417
           LL G  P
Sbjct: 243 LLCGFEP 249

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  138 bits (348), Expect = 5e-35
 Identities = 55/264 (20%), Positives = 95/264 (35%), Gaps = 28/264 (10%)

Query: 226 GSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
              +A G  G +Y         + V +K L     +++ Q     E   + +V H ++VQ
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 283 FI-----GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
                        P   IV E++ G S+            +   +   +++   ++YLH 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS 200

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
             +++ DLK  N+++ E + +K+ D G        G +    GT  + APE++   P   
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TV 255

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQ 456
             D+++ G  L  L                 G    GL    P          LL R   
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPEDDPVLKTYDSYGRLLRRAID 306

Query: 457 QDPALRP-DFSEIIEILQQIAKEV 479
            DP  R     E+   L  + +EV
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREV 330

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  132 bits (334), Expect = 6e-35
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 275
                + SG+ G++         + VAIK++   +        +D       E+ I++K+
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
            H  +++            IV E M GG ++D +       K  +       +   + YL
Sbjct: 73  NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 130

Query: 336 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 391
           H+N IIHRDLK  N+L+   +E+ ++K+ DFG +++  ++ +M    GT  ++APEV+  
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

Query: 392 --HKPYDHKADVFSFGIVLWELLTGKLP 417
                Y+   D +S G++L+  L+G  P
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  130 bits (329), Expect = 1e-34
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 277
           + G ++ SG +  + +       ++ A K +K  R++S  +    +E  +EV I+R++RH
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            N++           + ++ E +SGG ++D+L + K         +    +  G++YLH 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS 126

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++      N  +K+ DFG+A             GT  ++APE++ ++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 394 PYDHKADVFSFGIVLWELLTG 414
           P   +AD++S G++ + LL+G
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  132 bits (333), Expect = 2e-34
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 14/207 (6%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHK 278
           +    +  G +  + R       Q  A+K++   +  S      ++  +E  I   ++H 
Sbjct: 27  ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNY 334
           ++V+ +   +    L +V EFM G  +   + K +          VA    +     + Y
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY 145

Query: 335 LHQNNIIHRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 390
            H NNIIHRD+K   +L+   + +  VK+  FGVA  +     V     GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLP 417
           + +PY    DV+  G++L+ LL+G LP
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  131 bits (331), Expect = 2e-34
 Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 7/194 (3%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGAC 287
            G +  + +    S  Q+ A K LK  R   D + E   E+ ++   +    V+      
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98

Query: 288 TKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                + ++ E+ +GG ++     +L  +     ++++   + +G+ YLHQNNI+H DLK
Sbjct: 99  ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158

Query: 347 AANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
             N+L+        +K+ DFG++R    +  +    GT  ++APE++ + P     D+++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218

Query: 404 FGIVLWELLTGKLP 417
            GI+ + LLT   P
Sbjct: 219 IGIIAYMLLTHTSP 232

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  130 bits (329), Expect = 2e-34
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 274
           +    +  G    + R  +    ++ A+K++      S       ++++   +EV I+RK
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 275 V-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           V  H N++Q            +V + M  G ++DYL + K         K+   + + + 
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 138

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 391
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198

Query: 392 ----HKPYDHKADVFSFGIVLWELLTGKLP 417
               H  Y  + D++S G++++ LL G  P
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  131 bits (332), Expect = 2e-34
 Identities = 52/250 (20%), Positives = 114/250 (45%), Gaps = 18/250 (7%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
               + +     E+   +S     ++P+      E   +       +  G    + R  +
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFY-QKYDPKDVIGRGVSSVVRRCVH 115

Query: 243 CS--QDVAIKVLK------PERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 293
            +   + A+K+++            ++++   +E  I+R+V  H +++  I +      +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 353
            +V + M  G ++DYL + K          +   + + +++LH NNI+HRDLK  N+L+D
Sbjct: 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234

Query: 354 ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIV 407
           +N  ++++DFG +        +    GT  ++APE+++      H  Y  + D+++ G++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 408 LWELLTGKLP 417
           L+ LL G  P
Sbjct: 295 LFTLLAGSPP 304

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  130 bits (329), Expect = 3e-34
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 277
             G ++ SG +  + +    S   + A K +K  +  +  +    +E  +EV I+R+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            NV+           + ++ E +SGG ++D+L + K              +  G+NYLH 
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 394 PYDHKADVFSFGIVLWELLTGKLP 417
           P   +AD++S G++ + LL+G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  134 bits (340), Expect = 3e-34
 Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 14/268 (5%)

Query: 159 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD-VWE 217
           P E T  +    ++   +  R+G+                     Y   I         E
Sbjct: 93  PCEPTAPVLIPGDE---RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 218 IDPKHLK----FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 271
           I   H+        ++ +G++G ++R T  +   + A K +     +   ++   +E+  
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQT 207

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  +RH  +V    A      + ++ EFMSGG +++ +            ++    V KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267

Query: 332 MNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           + ++H+NN +H DLK  N++     +  +K+ DFG+         +   TGT  + APEV
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLP 417
            E KP  +  D++S G++ + LL+G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  133 bits (337), Expect = 4e-34
 Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLK-----------PERINSDMQKEFAQ 267
           +      K+ SG+YG++      +   + AIKV+K             +      +E   
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
           E+ +++ + H N+++            +VTEF  GG +++ +   +  F       +   
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRW 384
           +  G+ YLH++NI+HRD+K  N+L+   +    +K+ DFG++   ++   +    GT  +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 417
           +APEV+  K Y+ K DV+S G++++ LL G  P
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  130 bits (328), Expect = 4e-34
 Identities = 42/198 (21%), Positives = 88/198 (44%), Gaps = 7/198 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                +  G +G ++R    S  +    K +K +  +  + K   +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
               +      L ++ EF+SG  +++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 342 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 400 DVFSFGIVLWELLTGKLP 417
           D++S G +++ LL+G  P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  130 bits (330), Expect = 4e-34
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRH 277
             G ++ SG +  + +    S   + A K +K            ++E  +EV I+R+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            N++           + ++ E +SGG ++D+L + K              +  G+NYLH 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 394 PYDHKADVFSFGIVLWELLTGKLP 417
           P   +AD++S G++ + LL+G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (324), Expect = 1e-33
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQK----EFAQEVFIMRKVRH 277
             G ++ SG +  + +    S     A K +K  R  S  +     +  +EV I+++++H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            NV+           + ++ E ++GG ++D+L + K         +    +  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 132

Query: 338 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++         +K+ DFG+A             GT  ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 394 PYDHKADVFSFGIVLWELLTGKLP 417
           P   +AD++S G++ + LL+G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  129 bits (327), Expect = 1e-33
 Identities = 41/198 (20%), Positives = 93/198 (46%), Gaps = 6/198 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
               ++ SG++G ++R    +  +    K +         +     E+ IM ++ H  ++
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
               A      + ++ EF+SGG ++D +           ++       +G+ ++H+++I+
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171

Query: 342 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           H D+K  N++    +   VK+ DFG+A       ++   T T  + APE+++ +P     
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231

Query: 400 DVFSFGIVLWELLTGKLP 417
           D+++ G++ + LL+G  P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  129 bits (325), Expect = 2e-33
 Identities = 46/299 (15%), Positives = 93/299 (31%), Gaps = 59/299 (19%)

Query: 220 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVR 276
           P+ L  G+ +           T     +   + V    ER  S+  K+  +EV  +R +R
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 277 -------------------------HKNVVQFIGACTKP--PSLCIVTEFMSG--GSVYD 307
                                     K +++           S   +   M     +  +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 308 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
            L       K       L++ + V + +  LH   ++H  L+  ++++D+   V +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 365 VARVKAQSGVMTAETGTYRWMAPEVI-----------EHKPYDHKADVFSFGIVLWELLT 413
                 + G     + +  +  PE+                     D ++ G+V++ +  
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 414 GKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
             LP        AA+G  +   R    IP      +  LLE   +     R    + +E
Sbjct: 309 ADLPIT----KDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  130 bits (327), Expect = 2e-33
 Identities = 39/294 (13%), Positives = 91/294 (30%), Gaps = 50/294 (17%)

Query: 220 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRK-- 274
           P+ L  G+ +           T     +   + V    ER  S+  K+  +EV  +R   
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 275 --------------------VRHKNVVQFIGACTKPPSLCIVTEF-------MSGGSVYD 307
                               V+     + I        + +++ F        +  +  +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 308 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
            L       K       L++ + V + +  LH   ++H  L+  ++++D+   V +  F 
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 365 VARVKAQSGVMTAETGTY---RWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKL 416
               +  +  ++     +      A  ++              D ++ G+ ++ +    L
Sbjct: 257 HLV-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 417 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
           P      L  +  + +      IP      +  LLE   +     R    + +E
Sbjct: 316 PNTDDAALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  125 bits (317), Expect = 1e-32
 Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 13/194 (6%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC 287
            GS+    +  +    Q  A+K+     I+  M+    +E+  ++    H N+V+     
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 347
                  +V E ++GG +++ + K K  F       +   +   ++++H   ++HRDLK 
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134

Query: 348 ANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 403
            NLL    ++N  +K+ DFG AR     +  +     T  + APE++    YD   D++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194

Query: 404 FGIVLWELLTGKLP 417
            G++L+ +L+G++P
Sbjct: 195 LGVILYTMLSGQVP 208

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  125 bits (315), Expect = 5e-32
 Identities = 51/247 (20%), Positives = 106/247 (42%), Gaps = 14/247 (5%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSK--------VASGSY 234
            S+   +     +     +    +  P    D   +  K     S         +  G +
Sbjct: 43  WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102

Query: 235 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 292
           G +++    +    +A K++K   +    ++E   E+ +M ++ H N++Q   A      
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKND 160

Query: 293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           + +V E++ GG ++D +            +     + +G+ ++HQ  I+H DLK  N+L 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220

Query: 353 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 410
              + + +K+ DFG+AR       +    GT  ++APEV+ +       D++S G++ + 
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM 280

Query: 411 LLTGKLP 417
           LL+G  P
Sbjct: 281 LLSGLSP 287

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  123 bits (311), Expect = 1e-31
 Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 15/202 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNV 280
           +    +  GSY    R  + +   + A+K++         +++  +E+ I+ +  +H N+
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           +           + +VTE M GG + D + + +  F       V   ++K + YLH   +
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 341 IHRDLKAANLLM----DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPY 395
           +HRDLK +N+L        E +++ DFG A+ ++A++G++     T  ++APEV+E + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 396 DHKADVFSFGIVLWELLTGKLP 417
           D   D++S G++L+ +LTG  P
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTP 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  120 bits (302), Expect = 1e-30
 Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 17/241 (7%)

Query: 232 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 286
           GS+  +       T  S++ AIK+L+   I  + +  +   E  +M ++ H   V+    
Sbjct: 41  GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                 L     +   G +  Y+ K  G F          ++   + YLH   IIHRDLK
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157

Query: 347 AANLLMDENEVVKVADFGVA-RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 403
             N+L++E+  +++ DFG A  +  +S    A +  GT ++++PE++  K     +D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 461
            G ++++L+ G  P+           + QK   L    P+   PK  +L+E+    D   
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

Query: 462 R 462
           R
Sbjct: 274 R 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  123 bits (310), Expect = 3e-30
 Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 9/230 (3%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L+ +RI     +  A  E  I+ KV  + VV    A     +LC+V   M+GG + 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 307 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
            +++ + +  F     +  A ++  G+  LH+  I++RDLK  N+L+D++  ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 366 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 425
           A    +   +    GT  +MAPEV++++ Y    D ++ G +L+E++ G+ P++      
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 392

Query: 426 AAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 468
               V +          +   P+   L  +   +DPA R         E+
Sbjct: 393 KREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  119 bits (301), Expect = 3e-30
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 8/234 (3%)

Query: 232 GSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 288
           GS+G   L +        A+K+L  +++    Q E    E  I++ V    +V+   +  
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
              +L +V E+++GG ++ +L +  G F  P     A  +     YLH  ++I+RDLK  
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 408
           NLL+D+   ++V DFG A  K   G      GT   +APE+I  K Y+   D ++ G+++
Sbjct: 171 NLLIDQQGYIQVTDFGFA--KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228

Query: 409 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
           +E+  G  P+    P+Q    +V   +R   P +    L +LL    Q D   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  122 bits (308), Expect = 5e-30
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 9/223 (4%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A K L  +R+      + A  E  I+ KV  + +V    A      LC+V   M+GG + 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 307 DYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
            +++ +      F+ P  +     +  G+ +LHQ NII+RDLK  N+L+D++  V+++D 
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 364 GVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 421
           G+A V+ ++G    +   GT  +MAPE++  + YD   D F+ G+ L+E++  + P+   
Sbjct: 334 GLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

Query: 422 TPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 462
                   + Q+ L    T P    P   +  E   Q+DP  R
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  119 bits (301), Expect = 5e-30
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 9/228 (3%)

Query: 248 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+K +  ++     +     +E+ IM+ + H  +V    +      + +V + + GG + 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
            +L +    FK  ++     ++   ++YL    IIHRD+K  N+L+DE+  V + DF +A
Sbjct: 104 YHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 367 RVKAQSGVMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYL-- 421
            +  +   +T   GT  +MAPE+   +    Y    D +S G+  +ELL G+ PY     
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEI 468
           T  +  V   +     T P     ++  LL++  + +P  R    S++
Sbjct: 223 TSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  119 bits (299), Expect = 1e-29
 Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 26/250 (10%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
           P+     P ++P     +  P              I   +      +  G  G + +   
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 243 CS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCI 295
               +  A+K+L       D  K   +EV +  +  +  ++V+ +            L I
Sbjct: 84  KRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136

Query: 296 VTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 350
           V E + GG ++  +   +G           ++K    + + + YLH  NI HRD+K  NL
Sbjct: 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENL 192

Query: 351 LM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 407
           L      N ++K+ DFG A+       +T    T  ++APEV+  + YD   D++S G++
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

Query: 408 LWELLTGKLP 417
           ++ LL G  P
Sbjct: 253 MYILLCGYPP 262

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  117 bits (295), Expect = 2e-29
 Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 39/248 (15%)

Query: 185 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 244
           H   S   E    G +   Y +      TD +++  + L  G     G  G +    +  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAV------TDDYQLSKQVL--GL----GVNGKVLECFHRR 52

Query: 245 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCIVT 297
             Q  A+K+L           +  QEV    +     ++V  +            L I+ 
Sbjct: 53  TGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105

Query: 298 EFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 352
           E M GG ++  + + +G           +++   D+   + +LH +NI HRD+K  NLL 
Sbjct: 106 ECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLY 161

Query: 353 ---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 409
              +++ V+K+ DFG A+ +     +     T  ++APEV+  + YD   D++S G++++
Sbjct: 162 TSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220

Query: 410 ELLTGKLP 417
            LL G  P
Sbjct: 221 ILLCGFPP 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  117 bits (296), Expect = 2e-29
 Identities = 56/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A+KV+K E +N D   ++ Q E  +  +   H  +V           L  V E+++GG +
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
             ++ + +           + ++S  +NYLH+  II+RDLK  N+L+D    +K+ D+G+
Sbjct: 98  MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 366 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
            +   + G  T+ T  GT  ++APE++  + Y    D ++ G++++E++ G+ P++ +  
Sbjct: 157 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

Query: 424 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 462
                   +  L       +  IP++   K A +L+    +DP  R
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  115 bits (290), Expect = 6e-29
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 32/240 (13%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVL--KPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 285
            G++  +         Q+ A+K++  +P  I S +     +EV ++ + + H+NV++ I 
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLELIE 78

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
              +     +V E M GGS+  ++HK +  F       V  DV+  +++LH   I HRDL
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137

Query: 346 KAANLLM---DENEVVKVADFGVARV--------KAQSGVMTAETGTYRWMAPEVIE--- 391
           K  N+L    ++   VK+ DF +              +  +    G+  +MAPEV+E   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 392 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
                YD + D++S G++L+ LL+G        P     G      R       Q  L E
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGSDCGWDRGEACPACQNMLFE 251

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  116 bits (293), Expect = 9e-29
 Identities = 55/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A++V+K E +N D   ++ Q E  +  +   H  +V           L  V E+++GG +
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
             ++ + +           + ++S  +NYLH+  II+RDLK  N+L+D    +K+ D+G+
Sbjct: 141 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199

Query: 366 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
            +   + G  T+ T  GT  ++APE++  + Y    D ++ G++++E++ G+ P++ +  
Sbjct: 200 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

Query: 424 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 462
                   +  L       +  IP++   K A +L+    +DP  R
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  113 bits (286), Expect = 3e-28
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+K+L+ E I +  +      E  +++  RH  +     A      LC V E+ +GG ++
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
            +L + + VF          ++   + YLH  ++++RD+K  NL++D++  +K+ DFG+ 
Sbjct: 94  FHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

Query: 367 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 424
           +     G     T  GT  ++APEV+E   Y    D +  G+V++E++ G+LP+      
Sbjct: 153 KEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

Query: 425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 468
           +    ++ + +R   P+   P+   LL    ++DP  R      D  E+
Sbjct: 212 RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  113 bits (285), Expect = 4e-28
 Identities = 52/174 (29%), Positives = 95/174 (54%), Gaps = 4/174 (2%)

Query: 248 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 307
           A+KVLK   +    +     E  I+ +V H  +V+   A      L ++ +F+ GG ++ 
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115

Query: 308 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 367
            L K + +F    +     +++  +++LH   II+RDLK  N+L+DE   +K+ DFG+++
Sbjct: 116 RLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

Query: 368 VKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
                      +  GT  +MAPEV+  + +   AD +SFG++++E+LTG LP++
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  112 bits (283), Expect = 7e-28
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 6/216 (2%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+KVLK E +    Q E    E  ++  V H  +++  G       + ++ +++ GG ++
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
             L K    F  P     A +V   + YLH  +II+RDLK  N+L+D+N  +K+ DFG A
Sbjct: 95  SLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153

Query: 367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 426
             K    V     GT  ++APEV+  KPY+   D +SFGI+++E+L G  P+     ++ 
Sbjct: 154 --KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
              ++   LR   P      + +LL R   +D + R
Sbjct: 212 YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  115 bits (290), Expect = 1e-27
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 10/222 (4%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKN---VVQFIGACTKPPSLCIVTEFMSGG 303
           A+K L  +RI     +  A  E  ++  V   +   +V    A   P  L  + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 363
            ++ +L +  GVF    +   A ++  G+ ++H   +++RDLK AN+L+DE+  V+++D 
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336

Query: 364 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT 422
           G+A          A  GT+ +MAPEV++    YD  AD FS G +L++LL G  P+    
Sbjct: 337 GLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQH 394

Query: 423 PLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 462
             +    + +  L     +P +  P+L  LLE   Q+D   R
Sbjct: 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (281), Expect = 1e-27
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            V  GSYG + +       + VAIK       +  ++K   +E+ +++++RH+N+V  + 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
            C K     +V EF+   ++ D L           + K    +  G+ + H +NIIHRD+
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150

Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKPYDHKADV 401
           K  N+L+ ++ VVK+ DFG AR  A    V   E  T  YR  APE++     Y    DV
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVDV 208

Query: 402 FSFGIVLWELLTGK 415
           ++ G ++ E+  G+
Sbjct: 209 WAIGCLVTEMFMGE 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (281), Expect = 2e-27
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 36/209 (17%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVRH 277
            +  G +  +Y+      +Q VAIK     +I    + E           E+ +++++ H
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------K 330
            N++  + A     ++ +V +FM           L+ + K  SL+     +        +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAP 387
           G+ YLHQ+ I+HRDLK  NLL+DEN V+K+ADFG+A+     +   T +  T  YR  AP
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--AP 181

Query: 388 EVIEH-KPYDHKADVFSFGIVLWELLTGK 415
           E++   + Y    D+++ G +L ELL   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  113 bits (285), Expect = 2e-27
 Identities = 74/321 (23%), Positives = 146/321 (45%), Gaps = 25/321 (7%)

Query: 161 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 220
           EE E+   A++     L++Q   +       S  +++G +     L  P        +  
Sbjct: 94  EEREEWTTAIQTVADGLKKQ-AAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-----RVTM 147

Query: 221 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV 275
              ++   +  G++G +     + T   +  A+K+LK E I +  +      E  +++  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           RH  +     +      LC V E+ +GG ++ +L + + VF          ++   ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYL 264

Query: 336 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEH 392
           H + N+++RDLK  NL++D++  +K+ DFG+ +   + G     T  GT  ++APEV+E 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLED 323

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
             Y    D +  G+V++E++ G+LP+      +    ++ + +R   P+   P+   LL 
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLS 381

Query: 453 RCWQQDPALR-----PDFSEI 468
              ++DP  R      D  EI
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEI 402

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  111 bits (280), Expect = 3e-27
 Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 6/176 (3%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A+KVLK + I  D   E    E  I+     H  + Q       P  L  V EF++GG +
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
             ++ K    F        A ++   + +LH   II+RDLK  N+L+D     K+ADFG+
Sbjct: 112 MFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170

Query: 366 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
            +    +GV TA T  GT  ++APE+++   Y    D ++ G++L+E+L G  P+E
Sbjct: 171 CKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  109 bits (276), Expect = 3e-27
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 228 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNVV 281
           K+  G+YG +Y+      +  A+K     +I  + + E       +E+ I+++++H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
           +          L +V E +      D    L   +G  +  +     + +  G+ Y H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 339 NIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKP 394
            ++HRDLK  NLL++    +K+ADFG+AR         T E  T  YR  AP+V+   K 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKK 177

Query: 395 YDHKADVFSFGIVLWELLTGK 415
           Y    D++S G +  E++ G 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  111 bits (279), Expect = 4e-27
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 37/214 (17%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-F----AQEVFIMRKVRHKNV 280
           K+  G++G++++       Q VA+K     ++  + +KE F     +E+ I++ ++H+NV
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHENV 78

Query: 281 VQFIGACT--------KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVS 329
           V  I  C            S+ +V +F      +D    L  +   F L  + +V   + 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--Y 382
            G+ Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q    T    T  Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 383 RWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           R   PE++   + Y    D++  G ++ E+ T  
Sbjct: 195 R--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  114 bits (286), Expect = 4e-27
 Identities = 60/250 (24%), Positives = 116/250 (46%), Gaps = 12/250 (4%)

Query: 178 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 237
             +        +   +      +     +   ++  +   +      F   +  GS+G +
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357

Query: 238 ----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPP 291
                +GT   +  A+K+LK + +  D   E    E  ++    +   + Q         
Sbjct: 358 MLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
            L  V E+++GG +  ++ +  G FK P  +  A +++ G+ +L    II+RDLK  N++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLW 409
           +D    +K+ADFG+ +     GV T  T  GT  ++APE+I ++PY    D ++FG++L+
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533

Query: 410 ELLTGKLPYE 419
           E+L G+ P+E
Sbjct: 534 EMLAGQAPFE 543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  110 bits (277), Expect = 4e-27
 Identities = 55/177 (31%), Positives = 97/177 (54%), Gaps = 8/177 (4%)

Query: 248 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           A+KVLK   I  +  K+ A    E  I+ +V+H  +V  I A      L ++ E++SGG 
Sbjct: 49  AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           ++  L + +G+F   +      ++S  + +LHQ  II+RDLK  N++++    VK+ DFG
Sbjct: 108 LFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 365 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           + +     G +T  T  GT  +MAPE++    ++   D +S G +++++LTG  P+ 
Sbjct: 167 LCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (275), Expect = 6e-27
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
           K+  GSYG +++       Q VAIK       +  ++K   +E+ ++++++H N+V  + 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
              +   L +V E+    +V   L + +       +  +     + +N+ H++N IHRD+
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128

Query: 346 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVIEH-KPYDHKADV 401
           K  N+L+ ++ V+K+ DFG AR+    S     E  T  YR  +PE++     Y    DV
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYGPPVDV 186

Query: 402 FSFGIVLWELLTGK 415
           ++ G V  ELL+G 
Sbjct: 187 WAIGCVFAELLSGV 200

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  110 bits (276), Expect = 9e-27
 Identities = 54/176 (30%), Positives = 96/176 (54%), Gaps = 6/176 (3%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A+K+LK + +  D   E    E  ++    +   + Q          L  V E+++GG +
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
             ++ +  G FK P  +  A +++ G+ +L    II+RDLK  N+++D    +K+ADFG+
Sbjct: 109 MYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167

Query: 366 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
            +     GV T  T  GT  ++APE+I ++PY    D ++FG++L+E+L G+ P+E
Sbjct: 168 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  109 bits (274), Expect = 1e-26
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)

Query: 228 KVASGSYGDLYRG---TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKN 279
           KV  G+YG +Y+        + VA+K     RI  D + E       +E+ +++++ H N
Sbjct: 28  KVGEGTYGVVYKAKDSQ--GRIVALK-----RIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           +V  I        L +V EFM      D    L + K   +   +      + +G+ + H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EH 392
           Q+ I+HRDLK  NLL++ +  +K+ADFG+AR         T E  T  YR  AP+V+   
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGS 194

Query: 393 KPYDHKADVFSFGIVLWELLTGK 415
           K Y    D++S G +  E++TGK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  109 bits (275), Expect = 1e-26
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 10/220 (4%)

Query: 248 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 304
           AIK LK + +  D   E       V       H  +           +L  V E+++GG 
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104

Query: 305 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
           +  ++      F L      A ++  G+ +LH   I++RDLK  N+L+D++  +K+ADFG
Sbjct: 105 LMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 365 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 422
           + +        T  T  GT  ++APE++  + Y+H  D +SFG++L+E+L G+ P+    
Sbjct: 164 MCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

Query: 423 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 462
             +    +         P+  + +  +LL + + ++P  R
Sbjct: 223 EEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  110 bits (276), Expect = 1e-26
 Identities = 58/338 (17%), Positives = 111/338 (32%), Gaps = 87/338 (25%)

Query: 198 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKV 251
           GM++             +  +   +      ++SGSYG       C+        VAIK 
Sbjct: 1   GMQAKGEAAMRDLIAE-LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKR 53

Query: 252 LKPERINSDMQKEF-----AQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IV 296
           +     +             +    E+ ++    H N++  +                +V
Sbjct: 54  VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLV 112

Query: 297 TEFMSGGSVYDYLHKL--KGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDL 345
           TE M      D L ++       +           +L        G++ LH+  ++HRDL
Sbjct: 113 TELMR----TD-LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHRDL 160

Query: 346 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVF 402
              N+L+ +N  + + DF +AR        T       YR  APE++ + K +    D++
Sbjct: 161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMW 218

Query: 403 SFGIVLWELLTGK-------------LPYEYL-TPLQAAVGVVQ--------KGLRPTIP 440
           S G V+ E+   K                E + TP    V +          +     +P
Sbjct: 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278

Query: 441 K--------NSQPKLAELLERCWQQDPALRPDFSEIIE 470
                     + P   +L+ +  + +P  R    + + 
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  111 bits (278), Expect = 1e-26
 Identities = 43/197 (21%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 232 GSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 288
           G++G+  + +     +  A+K+L    +    +   F +E  ++     K +     A  
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144

Query: 289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 348
              +L +V ++  GG +   L K +             ++   ++ +HQ + +HRD+K  
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204

Query: 349 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP-----YDHKADV 401
           N+LMD N  +++ADFG      + G + +    GT  +++PE+++        Y  + D 
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

Query: 402 FSFGIVLWELLTGKLPY 418
           +S G+ ++E+L G+ P+
Sbjct: 265 WSLGVCMYEMLYGETPF 281

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  107 bits (271), Expect = 1e-26
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 280
           K+  G+YG +++       + VA+K     R+  D   E       +E+ ++++++HKN+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
           V+          L +V EF       D   Y     G      +      + KG+ + H 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EHK 393
            N++HRDLK  NLL++ N  +K+A+FG+AR         +AE  T  YR   P+V+   K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAK 177

Query: 394 PYDHKADVFSFGIVLWELLTGKLPY 418
            Y    D++S G +  EL     P 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (270), Expect = 1e-26
 Identities = 32/263 (12%), Positives = 79/263 (30%), Gaps = 46/263 (17%)

Query: 226 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQ 282
                       ++   T   + VA+  + P+ +   D+ +E       + ++    V +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
            +          +V E++ GGS+ +              ++    ++   +  H+  +  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 402
                + + +  +  V +A                                  + + D+ 
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDIR 186

Query: 403 SFGIVLWELLTGKLPYE---YLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLER 453
             G  L+ LL  + P       + L  A             +   IP     +++ +  R
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAAR 242

Query: 454 CWQQDPALRPDFSEIIEILQQIA 476
             Q D  +R   S ++ ++QQ  
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQAT 264

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (272), Expect = 2e-26
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 28/203 (13%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHKN 279
           K+  G+Y  +Y+G        VA+K ++       ++ E        +EV +++ ++H N
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           +V          SL +V E++      D   YL     +  + ++      + +G+ Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EH 392
           +  ++HRDLK  NLL++E   +K+ADFG+AR K+  +     E  T  YR   P+++   
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGS 175

Query: 393 KPYDHKADVFSFGIVLWELLTGK 415
             Y  + D++  G + +E+ TG+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (270), Expect = 3e-26
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVR- 276
           ++  G+YG +Y+    +    VA+K      +                  EV ++R++  
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 277 --HKNVVQFIGACT-----KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VA 325
             H NVV+ +  C      +   + +V E +      D   YL K          +K + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YR 383
               +G+++LH N I+HRDLK  N+L+     VK+ADFG+AR+ +    +T    T  YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
             APEV+    Y    D++S G +  E+   K
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  108 bits (271), Expect = 5e-26
 Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 12/229 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 305
           A+KVL+ + I    +++    E  ++ + V+H  +V    +      L  V ++++GG +
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 306 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
           + +L + +  F  P     A +++  + YLH  NI++RDLK  N+L+D    + + DFG+
Sbjct: 127 FYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185

Query: 366 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 423
            +   +    T+ T  GT  ++APEV+  +PYD   D +  G VL+E+L G  P+     
Sbjct: 186 CKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244

Query: 424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR----PDFSEI 468
            +    ++ K L+  +  N       LLE   Q+D   R     DF EI
Sbjct: 245 AEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  105 bits (265), Expect = 2e-25
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 39/211 (18%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 280
           K+ +G+Y  +Y+G   +    VA+K +K +       +E       +E+ +M++++H+N+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHENI 65

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS----------- 329
           V+          L +V EFM         + LK      ++      +            
Sbjct: 66  VRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 330 -KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWM 385
            +G+ + H+N I+HRDLK  NLL+++   +K+ DFG+AR         ++E  T  YR  
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR-- 175

Query: 386 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           AP+V+   + Y    D++S G +L E++TGK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (264), Expect = 2e-25
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 228 KVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-----QEVFIMRKVR--- 276
           ++  G+YG +++          VA+K     R+     +E       +EV ++R +    
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 277 HKNVVQFI-----GACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAID 327
           H NVV+           +   L +V E +      D   YL K+         +K +   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWM 385
           + +G+++LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  YR  
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGK 415
           APEV+    Y    D++S G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  106 bits (266), Expect = 2e-25
 Identities = 65/308 (21%), Positives = 130/308 (42%), Gaps = 26/308 (8%)

Query: 183 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG------- 235
                +S         + +  + L+  N      ++  ++ +    + +G+YG       
Sbjct: 16  GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75

Query: 236 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN-VVQFIGACTKPP 291
                T   +  A+KVLK   I     K       E  ++  +R    +V    A     
Sbjct: 76  ISGHDT--GKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132

Query: 292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 351
            L ++ ++++GG ++ +L + +  F    +     ++   + +LH+  II+RD+K  N+L
Sbjct: 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191

Query: 352 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI--EHKPYDHKADVFSFGIV 407
           +D N  V + DFG+++         A    GT  +MAP+++      +D   D +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251

Query: 408 LWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR--- 462
           ++ELLTG  P+       +   + ++ L+  P  P+       +L++R   +DP  R   
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 311

Query: 463 --PDFSEI 468
              D  EI
Sbjct: 312 GPRDADEI 319

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (266), Expect = 6e-25
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 37/221 (16%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----E 268
            + +  ++ +    + SG+ G +         ++VAIK  K  R   +  +  A+    E
Sbjct: 57  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN--QTHAKRAYRE 111

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           + +M+ V HKN++  +   T   +L       +V E M      + L ++     +   L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQV-----IQMEL 161

Query: 323 K------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 376
                  +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

Query: 377 AETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
               T  YR  APEVI    Y    D++S G ++ E++  K
Sbjct: 222 PYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  105 bits (264), Expect = 9e-25
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 40/211 (18%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            + +GS+G +Y+   C   + VAIK     ++  D + +  +E+ IMRK+ H N+V+ + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN-RELQIMRKLDHCNIVR-LR 113

Query: 286 ACTKPPS-------LCIVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDV 328
                         L +V +++   +VY    H  +    LP          L +     
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR----- 167

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGT--YRWM 385
              + Y+H   I HRD+K  NLL+D +  V+K+ DFG A+   +     +   +  YR  
Sbjct: 168 --SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR-- 223

Query: 386 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           APE+I     Y    DV+S G VL ELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  105 bits (263), Expect = 1e-24
 Identities = 38/201 (18%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 232 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 286
           G++ ++     + T   Q  A+K++    +    +    + E  ++     + + Q   A
Sbjct: 72  GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129

Query: 287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 346
                 L +V E+  GG +   L K               ++   ++ +H+   +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189

Query: 347 AANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE-------HKPYDH 397
             N+L+D    +++ADFG        G + +    GT  +++PE+++          Y  
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249

Query: 398 KADVFSFGIVLWELLTGKLPY 418
           + D ++ G+  +E+  G+ P+
Sbjct: 250 ECDWWALGVFAYEMFYGQTPF 270

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  104 bits (262), Expect = 1e-24
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 43/255 (16%)

Query: 185 HRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 243
             S++P +  +   +      +K+  +DG    + +  +      + +GS+G +++    
Sbjct: 4   TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNC-KVIGNGSFGVVFQAKLV 62

Query: 244 -SQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPS-------LC 294
            S +VAIK     ++  D  K F   E+ IMR V+H NVV  + A             L 
Sbjct: 63  ESDEVAIK-----KVLQD--KRFKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLN 114

Query: 295 IVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRD 344
           +V E++   +VY    H  K    +P          LL+        + Y+H   I HRD
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRD 166

Query: 345 LKAANLLMDENE-VVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEVI-EHKPYDHKAD 400
           +K  NLL+D    V+K+ DFG A++        +   +  YR  APE+I     Y    D
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNID 224

Query: 401 VFSFGIVLWELLTGK 415
           ++S G V+ EL+ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  103 bits (259), Expect = 1e-24
 Identities = 45/218 (20%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 272
            W       +   K+  G Y +++     +  + V +K+LKP +     +K+  +E+ I+
Sbjct: 31  EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84

Query: 273 RKVR-HKNVVQ----FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI- 326
             +R   N++          ++ P+L +     +     D   +L       +L    I 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNN----TD-FKQL-----YQTLTDYDIR 133

Query: 327 ----DVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGT 381
               ++ K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A              +
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193

Query: 382 YRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGKLP 417
            R+   PE++ +++ YD+  D++S G +L  ++  K P
Sbjct: 194 -RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  103 bits (259), Expect = 2e-24
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 45/225 (20%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ----E 268
            + +  ++ +    + SG+ G +         ++VAIK  K  R   +  +  A+    E
Sbjct: 20  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN--QTHAKRAYRE 74

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLP--- 319
           + +M+ V HKN++  +   T   SL       IV E M      + L +   V ++    
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ---VIQMELDH 126

Query: 320 --------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 371
                    +L        G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    
Sbjct: 127 ERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179

Query: 372 SGVMTAETGTYRWM-APEVIEHKPYDHKADVFSFGIVLWELLTGK 415
           S +MT    T R+  APEVI    Y    D++S G ++ E++ G 
Sbjct: 180 SFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  102 bits (256), Expect = 6e-24
 Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 268
            WE+     +    V SG+YG +           VAIK  K  R      + FA+    E
Sbjct: 20  AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS--ELFAKRAYRE 74

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           + +++ +RH+NV+  +   T   +L       +V  FM      D L K   + K   L 
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGK---LMKHEKLG 126

Query: 323 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
           +  I      + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT 
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTG 184

Query: 378 ETGTYRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
              T RW  APEVI     Y    D++S G ++ E++TGK
Sbjct: 185 YVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (256), Expect = 6e-24
 Identities = 45/220 (20%), Positives = 98/220 (44%), Gaps = 43/220 (19%)

Query: 227 SKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---- 276
            K+  G +       D+   T+    VA+K+++    +    +    E+ ++++V     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 77

Query: 277 -------HKNVVQ------FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLL 322
                    ++++        G       + +V E + G ++   + K +     L  + 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134

Query: 323 KVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------VVKVADFGVARVKAQSGVM 375
           +++  +  G++Y+H+   IIH D+K  N+LM+  +       +K+AD G A    +    
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
           + +T  YR  +PEV+   P+   AD++S   +++EL+TG 
Sbjct: 195 SIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  101 bits (254), Expect = 9e-24
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           V+++ P++    S +  G+YG +           VAIK + P    +  Q+   +E+ I+
Sbjct: 22  VFDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKIL 79

Query: 273 RKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
            + RH+N++         P++       IV + M      D L+K   + K   L    I
Sbjct: 80  LRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME----TD-LYK---LLKTQHLSNDHI 130

Query: 327 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTA 377
                 + +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T 
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 378 ETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
              T  YR  APE++   K Y    D++S G +L E+L+ +
Sbjct: 191 YVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  101 bits (253), Expect = 2e-23
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 9/178 (5%)

Query: 248 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 306
           A+K+L    +       F   E  IM       VVQ   A      L +V E+M GG + 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157

Query: 307 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
           + +                 +V   ++ +H    IHRD+K  N+L+D++  +K+ADFG  
Sbjct: 158 NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

Query: 367 RVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPY 418
               + G++  +T  GT  +++PEV++ +     Y  + D +S G+ L+E+L G  P+
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 3e-23
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 268
            WE+ PK     + V SG+YG +         + VAIK  K  R      + FA+    E
Sbjct: 19  AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQS--EIFAKRAYRE 73

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           + +++ ++H+NV+  +   T   SL       +V  FM      D L K+ G+      +
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKI 128

Query: 323 KVAI-DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 381
           +  +  + KG+ Y+H   ++HRDLK  NL ++E+  +K+ DFG+AR       MT    T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVT 186

Query: 382 YRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
            RW  APEVI     Y+   D++S G ++ E+LTGK
Sbjct: 187 -RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 37/210 (17%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 280
           K+  G+YG++Y+       + VAIK     RI  + ++E       +EV ++++++H+N+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS------KGMNY 334
           ++          L ++ E+          + LK        + + +  S       G+N+
Sbjct: 96  IELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 335 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKA-QSGVMTAETGT--YRWMA 386
            H    +HRDLK  NLL+  ++     V+K+ DFG+AR         T E  T  YR   
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--P 205

Query: 387 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           PE++   + Y    D++S   +  E+L   
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 48/218 (22%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA----QEVFIMRKVRHKNVV 281
               G++G +  G   S    VAIK     ++  D    F     Q +  +  + H N+V
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQD--PRFRNRELQIMQDLAVLHHPNIV 82

Query: 282 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---- 329
           Q + +              L +V E++      D LH+     +     +VA        
Sbjct: 83  Q-LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKV 133

Query: 330 ------KGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETG 380
                 + +  LH    N+ HRD+K  N+L++  +  +K+ DFG A+  + S    A   
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 381 T--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
           +  YR  APE+I  ++ Y    D++S G +  E++ G+
Sbjct: 194 SRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.9 bits (249), Expect = 6e-23
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)

Query: 224 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
             G KV  G+YG +Y+         +D A+K ++   I+    +E    + ++R+++H N
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79

Query: 280 VVQFIGACT--KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSK---- 330
           V+             + ++ ++      +D    +   +        +++   + K    
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 331 ----GMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR-----VKAQSGVMTA 377
               G++YLH N ++HRDLK AN+L+     E   VK+AD G AR     +K  +  +  
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDP 194

Query: 378 ETGT--YRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 415
              T  YR  APE++    H  Y    D+++ G +  ELLT +
Sbjct: 195 VVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 98.6 bits (246), Expect = 9e-23
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 35/220 (15%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ----E 268
           +WE+  ++ +  S V SG+YG +     T     VA+K  K  R         A+    E
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS--IIHAKRTYRE 78

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 322
           + +++ ++H+NV+  +   T   SL       +VT  M      D L+    + K   L 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNN---IVKCQKLT 130

Query: 323 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 377
              +      + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR    +  MT 
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTG 188

Query: 378 ETGTYRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
              T RW  APE++     Y+   D++S G ++ ELLTG+
Sbjct: 189 YVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)

Query: 225 FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 281
               +  G  G + +       +  A+K+L       D  K   +EV +  +  +  ++V
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIV 74

Query: 282 QFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGM 332
           + +            L IV E + GG ++  +   +G           ++K    + + +
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAI 130

Query: 333 NYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
            YLH  NI HRD+K  NLL      N ++K+ DFG                     A E 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET 170

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLP 417
              + YD   D++S G++++ LL G  P
Sbjct: 171 T-GEKYDKSCDMWSLGVIMYILLCGYPP 197

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 50/233 (21%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 267
           V+ I     +  S +  G+YG       CS       + VAIK ++P        +   +
Sbjct: 6   VYNISSDF-QLKSLLGEGAYG-----VVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-R 58

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 321
           E+ I++  +H+N++  I    +P S        I+ E M      D LH+   V     L
Sbjct: 59  EIKILKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VISTQML 109

Query: 322 LKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 368
               I        + +  LH +N+IHRDLK +NLL++ N  +KV DFG+AR+        
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 369 ---KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 415
                Q   M     T  YR  APEV+     Y    DV+S G +L EL   +
Sbjct: 170 SEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 80/311 (25%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 267
            +++  ++      +  G  G        S       + VAIK +        ++    +
Sbjct: 6   GFDLGSRY-MDLKPLGCGGNG-----LVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL-R 57

Query: 268 EVFIMRKVRHKNVVQFIGACTKPPSLC--------------IVTEFMSGGSVYDYLHKLK 313
           E+ I+R++ H N+V+         S                IV E+M      D L    
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN-- 110

Query: 314 GVFKLPSLLKVAID-----VSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVAR 367
            V +   LL+         + +G+ Y+H  N++HRDLK ANL ++ E+ V+K+ DFG+AR
Sbjct: 111 -VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 368 V----KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK----- 415
           +     +  G ++    T  YR  +P ++     Y    D+++ G +  E+LTGK     
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227

Query: 416 --------LPYEYL-TPLQAAVGVVQKGLR------PTIPK--------NSQPKLAELLE 452
                   L  E +    +     +   +        T P             +  + LE
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287

Query: 453 RCWQQDPALRP 463
           +     P  R 
Sbjct: 288 QILTFSPMDRL 298

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 93.6 bits (233), Expect = 9e-21
 Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 31/188 (16%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVTE 298
           Q VA+K+++         ++ A+E+ I+  +R +      NV+  +   T    +C+  E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179

Query: 299 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            +S  ++Y+ +  +K +G F LP + K A  + + ++ LH+N IIH DLK  N+L+ +  
Sbjct: 180 LLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237

Query: 357 --VVKVADFGVARVKAQSGVMTAETGT-------YRWMAPEVIEHKPYDHKADVFSFGIV 407
              +KV DFG       S     +          YR  APEVI    Y    D++S G +
Sbjct: 238 RSGIKVIDFG-------SSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCI 288

Query: 408 LWELLTGK 415
           L ELLTG 
Sbjct: 289 LAELLTGY 296

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 68/296 (22%)

Query: 168 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 227
           ++ E    +    G     S S     +     S      +P   +D W+I  ++ +   
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD-WQIPDRY-EIRH 59

Query: 228 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-FAQ----EVFIMRKVRHKNV 280
            + +GSYG +         + VAIK     +I    +     +    E+ I+ ++ H +V
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 281 VQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DV 328
           V+ +     P  +       +V E        D   K   +F+ P  L          ++
Sbjct: 115 VK-VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---LFRTPVYLTELHIKTLLYNL 165

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------------- 368
             G+ Y+H   I+HRDLK AN L++++  VKV DFG+AR                     
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 369 --------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 413
                   K     +T    T  YR  APE+I   + Y    DV+S G +  ELL 
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLN 279

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 80/312 (25%)

Query: 210 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQ 262
             G     +   +      +  GSYG                ++VAIK  K  R+  D  
Sbjct: 16  FQGIKNVHVPDNY-IIKHLIGRGSYG-----YVYLAYDKNTEKNVAIK--KVNRMFED-- 65

Query: 263 KEFAQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKL 312
               +    E+ I+ +++   +++       P  L       IV E        D L K 
Sbjct: 66  LIDCKRILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIAD----SD-LKK- 118

Query: 313 KGVFKLPSLLK------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 366
             +FK P  L       +  ++  G N++H++ IIHRDLK AN L++++  VKV DFG+A
Sbjct: 119 --LFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 367 RV-----------------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKAD 400
           R                        K     +T+   T  YR  APE+I   + Y    D
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSID 234

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
           ++S G +  ELL     +                  P  P +S   L+         + +
Sbjct: 235 IWSTGCIFAELLNMLQSHINDPT----------NRFPLFPGSSCFPLSPDRNSKKVHEKS 284

Query: 461 LRPDFSEIIEIL 472
            R   + I  I+
Sbjct: 285 NRDQLNIIFNII 296

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 72/243 (29%)

Query: 228 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQ-- 282
            + +GS+G +         +  A+K     ++  D    +   E+ IM+ + H N+++  
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHVNIIKLV 66

Query: 283 ------------------------------FIGACTKPPS------LCIVTEFMSGGSVY 306
                                              +   +      L ++ E++   +++
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125

Query: 307 DYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-EN 355
             L   ++    +P          L +        + ++H   I HRD+K  NLL++ ++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 356 EVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELL 412
             +K+ DFG A+    S    A   +  YR  APE++     Y    D++S G V  EL+
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 413 TGK 415
            GK
Sbjct: 237 LGK 239

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 66/245 (26%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ- 267
             +  K+ +   K+  G+YG                + VA+K  K      +     AQ 
Sbjct: 5   RHVLRKY-ELVKKLGKGAYG-----IVWKSIDRRTGEVVAVK--KIFDAFQN--STDAQR 54

Query: 268 ---EVFIMRKVR-HKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPS 320
              E+ I+ ++  H+N+V  +    +  +   + +V ++M      D LH    V +   
Sbjct: 55  TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYME----TD-LHA---VIRANI 105

Query: 321 LLKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV------- 368
           L  V        + K + YLH   ++HRD+K +N+L++    VKVADFG++R        
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 369 ---------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWE 410
                               ++T    T  YR  APE++     Y    D++S G +L E
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGE 223

Query: 411 LLTGK 415
           +L GK
Sbjct: 224 ILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 19/183 (10%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPPSLCIVTE 298
           + VAIK++K          +   EV ++  +          +V           LC+V E
Sbjct: 80  EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136

Query: 299 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLM-- 352
            +S  ++YD L     +G   L    K A  +   + +L     +IIH DLK  N+L+  
Sbjct: 137 MLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 353 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 412
            +   +K+ DFG +    Q      ++  YR  +PEV+   PYD   D++S G +L E+ 
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMH 252

Query: 413 TGK 415
           TG+
Sbjct: 253 TGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 31/285 (10%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 278
             + G K+ SGS+GD+Y GT  +  ++VAIK+   E + +   +    E  I + ++   
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGGV 65

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            +        +     +V E + G S+ D  +     F L ++L +A  +   + Y+H  
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 339 NIIHRDLKAANLLM---DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 385
           N IHRD+K  N LM    +  +V + DFG+A+    A++            TGT R+   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 386 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP- 440
                IE    D   D+ S G VL     G LP++ L   T  Q    + +K +   I  
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241

Query: 441 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
             K    + A  L  C       +PD+S + ++ + +    G   
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 48/206 (23%)

Query: 244 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 297
            + VA+K++K         +    E+ ++  +           VQ +        +CIV 
Sbjct: 40  GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96

Query: 298 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 355
           E + G S YD++  +     F+L  + K+A  + K +N+LH N + H DLK  N+L  ++
Sbjct: 97  ELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154

Query: 356 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 389
           +                    +KV DFG       S     E  +       YR  APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGK 415
           I    +    DV+S G +L E   G 
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGF 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 50/206 (24%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 297
             VA+K+++    N    +E A+ E+ +++K++ K        V           +CI  
Sbjct: 46  SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 298 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 355
           E + G + +++L  +  +  + LP +  +A  +   + +LH+N + H DLK  N+L   +
Sbjct: 102 ELL-GKNTFEFLKENNFQP-YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159

Query: 356 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 389
           E                    ++VADFG       S     E  T       YR   PEV
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEV 210

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGK 415
           I    +    DV+S G +L+E   G 
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 55/211 (26%)

Query: 245 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH-----KNVVQFIGACTKPPSLCIVTE 298
           +  A+KV++    N       A+ E  I++K+++      N+V++ G       +C++ E
Sbjct: 61  KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116

Query: 299 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 356
            + G S+Y+ +  +   G F +  +    I++ K +NYL + ++ H DLK  N+L+D+  
Sbjct: 117 PL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174

Query: 357 V-------------------------VKVADFGVARVKAQSGVMTAETGT-------YRW 384
                                     +K+ DFG            ++          YR 
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGK 415
            APEVI +  +D  +D++SFG VL EL TG 
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 61/285 (21%), Positives = 118/285 (41%), Gaps = 30/285 (10%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 278
           + + G K+  G++G+L  G      + VAIK+   E + S   +    E    +++    
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLH-LEYRFYKQLGSGD 65

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            + Q            +V E + G S+ D        F L ++L +AI +   M Y+H  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 339 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSG--VMTAE----TGTYRWM 385
           N+I+RD+K  N L+        +V+ + DF +A+  +  ++   +   E    TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

Query: 386 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 440
           +  +  H   +   + D+ + G +    L G LP++ L   T  +    +        I 
Sbjct: 185 S--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242

Query: 441 K--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
               + P++A  L    + D   +PD+  + ++   +    G   
Sbjct: 243 VLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 52/286 (18%), Positives = 107/286 (37%), Gaps = 31/286 (10%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 278
           H K G ++  GS+G ++ GT     Q VAIK    E   SD   +   E    + +    
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCT 66

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            +        +     +V + + G S+ D L      F + ++   A  +   +  +H+ 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 339 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM 385
           ++++RD+K  N L+         ++ V DFG+ +      +            +GT R+M
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

Query: 386 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 440
           +  +  H   +   + D+ + G V    L G LP++ L   T  Q    + +K     + 
Sbjct: 186 S--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 441 ---KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
                   +  + +           PD+  +  +  ++ + +    
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 60/349 (17%), Positives = 114/349 (32%), Gaps = 56/349 (16%)

Query: 182 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT 241
              H SS      E+   +S    L+    GT + +   +  K  S     + G LY   
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62

Query: 242 ----------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 291
                        Q  ++K+   +  +  +  E     F  R  +   V          P
Sbjct: 63  PTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQN---FFQRAAKPLQV-NKWKKLYSTP 115

Query: 292 SLCIVTEFMSGGSVYDY-----------LHKL-----KGVFKLPSLLKVAIDVSKGMNYL 335
            L I T    G     Y           L        K V    S+L+VA  +   + +L
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175

Query: 336 HQNNIIHRDLKAANLLMDENEVVKV--ADFGVAR--------VKAQSGVMTAETGTYRWM 385
           H+N  +H ++ A N+ +D  +  +V  A +G A         V    G  +   G   ++
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

Query: 386 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK-- 441
           +  +  HK      ++D+ S G  + + L G LP+    P    +   ++          
Sbjct: 236 S--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV 293

Query: 442 ------NSQPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
                     + L + L+         +P ++ +   L+ + +++    
Sbjct: 294 GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 71/258 (27%)

Query: 227 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-------- 276
            K+  G +  ++        + VA+KV+K         +    E+ +++ VR        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPN 99

Query: 277 HKNVVQFIGACT-KPPS---LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKG 331
            + VVQ +        +   +C+V E + G  +  ++ K       LP + K+   V +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 332 MNYLH-QNNIIHRDLKAANLLM-------------------------------------- 352
           ++YLH +  IIH D+K  N+L+                                      
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 353 -----------DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 401
                       E   VK+AD G A    +      +T  YR  + EV+    Y+  AD+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADI 276

Query: 402 FSFGIVLWELLTGKLPYE 419
           +S   + +EL TG   +E
Sbjct: 277 WSTACMAFELATGDYLFE 294

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 68/339 (20%), Positives = 126/339 (37%), Gaps = 51/339 (15%)

Query: 184 SHRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 242
            H  SS      +       Y   +P  +G  + +++      G K+ SG +G +Y    
Sbjct: 4   HHHHSSGVDLGTENL-----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58

Query: 243 --CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 300
               +  A  V+K E   +        E+   ++V  K+ ++      +   L I   + 
Sbjct: 59  TNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115

Query: 301 SGGSVY---DY--------------LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 343
           SG + +    Y              +    G FK  ++L++ I +   + Y+H+N  +H 
Sbjct: 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175

Query: 344 DLKAANLLMDENEVVKV--ADFGVARVKAQSGVM--------TAETGTYRWMAPEVIEHK 393
           D+KAANLL+      +V  AD+G++     +G              GT  + +  +  HK
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS--LDAHK 233

Query: 394 PYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------GVVQKGLRPTIPKNS 443
                 ++DV   G  +   L GKLP+E       AV          + + +    P  S
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293

Query: 444 QPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 481
               +A+ L          +P++  + +IL      +G 
Sbjct: 294 SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 54/301 (17%), Positives = 108/301 (35%), Gaps = 44/301 (14%)

Query: 224 KFGSKVASGSYGDLYRGT-YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
           K G  +  G +G +Y      S+ V        ++          E+   ++      +Q
Sbjct: 38  KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97

Query: 283 FIGACTKPPSLCI-------------------VTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
                 K   L +                   + +   G  +          F   ++L+
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV--ADFGVARVKAQSGVMTAE--- 378
           +++ +   + Y+H++  +H D+KA+NLL++     +V   D+G+A      GV  A    
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 379 -----TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 431
                 GT  + +  +  H       + D+   G  + + LTG LP+E        V   
Sbjct: 217 PKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274

Query: 432 QKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 482
           +   R  I           N+  ++A+ +E     D   +P +  + +IL Q  K +G +
Sbjct: 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334

Query: 483 N 483
           +
Sbjct: 335 D 335

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 31/285 (10%)

Query: 222 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK 278
             + G K+ SGS+G++Y GT    +++VAIK+   E + +    +   E  I R ++   
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGT 63

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
            +        +     +V + + G S+ D  +       L ++L +A  +   + ++H  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 339 NIIHRDLKAANLLMDENE---VVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 385
           + +HRD+K  N LM        V + DFG+A+      +            TGT R+   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 386 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLP---YEYLTPLQAAVGVVQKGLRPTIP- 440
                IE    D   D+ S G VL   L G LP    +  T  Q    + +K +  +I  
Sbjct: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239

Query: 441 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
             +    + A     C       +PD+S +  + + +    G + 
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.1 bits (160), Expect = 6e-12
 Identities = 33/186 (17%), Positives = 63/186 (33%), Gaps = 48/186 (25%)

Query: 228 KVASGSYGDLYRGTYCSQDVAIKVL---KPERINSDMQK---EFAQEVFIMRKV------ 275
           K+  G +G++++       VAIK++    P+ +N   QK   E   E+ I +++      
Sbjct: 27  KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 276 ---RHKNVVQFIGAC----TKPPSLC--------------------------IVTEFMSG 302
              R +  +          + PP L                           IV EF  G
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVA 361
           G   D       +  L +   +   ++  +     +    HRDL   N+L+ +  + K+ 
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 362 DFGVAR 367
                +
Sbjct: 205 YTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.0 bits (147), Expect = 6e-10
 Identities = 74/483 (15%), Positives = 132/483 (27%), Gaps = 174/483 (36%)

Query: 12  RDYYIWLM--IRE--IDPQLKSVL---CR----NGNCLFVQVHPVSDRNSAVSSL---LD 57
           R  Y +LM  I+     P + + +    R    N N +F + + VS R      L   L 
Sbjct: 88  RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK-YNVS-RLQPYLKLRQALL 145

Query: 58  SEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDD 117
              PA+   I      G +     +A++   S+ +          +    +  +     +
Sbjct: 146 ELRPAKNVLIDGVLGSGKT----WVALDVCLSYKVQ--------CKMDFKIFWLNLKNCN 193

Query: 118 KPK-LLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 176
            P+ +L  L  LL  I  N       S+                     ++A L + +LK
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSN-------------IKLRIHSIQAEL-RRLLK 239

Query: 177 LERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLK-FGSKVASGSYG 235
                                  K +   L +     +V   + K    F          
Sbjct: 240 S----------------------KPYENCLLVL-L--NVQ--NAKAWNAF---------- 262

Query: 236 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC 294
                     +++ K+L    + +                R K V  F+ A  T   SL 
Sbjct: 263 ----------NLSCKIL----LTT----------------RFKQVTDFLSAATTTHISL- 291

Query: 295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 354
              +  S     D +  L        LLK               +   +DL         
Sbjct: 292 ---DHHSMTLTPDEVKSL--------LLKYL-------------DCRPQDLP-------- 319

Query: 355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 414
            EV+      ++ +        A      W   +  +H   D    +    +    +L  
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLA-----TW---DNWKHVNCDKLTTIIESSL---NVLE- 367

Query: 415 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 474
             P EY       + V        IP         LL   W          S+++ ++ +
Sbjct: 368 --PAEYRKMFD-RLSVFPPSAH--IP-------TILLSLIWFDV-----IKSDVMVVVNK 410

Query: 475 IAK 477
           + K
Sbjct: 411 LHK 413

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 5e-08
 Identities = 48/436 (11%), Positives = 120/436 (27%), Gaps = 118/436 (27%)

Query: 137 QEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK------------------LE 178
           +  + +  +     D FV +    +  +  ++ L KE +                   L 
Sbjct: 13  EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72

Query: 179 RQG-----------------WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT-----DVW 216
            +                  +      +   +P            ++ ND       +V 
Sbjct: 73  SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132

Query: 217 EIDPKH--------LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 268
            + P          L+    V     G L  G      VA+ V    ++    Q +   +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVL--IDGVLGSGKTW---VALDVCLSYKV----QCKMDFK 183

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
           +F +           +  C  P ++  + + +      ++  +      +   +     +
Sbjct: 184 IFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH---SI 230

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWM 385
              +  L    +  +  +   L++      +     +    ++     + T       ++
Sbjct: 231 QAELRRL----LKSKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFL 281

Query: 386 APEVIEHKPYDHKADVFS-------FGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLR 436
           +     H   DH +   +           L +     LP E LT  P    + ++ + +R
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTNPR--RLSIIAESIR 338

Query: 437 --PTIPKNSQ----PKLAELLERCW-QQDPA-LRPDF-------------SEIIEIL-QQ 474
                  N +     KL  ++E      +PA  R  F             + ++ ++   
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398

Query: 475 IAKEVGEE--NEERRK 488
           + K       N+  + 
Sbjct: 399 VIKSDVMVVVNKLHKY 414

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 6e-07
 Identities = 65/428 (15%), Positives = 128/428 (29%), Gaps = 137/428 (32%)

Query: 5   LRMYLCTRDYYIWLMI-REI-DPQ-LKSVLCRNGNC--LFVQVHPVSDRNSAVSSLLDSE 59
           LR  L ++ Y   L++   + + +   +    N +C  L      ++ R   V+  L + 
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAF---NLSCKIL------LTTRFKQVTDFLSAA 284

Query: 60  VPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKP 119
                   H             L    +                             D P
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCR-------------------------PQDLP 319

Query: 120 KLLSQLTAL-LADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE 178
           + +       L+ I  +I++  A              D W +   ++L   +E  +  LE
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATW------------DNWKHVNCDKLTTIIESSLNVLE 367

Query: 179 ----RQGW------------PSHR-----SSSPTSEPEDTGMKSHPYHL--KIPNDGTDV 215
               R+ +            P+            S+      K H Y L  K P + T  
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST-- 425

Query: 216 WEIDPKHLKFGSKVAS---------GSYGDLYRGTYCSQDVAIKV------------LKP 254
             I   +L+   K+ +           Y ++ +  + S D+                LK 
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHY-NIPKT-FDSDDLIPPYLDQYFYSHIGHHLKN 483

Query: 255 ERINSDMQKEFAQEV----FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 310
              + +    F        F+ +K+RH +      A                GS+ + L 
Sbjct: 484 IE-HPERMTLFRMVFLDFRFLEQKIRHDST-----AWNAS------------GSILNTLQ 525

Query: 311 KLKGVFK------LPSLLKVAIDVSKGMNYLHQ--NNII---HRDLKAANLLMDENEVVK 359
           +LK  +K       P   ++   +   +++L +   N+I   + DL    L+ ++  + +
Sbjct: 526 QLK-FYKPYICDNDPKYERLVNAI---LDFLPKIEENLICSKYTDLLRIALMAEDEAIFE 581

Query: 360 VADFGVAR 367
            A   V R
Sbjct: 582 EAHKQVQR 589

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 Length = 192

 Score = 40.5 bits (94), Expect = 4e-04
 Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 2/84 (2%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 170
           IT    D+P + +++  L+   G NI ++        ++L + +          ++   L
Sbjct: 9   ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI--SGSPSNITRVETTL 66

Query: 171 EKEVLKLERQGWPSHRSSSPTSEP 194
                + +        S       
Sbjct: 67  PLLGQQHDLITMMKRTSPHDHQTH 90

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	504
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.29
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.21
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.83
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.58
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.54
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.23
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.89
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.83
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.78
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.52
1u8s_A	192	Glycine cleavage system transcriptional repressor,	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.19
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.79
2nyi_A	195	Unknown protein; protein structure initiative, PSI	95.46
1zpv_A	91	ACT domain protein; structural genomics, PSI, prot	95.41
2ko1_A	88	CTR148A, GTP pyrophosphokinase; homodimer, alpha+b	93.68
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.49
2nyi_A	195	Unknown protein; protein structure initiative, PSI	91.69
2f1f_A	164	Acetolactate synthase isozyme III small subunit; f	91.35
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.33
1u8s_A	192	Glycine cleavage system transcriptional repressor,	89.01
2pc6_A	165	Probable acetolactate synthase isozyme III (small;	88.87
3obi_A	288	Formyltetrahydrofolate deformylase; structural gen	85.96
3nrb_A	287	Formyltetrahydrofolate deformylase; N-terminal ACT	84.74
3n0v_A	286	Formyltetrahydrofolate deformylase; formyl transfe	82.25
3p96_A	415	Phosphoserine phosphatase SERB; ssgcid, structural	82.03
3o1l_A	302	Formyltetrahydrofolate deformylase; structural gen	81.25
3lou_A	292	Formyltetrahydrofolate deformylase; structural gen	80.4
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.3

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-60  Score=480.36  Aligned_cols=267  Identities=36%  Similarity=0.685  Sum_probs=231.1

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      +....|+|+.+++++.++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. 
T Consensus        26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-  103 (307)
T 3omv_A           26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-  103 (307)
T ss_dssp             ---CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence            3456799999999999999999999999998765 59999998776677778899999999999999999999998865 


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +.+|||||||+||+|.++|+...+.+++..+..|+.||+.||+|||+++||||||||+|||+++++.+||+|||+|+...
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            56899999999999999998877889999999999999999999999999999999999999999999999999998654


Q ss_pred             CC---CccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CCC
Q 010680          371 QS---GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----TIP  440 (504)
Q Consensus       371 ~~---~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p----~~p  440 (504)
                      ..   ......+||+.|||||++.+   .+|+.++|||||||+||||+||+.||.+.+........+..+..+    ..+
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            32   23455689999999999953   469999999999999999999999999888777666666555432    356


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      ..+++++.+|+.+||+.||++||||.||++.|+.+...+
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            789999999999999999999999999999998875543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.6e-59  Score=477.43  Aligned_cols=261  Identities=31%  Similarity=0.576  Sum_probs=227.7

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEe
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA  286 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~  286 (504)
                      ..+.|+.+++.+.++||+|+||+||+|++.       ++.||||+++..  +....++|.+|+.+|++++|||||+++|+
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345788889999999999999999999874       467999999854  45567889999999999999999999999


Q ss_pred             eeCCCCceeEEEecCCCchHHHHHhhc--------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010680          287 CTKPPSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM  352 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl  352 (504)
                      |.+++.+|||||||++|+|.+++++..              +.+++..++.|+.||+.||.|||+++||||||||+|||+
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            999999999999999999999997632              468999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 010680          353 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV  428 (504)
Q Consensus       353 ~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~  428 (504)
                      ++++.+||+|||+++......   ......||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+...
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999998654432   2234579999999999999999999999999999999999 999999999887765


Q ss_pred             HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       429 ~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .+ ..+.+++.|..+++++.+||.+||+.||++||||.||++.|+.+.+
T Consensus       272 ~i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          272 CI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HH-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HH-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            54 4567788999999999999999999999999999999999998865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-59  Score=470.91  Aligned_cols=260  Identities=29%  Similarity=0.571  Sum_probs=230.7

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      +.|+.++|.+.++||+|+||+||+|++.       +..||||+++..  +....++|.+|+.+|++++|||||+++|+|.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4677889999999999999999999874       467999999854  4556788999999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhc------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      +++.+|||||||+||+|.++|+...            ..+++..+..++.||+.||.|||+++||||||||+|||+++++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            9999999999999999999997642            4699999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCCcc---ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 010680          357 VVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~  432 (504)
                      .+||+|||+|+........   ....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+....+. 
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            9999999999865443221   23458999999999999999999999999999999999 999999999887776654 


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+.++..|..+++++.+||.+||+.||++||||.+|.+.|+++.+.
T Consensus       245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            5667788999999999999999999999999999999999988653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-58  Score=468.80  Aligned_cols=259  Identities=27%  Similarity=0.544  Sum_probs=229.6

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      .++|+.+++++.++||+|+||+||+|++.       ++.||||+++... .....++|.+|+.+|++++|||||+++|+|
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            34778889999999999999999999873       4679999998653 334567899999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhh---------------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM  352 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl  352 (504)
                      ..++.+|||||||++|+|.++|...               ...+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            9999999999999999999999653               2458999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 010680          353 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV  428 (504)
Q Consensus       353 ~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~  428 (504)
                      ++++.+||+|||+++......   ......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+...
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999998654322   3345679999999999999999999999999999999998 999999999877766


Q ss_pred             HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       429 ~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+ ..+.+++.|..+++++.+|+.+||+.||.+||||.||++.|++.
T Consensus       259 ~i-~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 MI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH-HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            54 45667788999999999999999999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.7e-58  Score=472.66  Aligned_cols=265  Identities=32%  Similarity=0.624  Sum_probs=236.6

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~  285 (504)
                      +.|+|+.++|+++++||+|+||+||+|++.+       +.||||+++... .....+.|.+|+.+|++++| ||||+++|
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            5799999999999999999999999998754       469999998653 34456789999999999976 89999999


Q ss_pred             eeeCC-CCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          286 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       286 ~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      +|..+ ..+|||||||++|+|.++|+...               ..+++..+..++.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            99764 56899999999999999997642               348899999999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~  425 (504)
                      ||+++++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986654332   234568999999999999999999999999999999998 999999988777


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .....+..+.++..|..+++++.++|.+||+.||++||||.||++.|+++++..
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            777778888999999999999999999999999999999999999999998743

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-57  Score=468.15  Aligned_cols=251  Identities=26%  Similarity=0.475  Sum_probs=222.4

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..++|+++++||+|+||+||+|++.  |+.||||+++.........+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            3578999999999999999999875  78899999988777777788899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-c
Q 010680          297 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~  374 (504)
                      ||||+||+|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99999999999997644 457899999999999999999999999999999999999999999999999998665432 2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      .+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.... .+..+..+++++.+||.+|
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHH
Confidence            345679999999999999999999999999999999999999999999988887776654 4567788999999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |++||++|||+.|+++
T Consensus       261 L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          261 FKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-57  Score=462.07  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=225.8

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      +..+...|++.++||+|+||.||+|++.  |+.||||+++.+...       .+|+.+|+.++|||||++++++.+++.+
T Consensus        53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3445567999999999999999999975  788999999865432       4699999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~  372 (504)
                      |||||||+||+|.+++++ .+.+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus       126 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             EEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999999999986 57899999999999999999999999999999999999999987 6999999999876543


Q ss_pred             Cc------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcH
Q 010680          373 GV------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQP  445 (504)
Q Consensus       373 ~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-p~~p~~~~~  445 (504)
                      ..      ....+||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+....+...... ..+|..+++
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  284 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP  284 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence            21      12347999999999999999999999999999999999999999887776666666554332 246789999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ++.+||.+||++||.+|||+.|+++.|..++++++.
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            999999999999999999999999999999988764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-57  Score=458.06  Aligned_cols=248  Identities=23%  Similarity=0.417  Sum_probs=223.2

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|+++++||+|+||+||+|++.  ++.||||++++... .....+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467999999999999999999974  78899999975432 22335678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--  373 (504)
                      |||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......  
T Consensus       110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999999986 5789999999999999999999999999999999999999999999999999998765332  


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+....  +.+|..+++++.+||.
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHHH
Confidence             3456689999999999999999999999999999999999999999999888887777654  4578899999999999


Q ss_pred             HhhhcCCCCCCCHHHHH
Q 010680          453 RCWQQDPALRPDFSEII  469 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell  469 (504)
                      +||.+||.+|||+.|++
T Consensus       267 ~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHSCSSGGGSTTSGGGT
T ss_pred             HHccCCHhHCcChHHHc
Confidence            99999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-56  Score=447.14  Aligned_cols=245  Identities=29%  Similarity=0.563  Sum_probs=215.2

Q ss_pred             eeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC----CCCceeE
Q 010680          223 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIV  296 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV  296 (504)
                      |++.++||+|+||+||+|.+.  +..||||++..........+.|.+|+.+|++++|||||++++++..    ++.+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            578889999999999999985  5779999998777777777889999999999999999999999854    3558999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCcEEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~  373 (504)
                      ||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++|  ||||||||+|||++ .++.+||+|||+|+.... .
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S  185 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence            999999999999986 578999999999999999999999998  99999999999997 478999999999975443 3


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAELLE  452 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-~~p~~~~~~l~~Ll~  452 (504)
                      .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+........+..+..| .++..+++++.+||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            4456789999999999976 59999999999999999999999998776666555555555443 456778899999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||+.||++|||+.|+++
T Consensus       265 ~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-56  Score=456.86  Aligned_cols=246  Identities=29%  Similarity=0.459  Sum_probs=219.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ..|++.++||+|+||+||+|++.  |+.||||+++......  .+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46999999999999999999984  7889999997553322  3568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~  377 (504)
                      ||+||+|.+++.+  +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ...+.
T Consensus       152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            9999999999975  67999999999999999999999999999999999999999999999999999876554 34567


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..+....+.... .....+..+++++.+||.+||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            799999999999999999999999999999999999999999998888776655432 1223345789999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++|||+.|+++
T Consensus       310 ~dP~~R~ta~e~l~  323 (346)
T 4fih_A          310 RDPAQRATAAELLK  323 (346)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.8e-56  Score=442.45  Aligned_cols=246  Identities=27%  Similarity=0.488  Sum_probs=205.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+|++.+.||+|+||+||+|.+  +++.||||+++..... ......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            4799999999999999999987  4788999999866543 344567999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+ +|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            999 7899999976 67899999999999999999999999999999999999999999999999999987776666667


Q ss_pred             CCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..+....+...  .+.+|..+++++.+||.+||+
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcc
Confidence            899999999999999887 57999999999999999999999998877766665543  345788999999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++|||+.|+++
T Consensus       249 ~dP~~R~s~~eil~  262 (275)
T 3hyh_A          249 VNPLNRISIHEIMQ  262 (275)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHc
Confidence            99999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5e-57  Score=456.15  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+++++|+++++||+|+||+||+|+.     .++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            56678999999999999999999987     3467999999865544333456889999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+|||||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999999986 57899999999999999999999999999999999999999999999999999986544


Q ss_pred             C-CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          372 S-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       372 ~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      . ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+....+....  +.+|..+++++.+|
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSL  256 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCcCCHHHHHH
Confidence            3 34456789999999999999999999999999999999999999999999988887776653  45788999999999


Q ss_pred             HHHhhhcCCCCCCCH
Q 010680          451 LERCWQQDPALRPDF  465 (504)
Q Consensus       451 l~~cl~~dP~~RPs~  465 (504)
                      |.+||++||++|||+
T Consensus       257 i~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          257 LRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHTCSSGGGSTTC
T ss_pred             HHHHcccCHHHCCCC
Confidence            999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.9e-55  Score=458.19  Aligned_cols=246  Identities=29%  Similarity=0.457  Sum_probs=220.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.++||+|+||.||+|++.  |+.||||+++.....  ..+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            56999999999999999999985  788999999765332  23568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~  377 (504)
                      ||+||+|.+++..  +.+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... .....
T Consensus       229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            9999999999964  57999999999999999999999999999999999999999999999999999876554 34566


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.+....+.... .....+..+++++.+||.+||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            789999999999999999999999999999999999999999999888777665432 1233456789999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||++|||+.|+++
T Consensus       387 ~dP~~R~ta~ell~  400 (423)
T 4fie_A          387 RDPAQRATAAELLK  400 (423)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-54  Score=437.55  Aligned_cols=253  Identities=27%  Similarity=0.525  Sum_probs=208.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC----CceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~lV  296 (504)
                      ++|.+.++||+|+||+||+|+++|+.||||+++...   .....+..|+..+.+++|||||++++++..++    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            468899999999999999999999999999997542   22223345677778899999999999997654    47999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ||||+||+|.++++.  ..+++..+.+++.|++.||+|||++        +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999975  5689999999999999999999987        999999999999999999999999999987


Q ss_pred             ccCCCc-----cccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhCCCCCC----------CC-----C
Q 010680          369 KAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYE----------YL-----T  422 (504)
Q Consensus       369 ~~~~~~-----~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~----------~~-----~  422 (504)
                      ......     ....+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.          ..     .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            655432     2235799999999999764      46789999999999999999977653          22     2


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          423 PLQAAVGVVQKGLRPTIPKN-----SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       423 ~~~~~~~v~~~~~~p~~p~~-----~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ..+....+.....+|.+|..     +++.+.+|+.+||+.||++||||.||++.|+++.++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            23344445567778877754     345789999999999999999999999999988763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.4e-53  Score=426.93  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=193.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-------  291 (504)
                      ++|++.+.||+|+||+||+|++.  ++.||||+++... .....+.+.+|+.+|++++|||||++++++...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            35899999999999999999975  7889999997543 3445678999999999999999999999986543       


Q ss_pred             -----CceeEEEecCCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          292 -----SLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       292 -----~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                           .+|||||||+||+|.+++....  ...+...++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 3689999999999999997632  224456688999999999999999999999999999999999999999999


Q ss_pred             cceeccCCC-------------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 010680          365 VARVKAQSG-------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV  431 (504)
Q Consensus       365 la~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~  431 (504)
                      +|+......             ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||.............
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            998654432             1234579999999999999999999999999999999996   776533222222223


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          432 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       432 ~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .....|+.+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333333333455677899999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-52  Score=433.87  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=214.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC------CCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~  292 (504)
                      ++|+++++||+|+||+||+|.+.  |+.||||+++.........+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999984  7889999998776666667889999999999999999999998754      357


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|||||||+ |+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            899999995 689999976 678999999999999999999999999999999999999999999999999999865332


Q ss_pred             -----CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 010680          373 -----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------  438 (504)
Q Consensus       373 -----~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--------  438 (504)
                           ......+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+......|.        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 234567899999999998775 569999999999999999999999999988777766553222111        


Q ss_pred             ---------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ---------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                           +...+++++.+||.+||..||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                 11356889999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.1e-50  Score=403.86  Aligned_cols=269  Identities=42%  Similarity=0.738  Sum_probs=232.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+.+++...+|++.++||+|+||.||+|++.++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            45678888999999999999999999999999999999998877677777889999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +++||||+++++|.+++....  ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999997643  24899999999999999999999999  99999999999999999999999999976


Q ss_pred             ccCCC-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          369 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       369 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....+..++..+++++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            54432 23456799999999999999999999999999999999999999999999888877776777788899999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      .++|.+||+.||.+|||+.++++.|+.+++....
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999876543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-50  Score=439.79  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=224.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|...  |+.||||+++...  ......+.+|+.+|+.++|||||++++++.+...+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57999999999999999999884  7889999997643  3345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~~~~  376 (504)
                      ||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.........
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            999999999997767789999999999999999999999999999999999999854  899999999999887776677


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..+||+.|||||++.+.+|+.++|||||||+||||++|..||.+.+..+....+......  +..+..+++++.+||.+|
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~  394 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  394 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            789999999999999999999999999999999999999999999998888777655433  233467899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |..||.+|||+.|+++
T Consensus       395 L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          395 LLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-49  Score=410.25  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=198.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++|++.++||+|+||+||+|+..     ++.||||.+....    ....+.+|+.+|+.+ +|||||++++++.+.+++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            56999999999999999999863     4679999987542    235678899999998 6999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~  373 (504)
                      |||||++||+|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999984    48999999999999999999999999999999999999876 799999999998544321


Q ss_pred             -----------------------------ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Q 010680          374 -----------------------------VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYL-T  422 (504)
Q Consensus       374 -----------------------------~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~-~  422 (504)
                                                   ..+..+||+.|||||++.+. .|+.++||||+||++|||++|+.||... +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                         12345799999999999775 5899999999999999999999999543 3


Q ss_pred             HHHHHHHHHhc----------------------------------------------------CCCCCCCCCCcHHHHHH
Q 010680          423 PLQAAVGVVQK----------------------------------------------------GLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       423 ~~~~~~~v~~~----------------------------------------------------~~~p~~p~~~~~~l~~L  450 (504)
                      ..+....+..-                                                    .........+++++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            33322221110                                                    00011234678999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      |.+||..||.+|||+.|+++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.9e-49  Score=431.81  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +..++|+++++||+|+||.||+|+..  |+.||||++++...    ..........++.+++.++|||||++++++.+++
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            44568999999999999999999884  78899999975432    1122223344567777889999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+|||||||+||+|.++|.+ .+.+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999986 57899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~---~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      . .....+||+.|||||++. +..|+.++|||||||+||||++|.+||.+.   +..+....+..  ..+.+|..+++++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~a  421 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL  421 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHHH
Confidence            4 344678999999999996 468999999999999999999999999753   23333333333  3456788999999


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHHH
Q 010680          448 AELLERCWQQDPALRPD-----FSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs-----~~ell~  470 (504)
                      .+||.+||..||.+|++     +.||++
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            99999999999999998     677753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-48  Score=382.99  Aligned_cols=261  Identities=35%  Similarity=0.717  Sum_probs=231.9

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +..|.++.++|++.++||+|+||.||+|.+ .++.||||+++......   +.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            457899999999999999999999999998 56779999998764443   56889999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999999999987777899999999999999999999999999999999999999999999999999975543


Q ss_pred             CC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          372 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       372 ~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ .....+..+..+++.+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY  237 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHH
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCCHHHH
Confidence            22  2233456788999999998999999999999999999999 99999998887766554 44566777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +++.+||+.||.+||++.++++.|+++.+
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-48  Score=405.58  Aligned_cols=264  Identities=34%  Similarity=0.655  Sum_probs=234.5

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+.|+++.++|++.++||+|+||.||+|++.  ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            3578999999999999999999999999985  788999999854 3445566789999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +.+|+||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999999998766779999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCccc---cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          371 QSGVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       371 ~~~~~~---~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ......   ...+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+... .+..+.++..|..++++
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELCPDA  343 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCCCTTCCHH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence            332111   1234678999999998899999999999999999998 999999988776554 45566777888999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999998763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.3e-48  Score=394.08  Aligned_cols=248  Identities=28%  Similarity=0.493  Sum_probs=226.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..+|++.+.||+|+||.||+|.+  +++.||||++.....+......+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999997  5788999999877667777788999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            99999999999976 56799999999999999999999999999999999999999999999999999987776666777


Q ss_pred             CCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....  ..+|..+++++.+|+.+||.
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYMSTDCENLLKRFLV  250 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHCC
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHCC
Confidence            8899999999999888875 79999999999999999999999998888777766543  35677899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+|||+.|+++
T Consensus       251 ~dP~~R~t~~eil~  264 (328)
T 3fe3_A          251 LNPIKRGTLEQIMK  264 (328)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-48  Score=398.31  Aligned_cols=265  Identities=31%  Similarity=0.624  Sum_probs=233.0

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|++..++|++++.||+|+||.||+|++.+         ..||||+++... .......+.+|+.+|+.+ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3467788899999999999999999998732         359999998653 344567899999999999 89999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++...+.+|+||||++||+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            999999999999999999999999998643               34789999999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999998655432   2234467889999999999999999999999999999999 99999988765


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +... .+..+.++..+..+++++.++|.+||+.||.+||++.|+++.|++++....
T Consensus       313 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          313 ELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             GHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            5543 455666778889999999999999999999999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.7e-48  Score=378.78  Aligned_cols=257  Identities=32%  Similarity=0.622  Sum_probs=234.1

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--CCc
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL  293 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~  293 (504)
                      +.++.++|++.++||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++...  +..
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            467778999999999999999999999999999999998776777778899999999999999999999999877  788


Q ss_pred             eeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          294 CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ++||||+++++|.+++....+ .+++..++.++.||+.||.|||++|  |+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999999987443 5899999999999999999999999  9999999999999999999999999875422


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDH---KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                          .....||+.|+|||++.+..++.   ++||||||+++|+|++|..||...+..+....+.....++..+..+++++
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                23457899999999998765544   89999999999999999999999999888888888888899999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+++.+||+.||.+|||+.++++.|+++.
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            99999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.9e-48  Score=380.93  Aligned_cols=262  Identities=33%  Similarity=0.672  Sum_probs=231.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ...|+++.++|++.++||+|+||.||++.+.+ ..||||+++......   ..+.+|+.++++++||||+++++++....
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            45789999999999999999999999999875 479999998765443   56889999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999987777899999999999999999999999999999999999999999999999999975543


Q ss_pred             CC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          372 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       372 ~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....++..+..+++.+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcccCCCCCCcCCHHHH
Confidence            22  2223456788999999998899999999999999999998 99999998887766654 45566777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +++.+||+.||.+|||+.++++.|++++.+
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=390.53  Aligned_cols=263  Identities=34%  Similarity=0.601  Sum_probs=231.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .++...+|++.++||+|+||.||+|.+.     +..||||+++... .....+.+.+|+.++++++||||+++++++...
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4677889999999999999999999984     3349999998643 455567899999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ...|+||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999999998767789999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ...    ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ..+.++..+..+++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  281 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCPH  281 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCCCCCCCCcCH
Confidence            432    1223356788999999998999999999999999999999 99999998887766554 44566778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .+.+||.+||..||.+|||+.++++.|+.++....
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            99999999999999999999999999999987543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.8e-48  Score=408.65  Aligned_cols=257  Identities=35%  Similarity=0.687  Sum_probs=228.9

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-C
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-S  292 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~  292 (504)
                      ..|+++.++|++.++||+|+||.||+|++.++.||||+++...    ..+.|.+|+.+|++++||||+++++++.... .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            4689999999999999999999999999999999999998653    2467899999999999999999999987655 7


Q ss_pred             ceeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      +|+||||+++|+|.+++..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            8999999999999999987544 379999999999999999999999999999999999999999999999999985443


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .  .....+++.|+|||++.+..++.++||||||++||||++ |..||...+..+.... +..+.++..|..+++.+.+|
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence            2  223467899999999999999999999999999999998 9999998877665544 45677888899999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      |.+||+.||.+|||+.++++.|+++..
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=392.12  Aligned_cols=261  Identities=33%  Similarity=0.543  Sum_probs=225.4

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      +.+..++|+++++||+|+||.||++.+.  ++.||+|++...  .......+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            4567789999999999999999999985  678999998643  456678899999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999999998877889999999999999999999999999999999999999999999999999998654432


Q ss_pred             cc---------------ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhc
Q 010680          374 VM---------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-----AVGVVQK  433 (504)
Q Consensus       374 ~~---------------~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-----~~~v~~~  433 (504)
                      ..               ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...     ...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence            21               145799999999999999999999999999999999999999875432110     111111 


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                         ...+..+++.+.+++.+||+.||++|||+.++++.|+++...+.+.
T Consensus       242 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          242 ---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             ---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             ---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence               2346778899999999999999999999999999999998877643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.7e-48  Score=384.00  Aligned_cols=262  Identities=28%  Similarity=0.538  Sum_probs=221.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-  289 (504)
                      ++...+|++.++||+|+||.||++++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++.. 
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            56778999999999999999999986      4678999999854  45556789999999999999999999998854 


Q ss_pred             -CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                       ...+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             3568999999999999999988777799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHH
Q 010680          369 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAVG  429 (504)
Q Consensus       369 ~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------------~~~~~  429 (504)
                      .....    ......+|..|+|||++.+..++.++||||||+++|+|++|..||......               .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            54432    223345778899999999999999999999999999999999998643211               12233


Q ss_pred             HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       430 v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ......++..+..+++++.+++.+||+.||.+|||+.++++.|+++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            345566777888999999999999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-47  Score=380.65  Aligned_cols=267  Identities=30%  Similarity=0.621  Sum_probs=237.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      ...|++..++|++.+.||+|+||.||+|++       .++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            456889999999999999999999999986       24679999998653 334567899999999999 899999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhcc-----------------cCChHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG-----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA  347 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp  347 (504)
                      +++...+..++||||+++++|.+++.....                 .+++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            999999999999999999999999986543                 489999999999999999999999999999999


Q ss_pred             CcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCH
Q 010680          348 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP  423 (504)
Q Consensus       348 ~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~  423 (504)
                      +||+++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999986654432   223456789999999999999999999999999999999 9999998877


Q ss_pred             HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          424 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       424 ~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ............++..+..+++.+.+++.+||+.||.+|||+.++++.|++++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            666677777777777888999999999999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-47  Score=392.69  Aligned_cols=266  Identities=32%  Similarity=0.626  Sum_probs=233.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      ...|++..++|++.++||+|+||.||+|++.+       +.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            35789999999999999999999999998532       679999998653 344567899999999999 789999999


Q ss_pred             EeeeCCCC-ceeEEEecCCCchHHHHHhhcc-------------------------------------------------
Q 010680          285 GACTKPPS-LCIVTEFMSGGSVYDYLHKLKG-------------------------------------------------  314 (504)
Q Consensus       285 ~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~-------------------------------------------------  314 (504)
                      +++...+. +++||||++||+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99877554 8999999999999999976432                                                 


Q ss_pred             ----------------cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---cc
Q 010680          315 ----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  375 (504)
Q Consensus       315 ----------------~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~  375 (504)
                                      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                            18899999999999999999999999999999999999999999999999998654432   22


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ....||+.|+|||++.+..++.++||||||+++|||++ |..||......+.....+..+..+..+..+++++.+++.+|
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            34467899999999999999999999999999999998 99999988776667677777778888899999999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          455 WQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      |+.||.+|||+.++++.|+++++..
T Consensus       333 l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-47  Score=382.11  Aligned_cols=264  Identities=36%  Similarity=0.732  Sum_probs=217.6

Q ss_pred             CCCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       212 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +.+.++|...+|++.++||+|+||.||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++. .+
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~   92 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP   92 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC
Confidence            345679999999999999999999999998765 5999999987777777788999999999999999999999654 55


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            68999999999999999987677899999999999999999999999999999999999999999999999999975543


Q ss_pred             C---CccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C---CCCC
Q 010680          372 S---GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-P---TIPK  441 (504)
Q Consensus       372 ~---~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-p---~~p~  441 (504)
                      .   .......||+.|+|||++.   +..++.++||||||+++|+|++|..||......+.....+..+.. +   ..+.
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS  252 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence            2   2234457999999999996   677899999999999999999999999887766666555544432 2   2345


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .+++.+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus       253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            789999999999999999999999999999988753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-47  Score=374.96  Aligned_cols=256  Identities=36%  Similarity=0.713  Sum_probs=218.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +++..+|++.++||+|+||.||+|.+.++.||||+++.....  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            567789999999999999999999999999999998765332  233567899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECC--------CCcEEEEee
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADF  363 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~---IiHrDLkp~NILl~~--------~~~vkL~DF  363 (504)
                      +||||++|++|.+++.  .+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999999985  467999999999999999999999999   999999999999986        678999999


Q ss_pred             ccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      |+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..............+..+..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9997654432 234579999999999999999999999999999999999999999999888888888777788888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999999999754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-47  Score=373.62  Aligned_cols=259  Identities=32%  Similarity=0.614  Sum_probs=230.3

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .|++..++|++.+.||+|+||.||+|.+.+ ..||||+++.....   ...+.+|+.++++++||||+++++++......
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            457888999999999999999999999875 46999999876444   35688999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998866779999999999999999999999999999999999999999999999999998765543


Q ss_pred             c--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      .  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. ....+..+..+++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence            2  223456778999999999899999999999999999999 999999988877766544 455666778889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +.+||+.||.+|||+.++++.|+.+.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            999999999999999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.9e-47  Score=377.62  Aligned_cols=263  Identities=32%  Similarity=0.604  Sum_probs=219.6

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..|++..++|++.+.||+|+||.||+|.+..     ..||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            4578888999999999999999999998743     359999987642 4455678999999999999999999999985


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                       .+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             4578999999999999999987666799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          369 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       369 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ..+.++..+..+++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCH
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence            654332  223456789999999999999999999999999999997 99999988776655444 34555677889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+.+++.+||+.||.+|||+.++++.|++++++.
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=391.27  Aligned_cols=267  Identities=31%  Similarity=0.625  Sum_probs=237.0

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|++..++|.++++||+|+||.||+|++.+         ..||||+++.. ........+.+|+.+++++ +||||+++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            4678888999999999999999999998743         45999999865 3445567899999999999 89999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++...+..++||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            999999999999999999999999998753               35899999999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998655432   2334467889999999999999999999999999999999 99999988876


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +... .+..+.++..+..+++++.+++.+||+.||.+|||+.++++.|++++.....+
T Consensus       301 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          301 ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHH-HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            6554 45566677788899999999999999999999999999999999999877654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=390.17  Aligned_cols=267  Identities=30%  Similarity=0.573  Sum_probs=231.2

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      ...|++..++|++.+.||+|+||.||+|++       .+..||||+++... .......+.+|+.+++++ +||||++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            346899999999999999999999999997       23569999998543 233457789999999999 899999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhcc----------------------cCChHHHHHHHHHHHHHHHHHHHCCcee
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG----------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIH  342 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~qI~~gL~yLH~~~IiH  342 (504)
                      +++...+..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++||+|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999999999999999999999999976543                      3788999999999999999999999999


Q ss_pred             ccCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 010680          343 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY  418 (504)
Q Consensus       343 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf  418 (504)
                      |||||+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999986544332   223456889999999998999999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          419 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       419 ~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ............+..+..+..+..+++++.+|+.+||+.||.+|||+.++++.|+.++....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            98877777777777888888889999999999999999999999999999999999877654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-47  Score=371.27  Aligned_cols=259  Identities=36%  Similarity=0.728  Sum_probs=230.7

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .|.++.++|++.+.||+|+||.||++.+. ++.||+|+++.....   .+.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            58899999999999999999999999984 568999999876443   35788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999997554321


Q ss_pred             --ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                        ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ..+.++..+..+++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCcCCCCccCcHHHHHH
Confidence              1233457789999999998899999999999999999999 99999988877666554 4455667788899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +.+||+.||.+||++.++++.|+++.+
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3e-47  Score=387.00  Aligned_cols=264  Identities=31%  Similarity=0.588  Sum_probs=229.8

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      .+++..++|++.+.||+|+||.||+|++.+       +.||||+++... .......+.+|+.++++++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            356777899999999999999999999864       679999998653 445567899999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhc-----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceecc
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD  344 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrD  344 (504)
                      ...+..|+||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            99999999999999999999997642                       5689999999999999999999999999999


Q ss_pred             CCCCcEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 010680          345 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY  420 (504)
Q Consensus       345 Lkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~  420 (504)
                      |||+|||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999997543321   2334567899999999998899999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          421 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       421 ~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .+..+....+ ..+..+..+..+++.+.+++.+||+.||.+||++.++++.|+++.+...
T Consensus       280 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          280 MAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             SCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CChHHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            8887766554 4455567788999999999999999999999999999999999876553

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.6e-47  Score=376.46  Aligned_cols=268  Identities=29%  Similarity=0.539  Sum_probs=229.9

Q ss_pred             CceeeCCCceeeee-eeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          214 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..+.++..+|++.+ .||+|+||.||+|.+.    ++.||||+++.........+.+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            44577788999998 9999999999999663    46799999987765566678899999999999999999999999 


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ..+..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            45678999999999999999986 56799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          369 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       369 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      ......    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  245 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC  245 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            654432    223356789999999998889999999999999999999 9999999887665544 4556677788899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccchH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE  484 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~  484 (504)
                      ++.+.+++.+||+.||.+||++.++++.|++++....+.+.
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~  286 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH  286 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence            99999999999999999999999999999999998875543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-47  Score=405.25  Aligned_cols=262  Identities=34%  Similarity=0.661  Sum_probs=231.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|++..++|++.++||+|+||.||+|.+. +..||||+++.....   .+.|.+|+.+|++++||||+++++++. .+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4678999999999999999999999999986 577999999875432   567999999999999999999999987 56


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            7899999999999999997643 368999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...  ......+|..|+|||++....++.++||||||++||||++ |+.||.+.+..+....+ ..+.++..|..+++++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTSCHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHH
Confidence            322  1223346788999999998899999999999999999999 99999999887776554 4567777888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .++|.+||+.||++|||+.+|++.|+++....
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999886543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.1e-47  Score=387.43  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=221.5

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +..++|++.+.||+|+||.||+++..  ++.||||+++.... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            34578999999999999999999884  78899999975422 2223567889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-CC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~~  373 (504)
                      +||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999999976 56799999999999999999999999999999999999999999999999999986433 33


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  ..+|..+++++.+||.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            4556689999999999999999999999999999999999999999988877776666543  44678899999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHH
Q 010680          454 CWQQDPALRP-----DFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RP-----s~~ell~  470 (504)
                      ||+.||.+||     ++.++++
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHc
Confidence            9999999999     8998875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-47  Score=385.93  Aligned_cols=263  Identities=29%  Similarity=0.466  Sum_probs=220.9

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      +++..+.++.++|++.++||+|+||.||+|++.++.||||+++..   ......+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            456778999999999999999999999999999999999999754   23345566799999999999999999998775


Q ss_pred             CC----ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEECCCC
Q 010680          291 PS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN----------NIIHRDLKAANLLMDENE  356 (504)
Q Consensus       291 ~~----~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~----------~IiHrDLkp~NILl~~~~  356 (504)
                      ..    +++||||+++|+|.+++..  +.+++..++.++.||+.||.|||++          ||+||||||+|||++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            43    6999999999999999975  5699999999999999999999999          999999999999999999


Q ss_pred             cEEEEeeccceeccCCC---ccccCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCC-------
Q 010680          357 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYL-------  421 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~-------  421 (504)
                      .+||+|||+++......   ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+.       
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            99999999998765433   23345799999999999763     4667899999999999999999999643       


Q ss_pred             ---------CHHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          422 ---------TPLQAAVGVVQKGLRPTIPKN-----SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       422 ---------~~~~~~~~v~~~~~~p~~p~~-----~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                               ........+.....++..+..     +++++.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                     222333333444444444432     345699999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.8e-47  Score=391.52  Aligned_cols=262  Identities=32%  Similarity=0.602  Sum_probs=220.6

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+++..+|++.+.||+|+||.||+|++.     +..||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4677789999999999999999999864     5679999998653 445567899999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ...++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998866789999999999999999999999999999999999999999999999999998655


Q ss_pred             CCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+.... +..+.++..+..+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLPPPMDCPA  277 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEECCCCTTCBH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccccH
Confidence            4321    122345778999999999999999999999999999998 9999998887766554 445556667788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+.+++.+||+.||.+||++.++++.|+++....
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            9999999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-46  Score=377.20  Aligned_cols=263  Identities=29%  Similarity=0.599  Sum_probs=231.7

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEe
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA  286 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~  286 (504)
                      ..|++..++|++.+.||+|+||.||+|++.       ++.||||+++... .....+.+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            467888899999999999999999999863       3679999998543 45556789999999999999999999999


Q ss_pred             eeCCCCceeEEEecCCCchHHHHHhhc-----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceec
Q 010680          287 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR  343 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHr  343 (504)
                      +...+..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999997643                       248899999999999999999999999999


Q ss_pred             cCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 010680          344 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE  419 (504)
Q Consensus       344 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~  419 (504)
                      ||||+|||++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986654332   233457889999999999899999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       420 ~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ..+..+... .+..+..+..+..+++.+.+++.+||+.||.+||++.++++.|++++..
T Consensus       255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHH-HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            887765543 4455666778889999999999999999999999999999999998763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.7e-46  Score=368.53  Aligned_cols=265  Identities=31%  Similarity=0.621  Sum_probs=231.4

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|++..++|++.+.||+|+||.||+|.+.+ ..||||+++.....   ...+.+|+.++++++||||+++++++.. +
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            46799999999999999999999999999865 57999999865433   4678899999999999999999999875 4


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            6899999999999999997643 369999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ....  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  239 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEEL  239 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccccHHH
Confidence            5432  223456789999999998889999999999999999999 9999998887766554 44556677788999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      .+++.+||+.||.+|||+.++++.|++++.....+
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  274 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ  274 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred             HHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence            99999999999999999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-46  Score=380.31  Aligned_cols=266  Identities=30%  Similarity=0.596  Sum_probs=235.1

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI  284 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~  284 (504)
                      ...|++..++|++.+.||+|+||.||+|.+.+       ..||+|+++... .......+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34689999999999999999999999999853       369999998653 344567899999999999 899999999


Q ss_pred             EeeeCCCCceeEEEecCCCchHHHHHhhc-------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010680          285 GACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL  351 (504)
Q Consensus       285 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NIL  351 (504)
                      +++...+..++||||+++|+|.+++....             ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            99999999999999999999999997642             35789999999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 010680          352 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA  427 (504)
Q Consensus       352 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~  427 (504)
                      ++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            99999999999999986544322   223456789999999999999999999999999999998 99999987776666


Q ss_pred             HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          428 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       428 ~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .........+..+..+++.+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            6777777777788889999999999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-46  Score=376.86  Aligned_cols=246  Identities=27%  Similarity=0.506  Sum_probs=218.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .+|++.++||+|+||.||+|.+  .++.||||++.......  ...+.+|+.++++++||||+++++++...+.+|+|||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            5789999999999999999976  57889999987654332  4668899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            9999999999975  468999999999999999999999999999999999999999999999999998765443 3445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ..||+.|+|||++.+..|+.++||||||+++|+|++|..||...++......+..... ....+..+++.+.++|.+||+
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  255 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE  255 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence            6899999999999999999999999999999999999999999888777666554432 344567889999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+|||+.|+++
T Consensus       256 ~dp~~Rps~~ell~  269 (297)
T 3fxz_A          256 MDVEKRGSAKELLQ  269 (297)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.7e-47  Score=402.91  Aligned_cols=304  Identities=23%  Similarity=0.383  Sum_probs=227.9

Q ss_pred             CChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCCCceeeCCCceeeeeeeeeeCceEE
Q 010680          158 WPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL  237 (504)
Q Consensus       158 ~~~~~~~~l~~~l~~~~~~~~~~~~~s~~sss~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~i~~~LG~G~fG~V  237 (504)
                      -..++.+++..+++..+..+..+........+.+..... +......     ......+.+..++|++.++||+|+||.|
T Consensus        91 ~~~ee~e~W~~ai~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~y~~~~~lG~G~~g~V  164 (446)
T 4ejn_A           91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNS-GAEEMEV-----SLAKPKHRVTMNEFEYLKLLGKGTFGKV  164 (446)
T ss_dssp             SSHHHHHHHHHHHHHHCCC----------------------------------------CCCGGGEEEEEEEEEETTEEE
T ss_pred             CCHHHHHHHHHHHHhhhhhhhcccccccccCCCCCcccc-ccccccc-----cccCcccCCChHHcEEeEEEeeCcCEEE
Confidence            457788999999998775554443222111111100000 0000000     0111233556678999999999999999


Q ss_pred             EEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcc
Q 010680          238 YRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG  314 (504)
Q Consensus       238 y~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~  314 (504)
                      |++...  ++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++.. .+
T Consensus       165 ~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  243 (446)
T 4ejn_A          165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ER  243 (446)
T ss_dssp             EEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HS
T ss_pred             EEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cC
Confidence            999874  67899999986432 333456788999999999999999999999999999999999999999999976 56


Q ss_pred             cCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccCCCCCCccCcccccC
Q 010680          315 VFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEVIEH  392 (504)
Q Consensus       315 ~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~APE~l~~  392 (504)
                      .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+
T Consensus       244 ~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  323 (446)
T 4ejn_A          244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED  323 (446)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC
Confidence            79999999999999999999998 99999999999999999999999999999764332 34456789999999999999


Q ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHH
Q 010680          393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP-----DFSE  467 (504)
Q Consensus       393 ~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RP-----s~~e  467 (504)
                      ..|+.++|||||||++|||++|+.||...+..+....+....  ..+|..+++++.+||.+||+.||.+||     ++.|
T Consensus       324 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e  401 (446)
T 4ejn_A          324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE  401 (446)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH
Confidence            999999999999999999999999999988887777766654  346788999999999999999999999     9999


Q ss_pred             HHH
Q 010680          468 IIE  470 (504)
Q Consensus       468 ll~  470 (504)
                      +++
T Consensus       402 ll~  404 (446)
T 4ejn_A          402 IMQ  404 (446)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-46  Score=387.09  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=220.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +.|++++.||+|+||.||++...  ++.||||+++......    .....+.+|+.+|++++||||+++++++.....+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            56999999999999999999985  7889999998654322    13567899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                      +||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999976 56799999999999999999999999999999999999998877    79999999998876


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA  448 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~  448 (504)
                      .........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......  +..+..+++++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            665566778999999999999999999999999999999999999999998887777666544322  122367899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +||.+||..||.+|||+.|+++
T Consensus       251 ~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999984

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=388.11  Aligned_cols=263  Identities=30%  Similarity=0.555  Sum_probs=228.4

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      .+++..++|++.++||+|+||.||+|++.       ++.||||+++.. ........+.+|+.++++++||||+++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34677789999999999999999999854       356999999754 3445567789999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhc------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cE
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VV  358 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~v  358 (504)
                      ......++||||++||+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999998654      3588999999999999999999999999999999999999555   59


Q ss_pred             EEEeeccceeccCC---CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 010680          359 KVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  434 (504)
Q Consensus       359 kL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~  434 (504)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+.... +..+
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC
Confidence            99999999754322   22334567999999999999999999999999999999998 9999999887766555 4455


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .++..+..+++.+.+|+.+||+.||.+||++.++++.|+.+.+..
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            567778899999999999999999999999999999999887643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-46  Score=386.13  Aligned_cols=249  Identities=21%  Similarity=0.405  Sum_probs=222.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++...........+.+|+.++++++||||+++++++...+..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            57999999999999999999885  6789999998876666667889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~~~~  375 (504)
                      |++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++........
T Consensus       109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            9999999999976 56799999999999999999999999999999999999998654   5999999999877666556


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+.........+  ..+++++.+||.+
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  267 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS  267 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            66789999999999999999999999999999999999999999888877766665544332222  4679999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+||++.++++
T Consensus       268 ~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          268 MLTVNPKKRITADQALK  284 (362)
T ss_dssp             HSCSSGGGSCCHHHHTT
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=372.59  Aligned_cols=265  Identities=28%  Similarity=0.549  Sum_probs=232.6

Q ss_pred             ceeeCCCceeeee-eeeeeCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          215 VWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~----~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .|.+..++|.+.+ .||+|+||.||+|.+    .+..||||+++... .......+.+|+.++++++||||+++++++. 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            4567778888887 999999999999986    35679999998653 4455678999999999999999999999995 


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            45689999999999999999876678999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          370 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       370 ~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~  239 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  239 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCCCCCCcC
Confidence            54332    223456889999999998889999999999999999998 9999998877665544 44566677888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +++.++|.+||+.||.+||++.++++.|++++...+..
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999999877654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=377.05  Aligned_cols=263  Identities=33%  Similarity=0.621  Sum_probs=226.4

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      +++..++|++.+.||+|+||.||+|.+..      ..||||+++... .......+.+|+.++++++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            47888999999999999999999998753      249999998653 44556789999999999999999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      .+..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999876778999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          370 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       370 ~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCP  276 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCB
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCCcccCC
Confidence            44321    223356789999999999999999999999999999999 9999998887766554 44556667788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +.+.+++.+||+.||.+||++.++++.|++++....
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            999999999999999999999999999999987543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-46  Score=379.65  Aligned_cols=267  Identities=27%  Similarity=0.505  Sum_probs=213.9

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .+.+..++|++.+.||+|+||.||+|.+...     .||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3467778999999999999999999987532     69999998776666667889999999999999999999999987


Q ss_pred             CCCc------eeEEEecCCCchHHHHHhhc-----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 010680          290 PPSL------CIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       290 ~~~~------~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~v  358 (504)
                      ....      ++||||+++++|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7655      99999999999999996542     158999999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 010680          359 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG  434 (504)
Q Consensus       359 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~  434 (504)
                      ||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. ..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cC
Confidence            9999999976544322   223456789999999999999999999999999999999 999999888776655544 44


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ..+..+..+++++.+++.+||+.||.+|||+.++++.|++++......
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            456678889999999999999999999999999999999998866543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-46  Score=400.05  Aligned_cols=263  Identities=36%  Similarity=0.658  Sum_probs=227.8

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.. +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            46789999999999999999999999999975 56999999875433   3578999999999999999999999876 6


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            7899999999999999997543 458999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...  ......+|..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.... +..+.++..|..+++.+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  410 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTSCHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            432  1223456789999999998899999999999999999999 9999999988776655 45667778889999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .++|.+||+.||++|||+.++++.|++++....
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            999999999999999999999999998876443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-46  Score=369.06  Aligned_cols=263  Identities=29%  Similarity=0.576  Sum_probs=226.2

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..|.+..++|++.+.||+|+||.||+|.+.+.     .||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            45677888999999999999999999987532     49999998653 3455678999999999999999999999987


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .+ ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 57899999999999999988777799999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          369 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       369 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+.... +.....+..+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCTTCCH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCCCCCH
Confidence            54432  2233457889999999998999999999999999999998 9999987776655443 444556667888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+.+++.+||+.||.+||++.++++.|+++.+..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999997743

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-46  Score=373.00  Aligned_cols=265  Identities=36%  Similarity=0.664  Sum_probs=234.4

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +.|++..++|++.++||+|+||.||+|.+.  +..||||+++...   ...+.+.+|+.++++++||||+++++++...+
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            568899999999999999999999999986  6789999998542   33577899999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999999997643 458999999999999999999999999999999999999999999999999997655


Q ss_pred             CCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++.+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHH
Confidence            4332  223356789999999999999999999999999999999 9999998876655443 45566777888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      .+++.+||..||.+|||+.++++.|++++.+....
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~  276 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS  276 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-46  Score=375.76  Aligned_cols=266  Identities=32%  Similarity=0.621  Sum_probs=231.9

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~  285 (504)
                      ..|++..++|++.+.||+|+||.||+|.+.       ++.||||+++... .......+.+|+.+++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            467888899999999999999999999853       3679999998653 344567899999999999 6899999999


Q ss_pred             eeeCCC-CceeEEEecCCCchHHHHHhhccc---------------CChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          286 ACTKPP-SLCIVTEFMSGGSVYDYLHKLKGV---------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       286 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      ++...+ .+++||||+++++|.+++......               +++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987654 489999999999999999864332               8899999999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~  425 (504)
                      |+++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999986544322   223457889999999999999999999999999999998 999998877666


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .....+..+..+..+..+++.+.+++.+||+.||.+|||+.++++.|+++++...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            6666666677777888899999999999999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.9e-46  Score=376.54  Aligned_cols=266  Identities=31%  Similarity=0.618  Sum_probs=233.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|++..++|++.+.||+|+||.||+|++.         +..||||+++... .......+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            567889999999999999999999999874         3569999998653 445567899999999999 89999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++...+.+++||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999997643               24889999999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999987654332   233457889999999988889999999999999999999 99999988876


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      +.... +..+.++..+..+++.+.+++.+||+.||.+||++.++++.|++++.....
T Consensus       267 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          267 ELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            65544 445566778889999999999999999999999999999999999886654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-46  Score=373.35  Aligned_cols=258  Identities=25%  Similarity=0.449  Sum_probs=221.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .++|++.++||+|+||.||++.+.  ++.||||++..... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999874  67899999865433 445567899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--c
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~  374 (504)
                      |||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus        90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            999999999999976 4679999999999999999999999999999999999999999999999999997654332  2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCcHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAELL  451 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p---~~p~~~~~~l~~Ll  451 (504)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+............   ..+..+++.+.+++
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI  248 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHH
Confidence            234569999999999999999999999999999999999999999998887776666543321   24567899999999


Q ss_pred             HHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRP-DFSEIIEILQQIAKE  478 (504)
Q Consensus       452 ~~cl~~dP~~RP-s~~ell~~L~~l~~~  478 (504)
                      .+||+.||.+|| ++.++.+.|++++.+
T Consensus       249 ~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          249 LRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             HHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            999999999998 899998888877653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.2e-46  Score=369.60  Aligned_cols=255  Identities=33%  Similarity=0.673  Sum_probs=221.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHH-----HHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-----KEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~-----~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .+..++|++.+.||+|+||.||+|++  .++.||||++..........     +.+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45668899999999999999999998  47789999987654332211     678999999999999999999999876


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCc-----EEEEe
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV-----VKVAD  362 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~-----vkL~D  362 (504)
                      ..  ++||||+++++|.+++......+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            54  7999999999999999877778999999999999999999999999  999999999999988776     99999


Q ss_pred             eccceeccCCCccccCCCCCCccCcccc--cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCC
Q 010680          363 FGVARVKAQSGVMTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAAVGVVQKGLRPT  438 (504)
Q Consensus       363 FGla~~~~~~~~~~~~~gt~~y~APE~l--~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--~~~~~v~~~~~~p~  438 (504)
                      ||+++....  ......||+.|+|||++  ....++.++||||||+++|+|++|..||...+..  .....+.....++.
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999975433  34456799999999999  4556889999999999999999999999865533  33555566777888


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       439 ~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .+..+++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8999999999999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=379.89  Aligned_cols=247  Identities=19%  Similarity=0.315  Sum_probs=221.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++..   ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            67999999999999999999985  678999998754   3345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      |++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence            99999999999876667999999999999999999999999999999999999987  7899999999998876665566


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~c  454 (504)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........  ....+++++.+|+.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence            67899999999999999899999999999999999999999999888887777666543322  2257899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |..||.+|||+.|+++
T Consensus       242 L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             cCCChhHCcCHHHHhc
Confidence            9999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-45  Score=364.65  Aligned_cols=250  Identities=20%  Similarity=0.385  Sum_probs=224.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||+|+++...........+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999875  678999999887767777788999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~---vkL~DFGla~~~~~~~~  374 (504)
                      ||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++........
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            99999999999876 467999999999999999999999999999999999999986655   99999999988776666


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLE  452 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~  452 (504)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........  ...+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            66778999999999999999999999999999999999999999998888777766655443322  2578999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||+.||.+|||+.|+++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcccChhhCCCHHHHhc
Confidence            999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.3e-46  Score=369.05  Aligned_cols=259  Identities=36%  Similarity=0.688  Sum_probs=220.2

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-C
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-P  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~  291 (504)
                      ...|.++.++|++.+.||+|+||.||++++.++.||||+++...    ..+.+.+|+.++++++||||+++++++... +
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            35678889999999999999999999999999999999998543    346789999999999999999999986544 5


Q ss_pred             CceeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            78999999999999999976433 38999999999999999999999999999999999999999999999999997554


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      ..  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.+
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  245 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYE  245 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHH
T ss_pred             cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCHHHHH
Confidence            33  233467889999999999999999999999999999998 9999988776555444 4456677788899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ++.+||+.||.+||++.++++.|+++...
T Consensus       246 li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          246 VMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999998763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-46  Score=371.96  Aligned_cols=259  Identities=30%  Similarity=0.546  Sum_probs=222.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+....|++.++||+|+||.||++.+      .++.||||+++.... ......+.+|+.+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            45567799999999999999999985      467899999986542 23357789999999999999999999999876


Q ss_pred             --CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          291 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       291 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                        ..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              668999999999999999987778899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC--------------CCHHHHHHHH
Q 010680          369 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY--------------LTPLQAAVGV  430 (504)
Q Consensus       369 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~--------------~~~~~~~~~v  430 (504)
                      ......    .....||..|+|||++.+..++.++||||||+++|+|++|..|+..              ..........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            655432    2344678889999999999999999999999999999999987632              2233444455


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       431 ~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      ...+.+...+..+++.+.+|+.+||+.||.+|||+.++++.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            5666777788899999999999999999999999999999999886

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-46  Score=403.59  Aligned_cols=262  Identities=36%  Similarity=0.690  Sum_probs=233.0

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+.|++...+|++.++||+|+||.||+|.+.  +..||||+++.....   ...|.+|+.+|++++||||+++++++...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678999999999999999999999999986  678999999865433   46799999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999999998643 46899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          370 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       370 ~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      .....  .....++..|+|||++.+..|+.++|||||||+||||++ |..||...+..+.. ..+..+.+...+..+++.
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCCTTCCHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCHH
Confidence            54322  223346788999999998999999999999999999999 99999988776554 345667778888999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +.+||.+||+.||.+|||+.++++.|+.++++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999999988653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=376.32  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=219.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +.|++.+.||+|+||.||++...  ++.||||+++......    .....+.+|+.+|++++||||+++++++.....++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56899999999999999999985  7889999997654322    13567899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999976 56799999999999999999999999999999999999999887    89999999998876


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA  448 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~  448 (504)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......  ..+..+++.+.
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence            5555566789999999999999999999999999999999999999999888877766655433221  12357889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +||.+||+.||.+|||+.++++
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.9e-46  Score=373.34  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=210.4

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      -.++|++.++||+|+||.||+|++ .++.||||+++...........+.+|+.++++++||||+++++++..+..+++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999998 4678999999876555555678899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  376 (504)
                      ||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            9996 5899988876777999999999999999999999999999999999999999999999999999876543 2345


Q ss_pred             cCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Q 010680          377 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-----------------  438 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-----------------  438 (504)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+.                 
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT  257 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred             CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence            5678999999999876 5689999999999999999999999987766555444332111110                 


Q ss_pred             -----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 -----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 -----------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                 +...+++++.+||.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       12346789999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=386.94  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=215.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.++||+|+||.||++++.  ++.||||+++.... .......+.+|..+++.+ +||||+++++++.....
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            456678999999999999999999885  67899999986422 223346688899999988 69999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999999976 577999999999999999999999999999999999999999999999999999854333


Q ss_pred             -CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          373 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  ..+|..+++++.+||
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  255 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLHEDATGIL  255 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence             23445689999999999999999999999999999999999999999999888887776654  446778999999999


Q ss_pred             HHhhhcCCCCCCCH------HHHHH
Q 010680          452 ERCWQQDPALRPDF------SEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~------~ell~  470 (504)
                      .+||+.||.+||++      .++++
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhh
Confidence            99999999999998      66654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.2e-46  Score=370.19  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=210.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.++++++||||+++++++...+.+++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999985 78899999986654444456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-CccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~  378 (504)
                      +++ +|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            964 999999877788999999999999999999999999999999999999999999999999999765433 233455


Q ss_pred             CCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------C----
Q 010680          379 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------------P----  437 (504)
Q Consensus       379 ~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~----------------p----  437 (504)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......                +    
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            78999999999976 45899999999999999999999999998877666555432100                0    


Q ss_pred             -------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                             .....+++++.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   112457899999999999999999999999874

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=391.23  Aligned_cols=249  Identities=19%  Similarity=0.362  Sum_probs=220.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||++..  .++.||+|+++...........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            5799999999999999999987  47889999998776666667789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEEeeccceeccCCC-c
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSG-V  374 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~~-~  374 (504)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... .
T Consensus        91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9999999999986 57799999999999999999999999999999999999998   46789999999997665433 3


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLE  452 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~  452 (504)
                      .....||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+.........  ...+++++.+||.
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  249 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN  249 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            34568999999999999999999999999999999999999999998888777776655443322  2578999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||+.||.+|||+.|+++
T Consensus       250 ~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          250 KMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHSCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCCCHHHHhc
Confidence            999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-46  Score=387.75  Aligned_cols=265  Identities=20%  Similarity=0.308  Sum_probs=214.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNV  280 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~---------~~~~~~Ei~iL~~l~HpnI  280 (504)
                      ++...+|++.++||+|+||.||+|.+.       ++.||||++.........         ...+.+|+..++.++||||
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            456789999999999999999999874       367999998765311100         1124456667778889999


Q ss_pred             eEEEEeeeCC----CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--C
Q 010680          281 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--E  354 (504)
Q Consensus       281 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~--~  354 (504)
                      +++++++...    ...||||||+ |++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++  .
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            9999998764    4479999999 9999999988668899999999999999999999999999999999999999  8


Q ss_pred             CCcEEEEeeccceeccCCCc--------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 010680          355 NEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA  426 (504)
Q Consensus       355 ~~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~  426 (504)
                      ++.+||+|||+++.......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            89999999999986544321        1234599999999999999999999999999999999999999985432222


Q ss_pred             HHHHHhcCCCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          427 AVGVVQKGLRPT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       427 ~~~v~~~~~~p~---------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ..........+.         .+..+++++.+++..||+.||.+||++.+|++.|+++++..+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            211111111111         12577899999999999999999999999999999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-45  Score=375.21  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=211.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .+..++|++.+.||+|+||.||+++.     .++.||||+++.....  ......+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            45668899999999999999999987     4678999999875432  2334668889999999999999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      .+.+|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999999999976 567899999999999999999999999999999999999999999999999999754


Q ss_pred             cCCC-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          370 AQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       370 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....  ..+|..+++++.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~  249 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEAR  249 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSCHHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHH
Confidence            4332 3345679999999999999999999999999999999999999999988887777766543  456788999999


Q ss_pred             HHHHHhhhcCCCCCC-----CHHHHHH
Q 010680          449 ELLERCWQQDPALRP-----DFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RP-----s~~ell~  470 (504)
                      +||.+||..||.+||     ++.++++
T Consensus       250 ~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            999999999999999     6777764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.8e-46  Score=368.14  Aligned_cols=261  Identities=18%  Similarity=0.275  Sum_probs=222.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  293 (504)
                      .+-.++|++.+.||+|+||.||+|..  .++.||||+++.....    ..+.+|+.+++.+ +|+|++++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            34567899999999999999999995  5788999998754322    3577899999999 799999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----EEEEeecccee
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARV  368 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~-----vkL~DFGla~~  368 (504)
                      ++||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 99999999876677999999999999999999999999999999999999987765     99999999987


Q ss_pred             ccCCCc--------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcC---
Q 010680          369 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKG---  434 (504)
Q Consensus       369 ~~~~~~--------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~---~~~~~~~v~~~~---  434 (504)
                      ......        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+   ..+....+....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            654422        234579999999999999999999999999999999999999998743   333333332221   


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ..+.....+++++.+++.+||+.||.+||++.++++.|++++++.+..
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            122234578999999999999999999999999999999999877643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.6e-46  Score=371.94  Aligned_cols=267  Identities=28%  Similarity=0.514  Sum_probs=222.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      ...+.++.++|++.+.||+|+||.||+|.+..     ..||||+++...........+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34567888999999999999999999998743     3699999987766667778899999999999999999999998


Q ss_pred             eCCC-----CceeEEEecCCCchHHHHHhh-----cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010680          288 TKPP-----SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  357 (504)
Q Consensus       288 ~~~~-----~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~  357 (504)
                      ....     ..++||||+++++|.+++...     ...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7654     349999999999999998532     356999999999999999999999999999999999999999999


Q ss_pred             EEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 010680          358 VKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK  433 (504)
Q Consensus       358 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~  433 (504)
                      +||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-Hc
Confidence            9999999997654332   2233457889999999999999999999999999999999 99999988776655543 44


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +.++..+..+++.+.+++.+||+.||.+||++.++++.|+++++.+.
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            55677788999999999999999999999999999999999988764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.1e-46  Score=377.24  Aligned_cols=259  Identities=30%  Similarity=0.607  Sum_probs=220.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~----VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+...+|++.++||+|+||.||+|++.  ++.    ||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            456688999999999999999999874  333    5888776432 233457899999999999999999999999875


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      . .++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 789999999999999998877889999999999999999999999999999999999999999999999999998665


Q ss_pred             CCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          371 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       371 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ....   .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+.. ..+..+.+...+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence            4332   223456889999999999999999999999999999999 99999987765544 445566677788899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +.+++.+||+.||.+||++.++++.|+.+...
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999988653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-45  Score=374.50  Aligned_cols=264  Identities=28%  Similarity=0.505  Sum_probs=225.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee--
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--  288 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--  288 (504)
                      -++.++|++.++||+|+||.||++++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++.  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            46678999999999999999999985      4577999999865  4455677999999999999999999999876  


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            45568999999999999999988777899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHH
Q 010680          369 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGV  430 (504)
Q Consensus       369 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--------------~~~~~~v  430 (504)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....              .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            654432    2334678889999999999999999999999999999999999854322              2344455


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       431 ~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +..+.++..+..+++.+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            6667777888999999999999999999999999999999999998766543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-45  Score=365.75  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=212.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||+||+|.+.  ++.||||+++...........+.+|+.++++++||||+++++++.....+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999984  6789999998776666667888999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++ ++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            996 57777777667889999999999999999999999999999999999999999999999999998765432 3455


Q ss_pred             CCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCC-------------------
Q 010680          378 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLR-------------------  436 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~~v~~~~~~-------------------  436 (504)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+......                   
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            68899999999997765 89999999999999999987766 5565555555444331111                   


Q ss_pred             --------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 --------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 --------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              ......+++++.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    1122357899999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=375.94  Aligned_cols=247  Identities=26%  Similarity=0.455  Sum_probs=220.1

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|++.+.||+|+||.||+++..  ++.||||+++..... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            4568999999999999999999884  788999999754221 1234668889999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ..
T Consensus        84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred             EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence            9999999999999986 56799999999999999999999999999999999999999999999999999986543  23


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  ..+|..+++++.++|.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHh
Confidence            45689999999999999999999999999999999999999999988888777777654  4567889999999999999


Q ss_pred             hcCCCCCC-----CHHHHHH
Q 010680          456 QQDPALRP-----DFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RP-----s~~ell~  470 (504)
                      ..||.+||     ++.++++
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             ccCHHHcCCCcCCCHHHHhc
Confidence            99999999     8888873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=369.91  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=211.1

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh------------------------HHHHHHHHHHHHH
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS------------------------DMQKEFAQEVFIM  272 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~------------------------~~~~~~~~Ei~iL  272 (504)
                      ..++|++.+.||+|+||.||+|...  ++.||||+++......                        ...+.+.+|+.+|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            4468999999999999999999874  6789999997653211                        1235688999999


Q ss_pred             HhcCCCCceEEEEeeeC--CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010680          273 RKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL  350 (504)
Q Consensus       273 ~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NI  350 (504)
                      ++++||||+++++++..  ...+|+||||+++++|.+++.  .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            99999999999999876  567899999999999988764  36799999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeeccceeccCCC-ccccCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 010680          351 LMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQA  426 (504)
Q Consensus       351 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~  426 (504)
                      |++.++.+||+|||+++...... ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||........
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765433 344568999999999997765   47899999999999999999999998887776


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          427 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       427 ~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ...+.......+.+..+++++.++|.+||+.||.+||++.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            66666555544445678999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=386.12  Aligned_cols=246  Identities=21%  Similarity=0.384  Sum_probs=210.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.++||+|+||.||+++..  ++.||||+++...... .....+.+|..+++++ +||||+++++++.....
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            456678999999999999999999885  5679999998764432 3345678899999887 89999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc-C
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~-~  371 (504)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus       128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999999986 5679999999999999999999999999999999999999999999999999998633 3


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcCCCCCCCCC
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---------PLQAAVGVVQKGLRPTIPKN  442 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~---------~~~~~~~v~~~~~~p~~p~~  442 (504)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....         .......+..  ....+|..
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~  284 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS  284 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCTT
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCCc
Confidence            334556789999999999999999999999999999999999999996432         1122223333  34567888


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCH
Q 010680          443 SQPKLAELLERCWQQDPALRPDF  465 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~  465 (504)
                      +++++.+||.+||+.||.+||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            99999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-45  Score=371.12  Aligned_cols=263  Identities=31%  Similarity=0.573  Sum_probs=229.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG  285 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~  285 (504)
                      .+.|++..++|++.+.||+|+||.||+|.+.       ++.||||+++... .......+.+|+.++++++||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4578888999999999999999999999865       4679999998543 3445667999999999999999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhhc---------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      ++......++||||+++++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            9999999999999999999999997643         3568899999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 010680          357 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~  432 (504)
                      .+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999997554332   1223456889999999999999999999999999999999 8999999888776655444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          433 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       433 ~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                       +..+..+..+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             44556778899999999999999999999999999999887644

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=405.14  Aligned_cols=265  Identities=27%  Similarity=0.546  Sum_probs=228.0

Q ss_pred             ceeeCCCceeeee-eeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          215 VWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      .|.+...++.+.+ +||+|+||.||+|.+.    +..||||+++... .....+.|.+|+.+|++++||||+++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            4567777787777 8999999999999874    3469999998653 23346789999999999999999999999987


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                       +.+++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5689999999999999999876778999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          370 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       370 ~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .....    .....+|+.|+|||++.+..|+.++|||||||+||||++ |+.||...+..+.... +..+.++..|..++
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP  565 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCCTTCC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCC
Confidence            43221    122345789999999999999999999999999999998 9999999887766544 45667788889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +++.+||.+||+.||.+||++.++++.|++++..+...
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999998877643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=369.93  Aligned_cols=257  Identities=35%  Similarity=0.681  Sum_probs=216.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .++.++|++.+.||+|+||.||++++.++.||||+++..    ...+.|.+|+.++++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            467788999999999999999999999999999998743    345778999999999999999999998874  48999


Q ss_pred             EEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEECCCCc-EEEEeeccceecc
Q 010680          297 TEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQ---NNIIHRDLKAANLLMDENEV-VKVADFGVARVKA  370 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~---~~IiHrDLkp~NILl~~~~~-vkL~DFGla~~~~  370 (504)
                      |||++|++|.+++.....  .++...++.++.||++||.|||+   +||+||||||+|||++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999976432  47888999999999999999999   89999999999999998886 7999999997544


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..........+.++..+..+++.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence            32  3345699999999999999999999999999999999999999986432 22223334556677788899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ++.+||+.||.+|||+.++++.|+++.+....
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            99999999999999999999999999876654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-45  Score=376.50  Aligned_cols=245  Identities=22%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCc
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~  293 (504)
                      +..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.+++++ +||||+++++++.....+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45578999999999999999999985  67899999987654 344567788999999988 899999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-C
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~  372 (504)
                      |+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999999976 56799999999999999999999999999999999999999999999999999986433 2


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCC
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---------TPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~---------~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...         ........+...  ...+|..+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence            3445668999999999999999999999999999999999999999752         222222333332  34577889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCH
Q 010680          444 QPKLAELLERCWQQDPALRPDF  465 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~  465 (504)
                      ++++.+||.+||+.||.+||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            9999999999999999999996

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-45  Score=383.26  Aligned_cols=262  Identities=21%  Similarity=0.385  Sum_probs=218.3

Q ss_pred             CceeeCCCceeeeeeeeee--CceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          214 DVWEIDPKHLKFGSKVASG--SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G--~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      ..+..+..+|++.++||+|  +||.||+|++.  ++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3445667889999999999  99999999985  7889999998877677777889999999999999999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      .+.+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999999999764 35699999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCC--------ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---
Q 010680          369 KAQSG--------VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---  435 (504)
Q Consensus       369 ~~~~~--------~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---  435 (504)
                      .....        ......||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.+..+..........   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            43221        2223478999999999987  6799999999999999999999999987655444433221110   


Q ss_pred             -----------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--H
Q 010680          436 -----------------------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--L  472 (504)
Q Consensus       436 -----------------------------------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~--L  472 (504)
                                                               ....+..+++++.+||.+||+.||.+|||+.|+++.  |
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                                                     112345678999999999999999999999999843  4


Q ss_pred             HHH
Q 010680          473 QQI  475 (504)
Q Consensus       473 ~~l  475 (504)
                      +++
T Consensus       338 ~~~  340 (389)
T 3gni_B          338 KQI  340 (389)
T ss_dssp             GGC
T ss_pred             HHH
Confidence            444

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.6e-46  Score=376.91  Aligned_cols=258  Identities=28%  Similarity=0.562  Sum_probs=220.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~----VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+..++|++.++||+|+||.||+|.+.  ++.    ||+|++..... ......+.+|+.++++++||||+++++++. .
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            456788999999999999999999875  343    78887764422 222345778999999999999999999886 4


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +..++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56899999999999999998777789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          371 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       371 ~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+.++..+..++++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCCCcCcHH
Confidence            432   2334567889999999998999999999999999999999 9999998776555443 4555667778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +.+++.+||+.||.+||++.++++.|+.+..
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999998855

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-45  Score=375.37  Aligned_cols=256  Identities=21%  Similarity=0.321  Sum_probs=217.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..+|++.+.||+|+||.||+|+.  .++.||||++......    ..+.+|+.+++++ +||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            47899999999999999999996  5788999998755322    3578899999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----EEEEeeccceeccC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARVKAQ  371 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~-----vkL~DFGla~~~~~  371 (504)
                      |||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999 99999999876778999999999999999999999999999999999999998887     99999999987554


Q ss_pred             CCc--------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCC---
Q 010680          372 SGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKGLRP---  437 (504)
Q Consensus       372 ~~~--------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~---~~~~~~~v~~~~~~p---  437 (504)
                      ...        .....||+.|+|||++.+..++.++|||||||++|||++|..||...+   ..+....+.......   
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence            332        235679999999999999999999999999999999999999998743   333333322211111   


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      .....++ ++.+++.+||+.||.+||++.+|++.|+++....+.
T Consensus       243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1123355 999999999999999999999999999999988754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=363.32  Aligned_cols=259  Identities=31%  Similarity=0.584  Sum_probs=222.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEECC--c---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc-ee
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL-CI  295 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g--~---~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~l  295 (504)
                      .|++.++||+|+||.||+|.+.+  +   .||+|+++.. ......+.+.+|+.++++++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45677999999999999998732  2   5999998753 2345567899999999999999999999999776655 99


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC---
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---  372 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~---  372 (504)
                      ||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            99999999999999876778999999999999999999999999999999999999999999999999999754332   


Q ss_pred             --CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          373 --GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       373 --~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                        .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+... .......+..+..+++.+.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-HhhcCCCCCCCccchHHHHH
Confidence              12234567899999999999999999999999999999999 556666666655443 34455566778889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ++.+||+.||.+|||+.++++.|++++..+.+.
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            999999999999999999999999999987643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=404.24  Aligned_cols=263  Identities=36%  Similarity=0.658  Sum_probs=231.9

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|++..++|++.++||+|+||.||+|++.+ ..||||+++.....   .+.|.+|+.+|++++||||+++++++.. .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            46799999999999999999999999999975 56999999876433   3578999999999999999999999876 6


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            7899999999999999997543 458999999999999999999999999999999999999999999999999997554


Q ss_pred             CCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...  ......++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.... +..+.+...+..+++.+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL  493 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence            321  1223356789999999998899999999999999999999 9999999888776655 45667777888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .+||.+||+.||++|||+.+|++.|++++....
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            999999999999999999999999998876544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.7e-46  Score=381.47  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=218.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.+.||+|+||.||+|++.  ++.||||+++.... .......+..|..+++.+ +||||+++++++.....
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456678999999999999999999985  67899999976421 122345678899999887 89999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-  371 (504)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999999999976 56799999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+...  .+.+|..+++++.+||
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  249 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence            23445668999999999999999999999999999999999999999998887777666554  3557788999999999


Q ss_pred             HHhhhcCCCCCCCHH-HHH
Q 010680          452 ERCWQQDPALRPDFS-EII  469 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~-ell  469 (504)
                      .+||..||.+||++. +++
T Consensus       250 ~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGG
T ss_pred             HHHhcCCHhHcCCChHHHH
Confidence            999999999999987 654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-45  Score=380.29  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=218.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.+.||+|+||.||+++..  ++.||||+++.... .......+..|..+++.+ +||||+++++++...+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            456688999999999999999999986  46799999976432 122346688899999988 79999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999999976 467999999999999999999999999999999999999999999999999999864332


Q ss_pred             -CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          373 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  +.+|..+++++.+||
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence             34456689999999999999999999999999999999999999999998888777776654  457788999999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHH
Q 010680          452 ERCWQQDPALRPD-----FSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs-----~~ell~  470 (504)
                      .+||..||.+||+     +.++++
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999995     466653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=384.47  Aligned_cols=252  Identities=23%  Similarity=0.400  Sum_probs=217.5

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ..+..++|++.+.||+|+||.||++.+.  ++.||||+++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3667789999999999999999999885  56799999875421 22335678899999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999999976 567999999999999999999999999999999999999999999999999999987766


Q ss_pred             CccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          373 GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~---~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ......+||+.|+|||++.   +..|+.++|||||||++|+|++|..||...+   ..+....+..  .....|..+++.
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~  246 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQE  246 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHH
Confidence            6677789999999999996   4568999999999999999999999997533   2333333222  334577889999


Q ss_pred             HHHHHHHhhhcCCCCCCC-HHHHHH
Q 010680          447 LAELLERCWQQDPALRPD-FSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs-~~ell~  470 (504)
                      +.+||.+||+.||.+||+ +.++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999999999999999998 666653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-45  Score=365.36  Aligned_cols=261  Identities=32%  Similarity=0.624  Sum_probs=220.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECC---c--cEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---~--~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      ..+..++|++.++||+|+||.||+|++..   +  .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            36677899999999999999999998632   2  589999886543 33556789999999999999999999999987


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +. .++||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 88999999999999999887778999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          370 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       370 ~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+......+..+..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            54432    223457889999999998889999999999999999999 9999999998888877777777777788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +++.+++.+||+.||.+||++.++++.|+++..
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            999999999999999999999999999988754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.7e-45  Score=365.80  Aligned_cols=259  Identities=31%  Similarity=0.558  Sum_probs=221.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee-eCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~  294 (504)
                      .+|++.++||+|+||.||+|++...     .||+|.++.. ........+.+|+.++++++||||+++++++ ..++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4688999999999999999986432     4899998863 3445567899999999999999999999985 4566789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            9999999999999998767779999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          374 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                          ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+ ..+..+..+..+++.+.
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  262 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLY  262 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHH
Confidence                2234467889999999999999999999999999999999 77888777666555443 34555667788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      +++.+||+.||.+|||+.++++.|++++....+
T Consensus       263 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            999999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-45  Score=379.00  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=219.8

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ..++|++.+.||+|+||.||++++.  ++.||||+++.... .......+.+|+.+|+.++||||+++++++.+...+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3468999999999999999999984  78899999975422 12235678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            9999999999999986 467999999999999999999999999999999999999999999999999999866433  3


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+....  ..+|..+++++.++|.+||
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence            45679999999999999999999999999999999999999999998888777766543  4567889999999999999


Q ss_pred             hcCCCCCCC-----HHHHHH
Q 010680          456 QQDPALRPD-----FSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs-----~~ell~  470 (504)
                      +.||.+||+     +.++++
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCHHhccCCccCCHHHHHh
Confidence            999999998     777754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=382.03  Aligned_cols=248  Identities=19%  Similarity=0.369  Sum_probs=220.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.++||+|+||.||+|...  ++.||+|++....  ......+.+|+.+|+.++||||+++++++.....+++|||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            57999999999999999999884  6789999997542  3345678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      |++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.........
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence            99999999999876668999999999999999999999999999999999999974  4679999999998876655556


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .+.....+++++.+||.+|
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  288 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  288 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence            66899999999999999999999999999999999999999999888777766655433  2334467899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.++++
T Consensus       289 L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          289 LQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             cCCChhHCcCHHHHhh
Confidence            9999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.7e-46  Score=368.65  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=217.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      ++..++|++.+.||+|+||.||+|.+..         ..||+|+++...  ....+.+.+|+.++++++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            5677899999999999999999998653         459999997542  34457799999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------EE
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VK  359 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~--------vk  359 (504)
                      ..++..++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999999999886666999999999999999999999999999999999999998886        99


Q ss_pred             EEeeccceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 010680          360 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP  437 (504)
Q Consensus       360 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p  437 (504)
                      |+|||++.....   .....||+.|+|||++.+ ..++.++||||||+++|+|++ |.+||........... ...  .+
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~--~~  235 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YED--RH  235 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT--TC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhc--cC
Confidence            999999864432   223457899999999987 779999999999999999999 5666666665544433 222  34


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ..+...++++.+++.+||+.||.+|||+.++++.|++++.-.+
T Consensus       236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            5667778899999999999999999999999999999987443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-45  Score=384.00  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=210.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCCceEEEEeeeCCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+..++|++.+.||+|+||.||++++.  ++.||||+++..... ......+.+|..+ ++.++||||+++++++...+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            345678999999999999999999985  567999999876442 2334566777776 577899999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC-
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-  371 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-  371 (504)
                      +|+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999999976 56799999999999999999999999999999999999999999999999999986433 


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+....  ..++..+++++.+||
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Confidence            334456689999999999999999999999999999999999999999998888877777654  346778999999999


Q ss_pred             HHhhhcCCCCCCCHHH
Q 010680          452 ERCWQQDPALRPDFSE  467 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~e  467 (504)
                      .+||+.||.+||++.+
T Consensus       271 ~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHTCSSGGGSTTTTT
T ss_pred             HHHcccCHHhCCCCCC
Confidence            9999999999999753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.4e-45  Score=404.04  Aligned_cols=264  Identities=29%  Similarity=0.540  Sum_probs=227.4

Q ss_pred             CceeeCCCceeeee-eeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          214 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..|.++...+.+.. +||+|+||.||+|.+.    ++.||||+++.........+++.+|+.+|++++|||||++++++.
T Consensus       361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  440 (635)
T 4fl3_A          361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE  440 (635)
T ss_dssp             SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34566666666644 8999999999999763    467999999877666666788999999999999999999999997


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      . +..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            5 458899999999999999976 56799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          369 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       369 ~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      .....    ......+|+.|+|||++.+..|+.++|||||||+||||++ |+.||.+.+..+.... +..+.++..+..+
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~  597 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC  597 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            54432    2233456789999999999999999999999999999998 9999999888765544 5566677888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ++++.+||.+||+.||++||++.++++.|++++.++.
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999999988764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-45  Score=370.96  Aligned_cols=263  Identities=29%  Similarity=0.544  Sum_probs=224.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .++...|++.++||+|+||.||++.+      .++.||||+++.. ........+.+|+.++++++||||+++++++...
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            34555569999999999999999876      4677999999865 3445567899999999999999999999999764


Q ss_pred             --CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          291 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       291 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                        ..+++||||+++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence              567999999999999999965  4589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Q 010680          369 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGV  430 (504)
Q Consensus       369 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--------------~~~~~v  430 (504)
                      ......    .....+|+.|+|||++.+..++.++||||||+++|+|++|..||......              ......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            655432    23446788899999999989999999999999999999999999653221              123344


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       431 ~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +....++..+..+++++.+||.+||+.||.+|||+.++++.|+++.+....+
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            5566777788899999999999999999999999999999999998877654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-45  Score=363.63  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      +++..++|++.++||+|+||.||++.+  .++.||||+++...........+.++...++.++||||+++++++..++..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            467778999999999999999999998  578899999987654444445556666678899999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          294 CIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ++||||++ ++|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999996 588888754   346799999999999999999999998 9999999999999999999999999999876


Q ss_pred             cCCCccccCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          370 AQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      ..........||+.|+|||++    .+..++.++||||||+++|+|++|..||.. ..+................+..++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            665555556899999999996    566799999999999999999999999986 445555555555554444456789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIE--ILQQ  474 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~  474 (504)
                      +++.+++.+||+.||.+|||+.|+++  .++.
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999986  4443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.7e-45  Score=377.57  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=202.4

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      .+.++|++.++||+|+||.||+++..  ++.||||+++.....   ...+.+|+.+++.++||||+++++++.....+|+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            45678999999999999999999984  678999999865432   2457899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEEeeccceeccCCC
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQSG  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~--vkL~DFGla~~~~~~~  373 (504)
                      ||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999999976 567999999999999999999999999999999999999987765  9999999998655555


Q ss_pred             ccccCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~k-sDVwSlGvvL~eLltG~~Pf~~~~~----~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....    ......+.......+....+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            5556789999999999988888766 8999999999999999999986543    3333344443333334446899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +||.+||+.||.+|||+.|+++
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          253 HLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHHh
Confidence            9999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=368.06  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=207.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.++||+|+||+||+|.+.  ++.||||++............+..|+..+.++ +||||+++++++...+.+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999985  78899999887655555556666777666665 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  215 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV  215 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence            999 7799999988777899999999999999999999999999999999999999999999999999987766666666


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..||+.|+|||++.+ .++.++|||||||++|||++|..|+.....   ...+......+..+..+++++.++|.+||+.
T Consensus       216 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             CCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             cCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence            789999999999986 699999999999999999999766654322   2222333333445677899999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      ||++|||+.|+++
T Consensus       292 dP~~Rpt~~ell~  304 (311)
T 3p1a_A          292 DPKLRATAEALLA  304 (311)
T ss_dssp             STTTSCCHHHHHT
T ss_pred             ChhhCcCHHHHHh
Confidence            9999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=369.39  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=214.4

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC--Cc
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL  293 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~  293 (504)
                      +...+|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            34578999999999999999999986  788999999864322 22467789999999999999999999987655  67


Q ss_pred             eeEEEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEEeeccce
Q 010680          294 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  367 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl----~~~~~vkL~DFGla~  367 (504)
                      |+||||+++++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999986433  38999999999999999999999999999999999999    778889999999999


Q ss_pred             eccCCCccccCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCC
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIE--------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL  435 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~----~~~~~~v~~~~~  435 (504)
                      ............||+.|+|||++.        +..++.++|||||||++|||++|..||.....    .+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            877766666778999999999986        57899999999999999999999999964332    333334333221


Q ss_pred             C-----------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          436 R-----------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       436 ~-----------------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      .                       ..++..+++.+.++|.+||+.||++|||+.|+++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1                       012234467899999999999999999999998877754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-45  Score=372.71  Aligned_cols=262  Identities=32%  Similarity=0.598  Sum_probs=224.2

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--Ccc--EEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD--VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  291 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~--VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~  291 (504)
                      .++.++|++.+.||+|+||.||+|++.  +..  ||||.++... .......+.+|+.+++++ +||||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            456688999999999999999999864  443  5999987532 333456789999999999 8999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      ..|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997643               3689999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 010680          357 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      .+||+|||+++............+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhcCC
Confidence            999999999975443333445567889999999998889999999999999999998 9999999887766554 44556


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ++..+..+++.+.+++.+||..||.+|||+.++++.|++++.+..
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            677788999999999999999999999999999999999988544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=370.43  Aligned_cols=262  Identities=27%  Similarity=0.539  Sum_probs=224.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+...+|++.++||+|+||.||++++      .++.||||+++..  .....+.+.+|+.++++++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            45667899999999999999999986      4678999999864  345567899999999999999999999988664


Q ss_pred             C--CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          291 P--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       291 ~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      +  .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  78999999999999999988667799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHH
Q 010680          369 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------------LQAAVG  429 (504)
Q Consensus       369 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---------------~~~~~~  429 (504)
                      ......    .....++..|+|||++.+..++.++||||||+++|+|++|..||.....               ......
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            655432    2234577889999999988899999999999999999999999864211               112233


Q ss_pred             HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          430 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       430 v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .+....++..+..+++++.++|.+||+.||.+|||+.++++.|+++..++.
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            445556667788999999999999999999999999999999999988764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=371.61  Aligned_cols=258  Identities=30%  Similarity=0.607  Sum_probs=218.5

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~----VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+...+|++.++||+|+||.||+|.+.  ++.    ||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            466789999999999999999999984  444    5777776433 233457889999999999999999999999875


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      . .++|+||+.+++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 789999999999999998877889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          371 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       371 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ....   .....+|+.|+|||++.+..|+.++||||||+++|+|++ |..||...+..+... .+.....+..+..++++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence            4322   223456889999999999999999999999999999999 999999887765544 45556667788899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +.+++.+||+.||.+||++.++++.|+.+..
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-45  Score=376.59  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=210.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++....   .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57999999999999999999874  68899999864321   11135678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEEeeccceec
Q 010680          296 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK  369 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~---vkL~DFGla~~~  369 (504)
                      ||||++|++|.+++....   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            999999999998886532   35899999999999999999999999999999999999986654   999999999876


Q ss_pred             cCCCc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHH
Q 010680          370 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPK  446 (504)
Q Consensus       370 ~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~  446 (504)
                      ..... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.... .+....+.......  .....++++
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~  262 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES  262 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence            65443 345679999999999999999999999999999999999999998753 33334444332221  122578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.+||.+||+.||.+|||+.++++
T Consensus       263 ~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          263 AKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-45  Score=365.89  Aligned_cols=250  Identities=31%  Similarity=0.600  Sum_probs=206.6

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEEeeeC----CCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTK----PPS  292 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~----~~~  292 (504)
                      -.++|++.++||+|+||.||+|++.++.||||+++..     ....+..|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3468999999999999999999999999999998753     23456667777766  789999999998643    345


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                      +++||||+++|+|.++++.  ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            7999999999999999954  57999999999999999999999        9999999999999999999999999999


Q ss_pred             cceeccCCCc-----cccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCCCH
Q 010680          365 VARVKAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYLTP  423 (504)
Q Consensus       365 la~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf~~~~~  423 (504)
                      +++.......     .....||+.|+|||++.+.      .++.++||||||+++|||++|          ..||....+
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            9986554432     2234799999999999876      455799999999999999999          888865322


Q ss_pred             ----HHHHHH-HHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          424 ----LQAAVG-VVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       424 ----~~~~~~-v~~~~~~p~~p~-----~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                          ...... ......++.++.     .+++.+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                222222 233344444443     2567899999999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=378.19  Aligned_cols=250  Identities=20%  Similarity=0.343  Sum_probs=215.7

Q ss_pred             eeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEecC
Q 010680          224 KFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS  301 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  301 (504)
                      ...+.||+|+||.||+|...  ++.||+|+++...  ......+.+|+.+|++++||||+++++++...+.+++||||++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            33678999999999999874  7789999998653  3445789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--CCCCcEEEEeeccceeccCCCccccCC
Q 010680          302 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAET  379 (504)
Q Consensus       302 ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~  379 (504)
                      +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++............
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            999999998766789999999999999999999999999999999999999  567899999999999876665566678


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhc
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........  ....+++++.+||.+||+.
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999999988887777666543322  2357899999999999999


Q ss_pred             CCCCCCCHHHHHH--HHHHH
Q 010680          458 DPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       458 dP~~RPs~~ell~--~L~~l  475 (504)
                      ||.+||++.|+++  .|.+.
T Consensus       330 dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          330 EKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SGGGSCCHHHHHHSHHHHCH
T ss_pred             ChhhCCCHHHHhcCcCcCCC
Confidence            9999999999986  55544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.1e-46  Score=374.87  Aligned_cols=258  Identities=27%  Similarity=0.469  Sum_probs=216.0

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..++|++.+.||+|+||.||+|++. ++.||||++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            4578999999999999999999975 6889999987653  334577999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          298 EFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+++++|.+++....   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999996533   358999999999999999999999999999999999999999999999999998644322 


Q ss_pred             --ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh---------cCCC
Q 010680          374 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ------AAVGVVQ---------KGLR  436 (504)
Q Consensus       374 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~------~~~~v~~---------~~~~  436 (504)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+      .......         ....
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence              2234468999999999988899999999999999999999999997543321      1111111         1111


Q ss_pred             CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       437 p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ..++..++..+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            223344567899999999999999999999999999998763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-45  Score=373.39  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=209.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            57999999999999999999875  778999999755332 234668899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---cc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~  375 (504)
                      |++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            9999999999975 5679999999999999999999999999999999999999999999999999998654332   23


Q ss_pred             ccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..... ...............+++.+.+||.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHH
Confidence            45689999999999987776 77999999999999999999999876554222 22233333333346789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+|||+.|+++
T Consensus       245 ~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          245 ILVENPSARITIPDIKK  261 (323)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHhh
Confidence            99999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=371.93  Aligned_cols=252  Identities=21%  Similarity=0.379  Sum_probs=215.5

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCCCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPS  292 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~  292 (504)
                      ..+...+|++.++||+|+||.||++... ++.||||+++...........+.+|+.+|++++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4667789999999999999999999874 5679999998777677777889999999999987  999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+|||+ .+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus        84 ~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9999995 58899999987 56799999999999999999999999999999999999997 578999999999865443


Q ss_pred             C---ccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCC
Q 010680          373 G---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRP  437 (504)
Q Consensus       373 ~---~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~p  437 (504)
                      .   ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.... .......+.......
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            2   2335579999999999864           678999999999999999999999998754 344555555556667


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..+...++++.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            788888999999999999999999999999974

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=382.15  Aligned_cols=259  Identities=30%  Similarity=0.550  Sum_probs=214.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee-CCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~  294 (504)
                      ..|++.++||+|+||.||+|++.+     ..||||.++.. ........|.+|+.++++++||||+++++++. ..+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            357788999999999999998742     24899998754 33455688999999999999999999999865 456789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999999999998766779999999999999999999999999999999999999999999999999997554322 


Q ss_pred             ----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          374 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                          ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..+.... +..+.++..|..+++.+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHH
Confidence                1233457889999999999999999999999999999999 7889987766555444 344556677888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      +++.+||+.||.+||++.++++.|++++....+
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999987764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=375.31  Aligned_cols=265  Identities=29%  Similarity=0.591  Sum_probs=222.7

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ...|++..++|++.+.||+|+||.||+|.+.+ .||+|+++.........+.+.+|+.++++++||||+++++++...+.
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            35788999999999999999999999999865 59999998765444445667889999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.....
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999999987666799999999999999999999999999999999999998 679999999998654321


Q ss_pred             ------CccccCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 010680          373 ------GVMTAETGTYRWMAPEVIEH---------KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP  437 (504)
Q Consensus       373 ------~~~~~~~gt~~y~APE~l~~---------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p  437 (504)
                            .......||+.|+|||++.+         ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                  22334568999999999864         458999999999999999999999999988877666554433322


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      ..+..+++++.+++.+||..||.+|||+.++++.|+++....
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            333468899999999999999999999999999999987754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.6e-46  Score=381.37  Aligned_cols=246  Identities=29%  Similarity=0.496  Sum_probs=212.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+|++.+.||+|+||.||+|.+  .++.||||+++..... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999998  5788999998754221 122356889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+ +|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence            999 7899999876 56799999999999999999999999999999999999999999999999999987766656667


Q ss_pred             CCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+  .......|..+++++.+||.+||+
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~  244 (336)
T 3h4j_B          167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIV  244 (336)
T ss_dssp             CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred             ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHcC
Confidence            789999999999988876 78999999999999999999999765432221111  122345677899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+|||+.|+++
T Consensus       245 ~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          245 ADPMQRITIQEIRR  258 (336)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhHCcCHHHHHh
Confidence            99999999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.3e-46  Score=393.00  Aligned_cols=254  Identities=19%  Similarity=0.316  Sum_probs=219.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.++||+|+||+||+|++.  ++.||||+++..... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            445678999999999999999999985  577999999753211 11123488899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+|||||+||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999999999999998767889999999999999999999999999999999999999999999999999998765543


Q ss_pred             c--cccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCC
Q 010680          374 V--MTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---RPTIPKNS  443 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---~p~~p~~~  443 (504)
                      .  ....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||...+..+....++....   .|.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence            3  23468999999999996     56799999999999999999999999999998888777764332   23333568


Q ss_pred             cHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPAL--RPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~--RPs~~ell~  470 (504)
                      ++++.+||.+||..+|++  ||++.|+++
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            999999999999888887  999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-45  Score=370.52  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=213.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc---
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL---  293 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~---  293 (504)
                      .++|++.++||+|+||.||++.+  .++.||||+++.... .......+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999996  467899999987644 345567899999999999999999999998766554   


Q ss_pred             -eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 -CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 -~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                       |+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence             999999999999999976 567999999999999999999999999999999999999999999999999999765443


Q ss_pred             C----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHH
Q 010680          373 G----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPK  446 (504)
Q Consensus       373 ~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~  446 (504)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...++.+...........+.  .+..++++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2    22234689999999999999999999999999999999999999999998887777666544332  23568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHH-HHHHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFS-EIIEILQQIAK  477 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~-ell~~L~~l~~  477 (504)
                      +.++|.+||+.||.+||++. ++...|..+..
T Consensus       250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            99999999999999999655 45556665544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-44  Score=366.17  Aligned_cols=249  Identities=22%  Similarity=0.398  Sum_probs=219.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++......    .....+.+|+.++++++||||+++++++.....++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            57999999999999999999985  6789999998654322    13577899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                      +||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999976 56799999999999999999999999999999999999999887    79999999998776


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA  448 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~  448 (504)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  +..+..+++.+.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            655556678999999999999999999999999999999999999999988887766665443221  122357889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++|.+||+.||.+|||+.++++
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhc
Confidence            9999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-44  Score=372.66  Aligned_cols=246  Identities=30%  Similarity=0.458  Sum_probs=218.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ..|++.+.||+|+||.||+|..  .++.||||+++..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4589999999999999999986  4788999999865433 344577999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   ...
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~  209 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  209 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence            9996 689999877678899999999999999999999999999999999999999999999999999976543   235


Q ss_pred             CCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          378 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       378 ~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ..||+.|+|||++.   ...++.++|||||||++|||++|..||...+.......+.........+..+++.+.+||.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            67999999999984   567999999999999999999999999998888877776665555455678899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.++++
T Consensus       290 l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             cccChhhCcCHHHHhh
Confidence            9999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=363.51  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=209.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||++............+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999985  7889999998776666667888999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            9999999988865 5679999999999999999999999999999999999999999999999999998765432 3445


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------CCCC
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLRP  437 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~-------------------~~~p  437 (504)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...                   ....
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            679999999999975 67899999999999999999999999988876655443321                   0000


Q ss_pred             CC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 TI----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ~~----------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..          ...+++.+.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00          1467889999999999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.2e-44  Score=360.31  Aligned_cols=263  Identities=21%  Similarity=0.421  Sum_probs=212.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..+|++.+.||+|+||.||+|..  .++.||||+++... ........+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999987  47889999998643 3455677899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            9999999999998653   4568999999999999999999999999999999999999999999999999997654432


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--TPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~--~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||...  ........+......+..+..+++++.++
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  270 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  270 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHH
T ss_pred             ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHH
Confidence             233457899999999999999999999999999999999999999654  33333334333333333446789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          451 LERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      +.+||+.||.+|||+.++++.|+++.......
T Consensus       271 i~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence            99999999999999999999999998877643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-44  Score=366.46  Aligned_cols=244  Identities=29%  Similarity=0.461  Sum_probs=214.1

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      .|+..++||+|+||.||+|+..  |+.||||+++.....  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            3677789999999999999884  788999999765332  346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      ++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus       124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999864  569999999999999999999999999999999999999999999999999998765432 34456


Q ss_pred             CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhh
Q 010680          379 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       379 ~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~cl~  456 (504)
                      .||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+... ..+.  .+..+++.+.+++.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHHHcc
Confidence            8999999999999999999999999999999999999999988887776655443 2222  234678999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+|||+.++++
T Consensus       281 ~dp~~Rps~~ell~  294 (321)
T 2c30_A          281 RDPQERATAQELLD  294 (321)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=373.65  Aligned_cols=246  Identities=24%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+.|++.++||+|+||.||+|++.  ++.||||+++...    ..+.+.+|+.+|++++||||+++++++......++||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            357999999999999999999985  5679999998642    2356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.......
T Consensus       128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            99999999999976 567999999999999999999999999999999999999975   88999999999987665555


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCC--CCCCCCCcHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLR--PTIPKNSQPKLAELL  451 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~-v~~~~~~--p~~p~~~~~~l~~Ll  451 (504)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.... +......  ......+++++.+||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            5667899999999999999999999999999999999999999987766553333 3332221  223357899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||+.||++|||+.++++
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.9e-44  Score=355.95  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=217.2

Q ss_pred             CceeeeeeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.+  ..||+|++......  ....+.+|+.++++++||||+++++++......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            579999999999999999999864  57999998765332  24678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.........
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            9999999999976 5679999999999999999999999999999999999999   78899999999999887766666


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+..........  ..+++.+.+++.+
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence            677899999999998765 9999999999999999999999999988877777665544332111  2688999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+||++.++++
T Consensus       245 ~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          245 LLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-45  Score=388.48  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=217.4

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.++||+|+||.||++++.  ++.||||+++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            445678999999999999999999985  67899999875321 111123478899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            999999999999999965  568999999999999999999999999999999999999999999999999998765544


Q ss_pred             c--cccCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCcH
Q 010680          374 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPKNSQP  445 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--~~p~~p~~~~~  445 (504)
                      .  ....+||+.|+|||++.+..    |+.++|||||||++|||++|..||...+..+....++...  ...+....+++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence            2  33568999999999997765    8899999999999999999999999999888877776543  22223357899


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHH
Q 010680          446 KLAELLERCWQQDPAL--RPDFSEIIE  470 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~--RPs~~ell~  470 (504)
                      ++.+||.+||..+|.+  ||++.|+++
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            9999999999988888  999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-44  Score=376.03  Aligned_cols=248  Identities=22%  Similarity=0.375  Sum_probs=202.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCC--Ccee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~--~~~l  295 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||++............+.+|+.+++.+. ||||+++++++..++  .+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            67999999999999999999874  788999999876556666788899999999998 999999999987544  6899


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC----
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----  371 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~----  371 (504)
                      |||||+ ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....    
T Consensus        89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence            999996 699999875  5789999999999999999999999999999999999999999999999999986532    


Q ss_pred             ------------------CCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 010680          372 ------------------SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ  432 (504)
Q Consensus       372 ------------------~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~  432 (504)
                                        ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                              112344579999999999976 6799999999999999999999999999887776655543


Q ss_pred             cCCCCC---------------------------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 010680          433 KGLRPT---------------------------------------------IPKNSQPKLAELLERCWQQDPALRPDFSE  467 (504)
Q Consensus       433 ~~~~p~---------------------------------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~e  467 (504)
                      ....|.                                             .+..+++++.+||.+||..||.+|||+.|
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            211111                                             12367899999999999999999999999


Q ss_pred             HHHH
Q 010680          468 IIEI  471 (504)
Q Consensus       468 ll~~  471 (504)
                      +++.
T Consensus       326 ~l~H  329 (388)
T 3oz6_A          326 ALKH  329 (388)
T ss_dssp             HTTS
T ss_pred             HhCC
Confidence            8753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-44  Score=366.49  Aligned_cols=260  Identities=30%  Similarity=0.564  Sum_probs=222.6

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      .++..++|++.+.||+|+||.||+|++       .++.||||+++.. ........+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            367778999999999999999999984       3457999999754 34455678999999999999999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhc------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVK  359 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vk  359 (504)
                      .....|+||||++|++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753      34889999999999999999999999999999999999984   44699


Q ss_pred             EEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 010680          360 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       360 L~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~  262 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSGG  262 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTTC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-HhcCC
Confidence            99999997543322   2234467899999999998899999999999999999998 9999998877665544 44555


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      ++..+..+++.+.++|.+||+.||.+||++.++++.|..+..
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            667788999999999999999999999999999999998866

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-44  Score=356.27  Aligned_cols=255  Identities=24%  Similarity=0.448  Sum_probs=217.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||+|+++......    .....+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999985  7889999998654332    13577899999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                      +||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999976 56799999999999999999999999999999999999998877    89999999998776


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA  448 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~  448 (504)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  +..+..+++.+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            555555667999999999999999999999999999999999999999998877766555433221  122357789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE--ILQQIA  476 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~--~L~~l~  476 (504)
                      +++.+||..||.+||++.++++  .++++.
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            9999999999999999999986  455553

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-44  Score=388.53  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=216.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  +..||||+++...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999984  6789999998765444445778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~~~~  375 (504)
                      |++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++........
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            9999999999876 5679999999999999999999999999999999999999764   45999999999887766666


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+..+....+.........  ...+++.+.+||.+
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            67789999999999874 6999999999999999999999999999988877776665444332  25789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH--HHHHH
Q 010680          454 CWQQDPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~--~L~~l  475 (504)
                      ||+.||.+|||+.++++  .|++.
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            99999999999999984  35544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=387.25  Aligned_cols=253  Identities=17%  Similarity=0.298  Sum_probs=216.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.++||+|+||.||+++..  ++.||||+++.... .......+.+|+.++..++||||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            445678999999999999999999984  78899999975321 112234578899999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998766689999999999999999999999999999999999999999999999999998765544


Q ss_pred             c--cccCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CCCCCCC
Q 010680          374 V--MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---LRPTIPK  441 (504)
Q Consensus       374 ~--~~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~---~~p~~p~  441 (504)
                      .  ....+||+.|+|||++.       ...|+.++|||||||++|||++|+.||...+..+....++...   ..|..+.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            3  23458999999999997       4578999999999999999999999999998888777766422   2233456


Q ss_pred             CCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALR---PDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~R---Ps~~ell~  470 (504)
                      .+++++.+||.+||. +|.+|   |++.++++
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            899999999999999 99998   58888864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-44  Score=375.83  Aligned_cols=253  Identities=21%  Similarity=0.373  Sum_probs=216.0

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCCceEEEEeeeCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPP  291 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~  291 (504)
                      ...+....|++.++||+|+||.||++... ++.||||+++...........+.+|+.+|++++  ||||+++++++...+
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            34566678999999999999999999875 677999999877666777788999999999997  499999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+|+||| +.+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9999999 458899999987 46789999999999999999999999999999999999996 58899999999986543


Q ss_pred             CC---ccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC
Q 010680          372 SG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLR  436 (504)
Q Consensus       372 ~~---~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~  436 (504)
                      ..   .....+||+.|+|||++.+           ..|+.++|||||||++|||++|..||.... .......++.....
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345679999999999865           468999999999999999999999998754 34455555655666


Q ss_pred             CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ...+...++++.+||.+||+.||.+||++.|+++
T Consensus       287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            6777888999999999999999999999999974

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-44  Score=358.09  Aligned_cols=248  Identities=23%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|.+.++||+|+||.||++...  +..||+|++...... .....+.+|+.++++++||||+++++++......++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            57999999999999999999975  678999999865432 235678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCC
Q 010680          299 FMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       299 ~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~  372 (504)
                      |+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            99999999998653   3679999999999999999999999999999999999999   45678999999999876665


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLAELL  451 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-~p~~~~~~l~~Ll  451 (504)
                      .......||+.|+|||++. ..++.++||||||+++|+|++|+.||...+..+............. ....+++++.+|+
T Consensus       181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL  259 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred             ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence            5556678999999999986 4689999999999999999999999999887776655544332222 2245789999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||+.||.+|||+.|+++
T Consensus       260 ~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          260 KQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.8e-45  Score=366.78  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=198.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++.... ......+.+|+.++++++||||+++++++..++.+|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            357899999999999999999874  78899999976542 222456889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhc-----ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          298 EFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      ||++ ++|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            9996 59999987643     45899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------
Q 010680          373 G-VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------  435 (504)
Q Consensus       373 ~-~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------  435 (504)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....               
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            2 3445678999999999976 4689999999999999999999999998887766655443110               


Q ss_pred             -----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 -----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 -----------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                       .+..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                             01122357889999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.9e-45  Score=358.61  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=217.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee--CCCCcee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCI  295 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~l  295 (504)
                      .++|++.+.||+|+||.||++.+.  ++.||+|+++.........+.+.+|+.++++++||||+++++++.  ....+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357999999999999999999984  678999999887666777788999999999999999999999874  4567899


Q ss_pred             EEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          296 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~-----IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      ||||+++++|.+++....   ..+++..++.++.||+.||.|||++|     |+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997643   34899999999999999999999999     9999999999999999999999999997


Q ss_pred             eccCCCc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          368 VKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       368 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+ ..+..+.++..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCCCCCCTTSCHH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-hhcccccCCcccCHH
Confidence            6543321 23456899999999999999999999999999999999999999988876665554 345556778899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEIL  472 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L  472 (504)
                      +.+++.+||+.||.+||++.++++.+
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            99999999999999999999998643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=370.25  Aligned_cols=261  Identities=27%  Similarity=0.458  Sum_probs=207.8

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHH--HHHHHhcCCCCceEEEEeee-----
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMRKVRHKNVVQFIGACT-----  288 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~E--i~iL~~l~HpnIv~l~~~~~-----  288 (504)
                      +.++.++|++.++||+|+||.||+|++.++.||||+++...     ...+..|  +..+..++||||+++++.+.     
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            36677899999999999999999999999999999997532     2334444  44455689999999997442     


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCcEE
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVK  359 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------~IiHrDLkp~NILl~~~~~vk  359 (504)
                      ....+++||||+++|+|.+++..  ...++..++.++.||+.||.|||++         ||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            33357899999999999999965  4458889999999999999999999         999999999999999999999


Q ss_pred             EEeeccceeccCCC---------ccccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 010680          360 VADFGVARVKAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLTGKLPYEYL--  421 (504)
Q Consensus       360 L~DFGla~~~~~~~---------~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~--  421 (504)
                      |+|||+++......         ......||+.|+|||++.+       ..++.++|||||||++|||++|..||...  
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998654321         2224579999999999987       45677899999999999999997665321  


Q ss_pred             ----------------CHHHHHHHHHhcCCCCCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          422 ----------------TPLQAAVGVVQKGLRPTIPKN------SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       422 ----------------~~~~~~~~v~~~~~~p~~p~~------~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                                      ........+.....++.++..      +++++.+||.+||+.||.+|||+.|+++.|++++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                            111222223334455555554      4458999999999999999999999999999999877


Q ss_pred             ccch
Q 010680          480 GEEN  483 (504)
Q Consensus       480 ~~~~  483 (504)
                      ..++
T Consensus       321 ~~~~  324 (336)
T 3g2f_A          321 ERNK  324 (336)
T ss_dssp             CC--
T ss_pred             Hhcc
Confidence            6543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=364.95  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC---CCCceEEEEeeeC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK  289 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~---~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~  289 (504)
                      +..++|++.++||+|+||+||+|.+  .++.||||+++.....   ......+.+|+.+++.+.   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3457899999999999999999995  5788999998743321   112345667777777665   9999999999876


Q ss_pred             CC-----CceeEEEecCCCchHHHHHhhcc-cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          290 PP-----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       290 ~~-----~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      ..     .+++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     4799999995 699999976443 3999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-----  438 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-----  438 (504)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.     
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            999876666566677899999999999999999999999999999999999999999888777666554211110     


Q ss_pred             --------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 --------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 --------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                          ....+++.+.+||.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                11357899999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-44  Score=358.36  Aligned_cols=256  Identities=26%  Similarity=0.379  Sum_probs=214.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee-eCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||+|++  .++.||||++......    ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            6899999999999999999996  5788999998765433    3578899999999998766655554 5667789999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999 9999999987677899999999999999999999999999999999999994   788999999999987655432


Q ss_pred             --------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---CCCCCCC
Q 010680          375 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQK---GLRPTIP  440 (504)
Q Consensus       375 --------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~---~~~p~~p  440 (504)
                              .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.   .+....+...   ...+..+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence                    2355799999999999999999999999999999999999999986432   1222222221   1112234


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ..+++++.+++.+||+.||.+||++.++++.|+++..+.+.
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            67899999999999999999999999999999999987764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-45  Score=389.20  Aligned_cols=249  Identities=27%  Similarity=0.516  Sum_probs=221.5

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ...+|.+++.||+|+||.||+|++.  ++.||||+++..... .+....+.+|+.+|+.++||||+++++++.....+|+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3468999999999999999999884  788999999754221 1234678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcc
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            9999999999999976 567999999999999999999999999999999999999999999999999999987766666


Q ss_pred             ccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          376 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....  ...|..+++++.+||.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~  250 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNPSVISLLKHM  250 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCHHHHHHHHHH
Confidence            67789999999999988876 689999999999999999999999887776666655432  346778999999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.++++
T Consensus       251 L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          251 LQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TCSSTTTSCCHHHHHT
T ss_pred             cCCCchhCcCHHHHHh
Confidence            9999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.6e-45  Score=388.44  Aligned_cols=248  Identities=26%  Similarity=0.478  Sum_probs=216.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||++.+.  ++.||||+++...........+.+|+.+|++++||||+++++++.....+|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            57999999999999999999985  7889999987543333335778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++........
T Consensus       102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            9999999999976 46799999999999999999999999999999999999995   4567999999999876666556


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+.........+  ..+++++.+||.+
T Consensus       181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  259 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK  259 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred             CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence            67789999999999986 49999999999999999999999999998888777766654443333  4689999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+|||+.++++
T Consensus       260 ~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          260 MLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-44  Score=386.61  Aligned_cols=248  Identities=25%  Similarity=0.433  Sum_probs=216.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh-----------HHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-----------DMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~-----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      ++|+++++||+|+||+||+|...  ++.||||+++......           .....+.+|+.+|++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            67999999999999999999985  5789999998654321           2356789999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeec
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFG  364 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFG  364 (504)
                      .....+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            999999999999999999999976 56799999999999999999999999999999999999998776   69999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCC
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKN  442 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~--p~~  442 (504)
                      +++............||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.........  ...
T Consensus       195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (504)
T 3q5i_A          195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN  273 (504)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred             CCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCC
Confidence            9988776666677789999999999875 5999999999999999999999999999988877776665433222  257


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++.+||.+||+.||.+|||+.|+++
T Consensus       274 ~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          274 ISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            8999999999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-44  Score=381.13  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=194.3

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC---
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---  289 (504)
                      .|.+. ++|++.++||+|+||.||+|.+.  ++.||||++..........+.+.+|+.+|++++||||+++++++..   
T Consensus        48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            34443 68999999999999999999774  6889999998765566667889999999999999999999999843   


Q ss_pred             --CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          290 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       290 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                        ...+|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             ccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence              35689999998 6799999976 5679999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC----------------------------ccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHh-----
Q 010680          368 VKAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT-----  413 (504)
Q Consensus       368 ~~~~~~----------------------------~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLlt-----  413 (504)
                      ......                            ..+..+||+.|+|||++ ....|+.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654321                            23455789999999986 56679999999999999999999     


Q ss_pred             ------CCCCCCCCCHH--------------------HHHHHHHh----------------------cCCC-------CC
Q 010680          414 ------GKLPYEYLTPL--------------------QAAVGVVQ----------------------KGLR-------PT  438 (504)
Q Consensus       414 ------G~~Pf~~~~~~--------------------~~~~~v~~----------------------~~~~-------p~  438 (504)
                            |+++|.+.+..                    +....+..                      ....       ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  77777654321                    11111110                      0000       01


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ....+++++.+||.+||..||.+|||+.|+++
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            12456899999999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-44  Score=352.58  Aligned_cols=243  Identities=23%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++...........+.+|+.++..+ +||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999985  78899999987766666678889999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-------------------
Q 010680          298 EFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------------  355 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-------------------  355 (504)
                      ||++|++|.+++....   +.+++..++.++.||+.||.|||++||+||||||+|||++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            9999999999997642   568999999999999999999999999999999999999844                   


Q ss_pred             CcEEEEeeccceeccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 010680          356 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG  434 (504)
Q Consensus       356 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~  434 (504)
                      ..+||+|||.+......   ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+......    ..+..+
T Consensus       171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~~  243 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----HEIRQG  243 (289)
T ss_dssp             CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----HHHHTT
T ss_pred             eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----HHHHcC
Confidence            47999999999876543   234699999999999766 6678999999999999999999877554332    223455


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ..+.++..+++++.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            667788899999999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.6e-44  Score=357.11  Aligned_cols=250  Identities=26%  Similarity=0.464  Sum_probs=215.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ...++|++.+.||+|+||.||+|.+.  ++.||||++...... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            34468999999999999999999885  457999998654221 123467889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus        86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            99999999999999976 467999999999999999999999999999999999999999999999999998644332 2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC  454 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~c  454 (504)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ....+..+++.+.+||.+|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHH
Confidence            34557899999999999999999999999999999999999999988887766665443  3456788999999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 010680          455 WQQDPALRPDFSEIIEI  471 (504)
Q Consensus       455 l~~dP~~RPs~~ell~~  471 (504)
                      |+.||.+||++.|+++.
T Consensus       242 l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCSSGGGSCCHHHHHHC
T ss_pred             hccChhhCCCHHHHhhC
Confidence            99999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.9e-44  Score=356.82  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=212.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee-eCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||+|++  .++.||||++......    ..+.+|+.+++.++|++++..++.+ ......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            6799999999999999999996  5778999987654322    3478899999999988777666655 6667789999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCCCc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      ||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 999999998767789999999999999999999999999999999999999   7889999999999987654322


Q ss_pred             --------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC---CCCCCC
Q 010680          375 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKG---LRPTIP  440 (504)
Q Consensus       375 --------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---~~~~~v~~~~---~~p~~p  440 (504)
                              .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..   +....+....   ..+...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence                    23457999999999999999999999999999999999999999764321   1222222111   111233


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ..+++++.+++.+||+.||.+|||+.++++.|++++++.+..
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            677899999999999999999999999999999999887643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=363.20  Aligned_cols=262  Identities=25%  Similarity=0.430  Sum_probs=203.9

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeee--
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT--  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~--  288 (504)
                      ..+++...+|++.++||+|+||.||+|.+  .++.||||++...  .......+.+|+.+++++. ||||+++++++.  
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            46788888999999999999999999998  5788999998654  3445677899999999996 999999999983  


Q ss_pred             ------CCCCceeEEEecCCCchHHHHHhh--cccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcE
Q 010680          289 ------KPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV  358 (504)
Q Consensus       289 ------~~~~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~~~~~v  358 (504)
                            ....+++||||+ +|+|.+++...  .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  344579999999 57999998653  456999999999999999999999999  9999999999999999999


Q ss_pred             EEEeeccceeccCCCcc-------------ccCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 010680          359 KVADFGVARVKAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLT  422 (504)
Q Consensus       359 kL~DFGla~~~~~~~~~-------------~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~  422 (504)
                      ||+|||+++........             ....||+.|+|||++   .+..++.++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999865543221             134589999999998   56778999999999999999999999998655


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccc
Q 010680          423 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       423 ~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~  482 (504)
                      ....    .........+...++.+.+|+.+||+.||.+||++.++++.|+.+.......
T Consensus       258 ~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          258 KLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            4432    3333444456677888999999999999999999999999999998865543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-44  Score=365.68  Aligned_cols=248  Identities=27%  Similarity=0.453  Sum_probs=220.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..+|.+.+.||+|+||.||++.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999985  57799999876543 345567889999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            999999999999876 5679999999999999999999999999999999999999999999999999998765332 34


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....  ..++..+++.+.+||.+||
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHc
Confidence            45679999999999999999999999999999999999999999888777666555433  3467789999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.||.+||++.++++
T Consensus       277 ~~dp~~Rps~~ell~  291 (335)
T 2owb_A          277 QTDPTARPTINELLN  291 (335)
T ss_dssp             CSSGGGSCCGGGGGG
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999976

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-44  Score=367.81  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=211.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||+++...   ........+.+|+.++++++||||+++++++...+..|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            67999999999999999999884  5679999987542   133456789999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhh---------------------------------------cccCChHHHHHHHHHHHHHHHHHH
Q 010680          296 VTEFMSGGSVYDYLHKL---------------------------------------KGVFKLPSLLKVAIDVSKGMNYLH  336 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qI~~gL~yLH  336 (504)
                      ||||++||+|.+++...                                       ...+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998521                                       112467788899999999999999


Q ss_pred             HCCceeccCCCCcEEECCCC--cEEEEeeccceeccCCC-----ccccCCCCCCccCcccccC--CCCCchhHHHHHHHH
Q 010680          337 QNNIIHRDLKAANLLMDENE--VVKVADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV  407 (504)
Q Consensus       337 ~~~IiHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvv  407 (504)
                      ++||+||||||+|||++.++  .+||+|||+++......     ......||+.|+|||++.+  ..++.++||||||++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            99999999999999998776  89999999998654322     2345679999999999965  678999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          408 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       408 L~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +|+|++|..||...+..+....+.........+  ..+++.+.+||.+||+.||.+||++.++++
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999888888877766544333  247899999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=376.34  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=204.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC-----CccEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCCceE
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNVVQ  282 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----g~~VAvK~lk~~~~~~~---------~~~~~~~Ei~iL~~l~HpnIv~  282 (504)
                      ++..++|++.++||+|+||.||+|.+.     +..||||++........         ....+.+|+.+++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            456689999999999999999999984     46799999876532110         1123667889999999999999


Q ss_pred             EEEeeeC----CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC--
Q 010680          283 FIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE--  356 (504)
Q Consensus       283 l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~--  356 (504)
                      +++++..    ....|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            9999877    67889999999 99999999763 4899999999999999999999999999999999999999877  


Q ss_pred             cEEEEeeccceeccCCC--------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 010680          357 VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV  428 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~  428 (504)
                      .+||+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            99999999998654321        1244579999999999999999999999999999999999999996522211111


Q ss_pred             HHHhcCCCCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          429 GVVQKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       429 ~v~~~~~~p~~p---------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      ........+.++         ..+++++.++|.+||+.||.+||++.++++.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111112222         278899999999999999999999999999988753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-44  Score=365.20  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=201.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-------  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-------  291 (504)
                      ++|++.++||+|+||.||+|++.  ++.||||+++... .....+.+.+|+.+|++++||||+++++++...+       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            46899999999999999999984  7889999998654 3344678999999999999999999999885443       


Q ss_pred             --------------------------------------------------CceeEEEecCCCchHHHHHhhc--ccCChH
Q 010680          292 --------------------------------------------------SLCIVTEFMSGGSVYDYLHKLK--GVFKLP  319 (504)
Q Consensus       292 --------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~--~~l~~~  319 (504)
                                                                        ..++||||++|++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999997643  234556


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-------------ccccCCCCCCccC
Q 010680          320 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------------VMTAETGTYRWMA  386 (504)
Q Consensus       320 ~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-------------~~~~~~gt~~y~A  386 (504)
                      .++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......             ......||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            789999999999999999999999999999999999999999999998765542             2234579999999


Q ss_pred             cccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 010680          387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS  466 (504)
Q Consensus       387 PE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~  466 (504)
                      ||++.+..++.++||||||+++|+|++|..|+..   .............+..+...++++.++|.+||+.||.+|||+.
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            9999999999999999999999999998776421   1112222233333333345678899999999999999999999


Q ss_pred             HHHH
Q 010680          467 EIIE  470 (504)
Q Consensus       467 ell~  470 (504)
                      |+++
T Consensus       322 ~~l~  325 (332)
T 3qd2_B          322 DIIE  325 (332)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            9975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-44  Score=367.61  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=202.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.++||+|+||.||+|.+  .++.||||+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            45799999999999999999987  4678999999876655555677889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-----CCCCcEEEEeeccceeccCC
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-----DENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl-----~~~~~vkL~DFGla~~~~~~  372 (504)
                      ||++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+     +.++.+||+|||+++.....
T Consensus       113 e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          113 EYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             ECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             ecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            9996 599999976 5679999999999999999999999999999999999999     45556999999999765433


Q ss_pred             -CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-----------
Q 010680          373 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI-----------  439 (504)
Q Consensus       373 -~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~-----------  439 (504)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......+..           
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD  270 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence             234456789999999999774 5899999999999999999999999998887777666543211110           


Q ss_pred             -----------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          440 -----------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       440 -----------------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                       +..+++++.+||.+||+.||.+|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                             0126789999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-44  Score=386.73  Aligned_cols=249  Identities=24%  Similarity=0.455  Sum_probs=221.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .++|++.++||+|+||.||++...  ++.||||++...... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357999999999999999999984  788999999765432 33457789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            999999999999976 5679999999999999999999999999999999999999   567899999999998776666


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELL  451 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll  451 (504)
                      ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+..+....+.........+  ..+++++.+||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  262 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI  262 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHH
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHH
Confidence            6666789999999999976 69999999999999999999999999999888887776665444333  56899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||+.||.+|||+.++++
T Consensus       263 ~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          263 RKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhh
Confidence            9999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=369.33  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=210.5

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ..|++. ++|++.+.||+|+||.||+|.+  +++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus        19 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           19 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             SEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             ceeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            345554 6899999999999999999987  4788999999776556666788999999999999999999999987663


Q ss_pred             ------CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          292 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       292 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                            .+|+||||+ +++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence                  459999999 8899999975  6799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 010680          366 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------  436 (504)
Q Consensus       366 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------  436 (504)
                      ++....  ..+...+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+......        
T Consensus       175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            987543  3456689999999999876 78999999999999999999999999988876665544331111        


Q ss_pred             ---------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ---------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ---------------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                           ..+...+++.+.+||.+||..||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                 1123567899999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7e-44  Score=355.22  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=220.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ..+|++.+.||+|+||.||++.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999985  67899999876543 345567889999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~  375 (504)
                      |||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            999999999998876 5679999999999999999999999999999999999999999999999999998765332 34


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...  ....+..+++.+.+++.+||
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  250 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML  250 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHHHHc
Confidence            4567999999999999999999999999999999999999999988877766555433  34567889999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.||.+|||+.++++
T Consensus       251 ~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          251 QTDPTARPTINELLN  265 (294)
T ss_dssp             CSSGGGSCCGGGGGG
T ss_pred             ccChhhCcCHHHHhh
Confidence            999999999999876

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.2e-44  Score=354.88  Aligned_cols=251  Identities=29%  Similarity=0.547  Sum_probs=215.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC----C
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----P  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~  290 (504)
                      ..+...|++.++||+|+||.||+|.+.  +..||+|+++...........+.+|+.++++++||||+++++++..    .
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            344567899999999999999999885  5679999998777777778889999999999999999999998754    4


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCcEEEEeeccce
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVAR  367 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~-~~~~vkL~DFGla~  367 (504)
                      ..+++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            558999999999999999976 467999999999999999999999999  99999999999998 78999999999996


Q ss_pred             eccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHH
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPK  446 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-p~~p~~~~~~  446 (504)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...............+.. ...+...+++
T Consensus       181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            54332 3445679999999999875 4999999999999999999999999886665555554444433 3455677899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.++|.+||+.||.+|||+.++++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhh
Confidence            999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-44  Score=360.47  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=211.0

Q ss_pred             eeeeeeeeeeCceEEEEEEECCccEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEec
Q 010680          223 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      +..+++||+|+||.||+|.+.++.||||++....  ........+.+|+.++++++||||+++++++...+..++||||+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            3445899999999999999999999999997643  23345678999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhhc--ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc---c
Q 010680          301 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M  375 (504)
Q Consensus       301 ~ggsL~~~l~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~  375 (504)
                      ++++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......   .
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            9999999997543  4589999999999999999999999999999999999999999999999999986554321   2


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc----------CCCCCCCCC
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV---VQK----------GLRPTIPKN  442 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v---~~~----------~~~p~~p~~  442 (504)
                      ....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+   ...          ...+..+..
T Consensus       193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST  271 (307)
T ss_dssp             SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred             cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence            34578999999999876 4899999999999999999999999765432211111   111          111223345


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      +++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            5678999999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-44  Score=362.84  Aligned_cols=259  Identities=18%  Similarity=0.314  Sum_probs=211.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      .++|++.+.||+|+||.||++.+.  ++.||||+++.... .......+.+|+.++++++||||+++++++...+..|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999974  67899999986543 344567899999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--c
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~  374 (504)
                      |||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus       113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            999999999999986 4679999999999999999999999999999999999999999999999999997655432  2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLE  452 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~~Ll~  452 (504)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+....... ......  ...+..+++++.++|.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-HHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-hccCCCCccccCCCCCHHHHHHHH
Confidence            3345789999999999999999999999999999999999999988766533332 332221  1345678999999999


Q ss_pred             HhhhcCCCCCC-CHHHHHHHHHHHHHHhc
Q 010680          453 RCWQQDPALRP-DFSEIIEILQQIAKEVG  480 (504)
Q Consensus       453 ~cl~~dP~~RP-s~~ell~~L~~l~~~~~  480 (504)
                      +||+.||.+|| ++.++++.|++++....
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999 99999999998876554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=372.81  Aligned_cols=257  Identities=18%  Similarity=0.254  Sum_probs=212.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC----------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceE----
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC----------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ----  282 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~----------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~----  282 (504)
                      ....++|++.+.||+|+||.||+|++.          ++.||||+++..       ..+.+|+.++++++||||++    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence            344589999999999999999999874          578999998754       35788999999999999887    


Q ss_pred             -----------EEEeeeC-CCCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          283 -----------FIGACTK-PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       283 -----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                                 +++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       5666654 67789999999 99999999874 3679999999999999999999999999999999999


Q ss_pred             EEECCCC--cEEEEeeccceeccCCC--------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 010680          350 LLMDENE--VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  419 (504)
Q Consensus       350 ILl~~~~--~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~  419 (504)
                      ||++.++  .+||+|||+++......        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  99999999997654322        1234479999999999999999999999999999999999999998


Q ss_pred             CCC-HHHHHHHHHh--cCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          420 YLT-PLQAAVGVVQ--KGLRPTIP------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       420 ~~~-~~~~~~~v~~--~~~~p~~p------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ... ..........  ....+.++      ..+++++.+++.+||+.||.+||++.++++.|+++++..+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            764 2222222111  11111111      25689999999999999999999999999999999987754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-44  Score=353.87  Aligned_cols=251  Identities=26%  Similarity=0.501  Sum_probs=210.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+...+|++.+.||+|+||.||+|.+.  ++.||||+++.... .......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            344568999999999999999999985  78899999875422 122346788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999999976 4678999999999999999999999999999999999999999999999999998766554


Q ss_pred             ccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+...  ....+..+++.+.+++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHH
Confidence            4556679999999999988776 68999999999999999999999988776665554433  33467788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||+.||.+|||+.++++
T Consensus       244 ~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCCCHHHHHh
Confidence            999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.6e-44  Score=382.66  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------  291 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||||++............+.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            378999999999999999999874  678999999876556666788999999999999999999999987654      


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+|+||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            45999999965 5766664   3589999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  437 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------------  437 (504)
                      ....+..+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....++.....|              
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            666777899999999999999999999999999999999999999999988776665554321111              


Q ss_pred             ------CCC---------CC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------TIP---------KN-----------SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------~~p---------~~-----------~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            ...         ..           .++++.+||.+||..||.+|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  000         00           1567999999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5e-44  Score=366.70  Aligned_cols=248  Identities=25%  Similarity=0.409  Sum_probs=209.8

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCceEEEEeeeC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----HKNVVQFIGACTK  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~~~~~~  289 (504)
                      .+-.++|++.++||+|+||.||+|++  .++.||||+++..   ......+..|+.+++.+.     ||||+++++++..
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            34457899999999999999999998  5678999999743   344567788999999997     9999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--------------
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--------------  354 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--------------  354 (504)
                      .+..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 999999997643 35999999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Q 010680          355 -----------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP  423 (504)
Q Consensus       355 -----------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~  423 (504)
                                 ++.+||+|||+++.....  .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                       789999999999865443  3456799999999999999999999999999999999999999998777


Q ss_pred             HHHHHHHHhcCCCC------------------------CCC--------------------CCCcHHHHHHHHHhhhcCC
Q 010680          424 LQAAVGVVQKGLRP------------------------TIP--------------------KNSQPKLAELLERCWQQDP  459 (504)
Q Consensus       424 ~~~~~~v~~~~~~p------------------------~~p--------------------~~~~~~l~~Ll~~cl~~dP  459 (504)
                      .+....+.......                        ..|                    ...++.+.+||.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            66554433211100                        001                    1123778899999999999


Q ss_pred             CCCCCHHHHHH
Q 010680          460 ALRPDFSEIIE  470 (504)
Q Consensus       460 ~~RPs~~ell~  470 (504)
                      .+|||+.|+++
T Consensus       345 ~~Rpta~elL~  355 (360)
T 3llt_A          345 TLRPSPAELLK  355 (360)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCCCHHHHhc
Confidence            99999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=358.99  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=192.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||+|+.  .++.||||++..... .......+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5799999999999999999997  578899999875422 1123467889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  170 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY  170 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence            9999999999998766789999999999999999999999999999999999999999999999999998655332 233


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ....|..+++++.++|.+||+
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  248 (278)
T 3cok_A          171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKDLIHQLLR  248 (278)
T ss_dssp             ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHHHHHHHSC
T ss_pred             eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHHHHHHHcc
Confidence            457899999999999999999999999999999999999999876554443332222  234667889999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+||++.++++
T Consensus       249 ~dp~~Rps~~~~l~  262 (278)
T 3cok_A          249 RNPADRLSLSSVLD  262 (278)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCHhhCCCHHHHhc
Confidence            99999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-43  Score=366.54  Aligned_cols=249  Identities=22%  Similarity=0.438  Sum_probs=217.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC--Ch----HHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI--NS----DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  291 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~--~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~  291 (504)
                      .+|++.+.||+|+||.||+|.+.  |+.||||+++....  ..    .....+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            56999999999999999999985  78999999976542  11    2345688999999999 7999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999976 56799999999999999999999999999999999999999999999999999987766


Q ss_pred             CCccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCC
Q 010680          372 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNS  443 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~  443 (504)
                      ........||+.|+|||++.      ...++.++|||||||++|+|++|..||...+.......+.........+  ..+
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  332 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR  332 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            65566778999999999985      3468899999999999999999999999888777666655544333222  467


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+.++|.+||+.||.+||++.++++
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            899999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-44  Score=361.60  Aligned_cols=252  Identities=31%  Similarity=0.595  Sum_probs=207.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEEeeeCC----CCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKP----PSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~----~~~~  294 (504)
                      ++|++.++||+|+||.||+|++.++.||||++....     ...+..|..++..  ++||||+++++++...    ...|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            579999999999999999999999999999986431     2334455555554  4899999999998776    6789


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      +||||+++++|.+++..  ..+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+|||++
T Consensus       112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            99999999999999965  5799999999999999999999999        9999999999999999999999999999


Q ss_pred             eeccCCCc-----cccCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHhC----------CCCCCCCCH--
Q 010680          367 RVKAQSGV-----MTAETGTYRWMAPEVIEHKPYDHK------ADVFSFGIVLWELLTG----------KLPYEYLTP--  423 (504)
Q Consensus       367 ~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~k------sDVwSlGvvL~eLltG----------~~Pf~~~~~--  423 (504)
                      +.......     .....||+.|+|||++.+..++.+      +|||||||++|||++|          ..||....+  
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            76544322     124579999999999988766654      9999999999999999          777765322  


Q ss_pred             ---HHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          424 ---LQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       424 ---~~~~~~v~~~~~~p~~p~-----~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                         ......+.....++..+.     .+++++.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence               222223334445555554     56778999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.5e-44  Score=363.47  Aligned_cols=250  Identities=20%  Similarity=0.377  Sum_probs=214.8

Q ss_pred             Cceeee-eeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeE
Q 010680          221 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~-~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.|.+. ++||+|+||.||+|...  ++.||||+++...........+.+|+.+++.+. ||||+++++++......++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            456666 88999999999999885  788999999876655555678999999999995 69999999999999999999


Q ss_pred             EEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceeccCC
Q 010680          297 TEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQS  372 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~  372 (504)
                      |||++|++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999999999998543 467999999999999999999999999999999999999997   789999999999887666


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAEL  450 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~p~~p~~~~~~l~~L  450 (504)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....  ....+..+++.+.++
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  267 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF  267 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence            555667899999999999999999999999999999999999999999888777766655433  233446789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      |.+||+.||.+|||+.++++
T Consensus       268 i~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          268 IQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCChhhCcCHHHHhC
Confidence            99999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-44  Score=364.52  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=207.8

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ..+|++.+.||+|+||.||+|.+.  ++.||||+++......   .....+.+|+.+++.++||||+++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            467999999999999999999874  6789999997643221   12346889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-C
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~  373 (504)
                      +||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999965 999999876678999999999999999999999999999999999999999999999999999865443 2


Q ss_pred             ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Q 010680          374 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------------  438 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--------------  438 (504)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+.              
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            3455689999999999965 4589999999999999999999999999888777766654321110              


Q ss_pred             ------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                  +...+++++.+||.+||..||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                        01456789999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.7e-44  Score=373.87  Aligned_cols=243  Identities=23%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             Cceeee-eeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHH-HhcCCCCceEEEEeeeC----CCC
Q 010680          221 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS  292 (504)
Q Consensus       221 ~~~~i~-~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~~~  292 (504)
                      ++|.+. ++||+|+||.||++.+.  ++.||||+++..       ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            456665 78999999999999885  678999999743       3567788887 45589999999998764    567


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~  368 (504)
                      +||||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            899999999999999998643 35999999999999999999999999999999999999997   78999999999987


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCC--CCCCC
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ----AAVGVVQKGLRP--TIPKN  442 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~----~~~~v~~~~~~p--~~p~~  442 (504)
                      ..........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......    ....+.......  .....
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  293 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  293 (400)
T ss_dssp             CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred             cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence            766555667789999999999999999999999999999999999999997654321    122222222221  12257


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++.+||.+||+.||.+|||+.++++
T Consensus       294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          294 VSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-43  Score=351.78  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=219.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC---C----hHHHHHHHHHHHHHHhcC-CCCceEEEEeeeC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---N----SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK  289 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~---~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~  289 (504)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++....   .    ......+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999984  67899999976532   1    123467889999999996 9999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999999999976 567999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--C
Q 010680          370 AQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--K  441 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~  441 (504)
                      ..........||+.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+.........+  .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            6665566678999999999984      5678999999999999999999999999888877766666554433322  4


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++.+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            68899999999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.9e-44  Score=353.97  Aligned_cols=250  Identities=23%  Similarity=0.430  Sum_probs=219.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+..++|++.+.||+|+||.||+|...  ++.||||++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            344568999999999999999999985  567999998653221 12246788999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999999999999976 467999999999999999999999999999999999999999999999999999765432 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...  ...++..+++.+.++|.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcCCHHHHHHHHH
Confidence            234567999999999999999999999999999999999999999988877766555443  345778899999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+||++.++++
T Consensus       246 ~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HhhcCHhhCCCHHHHhh
Confidence            99999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.8e-44  Score=366.55  Aligned_cols=251  Identities=25%  Similarity=0.424  Sum_probs=213.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++..++|++.++||+|+||.||++.+.  ++.||+|+++... .......+.+|+.++++++||||+++++++...+..|
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            455678999999999999999999986  7789999998653 4555678999999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +||||++|++|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... 
T Consensus       108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999976 46799999999999999999999996 9999999999999999999999999998654332 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------------------
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-------------------------  428 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-------------------------  428 (504)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+...                         
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            2334579999999999999999999999999999999999999998766543321                         


Q ss_pred             -----------------HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          429 -----------------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       429 -----------------~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                       .+.........+..+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                             111111222223457899999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=365.20  Aligned_cols=262  Identities=21%  Similarity=0.354  Sum_probs=215.4

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee---
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT---  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~---  288 (504)
                      ..+.++.++|++.+.||+|+||.||++..  .++.||||++...  .......+.+|+.+++.++||||+++++++.   
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            45678889999999999999999999996  5788999998653  3455678999999999999999999999886   


Q ss_pred             -CCCCceeEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          289 -KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       289 -~~~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                       .....++||||+++++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             345789999999999999999763   4679999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCc----------cccCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 010680          365 VARVKAQSGV----------MTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGV  430 (504)
Q Consensus       365 la~~~~~~~~----------~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~~v  430 (504)
                      +++.......          .....||+.|+|||++.+..   ++.++||||||+++|+|++|..||...... ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            9875432111          12335799999999997654   789999999999999999999999532110 011122


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          431 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       431 ~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .........+..+++.+.++|.+||+.||.+||++.++++.|+++..
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            33344445567889999999999999999999999999999988754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-43  Score=355.29  Aligned_cols=246  Identities=24%  Similarity=0.456  Sum_probs=213.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||+++..  ++.||||+++....  .....+.+|+.++++++||||+++++++......|+|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            57899999999999999999984  78899999986432  223568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      |+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++..... ..
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~  164 (304)
T 2jam_A           87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM  164 (304)
T ss_dssp             CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred             cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence            9999999999976 5679999999999999999999999999999999999999   78889999999999754332 23


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......  ...+..+++++.++|.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence            3456899999999999999999999999999999999999999988877766665554332  23446789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||..||.+||++.++++
T Consensus       245 ~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          245 LLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHCSSTTTSCCHHHHHT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-43  Score=354.52  Aligned_cols=248  Identities=33%  Similarity=0.583  Sum_probs=220.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+.|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.+++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            356999999999999999999874  678999999865432 34577999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||+++++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus       100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A          100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999964  679999999999999999999999999999999999999999999999999998765433 334


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+ .....+..+..+++.+.+++.+||+
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCCCccccCHHHHHHHHHHcC
Confidence            567899999999999999999999999999999999999999988877665544 3455667788899999999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 010680          457 QDPALRPDFSEIIEI  471 (504)
Q Consensus       457 ~dP~~RPs~~ell~~  471 (504)
                      .||.+|||+.++++.
T Consensus       257 ~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          257 KEPSFRPTAKELLKH  271 (303)
T ss_dssp             SSGGGSCCHHHHTTC
T ss_pred             CChhhCcCHHHHhhC
Confidence            999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.6e-44  Score=361.76  Aligned_cols=253  Identities=29%  Similarity=0.581  Sum_probs=215.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEEeeeCCC----Cc
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL  293 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~~  293 (504)
                      .++|++.+.||+|+||.||+|++.++.||||+++..     ....+.+|+.+++.  ++||||+++++++....    .+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            367999999999999999999999999999998743     24567889999887  78999999999998776    78


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      ++||||+++++|.+++..  ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|||+
T Consensus       116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999975  56899999999999999999999        89999999999999999999999999999


Q ss_pred             ceeccCCCc-----cccCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCCC--
Q 010680          366 ARVKAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYLT--  422 (504)
Q Consensus       366 a~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf~~~~--  422 (504)
                      ++.......     .....||+.|+|||++.+.      .++.++||||||+++|||++|          ..||....  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            987655432     2445799999999999776      234789999999999999999          78997642  


Q ss_pred             ---HHHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          423 ---PLQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       423 ---~~~~~~~v~~~~~~p~~p~-----~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                         .......+.....++.++.     .+++.+.+|+.+||+.||.+|||+.++++.|+++.++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence               2333333445556666554     34568999999999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=357.19  Aligned_cols=250  Identities=30%  Similarity=0.507  Sum_probs=209.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeC-----
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK-----  289 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~-----  289 (504)
                      ....+|++.+.||+|+||.||+|++  .++.||||++......   ...+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3457899999999999999999998  5788999999765332   35788999999999 79999999999865     


Q ss_pred             -CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          290 -PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       290 -~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                       ...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             457899999999999999998643 568999999999999999999999999999999999999999999999999997


Q ss_pred             eccCCC-ccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          368 VKAQSG-VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       368 ~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      ...... ......||+.|+|||++.     +..++.++||||||+++|+|++|..||...+.......+.........+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            654332 234457999999999996     56789999999999999999999999999888777766665554444567


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++.+.++|.+||..||.+||++.++++
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            78999999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1e-43  Score=394.46  Aligned_cols=263  Identities=32%  Similarity=0.601  Sum_probs=227.9

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      ..+++..++|++.+.||+|+||.||+|.+..     ..||||+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4567888899999999999999999998843     35999998754 24455678999999999999999999999985


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      . +..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            4 568999999999999999987666799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          369 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       369 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+. .+.++..+..+++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~  619 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP  619 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccH
Confidence            544332  223456789999999999999999999999999999997 999999988877665544 4556678889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+.++|.+||+.||.+||++.++++.|++++.+.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=365.56  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            57999999999999999999985  678999999754321 112245679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            996 69999998877779999999999999999999999999999999999999999999999999998654332 3345


Q ss_pred             CCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Q 010680          378 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------  438 (504)
Q Consensus       378 ~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~------------------  438 (504)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+.                  
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            578999999999876 6789999999999999999999999999888776655543211110                  


Q ss_pred             ----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 010680          439 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       439 ----------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l  475 (504)
                                ....+++++.+||.+||+.||.+|||+.|+++  .|.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                      11356889999999999999999999999986  34443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=368.56  Aligned_cols=242  Identities=22%  Similarity=0.398  Sum_probs=211.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ++|++.+.||+|+||.||+|.+  .++.||||+++.......      ....+.+|+.++++++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            5799999999999999999986  467899999987643221      33457789999999999999999999999999


Q ss_pred             ceeEEEecCCC-chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          293 LCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       293 ~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      +++||||+.+| +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            99999999766 99999976 56799999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....      ..  ......+..+++++.+|
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--EAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT--TTCCCCSSCCCHHHHHH
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH--hhccCCCcccCHHHHHH
Confidence            666666789999999999988887 8899999999999999999999976322      11  12234566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIEI  471 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~~  471 (504)
                      |.+||+.||.+|||+.++++.
T Consensus       255 i~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.1e-44  Score=365.98  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=213.8

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+....++|++.+.||+|+||.||+|.+.  ++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            34455678999999999999999999985  6789999998776666667788999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999888887654 567999999999999999999999999999999999999999999999999999765443


Q ss_pred             C-ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Q 010680          373 G-VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------  434 (504)
Q Consensus       373 ~-~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------  434 (504)
                      . ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....                
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            2 34456799999999999775 78999999999999999999999999888766655443210                


Q ss_pred             ---CC-CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 ---LR-PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ---~~-p~---------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                         .+ +.         ....+++.+.+||.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00 11         11357899999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-44  Score=353.41  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=212.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC---------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---------  289 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---------  289 (504)
                      .+|++.+.||+|+||.||+|.+.  ++.||||+++...      ..+.+|+.++++++||||+++++++..         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            56899999999999999999985  7889999998642      346789999999999999999998753         


Q ss_pred             -------CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEE
Q 010680          290 -------PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA  361 (504)
Q Consensus       290 -------~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~  361 (504)
                             ...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                   345799999999999999997643 578999999999999999999999999999999999999999999999


Q ss_pred             eeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010680          362 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK  441 (504)
Q Consensus       362 DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~  441 (504)
                      |||+++............||+.|+|||++.+..++.++||||||+++|+|++|..||....   ........   ..++.
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~---~~~~~  238 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLRD---GIISD  238 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHHT---TCCCT
T ss_pred             cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhhc---ccccc
Confidence            9999987766655566789999999999999999999999999999999999998874321   11122222   34567


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      .+++.+.++|.+||+.||.+||++.++++.|..+.+..
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            78999999999999999999999999999998886543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.9e-44  Score=356.94  Aligned_cols=256  Identities=24%  Similarity=0.462  Sum_probs=199.8

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      ...|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++.........+.+.++..+++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            4567788889999999999999999999984  78899999987654444445555666778899999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +..++||||+ ++.+..+.....+.+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 6677777666567899999999999999999999996 9999999999999999999999999999766


Q ss_pred             cCCCccccCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCC--C
Q 010680          370 AQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRPTIP--K  441 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~p~~p--~  441 (504)
                      ..........||+.|+|||++.     ...++.++||||||+++|+|++|..||.... ..+....+. ....+..+  .
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCccC
Confidence            5555555667999999999994     5678999999999999999999999998754 334443433 33334343  4


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+++++.++|.+||+.||.+||++.++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            58999999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-45  Score=371.29  Aligned_cols=259  Identities=30%  Similarity=0.531  Sum_probs=211.4

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      .+.+..++|++.+.||+|+||.||+|... ++.||||+++...... ....+.+|+.+++.++||||+++++++......
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            44666788999999999999999999864 7889999998654322 223688999999999999999999999999999


Q ss_pred             eeEEEecCCCchHHHHHhhc---ccCChHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          294 CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~---~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      ++||||+++++|.+++....   ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999997643   3489999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHh-----
Q 010680          368 VKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--------TPLQAAVGVVQ-----  432 (504)
Q Consensus       368 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~--------~~~~~~~~v~~-----  432 (504)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...        ...+.......     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE  262 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence            765432  233456999999999998888999999999999999999999999521        01111111000     


Q ss_pred             ----cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 010680          433 ----KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       433 ----~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~  474 (504)
                          ....+..+...++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                011112223345789999999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-43  Score=352.91  Aligned_cols=248  Identities=26%  Similarity=0.475  Sum_probs=217.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|+..  ++.||||+++...........+.+|+.++++++||||+++++++......++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            57999999999999999999984  7889999997665544456789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~~~~  375 (504)
                      |+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.........
T Consensus       102 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~  180 (287)
T 2wei_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (287)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence            9999999999876 4679999999999999999999999999999999999999754   47999999999866555444


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p--~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++.++|.+
T Consensus       181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  259 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK  259 (287)
T ss_dssp             SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence            455689999999998765 8999999999999999999999999988877766665544333333  5789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+|||+.++++
T Consensus       260 ~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          260 MLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcccChhhCcCHHHHhc
Confidence            99999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-43  Score=364.56  Aligned_cols=247  Identities=25%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------  291 (504)
                      .++|++.+.||+|+||.||+|...  ++.||||+++...........+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999874  678999999876556666788999999999999999999999987665      


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..|+||||++ ++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            5799999995 58888884   4589999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------  437 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------------  437 (504)
                      ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....++.....+              
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            555566789999999999999999999999999999999999999999988776665554322111              


Q ss_pred             ------CC--------------CC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------TI--------------PK------NSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------~~--------------p~------~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            ..              |.      ..++++.+||.+||..||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  00              00      11578999999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=379.40  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=216.3

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC--Cc
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL  293 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~  293 (504)
                      +...+|++.++||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            34568999999999999999999986  788999999864322 22467789999999999999999999987655  67


Q ss_pred             eeEEEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEEeeccce
Q 010680          294 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR  367 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl----~~~~~vkL~DFGla~  367 (504)
                      |+||||++|++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999999976433  38999999999999999999999999999999999999    777889999999998


Q ss_pred             eccCCCccccCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCC
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLPYEYL----TPLQAAVGVVQKGL  435 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~----~~~~~~~~v~~~~~  435 (504)
                      ............||+.|+|||++.+        ..++.++|||||||++|||++|+.||...    ...+....+.....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            7766655566789999999999864        56788999999999999999999999643    23344444443221


Q ss_pred             CC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          436 RP-----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       436 ~p-----------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      ..                       .++..+++.+.+++.+||..||++||++.++++.+.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            10                       11233467789999999999999999999999999998774

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-43  Score=363.42  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------  290 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-------  290 (504)
                      .++|++.++||+|+||.||+|++  .++.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36899999999999999999998  467899999977655544456788999999999999999999998763       


Q ss_pred             -CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 -PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                       +.+|+||||++ ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence             45799999996 5888888776778999999999999999999999999999999999999999999999999999865


Q ss_pred             cCC-----CccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCC
Q 010680          370 AQS-----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--LRPTIPK  441 (504)
Q Consensus       370 ~~~-----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~--~~p~~p~  441 (504)
                      ...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....  ..+....
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            422     23345678999999999976 568999999999999999999999999988776655544321  1111111


Q ss_pred             C----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          442 N----------------------------SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       442 ~----------------------------~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .                            .++.+.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1                            2678999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-43  Score=349.35  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=210.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            46899999999999999999885  788999999765432 345778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---cc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~  375 (504)
                      |+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......   ..
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9999999999865 4679999999999999999999999999999999999999999999999999997654322   23


Q ss_pred             ccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ................+++.+.++|.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence            45678999999999988775 7899999999999999999999987654322 222222222223345689999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+|||+.++++
T Consensus       245 ~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          245 ILVENPSARITIPDIKK  261 (276)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HCCCCchhCCCHHHHhc
Confidence            99999999999999865

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7e-44  Score=355.84  Aligned_cols=249  Identities=28%  Similarity=0.496  Sum_probs=211.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            367999999999999999999985  6789999987653  233567899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Cccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~  376 (504)
                      ||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            999999999999877788999999999999999999999999999999999999999999999999997533221 1223


Q ss_pred             cCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHH
Q 010680          377 AETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAEL  450 (504)
Q Consensus       377 ~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-p~~p~~~~~~l~~L  450 (504)
                      ...||+.|+|||++     .+..++.++||||||+++|+|++|..||...+.......+...... ...+..+++.+.++
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  255 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF  255 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence            45789999999998     4678999999999999999999999999998887776665544322 22356788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      |.+||+.||.+|||+.++++
T Consensus       256 i~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          256 LKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHcccChhhCCCHHHHhc
Confidence            99999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-43  Score=370.36  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC--
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--  290 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--  290 (504)
                      .+.+ .++|++.+.||+|+||.||+|.+.  ++.||||+++.........+.+.+|+.+|++++||||+++++++...  
T Consensus        21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            3444 368999999999999999999885  57799999987655666678899999999999999999999998766  


Q ss_pred             ---CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          291 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       291 ---~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                         ..+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence               56899999995 699999976 5679999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCC-----------------------ccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhC---------
Q 010680          368 VKAQSG-----------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTG---------  414 (504)
Q Consensus       368 ~~~~~~-----------------------~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG---------  414 (504)
                      ......                       ..+..+||+.|+|||++ ....|+.++|||||||++|||++|         
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            754432                       23567899999999986 566799999999999999999984         


Q ss_pred             --CCCCCCCCH-----------------HHHHHHHH-----------------------hc-CCCCCC-----CCCCcHH
Q 010680          415 --KLPYEYLTP-----------------LQAAVGVV-----------------------QK-GLRPTI-----PKNSQPK  446 (504)
Q Consensus       415 --~~Pf~~~~~-----------------~~~~~~v~-----------------------~~-~~~p~~-----p~~~~~~  446 (504)
                        .++|.+.+.                 .+....+.                       .. ......     ...++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence              444433321                 11111111                       10 011111     1467899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          447 LAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +.+||.+||..||.+|||+.|+++
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=373.36  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=210.6

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCCceEEEEeee
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT  288 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~  288 (504)
                      .+...+|++.++||+|+||.||+++.     .++.||||+++....  .......+.+|+.+|+++ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            45567899999999999999999988     578899999975432  112234577899999999 5999999999999


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ....+++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999976 46799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC--ccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCC
Q 010680          369 KAQSG--VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIP  440 (504)
Q Consensus       369 ~~~~~--~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~p~~p  440 (504)
                      .....  ......||+.|+|||++.+  ..++.++|||||||++|+|++|..||....    .......+..  ..+..+
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence            54332  2334579999999999975  457899999999999999999999996432    2233333322  345677


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 010680          441 KNSQPKLAELLERCWQQDPALRP-----DFSEIIEI  471 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RP-----s~~ell~~  471 (504)
                      ..+++.+.+||.+||..||.+||     ++.++++.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            88999999999999999999999     88888753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-44  Score=366.18  Aligned_cols=243  Identities=24%  Similarity=0.439  Sum_probs=207.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++.+.||+|+||.||++.+.  ++.||||+++.....      +.+|+.++.++ +||||+++++++.+...+|+||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999985  678999999865332      34688888888 7999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEEEEeeccceeccCC-
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQS-  372 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~----~~vkL~DFGla~~~~~~-  372 (504)
                      ||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            99999999999976 5679999999999999999999999999999999999998543    35999999999866543 


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCCC--CCCCCCCcHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY---LTPLQAAVGVVQKGLR--PTIPKNSQPKL  447 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~---~~~~~~~~~v~~~~~~--p~~p~~~~~~l  447 (504)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..   .+..+....+......  ...+..+++++
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  254 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA  254 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence            344566899999999999888899999999999999999999999975   3444554444443322  22346789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||.+||..||.+||++.++++
T Consensus       255 ~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          255 KDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.7e-43  Score=354.58  Aligned_cols=243  Identities=19%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeC--CCCc
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSL  293 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~  293 (504)
                      ..++|++.++||+|+||.||+|.+  .++.||||+++...     ...+.+|+.++++++ ||||+++++++..  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            347899999999999999999987  46889999998532     367889999999997 9999999999987  5678


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~  372 (504)
                      ++||||+++++|.+++..    +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999998853    89999999999999999999999999999999999999776 8999999999877666


Q ss_pred             CccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH------------hcC----
Q 010680          373 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVV------------QKG----  434 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~-~~~~~~~~v~------------~~~----  434 (504)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.            ...    
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            66667789999999999977 67999999999999999999999999543 2222221111            000    


Q ss_pred             -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 -------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 -------------------~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                         .....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                               011122337899999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.3e-44  Score=397.33  Aligned_cols=251  Identities=23%  Similarity=0.389  Sum_probs=219.3

Q ss_pred             eeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC
Q 010680          216 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  291 (504)
Q Consensus       216 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~  291 (504)
                      ..+..++|++.++||+|+||.||+|.+.  ++.||||+++.... .......+..|..+|..+ +||+|+++++++.+.+
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3566789999999999999999999985  56799999985422 122345678899999987 6999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+||||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999999986 46799999999999999999999999999999999999999999999999999986443


Q ss_pred             C-CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010680          372 S-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       372 ~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                      . ......+||+.|+|||++.+..|+.++||||||++||||++|..||.+.+..+....++...  ..+|..+++++.+|
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAI  572 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHH
Confidence            3 34556789999999999999999999999999999999999999999999888887776544  45778999999999


Q ss_pred             HHHhhhcCCCCCCCH-----HHHH
Q 010680          451 LERCWQQDPALRPDF-----SEII  469 (504)
Q Consensus       451 l~~cl~~dP~~RPs~-----~ell  469 (504)
                      |.+||+.||.+||++     .+|+
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHh
Confidence            999999999999997     6665

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.8e-44  Score=390.75  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=217.8

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +..++|++.+.||+|+||.||+++..  ++.||||+++..... ......+.+|+.+|++++||||+++++++.....+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            56678999999999999999999984  788999999754321 123456889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997643 349999999999999999999999999999999999999999999999999998876665


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....    ..+....+.  .....++..+++++.+
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARS  418 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHHHHH
Confidence            5666789999999999999999999999999999999999999998753    233333322  2345577889999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHH
Q 010680          450 LLERCWQQDPALRP-----DFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RP-----s~~ell~  470 (504)
                      ||.+||+.||.+||     ++.|+++
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            99999999999999     7788864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-43  Score=366.81  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=211.1

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-----
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-----  289 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----  289 (504)
                      +....+|++.++||+|+||.||+|.+  +++.||||++......      ..+|+.+|+.++||||+++++++..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            45567899999999999999999987  4788999998755322      2369999999999999999998843     


Q ss_pred             ---------------------------------CCCceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHH
Q 010680          290 ---------------------------------PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMN  333 (504)
Q Consensus       290 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~  333 (504)
                                                       ...+++||||++ ++|.+.+..   ....+++..+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             334789999996 588887753   2467999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEC-CCCcEEEEeeccceeccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHH
Q 010680          334 YLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWEL  411 (504)
Q Consensus       334 yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eL  411 (504)
                      |||++||+||||||+|||++ .++.+||+|||+++............||+.|+|||++.+. .|+.++|||||||++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 6889999999999987666666677899999999998765 499999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 010680          412 LTGKLPYEYLTPLQAAVGVVQKGLRP---------------------------TIPKNSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       412 ltG~~Pf~~~~~~~~~~~v~~~~~~p---------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                      ++|+.||.+.+..+....++.....|                           .++..+++++.+||.+||..||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999999988877766655321111                           145568899999999999999999999


Q ss_pred             HHHHHH--HHHHHHH
Q 010680          465 FSEIIE--ILQQIAK  477 (504)
Q Consensus       465 ~~ell~--~L~~l~~  477 (504)
                      +.|+++  .++++..
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999983  4555543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=363.66  Aligned_cols=259  Identities=17%  Similarity=0.256  Sum_probs=216.3

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEE-------ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceE
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQ  282 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~-------~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~  282 (504)
                      ...+++..++|.+.++||+|+||.||+|.       ..++.||||+++...     ..++..|+.+++.++   |+||++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            35678888999999999999999999993       357889999998642     356777888888877   899999


Q ss_pred             EEEeeeCCCCceeEEEecCCCchHHHHHhh----cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----
Q 010680          283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----  354 (504)
Q Consensus       283 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~----  354 (504)
                      +++++...+..|+||||++||+|.+++...    ...+++..++.++.||+.||+|||++||+||||||+|||++.    
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            999999999999999999999999999753    456999999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEEeeccceeccC---CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 010680          355 -------NEVVKVADFGVARVKAQ---SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL  424 (504)
Q Consensus       355 -------~~~vkL~DFGla~~~~~---~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~  424 (504)
                             ++.+||+|||+++....   ........||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   89999999999976432   23445668999999999999999999999999999999999999999543221


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHhccc
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEIIEILQQIAKEVGEE  482 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~R-Ps~~ell~~L~~l~~~~~~~  482 (504)
                      ...   . ...  ......++.+.+++.+||+.+|.+| |++.++.+.|++++.....+
T Consensus       292 ~~~---~-~~~--~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~  344 (365)
T 3e7e_A          292 ECK---P-EGL--FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN  344 (365)
T ss_dssp             EEE---E-CSC--CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             cee---e-chh--ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhh
Confidence            000   0 011  1112346789999999999999998 57899999999998875443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=352.97  Aligned_cols=250  Identities=30%  Similarity=0.468  Sum_probs=211.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ....++|++.+.||+|+||.||+|.+.  ++.||||+++....    ...+.+|+.+++.++||||+++++++...+..|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            344578999999999999999999985  78899999986532    356889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  373 (504)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999999998667789999999999999999999999999999999999999999999999999997655432 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~  452 (504)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..+++.+.++|.
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            23455789999999999999999999999999999999999999998887766554433221 12234567899999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||..||.+||++.++++
T Consensus       261 ~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.9e-44  Score=357.92  Aligned_cols=255  Identities=33%  Similarity=0.572  Sum_probs=197.0

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .|.+..++|++.+.||+|+||.||+|.+  .++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            3678889999999999999999999976  578899999875532 2335678899999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhh-------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          293 LCIVTEFMSGGSVYDYLHKL-------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~-------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      .++||||++|++|.+++...       .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999999999742       45689999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCC------ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--
Q 010680          366 ARVKAQSG------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--  436 (504)
Q Consensus       366 a~~~~~~~------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--  436 (504)
                      +.......      ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            87544322      1234578999999999965 56899999999999999999999999988776655544433211  


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            +.....+++++.+++.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  2234567899999999999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.6e-44  Score=361.80  Aligned_cols=237  Identities=22%  Similarity=0.428  Sum_probs=183.0

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      ++||+|+||.||++.+.  ++.||||+++..     ....+.+|+.+++.+. ||||+++++++.+....|+||||++|+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            78999999999999985  678999998743     3466788999999997 999999999999999999999999999


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeeccceeccCCC-ccccCC
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSG-VMTAET  379 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~~-~~~~~~  379 (504)
                      +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++...... ......
T Consensus        92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  170 (325)
T 3kn6_A           92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC  170 (325)
T ss_dssp             BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence            99999987 57799999999999999999999999999999999999998765   89999999998655432 344567


Q ss_pred             CCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCC--CCCCCcHHHHHH
Q 010680          380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVVQKGLRPT--IPKNSQPKLAEL  450 (504)
Q Consensus       380 gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-------~~~~~~v~~~~~~p~--~p~~~~~~l~~L  450 (504)
                      ||+.|+|||++.+..|+.++||||||+++|+|++|..||...+.       .+....+........  ....+++++.+|
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL  250 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence            89999999999999999999999999999999999999976443       233333322221111  113588999999


Q ss_pred             HHHhhhcCCCCCCCHHHHH
Q 010680          451 LERCWQQDPALRPDFSEII  469 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell  469 (504)
                      |.+||+.||.+|||+.+++
T Consensus       251 i~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTST
T ss_pred             HHHHCCCChhHCCCHHHHh
Confidence            9999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.2e-45  Score=375.91  Aligned_cols=251  Identities=16%  Similarity=0.200  Sum_probs=201.1

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHH---HHHHhcCCCCceEEE-------
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEV---FIMRKVRHKNVVQFI-------  284 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei---~iL~~l~HpnIv~l~-------  284 (504)
                      ...++|++.+.||+|+||.||+|++  .++.||||+++.... .....+.+.+|+   .++++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3456899999999999999999986  478999999985432 344567899999   555566899999988       


Q ss_pred             EeeeCCC-----------------CceeEEEecCCCchHHHHHhhcccCCh-------HHHHHHHHHHHHHHHHHHHCCc
Q 010680          285 GACTKPP-----------------SLCIVTEFMSGGSVYDYLHKLKGVFKL-------PSLLKVAIDVSKGMNYLHQNNI  340 (504)
Q Consensus       285 ~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~~l~~-------~~~~~i~~qI~~gL~yLH~~~I  340 (504)
                      +++..++                 ..|+||||+ +|+|.+++... +.++.       ..++.++.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5555443                 378999999 68999999864 33444       7888899999999999999999


Q ss_pred             eeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccccCC-----------CCCchhHHHHHHHHHH
Q 010680          341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-----------PYDHKADVFSFGIVLW  409 (504)
Q Consensus       341 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGvvL~  409 (504)
                      +||||||+|||++.++.+||+|||+++....  ......| +.|+|||++.+.           .|+.++|||||||++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986433  3445677 999999999877           8999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHHh
Q 010680          410 ELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEV  479 (504)
Q Consensus       410 eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l~~~~  479 (504)
                      ||++|+.||...+.......+.      ..+..+++++.+||.+||+.||.+||++.++++  .++++...+
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            9999999997655433222111      123678999999999999999999999999985  566655443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=349.84  Aligned_cols=254  Identities=27%  Similarity=0.476  Sum_probs=211.9

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      .+.+...++.....||+|+||.||+|.+.  ++.||||+++...  ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            34555556666679999999999999984  5789999987653  3345778999999999999999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceec
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVK  369 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~  369 (504)
                      .++||||+++++|.+++....+  .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999999987543  4568889999999999999999999999999999999987 899999999999865


Q ss_pred             cCCC-ccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCcH
Q 010680          370 AQSG-VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       370 ~~~~-~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      .... ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||...... ............+.++..+++
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            5432 23455789999999999764  3899999999999999999999999765433 233333344566778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.++|.+||+.||++||++.++++
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-43  Score=384.23  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=212.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +..++|++.+.||+|+||.||+++..  ++.||||+++..... ......+.+|+.+|++++||||+++++++.....+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            44578999999999999999999984  788999999754321 123467889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          295 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      +||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999764   24699999999999999999999999999999999999999999999999999987655


Q ss_pred             CCc-cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          372 SGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL----TPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       372 ~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~----~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...    ...+....+...  ....|..+++.
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA  419 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCHH
Confidence            443 33458999999999999999999999999999999999999999765    334444444433  34567889999


Q ss_pred             HHHHHHHhhhcCCCCCCCH
Q 010680          447 LAELLERCWQQDPALRPDF  465 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~  465 (504)
                      +.+||.+||+.||.+||++
T Consensus       420 ~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHhccCCHhHCCCC
Confidence            9999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-43  Score=356.17  Aligned_cols=250  Identities=23%  Similarity=0.397  Sum_probs=211.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEEeee-----
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----  288 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~-----  288 (504)
                      .++|++.+.||+|+||.||+|.+.   ++.||||+++...........+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            367999999999999999999983   57799999876543332234566778777766   8999999999986     


Q ss_pred             CCCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          289 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       289 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      .....++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5667899999996 69999997653 348999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-----------  436 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-----------  436 (504)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......           
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            765544455678999999999999999999999999999999999999999998877766555432110           


Q ss_pred             --------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 --------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 --------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                    ...+..+++.+.+||.+||+.||.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          1133568899999999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.1e-44  Score=375.23  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=199.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .++|.+.++||+|+||.||+|.+.  ++.||||+++.....      ......+.+|+.+|++++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            367999999999999999999884  578999999764321      12233588999999999999999999998654 


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEEeecccee
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARV  368 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---~vkL~DFGla~~  368 (504)
                      ..|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            57999999999999998875 56799999999999999999999999999999999999997544   599999999987


Q ss_pred             ccCCCccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCC
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKN  442 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~---~p~~  442 (504)
                      ...........||+.|+|||++.   ...|+.++|||||||++|+|++|..||............+..+....   ....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            76665566778999999999985   36788999999999999999999999986544333333333332222   2356


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++.+.+||.+||+.||.+||++.|+++
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            8999999999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-43  Score=373.43  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------CC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~  292 (504)
                      .+|++.++||+|+||.||+|++.  ++.||||++.....      .+.+|+.+|+.++||||+++++++...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46999999999999999999984  78899999875421      234699999999999999999987432      23


Q ss_pred             ceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-~~vkL~DFGla~~  368 (504)
                      +++||||+++ +|.+.+..   ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            6799999964 77766643   34679999999999999999999999999999999999999965 5789999999987


Q ss_pred             ccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-----------  436 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-----------  436 (504)
                      ...........||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+....++.....           
T Consensus       207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            7665555667899999999999764 7999999999999999999999999998877666555432110           


Q ss_pred             -------CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 -------PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 -------p~---------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                             +.         ++..+++++.+||.+||..||.+||++.|+++
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                   00         23467899999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.5e-44  Score=359.88  Aligned_cols=256  Identities=30%  Similarity=0.505  Sum_probs=191.2

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCceEEEEeeeC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~  289 (504)
                      ...|.+..++|++.+.||+|+||.||+|.+.  ++.||||+++.... ......+..|+. +++.++||||+++++++..
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            4678899999999999999999999999986  78899999986533 333455566665 7788899999999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHh----hcccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEEeec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                      .+..++||||++ ++|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            999999999996 488888763    246789999999999999999999999 99999999999999999999999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP  440 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p  440 (504)
                      +++............||+.|+|||++    .+..++.++||||||+++|+|++|..||...............+..+.++
T Consensus       172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred             CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            99876655445556799999999999    56679999999999999999999999998765432221112222222222


Q ss_pred             ----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          441 ----KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       441 ----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                          ..+++.+.+|+.+||+.||.+||++.++++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                468999999999999999999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-43  Score=356.17  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=200.2

Q ss_pred             Cceeee-eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeE
Q 010680          221 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~-~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.|++. +.||+|+||.||+|.+  .++.||||+++....  .....+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            467774 7899999999999986  478899999976532  2356788999999985 799999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~---vkL~DFGla~~~~~~~  373 (504)
                      |||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++......
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            999999999999987 467999999999999999999999999999999999999998775   9999999987543221


Q ss_pred             --------ccccCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--------------HHH
Q 010680          374 --------VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQA  426 (504)
Q Consensus       374 --------~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--------------~~~  426 (504)
                              ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.....              ...
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                    1223469999999999975     5688999999999999999999999976542              112


Q ss_pred             HHHHHhcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          427 AVGVVQKGLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       427 ~~~v~~~~~~p~~p----~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ....+..+. ...+    ..+++++.+||.+||+.||.+|||+.|+++
T Consensus       249 ~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          249 LFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            222222221 1222    468899999999999999999999999976

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-43  Score=358.35  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=204.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ++|++.+.||+|+||.||+|.+.  ++.||||+++.....      ......+.+|+.++++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            57999999999999999999884  578999999765321      122345889999999999999999999987665 


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEEeeccceec
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK  369 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~---vkL~DFGla~~~  369 (504)
                      .|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            8999999999999999875 567999999999999999999999999999999999999987664   999999999876


Q ss_pred             cCCCccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCC
Q 010680          370 AQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS  443 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---p~~p~~~  443 (504)
                      ..........||+.|+|||++.   ...++.++||||||+++|+|++|..||............+..+..   +..+..+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            6544444567999999999973   567899999999999999999999999765433222222322222   2223578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+.+++.+||+.||.+||++.++++
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            899999999999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.7e-43  Score=351.07  Aligned_cols=254  Identities=21%  Similarity=0.376  Sum_probs=215.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCCceEEEEeeeCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP  290 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~  290 (504)
                      ....+...+|++.+.||+|+||.||++.+. ++.||||+++...........+.+|+.++++++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            455778889999999999999999999874 677999999877666777788999999999998  49999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +..++|||+ .+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus       101 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             CEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999999994 58899999986 567899999999999999999999999999999999999964 899999999997654


Q ss_pred             CCC---ccccCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCC
Q 010680          371 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGL  435 (504)
Q Consensus       371 ~~~---~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~-~~~~~~~v~~~~~  435 (504)
                      ...   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||.... .............
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            332   2234578999999999875           478999999999999999999999998764 3444455555556


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ....+...++++.++|.+||+.||.+||++.++++
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            66778888999999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-43  Score=366.56  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=197.2

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-  290 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-  290 (504)
                      ..|++. ++|++.+.||+|+||.||+|.+  .++.||||+++...........+.+|+.+|+.++||||+++++++... 
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            456665 7899999999999999999987  467899999987655566678899999999999999999999998654 


Q ss_pred             -----CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          291 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       291 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                           ...|+||||+ +++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                 5679999999 8899999865  6799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 010680          366 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------  437 (504)
Q Consensus       366 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-------  437 (504)
                      ++....  ..+...||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+......|       
T Consensus       179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            986543  2455689999999999977 679999999999999999999999999888766555443311110       


Q ss_pred             --------------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 --------------T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 --------------~--------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                    .        ....+++.+.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                          0        11356889999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-43  Score=361.68  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=212.5

Q ss_pred             CCCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       212 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      ....|++. ++|.+.+.||+|+||.||+|.+.  ++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus        34 ~~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  112 (371)
T 4exu_A           34 NKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP  112 (371)
T ss_dssp             TTEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             ccceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence            34556665 68999999999999999999874  7889999998776666667889999999999999999999999987


Q ss_pred             CCCc------eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          290 PPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       290 ~~~~------~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      ....      |+||||+. ++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          113 ASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred             cCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence            7665      99999995 68888773   45999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----  437 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----  437 (504)
                      |+++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+     
T Consensus       189 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          189 GLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             TCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            999765432  445678999999999977 789999999999999999999999999888776665554321111     


Q ss_pred             ------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                              ..+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                    112467899999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.1e-43  Score=374.49  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=216.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV  296 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++.....    ..+.+|+.+++.++| ++|+.+..++......+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            367999999999999999999974  788999998765433    247789999999987 5666676777778888999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEEeeccceeccCCC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 999999998777889999999999999999999999999999999999999   588999999999998765543


Q ss_pred             c--------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC---CCCC
Q 010680          374 V--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGL---RPTI  439 (504)
Q Consensus       374 ~--------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~---~~~~~~v~~~~~---~p~~  439 (504)
                      .        .....||+.|+|||++.+..++.++|||||||+||||++|+.||.....   .+....+.....   ...+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            2        1255799999999999999999999999999999999999999987543   333333322221   1223


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          440 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       440 p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      +..+++++.+||.+||+.||++||++.+|++.|++++...+
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            36788999999999999999999999999999999988664

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.6e-44  Score=369.62  Aligned_cols=255  Identities=13%  Similarity=0.134  Sum_probs=193.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc--CCCCceEEE-------Eee
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV--RHKNVVQFI-------GAC  287 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l--~HpnIv~l~-------~~~  287 (504)
                      ..+|++.++||+|+||.||+|++.  ++.||||+++..... ......+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999974  678999999986543 34556777886555555  599988866       333


Q ss_pred             eCC-----------------CCceeEEEecCCCchHHHHHhhcccCChHHH------HHHHHHHHHHHHHHHHCCceecc
Q 010680          288 TKP-----------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------LKVAIDVSKGMNYLHQNNIIHRD  344 (504)
Q Consensus       288 ~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~qI~~gL~yLH~~~IiHrD  344 (504)
                      ..+                 ..+|+||||++ ++|.+++......++...+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            222                 23799999997 8999999876666666666      78889999999999999999999


Q ss_pred             CCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 010680          345 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT  422 (504)
Q Consensus       345 Lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~  422 (504)
                      |||+|||++.++.+||+|||+++.....  .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|+.||....
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            9999999999999999999999866432  224567799999999987  789999999999999999999999998764


Q ss_pred             HHHHHH-------HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 010680          423 PLQAAV-------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK  477 (504)
Q Consensus       423 ~~~~~~-------~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l~~  477 (504)
                      +.....       ...........+..+++.+.+||.+||+.||++|||+.++++  .++++..
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            321100       000111222233578999999999999999999999999974  4555544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-43  Score=362.20  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             CCceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCC---------ChHHHHHHHHHHHHHHhcCCCCceEEEEeee-
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERI---------NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-  288 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~---------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-  288 (504)
                      .++|++.+.||+|+||.||+|.. .++.||||++.....         .....+.+.+|+.++++++||||+++++++. 
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            46799999999999999999976 467899999865432         2233478999999999999999999999883 


Q ss_pred             ----CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeec
Q 010680          289 ----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG  364 (504)
Q Consensus       289 ----~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFG  364 (504)
                          ....+|+||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence                3345799999996 69999988766789999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  437 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------  437 (504)
                      +++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+      
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (362)
T 3pg1_A          180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV  259 (362)
T ss_dssp             C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence            9986666555666789999999999976 679999999999999999999999999888766665554321111      


Q ss_pred             ------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                              ..+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                    112456889999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-42  Score=365.86  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=208.7

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc------CCCCceEEEEeeeCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV------RHKNVVQFIGACTKPP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~~~~  291 (504)
                      ..+|++.++||+|+||.||+|.+.  ++.||||+++..   ......+.+|+.+++.+      +|+||+++++++....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            467999999999999999999885  578999999854   34456778899998887      5679999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEEeecccee
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV  368 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~--vkL~DFGla~~  368 (504)
                      .+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999999995 69999997654 45999999999999999999999999999999999999999887  99999999976


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  437 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----------  437 (504)
                      ....  .....||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......+           
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          252 EHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             cCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            5432  445689999999999999999999999999999999999999999888776655444211000           


Q ss_pred             ----------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ----------------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ----------------------------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                                                    .++...++.+.+||.+||+.||.+|||+.|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                          012234788999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=347.34  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=208.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCceEEEEee--eCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~~~  294 (504)
                      .+|++.+.||+|+||.||++.+  .++.||||+++....  .......+.+|+.++++++||||+++++++  ......|
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            5799999999999999999987  467899999975432  123457799999999999999999999998  4456789


Q ss_pred             eEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-
Q 010680          295 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-  372 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  372 (504)
                      +||||++++ |.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999765 77777653 456999999999999999999999999999999999999999999999999999865432 


Q ss_pred             --CccccCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          373 --GVMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       373 --~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                        .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||...+..+....+...  ...++..+++.+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~  241 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLS  241 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHH
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHH
Confidence              2234557999999999997654  378999999999999999999999988877666555443  3456778999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++|.+||+.||.+|||+.++++
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhc
Confidence            9999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-43  Score=360.83  Aligned_cols=250  Identities=21%  Similarity=0.387  Sum_probs=213.7

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCCh---------------HHHHHHHHHHHHHHhcCCCCceE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS---------------DMQKEFAQEVFIMRKVRHKNVVQ  282 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~---------------~~~~~~~~Ei~iL~~l~HpnIv~  282 (504)
                      +..++|++.+.||+|+||.||+|.+.++.||||++.......               .....+.+|+.++++++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            345689999999999999999999999999999987542211               11277899999999999999999


Q ss_pred             EEEeeeCCCCceeEEEecCCCchHHH------HHhh-cccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECC
Q 010680          283 FIGACTKPPSLCIVTEFMSGGSVYDY------LHKL-KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDE  354 (504)
Q Consensus       283 l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~  354 (504)
                      +++++...+..++||||+++++|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      5442 4679999999999999999999999 99999999999999999


Q ss_pred             CCcEEEEeeccceeccCCCccccCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q 010680          355 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH-KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVV  431 (504)
Q Consensus       355 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~~v~  431 (504)
                      ++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||...+. .+....+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999876443 44556799999999999887 6776 99999999999999999999988776 44443333


Q ss_pred             hcCCCCCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          432 QKGLRPTIP-------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       432 ~~~~~p~~p-------------------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ...  ...+                   ..+++++.+||.+||+.||.+||++.++++
T Consensus       267 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          267 TKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222  2233                   678999999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-42  Score=357.86  Aligned_cols=246  Identities=24%  Similarity=0.395  Sum_probs=207.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----CCc
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~  293 (504)
                      .+|++.++||+|+||.||+|.+.  ++.||||+++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            68999999999999999999874  6779999998543 344567889999999999999999999998654     368


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |+||||++ ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            99999995 699999965  569999999999999999999999999999999999999999999999999998665432


Q ss_pred             ----ccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 010680          374 ----VMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----------  437 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----------  437 (504)
                          ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....+......+           
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                234458999999999874 5568999999999999999999999998877655544443211110           


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                        .....+++++.+||.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                              012467899999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.1e-43  Score=363.78  Aligned_cols=244  Identities=25%  Similarity=0.365  Sum_probs=202.8

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC------C
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------S  292 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------~  292 (504)
                      ..+|++.++||+|+||.||+|++. +..||+|.+......      ..+|+.+|+.++||||+++++++....      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            357999999999999999999984 455999887654221      236999999999999999999985433      3


Q ss_pred             ceeEEEecCCCchHHHHH---hhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLH---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFGla~~  368 (504)
                      +++||||++++ +.+.+.   .....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus       113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            78999999764 444432   2256799999999999999999999999999999999999999 799999999999998


Q ss_pred             ccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------  437 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p----------  437 (504)
                      ...........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+......|          
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            7666666677899999999999765 59999999999999999999999999988777666554321110          


Q ss_pred             -----------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -----------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -----------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                       .++..+++++.+||.+||..||.+|||+.|+++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                             123458899999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-42  Score=351.94  Aligned_cols=247  Identities=26%  Similarity=0.350  Sum_probs=206.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC-----CC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PS  292 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~  292 (504)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++.. ........+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            368999999999999999999986  788999999754 2344567788999999999999999999987654     67


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      .|+||||+. ++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            899999995 699999875  57999999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----------ccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---
Q 010680          373 G-----------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---  437 (504)
Q Consensus       373 ~-----------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p---  437 (504)
                      .           ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+   
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            2           1223478999999998754 779999999999999999999999999887665544333211110   


Q ss_pred             ---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ---------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ---------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                                 ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                       012467899999999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=353.24  Aligned_cols=250  Identities=27%  Similarity=0.435  Sum_probs=209.4

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      ..|++. .+|.+.+.||+|+||.||+|.+.  ++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus        18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            345554 67999999999999999999874  788999999876666666788999999999999999999999998765


Q ss_pred             C------ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          292 S------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       292 ~------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                      .      +|+||||+. ++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence            4      499999996 68888774   3599999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Q 010680          366 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------  434 (504)
Q Consensus       366 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~----------  434 (504)
                      ++.....  .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....          
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9764432  345678999999999976 678999999999999999999999999887766554443210          


Q ss_pred             ----------------CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 ----------------LR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ----------------~~---p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                      .+   ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                            01   1233567899999999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-42  Score=348.45  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEE---CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC------ceEEEEeeeC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTK  289 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~---~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~  289 (504)
                      -.++|++.++||+|+||.||+|.+   .++.||||+++..   ......+.+|+.+++.++|++      |+++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            346899999999999999999987   4678999999753   344577889999999997654      9999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--------------
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--------------  354 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--------------  354 (504)
                      .+..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999999 899999997643 36889999999999999999999999999999999999987              


Q ss_pred             -----CCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 010680          355 -----NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG  429 (504)
Q Consensus       355 -----~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~  429 (504)
                           ++.+||+|||+++.....  .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  245 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM  245 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                 668999999999865433  3456799999999999999999999999999999999999999998877654433


Q ss_pred             HHhcCCC------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 010680          430 VVQKGLR------------------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSE  467 (504)
Q Consensus       430 v~~~~~~------------------------------------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~e  467 (504)
                      +......                                          ...+...++++.+||.+||+.||.+|||+.|
T Consensus       246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  325 (339)
T 1z57_A          246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE  325 (339)
T ss_dssp             HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence            2211000                                          0112234678999999999999999999999


Q ss_pred             HHH
Q 010680          468 IIE  470 (504)
Q Consensus       468 ll~  470 (504)
                      +++
T Consensus       326 ll~  328 (339)
T 1z57_A          326 ALK  328 (339)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=345.80  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=201.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee---------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT---------  288 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~---------  288 (504)
                      .++|++.+.||+|+||.||+|.+.  ++.||||++...  .....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            368999999999999999999986  688999998754  3455678999999999999999999999873         


Q ss_pred             -----CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEe
Q 010680          289 -----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVAD  362 (504)
Q Consensus       289 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~D  362 (504)
                           .....|+||||++ ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+|
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                 3456799999996 699999964  6789999999999999999999999999999999999997 567999999


Q ss_pred             eccceeccCC----CccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Q 010680          363 FGVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-  436 (504)
Q Consensus       363 FGla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-  436 (504)
                      ||+++.....    .......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865432    12334567999999998865 77999999999999999999999999988877665554432110 


Q ss_pred             ----------------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ----------------------P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ----------------------p-----~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                            +     ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                  1     112468899999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-42  Score=358.67  Aligned_cols=245  Identities=24%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC--------CCCceEEEEeee-
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--------HKNVVQFIGACT-  288 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~~~~~-  288 (504)
                      ..+|++.++||+|+||.||+|.+.  ++.||||+++..   ......+.+|+.+++.++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            478999999999999999999874  678999999753   445677889999999996        788999999987 


Q ss_pred             ---CCCCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCC-------
Q 010680          289 ---KPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE-------  356 (504)
Q Consensus       289 ---~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~~~~-------  356 (504)
                         ....+|+||||+ +++|.+++... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence               566789999999 66666666543 36799999999999999999999998 999999999999999775       


Q ss_pred             ------------------------------------------cEEEEeeccceeccCCCccccCCCCCCccCcccccCCC
Q 010680          357 ------------------------------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP  394 (504)
Q Consensus       357 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~  394 (504)
                                                                .+||+|||+++.....  .....||+.|+|||++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence                                                      7999999999876543  44567999999999999999


Q ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc-CCC-------------------------------
Q 010680          395 YDHKADVFSFGIVLWELLTGKLPYEYLTP------LQAAVGVVQK-GLR-------------------------------  436 (504)
Q Consensus       395 ~s~ksDVwSlGvvL~eLltG~~Pf~~~~~------~~~~~~v~~~-~~~-------------------------------  436 (504)
                      |+.++|||||||+||+|++|+.||...+.      ......+... +..                               
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            99999999999999999999999976442      1221111110 000                               


Q ss_pred             --------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 --------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 --------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                              ...+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    0122344577899999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-42  Score=341.83  Aligned_cols=244  Identities=24%  Similarity=0.448  Sum_probs=198.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC---------
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK---------  289 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---------  289 (504)
                      ++|++.+.||+|+||.||+|+.  .++.||||+++..   ......+.+|+.++++++||||+++++++..         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4689999999999999999997  4788999998643   3446778999999999999999999998754         


Q ss_pred             ----CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecc
Q 010680          290 ----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV  365 (504)
Q Consensus       290 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGl  365 (504)
                          ....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                3467999999999999999987666788899999999999999999999999999999999999999999999999


Q ss_pred             ceeccCC---------------CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 010680          366 ARVKAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG  429 (504)
Q Consensus       366 a~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~  429 (504)
                      ++.....               .......||+.|+|||++.+. .++.++||||||+++|+|++   ||...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9765422               123345689999999999765 68999999999999999998   5543322222222


Q ss_pred             HHhc---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          430 VVQK---GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       430 v~~~---~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+..   ...+..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2222   2334455677888999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-42  Score=353.29  Aligned_cols=250  Identities=20%  Similarity=0.216  Sum_probs=196.9

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC--
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--  292 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--  292 (504)
                      ....++|++.++||+|+||.||+|++.  ++.||||++......   ...+.+|+..++.++||||+++++++.....  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            344568999999999999999999985  678999998654322   2346678888999999999999999865333  


Q ss_pred             -----ceeEEEecCCCchHHHHHh---hcccCChHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEECC-CCcEEEE
Q 010680          293 -----LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMDE-NEVVKVA  361 (504)
Q Consensus       293 -----~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qI~~gL~yLH--~~~IiHrDLkp~NILl~~-~~~vkL~  361 (504)
                           +++||||+++ +|.+.+..   ....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                 7899999976 55554432   3567899999999999999999999  999999999999999997 8999999


Q ss_pred             eeccceeccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----
Q 010680          362 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-----  435 (504)
Q Consensus       362 DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-----  435 (504)
                      |||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....     
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            99999877766666677899999999998665 489999999999999999999999999888776666543211     


Q ss_pred             -------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 -------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 -------------------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                               .+..+...++++.+||.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                     11223346789999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=358.31  Aligned_cols=244  Identities=23%  Similarity=0.387  Sum_probs=183.9

Q ss_pred             ceee-eeeeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee--eCCCCce
Q 010680          222 HLKF-GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC  294 (504)
Q Consensus       222 ~~~i-~~~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~~~  294 (504)
                      .|.+ +++||+|+||.||+|++.    ++.||||+++.....    ..+.+|+.+|++++||||+++++++  .....+|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            3555 568999999999999965    577999999865433    3577899999999999999999998  4467789


Q ss_pred             eEEEecCCCchHHHHHhhc--------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEEe
Q 010680          295 IVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVAD  362 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl----~~~~~vkL~D  362 (504)
                      +||||++ ++|.+++....        ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9999995 68888886432        248999999999999999999999999999999999999    6778999999


Q ss_pred             eccceeccCC----CccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHH
Q 010680          363 FGVARVKAQS----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAV  428 (504)
Q Consensus       363 FGla~~~~~~----~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------~~~~  428 (504)
                      ||+++.....    .......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||......         +...
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999865443    223456789999999999874 5999999999999999999999999765431         2222


Q ss_pred             HHHhcCCCCC------------------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          429 GVVQKGLRPT------------------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       429 ~v~~~~~~p~------------------------------------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+......|.                                    .....++.+.+||.+||..||.+|||+.|+++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            2221110000                                    01123678999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-41  Score=343.76  Aligned_cols=245  Identities=23%  Similarity=0.401  Sum_probs=204.2

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--C-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC------ceEEEEeeeCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTKP  290 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~~  290 (504)
                      .++|++.+.||+|+||.||+|.+.  + +.||||+++..   ......+.+|+.+++.++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            478999999999999999999874  3 57999999753   344577889999999998766      89999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-----------------
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-----------------  352 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl-----------------  352 (504)
                      +..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+                 
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence            9999999999 667777776543 569999999999999999999999999999999999999                 


Q ss_pred             --CCCCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 010680          353 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV  430 (504)
Q Consensus       353 --~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v  430 (504)
                        +.++.+||+|||+++.....  .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence              56789999999999865433  34567999999999999999999999999999999999999999987766544332


Q ss_pred             HhcCCC-C-----------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 010680          431 VQKGLR-P-----------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEI  468 (504)
Q Consensus       431 ~~~~~~-p-----------------------------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~el  468 (504)
                      ...... |                                         ......++++.+||.+||+.||.+|||+.|+
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            221000 0                                         0111235689999999999999999999998


Q ss_pred             HH
Q 010680          469 IE  470 (504)
Q Consensus       469 l~  470 (504)
                      ++
T Consensus       332 l~  333 (355)
T 2eu9_A          332 LL  333 (355)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=343.24  Aligned_cols=244  Identities=25%  Similarity=0.462  Sum_probs=200.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh----HHHHHHHHHHHHHHhc----CCCCceEEEEe
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKV----RHKNVVQFIGA  286 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l----~HpnIv~l~~~  286 (504)
                      +.-.++|++.+.||+|+||.||+|.+  .++.||||+++......    .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44457899999999999999999987  46789999997654322    1234466799999999    89999999999


Q ss_pred             eeCCCCceeEEEe-cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEeec
Q 010680          287 CTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFG  364 (504)
Q Consensus       287 ~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFG  364 (504)
                      +...+..++|||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            9999999999999 789999999987 56799999999999999999999999999999999999999 88999999999


Q ss_pred             cceeccCCCccccCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010680          365 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS  443 (504)
Q Consensus       365 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~  443 (504)
                      +++..... ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||.....      +...  ...++..+
T Consensus       186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~~~~~~~~  256 (312)
T 2iwi_A          186 SGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--ELHFPAHV  256 (312)
T ss_dssp             SCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--CCCCCTTS
T ss_pred             hhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--ccCCcccC
Confidence            99876543 34456799999999999776664 589999999999999999999975321      1222  34567789


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+.++|.+||+.||++||++.++++
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-41  Score=347.17  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=175.3

Q ss_pred             Cceeeee-eeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC----CCCc
Q 010680          221 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSL  293 (504)
Q Consensus       221 ~~~~i~~-~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~  293 (504)
                      ++|.+.+ .||+|+||.||+|.+.  ++.||||++...   ..   ...+....++.++||||+++++++..    ...+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            5688855 6999999999999986  788999998753   22   12223334667789999999999865    4458


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceec
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK  369 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~  369 (504)
                      ++||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999999998653 36999999999999999999999999999999999999976   455999999999865


Q ss_pred             cCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcCCCCCCCCCC
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV------QKGLRPTIPKNS  443 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~------~~~~~p~~p~~~  443 (504)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............      ...........+
T Consensus       182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             ccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence            533 3345678999999999999999999999999999999999999997665443321111      111222233578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++++.+||.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3e-41  Score=350.16  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=205.0

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CC-----CceEEEEeeeCCC
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK-----NVVQFIGACTKPP  291 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~~~~~  291 (504)
                      .++|++.++||+|+||.||+|.+.  ++.||||+++..   ......+..|+.+++.++ |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            468999999999999999999875  677999999853   344567788999998886 44     4999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEC--CCCcEEEEeeccc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMD--ENEVVKVADFGVA  366 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH--~~~IiHrDLkp~NILl~--~~~~vkL~DFGla  366 (504)
                      ..|+||||++ ++|.+++.... +.+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999995 59999997654 56999999999999999999999  57999999999999995  4778999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------  438 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--------  438 (504)
                      +.....  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+......+.        
T Consensus       209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            876433  4456899999999999999999999999999999999999999999887776655543211100        


Q ss_pred             --------CC------------------C----------------------------CCcHHHHHHHHHhhhcCCCCCCC
Q 010680          439 --------IP------------------K----------------------------NSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       439 --------~p------------------~----------------------------~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                              ++                  .                            ...+++.+||.+||+.||.+|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence                    00                  0                            00147899999999999999999


Q ss_pred             HHHHHH
Q 010680          465 FSEIIE  470 (504)
Q Consensus       465 ~~ell~  470 (504)
                      +.|+++
T Consensus       367 a~e~L~  372 (382)
T 2vx3_A          367 PYYALQ  372 (382)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-42  Score=347.26  Aligned_cols=244  Identities=25%  Similarity=0.465  Sum_probs=208.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCCceEEEEeee
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACT  288 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~  288 (504)
                      +.-.++|++.+.||+|+||.||+|.+  .++.||||+++......    .....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44567899999999999999999987  46789999997654322    12245678999999996  599999999999


Q ss_pred             CCCCceeEEEecCC-CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEEeeccc
Q 010680          289 KPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVA  366 (504)
Q Consensus       289 ~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~-~~~~vkL~DFGla  366 (504)
                      .++..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999976 899999976 57799999999999999999999999999999999999999 7889999999999


Q ss_pred             eeccCCCccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          367 RVKAQSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      +..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....      +...  ....+..+++
T Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~~  268 (320)
T 3a99_A          198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQRVSS  268 (320)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSSCCCH
T ss_pred             cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--cccccccCCH
Confidence            876543 3345679999999999977665 6889999999999999999999975421      1222  2345678899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ++.+||.+||+.||.+||++.++++
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-41  Score=348.92  Aligned_cols=248  Identities=20%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCCceEE
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQF  283 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l  283 (504)
                      .+...+|++.++||+|+||.||+|++  .++.||||+++..   ......+.+|+.++++++           ||||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            55678999999999999999999997  4788999999753   334567889999999887           8999999


Q ss_pred             EEeeeCCC----CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEC----
Q 010680          284 IGACTKPP----SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD----  353 (504)
Q Consensus       284 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~-~IiHrDLkp~NILl~----  353 (504)
                      ++++...+    .+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987543    689999999 999999997643 4599999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH------HH
Q 010680          354 --ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP------LQ  425 (504)
Q Consensus       354 --~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~------~~  425 (504)
                        ..+.+||+|||+++.....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              4448999999999876543  3455799999999999999999999999999999999999999986542      11


Q ss_pred             HHHHHHhc-C---------------------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 010680          426 AAVGVVQK-G---------------------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDF  465 (504)
Q Consensus       426 ~~~~v~~~-~---------------------------------------~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~  465 (504)
                      ....+... +                                       ....++..+++++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111110 0                                       0112334567889999999999999999999


Q ss_pred             HHHHH
Q 010680          466 SEIIE  470 (504)
Q Consensus       466 ~ell~  470 (504)
                      .|+++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=358.09  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceE-EEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  291 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~-Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~  291 (504)
                      +.+.+...+|.+.+.||+|+||+ ||++...++.||||++.....     ..+.+|+.+|+++ +||||+++++++....
T Consensus        17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            45677888899999999999998 567777899999999976432     2356799999999 7999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CcEEEEeeccc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVA  366 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-----~~vkL~DFGla  366 (504)
                      ..|+||||++ |+|.+++......++...++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||++
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999999995 69999998766667777788999999999999999999999999999999532     35889999999


Q ss_pred             eeccCCC----ccccCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC-
Q 010680          367 RVKAQSG----VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP-  437 (504)
Q Consensus       367 ~~~~~~~----~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p-  437 (504)
                      +......    ......||+.|+|||++.   ...++.++|||||||++|||++ |..||......+............ 
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            8655432    234567999999999997   4667889999999999999999 999997665544433221111111 


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEII  469 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell  469 (504)
                      ..+...++.+.+||.+||+.||.+|||+.+++
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            11233456789999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-40  Score=348.64  Aligned_cols=242  Identities=22%  Similarity=0.380  Sum_probs=188.5

Q ss_pred             CceeeeeeeeeeCceEEE-EEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLY-RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy-~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|.+.+.||+|+||+|| .+...|+.||||++...     ....+.+|+.+|+++ +||||+++++++.....+|+|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            345667889999999996 45567899999998753     235678899999887 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhhccc------CChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-------------CcEE
Q 010680          299 FMSGGSVYDYLHKLKGV------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------EVVK  359 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~------l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~-------------~~vk  359 (504)
                      |++ |+|.+++......      .++..++.++.||+.||.|||++||+||||||+|||++.+             ..+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            995 6999999763221      1333567899999999999999999999999999999754             4899


Q ss_pred             EEeeccceeccCCCc-----cccCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 010680          360 VADFGVARVKAQSGV-----MTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA  426 (504)
Q Consensus       360 L~DFGla~~~~~~~~-----~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~  426 (504)
                      |+|||+++.......     .....||+.|+|||++.+       ..++.++|||||||++|||++ |..||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            999999987654321     234579999999999965       678999999999999999999 9999976654432


Q ss_pred             HHHHHhcCCCCC-C----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          427 AVGVVQKGLRPT-I----PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       427 ~~~v~~~~~~p~-~----p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                        .+........ .    +..+++++.+||.+||+.||.+|||+.++++
T Consensus       249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              2232222211 1    1234688999999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.5e-40  Score=328.23  Aligned_cols=232  Identities=13%  Similarity=0.166  Sum_probs=193.1

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      +-..+|++.+.||+|+||.||+|.+.  ++.||||+++..... ......+.+|+.++++++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44467999999999999999999986  788999999876543 455678999999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV  374 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  374 (504)
                      +||||++|++|.+++..  + .....+..++.||+.||.|||++||+||||||+|||++.++.+||+++|          
T Consensus       108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999954  3 3556788999999999999999999999999999999999999998543          


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCCcHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV---GVVQKGLRP--TIPKNSQPKLAE  449 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~---~v~~~~~~p--~~p~~~~~~l~~  449 (504)
                               |++       +++.++|||||||++|+|++|+.||...+..+...   ........+  ..+..+++++.+
T Consensus       175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                     333       37999999999999999999999998765432110   001111110  133578999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          450 LLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +|.+||+.||.+| |+.++++.|+++....
T Consensus       239 li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999 9999999999886543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-40  Score=348.18  Aligned_cols=242  Identities=17%  Similarity=0.194  Sum_probs=189.0

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC-CCc--------------
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNV--------------  280 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~H-pnI--------------  280 (504)
                      ....|++++.||+|+||.||+|++.  ++.||||+++.... .....+.+.+|+.+++.++| +|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456889999999999999999986  88999999984332 23345778999999999987 221              


Q ss_pred             -------eEEEEeeeC-----CCCceeEEEecCCCchHHHHHhh------cccCChHHHHHHHHHHHHHHHHHHHCCcee
Q 010680          281 -------VQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIH  342 (504)
Q Consensus       281 -------v~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiH  342 (504)
                             ..++.++..     ...++++|+++ +++|.+++...      .+.+++..++.++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                   111111111     22457777776 78999998532      455788899999999999999999999999


Q ss_pred             ccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCCCCccCcccc----------cCCCCCchhHHHHHHHHHHHHH
Q 010680          343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----------EHKPYDHKADVFSFGIVLWELL  412 (504)
Q Consensus       343 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~ksDVwSlGvvL~eLl  412 (504)
                      |||||+|||++.++.+||+|||+++.....  ....+| +.|+|||++          ....|+.++|||||||++|||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999865543  455678 999999999          6667899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          413 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       413 tG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +|+.||...+..+....+..      ....+++++.+||.+||+.||.+||++.++++
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999987654332222111      22467899999999999999999999888754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.4e-39  Score=322.13  Aligned_cols=222  Identities=23%  Similarity=0.414  Sum_probs=181.1

Q ss_pred             Cceeee-eeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHH-HhcCCCCceEEEEeeeC----CCC
Q 010680          221 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS  292 (504)
Q Consensus       221 ~~~~i~-~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~~~  292 (504)
                      .+|.+. +.||+|+||.||++.+  .++.||||+++..       ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            456666 7899999999999988  4678999999743       3567888887 66689999999999876    667


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~  368 (504)
                      +++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            899999999999999998743 36999999999999999999999999999999999999998   78899999999864


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCC----CC
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIP----KN  442 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~p~~p----~~  442 (504)
                      ..                     +..|+.++|||||||++|+|++|..||.................  ....+    ..
T Consensus       170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (299)
T 3m2w_A          170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  228 (299)
T ss_dssp             CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTT
T ss_pred             cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhccc
Confidence            33                     24578899999999999999999999987655433222111111  11122    56


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            8899999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=360.88  Aligned_cols=244  Identities=20%  Similarity=0.251  Sum_probs=201.8

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC---
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS---  292 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---  292 (504)
                      -..+|++.++||+|+||.||+|.+.   ++.||||++... ........+.+|+.++++++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            3478999999999999999999884   678999998754 234556788999999999999999999999987665   


Q ss_pred             --ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          293 --LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       293 --~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                        .||||||++|++|.+++..   .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence              6999999999999988754   79999999999999999999999999999999999999985 89999999998765


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLAE  449 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~-~p~~~~~~l~~  449 (504)
                      ..   ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.....         ...... .....++.+.+
T Consensus       233 ~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~  299 (681)
T 2pzi_A          233 SF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGR  299 (681)
T ss_dssp             CC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHH
T ss_pred             cC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHH
Confidence            43   456799999999999765 48999999999999999999999864211         011000 01123578999


Q ss_pred             HHHHhhhcCCCCCC-CHHHHHHHHHHHHHHhc
Q 010680          450 LLERCWQQDPALRP-DFSEIIEILQQIAKEVG  480 (504)
Q Consensus       450 Ll~~cl~~dP~~RP-s~~ell~~L~~l~~~~~  480 (504)
                      +|.+||+.||.+|| ++.++...|..++.+..
T Consensus       300 li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  331 (681)
T 2pzi_A          300 LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV  331 (681)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred             HHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence            99999999999999 57778888888877653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.4e-40  Score=361.36  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC------CCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~  292 (504)
                      .+|++.++||+|+||.||+|.+  .++.||||+++.. ........+.+|+.++++++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            5789999999999999999987  4788999998865 345556789999999999999999999998765      677


Q ss_pred             ceeEEEecCCCchHHHHHhhcc--cCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEEeeccce
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVAR  367 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~---vkL~DFGla~  367 (504)
                      .|+||||++|++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            8999999999999999986432  6899999999999999999999999999999999999997664   9999999998


Q ss_pred             eccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------HHhcC---
Q 010680          368 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG----------VVQKG---  434 (504)
Q Consensus       368 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~----------v~~~~---  434 (504)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||...........          .....   
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            87766666677899999999999999999999999999999999999999975432211100          00000   


Q ss_pred             -----CC----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH-----HHHHHHHHH
Q 010680          435 -----LR----PTIPKNSQPKLAELLERCWQQDPALRPDFSEI-----IEILQQIAK  477 (504)
Q Consensus       435 -----~~----p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~el-----l~~L~~l~~  477 (504)
                           ..    ...+..+++.+.++|.+||..||.+|||+.++     .+.+.+++.
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                 00    11223467899999999999999999999884     455555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-40  Score=337.43  Aligned_cols=240  Identities=16%  Similarity=0.237  Sum_probs=191.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC---------CCCceE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR---------HKNVVQ  282 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~------~~~~~~~~~~Ei~iL~~l~---------HpnIv~  282 (504)
                      +..++|++.++||+|+||.||+|+++++.||||+++....      .......+.+|+.+|+.++         ||||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4457899999999999999999999999999999986542      2233467889999999886         778877


Q ss_pred             EEEeee------------------------------CCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHH
Q 010680          283 FIGACT------------------------------KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM  332 (504)
Q Consensus       283 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL  332 (504)
                      +++++.                              ....+||||||+++|++.+.+.+  +.+++..+..++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            777532                              26789999999999987776643  6789999999999999999


Q ss_pred             HHHH-HCCceeccCCCCcEEECCCC--------------------cEEEEeeccceeccCCCccccCCCCCCccCccccc
Q 010680          333 NYLH-QNNIIHRDLKAANLLMDENE--------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE  391 (504)
Q Consensus       333 ~yLH-~~~IiHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~  391 (504)
                      .||| ++||+||||||+|||++.++                    .+||+|||+|+.....    ...||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    8999999999876543    347999999999998


Q ss_pred             CCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCHHHHH-HHHHhcC-CCCC----CCCCCcHHHHHHHHHhhhcCCCCCCC
Q 010680          392 HKPYDHKADVFSFGIV-LWELLTGKLPYEYLTPLQAA-VGVVQKG-LRPT----IPKNSQPKLAELLERCWQQDPALRPD  464 (504)
Q Consensus       392 ~~~~s~ksDVwSlGvv-L~eLltG~~Pf~~~~~~~~~-~~v~~~~-~~p~----~p~~~~~~l~~Ll~~cl~~dP~~RPs  464 (504)
                      +.. +.++|||||+++ .+++++|..||......... ..+.... ....    .+..+++++.+||.+||+.|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            776 999999998777 77788899998543211112 1222111 1111    12357889999999999976     8


Q ss_pred             HHHHH
Q 010680          465 FSEII  469 (504)
Q Consensus       465 ~~ell  469 (504)
                      +.|++
T Consensus       325 a~e~l  329 (336)
T 2vuw_A          325 ATDLL  329 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.7e-33  Score=301.89  Aligned_cols=182  Identities=14%  Similarity=0.125  Sum_probs=131.3

Q ss_pred             eeeeCceEEEEE--EECCccEEEEEecCCCCC--------hHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCCCceeEE
Q 010680          229 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       229 LG~G~fG~Vy~~--~~~g~~VAvK~lk~~~~~--------~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      .+.|++|.+..+  .+.|+.||||++......        ....++|.+|+.+|+++ .|+||++++++++++..+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456666665544  457999999999865322        23456799999999999 6999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      ||++|++|.+++.. .+.++..   +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ...
T Consensus       322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99999999999986 5666653   588999999999999999999999999999999999999999998665443 345


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK  415 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~  415 (504)
                      ..+||+.|||||++.+. +..++|+||+|+++++|.++.
T Consensus       398 t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          398 NLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            56899999999999875 677899999999988775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6e-29  Score=269.95  Aligned_cols=184  Identities=20%  Similarity=0.251  Sum_probs=148.6

Q ss_pred             eeeeeeeeCceEEEEEEECCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          225 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ..++||+|+||.||+|++.++.+++|..........      ..+.+.+|+.+|++++||||+++..++......|||||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            356899999999999999999999998765433221      23558999999999999999954444556667899999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc----
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----  374 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----  374 (504)
                      |++|++|.+++..         +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++.......    
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            9999999999965         5689999999999999999999999999999998  999999999987655322    


Q ss_pred             ----cccCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 010680          375 ----MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYE  419 (504)
Q Consensus       375 ----~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~  419 (504)
                          .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                134579999999999977  678889999999999988888777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=5.2e-25  Score=219.70  Aligned_cols=146  Identities=15%  Similarity=0.146  Sum_probs=116.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCCh----------------HHHHHHHHHHHHHHhcCCCCceEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS----------------DMQKEFAQEVFIMRKVRHKNVVQF  283 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~~----------------~~~~~~~~Ei~iL~~l~HpnIv~l  283 (504)
                      ..|.+++.||+|+||.||+|.+ .++.||||+++......                .....+.+|+.+|++++|++++. 
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~-  168 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK-  168 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC-
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe-
Confidence            3466789999999999999998 46789999997543211                13567899999999999544444 


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                        ++.. +..|+||||++|++|.+ +.       ......++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus       169 --~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          169 --VYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             --EEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             --EEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence              3333 56799999999999988 42       234557999999999999999999999999999999 999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCccccc
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIE  391 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~  391 (504)
                      |+++.            +..++|||.+.
T Consensus       237 G~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHH
T ss_pred             CCCeE------------CCCCCHHHHHH
Confidence            99963            34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=3.2e-21  Score=189.45  Aligned_cols=138  Identities=16%  Similarity=0.198  Sum_probs=109.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEE--CCcc--EEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhc
Q 010680          222 HLKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINS----------------------DMQKEFAQEVFIMRKV  275 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~--~g~~--VAvK~lk~~~~~~----------------------~~~~~~~~Ei~iL~~l  275 (504)
                      -|.+.+.||+|+||.||+|.+  .|+.  ||||+++......                      .....+.+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999988  7888  9999986542111                      1123678899999999


Q ss_pred             CCCC--ceEEEEeeeCCCCceeEEEecCC-C----chHHHHHhhcccCChHHHHHHHHHHHHHHHHHH-HCCceeccCCC
Q 010680          276 RHKN--VVQFIGACTKPPSLCIVTEFMSG-G----SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKA  347 (504)
Q Consensus       276 ~Hpn--Iv~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~~IiHrDLkp  347 (504)
                      .|++  ++.+++.    ...+|||||+.+ |    +|.++...    .++..+..++.||+.||.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            9875  4555543    357899999942 3    66665432    345678899999999999999 99999999999


Q ss_pred             CcEEECCCCcEEEEeeccceec
Q 010680          348 ANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       348 ~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=1.9e-18  Score=179.12  Aligned_cols=137  Identities=16%  Similarity=0.215  Sum_probs=101.4

Q ss_pred             eeeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCC---------------hH-----HHHHHHHHHHHHHhcCCCCc-
Q 010680          223 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN---------------SD-----MQKEFAQEVFIMRKVRHKNV-  280 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~---------------~~-----~~~~~~~Ei~iL~~l~HpnI-  280 (504)
                      |.++++||.|+||.||+|.. .|+.||||+++....+               ..     .......|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            78889999999999999986 5788999998753211               00     01112356777777765443 


Q ss_pred             -eEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---
Q 010680          281 -VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---  356 (504)
Q Consensus       281 -v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~---  356 (504)
                       ...++.    ...+|||||++|++|.++.       ..+....++.||+.+|.|||++|||||||||.|||+++++   
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence             333332    1347999999998886543       2234567889999999999999999999999999998776   


Q ss_pred             -------cEEEEeeccceecc
Q 010680          357 -------VVKVADFGVARVKA  370 (504)
Q Consensus       357 -------~vkL~DFGla~~~~  370 (504)
                             .+.|+||+-+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                   38999999886433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1e-12  Score=128.04  Aligned_cols=139  Identities=12%  Similarity=0.084  Sum_probs=112.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEec
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      .|++...++.|+++.||+....++.+++|+........  ...+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            46777788889999999998878899999987532111  235788999999985 677889999988888899999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  337 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-------------------------------------------  337 (504)
                      +|.+|.+.+.      +......++.+++.+|..||+                                           
T Consensus        93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999887531      223345788999999999998                                           


Q ss_pred             ----------------CCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          338 ----------------NNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       338 ----------------~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                                      ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                            4589999999999998766678999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.9e-11  Score=117.74  Aligned_cols=132  Identities=12%  Similarity=0.135  Sum_probs=97.4

Q ss_pred             eeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEeeeCCCCceeEEEe
Q 010680          223 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       223 ~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~  299 (504)
                      +.+....+.|..+.||+.... |+.+++|+.....     ...+.+|+.+++.+.+.+  +++++++....+..++||||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            333333345667999999764 5679999976541     234678999999987544  56788888887788999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN----------------------------------------  339 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~----------------------------------------  339 (504)
                      ++|.+|.  ...    ..   ...++.+++..|..||+..                                        
T Consensus        97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  211    11   2356677777777777643                                        


Q ss_pred             ------------------ceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          340 ------------------IIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       340 ------------------IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                                        ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              99999999999998876677999999854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=4.3e-11  Score=122.18  Aligned_cols=140  Identities=14%  Similarity=0.242  Sum_probs=107.4

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEec--CCCCChHHHHHHHHHHHHHHhcC--CCCceEEEEeeeCC---CCceeEEE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKP---PSLCIVTE  298 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk--~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~~lV~E  298 (504)
                      .+.|+.|.++.||+.+..+..+++|+..  ..... .....+.+|+.+++.+.  +..+++++.++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4578999999999999888889999876  43211 12346788999999997  45688899988776   45789999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-----------------------------------------  337 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-----------------------------------------  337 (504)
                      |++|..+.+..   ...++......++.+++..|..||+                                         
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998875421   2346777888899999999999997                                         


Q ss_pred             -----------------CCceeccCCCCcEEECCCCc--EEEEeeccceec
Q 010680          338 -----------------NNIIHRDLKAANLLMDENEV--VKVADFGVARVK  369 (504)
Q Consensus       338 -----------------~~IiHrDLkp~NILl~~~~~--vkL~DFGla~~~  369 (504)
                                       ..++|+|+++.|||++.++.  +.|+||+.+...
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             36899999999999997653  699999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=9.4e-11  Score=116.96  Aligned_cols=182  Identities=18%  Similarity=0.210  Sum_probs=124.0

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCC--ceEEEEeeeCCC---CceeEEEec
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKN--VVQFIGACTKPP---SLCIVTEFM  300 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~  300 (504)
                      +.++.|.+..||+..   +.+++|+....    .....+.+|+.+|+.+. +..  +++++.......   ..|+|||++
T Consensus        26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            358999999999853   67999996532    34567889999999884 322  556666654433   347899999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-------------------------------------------  337 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-------------------------------------------  337 (504)
                      +|.+|.+...   ..++......++.+++..+..||+                                           
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9998875432   346777777888888888888886                                           


Q ss_pred             ---------------CCceeccCCCCcEEECC--CCcEEEEeeccceeccCCCccccCCCCCCccCccccc----C-CCC
Q 010680          338 ---------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE----H-KPY  395 (504)
Q Consensus       338 ---------------~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~----~-~~~  395 (504)
                                     ..++|+|++|.||+++.  .+.+.|+||+.+.................-..|+...    . ...
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                           13799999999999998  5668999999987654321111100000002232211    0 001


Q ss_pred             ---------CchhHHHHHHHHHHHHHhCCCCC
Q 010680          396 ---------DHKADVFSFGIVLWELLTGKLPY  418 (504)
Q Consensus       396 ---------s~ksDVwSlGvvL~eLltG~~Pf  418 (504)
                               ....+.|+++.++|.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     12368999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=3.5e-07  Score=91.37  Aligned_cols=133  Identities=17%  Similarity=0.165  Sum_probs=93.1

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---CceEEEEeee-CCCCceeEEEecCC
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACT-KPPSLCIVTEFMSG  302 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~g  302 (504)
                      +.++.|....||+.   +..+++|+-..    ......+.+|+.+|+.+.+.   .+++++.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788999999987   78899998532    33456788999999999752   3667777764 44567899999999


Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------------------------------------------  338 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------------------------------------------  338 (504)
                      .+|.+..-   ..++......++.++...|..||+.                                            
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88876321   1223333344444444444444431                                            


Q ss_pred             ----------------CceeccCCCCcEEECC---CCc-EEEEeeccceec
Q 010680          339 ----------------NIIHRDLKAANLLMDE---NEV-VKVADFGVARVK  369 (504)
Q Consensus       339 ----------------~IiHrDLkp~NILl~~---~~~-vkL~DFGla~~~  369 (504)
                                      .++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            4699999999999987   355 589999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.52  E-value=1.2e-06  Score=84.96  Aligned_cols=132  Identities=17%  Similarity=0.229  Sum_probs=93.9

Q ss_pred             eeeeeCce-EEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSYG-DLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG-~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      .+..|..| .||+....  +..+++|+-...     ....+.+|..+|+.+.. --+.+++.++...+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45556665 58987653  457999986533     34568889999998852 23678888888888899999999998


Q ss_pred             chHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 010680          304 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------------------------------------------  338 (504)
Q Consensus       304 sL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------------------------------------------  338 (504)
                      ++.+....     .......+..++...|.-||+.                                             
T Consensus       106 ~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            88765532     1122233444555555555521                                             


Q ss_pred             -------------CceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          339 -------------NIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       339 -------------~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                                   .++|+|+.+.|||++.++.+-|+||+.+...
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                         2799999999999998877789999998643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=4.8e-07  Score=91.79  Aligned_cols=79  Identities=14%  Similarity=0.084  Sum_probs=55.8

Q ss_pred             eeee-eeeCceEEEEEEEC--------CccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCC---CCceEEEEeeeCC
Q 010680          226 GSKV-ASGSYGDLYRGTYC--------SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKP  290 (504)
Q Consensus       226 ~~~L-G~G~fG~Vy~~~~~--------g~~VAvK~lk~~~---~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~  290 (504)
                      .+.| +.|....+|+.+..        +..+++|+.....   ...  ...+.+|+.+|+.+..   -.+++++.++...
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            4567 78888999998765        6779999865432   100  1346778888888853   3577888887655


Q ss_pred             ---CCceeEEEecCCCchH
Q 010680          291 ---PSLCIVTEFMSGGSVY  306 (504)
Q Consensus       291 ---~~~~lV~E~~~ggsL~  306 (504)
                         +..++||||++|.++.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.29  E-value=5.2e-06  Score=82.91  Aligned_cols=135  Identities=19%  Similarity=0.229  Sum_probs=80.0

Q ss_pred             eeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEe------eeCCCCceeEEE
Q 010680          227 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGA------CTKPPSLCIVTE  298 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~------~~~~~~~~lV~E  298 (504)
                      +.|+.|..+.||+....+..+++|+....   .   ..+..|+.+++.|..  -.+++++..      ....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            35666788999999877777999998752   1   233445566655531  133444431      123456789999


Q ss_pred             ecCCCchH-----------H---HHHhhcccC-------------ChHH-------------------------------
Q 010680          299 FMSGGSVY-----------D---YLHKLKGVF-------------KLPS-------------------------------  320 (504)
Q Consensus       299 ~~~ggsL~-----------~---~l~~~~~~l-------------~~~~-------------------------------  320 (504)
                      |++|.++.           .   .++.....+             .+..                               
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542           1   122211111             1100                               


Q ss_pred             HHHHHHHHHHHHHHHHH-------------CCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          321 LLKVAIDVSKGMNYLHQ-------------NNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       321 ~~~i~~qI~~gL~yLH~-------------~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      +..+..++..++.+|+.             ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11111234445666652             579999999999999888899999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.21  E-value=5.3e-06  Score=85.49  Aligned_cols=76  Identities=12%  Similarity=-0.017  Sum_probs=49.9

Q ss_pred             eeeeeeeCceEEEEEEE--CCccEEEEEecCCCC--Ch---HHHHHHHHHHHHHHhcCC--C-CceEEEEeeeCCCCcee
Q 010680          226 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NS---DMQKEFAQEVFIMRKVRH--K-NVVQFIGACTKPPSLCI  295 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~--~~---~~~~~~~~Ei~iL~~l~H--p-nIv~l~~~~~~~~~~~l  295 (504)
                      .+.||.|.++.||+++.  .++.++||...+...  ..   .....+..|..+|+.+..  + .+++++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            35789999999999954  467899998764321  00   112456778888888753  3 455666543  345689


Q ss_pred             EEEecCCC
Q 010680          296 VTEFMSGG  303 (504)
Q Consensus       296 V~E~~~gg  303 (504)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.88  E-value=0.00015  Score=68.61  Aligned_cols=137  Identities=15%  Similarity=0.169  Sum_probs=97.1

Q ss_pred             CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCCC
Q 010680          303 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT  381 (504)
Q Consensus       303 gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~gt  381 (504)
                      .||.+.|...+.++++.++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ +.+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            48999999999999999999999999999887622 2222344567899999999888764 2111           122


Q ss_pred             CCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC---
Q 010680          382 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD---  458 (504)
Q Consensus       382 ~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~d---  458 (504)
                      ..+.|||... ...+.+.=|||||++||.-+-                   -++.+..+..+++.|..||..|..-.   
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d~  160 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVEAD  160 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC--
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhccccc
Confidence            3456888763 345688999999999998865                   23445566789999999999997652   


Q ss_pred             ----------------------CCCCCCHHHHHHH
Q 010680          459 ----------------------PALRPDFSEIIEI  471 (504)
Q Consensus       459 ----------------------P~~RPs~~ell~~  471 (504)
                                            +..|+++++|++.
T Consensus       161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             ------------------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccccccccccccCcCCHHHHHHH
Confidence                                  3578889888654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.83  E-value=6.1e-05  Score=78.30  Aligned_cols=78  Identities=15%  Similarity=0.197  Sum_probs=48.5

Q ss_pred             HHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccCCC--CCCccCcccccCCC---CCchhHHHHHHHHHHH
Q 010680          336 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP---YDHKADVFSFGIVLWE  410 (504)
Q Consensus       336 H~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~g--t~~y~APE~l~~~~---~s~ksDVwSlGvvL~e  410 (504)
                      +...++|+|++|.|||++.++ ++|+||+.+..............  ...|++|+......   -....++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            346799999999999999876 99999999875442211111010  13455665543211   1123555677778887


Q ss_pred             HHhC
Q 010680          411 LLTG  414 (504)
Q Consensus       411 LltG  414 (504)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=8e-05  Score=74.72  Aligned_cols=75  Identities=16%  Similarity=0.129  Sum_probs=61.1

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEEeeeCCCCceeEEEecCC
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFMSG  302 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~g  302 (504)
                      .+.|+.|.+..+|+.+..+..+++|+....     ....+..|+..|+.|.   ...+++++.++...+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            357899999999999877888999987643     2466888999998885   35688899888877889999999998


Q ss_pred             Cch
Q 010680          303 GSV  305 (504)
Q Consensus       303 gsL  305 (504)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.58  E-value=0.00021  Score=71.47  Aligned_cols=137  Identities=15%  Similarity=0.115  Sum_probs=73.7

Q ss_pred             eeeeeCceE-EEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSYGD-LYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~fG~-Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      .|+.|.... +|+.+.. +..+++|...+...     ..+..|+.+++.+..  -.+++++.+....+  +++||++++.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            454454443 6676653 66677776543310     223456777776653  23567777644333  7899999776


Q ss_pred             chHHHHHhhc-------------------------ccCChHHHH-------H-H------------HHHHHHHHHHH---
Q 010680          304 SVYDYLHKLK-------------------------GVFKLPSLL-------K-V------------AIDVSKGMNYL---  335 (504)
Q Consensus       304 sL~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~qI~~gL~yL---  335 (504)
                      ++.+++....                         ..+......       . +            ...+...+..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            7655442110                         001111100       0 0            01112223333   


Q ss_pred             ---HHCCceeccCCCCcEEECCC----CcEEEEeeccceeccC
Q 010680          336 ---HQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ  371 (504)
Q Consensus       336 ---H~~~IiHrDLkp~NILl~~~----~~vkL~DFGla~~~~~  371 (504)
                         +...++|+|+.+.|||++.+    +.+.|+||+.+.....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence               13469999999999999875    6899999999876543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.54  E-value=0.00033  Score=69.17  Aligned_cols=134  Identities=18%  Similarity=0.217  Sum_probs=76.9

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEEEec-CCC
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFM-SGG  303 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~gg  303 (504)
                      .+.|+.|....+|+.    +.+++|+.......   .....+|+.+++.+...++ +++++..  +..-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            467889999999998    77999987653111   1123457877777753233 5666554  33457899999 765


Q ss_pred             chHHH------------------HHhhcccCC----h-HHHHHHHH--------------HHHHHHHHHH----H----C
Q 010680          304 SVYDY------------------LHKLKGVFK----L-PSLLKVAI--------------DVSKGMNYLH----Q----N  338 (504)
Q Consensus       304 sL~~~------------------l~~~~~~l~----~-~~~~~i~~--------------qI~~gL~yLH----~----~  338 (504)
                      +|...                  ++.....+.    . ..+..+..              .+...+..|.    .    .
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            55321                  111111111    0 11111111              1111122221    1    2


Q ss_pred             CceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          339 NIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       339 ~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      .++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            4899999999999 55667899999988644

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.00014  Score=72.23  Aligned_cols=139  Identities=14%  Similarity=0.162  Sum_probs=80.8

Q ss_pred             eeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEee------eCCCCceeEE
Q 010680          226 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGAC------TKPPSLCIVT  297 (504)
Q Consensus       226 ~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~------~~~~~~~lV~  297 (504)
                      .+.|+.|....+|+....+..+++|+......    ...+..|+.+++.+...+  +++++...      ...+..+++|
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            45678888899999987777899999875311    134556777777775322  33444221      1124568899


Q ss_pred             EecCCCchHH-----------H---HHhhcccC--------C---hHHHHH------------HHHHHHHHHHHHHH---
Q 010680          298 EFMSGGSVYD-----------Y---LHKLKGVF--------K---LPSLLK------------VAIDVSKGMNYLHQ---  337 (504)
Q Consensus       298 E~~~ggsL~~-----------~---l~~~~~~l--------~---~~~~~~------------i~~qI~~gL~yLH~---  337 (504)
                      +|++|..+..           .   ++.....+        .   +.....            +...+...++.++.   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865321           1   12111111        1   111000            01124445566653   


Q ss_pred             ----CCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          338 ----NNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       338 ----~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                          .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                3699999999999999876668999998853

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.39  E-value=0.0016  Score=63.77  Aligned_cols=78  Identities=14%  Similarity=0.106  Sum_probs=55.6

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CCceEEEEeeeCCCCceeEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++.-.+.+|.|..+.||+.+.. |+.|.+|+........  ...|..|+..|+.|.-   --+++++++.    .-++||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            4455678999999999999874 7889999866443221  2357789999998852   2356666653    247899


Q ss_pred             EecCCCch
Q 010680          298 EFMSGGSV  305 (504)
Q Consensus       298 E~~~ggsL  305 (504)
                      ||+.++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.23  E-value=0.0011  Score=69.18  Aligned_cols=71  Identities=13%  Similarity=0.270  Sum_probs=49.3

Q ss_pred             eeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeE
Q 010680          227 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIV  296 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV  296 (504)
                      +.|+.|....+|+....         ++.+++|+..... .   ...+..|..+++.+...++ +++++.+.+    .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            56888888999999874         3679999974321 1   1345579998888864333 677776543    389


Q ss_pred             EEecCCCch
Q 010680          297 TEFMSGGSV  305 (504)
Q Consensus       297 ~E~~~ggsL  305 (504)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987444

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0012  Score=67.06  Aligned_cols=72  Identities=13%  Similarity=0.180  Sum_probs=44.6

Q ss_pred             eeeeeeCceEEEEEEECC----------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCCCcee
Q 010680          227 SKVASGSYGDLYRGTYCS----------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCI  295 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g----------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~l  295 (504)
                      +.|+.|..-.+|+....+          ..+++|+.....   ........|..+++.+...+ ++++++...    -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence            467888888999988754          678888865431   11112356888888876434 456776542    368


Q ss_pred             EEEecCCCch
Q 010680          296 VTEFMSGGSV  305 (504)
Q Consensus       296 V~E~~~ggsL  305 (504)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988644

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.89  E-value=0.0037  Score=64.28  Aligned_cols=135  Identities=13%  Similarity=0.196  Sum_probs=80.3

Q ss_pred             eeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeE
Q 010680          227 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.|.-|....+|+.+..         ++.+.+|+.....   .....+.+|..+++.+. +.-.+++++.+.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            45666778888888763         3678888853211   12345568999998885 3334677776654    289


Q ss_pred             EEecCCCchHH--------------HH---Hhhcc----cC--ChHHHHHHHHHHHH-------------------HHHH
Q 010680          297 TEFMSGGSVYD--------------YL---HKLKG----VF--KLPSLLKVAIDVSK-------------------GMNY  334 (504)
Q Consensus       297 ~E~~~ggsL~~--------------~l---~~~~~----~l--~~~~~~~i~~qI~~-------------------gL~y  334 (504)
                      |||++|.+|..              .|   +...-    ..  -+..+.++..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99999865531              11   11111    11  12344445444322                   2333


Q ss_pred             HH----H----CCceeccCCCCcEEECCC----CcEEEEeecccee
Q 010680          335 LH----Q----NNIIHRDLKAANLLMDEN----EVVKVADFGVARV  368 (504)
Q Consensus       335 LH----~----~~IiHrDLkp~NILl~~~----~~vkL~DFGla~~  368 (504)
                      |.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    2    258999999999999876    7899999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.83  E-value=0.0055  Score=60.70  Aligned_cols=136  Identities=15%  Similarity=0.153  Sum_probs=78.2

Q ss_pred             eeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEEe-----eeCCCCceeEEEe
Q 010680          228 KVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA-----CTKPPSLCIVTEF  299 (504)
Q Consensus       228 ~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~E~  299 (504)
                      .|+ |....||+.... |+.+++|+..+.....   ..+..|..+++.+....  +++++..     ....+..+++|+|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            455 778889988754 5579999987543332   45566888888775322  3444443     1112345789999


Q ss_pred             cCCCchH-----H------H---HHhhcc--------cCChHHH----HHH---------------HHHHHHHHHHHH--
Q 010680          300 MSGGSVY-----D------Y---LHKLKG--------VFKLPSL----LKV---------------AIDVSKGMNYLH--  336 (504)
Q Consensus       300 ~~ggsL~-----~------~---l~~~~~--------~l~~~~~----~~i---------------~~qI~~gL~yLH--  336 (504)
                      ++|.++.     .      .   ++....        .+.....    ..+               ...+-..++.+.  
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875432     1      1   111110        1111110    001               111112223332  


Q ss_pred             -----HCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          337 -----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       337 -----~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                           ...++|+|+++.|||++ + .+.|+||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                 23589999999999999 4 8999999988644

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.78  E-value=0.0083  Score=63.18  Aligned_cols=72  Identities=19%  Similarity=0.155  Sum_probs=48.1

Q ss_pred             eeeeeeCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEEEecCCC
Q 010680          227 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~g--~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      +.|+.|-...+|+....+  ..+++|+.......   ...-.+|..+++.|...++ +++++.+..    .+||||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence            578888899999999876  78999987543111   0112478889998875444 567777632    3699999885


Q ss_pred             ch
Q 010680          304 SV  305 (504)
Q Consensus       304 sL  305 (504)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.52  E-value=0.0056  Score=61.62  Aligned_cols=33  Identities=21%  Similarity=0.412  Sum_probs=28.7

Q ss_pred             CCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       338 ~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      ..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            368999999999999988889999999886543

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=96.39  E-value=0.0045  Score=57.14  Aligned_cols=64  Identities=17%  Similarity=0.277  Sum_probs=52.9

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV  174 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~  174 (504)
                      +.|++.+.|+|+++++++.+|++.|+||.++..|.+.+++.+ .++|+. +....++++++|.+..
T Consensus         7 ~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~~~   70 (192)
T 1u8s_A            7 LVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPLLG   70 (192)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHHHH
T ss_pred             EEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHHHH
Confidence            579999999999999999999999999999999998888888 555553 3346677777777644

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.79  E-value=0.02  Score=59.71  Aligned_cols=72  Identities=13%  Similarity=0.186  Sum_probs=47.0

Q ss_pred             eeeeeeCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeCCCCceeE
Q 010680          227 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~---------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV  296 (504)
                      +.|..|....+|+....         ++.+++++.....   .......+|..+++.+.. .-.+++++.+.    -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            46667888889998876         5779999864421   111123468888887753 33456665442    3789


Q ss_pred             EEecCCCch
Q 010680          297 TEFMSGGSV  305 (504)
Q Consensus       297 ~E~~~ggsL  305 (504)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998664

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=95.46  E-value=0.014  Score=54.22  Aligned_cols=47  Identities=11%  Similarity=0.298  Sum_probs=42.9

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      ..|++++.|+|++.++++.+|++.|+||.++..|.+.++|.+ .+.|+
T Consensus         6 ~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~   52 (195)
T 2nyi_A            6 FVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS   52 (195)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred             EEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence            589999999999999999999999999999999999999999 44454

>1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7

Probab=95.41  E-value=0.033  Score=44.43  Aligned_cols=67  Identities=22%  Similarity=0.219  Sum_probs=52.2

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK  176 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~  176 (504)
                      ..+++.+.|+|++++.++.+|++.|.||.....+..- |...-.+.++.-.....+++.++|++....
T Consensus         6 ~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~~   72 (91)
T 1zpv_A            6 AIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQT   72 (91)
T ss_dssp             EEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred             EEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHHH
Confidence            5799999999999999999999999999998887654 655544555433345778888888765444

>2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A

Probab=93.68  E-value=0.086  Score=41.42  Aligned_cols=62  Identities=16%  Similarity=0.147  Sum_probs=42.7

Q ss_pred             ceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHH
Q 010680          108 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL  170 (504)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l  170 (504)
                      -..+.+...|+|++|.++++++++.|.||......... +....++.++.-..+..+++.+++
T Consensus         5 ~~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L   66 (88)
T 2ko1_A            5 LAGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAKD-GIFTCNLMIFVKNTDKLTTLMDKL   66 (88)
T ss_dssp             EEEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEECS-SEEEEEEEEEESSHHHHHHHHHHH
T ss_pred             EEEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEcC-CEEEEEEEEEECCHHHHHHHHHHH
Confidence            34788899999999999999999999999987775543 344444444443333444444433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.49  E-value=0.24  Score=50.76  Aligned_cols=30  Identities=23%  Similarity=0.462  Sum_probs=25.6

Q ss_pred             ceeccCCCCcEEE------CCCCcEEEEeeccceec
Q 010680          340 IIHRDLKAANLLM------DENEVVKVADFGVARVK  369 (504)
Q Consensus       340 IiHrDLkp~NILl------~~~~~vkL~DFGla~~~  369 (504)
                      ++|+|+.+.|||+      ++++.++++||..|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            6899999999999      45678999999998643

>2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria}

Probab=91.69  E-value=0.18  Score=46.44  Aligned_cols=69  Identities=19%  Similarity=0.089  Sum_probs=48.8

Q ss_pred             cceeeeeecCChhhHHHHHHHHHhhccccceeccccccC------CCceeeeEeecCCChhhHHHHHHHHHHHHHHh
Q 010680          107 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL  177 (504)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~------dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~~  177 (504)
                      .-+-+++++.|+|++++.++.+|++.|+||.++..+..-      +-|.+.+. ++.-.... ++|+++|.....++
T Consensus        92 ~~~iltv~g~DrpGiva~Vt~~La~~g~nI~~~~~~t~~~~~~~~~~F~m~~~-~~~~~~~~-~~l~~~l~~~a~~l  166 (195)
T 2nyi_A           92 REYELYVEGPDSEGIVEAVTAVLAKKGANIVELETETLPAPFAGFTLFRMGSR-VAFPFPLY-QEVVTALSRVEEEF  166 (195)
T ss_dssp             EEEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEEECSSTTCEEEEEEEE-EEEEGGGH-HHHHHHHHHHHHHH
T ss_pred             cEEEEEEEeCCCcCHHHHHHHHHHHcCCCEEEceeeecccccCCCCeEEEEEE-EEcCCCcc-HHHHHHHHHHHHHc
Confidence            446799999999999999999999999999999888543      22222222 22112234 77888887655443

>2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6

Probab=91.35  E-value=0.39  Score=43.16  Aligned_cols=63  Identities=21%  Similarity=0.187  Sum_probs=50.2

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCC-CceeeeEeecCCChhhHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK  172 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~d-g~~ldv~~v~~~~~~~~~~l~~~l~~  172 (504)
                      |.|.+-..|+|++|++++.++++-|.||.-..+..|-+ |.+-=.++|+ ...+..+++..++.+
T Consensus         4 ~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~-~d~~~leqI~kqL~K   67 (164)
T 2f1f_A            4 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTV-GDEKVLEQIEKQLHK   67 (164)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEE-SCHHHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEe-ccHHHHHHHHHHHcC
Confidence            78888899999999999999999999999988887775 7777777887 334455555555543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.33  E-value=0.014  Score=61.43  Aligned_cols=60  Identities=8%  Similarity=0.035  Sum_probs=16.5

Q ss_pred             eeeeeeeeCceEEEEEEECC--ccEEE------EEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          225 FGSKVASGSYGDLYRGTYCS--QDVAI------KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~~g--~~VAv------K~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      +.++||   ||.||+|.+.+  .+|||      |.++......+....|.+|..+++.++|||+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            345676   99999999875  47898      77776555555566788999999999999999988754

>1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5

Probab=89.01  E-value=0.72  Score=42.06  Aligned_cols=70  Identities=16%  Similarity=0.153  Sum_probs=50.2

Q ss_pred             cceeeeeecCChhhHHHHHHHHHhhccccceeccccccC--------CCceeeeEeecCCChhhHHHHHHHHHHHHHHh
Q 010680          107 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV--------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL  177 (504)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~--------dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~~  177 (504)
                      ..+-+++.+.|+|+++..++.+|++.|+||.++..|..-        +-|...+ .++.-...+.++|+++|.....++
T Consensus        92 ~~~~l~v~~~D~~Gil~~v~~~l~~~~~nI~~~~~~t~~~~~~~~~~~~F~~~~-~~~~~~~~~~~~l~~~l~~~~~~~  169 (192)
T 1u8s_A           92 YTVEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAI-SARVDSGCNLMQLQEEFDALCTAL  169 (192)
T ss_dssp             EEEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEE-EEEECTTSCHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEEeCCCccHHHHHHHHHHHcCCcHHHhhhhcccCCccCCCCCEEEEEE-EEeCCCCCCHHHHHHHHHHHHHHh
Confidence            456899999999999999999999999999999988542        1222222 122212336788888888655543

>2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6

Probab=88.87  E-value=0.72  Score=41.41  Aligned_cols=62  Identities=29%  Similarity=0.402  Sum_probs=48.4

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCC-CceeeeEeecCCChhhHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALE  171 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~d-g~~ldv~~v~~~~~~~~~~l~~~l~  171 (504)
                      |.|.+-..|+|+.|++++.++++-|.||.-..+..|-| |.+-=.++|++ .....+++..++.
T Consensus         5 ~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~~-d~~~leql~kQL~   67 (165)
T 2pc6_A            5 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQITKQLN   67 (165)
T ss_dssp             EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEE-CHHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEec-cHHHHHHHHHHhc
Confidence            78888899999999999999999999999988887774 77776777763 3344445554444

>3obi_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 1.95A {Rhodopseudomonas palustris}

Probab=85.96  E-value=0.85  Score=44.75  Aligned_cols=67  Identities=21%  Similarity=0.260  Sum_probs=49.5

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccC-CCceeeeEeecCCCh--hhHHHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPY--EETEQLRAALEKEVLK  176 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~-dg~~ldv~~v~~~~~--~~~~~l~~~l~~~~~~  176 (504)
                      +-+|+++.|+|++..++|..|++.|.||.+...|.+. .|...=...++ ++.  .+.++|+++|+..-.+
T Consensus         7 ~iLtv~g~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~~~L~~~f~~la~~   76 (288)
T 3obi_A            7 YVLTLSCPDRAGIVSAVSTFLFENGQNILDAQQYNDTESGHFFMRVVFN-AAAKVIPLASLRTGFGVIAAK   76 (288)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEE-ESSCCCCHHHHHHHHHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHHHHHCCCcEEeeeeeecCCCCceEEEEEEE-cCCCCCCHHHHHHHHHHHHHH
Confidence            4699999999999999999999999999999999543 44433333333 333  3578888888754433

>3nrb_A Formyltetrahydrofolate deformylase; N-terminal ACT domain, structural genomics, joint center for structural genomics, JCSG; HET: MSE FLC; 2.05A {Pseudomonas putida}

Probab=84.74  E-value=0.91  Score=44.50  Aligned_cols=64  Identities=22%  Similarity=0.346  Sum_probs=44.9

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccC-CCceeeeEeecCCChhhHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-DGYSLDVFVVDGWPYEETEQLRAALEKE  173 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~-dg~~ldv~~v~~~~~~~~~~l~~~l~~~  173 (504)
                      +=+|+++.|+|++...+|..|++.|.||.+...|.+. .|...=...++ ++....++|+++|+..
T Consensus         8 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~L~~~f~~l   72 (287)
T 3nrb_A            8 YVLSLACQDAPGIVSEVSTFLFNNGANIVEAEQFNDEDSSKFFMRVSVE-IPVAGVNDFNSAFGKV   72 (287)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEE-CCC---CHHHHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHHHHHCCCCEEeeeeeecCCCCeEEEEEEEE-cCCCCHHHHHHHHHHH
Confidence            3589999999999999999999999999999999543 44333333333 2322344777777643

>3n0v_A Formyltetrahydrofolate deformylase; formyl transferase, ACT domain, structural genomics, joint C structural genomics, JCSG; HET: MSE; 2.25A {Pseudomonas putida}

Probab=82.25  E-value=2  Score=42.08  Aligned_cols=65  Identities=15%  Similarity=0.081  Sum_probs=47.3

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceecccccc-CCCceeeeEeecCCChhhHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPYEETEQLRAALEKE  173 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t-~dg~~ldv~~v~~~~~~~~~~l~~~l~~~  173 (504)
                      +-+|+++.|+|++..++|..|++.|.||.+...|.. ..|...=...++.-...+.++|+++|+..
T Consensus         9 ~vLtv~c~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~L~~~f~~l   74 (286)
T 3n0v_A            9 WILTADCPSMLGTVDVVTRYLFEQRCYVTEHHSFDDRQSGRFFIRVEFRQPDDFDEAGFRAGLAER   74 (286)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEECCSSCCHHHHHHHHHHH
T ss_pred             EEEEEEeCCCCCHHHHHHHHHHHCCCCeeeeeeeccCCCCeeEEEEEEecCCCCCHHHHHHHHHHH
Confidence            469999999999999999999999999999999842 23433223333321123577888888754

>3p96_A Phosphoserine phosphatase SERB; ssgcid, structural genomics, structural genomics center for infectious disease, hydrolas; 2.05A {Mycobacterium avium}

Probab=82.03  E-value=1  Score=46.16  Aligned_cols=66  Identities=23%  Similarity=0.316  Sum_probs=48.1

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChh--hHHHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEVLK  176 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~--~~~~l~~~l~~~~~~  176 (504)
                      .=||+++.|+|++.+.++.+|++.|.||.+...+....-|+.-+. |+. +..  ..++|+++|+....+
T Consensus        13 ~~lt~~g~Dr~Giv~~vs~~l~~~~~nI~d~~q~~~~~~f~~~~~-~~~-~~~~~~~~~l~~~l~~~~~~   80 (415)
T 3p96_A           13 VLITVTGVDQPGVTATLFEVLSRHGVELLNVEQVVIRHRLTLGVL-VCC-PADVADGPALRHDVEAAIRK   80 (415)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHTTTTCEEEEEEEEEETTEEEEEEE-EEE-CHHHHTSHHHHHHHHHHHHH
T ss_pred             EEEEEEcCCCCCHHHHHHHHHHHCCCCEEEeeeEEECCEeEEEEE-EEe-cCCcCCHHHHHHHHHHHHHH
Confidence            359999999999999999999999999999988865444444443 332 222  347788888764333

>3o1l_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 2.20A {Pseudomonas syringae PV}

Probab=81.25  E-value=2.1  Score=42.21  Aligned_cols=67  Identities=15%  Similarity=0.182  Sum_probs=49.3

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceecccccc-CCCceeeeEeecCCCh--hhHHHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPY--EETEQLRAALEKEVLK  176 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t-~dg~~ldv~~v~~~~~--~~~~~l~~~l~~~~~~  176 (504)
                      +=+|+++.|+|++...+|..|++.|.||.+...|.. ..|...=...++ ++.  .+.++|+++|+....+
T Consensus        23 ~iLtv~c~DrpGIVa~VS~~La~~g~NI~d~~q~~d~~~g~FfMr~~~~-~~~~~~~~~~L~~~l~~la~~   92 (302)
T 3o1l_A           23 FRLVIACPDRVGIVAKVSNFLASHNGWITEASHHSDNLSGWFFMRHEIR-ADTLPFDLDGFREAFTPIAEE   92 (302)
T ss_dssp             EEEEEEEECCTTHHHHHHHHHHHTTCCEEEEEEEEETTTTEEEEEEEEE-GGGSSSCHHHHHHHHHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHHHHHCCCCEEEeeEEecCCCCeEEEEEEEe-cCCCCCCHHHHHHHHHHHHHH
Confidence            369999999999999999999999999999998853 235433333333 332  3578888888754443

>3lou_A Formyltetrahydrofolate deformylase; structural genomics, JOI for structural genomics, JCSG, protein structure initiative hydrolase; HET: MSE; 1.90A {Burkholderia mallei}

Probab=80.40  E-value=2.2  Score=41.90  Aligned_cols=68  Identities=15%  Similarity=0.139  Sum_probs=48.3

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccc-cCCCceeeeEeecCC--C-hhhHHHHHHHHHHHHHH
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGW--P-YEETEQLRAALEKEVLK  176 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~-t~dg~~ldv~~v~~~--~-~~~~~~l~~~l~~~~~~  176 (504)
                      +-+|+++.|+|++..++|..|++-|.||.+...|. ...|...=...++.-  . ..+.++|+++|+....+
T Consensus        11 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~~~~L~~~f~~la~~   82 (292)
T 3lou_A           11 FVLTLSCPSAAGQVAAVVGLLDRHRCYVDELTVFDDDLSARFFVRCVFHATDDADALRVDALRREFEPIAER   82 (292)
T ss_dssp             EEEEEEEESCSCHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEEECC----CCHHHHHHHHHHHHHH
T ss_pred             EEEEEEcCCCCCHHHHHHHHHHHCCCCEEeeEEEecCCCCceEEEEEEEccCcccCCCHHHHHHHHHHHHHh
Confidence            46999999999999999999999999999999984 223433323333322  1 23577888888764443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.30  E-value=5.3  Score=37.31  Aligned_cols=116  Identities=9%  Similarity=0.080  Sum_probs=76.2

Q ss_pred             CCCCceEEEEeeeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC
Q 010680          276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN  355 (504)
Q Consensus       276 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~  355 (504)
                      .||+++.. .+-...+.+.+.++.-+  +...+-.  -..++....++++.+|+....+++  .-+|--|.|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~--ik~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN--IKSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG--GGGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH--HHhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence            57888865 34455555544444332  2222221  134688889999999998775443  34777899999999999


Q ss_pred             CcEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 010680          356 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE  419 (504)
Q Consensus       356 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~  419 (504)
                      +.+++.-.|+-...                +|.     .++...=+-.+=|++..+++++..|+
T Consensus       116 ~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999887764211                111     23333444568899999999988774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	504
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-91
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-83
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-77
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-77
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-76
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-75
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-74
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-74
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-73
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-73
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-73
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-72
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-72
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-72
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-71
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-71
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-70
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-70
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-70
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-69
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-68
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-67
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-66
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-66
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-65
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-64
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-64
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-63
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-63
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-61
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-61
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-55
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-52
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-51
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-45
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-44
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-43
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-41
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-38
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-17
d1u8sa1	86	d.58.18.5 (A:2-87) putative transcriptional repres	7e-05
d1ygya3	78	d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena	7e-05
d1sc6a3	84	d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena	9e-05
d1y7pa2	77	d.58.18.12 (A:2-78) Hypothetical protein AF1403, N	3e-04
d2pc6a2	77	d.58.18.6 (A:1-77) Acetolactate synthase small sub	8e-04
d1zpva1	83	d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto	8e-04
d2f06a1	71	d.58.18.11 (A:71-141) Hypothetical protein BT0572	0.003
d2fgca2	78	d.58.18.6 (A:27-104) Acetolactate synthase small s	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  278 bits (713), Expect = 1e-91
 Identities = 97/276 (35%), Positives = 160/276 (57%), Gaps = 12/276 (4%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           D WEI    +  G ++ SGS+G +Y+G +   DVA+K+L          + F  EV ++R
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           K RH N++ F+G  T P  L IVT++  G S+Y +LH ++  F++  L+ +A   ++GM+
Sbjct: 60  KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMTAETGTYRWMAPEVI 390
           YLH  +IIHRDLK+ N+ + E+  VK+ DFG+A VK++   S      +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 391 EHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIPKNS 443
             +   PY  ++DV++FGIVL+EL+TG+LPY  +      + +V +G        +  N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 479
              +  L+  C ++    RP F +I+  ++ +A+ +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  256 bits (654), Expect = 5e-83
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 8/262 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           W ++ K LK    +  G +GD+  G Y    VA+K +K    N    + F  E  +M ++
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 276 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 333
           RH N+VQ +G   +    L IVTE+M+ GS+ DYL  + + V     LLK ++DV + M 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           YL  NN +HRDL A N+L+ E+ V KV+DFG+ +  + +          +W APE +  K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
            +  K+DV+SFGI+LWE+ +         PL+  V  V+KG +   P    P + E+++ 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235

Query: 454 CWQQDPALRPDFSEIIEILQQI 475
           CW  D A+RP F ++ E L+ I
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 5e-77
 Identities = 84/262 (32%), Positives = 145/262 (55%), Gaps = 8/262 (3%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDPK L F  ++ +G +G +  G +    DVAIK++K   ++   + EF +E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H+ +VQ  G CTK   + I+TE+M+ G + +YL +++  F+   LL++  DV + M YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKP 394
               +HRDL A N L+++  VVKV+DFG++R                 RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 395 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           +  K+D+++FG+++WE+ + GK+PYE  T  + A   + +GLR   P  +  K+  ++  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 454 CWQQDPALRPDFSEIIEILQQI 475
           CW +    RP F  ++  +  +
Sbjct: 237 CWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 9e-77
 Identities = 86/263 (32%), Positives = 146/263 (55%), Gaps = 6/263 (2%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 276
           IDP  L F  ++ SG +G ++ G + ++D VAIK ++   ++   +++F +E  +M K+ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58

Query: 277 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           H  +VQ  G C +   +C+V EFM  G + DYL   +G+F   +LL + +DV +GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 337 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP 394
           +  +IHRDL A N L+ EN+V+KV+DFG+ R        ++       +W +PEV     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 454
           Y  K+DV+SFG+++WE+ +              V  +  G R   P+ +   + +++  C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 455 WQQDPALRPDFSEIIEILQQIAK 477
           W++ P  RP FS ++  L +IA+
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 2e-76
 Identities = 80/266 (30%), Positives = 143/266 (53%), Gaps = 8/266 (3%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WE+  + LK   ++ +G +G+++ G Y     VA+K LK   ++      F  E  +M
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 331
           ++++H+ +V+     T+ P + I+TE+M  GS+ D+L    G+   +  LL +A  +++G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 389
           M ++ + N IHRDL+AAN+L+ +    K+ADFG+AR+    +           +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
           I +  +  K+DV+SFGI+L E++T              +  +++G R   P N   +L +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 450 LLERCWQQDPALRPDFSEIIEILQQI 475
           L+  CW++ P  RP F  +  +L+  
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 4e-75
 Identities = 93/266 (34%), Positives = 147/266 (55%), Gaps = 8/266 (3%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           D WEI  + L+   K+  G +G+++ GT+     VAIK LKP  ++    + F QE  +M
Sbjct: 10  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVM 66

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 331
           +K+RH+ +VQ     ++ P + IVTE+MS GS+ D+L    G   +LP L+ +A  ++ G
Sbjct: 67  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 389
           M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+    +           +W APE 
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 449
             +  +  K+DV+SFGI+L EL T           +  +  V++G R   P      L +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 450 LLERCWQQDPALRPDFSEIIEILQQI 475
           L+ +CW+++P  RP F  +   L+  
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  235 bits (599), Expect = 1e-74
 Identities = 93/280 (33%), Positives = 154/280 (55%), Gaps = 8/280 (2%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 271
           D WE++   +    K+  G YG++Y G +   S  VA+K LK + +     +EF +E  +
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 330
           M++++H N+VQ +G CT+ P   I+TEFM+ G++ DYL +  +       LL +A  +S 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPE 388
            M YL + N IHRDL A N L+ EN +VKVADFG++R+                +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
            + +  +  K+DV++FG++LWE+ T  +       L     +++K  R   P+    K+ 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 449 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK 488
           EL+  CWQ +P+ RP F+EI +  + + +E    +E  ++
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (594), Expect = 5e-74
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 12/269 (4%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 271
           I  K L+   K+  GS+G + RG + +       VA+K LKP+ ++  +   +F +EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  + H+N+++  G    PP + +VTE    GS+ D L K +G F L +L + A+ V++G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAP 387
           M YL     IHRDL A NLL+   ++VK+ DFG+ R          +       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 446
           E ++ + + H +D + FG+ LWE+ T G+ P+  L   Q    + ++G R   P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 447 LAELLERCWQQDPALRPDFSEIIEILQQI 475
           +  ++ +CW   P  RP F  + + L + 
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (594), Expect = 3e-73
 Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 35/292 (11%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 268
           WE   ++L+FG  + SG++G +          T  S  VA+K+LK E+ +S  ++    E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 90

Query: 269 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------- 313
           + +M ++  H+N+V  +GACT    + ++ E+   G + +YL   +              
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 314 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                    V     LL  A  V+KGM +L   + +HRDL A N+L+   +VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 366 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 421
           AR                  +WMAPE +    Y  K+DV+S+GI+LWE+ + G  PY  +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 422 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 473
                   ++Q G +   P  +  ++  +++ CW  D   RP F  +   L 
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 3e-73
 Identities = 74/263 (28%), Positives = 132/263 (50%), Gaps = 13/263 (4%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
            D + LKF  ++  GS+  +Y+G       +VA   L+  ++    ++ F +E  +++ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 276 RHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           +H N+V+F  +          + +VTE M+ G++  YL +   V K+  L      + KG
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124

Query: 332 MNYLHQNN--IIHRDLKAAN-LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 388
           + +LH     IIHRDLK  N  +      VK+ D G+A +K ++    A  GT  +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKL 447
           + E K YD   DV++FG+ + E+ T + PY            V  G++P +  K + P++
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 448 AELLERCWQQDPALRPDFSEIIE 470
            E++E C +Q+   R    +++ 
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 5e-73
 Identities = 78/277 (28%), Positives = 138/277 (49%), Gaps = 13/277 (4%)

Query: 218 IDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 272
           +D K L    K   SG++G + +G Y      + VA+K+LK E  +  ++ E   E  +M
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
           +++ +  +V+ IG C    S  +V E    G +  YL +     K  +++++   VS GM
Sbjct: 63  QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 388
            YL ++N +HRDL A N+L+      K++DFG+++     +      T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I +  +  K+DV+SFG+++WE  + G+ PY  +   +    +++KG R   P     ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 484
            +L+  CW  D   RP F+ +   L+    +V  E  
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 1e-72
 Identities = 68/258 (26%), Positives = 125/258 (48%), Gaps = 9/258 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 272
           W ++    + G  +  G +G++Y          +A+KVL   ++    ++ +  +EV I 
Sbjct: 3   WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 273 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
             +RH N+++  G       + ++ E+   G+VY  L K    F          +++  +
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 392
           +Y H   +IHRD+K  NLL+     +K+ADFG +   A S   T   GT  ++ PE+IE 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 393 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 452
           + +D K D++S G++ +E L GK P+E  T  +    + +  +  T P        +L+ 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236

Query: 453 RCWQQDPALRPDFSEIIE 470
           R  + +P+ RP   E++E
Sbjct: 237 RLLKHNPSQRPMLREVLE 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 4e-72
 Identities = 82/272 (30%), Positives = 141/272 (51%), Gaps = 11/272 (4%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEV 269
            EI P  +     + +G +G++Y+G   +        VAIK LK        + +F  E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
            IM +  H N+++  G  +K   + I+TE+M  G++  +L +  G F +  L+ +   ++
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 385
            GM YL   N +HRDL A N+L++ N V KV+DFG++RV       +   +      RW 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           APE I ++ +   +DV+SFGIV+WE++T      +       +  +  G R   P +   
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
            + +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 6e-72
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 13/279 (4%)

Query: 216 WEIDPKHLKFGS-KVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVF 270
             +   +L     ++  G++G + +G Y       DVAIKVLK         +E  +E  
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
           IM ++ +  +V+ IG C     L +V E   GG ++ +L   +    + ++ ++   VS 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMA 386
           GM YL + N +HRDL A N+L+      K++DFG+++      +     +A     +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 445
           PE I  + +  ++DV+S+G+ +WE L+ G+ PY+ +   +  +  +++G R   P    P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 239

Query: 446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 484
           +L  L+  CW      RPDF  + + ++     +  + E
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 2e-71
 Identities = 84/270 (31%), Positives = 139/270 (51%), Gaps = 9/270 (3%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 270
           +EI  + ++ G  +  G +GD+++G Y S +     VAIK  K    +  ++++F QE  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEAL 60

Query: 271 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 330
            MR+  H ++V+ IG  T+ P + I+ E  + G +  +L   K    L SL+  A  +S 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 331 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPE 388
            + YL     +HRD+ A N+L+  N+ VK+ DFG++R    S    A       +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 389 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 448
            I  + +   +DV+ FG+ +WE+L   +           +G ++ G R  +P N  P L 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 449 ELLERCWQQDPALRPDFSEIIEILQQIAKE 478
            L+ +CW  DP+ RP F+E+   L  I +E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  226 bits (578), Expect = 3e-71
 Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 16/289 (5%)

Query: 203 PYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPE 255
           P+  + PN+       EID   +K    + +G +G++  G           VAIK LK  
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 256 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 315
                 +++F  E  IM +  H NV+   G  TK   + I+TEFM  GS+  +L +  G 
Sbjct: 66  Y-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124

Query: 316 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 375
           F +  L+ +   ++ GM YL   N +HRDL A N+L++ N V KV+DFG++R        
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 376 TAET------GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 428
              T         RW APE I+++ +   +DV+S+GIV+WE+++ G+ PY  +T  Q  +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVI 243

Query: 429 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             +++  R   P +    L +L+  CWQ+D   RP F +I+  L ++ +
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-70
 Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 32/301 (10%)

Query: 207 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINS 259
           ++P D    WE     L FG  + +G++G +   T            VA+K+LKP   + 
Sbjct: 11  QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HL 67

Query: 260 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----- 313
             ++    E+ ++  +  H N+V  +GACT      ++TE+   G + ++L + +     
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 314 ------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 361
                           L  LL  +  V+KGM +L   N IHRDL A N+L+    + K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 362 DFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 417
           DFG+AR          +       +WMAPE I +  Y  ++DV+S+GI LWEL + G  P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 418 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           Y  +        ++++G R   P+++  ++ ++++ CW  DP  RP F +I++++++   
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 478 E 478
           E
Sbjct: 308 E 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 2e-70
 Identities = 72/264 (27%), Positives = 136/264 (51%), Gaps = 12/264 (4%)

Query: 217 EIDPK-HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 273
           +++P+   +   ++  G++G +Y+      S   A KV+  +  + +  +++  E+ I+ 
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILA 64

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
              H N+V+ + A     +L I+ EF +GG+V   + +L+       +  V       +N
Sbjct: 65  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-- 390
           YLH N IIHRDLKA N+L   +  +K+ADFGV+    ++     +  GT  WMAPEV+  
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 391 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-KGLRPTIPKNSQPK 446
              + +PYD+KADV+S GI L E+   + P+  L P++  + + + +      P      
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 447 LAELLERCWQQDPALRPDFSEIIE 470
             + L++C +++   R   S++++
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  224 bits (572), Expect = 4e-70
 Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 27/305 (8%)

Query: 209 PNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ-KE 264
           P+     ++ DP+ L     ++  GS+G +Y        + VAIK +      S+ + ++
Sbjct: 2   PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61

Query: 265 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 324
             +EV  ++K+RH N +Q+ G   +  +  +V E+  G +        K   +   +  V
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120

Query: 325 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 384
                +G+ YLH +N+IHRD+KA N+L+ E  +VK+ DFG A + A +       GT  W
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYW 177

Query: 385 MAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 441
           MAPEVI       YD K DV+S GI   EL   K P   +  + A   + Q         
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 442 NSQPKLAELLERCWQQDPALRPDFSEI---------------IEILQQIAKEVGE-ENEE 485
           +        ++ C Q+ P  RP    +               ++++Q+    V E +N +
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Query: 486 RRKEK 490
            RK K
Sbjct: 298 YRKMK 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 8e-70
 Identities = 81/282 (28%), Positives = 138/282 (48%), Gaps = 21/282 (7%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIM 272
            +D   +KF   +  G++G + +          D AIK +K    + D  ++FA E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64

Query: 273 RKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK---------------LKGVF 316
            K+  H N++  +GAC     L +  E+   G++ D+L K                    
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 317 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 376
               LL  A DV++GM+YL Q   IHRDL A N+L+ EN V K+ADFG++R +      T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 436
                 RWMA E + +  Y   +DV+S+G++LWE+++                 + +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 437 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 478
              P N   ++ +L+ +CW++ P  RP F++I+  L ++ +E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (563), Expect = 5e-69
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 34/295 (11%)

Query: 216 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 268
            E    ++++   +  G++G +++              VA+K+LK E  ++DMQ +F +E
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQRE 66

Query: 269 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-------------- 314
             +M +  + N+V+ +G C     +C++ E+M+ G + ++L  +                
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 315 ---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 365
                           L +A  V+ GM YL +   +HRDL   N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 366 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 422
           +R    +    A+       RWM PE I +  Y  ++DV+++G+VLWE+ +  L   Y  
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 423 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
             +  +  V+ G     P+N   +L  L+  CW + PA RP F  I  ILQ++ +
Sbjct: 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 6e-69
 Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 14/260 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +    + +GSYG   +    S  + +  K L    +    ++    EV ++R+++H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 282 QFIGACTKPPS--LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH 336
           ++        +  L IV E+  GG +   + K    +       +L+V   ++  +   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 337 Q-----NNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 390
           +     + ++HRDLK AN+ +D  + VK+ DFG+AR +   +    A  GT  +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
               Y+ K+D++S G +L+EL     P+   +  + A G +++G    IP     +L E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245

Query: 451 LERCWQQDPALRPDFSEIIE 470
           + R        RP   EI+E
Sbjct: 246 ITRMLNLKDYHRPSVEEILE 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 3e-68
 Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 14/281 (4%)

Query: 216 WEIDPKHLK--FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 268
             I P  L   F   +  G +G +Y GT    D      A+K L     +     +F  E
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTE 78

Query: 269 VFIMRKVRHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 327
             IM+   H NV+  +G C +   S  +V  +M  G + +++        +  L+   + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 328 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTY 382
           V+KGM +L     +HRDL A N ++DE   VKVADFG+AR             T      
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 383 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 442
           +WMA E ++ + +  K+DV+SFG++LWEL+T   P             + +G R   P+ 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

Query: 443 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 483
               L E++ +CW     +RP FSE++  +  I      E+
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 9e-67
 Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 9/257 (3%)

Query: 219 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 275
           DP K      K+  G+ G +Y     +  Q+VAI+ +  +      ++    E+ +MR+ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN 74

Query: 276 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
           ++ N+V ++ +      L +V E+++GGS+ D + +         +  V  +  + + +L
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL 132

Query: 336 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP 394
           H N +IHRD+K+ N+L+  +  VK+ DFG    +  +    +   GT  WMAPEV+  K 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 395 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER 453
           Y  K D++S GI+  E++ G+ PY    PL+A   +   G      P+       + L R
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 454 CWQQDPALRPDFSEIIE 470
           C   D   R    E+++
Sbjct: 253 CLDMDVEKRGSAKELLQ 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 3e-66
 Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 9/254 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                +  G+YG++         + VA+K++  +R   D  +   +E+ I + + H+NVV
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVV 66

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +F G   +     +  E+ SGG ++D +         P   +    +  G+ YLH   I 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 342 HRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD-H 397
           HRD+K  NLL+DE + +K++DFG+A V     +  ++    GT  ++APE+++ + +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
             DV+S GIVL  +L G+LP++  +   Q      +K       K        LL +   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245

Query: 457 QDPALRPDFSEIIE 470
           ++P+ R    +I +
Sbjct: 246 ENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 9e-66
 Identities = 88/297 (29%), Positives = 142/297 (47%), Gaps = 28/297 (9%)

Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 260
           +P D    WE     LK G  +  G++G +        D       VA+K+LK    +S+
Sbjct: 1   LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 261 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHK-------- 311
            +   ++   ++    H NVV  +GACTKP   L ++ EF   G++  YL          
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 312 -------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 364
                   K    L  L+  +  V+KGM +L     IHRDL A N+L+ E  VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 365 VARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEY 420
           +AR   +      +       +WMAPE I  + Y  ++DV+SFG++LWE+ +    PY  
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

Query: 421 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
           +   +     +++G R   P  + P++ + +  CW  +P+ RP FSE++E L  + +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 1e-65
 Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 31/296 (10%)

Query: 208 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERIN 258
           +P D    WE+    L  G  +  G++G +        D         VA+K+LK +   
Sbjct: 2   LPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59

Query: 259 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------- 310
            D+  +   E+ +M+ + +HKN++  +GACT+   L ++ E+ S G++ +YL        
Sbjct: 60  KDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 311 --------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 362
                     +       L+  A  V++GM YL     IHRDL A N+L+ E+ V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 363 FGVARVKAQSGVMTA---ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 419
           FG+AR                  +WMAPE +  + Y H++DV+SFG++LWE+ T      
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
              P++    ++++G R   P N   +L  ++  CW   P+ RP F +++E L +I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 6e-65
 Identities = 79/271 (29%), Positives = 138/271 (50%), Gaps = 13/271 (4%)

Query: 218 IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFI 271
           +     K    + SG++G +Y+G +  +       VAIK L+ E  +    KE   E ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64

Query: 272 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 331
           M  V + +V + +G C    ++ ++T+ M  G + DY+ + K       LL   + ++KG
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 332 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE 388
           MNYL    ++HRDL A N+L+   + VK+ DFG+A++                 +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 389 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 447
            I H+ Y H++DV+S+G+ +WEL+T G  PY+ +        +++KG R   P      +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242

Query: 448 AELLERCWQQDPALRPDFSEIIEILQQIAKE 478
             ++ +CW  D   RP F E+I    ++A++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 2e-64
 Identities = 65/299 (21%), Positives = 129/299 (43%), Gaps = 48/299 (16%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK 274
           E+     +  S++ +G+ G +++ ++      +A K++  E I   ++ +  +E+ ++ +
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60

Query: 275 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 334
                +V F GA      + I  E M GGS+   L K  G      L KV+I V KG+ Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 335 LHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
           L + + I+HRD+K +N+L++    +K+ DFGV+  +    +  +  GT  +M+PE ++  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQ------- 444
            Y  ++D++S G+ L E+  G+ P        L+   G   +G     P   +       
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 445 ---------------------------------PKLAELLERCWQQDPALRPDFSEIIE 470
                                             +  + + +C  ++PA R D  +++ 
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 8e-64
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 266
           D WE+  + +    ++  GS+G +Y G             VAIK +       + + EF 
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFL 71

Query: 267 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 317
            E  +M++    +VV+ +G  ++     ++ E M+ G +  YL  L+             
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---V 374
           L  ++++A +++ GM YL+ N  +HRDL A N ++ E+  VK+ DFG+ R   ++     
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 434
                   RWM+PE ++   +   +DV+SFG+VLWE+ T           +  +  V +G
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 435 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 475
                P N    L EL+  CWQ +P +RP F EII  +++ 
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  208 bits (531), Expect = 1e-63
 Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 12/265 (4%)

Query: 216 WEIDPKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 269
            EI   H+        ++ +G++G ++R T  +   + A K +     +   ++   +E+
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 74

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
             M  +RH  +V    A      + ++ EFMSGG +++ +            ++    V 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 330 KGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 387
           KG+ ++H+NN +H DLK  N++     +  +K+ DFG+         +   TGT  + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 388 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 445
           EV E KP  +  D++S G++ + LL+G  P+      +    V            S    
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 446 KLAELLERCWQQDPALRPDFSEIIE 470
              + + +    DP  R    + +E
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALE 279

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-63
 Identities = 72/303 (23%), Positives = 135/303 (44%), Gaps = 48/303 (15%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 280
           + +     +  G +G+++RG +  ++VA+K+        +       E++    +RH+N+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 59

Query: 281 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 336
           + FI A  K       L +V+++   GS++DYL++      +  ++K+A+  + G+ +LH
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117

Query: 337 Q--------NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTYR 383
                      I HRDLK+ N+L+ +N    +AD G+A     +            GT R
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 384 WMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------- 428
           +MAPEV++      H     +AD+++ G+V WE+             Q            
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 429 ------GVVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 477
                  V ++ LRP IP   Q       +A+++  CW  + A R     I + L Q+++
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

Query: 478 EVG 480
           + G
Sbjct: 298 QEG 300

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  207 bits (528), Expect = 4e-63
 Identities = 49/255 (19%), Positives = 114/255 (44%), Gaps = 8/255 (3%)

Query: 222 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 279
           +     ++ SG++G ++R    +  +    K +         +     E+ IM ++ H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           ++    A      + ++ EF+SGG ++D +           ++       +G+ ++H+++
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147

Query: 340 IIHRDLKAANLLMDENE--VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
           I+H D+K  N++ +  +   VK+ DFG+A       ++   T T  + APE+++ +P   
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCW 455
             D+++ G++ + LL+G  P+     L+    V +          S   P+  + ++   
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267

Query: 456 QQDPALRPDFSEIIE 470
           Q++P  R    + +E
Sbjct: 268 QKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (522), Expect = 8e-63
 Identities = 64/298 (21%), Positives = 136/298 (45%), Gaps = 23/298 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
            F   + +G++ ++         + VAIK +  + +    +     E+ ++ K++H N+V
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIV 70

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
                      L ++ + +SGG ++D + + KG +      ++   V   + YLH   I+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 342 HRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           HRDLK  NLL   +DE+  + ++DFG+++++    V++   GT  ++APEV+  KPY   
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQ 456
            D +S G++ + LL G  P+      +    +++       P          + +    +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 457 QDPALRPDFSEIIE-------------ILQQIAKEVGEENEERRKEKSSGGFLSVLRR 501
           +DP  R    + ++             I Q +++++ ++N  + K K +    +V+R 
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI-KKNFAKSKWKQAFNATAVVRH 306

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-61
 Identities = 58/258 (22%), Positives = 114/258 (44%), Gaps = 9/258 (3%)

Query: 217 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD-MQKEFAQEVFIMR 273
           +  P+  KFG  +  GS+  +      +  ++ AIK+L+   I  +       +E  +M 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 274 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           ++ H   V+          L     +   G +  Y+ K  G F          ++   + 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALE 122

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVI 390
           YLH   IIHRDLK  N+L++E+  +++ DFG A+V +         +  GT ++++PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 450
             K     +D+++ G ++++L+ G  P+           +++  L    P+   PK  +L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDL 240

Query: 451 LERCWQQDPALRPDFSEI 468
           +E+    D   R    E+
Sbjct: 241 VEKLLVLDATKRLGCEEM 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-61
 Identities = 51/280 (18%), Positives = 115/280 (41%), Gaps = 15/280 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                +  G +G ++R    S  +    K +K +      Q    +E+ I+   RH+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNIL 64

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
               +      L ++ EF+SG  +++ ++          ++     V + + +LH +NI 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 342 HRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           H D++  N++     +  +K+ +FG AR                + APEV +H       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 457
           D++S G +++ LL+G  P+   T  Q    ++            +   +  + ++R   +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 458 DPALRPDFSEII------EILQQIAKEVGEENEERRKEKS 491
           +   R   SE +      + +++++ +V    + RR   +
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  196 bits (499), Expect = 7e-60
 Identities = 60/265 (22%), Positives = 117/265 (44%), Gaps = 19/265 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 274
           +    +  G    + R  +    ++ A+K++      S       ++++   +EV I+RK
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 275 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
           V  H N++Q            +V + M  G ++DYL + K         K+   + + + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 391
            LH+ NI+HRDLK  N+L+D++  +K+ DFG +        +    GT  ++APE+IE  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 392 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 445
               H  Y  + D++S G++++ LL G  P+ +   +     ++    +   P+      
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 446 KLAELLERCWQQDPALRPDFSEIIE 470
            + +L+ R     P  R    E + 
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALA 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 9e-59
 Identities = 59/255 (23%), Positives = 118/255 (46%), Gaps = 10/255 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN 279
                +  GS+G ++   +    Q  AIK LK + +  + D++    ++  +     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 280 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 339
           +           +L  V E+++GG +  ++      F L      A ++  G+ +LH   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 340 IIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 398
           I++RDLK  N+L+D++  +K+ADFG+ +             GT  ++APE++  + Y+H 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 399 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 458
            D +SFG++L+E+L G+ P+      +    +      P  P+  + +  +LL + + ++
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241

Query: 459 PALRPDFSEIIEILQ 473
           P  R       +I Q
Sbjct: 242 PEKRLGVRG--DIRQ 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  193 bits (490), Expect = 2e-58
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 19/274 (6%)

Query: 220 PKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 272
           P HL    + G  +  G   +++        +DVA+KVL+ +          F +E    
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 273 RKVRHKNVVQFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
             + H  +V             P   IV E++ G ++ D +H  +G       ++V  D 
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADA 120

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRW 384
            + +N+ HQN IIHRD+K AN+++     VKV DFG+AR  A SG    +T    GT ++
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 385 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 444
           ++PE       D ++DV+S G VL+E+LTG+ P+   +P+  A   V++   P   ++  
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 445 --PKLAELLERCWQQDPALRP-DFSEIIEILQQI 475
               L  ++ +   ++P  R    +E+   L ++
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 2e-56
 Identities = 60/259 (23%), Positives = 117/259 (45%), Gaps = 13/259 (5%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD----MQKEFAQEVFIMRKVRH 277
             G ++ SG +  + +    S     A K +K  R  S      +++  +EV I+++++H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
            NV+           + ++ E ++GG ++D+L + K         +    +  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131

Query: 338 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 393
             I H DLK  N+++ +  V    +K+ DFG+A             GT  ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 394 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 451
           P   +AD++S G++ + LL+G  P+   T  +  A V  V          N+     + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 452 ERCWQQDPALRPDFSEIIE 470
            R   +DP  R    + ++
Sbjct: 252 RRLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (469), Expect = 4e-55
 Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 23/280 (8%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           + G K+ SGS+GD+Y GT  +  ++VAIK+   +        +   E  I + ++    +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
             I  C       ++   + G S+ D  +     F L ++L +A  +   + Y+H  N I
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 342 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVI 390
           HRD+K  N LM    +  +V + DFG+A+    +              TGT R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 391 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTIPKNSQ 444
                  + D+ S G VL     G LP++ L          +   +        + K   
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 484
            + A  L  C       +PD+S + ++ + +    G   +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  181 bits (461), Expect = 9e-54
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 10/258 (3%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 277
           +  +    + +GS+G ++        +  A+KVLK E +    Q E    E  ++  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             +++  G       + ++ +++ GG ++  L K    F  P     A +V   + YLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 397
            +II+RDLK  N+L+D+N  +K+ DFG A+      V     GT  ++APEV+  KPY+ 
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 398 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 457
             D +SFGI+++E+L G  P+     ++    ++        P      + +LL R   +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238

Query: 458 DPALRPDFSE--IIEILQ 473
           D + R    +    ++  
Sbjct: 239 DLSQRLGNLQNGTEDVKN 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  181 bits (461), Expect = 3e-53
 Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 12/260 (4%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ----EVFIMRKVRH 277
                +  G +G++Y        +  A+K L  +RI     +  A      + ++     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             +V    A   P  L  + + M+GG ++ +L +  GVF    +   A ++  G+ ++H 
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 396
             +++RDLK AN+L+DE+  V+++D G+A   ++     A  GT+ +MAPEV++    YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 184

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQPKLAELLERCW 455
             AD FS G +L++LL G  P+       +  +  +   +   +P +  P+L  LLE   
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 456 QQDPALRPDFSE--IIEILQ 473
           Q+D   R         E+ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKE 264

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 6e-53
 Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 19/257 (7%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 276
           + G  + SG +G +Y G   S    VAIK ++ +RI+   +         EV +++KV  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 277 -HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 335
               V++ +    +P S  ++ E              +G  +          V + + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 336 HQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 394
           H   ++HRD+K  N+L+D N   +K+ DFG   +   + V T   GT  +  PE I +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185

Query: 395 Y-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 453
           Y    A V+S GI+L++++ G +P+E+   +           +    +    +   L+  
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237

Query: 454 CWQQDPALRPDFSEIIE 470
           C    P+ RP F EI  
Sbjct: 238 CLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  178 bits (451), Expect = 1e-52
 Identities = 46/287 (16%), Positives = 101/287 (35%), Gaps = 25/287 (8%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 278
            H K G ++  GS+G ++ GT     Q VAIK             +   E    + +   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 60

Query: 279 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 338
             +  +    +     ++   + G S+ D L      F + ++   A  +   +  +H+ 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 339 NIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQSGV--------MTAETGTYRWM 385
           ++++RD+K  N L+         ++ V DFG+ +                   +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 386 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTI 439
           +      +    + D+ + G V    L G LP++ L          + G +        +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 440 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 486
                 +  + +           PD+  +  +  ++ + +    +E 
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-51
 Identities = 54/257 (21%), Positives = 105/257 (40%), Gaps = 24/257 (9%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 287
            G  G + +       +  A+K+L+          +  +EV +  +  +  ++V+ +   
Sbjct: 22  LGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 288 ----TKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                    L IV E + GG ++  +       F      ++   + + + YLH  NI H
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134

Query: 343 RDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 399
           RD+K  NLL      N ++K+ DFG A+       +T    T  ++APEV+  + YD   
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI------PKNSQPKLAELLER 453
           D++S G++++ LL G  P+     L  + G+  +                  ++  L+  
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254

Query: 454 CWQQDPALRPDFSEIIE 470
             + +P  R   +E + 
Sbjct: 255 LLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-51
 Identities = 60/259 (23%), Positives = 121/259 (46%), Gaps = 9/259 (3%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRH 277
               +   +  G++G +      +  +  A+K+L+ E I + D       E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 278 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 337
             +     A      LC V E+ +GG ++ +L + + VF          ++   + YLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123

Query: 338 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYD 396
            ++++RD+K  NL++D++  +K+ DFG+ +     G  M    GT  ++APEV+E   Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 397 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 456
              D +  G+V++E++ G+LP+      +    ++ +      P+   P+   LL    +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241

Query: 457 QDPALRP--DFSEIIEILQ 473
           +DP  R     S+  E+++
Sbjct: 242 KDPKQRLGGGPSDAKEVME 260

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-50
 Identities = 55/286 (19%), Positives = 114/286 (39%), Gaps = 36/286 (12%)

Query: 221 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRK--- 274
           +  +  +++  G+YG +++        + VA+K ++ +     M     +EV ++R    
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 275 VRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 329
             H NVV+    CT   +     L +V E +            +      ++  +   + 
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 330 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 389
           +G+++LH + ++HRDLK  N+L+  +  +K+ADFG+AR+ +    +T+   T  + APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 390 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----------- 438
           +    Y    D++S G +  E+   K  +   + +     ++     P            
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 439 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                            +      +LL +C   +PA R      + 
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-47
 Identities = 60/273 (21%), Positives = 118/273 (43%), Gaps = 34/273 (12%)

Query: 231 SGSYGDLYRGTYCS--QDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIG 285
            G +  +Y+    +  Q VAIK +K          + +   +E+ +++++ H N++  + 
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67

Query: 286 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 345
           A     ++ +V +FM    +   +     V     +    +   +G+ YLHQ+ I+HRDL
Sbjct: 68  AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126

Query: 346 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 403
           K  NLL+DEN V+K+ADFG+A+   + +   T +  T  + APE++   + Y    D+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186

Query: 404 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------------- 438
            G +L ELL         + L     + +    PT                         
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246

Query: 439 -IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
            I   +   L +L++  +  +P  R   ++ ++
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-46
 Identities = 53/278 (19%), Positives = 106/278 (38%), Gaps = 31/278 (11%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +   K+  G+YG +Y+       + VA+K ++ +     +     +E+ +++++ H N+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           + +        L +V EF+                 LP +      + +G+ + H + ++
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPY-DHKA 399
           HRDLK  NLL++    +K+ADFG+AR         T E  T  + APE++    Y     
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------------------- 438
           D++S G +  E++T +  +   + +     + +    P                      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 439 ------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                 +          LL +    DP  R      + 
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  160 bits (405), Expect = 5e-46
 Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 31/277 (11%)

Query: 224 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 282
               K+  G+YG +Y+      +  A+K ++ E+ +  +     +E+ I+++++H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 283 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 342
                     L +V E +        L   +G  +  +     + +  G+ Y H   ++H
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 343 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW-MAPEVIE-HKPYDHKAD 400
           RDLK  NLL++    +K+ADFG+AR                W  AP+V+   K Y    D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---------------------- 438
           ++S G +  E++ G   +  ++     + + +    P                       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243

Query: 439 -----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                  K       +LL +  + DP  R    + +E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-45
 Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 44/296 (14%)

Query: 215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 272
           V+++ P++    S +  G+YG +           VAIK + P   +    +   +E+ I+
Sbjct: 3   VFDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKIL 60

Query: 273 RKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 328
            + RH+N++        P         +   + G  +Y  L           +      +
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQI 118

Query: 329 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRW 384
            +G+ Y+H  N++HRDLK +NLL++    +K+ DFG+ARV       +G +T    T  +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 385 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 438
            APE++ +   Y    D++S G +L E+L+ +  +     L     ++     P+     
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 439 ------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                                   +  N+  K  +LL++    +P  R +  + + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (404), Expect = 4e-45
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 8/243 (3%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNV 280
                + +GS+G +    +       A+K+L  +++    Q E    E  I++ V    +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 281 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 340
           V+   +     +L +V E+++GG ++ +L +  G F  P     A  +     YLH  ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 341 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 400
           I+RDLK  NLL+D+   ++V DFG A+     G      GT   +APE+I  K Y+   D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 401 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 460
            ++ G++++E+  G  P+    P+Q    +V    +   P +    L +LL    Q D  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 461 LRP 463
            R 
Sbjct: 279 KRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-44
 Identities = 62/284 (21%), Positives = 130/284 (45%), Gaps = 17/284 (5%)

Query: 206 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSD 260
           L+  N      ++  ++ +    + +G+YG ++     S     +  A+KVLK   I   
Sbjct: 9   LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68

Query: 261 MQ--KEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 317
            +  +    E  ++  +R    +V    A      L ++ ++++GG ++ +L + +  F 
Sbjct: 69  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFT 127

Query: 318 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 375
              +     ++   + +LH+  II+RD+K  N+L+D N  V + DFG+++  V  ++   
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

Query: 376 TAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 433
               GT  +MAP+++      +D   D +S G++++ELLTG  P+       +   + ++
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247

Query: 434 GLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSE--IIEILQ 473
            L+  P  P+       +L++R   +DP  R         EI +
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-44
 Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 47/293 (16%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +  +K+  G++G++++  +    Q VA+K +  E           +E+ I++ ++H+NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 282 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 333
             I  C    S        + +V +F          + L   F L  + +V   +  G+ 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131

Query: 334 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 388
           Y+H+N I+HRD+KAAN+L+  + V+K+ADFG+AR       +Q    T    T  +  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 389 VI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------- 438
           ++   + Y    D++  G ++ E+ T     +  T       + Q     T         
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 439 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                                      P   +L+++    DPA R D  + + 
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 4e-43
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 40/295 (13%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 269
               WE+     +    V SG+YG +           VAIK L     +    K   +E+
Sbjct: 10  TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 270 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFM----SGGSVYDYLHKLKGVFKLPSLLKVA 325
            +++ +RH+NV+  +   T   +L   T+F       G+    L K         +  + 
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLV 127

Query: 326 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 385
             + KG+ Y+H   IIHRDLK  NL ++E+  +K+ DFG+AR       MT    T  + 
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYR 185

Query: 386 APEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------- 437
           APEVI     Y    D++S G ++ E++TGK  ++    L     +++    P       
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 438 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                                 +I  N+ P    LLE+    D   R    E + 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (383), Expect = 7e-43
 Identities = 55/279 (19%), Positives = 110/279 (39%), Gaps = 33/279 (11%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
           +   K+  G+YG +++       + VA+K ++ +  +  +     +E+ ++++++HKN+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 282 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 341
           +          L +V EF        +     G      +      + KG+ + H  N++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 342 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIE-HKPYDHKA 399
           HRDLK  NLL++ N  +K+A+FG+AR         +AE  T  +  P+V+   K Y    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 400 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------- 437
           D++S G +  EL     P      +   +  + + L                        
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 438 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                  +         +LL+   + +P  R    E ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 45/286 (15%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
                + +GS+G +Y+   C   + VAIK +  ++      +   +E+ IMRK+ H N+V
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76

Query: 282 QFIGACTKPPS------LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMN 333
           +                L +V +++         H  + K    +  +      + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 334 YLHQNNIIHRDLKAANL-LMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP-EVIE 391
           Y+H   I HRD+K  NL L  +  V+K+ DFG A+   +     +   +  + AP  +  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 392 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------- 438
              Y    DV+S G VL ELL G+  +   + +   V +++    PT             
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 439 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                             + P+   L  R  +  P  R    E   
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (357), Expect = 2e-38
 Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 53/307 (17%)

Query: 212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 269
           G   + +  K  +    + SG+ G +         ++VAIK L     N    K   +E+
Sbjct: 9   GDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 270 FIMRKVRHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 323
            +M+ V HKN++  +   T   +      + +V E M           ++       +  
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123

Query: 324 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 383
           +   +  G+ +LH   IIHRDLK +N+++  +  +K+ DFG+AR    S +MT    T  
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 384 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 438
           + APEVI    Y    D++S G ++ E++  K+ +     +     V+++   P      
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 439 -----------------------------------IPKNSQPKLAELLERCWQQDPALRP 463
                                                K    +  +LL +    DPA R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 464 DFSEIIE 470
              + ++
Sbjct: 304 SVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-38
 Identities = 57/293 (19%), Positives = 116/293 (39%), Gaps = 40/293 (13%)

Query: 214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 271
            +WE+ P+  +  S V SG+YG +           VA+K L     +    K   +E+ +
Sbjct: 12  TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 272 MRKVRHKNVVQFIGACTKPPSLC-----IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           ++ ++H+NV+  +   T   SL       +   + G  + + +           +  +  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128

Query: 327 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 386
            + +G+ Y+H  +IIHRDLK +NL ++E+  +K+ DFG+AR      +       +    
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187

Query: 387 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------- 438
             ++    Y+   D++S G ++ ELLTG+  +     +     +++    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 439 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 470
                                +   + P   +LLE+    D   R   ++ + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (351), Expect = 6e-38
 Identities = 52/310 (16%), Positives = 119/310 (38%), Gaps = 60/310 (19%)

Query: 212 GTDVWEIDPKHLKFGS--------KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDM 261
             + W+ +   +++G+        K+  G Y +++     +  + V +K+LKP +     
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 72

Query: 262 QKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKL 318
           +K+  +E+ I+  +R   N++        P S    +V E ++         +L      
Sbjct: 73  KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTD 128

Query: 319 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 377
             +     ++ K ++Y H   I+HRD+K  N+++D E+  +++ D+G+A           
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188

Query: 378 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL- 435
              +  +  PE+ ++++ YD+  D++S G +L  ++  K P+ +       +  + K L 
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 436 -----------------------------------RPTIPKNSQPKLAELLERCWQQDPA 460
                                                       P+  + L++  + D  
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 461 LRPDFSEIIE 470
            R    E +E
Sbjct: 309 SRLTAREAME 318

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 4e-26
 Identities = 47/317 (14%), Positives = 108/317 (34%), Gaps = 75/317 (23%)

Query: 224 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 281
               K+  G +  ++          VA+K+++ +++     +    E+ ++++V   +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNT 72

Query: 282 QFIGACTKPP---------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 326
           +                         + +V E +    +            L  + +++ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 327 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEV------VKVADFGVARVKAQSGVMTAET 379
            +  G++Y+H +  IIH D+K  N+LM+  +       +K+AD G A    +    +   
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190

Query: 380 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-------------------- 419
            T  + +PEV+   P+   AD++S   +++EL+TG   +E                    
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 420 -----------------YLTPLQAAVGVVQKGLRPT---------IPKNSQPKLAELLER 453
                            +         + +    P            K+   ++++ L  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 454 CWQQDPALRPDFSEIIE 470
             Q DP  R D   ++ 
Sbjct: 311 MLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.4 bits (187), Expect = 8e-17
 Identities = 22/195 (11%), Positives = 58/195 (29%), Gaps = 32/195 (16%)

Query: 226 GSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQK--------EFAQEVFIMRKVR 276
           G  +  G    ++        +  +K  K    +    K         F+       +  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 277 HKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 332
            + + +  G             ++ E +    +Y          ++ +  +V   + + +
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEV 116

Query: 333 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 388
              +   I+H DL   N+L+ E   + + DF  +        +  +         + +  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173

Query: 389 VIEHKPYDHKADVFS 403
               + Y  + D+ S
Sbjct: 174 ----RTYRTEKDINS 184

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

 Score = 39.4 bits (92), Expect = 7e-05
 Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 2/62 (3%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 170
           IT    D+P + +++  L+   G NI      +        + ++ G       ++   L
Sbjct: 8   ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65

Query: 171 EK 172
             
Sbjct: 66  PL 67

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 39.0 bits (91), Expect = 7e-05
 Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)

Query: 109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWP-YEETEQL 166
             +     D+P  L ++  LL   G+NIQ A      +   +  +  +D     +    +
Sbjct: 4   INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63

Query: 167 RA 168
            A
Sbjct: 64  AA 65

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

 Score = 38.9 bits (91), Expect = 9e-05
 Identities = 12/62 (19%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEET-EQL 166
             +    +++P +L+ L  + A+ G+NI   +  ++   GY +     D    E+  + +
Sbjct: 12  RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71

Query: 167 RA 168
           +A
Sbjct: 72  KA 73

>d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: AF1403 N-terminal domain-like
domain: Hypothetical protein AF1403, N-terminal domain
species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]

 Score = 37.4 bits (87), Expect = 3e-04
 Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 3/73 (4%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE-ETEQLRAA 169
           +    ++K  +L  LT ++A+ G NI  A  F    G      ++       + E++   
Sbjct: 4   LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILER 63

Query: 170 LEK--EVLKLERQ 180
           ++    ++++E +
Sbjct: 64  VKTFDYIIEIEEE 76

>d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Nitrosomonas europaea [TaxId: 915]

 Score = 36.1 bits (84), Expect = 8e-04
 Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)

Query: 109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 167
           H I+   +++   LS++  L +  G NI+      T D   S    V +G P E  EQ+ 
Sbjct: 3   HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQIT 61

Query: 168 AALEK--EVLKLE 178
             L K  EV+KL 
Sbjct: 62  KQLNKLIEVVKLI 74

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

 Score = 36.3 bits (84), Expect = 8e-04
 Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 170
           IT    DK  +++ ++  +A++GLNI +       + +++   V      +    LR   
Sbjct: 5   ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEKQDF-TYLRNEF 63

Query: 171 EK 172
           E 
Sbjct: 64  EA 65

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} Length = 71

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

 Score = 34.2 bits (79), Expect = 0.003
 Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 6/63 (9%)

Query: 111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 170
           +  S  + P  L+++   L+  G+ I+  ++F+  +  +  V           ++    L
Sbjct: 2   VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANNN-VANVVIRPS-----NMDKCIEVL 55

Query: 171 EKE 173
           +++
Sbjct: 56  KEK 58

>d2fgca2 d.58.18.6 (A:27-104) Acetolactate synthase small subunit, IlvH {Thermotoga maritima [TaxId: 2336]} Length = 78

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: IlvH-like
domain: Acetolactate synthase small subunit, IlvH
species: Thermotoga maritima [TaxId: 2336]

 Score = 34.2 bits (79), Expect = 0.004
 Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 4/73 (5%)

Query: 109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 167
           H ++    +KP ++ ++  L A  G NI       +   G S  V +V G   +  EQ+ 
Sbjct: 4   HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKG-DDKTIEQIE 62

Query: 168 AALEK--EVLKLE 178
               K  EV+K+ 
Sbjct: 63  KQAYKLVEVVKVT 75

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	504
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.36
d1u8sa1	86	putative transcriptional repressor VC2159 {Vibrio	96.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.18
d1zpva1	83	UPF0237 protein SP0238 {Streptococcus pneumoniae [	96.06
d1u8sa2	93	putative transcriptional repressor VC2159 {Vibrio	92.89
d2f06a1	71	Hypothetical protein BT0572 {Bacteroides thetaiota	89.54
d1ygya3	78	Phosphoglycerate dehydrogenase, regulatory (C-term	88.53
d1y7pa2	77	Hypothetical protein AF1403, N-terminal domain {Ar	88.0
d2f06a2	70	Hypothetical protein BT0572 {Bacteroides thetaiota	86.76
d1sc6a3	84	Phosphoglycerate dehydrogenase, regulatory (C-term	86.75

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-59  Score=461.16  Aligned_cols=264  Identities=36%  Similarity=0.712  Sum_probs=230.6

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      |+|+|+.++|+++++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            5799999999999999999999999998755 59999998776667777899999999999999999999998765 568


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +|||||++||+|.+++...++.+++..+..++.||++||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999999998777889999999999999999999999999999999999999999999999999997654432


Q ss_pred             ---ccccCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CCCCCC
Q 010680          374 ---VMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----TIPKNS  443 (504)
Q Consensus       374 ---~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p----~~p~~~  443 (504)
                         ......||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.++.......+..+..+    .++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence               3345679999999999964   458999999999999999999999999988777666666555432    356788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          444 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      ++++.+||.+||+.||++|||+.||++.|+.+.+.+
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999887644

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=439.79  Aligned_cols=256  Identities=35%  Similarity=0.717  Sum_probs=221.0

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      |++++|++.++||+|+||+||+|.+. ++.||||+++.....   .++|.+|+.++++++|||||+++|++..++.+++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            67889999999999999999999985 567999999865433   35799999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCc--
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--  374 (504)
                      |||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.......  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999999988778899999999999999999999999999999999999999999999999999986654432  


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.... +..+.++..|..+++++.+|+.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHH
Confidence            234578999999999999999999999999999999999 6777877777666554 45677888899999999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      ||+.||++|||++++++.|+++.+
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=440.80  Aligned_cols=261  Identities=31%  Similarity=0.629  Sum_probs=230.4

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      .+.|+|+.++|++.++||+|+||+||+|.+.+ +.||||+++.....   .+.|.+|+.+|++++|||||++++++.+ +
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence            47899999999999999999999999999864 67999999865433   3579999999999999999999998865 5


Q ss_pred             CceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      .+++||||+++|+|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence            6799999999999999886543 369999999999999999999999999999999999999999999999999999776


Q ss_pred             CCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          371 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       371 ~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...  ......||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+.. ..+..+.++..|..+++++
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHH
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCcccChHHH
Confidence            543  2345578999999999998999999999999999999999 55666666665554 4456678888999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+|+.+||+.||++|||+.++++.|+++++.
T Consensus       240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-56  Score=448.38  Aligned_cols=263  Identities=35%  Similarity=0.660  Sum_probs=232.1

Q ss_pred             CCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          213 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       213 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      .+.|+|+.++|++.++||+|+||+||+|++.  ++.||||+++.....   .++|.+|+.+|++++|||||++++++.++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            4679999999999999999999999999985  678999999865433   46799999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      +.++|||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+..
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999999999753 457899999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCc--cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          370 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       370 ~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|||++|..||............+..+.++..|..+++++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence            54432  2234578999999999999999999999999999999996665544444455556677888899999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+|+.+||+.||++|||+.++++.|+.++++
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999887553

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-56  Score=444.28  Aligned_cols=259  Identities=33%  Similarity=0.609  Sum_probs=221.7

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC--c---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~---~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +++.++|++.++||+|+||+||+|++..  +   .||||.+.... .....+.|.+|+.+|++++|||||++++++..++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            5677889999999999999999998742  2   48888887543 4455678999999999999999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      .+++|||||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999988777899999999999999999999999999999999999999999999999999986554


Q ss_pred             CCc------cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010680          372 SGV------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ  444 (504)
Q Consensus       372 ~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~  444 (504)
                      ...      .....||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+.... +..+.+++.|..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence            322      122357899999999999999999999999999999998 8999999988776655 45677788889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          445 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       445 ~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      +++.+|+.+||+.||++|||+.|+++.|+++++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            999999999999999999999999999999876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=438.01  Aligned_cols=262  Identities=29%  Similarity=0.558  Sum_probs=224.6

Q ss_pred             CCCceeee-eeeeeeCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCc
Q 010680          219 DPKHLKFG-SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL  293 (504)
Q Consensus       219 ~~~~~~i~-~~LG~G~fG~Vy~~~~~g----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~  293 (504)
                      +...+.+. ++||+|+||+||+|.+.+    +.||||+++....+....++|.+|+.+|++++|||||+++++|..+ ..
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~   82 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW   82 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence            34445554 469999999999998743    5699999987666666678899999999999999999999999754 57


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      +|||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            899999999999999976 5779999999999999999999999999999999999999999999999999998765433


Q ss_pred             c----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010680          374 V----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA  448 (504)
Q Consensus       374 ~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~  448 (504)
                      .    .....||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..+... .+.++.++..|..+++++.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHH
Confidence            2    223468999999999999999999999999999999998 999999988876554 4556778889999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhccch
Q 010680          449 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN  483 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~  483 (504)
                      +||.+||+.||++|||+.+|++.|++.+.++.+++
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e~  275 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  275 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCCC
Confidence            99999999999999999999999999887765543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=450.03  Aligned_cols=259  Identities=31%  Similarity=0.594  Sum_probs=229.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~  285 (504)
                      ..|+++.++|+++++||+|+||+||+|++.+       ..||+|++.... .......+.+|+.+|+++ +|||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4689999999999999999999999998753       249999987543 233456789999999998 8999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhhc----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceec
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR  343 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHr  343 (504)
                      ++...+.+|+|||||+||+|.++++..+                      +.+++..++.++.||+.||.|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997643                      348889999999999999999999999999


Q ss_pred             cCCCCcEEECCCCcEEEEeeccceeccCCCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 010680          344 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE  419 (504)
Q Consensus       344 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~  419 (504)
                      ||||+|||++.++.+||+|||+|+.......   .....||+.|||||++.+..|+.++|||||||+||||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987655432   224467999999999999999999999999999999998 999999


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 010680          420 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ  473 (504)
Q Consensus       420 ~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~  473 (504)
                      +.+..+....++..+.+++.|..+++++.+||.+||+.||++|||++||++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            988877788888889999999999999999999999999999999999999885

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=435.14  Aligned_cols=259  Identities=33%  Similarity=0.630  Sum_probs=223.4

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      +|++++|++.++||+|+||.||+|.+.+      ..||||+++... ......+|.+|+.+|++++|||||+++|++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            7888999999999999999999998753      259999997543 444567799999999999999999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +..++||||+.+++|.+++....+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999999998877889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ...    ......||+.|||||++.+..|+.++|||||||++|||++| .+||...+..+ ....+..+.+++.|..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCCCCCchhhHH
Confidence            432    22334689999999999999999999999999999999995 45555555544 4555677888899999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      ++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999999999999998876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=438.54  Aligned_cols=263  Identities=28%  Similarity=0.560  Sum_probs=232.3

Q ss_pred             eeeCCCceeeee-eeeeeCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          216 WEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       216 ~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      +.+..++|.+.+ +||+|+||+||+|.+.    +..||||+++... .....+.|.+|+.+|++++|||||++++++..+
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~   81 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE   81 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            456677888888 4999999999999874    3369999998653 455578899999999999999999999999764


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                       .+||||||++||+|.+++...++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence             6899999999999999987767889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ....    .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||...+..+... .+..+.++.+|..+++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECPP  239 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCCCTTCCH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCcCCH
Confidence            4432    234468999999999999999999999999999999998 999999988766554 4567788899999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ++.+||.+||+.||++||||.+|++.|++++..+..
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999998876654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=430.68  Aligned_cols=253  Identities=33%  Similarity=0.669  Sum_probs=229.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +++++|+++++||+|+||+||+|++. ++.||||+++.....   .++|.+|+.++++++||||++++|++.+++.+++|
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            46789999999999999999999996 457999999876544   35799999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--c
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V  374 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~  374 (504)
                      |||+++|+|.+++......+++..+.+++.||++||.|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999999999988877889999999999999999999999999999999999999999999999999998655443  2


Q ss_pred             cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          375 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       375 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||...+..+....+ ..+.++..|..+++++.+||.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHHHHHH
Confidence            334678999999999999999999999999999999998 89999999988776654 5677888999999999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIEILQQ  474 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~~L~~  474 (504)
                      ||+.||++||||.++++.|.+
T Consensus       237 cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHC
T ss_pred             HccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=432.97  Aligned_cols=262  Identities=32%  Similarity=0.608  Sum_probs=222.9

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      +|+|+.++|++++.||+|+||.||+|++..     ..||||.++.. ........|.+|+.+|++++|||||++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            589999999999999999999999998853     34888888654 344556789999999999999999999999964


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                       +.+|+||||+++|+|.+++....+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             6789999999999999998887788999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010680          370 AQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK  446 (504)
Q Consensus       370 ~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~  446 (504)
                      ....  ..+...||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..+....+ ..+.++++|..++++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT  237 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence            5432  2334568999999999999999999999999999999998 99999998887766654 456677889999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          447 LAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       447 l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +.+||.+||+.||++|||+.||++.|++++++-
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999988753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=432.03  Aligned_cols=246  Identities=27%  Similarity=0.481  Sum_probs=220.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|++++.||+|+||+||+|++.  ++.||||+++.... .......+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            47999999999999999999985  67899999875432 1233567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~  163 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT  163 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence            99999999999986 567999999999999999999999999999999999999999999999999999765543 3445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+...  .+.+|..+++++.+||.+||+.
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH  241 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHccC
Confidence            68999999999999999999999999999999999999999999888777665543  3567888999999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010680          458 DPALRPDFSEIIE  470 (504)
Q Consensus       458 dP~~RPs~~ell~  470 (504)
                      ||++|||+.|+++
T Consensus       242 dp~~R~t~~eil~  254 (263)
T d2j4za1         242 NPSQRPMLREVLE  254 (263)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             CHhHCcCHHHHHc
Confidence            9999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=432.14  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=211.7

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--CCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV  296 (504)
                      ++|++.+.||+|+||+||+|++.  |+.||||+++....+....+.+.+|+.+|++++|||||++++++.+  .+.+|||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999885  6789999999877777777889999999999999999999998854  4568999


Q ss_pred             EEecCCCchHHHHHhh---cccCChHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          297 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~-----IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      |||++||+|.+++.+.   .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653   457999999999999999999999976     99999999999999999999999999987


Q ss_pred             ccCCC-ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          369 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       369 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.. +..+.+|..+++++
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l  242 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL  242 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence            65443 34457899999999999999999999999999999999999999999988877766554 44456788999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||.+||+.||.+|||+.|+++
T Consensus       243 ~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         243 NEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHHh
Confidence            99999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=432.50  Aligned_cols=246  Identities=27%  Similarity=0.506  Sum_probs=220.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||+||+|.+.  |+.||||+++......  .+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            46899999999999999999864  7889999997653322  4678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      |++||+|.+++.+  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus        98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9999999998864  579999999999999999999999999999999999999999999999999998765443 4456


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ  456 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll~~cl~  456 (504)
                      .+||+.|+|||++.+.+|+.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++++.+||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            6899999999999999999999999999999999999999999888877776665433 345567899999999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010680          457 QDPALRPDFSEIIE  470 (504)
Q Consensus       457 ~dP~~RPs~~ell~  470 (504)
                      .||.+|||+.|+++
T Consensus       256 ~dP~~R~s~~eil~  269 (293)
T d1yhwa1         256 MDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=426.87  Aligned_cols=256  Identities=36%  Similarity=0.697  Sum_probs=222.7

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-CCCc
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL  293 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~  293 (504)
                      .|+|+.++|+++++||+|+||.||+|.+.|+.||||+++.+.    ..+.|.+|+.++++++||||+++++++.+ .+.+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            389999999999999999999999999999999999997643    24678999999999999999999999854 4668


Q ss_pred             eeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      |+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999997643 45899999999999999999999999999999999999999999999999999865433


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL  451 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll  451 (504)
                        .....+|+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.... +..+.++++|..+++++.+||
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHH
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHH
Confidence              334578999999999998999999999999999999998 8999998877776655 456788899999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIEILQQIAK  477 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~~L~~l~~  477 (504)
                      .+||+.||.+|||+.++++.|+++.+
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=430.48  Aligned_cols=248  Identities=26%  Similarity=0.443  Sum_probs=211.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||+||+|++.  ++.||||+++.... .+..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            47999999999999999999985  77899999976543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC---cc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~  375 (504)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+......   ..
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999975 5689999999999999999999999999999999999999999999999999998754432   34


Q ss_pred             ccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      +..+||+.|||||++.+.+| +.++|||||||++|||++|+.||...+..... ............+..+++++.+||.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  242 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence            55689999999999988886 57899999999999999999999776543333 33333333334446789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||++|||+.|+++
T Consensus       243 ~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         243 ILVENPSARITIPDIKK  259 (271)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=433.39  Aligned_cols=248  Identities=29%  Similarity=0.490  Sum_probs=219.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.++||+|+||.||+|.+.  ++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            35899999999999999999984  6789999997652  3345678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ||+||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            999999999988767789999999999999999999999999999999999999999999999999997654332 2345


Q ss_pred             CCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHH
Q 010680          378 ETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELL  451 (504)
Q Consensus       378 ~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~p~~p~~~~~~l~~Ll  451 (504)
                      ..||+.|||||++     ....|+.++|||||||++|||++|+.||.+.++.+....+..... ....+..+++++.+||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            6899999999998     356789999999999999999999999999988888777665432 2344568899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 010680          452 ERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       452 ~~cl~~dP~~RPs~~ell~  470 (504)
                      .+||+.||.+|||+.|+++
T Consensus       250 ~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=423.54  Aligned_cols=247  Identities=29%  Similarity=0.555  Sum_probs=214.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC----CCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~  294 (504)
                      .-|++.++||+|+||+||+|++.  ++.||+|+++.........+.|.+|+.+|++++|||||++++++..    ...+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            34578889999999999999985  5679999998776677777889999999999999999999998854    34579


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCcEEEEeeccceeccC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--IiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~  371 (504)
                      |||||++||+|.+++.+ .+.+++..+..++.||+.||+|||+++  |+||||||+|||++ +++.+||+|||+++....
T Consensus        89 ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999999976 567999999999999999999999998  99999999999996 578999999999975443


Q ss_pred             CCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHH
Q 010680          372 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAEL  450 (504)
Q Consensus       372 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-p~~p~~~~~~l~~L  450 (504)
                      . .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||............+..+.. +.++..+++++.+|
T Consensus       168 ~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  245 (270)
T d1t4ha_         168 S-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  245 (270)
T ss_dssp             T-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             C-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence            3 3446689999999999976 5999999999999999999999999877666555555555444 34566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 010680          451 LERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs~~ell~  470 (504)
                      |.+||+.||++|||+.|+++
T Consensus       246 i~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHhC
Confidence            99999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=429.11  Aligned_cols=264  Identities=35%  Similarity=0.644  Sum_probs=224.3

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      ...+.|+|+.++|+++++||+|+||.||+|++.+ +.||||+++.....   .+.|.+|+.+|++++|||||++++++.+
T Consensus         7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            4567899999999999999999999999999865 57999999865443   3679999999999999999999999865


Q ss_pred             CCCceeEEEecCCCchHHHHHhh-cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                       +.+++||||+++|+|..++... .+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence             5689999999999999998654 35699999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC--ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          369 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       369 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      .....  ......||+.|+|||++....++.++|||||||++|||++| .+||......+.. ..+..+.+++.+..+++
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~  241 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYRMPCPPECPE  241 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTSCH
T ss_pred             ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCCcccCH
Confidence            64433  33446789999999999999999999999999999999995 5555555555444 44556778889999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      ++.++|.+||+.||++||++.+|++.|++.+...
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999999999999998876543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=425.91  Aligned_cols=258  Identities=32%  Similarity=0.620  Sum_probs=222.0

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC-----ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP  290 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-----~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~  290 (504)
                      -|+.++|++.+.||+|+||+||+|++.+     ..||||+++.... .....+.|.+|+.+|++++||||++++|++.+ 
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            4677889999999999999999998743     2589999886644 33456789999999999999999999999976 


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +..++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            46889999999999999998877889999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCc----cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010680          371 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP  445 (504)
Q Consensus       371 ~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~  445 (504)
                      ....    .....||..|+|||++.+..++.++||||||+++|||+| |..||.+.+..+....+...+.+++.+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            5432    223457889999999999999999999999999999998 89999999999999888888889999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          446 KLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       446 ~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      ++.+|+.+||+.||++||||.+|++.|+++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999888764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=432.52  Aligned_cols=249  Identities=23%  Similarity=0.420  Sum_probs=219.5

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCcee
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI  295 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l  295 (504)
                      .+++|++++.||+|+||+||+|++.  ++.||||+++.... .......+.+|+.+|++++||||+++++++.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            3467999999999999999999984  67899999975432 22335678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC--
Q 010680          296 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--  373 (504)
Q Consensus       296 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--  373 (504)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+......  
T Consensus        86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999999876 5789999999999999999999999999999999999999999999999999998765432  


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|..||...+..+....+...  .+.+|..+++++.+||.
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVE  242 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence             334567999999999999999999999999999999999999999999888877776654  35678899999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 010680          453 RCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~  470 (504)
                      +||+.||.+|||+.|+++
T Consensus       243 ~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTC
T ss_pred             HHccCCHhHCcCHHHHcC
Confidence            999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-54  Score=432.80  Aligned_cols=248  Identities=22%  Similarity=0.443  Sum_probs=203.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      +.|++.+.||+|+||+||+|++.  ++.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999985  6789999998664433 24568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEEeeccceeccCCCcc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM  375 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~~~~  375 (504)
                      ||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+++........
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999976 67899999999999999999999999999999999999995   5789999999999877666666


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHH
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLER  453 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~~Ll~~  453 (504)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.......  +.+..+++++.+||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            67789999999999999999999999999999999999999999998888777776655433  3446889999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 010680          454 CWQQDPALRPDFSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs~~ell~  470 (504)
                      ||+.||.+|||+.|+++
T Consensus       247 ~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HccCCHhHCcCHHHHhc
Confidence            99999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=426.89  Aligned_cols=264  Identities=32%  Similarity=0.618  Sum_probs=223.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~  285 (504)
                      +.|+|+.++|+++++||+|+||.||+|++.+       +.||||+++... .....+.+.+|+.++.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            5799999999999999999999999998743       469999998543 344456788888888777 5899999999


Q ss_pred             eeeCC-CCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010680          286 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN  349 (504)
Q Consensus       286 ~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~N  349 (504)
                      ++..+ ..+++|||||++|+|.++++...               ..+++..+..++.||+.||.|||++|||||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            87654 46899999999999999997542               348899999999999999999999999999999999


Q ss_pred             EEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 010680          350 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQ  425 (504)
Q Consensus       350 ILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~  425 (504)
                      ||++.++.+||+|||+|+......   ......||+.|||||++.+..|+.++|||||||++|||++| .+||...+..+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998654432   23345799999999999999999999999999999999985 67898887777


Q ss_pred             HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          426 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       426 ~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .....+..+.++..|..+++++.++|.+||+.||++|||+.|+++.|+++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            77777888889999999999999999999999999999999999999999763

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-53  Score=428.99  Aligned_cols=245  Identities=29%  Similarity=0.434  Sum_probs=219.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      .|++.++||+|+||+||+|++.  ++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5899999999999999999874  677999999876543 3455779999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCccccC
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE  378 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  378 (504)
                      ||+||+|..++.. ++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....   ....
T Consensus        96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~  171 (309)
T d1u5ra_          96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF  171 (309)
T ss_dssp             CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred             ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence            9999998766654 67899999999999999999999999999999999999999999999999999986543   3456


Q ss_pred             CCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          379 TGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       379 ~gt~~y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      .||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+....+......+..+..+++++.+||.+||
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L  251 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL  251 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence            89999999999853   468999999999999999999999999999988888877766655566789999999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 010680          456 QQDPALRPDFSEIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~ell~  470 (504)
                      +.||.+|||+.|+++
T Consensus       252 ~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             cCChhHCcCHHHHHh
Confidence            999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-53  Score=434.45  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=224.0

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|+++++||+|+||.||+|++.  |+.||||+++...  ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47999999999999999999984  7889999997653  3445778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      ||+||+|.+++....+.+++..+..++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+++.........
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99999999999776778999999999999999999999999999999999999964  6789999999999877766667


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~c  454 (504)
                      ...||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+........  ....+++++.+||.+|
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  263 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL  263 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            78999999999999999999999999999999999999999999998888777766544322  3356899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.|+++
T Consensus       264 L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         264 LLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=422.55  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=222.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++|+++++||+|+||+||+|.+.  |+.||||+++......    ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56999999999999999999985  7889999997654322    23578999999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEEeeccceecc
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA  370 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  370 (504)
                      ||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999976 56799999999999999999999999999999999999998776    59999999999877


Q ss_pred             CCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA  448 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--~~p~~~~~~l~  448 (504)
                      .........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.......  ..+..+++++.
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            6666677789999999999999999999999999999999999999999999888877766544332  23467899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 010680          449 ELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       449 ~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +||.+||+.||.+|||+.|+++
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=431.67  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=214.3

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      ++..++|++.++||+|+||+||+|.+.  ++.||||+++... .......+.+|+.+|++++|||||++++++.+++.+|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456678999999999999999999985  6789999998653 3444578999999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      |||||++||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999999986 5679999999999999999999997 59999999999999999999999999999865432 


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------------------
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-------------------------  428 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-------------------------  428 (504)
                      .....+||+.|||||++.+.+|+.++|||||||++|||++|+.||...+..+...                         
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            2345689999999999999999999999999999999999999997644321110                         


Q ss_pred             ----------------HHHhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 010680          429 ----------------GVVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       429 ----------------~v~~~~~~p~~p-~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l  475 (504)
                                      ........+..+ ...++++.+||.+||..||.+|||+.|+++  .|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                            001111112222 246889999999999999999999999987  45543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-53  Score=424.04  Aligned_cols=260  Identities=31%  Similarity=0.583  Sum_probs=228.5

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEee
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC  287 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~  287 (504)
                      .|++..++|++.++||+|+||+||+|++.+       +.||||+++.. ...+..++|.+|+.+|++++||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            357777889999999999999999999854       56999999854 3455677899999999999999999999999


Q ss_pred             eCCCCceeEEEecCCCchHHHHHhhc-----------------------ccCChHHHHHHHHHHHHHHHHHHHCCceecc
Q 010680          288 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD  344 (504)
Q Consensus       288 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrD  344 (504)
                      ......+++|||+++|+|.+++....                       ..+++..++.++.||+.||+|||+++|||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            99999999999999999999996532                       2478889999999999999999999999999


Q ss_pred             CCCCcEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCC
Q 010680          345 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEY  420 (504)
Q Consensus       345 Lkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~  420 (504)
                      |||+|||++.++.+||+|||+++......   ..+...||+.|+|||++.+..|+.++|||||||++|||++|. +||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999997553322   233457899999999999999999999999999999999974 78998


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 010680          421 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA  476 (504)
Q Consensus       421 ~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~  476 (504)
                      .+..+.... +..+.++.+|..+++++.+||.+||+.||++||||.||++.|+++.
T Consensus       246 ~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            888877766 4556678889999999999999999999999999999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9e-53  Score=431.53  Aligned_cols=248  Identities=19%  Similarity=0.371  Sum_probs=224.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||.||+|.+.  |+.||||+++...  ......+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46999999999999999999974  7889999998653  3345678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCCcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~~~~~  376 (504)
                      ||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.........
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999999999877667899999999999999999999999999999999999998  67899999999999887766677


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p~~~~~~l~~Ll~~c  454 (504)
                      ...||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..+....+......  ...+..+++++.+||.+|
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  266 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL  266 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence            778999999999999999999999999999999999999999999988887777665443  234467899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |+.||.+|||+.|+++
T Consensus       267 L~~dp~~R~s~~eil~  282 (352)
T d1koba_         267 LQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=422.55  Aligned_cols=265  Identities=31%  Similarity=0.626  Sum_probs=238.0

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG  285 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g-------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~  285 (504)
                      ..|+++.++|+++++||+|+||.||+|++.+       +.||||+++... ......+|.+|+.+++++ +|||||++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            4799999999999999999999999998743       469999998654 344567899999999999 6999999999


Q ss_pred             eeeCCCCceeEEEecCCCchHHHHHhhc-----------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          286 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       286 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++..++.+++|||||++|+|.++++...                 ..+++..+..++.||+.||.|||+++|+||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997542                 25889999999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++......   ......||+.|+|||++....++.++|||||||++|||+| |.+||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998765432   2234578999999999999999999999999999999998 78888888887


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV  479 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~  479 (504)
                      +....++..+.++..+..+++++.+||.+||+.||.+||||.+|++.|++++.+.
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            7778888889999999999999999999999999999999999999999988764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=419.64  Aligned_cols=263  Identities=32%  Similarity=0.632  Sum_probs=229.1

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF  283 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l  283 (504)
                      ..|+|+.++|+++++||+|+||.||+|++.+         ..||||+++... ......++.+|+..+.++ +|||||++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            3599999999999999999999999998643         359999998654 444567889999999888 79999999


Q ss_pred             EEeeeCCCCceeEEEecCCCchHHHHHhhc---------------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010680          284 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA  348 (504)
Q Consensus       284 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~  348 (504)
                      ++++.+++..++||||+++|+|.+++....               ..+++..++.++.||+.||+|||+++||||||||+
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            999999999999999999999999997543               35899999999999999999999999999999999


Q ss_pred             cEEECCCCcEEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHH
Q 010680          349 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL  424 (504)
Q Consensus       349 NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~  424 (504)
                      |||++.++.+||+|||+++......   ......||+.|+|||.+.+..|+.++||||||+++|||++ |.+||...+..
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999999999998765543   2334578999999999999999999999999999999998 79999988876


Q ss_pred             HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          425 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       425 ~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      +.. ..+..+.++..|..+++++.+||.+||+.||.+|||+.|+++.|+++...
T Consensus       245 ~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 ELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            554 55667888999999999999999999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=428.66  Aligned_cols=250  Identities=24%  Similarity=0.445  Sum_probs=223.4

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCce
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC  294 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~  294 (504)
                      |..++|++++.||+|+||.||+|+..  ++.||||+++.... .......+.+|+.+|++++||||+++++++.++..+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            34568999999999999999999974  78899999975432 2234577889999999999999999999999999999


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-C
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~  373 (504)
                      +|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus        82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999987 678999999999999999999999999999999999999999999999999999865443 3


Q ss_pred             ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010680          374 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER  453 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~  453 (504)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....  +.+|..+++++.+||.+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence            4456789999999999999999999999999999999999999999999888777666543  56788999999999999


Q ss_pred             hhhcCCCCCCC-----HHHHHH
Q 010680          454 CWQQDPALRPD-----FSEIIE  470 (504)
Q Consensus       454 cl~~dP~~RPs-----~~ell~  470 (504)
                      ||++||.+||+     +.|+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hccCCchhhcccccccHHHHHc
Confidence            99999999995     778775

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=423.80  Aligned_cols=258  Identities=30%  Similarity=0.610  Sum_probs=222.9

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEECC--c----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTYCS--Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP  291 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~  291 (504)
                      +..++|+++++||+|+||+||+|.+..  +    .||||.++... +....++|.+|+.+|++++|||||+++++|.++ 
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            445679999999999999999998753  3    48899887543 333467899999999999999999999999875 


Q ss_pred             CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ  371 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  371 (504)
                      ..+++|||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57788999999999999988788899999999999999999999999999999999999999999999999999987554


Q ss_pred             CCc---cccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010680          372 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL  447 (504)
Q Consensus       372 ~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l  447 (504)
                      ...   .....||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+. ...+..+.+++.|..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccCHHH
Confidence            332   233468999999999999999999999999999999998 8999998877654 44566778888999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRPDFSEIIEILQQIAKE  478 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~  478 (504)
                      .+|+.+||+.||.+|||+.||++.|..+.++
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999887653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.4e-52  Score=411.25  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=218.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC----c
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----L  293 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~  293 (504)
                      ++|++.+.||+|+||+||+|++.  ++.||||+++.... +......|.+|+.+|+.++||||+++++++.....    +
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            56999999999999999999974  78899999987654 34556789999999999999999999999876543    7


Q ss_pred             eeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC
Q 010680          294 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG  373 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  373 (504)
                      ||||||++|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus        87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            899999999999999876 5789999999999999999999999999999999999999999999999999987554332


Q ss_pred             ----ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHH
Q 010680          374 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKL  447 (504)
Q Consensus       374 ----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l  447 (504)
                          .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.++.+.....+.....+.  .+..+|+++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence                33455799999999999999999999999999999999999999999999888887777655432  346789999


Q ss_pred             HHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 010680          448 AELLERCWQQDPALRP-DFSEIIEILQQIA  476 (504)
Q Consensus       448 ~~Ll~~cl~~dP~~RP-s~~ell~~L~~l~  476 (504)
                      .++|.+||+.||.+|| |+.+++..|.++.
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            9999999999999999 8999998888775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=423.21  Aligned_cols=262  Identities=32%  Similarity=0.586  Sum_probs=226.4

Q ss_pred             eeCCCceeeeeeeeeeCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeCCC
Q 010680          217 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP  291 (504)
Q Consensus       217 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~g--~--~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~  291 (504)
                      .|+.++|++.++||+|+||+||+|++.+  .  .||||.++... ..+..+.|.+|+.+|+++ +|||||++++++..++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            5677899999999999999999998854  3  47788876443 233456799999999998 7999999999999999


Q ss_pred             CceeEEEecCCCchHHHHHhh---------------cccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010680          292 SLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE  356 (504)
Q Consensus       292 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~  356 (504)
                      .+++||||++||+|.++++..               ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999753               25689999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCC
Q 010680          357 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGL  435 (504)
Q Consensus       357 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~~v~~~~~  435 (504)
                      .+||+|||+++............||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.... +..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhcC
Confidence            9999999999876655555566799999999999999999999999999999999996 568888887776655 45577


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          436 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       436 ~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ++..|..+++++.+||.+||+.||++|||+.++++.|++++++..
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            888999999999999999999999999999999999999987443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-52  Score=420.41  Aligned_cols=245  Identities=26%  Similarity=0.459  Sum_probs=220.8

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|+++++||+|+||+||+|++.  |+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975  78899999975432 1233567899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            99999999998876 677899999999999999999999999999999999999999999999999999876543  446


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      .+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....  ..+|..+++++.+++.+||..
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhh
Confidence            789999999999999999999999999999999999999999999988887776653  457788999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 010680          458 DPALRP-----DFSEIIE  470 (504)
Q Consensus       458 dP~~RP-----s~~ell~  470 (504)
                      ||.+|+     |+.++++
T Consensus       239 dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccchhhHHHHHc
Confidence            999996     8999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=417.90  Aligned_cols=260  Identities=31%  Similarity=0.571  Sum_probs=230.3

Q ss_pred             CceeeCCCceeeeeeeeeeCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEe
Q 010680          214 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA  286 (504)
Q Consensus       214 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~  286 (504)
                      +.|+|+.++|+++++||+|+||+||+|.+.       ++.||||+++.. ........|.+|+.++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            579999999999999999999999999874       357999999854 344556779999999999999999999999


Q ss_pred             eeCCCCceeEEEecCCCchHHHHHhhc---------ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010680          287 CTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV  357 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~  357 (504)
                      +..++..++||||+++|+|.+++....         ..+++..+..++.||+.||.|||+++|+||||||+|||++.+++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            999999999999999999999987542         23688899999999999999999999999999999999999999


Q ss_pred             EEEEeeccceeccCCC---ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhc
Q 010680          358 VKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQK  433 (504)
Q Consensus       358 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~~v~~~  433 (504)
                      +||+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..+....+. +
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-E  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-T
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-h
Confidence            9999999998654432   22344689999999999999999999999999999999997 68999998888776544 5


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 010680          434 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI  475 (504)
Q Consensus       434 ~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l  475 (504)
                      +.++..|..+++.+.++|.+||+.||++|||+.+|++.|++.
T Consensus       251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            667888999999999999999999999999999999887655

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-51  Score=407.91  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=221.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcC-CCCceEEEEeeeCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP  290 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~-------~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~  290 (504)
                      ++|++.++||+|+||+||+|+.  .++.||||+++......       ...+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999998  46889999997654321       23456889999999997 99999999999999


Q ss_pred             CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceecc
Q 010680          291 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA  370 (504)
Q Consensus       291 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~  370 (504)
                      +.+|||||||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            999999999999999999976 6789999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCC
Q 010680          371 QSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKN  442 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~  442 (504)
                      .....+...||+.|+|||.+.      ...|+.++||||+||++|+|++|+.||...++......+......+.  ....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            766667778999999999984      44578999999999999999999999999998887777766554433  3347


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            8999999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=416.16  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=221.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|+++++||+|+||+||+|.+.  ++.||||+++...   .....+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57999999999999999999974  6789999998652   334568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CcEEEEeeccceeccCCCccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~~~~  376 (504)
                      ||+||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++.........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            999999999998766689999999999999999999999999999999999999854  489999999998876666666


Q ss_pred             cCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 010680          377 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC  454 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~--~p~~~~~~l~~Ll~~c  454 (504)
                      ...+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+....+........  .+..+++++.+||.+|
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence            67899999999999999999999999999999999999999999998888877776544322  2247899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 010680          455 WQQDPALRPDFSEIIE  470 (504)
Q Consensus       455 l~~dP~~RPs~~ell~  470 (504)
                      |..||.+|||+.|+++
T Consensus       242 L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-51  Score=420.59  Aligned_cols=245  Identities=25%  Similarity=0.391  Sum_probs=220.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~  297 (504)
                      ++|+++++||+|+||.||+|.+.  |+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.....+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999984  78899999875432 2233567899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCCcccc
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA  377 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  377 (504)
                      ||+.||+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....  ...
T Consensus       121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            99999999999976 567999999999999999999999999999999999999999999999999999876533  445


Q ss_pred             CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 010680          378 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ  457 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl~~  457 (504)
                      ..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......+....  +..|..+++++.+||.+||..
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhh
Confidence            689999999999999999999999999999999999999999999888877776654  456788999999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 010680          458 DPALRP-----DFSEIIE  470 (504)
Q Consensus       458 dP~~RP-----s~~ell~  470 (504)
                      ||.+|+     ++.++++
T Consensus       276 dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccccccccHHHHHc
Confidence            999994     8899875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=410.85  Aligned_cols=257  Identities=29%  Similarity=0.513  Sum_probs=218.8

Q ss_pred             eeeeeeeeeCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC-CCCceeEE
Q 010680          224 KFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT  297 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~~g~-----~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~  297 (504)
                      .+.++||+|+||+||+|++...     .||||.++.. .+....++|.+|+.+|++++||||++++|++.. ++.+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4468999999999999998432     4899998753 355567889999999999999999999999764 56789999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC----
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----  373 (504)
                      |||++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++......    
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999999998877788899999999999999999999999999999999999999999999999998654432    


Q ss_pred             -ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010680          374 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE  452 (504)
Q Consensus       374 -~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~  452 (504)
                       ......||+.|+|||.+....++.++||||||+++|||+||..||............+..+.++..|..+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             2223468999999999999999999999999999999999766665443333334445567788899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          453 RCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       453 ~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      +||+.||++||++.||++.|+++++....
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            99999999999999999999999876544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=413.29  Aligned_cols=247  Identities=24%  Similarity=0.430  Sum_probs=217.3

Q ss_pred             CceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHH-hcCCCCceEEEEeeeCCCCceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~-~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~lV  296 (504)
                      ++|+++++||+|+||+||+|++  +++.||||++++... .......+..|+.++. .++|||||++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999998  478899999975422 1223455667777654 78999999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC-Ccc
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM  375 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~  375 (504)
                      ||||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999986 577999999999999999999999999999999999999999999999999999865443 345


Q ss_pred             ccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010680          376 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW  455 (504)
Q Consensus       376 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~Ll~~cl  455 (504)
                      +...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...  .+.+|..+++++.+||.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L  238 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLF  238 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhc
Confidence            5568999999999999999999999999999999999999999999988877776544  46788899999999999999


Q ss_pred             hcCCCCCCCHH-HHHH
Q 010680          456 QQDPALRPDFS-EIIE  470 (504)
Q Consensus       456 ~~dP~~RPs~~-ell~  470 (504)
                      ..||.+||++. ++++
T Consensus       239 ~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CSSGGGSBTTBSCGGG
T ss_pred             ccCCCCCcCHHHHHHh
Confidence            99999999985 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-50  Score=415.18  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=209.9

Q ss_pred             CCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCC
Q 010680          219 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS  292 (504)
Q Consensus       219 ~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~  292 (504)
                      ..++|++.++||+|+||.||+|++.  |+.||||++.......    .......+|+.+++.++|||||++++++..++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            3568999999999999999999984  7889999987543211    112223345677778889999999999999999


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +||||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999999976 577899999999999999999999999999999999999999999999999999876544


Q ss_pred             CccccCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCcHHHHHH
Q 010680          373 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLRPTIPKNSQPKLAEL  450 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-~v~~~~~~p~~p~~~~~~l~~L  450 (504)
                       ......||+.|+|||++. +..|+.++|||||||+||||+||+.||...+...... ........+..|..+++++.+|
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence             344568999999999996 4679999999999999999999999998754332221 1122334556778899999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHH
Q 010680          451 LERCWQQDPALRPD-----FSEIIE  470 (504)
Q Consensus       451 l~~cl~~dP~~RPs-----~~ell~  470 (504)
                      |.+||+.||.+|||     +.|+++
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHc
Confidence            99999999999999     688864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=403.65  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=212.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEEeee-----C
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K  289 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~---g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~-----~  289 (504)
                      ++|+++++||+|+||+||+|++.   ++.||||+++...........+.+|+.+|+.+   +||||+++++++.     .
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            68999999999999999999974   45699999976544433334566788877766   7999999999884     3


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ...++++|||+.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            34689999999888777666665677999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 010680          370 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------  436 (504)
Q Consensus       370 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------------  436 (504)
                      ..........||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+..+....+......             
T Consensus       167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  246 (305)
T d1blxa_         167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP  246 (305)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred             cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence            6666667789999999999999999999999999999999999999999999887776665432110             


Q ss_pred             ------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ------------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                  +..+..+++.+.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        1134567899999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=400.97  Aligned_cols=245  Identities=24%  Similarity=0.343  Sum_probs=203.1

Q ss_pred             eeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          225 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       225 i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      .+++||+|+||+||+|++  +|+.||||+++......   ...+.+.+|+.+|++++|||||++++++..++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999987  47889999997654322   2235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      +.|+++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            98876665554 46779999999999999999999999999999999999999999999999999998655443 34456


Q ss_pred             CCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Q 010680          379 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------------  437 (504)
Q Consensus       379 ~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p--------------------  437 (504)
                      +||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+.+..+....+......+                    
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            89999999999864 568999999999999999999999999988887766654321110                    


Q ss_pred             -C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -T-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -~-----~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                       .     ....+++++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             0     11356889999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=409.93  Aligned_cols=243  Identities=23%  Similarity=0.402  Sum_probs=203.2

Q ss_pred             Cceeeee-eeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEEeeeC----CCC
Q 010680          221 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS  292 (504)
Q Consensus       221 ~~~~i~~-~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~  292 (504)
                      ++|++.. .||+|+||.||+|++.  ++.||||+++..       ..+.+|+.++.++ +|||||++++++.+    ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            4688765 5999999999999974  688999999743       4567899987654 89999999998864    456


Q ss_pred             ceeEEEecCCCchHHHHHhhc-ccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeecccee
Q 010680          293 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV  368 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~  368 (504)
                      +|||||||+||+|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.   .+.+||+|||+|+.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999999999999997643 46999999999999999999999999999999999999985   56799999999998


Q ss_pred             ccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCC----CC
Q 010680          369 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIP----KN  442 (504)
Q Consensus       369 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p----~~  442 (504)
                      ...........||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+......  ..+|    ..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  243 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred             ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence            77777777889999999999999999999999999999999999999999776554433333222211  1222    35


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          443 SQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       443 ~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      +++++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         244 VSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            7899999999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=401.27  Aligned_cols=249  Identities=21%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||+||+|++.  ++.||||+++...........+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999985  7889999998765444456789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHH-HhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccc
Q 010680          299 FMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT  376 (504)
Q Consensus       299 ~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~  376 (504)
                      |+.+ ++.+++ ......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ...
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            9965 555554 4445679999999999999999999999999999999999999999999999999998765443 344


Q ss_pred             cCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------C-
Q 010680          377 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------------T-  438 (504)
Q Consensus       377 ~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p----------------~-  438 (504)
                      ...||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+......+                . 
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            568999999999987766 4789999999999999999999999988777665544321100                0 


Q ss_pred             ----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          439 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       439 ----------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                ....+++++.+||.+||..||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                      11356789999999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-49  Score=393.21  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=209.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEEe
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF  299 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~-g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~  299 (504)
                      ++|++.++||+|+||+||+|++. ++.||||+++.........+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999885 68899999987655555567899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-ccccC
Q 010680          300 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE  378 (504)
Q Consensus       300 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~  378 (504)
                      +.++.+..+. ...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            9766555554 446889999999999999999999999999999999999999999999999999998765433 33455


Q ss_pred             CCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 010680          379 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------  436 (504)
Q Consensus       379 ~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------------  436 (504)
                      .|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+......                     
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            78999999999865 45799999999999999999999999998877766554421110                     


Q ss_pred             ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          437 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       437 ------p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            +.....+++++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123567899999999999999999999999973

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=398.68  Aligned_cols=255  Identities=27%  Similarity=0.515  Sum_probs=208.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC----CceeE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV  296 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~lV  296 (504)
                      .+|.+.++||+|+||+||+|++.|+.||||+++...   .....+..|+..+++++||||+++++++....    .+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            468889999999999999999999999999987532   21222334566667889999999999987654    47899


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~--------~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ||||++|+|.+++++  ..+++..++.++.|++.||.|||+        +||+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999976  468999999999999999999996        5999999999999999999999999999987


Q ss_pred             ccCCC-----ccccCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCC---------------CC
Q 010680          369 KAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTGKLPYEY---------------LT  422 (504)
Q Consensus       369 ~~~~~-----~~~~~~gt~~y~APE~l~~~~------~s~ksDVwSlGvvL~eLltG~~Pf~~---------------~~  422 (504)
                      .....     ......||+.|+|||++.+..      ++.++|||||||+||||+||..||..               ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            65433     223457999999999987643      67799999999999999999887732               12


Q ss_pred             HHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          423 PLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       423 ~~~~~~~v~~~~~~p~~p~~~-----~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      .......+.....+|.++...     +..+.+|+.+||+.||.+|||+.||++.|+++.++-+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            333444455566777766543     3469999999999999999999999999999887543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=395.56  Aligned_cols=240  Identities=25%  Similarity=0.477  Sum_probs=205.5

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCCceEEEEeeeCCCC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~----~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~  292 (504)
                      ++|+++++||+|+||+||+|++.  ++.||||+++......    .....+.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999985  7889999997654322    11234678999999997  8999999999999999


Q ss_pred             ceeEEEecCC-CchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEEeeccceecc
Q 010680          293 LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKA  370 (504)
Q Consensus       293 ~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-~~~vkL~DFGla~~~~  370 (504)
                      .|+||||+.+ +++.+++.. ++.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 578888765 578999999999999999999999999999999999999985 4799999999998654


Q ss_pred             CCCccccCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010680          371 QSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE  449 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p~~p~~~~~~l~~  449 (504)
                      .. ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+      .+...  ...++..+++++.+
T Consensus       163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSSECQH  233 (273)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCHHHHH
T ss_pred             cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCHHHHH
Confidence            43 4456789999999999987765 577899999999999999999997632      12222  23567789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 010680          450 LLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       450 Ll~~cl~~dP~~RPs~~ell~  470 (504)
                      ||.+||+.||++|||+.|+++
T Consensus       234 li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHhc
Confidence            999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=393.78  Aligned_cols=253  Identities=27%  Similarity=0.399  Sum_probs=210.9

Q ss_pred             CCCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC
Q 010680          212 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK  289 (504)
Q Consensus       212 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~  289 (504)
                      +...|++. ++|+++++||+|+||+||+|.+.  ++.||||+++....+....+.+.+|+.+|++++|||||++++++..
T Consensus        10 ~~~~~~~~-~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~   88 (346)
T d1cm8a_          10 TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP   88 (346)
T ss_dssp             SSSEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred             cCceeecC-CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence            34567774 78999999999999999999975  7889999998776666777889999999999999999999999876


Q ss_pred             CC------CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          290 PP------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       290 ~~------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      .+      .+|+||||+ |.+|..+.+.  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus        89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          89 DETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence            55      469999999 7788887754  67999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-------  435 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~-------  435 (504)
                      |+|+....  ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.............       
T Consensus       166 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         166 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            99987654  3566789999999999865 4578999999999999999999999998876655443322110       


Q ss_pred             ----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          436 ----------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       436 ----------------------~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                            .......+++++.+||.+||..||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                  01233567899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-48  Score=384.52  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=209.1

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEEeeeCCCCceeEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVT  297 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~  297 (504)
                      ++|+++++||+|+||.||+|++.  ++.||||+++.....    .++.+|+.+++.++|+|+ +.+.+++...+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            46999999999999999999975  788999998765332    347789999999987665 55556667778889999


Q ss_pred             EecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEEeeccceeccCCC-
Q 010680          298 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSG-  373 (504)
Q Consensus       298 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~~-  373 (504)
                      ||+ +++|.+.+....+.+++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+...... 
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999 67888888776788999999999999999999999999999999999999864   4579999999998765432 


Q ss_pred             -------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---CCCCCCC
Q 010680          374 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV---QK---GLRPTIP  440 (504)
Q Consensus       374 -------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~---~~---~~~p~~p  440 (504)
                             ......||+.|||||++.+.+|+.++|||||||++|||++|..||...........+.   ..   ...+..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   2234579999999999999999999999999999999999999998766544332221   11   1122345


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 010680          441 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG  480 (504)
Q Consensus       441 ~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~  480 (504)
                      ..+|+++.+++.+||+.||++||++.++.+.|++++...+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            6889999999999999999999999999999999877554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.5e-47  Score=380.99  Aligned_cols=257  Identities=18%  Similarity=0.280  Sum_probs=216.9

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeCCCCceeE
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV  296 (504)
                      ..+|+++++||+|+||+||+|++.  |+.||||+++.....    ..+.+|+++++.+.| +|++.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            468999999999999999999975  678999998754322    346778899999976 8999999999999999999


Q ss_pred             EEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCcEEEEeeccceeccC
Q 010680          297 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQ  371 (504)
Q Consensus       297 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~-----~~~vkL~DFGla~~~~~  371 (504)
                      |||+ +++|.+++......++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 78999999887778999999999999999999999999999999999999974     57899999999987654


Q ss_pred             CC--------ccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc---CCCC
Q 010680          372 SG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQK---GLRP  437 (504)
Q Consensus       372 ~~--------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~---~~~~~~~v~~~---~~~p  437 (504)
                      ..        ......||+.|||||++.+..|+.++|||||||++|||++|..||.+..   ..+....+...   ...+
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            32        2234579999999999999999999999999999999999999997543   33333222221   1122


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhcc
Q 010680          438 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE  481 (504)
Q Consensus       438 ~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~~L~~l~~~~~~  481 (504)
                      ..+..+|+++.+++..||..+|++||++..+.+.|++++++.+.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            34567899999999999999999999999999999999876653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=387.40  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=205.6

Q ss_pred             ceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCC-
Q 010680          215 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-  291 (504)
Q Consensus       215 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-  291 (504)
                      .|+|.. +|+++++||+|+||+||+|.+.  ++.||||+++... .....+.+.+|+.+|++++||||+++++++.... 
T Consensus         3 ~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            456654 5999999999999999999874  7889999997643 4455678899999999999999999999986543 


Q ss_pred             ---CceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          292 ---SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       292 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                         ..+++++|+.||+|.+++..  +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence               23455566779999999965  5799999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC----ccccCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 010680          369 KAQSG----VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------  437 (504)
Q Consensus       369 ~~~~~----~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p------  437 (504)
                      .....    .....+||+.|+|||++ ....|+.++||||+||++|+|++|+.||...+..+...........+      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            54432    23455799999999998 55568999999999999999999999998877655444332211000      


Q ss_pred             -----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -----------------------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                             .....+++++.+|+.+||..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                   112467789999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=387.37  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             ceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC------CCCc
Q 010680          222 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPSL  293 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~~  293 (504)
                      +|+..++||+|+||+||+|++.  ++.||||+++.....      +.+|+.+|++++||||+++++++..      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            6889999999999999999984  788999999765322      2469999999999999999998843      2347


Q ss_pred             eeEEEecCCCchHHHHH--hhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceecc
Q 010680          294 CIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKA  370 (504)
Q Consensus       294 ~lV~E~~~ggsL~~~l~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~  370 (504)
                      |||||||+++.+..+..  .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            89999997654443332  2345799999999999999999999999999999999999999775 89999999999877


Q ss_pred             CCCccccCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------
Q 010680          371 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------  435 (504)
Q Consensus       371 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------------  435 (504)
                      .........||+.|+|||++.+ ..|+.++|||||||++|||++|..||...+..+....+.....              
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666677789999999998865 5799999999999999999999999998887766655432100              


Q ss_pred             -C---C---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 010680          436 -R---P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI  475 (504)
Q Consensus       436 -~---p---------~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~--~L~~l  475 (504)
                       .   +         .....+++++.+||.+||..||++|||+.|+++  .|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence             0   0         122457899999999999999999999999985  34444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-47  Score=381.36  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=202.5

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeC--------
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------  289 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--------  289 (504)
                      .++|+++++||+|+||+||+|++.  |+.||||+++...........+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999984  7889999987665555556778999999999999999999998754        


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ...+|+||||++++.+.. .......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            346899999997665554 4444678999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC-----ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCC-
Q 010680          370 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIP-  440 (504)
Q Consensus       370 ~~~~-----~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--p~~p-  440 (504)
                      ....     .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+.+....  +... 
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4322     23345799999999998755 6899999999999999999999999988876665544332111  1100 


Q ss_pred             ---------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          441 ---------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       441 ---------------------------~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                                 ...++++.+||.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                                       012567889999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=373.60  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=211.4

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCCCCceeEEE
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE  298 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E  298 (504)
                      ++|++.++||+|+||+||+|++.  ++.||||+++...........+.+|+.+|++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999984  6779999998776666677889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCCC-cccc
Q 010680          299 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA  377 (504)
Q Consensus       299 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~  377 (504)
                      ++.|++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            9999888887764 6788999999999999999999999999999999999999999999999999998766543 3344


Q ss_pred             CCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcC---------------------
Q 010680          378 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKG---------------------  434 (504)
Q Consensus       378 ~~gt~~y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~~v~~~~---------------------  434 (504)
                      ..+++.|+|||++.... ++.++|||||||++|||++|+.||.. .+..+....+....                     
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            56788999999987665 68999999999999999999988644 44444333322110                     


Q ss_pred             ------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          435 ------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       435 ------~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                            .....+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  111233566889999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=387.18  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=210.1

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCC-CCceEEEEeeeC
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTK  289 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~-----~g~~VAvK~lk~~~~--~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~  289 (504)
                      +..++|+++++||+|+||+||+|..     +|+.||||+++....  +....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3457899999999999999999986     357799999976532  12234567889999999987 899999999999


Q ss_pred             CCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceec
Q 010680          290 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK  369 (504)
Q Consensus       290 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~  369 (504)
                      ...++++|||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999999986 567889999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC--ccccCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCC
Q 010680          370 AQSG--VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNS  443 (504)
Q Consensus       370 ~~~~--~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~--~~~~p~~p~~~  443 (504)
                      ....  ......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...+..+....+..  ....+.+|..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            4332  33456799999999999654  478899999999999999999999976543322222221  12345677899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 010680          444 QPKLAELLERCWQQDPALRPD-----FSEIIE  470 (504)
Q Consensus       444 ~~~l~~Ll~~cl~~dP~~RPs-----~~ell~  470 (504)
                      ++++.+||.+||++||++|||     ++|+++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            999999999999999999995     778764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=384.15  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=212.3

Q ss_pred             CCCCceeeCCCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeee
Q 010680          211 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT  288 (504)
Q Consensus       211 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~  288 (504)
                      .+.+.|++. ++|++.++||+|+||+||+|.+.  |+.||||+++....+....+.+.+|+.+|++++|||||++++++.
T Consensus         9 ~~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1           9 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             CSSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            345678884 78999999999999999999874  788999999877666666778999999999999999999999885


Q ss_pred             CC-----CCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEee
Q 010680          289 KP-----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF  363 (504)
Q Consensus       289 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DF  363 (504)
                      ..     ...+++|+|+.||+|.+++..  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++||
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence            43     334667778889999999954  57999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 010680          364 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-----  437 (504)
Q Consensus       364 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p-----  437 (504)
                      |++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......+     
T Consensus       166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            99975433  34556789999999987665 46899999999999999999999999888766655544322111     


Q ss_pred             ----------------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 ----------------T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 ----------------~--------~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                      .        ....+++++.+||.+||..||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                            0        11357899999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-46  Score=376.70  Aligned_cols=242  Identities=19%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             CCceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeC--CCCce
Q 010680          220 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC  294 (504)
Q Consensus       220 ~~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~~  294 (504)
                      .++|+++++||+|+||+||+|++.  ++.||||+++...     .+.+.+|+.+|+++. ||||+++++++..  ...++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            357999999999999999999974  7889999998542     356889999999996 9999999999874  45689


Q ss_pred             eEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEEeeccceeccCCC
Q 010680          295 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG  373 (504)
Q Consensus       295 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~  373 (504)
                      +||||+++++|..+.    +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999987654    4699999999999999999999999999999999999998655 69999999999877666


Q ss_pred             ccccCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh------------c------
Q 010680          374 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQ------------K------  433 (504)
Q Consensus       374 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~~v~~------------~------  433 (504)
                      ......+|+.|+|||++.+. .|+.++||||+||++|+|++|..||...... +....+..            .      
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66777899999999998765 5899999999999999999999999765432 21111110            0      


Q ss_pred             -----------------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          434 -----------------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       434 -----------------~~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                                       .........+++++.+||.+||..||.+|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                             0111122346889999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=383.39  Aligned_cols=246  Identities=25%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             CceeeeeeeeeeCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEEeeeCC------CC
Q 010680          221 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS  292 (504)
Q Consensus       221 ~~~~i~~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~  292 (504)
                      ++|++.++||+|+||+||+|.+.  |+.||||+++....+......+.+|+.+|++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56999999999999999999985  78899999988776777777899999999999999999999998543      57


Q ss_pred             ceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccceeccCC
Q 010680          293 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS  372 (504)
Q Consensus       293 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  372 (504)
                      +|+||||+.++ +.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus        97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            79999999654 44444   356899999999999999999999999999999999999999999999999999887776


Q ss_pred             CccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 010680          373 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------  437 (504)
Q Consensus       373 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~~v~~~~~~p---------------  437 (504)
                      ...+...||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+......+               
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence            66777789999999999999999999999999999999999999998877665544433211000               


Q ss_pred             -----CC--------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 010680          438 -----TI--------------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE  470 (504)
Q Consensus       438 -----~~--------------------p~~~~~~l~~Ll~~cl~~dP~~RPs~~ell~  470 (504)
                           ..                    +...++++.+||.+||..||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 00                    0123567899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-40  Score=334.90  Aligned_cols=248  Identities=20%  Similarity=0.339  Sum_probs=189.2

Q ss_pred             eCCCceeeeeeeeeeCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCCceEEE
Q 010680          218 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQFI  284 (504)
Q Consensus       218 i~~~~~~i~~~LG~G~fG~Vy~~~~--~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~  284 (504)
                      +...+|+++++||+|+||+||+|++  +|+.||||+++..   ......+.+|+.+++.++           |+||++++
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            4446799999999999999999987  4788999999864   233456788999988875           57899999


Q ss_pred             EeeeC--CCCceeEEEecCCCchHHH--HHhhcccCChHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC---
Q 010680          285 GACTK--PPSLCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE---  356 (504)
Q Consensus       285 ~~~~~--~~~~~lV~E~~~ggsL~~~--l~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~IiHrDLkp~NILl~~~~---  356 (504)
                      +++..  ....+++++++..+.....  .......+++..+..++.||+.||+|||+ .||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  3445666666655443322  23334678999999999999999999998 8999999999999998665   


Q ss_pred             ---cEEEEeeccceeccCCCccccCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Q 010680          357 ---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL------QAA  427 (504)
Q Consensus       357 ---~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~------~~~  427 (504)
                         .++++|||.+......  ....+||+.|+|||++....|+.++|+||+||++++|++|+.||......      ...
T Consensus       167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence               4999999999866543  34567999999999999999999999999999999999999999644321      111


Q ss_pred             HH---HHh--------c---------------C--------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 010680          428 VG---VVQ--------K---------------G--------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSE  467 (504)
Q Consensus       428 ~~---v~~--------~---------------~--------------~~p~~p~~~~~~l~~Ll~~cl~~dP~~RPs~~e  467 (504)
                      ..   .+.        .               .              .....+...++++.+||.+||..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            00   000        0               0              011122334678999999999999999999999


Q ss_pred             HHH
Q 010680          468 IIE  470 (504)
Q Consensus       468 ll~  470 (504)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.2e-25  Score=205.20  Aligned_cols=165  Identities=14%  Similarity=0.141  Sum_probs=122.7

Q ss_pred             eeeeeeeeeCceEEEEEEE-CCccEEEEEecCCCCC----------------hHHHHHHHHHHHHHHhcCCCCceEEEEe
Q 010680          224 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----------------SDMQKEFAQEVFIMRKVRHKNVVQFIGA  286 (504)
Q Consensus       224 ~i~~~LG~G~fG~Vy~~~~-~g~~VAvK~lk~~~~~----------------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~  286 (504)
                      .++++||+|+||+||+|++ .|+.||||+++.....                ......+..|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4689999999999999986 5788999998743211                1112345678899999999999998876


Q ss_pred             eeCCCCceeEEEecCCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEEeeccc
Q 010680          287 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA  366 (504)
Q Consensus       287 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH~~~IiHrDLkp~NILl~~~~~vkL~DFGla  366 (504)
                      ..    .+++|||+++..+.        .++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.|
T Consensus        83 ~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a  149 (191)
T d1zara2          83 EG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS  149 (191)
T ss_dssp             ET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred             cC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence            42    47999999876543        25566678899999999999999999999999999999965 4899999999


Q ss_pred             eeccCCCccccCCCCCCccCc--cc---ccCCCCCchhHHHHHHHHH
Q 010680          367 RVKAQSGVMTAETGTYRWMAP--EV---IEHKPYDHKADVFSFGIVL  408 (504)
Q Consensus       367 ~~~~~~~~~~~~~gt~~y~AP--E~---l~~~~~s~ksDVwSlGvvL  408 (504)
                      +....+....       |...  +.   +..+.|+.++|+||+.--+
T Consensus       150 ~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         150 VEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            7655432211       1111  00   1235688899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.1e-07  Score=87.64  Aligned_cols=139  Identities=12%  Similarity=0.093  Sum_probs=92.2

Q ss_pred             ceeeeeeeeeeCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEEeeeCCCCceeEEEec
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM  300 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  300 (504)
                      .+++.+..+-++.+.||+.+..++.+.+|+........  ...+.+|...++.+. +--+++++.++..++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            44555554445557899998888889999876543221  234677888888775 333677888888888889999999


Q ss_pred             CCCchHHHHHhhcccCChHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 010680          301 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------------------------------------------  336 (504)
Q Consensus       301 ~ggsL~~~l~~~~~~l~~~~~~~i~~qI~~gL~yLH--------------------------------------------  336 (504)
                      +|.++.+....      ......++.++.+.+..||                                            
T Consensus        93 ~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            99877554311      0111122223333333333                                            


Q ss_pred             ---------HC------CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          337 ---------QN------NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       337 ---------~~------~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                               ..      .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                     11      279999999999999877777999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=2.3e-05  Score=72.68  Aligned_cols=136  Identities=13%  Similarity=0.155  Sum_probs=83.5

Q ss_pred             eeeeeCc-eEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEEeeeCCCCceeEEEecCCC
Q 010680          228 KVASGSY-GDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG  303 (504)
Q Consensus       228 ~LG~G~f-G~Vy~~~~~g-~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg  303 (504)
                      .+..|.. +.||+.+..+ ..+++|.-.....     ..+..|+..|+.+..  -.+++++.++..++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3344543 6789988765 4578888765432     235678888877753  23677888888888889999999887


Q ss_pred             chHHH--------------HHhhc------ccCC--hHHHHHHH--------------------HHHHHHHHHHHHC---
Q 010680          304 SVYDY--------------LHKLK------GVFK--LPSLLKVA--------------------IDVSKGMNYLHQN---  338 (504)
Q Consensus       304 sL~~~--------------l~~~~------~~l~--~~~~~~i~--------------------~qI~~gL~yLH~~---  338 (504)
                      ++.+.              +.+..      ..+.  ......-.                    ......+..+..+   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            65321              11110      0000  00000000                    0112223333332   


Q ss_pred             ----CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          339 ----NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       339 ----~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                          .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                379999999999999877788999998854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.66  E-value=6.5e-05  Score=75.15  Aligned_cols=77  Identities=12%  Similarity=0.012  Sum_probs=48.2

Q ss_pred             eeeeeeCceEEEEEEEC--CccEEEEEecCCC-CC----hHHHHHHHHHHHHHHhcC---CCCceEEEEeeeCCCCceeE
Q 010680          227 SKVASGSYGDLYRGTYC--SQDVAIKVLKPER-IN----SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV  296 (504)
Q Consensus       227 ~~LG~G~fG~Vy~~~~~--g~~VAvK~lk~~~-~~----~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV  296 (504)
                      +.||.|....||+.+..  ++.|+||.-.+.. ..    .....+...|...|+.+.   ...+++++.+.  +...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            46899999999998753  5678999754321 00    011223456777777664   24567777654  3456799


Q ss_pred             EEecCCCch
Q 010680          297 TEFMSGGSV  305 (504)
Q Consensus       297 ~E~~~ggsL  305 (504)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.91  E-value=0.0014  Score=63.31  Aligned_cols=129  Identities=15%  Similarity=0.132  Sum_probs=73.5

Q ss_pred             eEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce--EEEE-----eeeCCCCceeEEEecCCCchH
Q 010680          235 GDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV--QFIG-----ACTKPPSLCIVTEFMSGGSVY  306 (504)
Q Consensus       235 G~Vy~~~~-~g~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~HpnIv--~l~~-----~~~~~~~~~lV~E~~~ggsL~  306 (504)
                      -.||+.+. .|+.|++|+.++...+.   +++..|...+..|...+|.  ..+.     .....+..+.++++++|..+.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            46999876 57789999998775543   4566788888777533221  1111     112344567889998764321


Q ss_pred             -----HH------H---Hhh--------cccC-------------------ChHHHHHHHHHHHHHHHHHHH-------C
Q 010680          307 -----DY------L---HKL--------KGVF-------------------KLPSLLKVAIDVSKGMNYLHQ-------N  338 (504)
Q Consensus       307 -----~~------l---~~~--------~~~l-------------------~~~~~~~i~~qI~~gL~yLH~-------~  338 (504)
                           .+      +   +..        +..+                   +......+...+-..++.+..       .
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 11      1   110        0011                   111111222222333333332       3


Q ss_pred             CceeccCCCCcEEECCCCcEEEEeecccee
Q 010680          339 NIIHRDLKAANLLMDENEVVKVADFGVARV  368 (504)
Q Consensus       339 ~IiHrDLkp~NILl~~~~~vkL~DFGla~~  368 (504)
                      ++||+|+.+.|||++++  ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            68999999999999743  45899999864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.36  E-value=0.0053  Score=60.59  Aligned_cols=75  Identities=15%  Similarity=0.299  Sum_probs=49.3

Q ss_pred             ceeeeeeeeeeCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEEeeeCCC
Q 010680          222 HLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP  291 (504)
Q Consensus       222 ~~~i~~~LG~G~fG~Vy~~~~~g---------~~VAvK~lk~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~  291 (504)
                      .+++ +.|+-|-.=.+|+.+..+         +.|.+++.-..  ..  .....+|..+++.+.-.+ .+++++++.+  
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~--  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG--  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence            3443 467878888899988643         34666665421  11  234557888988886334 4578887753  


Q ss_pred             CceeEEEecCCCch
Q 010680          292 SLCIVTEFMSGGSV  305 (504)
Q Consensus       292 ~~~lV~E~~~ggsL  305 (504)
                        .+|+||++|.+|
T Consensus       117 --g~I~efi~g~~l  128 (395)
T d1nw1a_         117 --GRLEEYIPSRPL  128 (395)
T ss_dssp             --EEEECCCCEEEC
T ss_pred             --ceEEEEeccccC
Confidence              589999987544

>d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=96.26  E-value=0.0031  Score=48.73  Aligned_cols=65  Identities=15%  Similarity=0.227  Sum_probs=48.8

Q ss_pred             eeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHHHH
Q 010680          110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK  176 (504)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~  176 (504)
                      =|++.+.|+|+++++++.+|++.|.||.+...+..-+-+.+ ++.|. ++....++|+.+|++-..+
T Consensus         7 vitv~G~DrpGiva~vt~~l~~~g~NI~d~~~~~~~~~~~~-~~~v~-~~~~~~~~l~~~L~~l~~~   71 (86)
T d1u8sa1           7 VITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLIS-GSPSNITRVETTLPLLGQQ   71 (86)
T ss_dssp             EEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE-ECHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCChHHHHHHHHHHHCCCeEEEeEeEEECCeeEE-EEEEE-cCcccHHHHHHHHHHHHHH
Confidence            38899999999999999999999999999877655443333 33344 4556677788877765544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.18  E-value=0.011  Score=55.83  Aligned_cols=30  Identities=30%  Similarity=0.406  Sum_probs=27.3

Q ss_pred             CCceeccCCCCcEEECCCCcEEEEeeccce
Q 010680          338 NNIIHRDLKAANLLMDENEVVKVADFGVAR  367 (504)
Q Consensus       338 ~~IiHrDLkp~NILl~~~~~vkL~DFGla~  367 (504)
                      .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999998878999999985

>d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: SP0238-like
domain: UPF0237 protein SP0238
species: Streptococcus pneumoniae [TaxId: 1313]

Probab=96.06  E-value=0.0053  Score=46.86  Aligned_cols=65  Identities=22%  Similarity=0.274  Sum_probs=48.5

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHHHHHH
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK  176 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~~~~~  176 (504)
                      ||+++.|+|++++.+|.+|++.|.||.+...+...+-|..-+ .++.-...+.++++++|+....+
T Consensus         5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~~-~v~~~~~~~~~~l~~~l~~la~~   69 (83)
T d1zpva1           5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMA-VVSSDEKQDFTYLRNEFEAFGQT   69 (83)
T ss_dssp             EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEE-EEEESSCCCHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEeCCEEEEEE-EEEEecCCCHHHHHHHHHHHHHH
Confidence            789999999999999999999999999998876544444433 34322233577888888765444

>d1u8sa2 d.58.18.5 (A:88-180) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Glycine cleavage system transcriptional repressor
domain: putative transcriptional repressor VC2159
species: Vibrio cholerae [TaxId: 666]

Probab=92.89  E-value=0.12  Score=39.72  Aligned_cols=67  Identities=16%  Similarity=0.146  Sum_probs=45.3

Q ss_pred             eeeeecCChhhHHHHHHHHHhhccccceeccccccC---CC-----ceeeeEeecCCChhhHHHHHHHHHHHHHHh
Q 010680          110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV---DG-----YSLDVFVVDGWPYEETEQLRAALEKEVLKL  177 (504)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~---dg-----~~ldv~~v~~~~~~~~~~l~~~l~~~~~~~  177 (504)
                      +|++.+.|+|++++++|.+|++.|.||.+.......   .+     |...+- +..-.....++|+++|+.-..++
T Consensus         8 ~v~v~g~DrpGIV~~it~~la~~~~nI~~l~t~~~~a~~~~~~~~~f~~~~~-~~~p~~~~~~~l~~~l~~l~~~l   82 (93)
T d1u8sa2           8 EVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAIS-ARVDSGCNLMQLQEEFDALCTAL   82 (93)
T ss_dssp             EEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEE-EEECTTSCHHHHHHHHHHHHHHH
T ss_pred             EEEEEECCCCCHHHHHHHHHHHcCCCchhhhcccccccCCcccCccEEEEEE-EEcCccccHHHHHHHHHHHHHHc
Confidence            888999999999999999999999999886544311   11     222221 11112235678888887766554

>d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=89.54  E-value=0.33  Score=35.37  Aligned_cols=56  Identities=16%  Similarity=0.223  Sum_probs=45.1

Q ss_pred             eeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeecCCChhhHHHHHHHHHH
Q 010680          111 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK  172 (504)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~~~~~~~~~~l~~~l~~  172 (504)
                      |.+.-.|+|+-|..+.++|++-|.||.-..+|.+. +...-+|.||     +.+..++.|++
T Consensus         2 iaV~v~d~pG~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~   57 (71)
T d2f06a1           2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKE   57 (71)
T ss_dssp             EEEEEESSTTHHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHH
T ss_pred             EEEEecCCccHHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHH
Confidence            34556799999999999999999999999999986 6888888876     44555555554

>d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=88.53  E-value=0.82  Score=33.70  Aligned_cols=53  Identities=21%  Similarity=0.208  Sum_probs=42.2

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceecccccc-CCCceeeeEeecCCChh
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPYE  161 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t-~dg~~ldv~~v~~~~~~  161 (504)
                      |=+.+.-.|+|+.+.+++++|++-|.||...++.-. ..|.+.-++.+|+-..+
T Consensus         4 ~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~~   57 (78)
T d1ygya3           4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPD   57 (78)
T ss_dssp             EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCCH
T ss_pred             eEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCccH
Confidence            446677789999999999999999999999888654 45567777777775543

>d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: AF1403 N-terminal domain-like
domain: Hypothetical protein AF1403, N-terminal domain
species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]

Probab=88.00  E-value=0.11  Score=38.77  Aligned_cols=46  Identities=24%  Similarity=0.312  Sum_probs=35.0

Q ss_pred             eeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEee
Q 010680          110 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV  155 (504)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v  155 (504)
                      .|.+...|+|++|+.++.++++-+.||...+.+...+|.+--.+.+
T Consensus         3 ~i~i~~~Dr~GlL~di~~~ia~~~~NI~~i~~~~~~~g~~~~~~~i   48 (77)
T d1y7pa2           3 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALI   48 (77)
T ss_dssp             EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEE
T ss_pred             eEEEEEecCCChHHHHHHHHHHcCCCeEEEEeeccCCCeEEEEEEE
Confidence            5788899999999999999999999999999888777765444443

>d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: BT0572-like
domain: Hypothetical protein BT0572
species: Bacteroides thetaiotaomicron [TaxId: 818]

Probab=86.76  E-value=0.88  Score=32.89  Aligned_cols=48  Identities=17%  Similarity=0.276  Sum_probs=40.8

Q ss_pred             ceeeeeecCChhhHHHHHHHHHhhccccceeccccccCCCceeeeEeec
Q 010680          108 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD  156 (504)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~dg~~ldv~~v~  156 (504)
                      ++.|.+-..|+|+.|.+++.+|++-|.||.--.++.|.+ +.+--++||
T Consensus         3 ~~QisV~~eNkpG~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~   50 (70)
T d2f06a2           3 AKQLSIFLENKSGRLTEVTEVLAKENINLSALCIAENAD-FGILRGIVS   50 (70)
T ss_dssp             EEEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEES
T ss_pred             eEEEEEEEeCCCcHHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEEC
Confidence            467888889999999999999999999999988888876 555556776

>d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Ferredoxin-like
superfamily: ACT-like
family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
species: Escherichia coli [TaxId: 562]

Probab=86.75  E-value=0.52  Score=35.30  Aligned_cols=38  Identities=18%  Similarity=0.423  Sum_probs=34.1

Q ss_pred             eeeeeecCChhhHHHHHHHHHhhccccceeccccccCC
Q 010680          109 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD  146 (504)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a~~f~t~d  146 (504)
                      |=+++.-.|+|+.|.+++++|++-|+||..-+.-+.-+
T Consensus        12 ~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~   49 (84)
T d1sc6a3          12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQ   49 (84)
T ss_dssp             EEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSS
T ss_pred             eEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCC
Confidence            67888899999999999999999999999987766665